MOLECULAR DETECTION OF FOODBORNE PATHOGENS
MOLECULAR DETECTION OF FOODBORNE PATHOGENS EDITED BY
DONGYOU LIU
Boca Ra...
226 downloads
2232 Views
12MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
MOLECULAR DETECTION OF FOODBORNE PATHOGENS
MOLECULAR DETECTION OF FOODBORNE PATHOGENS EDITED BY
DONGYOU LIU
Boca Raton London New York
CRC Press is an imprint of the Taylor & Francis Group, an informa business
CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2010 by Taylor and Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Printed in the United States of America on acid-free paper 10 9 8 7 6 5 4 3 2 1 International Standard Book Number: 978-1-4200-7643-1 (Hardback) This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and information, but the author and publisher cannot assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint. Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers. For permission to photocopy or use material electronically from this work, please access www.copyright.com (http://www.copyright.com/) or contact the Copyright Clearance Center, Inc. (CCC), 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400. CCC is a not-for-profit organization that provides licenses and registration for a variety of users. For organizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged. Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent to infringe. Library of Congress Cataloging-in-Publication Data Molecular detection of foodborne pathogens / [edited by] Dongyou Liu. p. ; cm. Includes bibliographical references and index. ISBN 978-1-4200-7643-1 (hard back : alk. paper) 1. Foodborne diseases--Molecular diagnosis. 2. Food--Microbiology. I. Liu, Dongyou. II. Title. [DNLM: 1. Food Contamination--analysis. 2. Food Poisoning--microbiology. 3. Molecular Diagnostic Techniques--methods. WA 701 M718 2009] QR201.F62M65 2009 615.9’54--dc22 Visit the Taylor & Francis Web site at http://www.taylorandfrancis.com and the CRC Press Web site at http://www.crcpress.com
2009017320
This book is dedicated to my parents, Jiaye Liu and Yunlian Li, whose unselfish sacrifice and unrelenting love have been a constant source of inspiration in my pursuit of knowledge and betterment.
Contents Preface........................................................................................................................................................................................xiii Editor........................................................................................................................................................................................... xv Contributors...............................................................................................................................................................................xvii Chapter 1. Molecular Detection: Principles and Methods......................................................................................................... 1 Lisa Gorski and Andrew Csordas
Section I Foodborne Viruses Chapter 2. Adenoviruses.......................................................................................................................................................... 23 Charles P. Gerba and Roberto A. Rodríguez Chapter 3. Astroviruses........................................................................................................................................................... 33 Edina Meleg and Ferenc Jakab Chapter 4. Avian Influenza Virus............................................................................................................................................ 49 Giovanni Cattoli and Isabella Monne Chapter 5. Hepatitis A and E Viruses...................................................................................................................................... 63 Hiroshi Ushijima, Pattara Khamrin, and Niwat Maneekarn Chapter 6. Noroviruses............................................................................................................................................................ 75 Anna Charlotte Schultz, Jan Vinjé, and Birgit Nørrung Chapter 7. Rotaviruses............................................................................................................................................................. 91 Dongyou Liu, Larry A. Hanson, and Lesya M. Pinchuk Chapter 8. Sapoviruses...........................................................................................................................................................101 Grant S. Hansman Chapter 9. Slow Viral Diseases..............................................................................................................................................113 Takashi Onodera, Guangai Xue, Akikazu Sakudo, Gianluigi Zanusso, and Katsuaki Sugiura
Section II Foodborne Gram-Positive Bacteria Chapter 10. Bacillus................................................................................................................................................................. 129 Noura Raddadi, Aurora Rizzi, Lorenzo Brusetti, Sara Borin, Isabella Tamagnini, and Daniele Daffonchio
vii
viii
Contents
Chapter 11. Clostridium.......................................................................................................................................................... 145 Annamari Heikinheimo, Miia Lindström, Dongyou Liu, and Hannu Korkeala Chapter 12. Enterococcus........................................................................................................................................................ 157 Teresa Semedo-Lemsaddek, Rogério Tenreiro, Paula Lopes Alves, and Maria Teresa Barreto Crespo Chapter 13. Helicobacter..........................................................................................................................................................181 Norihisa Noguchi Chapter 14. Kocuria................................................................................................................................................................. 201 Edoardo Carretto and Daniela Barbarini Chapter 15. Listeria................................................................................................................................................................. 207 Dongyou Liu and Hans-Jürgen Busse Chapter 16. Micrococcus......................................................................................................................................................... 221 Friederike Hilbert and Hans-Jürgen Busse Chapter 17. Mycobacterium..................................................................................................................................................... 229 Irene R. Grant and Catherine E.D. Rees Chapter 18. Staphylococcus..................................................................................................................................................... 245 Paolo Moroni, Giuliano Pisoni, Paola Cremonesi, and Bianca Castiglioni Chapter 19. Streptococcus....................................................................................................................................................... 259 Mark van der Linden, Romney S. Haylett, Ralf René Reinert, and Lothar Rink
Section III Foodborne Gram-Negative Bacteria Chapter 20. Aeromonas............................................................................................................................................................ 273 Germán Naharro, Jorge Riaño, Laura de Castro, Sonia Alvarez, and José María Luengo Chapter 21. Arcobacter............................................................................................................................................................ 289 Kurt Houf Chapter 22. Bacteriodes........................................................................................................................................................... 307 Rama Chaudhry, Anubhav Pandey, and Nidhi Sharma Chapter 23. Brucella.................................................................................................................................................................317 Sascha Al Dahouk, Karsten Nöckler, and Herbert Tomaso Chapter 24. Burkholderia.........................................................................................................................................................331 Karlene H. Lynch and Jonathan J. Dennis
ix
Contents
Chapter 25. Campylobacter..................................................................................................................................................... 345 Aurora Fernández Astorga and Rodrigo Alonso Chapter 26. Enterobacter......................................................................................................................................................... 361 Angelika Lehner, Roger Stephan, Carol Iversen, and Seamus Fanning Chapter 27. Escherichia........................................................................................................................................................... 369 Devendra H. Shah, Smriti Shringi, Thomas E. Besser, and Douglas R. Call Chapter 28. Klebsiella.............................................................................................................................................................. 391 Beatriz Meurer Moreira, Marco Antonio Lemos Miguel, Angela Christina Dias de Castro, Maria Silvana Alves, and Rubens Clayton da Silva Dias Chapter 29. Plesiomonas......................................................................................................................................................... 405 Jesús A. Santos, Andrés Otero, and María-Luisa García-López Chapter 30. Proteus..................................................................................................................................................................417 Antoni Róz∙alski and Paweł Sta˛ czek Chapter 31. Pseudomonas........................................................................................................................................................431 Olga Zaborina and John Alverdy Chapter 32. Salmonella............................................................................................................................................................ 447 Charlotta Löfström, Jeffrey Hoorfar, Jenny Schelin, Peter Rådström, and Burkhard Malorny Chapter 33. Serratia................................................................................................................................................................. 459 Zhi-Qing Hu, Wei-Hua Zhao, and Zhuting Hu Chapter 34. Shigella................................................................................................................................................................. 471 Benjamin R. Warren, Keith A. Lampel, and Keith R. Schneider Chapter 35. Vibrio.................................................................................................................................................................... 485 Asim K. Bej Chapter 36. Yersinia................................................................................................................................................................. 501 Mikael Skurnik, Peter Rådström, Rickard Knutsson, Bo Segerman, Saija Hallanvuo, Susanne Thisted Lambertz, Hannu Korkeala, and Maria Fredriksson-Ahomaa
Section IV Foodborne Fungi Chapter 37. Alternaria............................................................................................................................................................. 521 Dongyou Liu, Stephen B. Pruett, and Cody Coyne Chapter 38. Aspergillus............................................................................................................................................................ 529 Giancarlo Perrone, Antonia Gallo, and Antonia Susca
x
Contents
Chapter 39. Candida................................................................................................................................................................ 549 P. Lewis White, Samantha J. Hibbitts, Michael D. Perry, and Rosemary A. Barnes Chapter 40. Debaryomyces...................................................................................................................................................... 565 Juan J. Córdoba, Maria J. Andrade, Elena Bermúdez, Félix Núñez, Miguel A. Asensio, and Mar Rodríguez Chapter 41. Fusarium.............................................................................................................................................................. 577 Antonio Moretti and Antonia Susca Chapter 42. Penicillium........................................................................................................................................................... 593 Joëlle Dupont Chapter 43. Rhodotorula......................................................................................................................................................... 603 Diego Libkind and José Paulo Sampaio Chapter 44. Saccharomyces......................................................................................................................................................619 Franca Rossi and Sandra Torriani
Section V Foodborne Protozoa Chapter 45. Acanthamoeba...................................................................................................................................................... 639 Hélène Yera, Pablo Goldschmidt, Christine Chaumeil, Muriel Cornet, and Marie-Laure Dardé Chapter 46. Cryptosporidium.................................................................................................................................................. 651 Una Ryan and Simone M. Cacciò Chapter 47. Cyclospora........................................................................................................................................................... 667 Dongyou Liu, G. Todd Pharr, and Frank W. Austin Chapter 48. Entamoeba........................................................................................................................................................... 677 Damien Stark and John Ellis Chapter 49. Encephalitozoon and Enterocytozoon................................................................................................................. 691 Jaco J. Verweij and Dongyou Liu Chapter 50. Giardia................................................................................................................................................................. 701 Yaoyu Feng and Lihua Xiao Chapter 51. Isospora.................................................................................................................................................................717 Somchai Jongwutiwes and Chaturong Putaporntip
xi
Contents
Chapter 52. Sarcocystis........................................................................................................................................................... 731 Benjamin M. Rosenthal Chapter 53. Toxoplasma...........................................................................................................................................................741 Chunlei Su and J.P. Dubey
Section VI Foodborne Helminthes Chapter 54. Anisakis................................................................................................................................................................ 757 Stefano D’Amelio, Marina Busi, Sofia Ingrosso, Lia Paggi, and Elisabetta Giuffra Chapter 55. Clonorchis............................................................................................................................................................ 769 Heinz Mehlhorn, Boris Müller, and Jürgen Schmidt Chapter 56. Diphyllobothrium . .............................................................................................................................................. 781 Jean Dupouy-Camet and Hélène Yera Chapter 57. Fasciola................................................................................................................................................................ 789 Xing-Quan Zhu, Qing-Jun Zhuang, Rui-Qing Lin, and Wei-Yi Huang Chapter 58. Heterophyidae...................................................................................................................................................... 795 Ron Dzikowski and Michael G. Levy Chapter 59. Metagonimus........................................................................................................................................................ 805 Jae-Ran Yu and Jong-Yil Chai Chapter 60. Opisthorchis......................................................................................................................................................... 813 Paiboon Sithithaworn, Thewarach Laha, and Ross H. Andrews Chapter 61. Paragonimus........................................................................................................................................................ 827 Kanwar Narain, Takeshi Agatsuma, and David Blair Chapter 62. Taenia................................................................................................................................................................... 839 Akira Ito, Minoru Nakao, Yasuhito Sako, Kazuhiro Nakaya, Tetsuya Yanagida, and Munehiro Okamoto Chapter 63. Trichinella............................................................................................................................................................ 851 Edoardo Pozio and Giuseppe La Rosa Index.......................................................................................................................................................................................... 865
Preface Foodborne pathogens are microorganisms (e.g., bacteria, viruses, fungi, and parasites) that are capable of infecting humans via contaminated food and/or water. In recent years, diseases caused by foodborne pathogens have become an important public health problem worldwide, resulting in significant morbidity and mortality. Currently, there are over 250 known foodborne diseases. Due to the introduction of pathogens to other geographic regions through population movement and globalization of the food supply, new foodborne infections are continuously emerging. Furthermore, pathogen evolution, changes in human immune status and life-style as well as food manufacturing practices also contribute to increased incidences of foodborne illnesses. As a consequence, large outbreaks of foodborne diseases have been reported with alarming frequencies. It is well known that one of the most effective ways to control and prevent human foodborne infections is to implement a surveillance system that includes a capability to rapidly and precisely detect, identify, and monitor foodborne pathogens at the nucleic acid level. The purpose of this book is to bring out an all-encompassing volume on the detection and identification of major foodborne bacterial, fungal, viral, and parasitic pathogens using state-of-art molecular techniques. Each chapter includes a concise review of the pathogen concerned with respect to its biology, epidemiology, and pathogenesis; a summary of the molecular detection methods available; a description of clinical/food sample collection and preparation procedures; a selection of robust, effective, step-wise molecular detection protocols for each pathogen; and a discussion on the challenges and continuing research needs to further extend the utility and performance of molecular diagnostic methods for foodborne diseases. With each chapter written by scientists with expertise in their respective foodborne pathogen research, this book provides comprehensive coverage of the molecular methodologies for the detection and identification of major foodborne pathogens. It is an indispensable tool for clinical, food, and industrial laboratory scientists involved in the diagnosis of foodborne diseases; a convenient textbook for prospective undergraduate and graduate students intending to pursue a career in food microbiology and medical technology; and a reliable reference for upcoming and experienced laboratory scientists wishing to develop and polish their skills in the molecular detection of major foodborne pathogens. Given the number of foodborne pathogens covered, and the breadth and depth of the topics discussed, an inclusive book like this is undoubtedly beyond the capacity of an individual’s effort. It is my fortune and honor to have a large panel of international scientists as chapter contributors, whose willingness to share their technical insights on foodborne pathogen detection has made this book possible. Moreover, the professionalism and dedication of senior editor, Steve Zollo, and other editorial staff at CRC Press have contributed to its enhanced presentation. I hope the readers will find it as stimulating and rewarding as I do through reading this book, which by presenting relevant background information and ready-to-run molecular detection protocols will serve to save readers’ time and patients’ lives. Dongyou Liu, PhD
xiii
Editor Dongyou Liu, PhD, is currently a member of the research faculty in the Department of Basic Sciences, College of Veterinary Medicine at Mississippi State University in Starkville. In 1982, he graduated with a veterinary science degree from Hunan Agricultural University in China. After one year of postgraduate training under the supervision of Professor Kong Fangyao at Beijing Agricultural University (presently China Agricultural University) in China, he completed his PhD study on the immunological diagnosis of human hydatid disease due to the parasitic tapeworm Echinococcus granulosus in the laboratory of Drs. Michael D. Rickard and Marshall W. Lightowlers at the University of Melbourne School of Veterinary Science in Australia in 1989. During the past two decades, he has worked in several research and clinical laboratories in Australia and the United States, with an emphasis on molecular microbiology, especially in the development of nucleic acid-based assays for species- and virulence-specific determination of microbial pathogens such as ovine footrot bacterium (Dichelobacter nodosus), dermatophyte fungi (Trichophyton, Microsporum, and Epidermophyton), and listeriae (Listeria species). He is the editor of the Handbook of Listeria monocytogenes and the Handbook of Nucleic Acid Purification, both of which have been published recently by Taylor & Francis/CRC Press.
xv
Contributors Takeshi Agatsuma Department of Environmental Health Sciences Kochi Medical School Nankoku City, Kochi, Japan Rodrigo Alonso Departamento de Inmunología, Microbiología y Parasitología Facultad de Farmacia Universidad del Pais Vasco/Euskal Herriko Unibertsitatea Vitoria-Gasteiz, Spain Sonia Alvarez Department of Animal Health University of León León, Spain John Alverdy Center for Surgical Infection Research and Therapeutics University of Chicago Chicago, Illinois Maria Silvana Alves Faculdade de Farmácia e Bioquímica Universidade Federal de Juiz de Fora Minas Gerais, Brazil Paula Lopes Alves Instituto de Biologia Experimental e Tecnológica (IBET) Av. da República, Quinta do Marquês Oeiras, Portugal M.J. Andrade Higiene y Seguridad Alimentaria Facultad de Veterinaria Universidad de Extremadura Cáceres, Spain Ross H. Andrews School of Pharmacy and Medical Sciences University of South Australia Adelaide, Australia M.A. Asensio Higiene y Seguridad Alimentaria Facultad de Veterinaria Universidad de Extremadura Cáceres, Spain
Aurora Fernández Astorga Departamento de Inmunología, Microbiología y Parasitología Facultad de Farmacia Universidad del Pais Vasco/Euskal Herriko Unibertsitatea Vitoria-Gasteiz, Spain Frank W. Austin Department of Basic Sciences College of Veterinary Medicine Mississippi State University Mississippi State, Mississippi Daniela Barbarini Bacteriology Laboratory Infectious Diseases, Laboratories of Experimental Researches Fondazione “IRCCS Policlinico San Matteo” Pavia, Italy Rosemary A. Barnes Department of Medical Microbiology Cardiff University University Hospital of Wales Cardiff, Wales, United Kingdom Asim K. Bej Department of Biology University of Alabama at Birmingham Birmingham, Alabama E. Bermúdez Higiene y Seguridad Alimentaria Facultad de Veterinaria Universidad de Extremadura Cáceres, Spain Thomas E. Besser Department of Veterinary Microbiology and Pathology College of Veterinary Medicine Washington State University Pullman, Washington David Blair School of Marine and Tropical Biology James Cook University Townsville, Australia Sara Borin Department of Food Science and Microbiology University of Milan Milan, Italy xvii
xviii
Contributors
Lorenzo Brusetti Department of Food Science and Microbiology University of Milan Milan, Italy
Jong-Yil Chai Department of Parasitology and Tropical Medicine Seoul National University College of Medicine Seoul, Korea
Marina Busi Department of Public Health Science Sapienza University of Rome Rome, Italy
Rama Chaudhry Department of Microbiology All India Institute of Medical Sciences New Delhi, India
Hans-Jürgen Busse Institute of Bacteriology, Mycology and Hygiene University of Veterinary Medicine Vienna, Austria
Christine Chaumeil Laboratoire du Centre National d’Ophtalmologie des Quinze-Vingts Paris, France
Simone M. Cacciò Department of Infectious, Parasitic and Immunomediated Diseases Istituto Superiore di Sanità Rome, Italy
J.J. Córdoba Higiene y Seguridad Alimentaria Facultad de Veterinaria Universidad de Extremadura Cáceres, Spain
Douglas R. Call Department of Veterinary Microbiology and Pathology College of Veterinary Medicine Washington State University Pullman, Washington
Muriel Cornet Laboratoire de Microbiologie Hôpital Hôtel-Dieu Paris, France
Edoardo Carretto Bacteriology Laboratory Infectious Diseases, Laboratories of Experimental Researches Fondazione “IRCCS Policlinico San Matteo” Pavia, Italy Bianca Castiglioni Institute of Agricultural Biology and Biotechnology Italian National Research Council Milan, Italy Angela Christina Dias de Castro Instituto de Microbiologia Universidade Federal do Rio de Janeiro Rio de Janeiro, Brazil Laura de Castro Department of Animal Health University of León León, Spain Giovanni Cattoli Istituto Zooprofilattico Sperimentale delle Venezie Research and Development Department OIE/FAO and National Reference Laboratory for Newcastle Disease and Avian Influenza OIE Collaborating Center for Epidemiology, Training and Control of Emerging Avian Diseases Legnaro, Padova, Italy
Cody Coyne Department of Basic Sciences College of Veterinary Medicine Mississippi State University Mississippi State, Mississippi Paola Cremonesi Institute of Agricultural Biology and Biotechnology Italian National Research Council Milan, Italy Maria Teresa Barreto Crespo Instituto de Biologia Experimental e Tecnológica (IBET) Av. da República, Quinta do Marquês Oeiras, Portugal Andrew Csordas Institute for Collaborative Biotechnologies University of California, Santa Barbara Santa Barbara, California Daniele Daffonchio Department of Food Science and Microbiology University of Milan Milan, Italy Sascha Al Dahouk Department of Internal Medicine III RWTH Aachen University Aachen, Germany
xix
Contributors
Stefano D’Amelio Department of Public Health Science Sapienza University of Rome Rome, Italy
Yaoyu Feng School of Resource and Environmental Engineering East China University of Science and Technology Shanghai, People’s Republic of China
Marie-Laure Dardé Laboratoire de Parasitologie-Mycologie CHU Limoges, France
Maria Fredriksson-Ahomaa Institute of Hygiene and Technology of Food of Animal Origin Ludwig-Maximilian University Munich, Germany
Jonathan J. Dennis Department of Biological Sciences University of Alberta Edmonton, Alberta, Canada Rubens Clayton da Silva Dias Division of Infectious Diseases and Immunity School of Public Health University of California Berkeley, California J.P. Dubey United States Department of Agriculture, Agricultural Research Service Animal and Natural Resources Institute Animal Parasitic Diseases Laboratory Beltsville, Maryland Joëlle Dupont Muséum National d’Histoire Naturelle Département Systématique et Evolution Paris, France Jean Dupouy-Camet Laboratoire de Parasitologie-Mycologie Hôpital Cochin AP-H Université Paris Descartes Paris, France Ron Dzikowski Department of Microbiology & Molecular Genetics The Kuvin Center for the Study of Infectious and Tropical Diseases The Institute for Medical Research Israel-Canada The Hebrew University–Hadassah Medical School Jerusalem, Israel John Ellis Department of Medical and Molecular Biosciences University of Technology Sydney Broadway, Australia Seamus Fanning Centre for Food Safety, School of Agriculture, Food Science and Veterinary Medicine Veterinary Sciences Centre University College Dublin Dublin, Ireland
Antonia Gallo Institute of Sciences of Food Production National Research Council (ISPA-CNR) Bari, Italy María-Luisa García-López Department of Food Hygiene and Food Microbiology University of León León, Spain Charles P. Gerba Department of Soil, Water and Environmental Science University of Arizona Tucson, Arizona Elisabetta Giuffra Parco Tecnologico Padano Lodi, Italy Pablo Goldschmidt Laboratoire du Centre National d’Ophtalmologie des Quinze-Vingts Paris, France Lisa Gorski Produce Safety and Microbiology Research Unit United States Department of Agriculture Agricultural Research Service Western Regional Research Center Albany, California Irene R. Grant School of Biological Sciences Queen’s University Belfast Belfast, Northern Ireland, United Kingdom Saija Hallanvuo Department of Animal Diseases and Food Safety Research Finnish Food Safety Authority Evira Helsinki, Finland Grant S. Hansman Department of Virology II National Institute of Infectious Diseases Musashi-murayama Tokyo, Japan
xx
Larry A. Hanson Department of Basic Sciences College of Veterinary Medicine Mississippi State University Mississippi State, Mississippi Romney S. Haylett Institute of Immunology RWTH Aachen University Hospital Aachen, Germany Annamari Heikinheimo Department of Food and Environmental Hygiene University of Helsinki Helsinki, Finland Samantha J. Hibbitts Department of Obstetrics and Gynaecology Cardiff University University Hospital of Wales Cardiff, Wales, United Kingdom Friederike Hilbert Institute of Meat Hygiene, Meat Technology and Food Science University of Veterinary Medicine Vienna, Austria Jeffrey Hoorfar National Food Institute Technical University of Denmark Søborg, Denmark Kurt Houf Department of Veterinary Public Health and Food Safety Ghent University Merelbeke, Belgium Zhi-Qing Hu Department of Microbiology and Immunology Showa University School of Medicine Tokyo, Japan Zhuting Hu Department of Biology International Christian University Tokyo, Japan
Contributors
Akira Ito Department of Parasitology Asahikawa Medical College Asahikawa, Japan Carol Iversen Centre for Food Safety, School of Agriculture, Food Science and Veterinary Medicine Veterinary Sciences Centre University College Dublin Dublin, Ireland Ferenc Jakab Department of Genetics and Molecular Biology Institute of Biology, Faculty of Sciences University of Pécs Pécs, Hungary Somchai Jongwutiwes Molecular Biology of Malaria and Opportunistic Parasites Research Unit Department of Parasitology Chulalongkorn University Bangkok, Thailand Pattara Khamrin Aino Health Science Center Aino University Tokyo, Japan Rickard Knutsson Department of Bacteriology National Veterinary Institute Uppsala, Sweden Hannu Korkeala Department of Food and Environmental Hygiene University of Helsinki Helsinki, Finland Thewarach Laha Department of Parasitology Liver Fluke and Cholangiocarcinoma Research Center Khon Kaen University Khon Kaen, Thailand
Wei-Yi Huang Department of Veterinary Medicine College of Animal Science and Technology Guangxi University Nanning, Guangxi, People’s Republic of China
Susanne Thisted Lambertz Research and Development Department National Food Administration Uppsala, Sweden
Sofia Ingrosso Department of Public Health Science Sapienza University of Rome Rome, Italy
Keith A. Lampel Food and Drug Administration Division of Microbiology College Park, Maryland
xxi
Contributors
Angelika Lehner Institute for Food Safety and Hygiene University of Zurich Zurich, Switzerland
Burkhard Malorny Federal Institute for Risk Assessment National Salmonella Reference Laboratory Berlin, Germany
Michael G. Levy Department of Population Health and Pathobiology College of Veterinary Medicine North Carolina State University Raleigh, North Carolina
Niwat Maneekarn Department of Microbiology, Chiang Mai University Chiang Mai, Thailand
Diego Libkind Laboratorio de Microbiología Aplicada y Biotecnología Instituto de Investigaciones en Biodiversidad y Medio Ambiente (INIBIOMA) Universidad Nacional del Comahue CRUB – Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET) Bariloche, Río Negro, Argentina Rui-Qing Lin Laboratory of Parasitology College of Veterinary Medicine South China Agricultural University Guangzhou, Guangdong, People’s Republic of China Mark van der Linden Institute of Medical Microbiology and National Reference Center for Streptococci RWTH Aachen University Hospital Aachen, Germany Miia Lindström Department of Food and Environmental Hygiene University of Helsinki Helsinki, Finland Dongyou Liu Department of Basic Sciences College of Veterinary Medicine Mississippi State University Mississippi State, Mississippi Charlotta Löfström National Food Institute Technical University of Denmark Søborg, Denmark
Heinz Mehlhorn Department of Parasitology Heinrich Heine University Düsseldorf, Germany Edina Meleg Department of Biophysics Faculty of Medicine University of Pécs Pécs, Hungary Marco Antonio Lemos Miguel Instituto de Microbiologia Universidade Federal do Rio de Janeiro Rio de Janeiro, Brazil Isabella Monne Istituto Zooprofilattico Sperimentale delle Venezie Research and Development Department OIE/FAO and National Reference Laboratory for Newcastle Disease and Avian Influenza OIE Collaborating Center for Epidemiology, Training and Control of Emerging Avian Diseases Legnaro, Padova, Italy Beatriz Meurer Moreira Instituto de Microbiologia Universidade Federal do Rio de Janeiro Rio de Janeiro, Brazil Antonio Moretti Institute of Sciences of Food Production National Research Council (ISPA-CNR) Bari, Italy
José María Luengo Department of Biochemistry and Molecular Biology University of León León, Spain
Paolo Moroni Department of Veterinary Pathology Hygiene and Public Health University of Milan Milan, Italy
Karlene H. Lynch Department of Biological Sciences University of Alberta Edmonton, Alberta, Canada
Boris Müller Department of Parasitology Heinrich Heine University Düsseldorf, Germany
xxii
Contributors
Germán Naharro Department of Animal Health University of León León, Spain
Lia Paggi Department of Public Health Science Sapienza University of Rome Rome, Italy
Minoru Nakao Department of Parasitology Asahikawa Medical College Asahikawa, Japan
Anubhav Pandey Department of Microbiology All India Institute of Medical Sciences New Delhi, India
Kazuhiro Nakaya Laboratory Animals for Medical Research Asahikawa Medical College Asahikawa, Japan
Giancarlo Perrone Institute of Sciences of Food Production National Research Council (ISPA-CNR) Bari, Italy
Kanwar Narain Regional Medical Research Centre, N.E. Region Indian Council of Medical Research Dibrugarh, Assam, India
Michael D. Perry NPHS Microbiology Cardiff University Hospital of Wales Cardiff, Wales, United Kingdom
Karsten Nöckler Federal Institute for Risk Assessment Berlin, Germany Norihisa Noguchi Department of Microbiology School of Pharmacy Tokyo University of Pharmacy and Life Sciences Hachioji, Tokyo, Japan Birgit Nørrung Department of Veterinary Pathobiology University of Copenhagen Frederiksberg C, Denmark F. Nuñez Higiene y Seguridad Alimentaria Facultad de Veterinaria Universidad de Extremadura Cáceres, Spain Munehiro Okamoto Department of Parasitology School of Veterinary Medicine Tottori University Tottori, Japan Takashi Onodera Department of Molecular Immunology, School of Agricultural and Life Sciences University of Tokyo Bunkyo-ku, Tokyo, Japan Andrés Otero Department of Food Hygiene and Food Microbiology University of León León, Spain
G. Todd Pharr Department of Basic Sciences College of Veterinary Medicine, Mississippi State University Mississippi State, Mississippi Lesya M. Pinchuk Department of Basic Sciences College of Veterinary Medicine Mississippi State University Mississippi State, Mississippi Giuliano Pisoni Department of Veterinary Pathology Hygiene and Public Health University of Milan Milan, Italy Edoardo Pozio Department of Infectious, Parasitic and Immunomediated Diseases Istituto Superiore di Sanità Rome, Italy Stephen B. Pruett Department of Basic Sciences College of Veterinary Medicine, Mississippi State University Mississippi State, Mississippi Chaturong Putaporntip Molecular Biology of Malaria and Opportunistic Parasites Research Unit Department of Parasitology Chulalongkorn University Bangkok, Thailand
xxiii
Contributors
Noura Raddadi Department of Food Science and Microbiology University of Milan Milan, Italy
Franca Rossi Dipartimento di Biotecnologie Universita degli Studi di Verona Verona, Italy
Peter Rådström Applied Microbiology Lund Institute of Technology Lund University Lund, Sweden
Antoni Róz∙ alski Institute of Microbiology and Immunology University of Łódz´ Łódz´, Poland
Catherine E.D. Rees School of Biosciences University of Nottingham Sutton Bonington Campus Leicestershire, England, United Kingdom Ralf René Reinert Wyeth Vaccines Research Paris la Défense, France Jorge Riaño Department of Animal Health University of León León, Spain Lothar Rink Institute of Immunology RWTH Aachen University Hospital Aachen, Germany Aurora Rizzi Department of Food Science and Microbiology University of Milan Milan, Italy M. Rodríguez Higiene y Seguridad Alimentaria Facultad de Veterinaria Universidad de Extremadura Cáceres, Spain Roberto A. Rodríguez Department of Environmental Science and Engineering University of North Carolina Chapel Hill, North Carolina Giuseppe La Rosa Department of Infectious, Parasitic and Immunomediated Diseases Istituto Superiore di Sanità Rome, Italy Benjamin M. Rosenthal United States Department of Agriculture Agricultural Research Service Animal Natural Resources Institute Animal Parasitic Diseases Laboratory Beltsville, Maryland
Una Ryan Division of Health Sciences School of Veterinary and Biomedical Science Murdoch University Perth, Australia Yasuhito Sako Department of Parasitology Asahikawa Medical College Asahikawa, Japan Akikazu Sakudo Department of Virology, Research Institute for Microbial Diseases Osaka University Suita, Osaka, Japan José Paulo Sampaio Centro de Recursos Microbiológicos Departamento de Ciências da Vida Universidade Nova de Lisboa Caparica, Portugal Jesús A. Santos Department of Food Hygiene and Food Microbiology University of León León, Spain Jenny Schelin Applied Microbiology Lund Institute of Technology Lund University Lund, Sweden Jürgen Schmidt Department of Parasitology Heinrich Heine University Düsseldorf, Germany Keith R. Schneider Food Science and Human Nutrition Department University of Florida Gainesville, Florida Anna Charlotte Schultz National Food Institute Technical University of Denmark (DTU) Søborg, Denmark
xxiv
Contributors
Bo Segerman Department of Bacteriology National Veterinary Institute Uppsala, Sweden
Roger Stephan Institute for Food Safety and Hygiene University of Zurich Zurich, Switzerland
Teresa Semedo-Lemsaddek Universidade de Lisboa Center for Biodiversity Functional and Integrative Genomics (BioFIG) Edifício ICAT, Campus da FCUL, Campo Grande Lisbon, Portugal
Chunlei Su Department of Microbiology University of Tennessee Knoxville, Tennessee
Devendra H. Shah Department of Veterinary Microbiology and Pathology College of Veterinary Medicine Washington State University Pullman, Washington Nidhi Sharma Department of Microbiology All India Institute of Medical Sciences New Delhi, India Smriti Shringi Department of Veterinary Microbiology and Pathology College of Veterinary Medicine Washington State University Pullman, Washington Paiboon Sithithaworn Department of Parasitology Liver Fluke and Cholangiocarcinoma Research Center Khon Kaen University Khon Kaen, Thailand Mikael Skurnik Department of Bacteriology and Immunology Infection Biology Research Program, Haartman Institute, University of Helsinki Helsinki, Finland and Helsinki University Central Hospital Laboratory Diagnostics Helsinki, Finland
Katsuaki Sugiura Food and Agricultural Materials Inspection Centre Chuo-ku, Saitama-shi Saitama, Japan Antonia Susca Institute of Sciences of Food Production National Research Council (ISPA-CNR) Bari, Italy Isabella Tamagnini Department of Food Science and Microbiology University of Milan Milan, Italy Rogério Tenreiro Universidade de Lisboa Center for Biodiversity Functional and Integrative Genomics (BioFIG) Edifício ICAT, Campus da FCUL, Campo Grande Lisbon, Portugal Herbert Tomaso Friedrich Loeffler Institute Institute of Bacterial Infections and Zoonoses Jena, Germany Sandra Torriani Dipartimento di Scienze, Tecnologie e Mercati della Vite e del Vino Università degli Studi di Verona Verona, Italy
Paweł Sta˛ czek Institute of Microbiology and Immunology University of Łódz´ Łódz´, Poland
Hiroshi Ushijima Aino Health Science Center Aino University Tokyo, Japan
Damien Stark Division of Microbiology, SydPath St. Vincent‘s Hospital Darlinghurst, Australia
Jaco J. Verweij Department of Parasitology Leiden University Medical Center Leiden, the Netherlands
xxv
Contributors
Jan Vinjé Division of Viral Diseases Center for Disease Control (CDC) Atlanta, Georgia
Jae-Ran Yu Department of Environmental and Tropical Medicine Konkuk University School of Medicine Seoul, Korea
Benjamin R. Warren Research, Quality, & Innovation ConAgra Foods, Inc. Omaha, Nebraska
Olga Zaborina Center for Surgical Infection Research and Therapeutics University of Chicago Chicago, Illinois
P. Lewis White NPHS Microbiology Cardiff University Hospital of Wales Cardiff, Wales, United Kingdom Lihua Xiao Division of Parasitic Diseases Centers for Disease Control and Prevention Atlanta, Georgia Guangai Xue Department of Molecular Immunology School of Agricultural and Life Sciences University of Tokyo Bunkyo-ku, Tokyo, Japan Tetsuya Yanagida Department of Parasitology Asahikawa Medical College Asahikawa, Japan Hélène Yera Laboratoire de Parasitologie-Mycologie Hôpital Cochin AP-HP Université Paris Descartes Paris, France
Gianluigi Zanusso Department of Neurological Sciences University of Verona Verona, Italy Wei-Hua Zhao Department of Microbiology and Immunology Showa University School of Medicine Tokyo, Japan Xing-Quan Zhu Laboratory of Parasitology College of Veterinary Medicine South China Agricultural University Guangzhou, Guangdong, People’s Republic of China Qing-Jun Zhuang Laboratory of Parasitology College of Veterinary Medicine South China Agricultural University Guangzhou, Guangdong, People’s Republic of China
Detection: 1 Molecular Principles and Methods Lisa Gorski
United States Department of Agriculture
Andrew Csordas
University of California
Contents 1.1 Introduction........................................................................................................................................................................... 1 1.2 Detection Methods................................................................................................................................................................ 3 1.2.1 Pathogen Detection in Complex Matrices—Sample Preparation.............................................................................. 3 1.2.2 Nucleic Acid Based Detection................................................................................................................................... 3 1.2.2.1 PCR............................................................................................................................................................. 3 1.2.2.2 Isothermal Amplification............................................................................................................................ 7 1.2.2.3 Microarray Detection.................................................................................................................................. 8 1.2.3 Fluorescence in situ Hybridization (FISH)................................................................................................................ 8 1.2.4 Immunological Detection Methods........................................................................................................................... 8 1.2.5 Combined Detection Methods................................................................................................................................... 9 1.2.6 Foodborne Pathogen Typing...................................................................................................................................... 9 1.2.7 Microfabrication and Microfluidics........................................................................................................................... 9 1.2.8 Other Molecular Detection Approaches.................................................................................................................... 9 1.2.9 Assay Design and Data Analysis Software.............................................................................................................. 10 1.3 Detection Targets................................................................................................................................................................. 10 1.3.1 Viral Targets............................................................................................................................................................ 10 1.3.1.1 RNA Targets.............................................................................................................................................. 11 1.3.1.2 Viral Structural Genes.............................................................................................................................. 11 1.3.1.3 Other Viral Targets.................................................................................................................................... 11 1.3.2 Nonviral Targets...................................................................................................................................................... 11 1.3.2.1 Ribosomal RNA Genes . .......................................................................................................................... 11 1.3.2.2 Cytoskeleton Proteins................................................................................................................................ 12 1.3.2.3 Virulence and Toxin Genes....................................................................................................................... 12 1.3.2.4 Unique Genes and Sequences................................................................................................................... 12 1.3.2.5 Insertion Elements..................................................................................................................................... 13 1.3.2.6 Mitochondrial Genes................................................................................................................................. 13 1.3.2.7 Genes for Surface Expressed Markers...................................................................................................... 13 1.3.3 Using Multiple Targets............................................................................................................................................. 14 1.4 Validation............................................................................................................................................................................ 14 1.5 Conclusions.......................................................................................................................................................................... 14 Acknowledgments........................................................................................................................................................................ 15 References.................................................................................................................................................................................... 15
1.1 Introduction While the vast majority of our food supplies are nutritious and safe, illness due to foodborne pathogens still affects millions if not billions of people each year. It is estimated that up to 30% of the population in industrialized nations suffer
from foodborne illness each year.1 In the U.S. there are an estimated 76 million cases each year that result in 325,000 hospitalizations, and 5000 deaths.2 Estimates of the number of cases in developing countries are difficult to obtain due to differences in reporting of cases in different countries; however, the rates of illness are expected to be higher.1,3,4 1
2
Molecular Detection of Foodborne Pathogens
Diarrheal diseases, a high number of which result from foodborne contamination, kill an estimated 1.8 million children worldwide.3 Table 1.1 summarizes the statistics of U.S. foodborne illness outbreaks for the year 2006 broken down by etiology. An outbreak is constituted by more than one person becoming ill by the same strain of an organism. The list displays only outbreaks from known etiologies of bacterial, viral, parasitic, and helminthic origin, and does not take into account outbreaks where an etiology could not be assigned. Nor does it take into account sporadic cases of illness, which far outnumber outbreak cases. Most of these sporadic cases are not reported to any official health tracking agency because they are not severe, or cultures are never obtained.1 An even greater number of people with sporadic cases of foodborne illness do not seek medical attention. Whether an illness is mild or severe, the underlying message from the statistics is that millions or billions of servings of food are contaminated with a pathogen or a toxin each year. Table 1.1 illustrates that the types of foods implicated is broad and comprises meats, dairy, produce, grains, processed foods, and water. While many cases of foodborne illness result from human cross-contamination in restaurants or in the home, a large amount results from foods that arrive
into the kitchen already contaminated. These organisms can contaminate the foods directly by association with feed animals or plants prior to or during processing, through contaminated water used for watering or washing, and through handling by infected people. One of the most difficult and fundamental issues in food safety is the detection of foodborne pathogens. The problem is terribly complex with a multitude of factors and variables with which to contend. With the infectious dose of some of the pathogens as low as <100 cells or particles, sensitivity is essential. In some instances, an enrichment step is necessary to amplify the number of pathogens in the sample simply so that they can be detected. However, enrichment does not work with viruses or toxins, and some organisms with long generation times can take weeks to enrich. Additionally nonprocessed or minimally processed foods are not sterile and native microflora can sometimes mask the presence of the pathogen. Finally the food matrix itself sometimes inhibits detection by affecting the chemistries used in detection methods. While an all-encompassing test that would detect every possible pathogen or toxin would be desirable, the technology does not yet exist. Ideally, the detection of pathogens should be fast and economical. Ultimately a balance between the financial burden of testing and the risk of selling of untested foods must
Table 1.1 Number of Foodborne Outbreaks with Confirmed Etiologies in the U.S. for the Year 2006 Agent
No. of Outbreaks
No. of Cases
Bacterial
Bacillus Brucella Campylobacter Clostridium Escherichia Listeria Salmonella Shigella Staphylococcus Vibrio Subtotal
3 1 22 20 29 3 116 9 12 8 223
35 5 283 745 520 7 2751 183 380 427 5336
Viral
Hepatitis A Norovirus Subtotal
3 333 336
34 10,970 11,004
Parasite
Cryptosporidium Cyclospora Giardia Subtotal
2 3 2 7
16 19 11 46
Helminth
Trichinella Subtotal
1 1
2 2
567
16,388
Total
Suspected Vehicles Produce, rice, meat Cheese Milk, cheese, seafood, produce, meat Produce, seafood, canned food, meat Milk, produce, meat Cheese, salad Meat, dairy, produce, peanut butter Salad, produce, meat Meat, dairy, seafood Seafood
Spring water, unspecified Salads, seafood, meat, produce Unspecified Fruit salad Unspecified Bear meat
Source: Compiled from Centers for Disease Control http://www.cdc.gov.
3
Molecular Detection: Principles and Methods
be met to ensure the safety of consumers and simultaneous profitability for food producers. The following chapters give detailed reviews of the latest methods and targets for detection of specific organisms. However, when reviewing the subject of molecular detection methods, common themes arise. These themes relate to the choices of detection methods and the molecular targets for detection.
1.2 Detection Methods A wide range of foodborne pathogen detection techniques have been developed including culturing methods, nucleic acid methods, immunological methods, microscopy, spectroscopy, and bioluminescence, with varying degrees of cost, specificity, sensitivity, and ease of use. The major considerations of a detection system include the cost of the process, the target for detection, and the specificity and sensitivity of the procedure selected for detection. In recent years painstaking methods of cell culture and microscopic observation have yielded faster, more efficient molecular methods of detection. While traditional microbial detection methods may yield adequate target specificity and sensitivity, the time to results is on the order of days, often relying upon pathogen growth. Numerous molecular techniques have emerged that offer the advantage of speed along with specific and sensitive detection. Molecular methods have also proven advantageous in cases where it is difficult to culture the target of interest, as can be the case with viruses. These methods require a solid understanding of the physiology of the target organism, its close relatives, and those with which it may coexist on a food surface.
1.2.1 Pathogen Detection in Complex Matrices—Sample Preparation Simultaneous advances in detection methods and in sample preparation prior to analysis are needed to ensure a safe food supply.5 Foodborne pathogens have been associated with a wide variety of foods including poultry, beef, shellfish, fruits, vegetables, and drinking water. Without appropriate preparation of a test sample prior to detection, a common potential problem to many detection methods is that the sample background material may drastically decrease the sensitivity of the detection step or even lead to false negative test results. Food derived polymerase chain reaction (PCR) inhibitors include Ca2+, fats, glycogen, and phenolic compounds.6 The presence of proteinases in cheese7 and milk8 may also inhibit PCR. Different approaches have been used to counteract poor PCR performance in difficult backgrounds. Bovine serum albumin has shown success in relieving PCR inhibition in certain cases,9 and the type of DNA polymerase used can greatly affect the outcome of a reaction in the presence of biological samples.10 Additional potential challenges of detecting foodborne pathogens include their nonuniform dispersal and very low concentrations within foods. Therefore, considerable effort is often required to prepare a sample such that it is suitable
for testing with a nucleic acid detection procedure. Methods that have been used for the removal of PCR inhibitors include physical separation techniques such as filtration, DNA extraction, and adsorptive methods such as immunomagnetic separation.11 Lampel et al.12 used filters capable of trapping and lysing microorganisms, then used these filters directly in PCR reactions. The detection limits of Shigella flexneri in artificially contaminated foods using the filter system were greatly improved as compared to unfiltered tests.
1.2.2 Nucleic Acid Based Detection Advances in nucleic acid testing have included rapid amplification techniques and associated automated instrumentation, microarray based technology, and lab-on-a-chip platforms. The relatively low cost and speed of oligonucleotide synthesis, the wide range of 3′ and 5′ oligonucleotide modifications readily available, and powerful software to aid in molecular assay design and data analysis have facilitated the growth of a wide range of nucleic acid based techniques applied to the detection of foodborne pathogens. 1.2.2.1 PCR Nucleic acid amplification techniques have an enormous range of applications and have become an indispensible tool in molecular biology and powerful rapid screening method in the detection of foodborne pathogens. By targeting and amplifying (or making copies of) DNA sequences in vitro, it has been possible to detect the presence of specific DNA sequences with sensitivities down to a single target copy per reaction, and in many cases quantify the results. PCR is a method for the amplification of double or single stranded (ss) DNA sequences in vitro. The reaction proceeds in response to temperature driven steps of double stranded (ds) DNA denaturation, primer or ss oligonucleotide annealing to complementary ss target DNA sequences, and DNA polymerase extension. These steps are repeated, and under appropriate conditions will generate a doubling of the initial number of target copy sequences with each cycle. The primers define the 5′ ends of the discrete products that are subsequently formed. Three step PCRs use three individual temperature steps for denaturation, annealing, and extension, while two step PCRs use a combined annealing and extension step. Reaction reagents typically include a thermostable DNA polymerase, deoxyribonucleoside triphosphates (dNTPs), user selected primers for targeting specific sequences, magnesium chloride, and template or target DNA. The process is rapid, requiring between minutes and hours to generate enough discrete sized target sequences for detection; a single thermal cycle may require as little as a few seconds to complete. The length of time required for a reaction is typically a function of variables such as the length of the target sequence and the heating and cooling rates of the thermal cycler used. However, it is now possible to find PCR systems capable of thermal cycling speeds so fast that decreasing cycle time further would not be worthwhile without first finding a DNA polymerase capable of working faster than those currently
4
Molecular Detection of Foodborne Pathogens
in use.13 While it is possible for PCR to routinely detect low copy numbers in a reaction, many reactions use between 5 and 10 µl sample volumes, yielding a lower detection limit of close to 103 CFU/ml.14 Among the expanding array of nucleic acid amplification techniques, PCR remains the most popular method, presumably as a result of its cost and ease of use,15 and has been used extensively for the detection of foodborne pathogens. By the early 1990s numerous primer sets had been developed for the detection of pathogens and the food industry had gained interest in this powerful method.16 The technique was initially reported in 1985,17 explained in full detail in 1986,18 and has since undergone several significant modifications including the use of a thermostable polymerase19 preventing enzyme destruction at denaturation temperatures, and “hot start” enzymes20 for temperature induced activation control, reducing the possibility of nonspecific product formation. Other major advances have included amplicon formation monitoring without opening the reaction tube,21,22 yielding facile quantification of initial target copy numbers, and the use of melting curve analysis to evaluate product specificity, which in some cases, allows extension of the quantifiable range beyond what is possible with threshold cycle analysis alone.23 In addition to evaluating a reaction’s specificity and detection limit, PCR reaction efficiency is often used to assess performance. The number of target copies generated after n cycles, xn, is a function of the initial target copy number xo and the amplification efficiency ε:
xn = xo(1 + ε)n,
(1.1)
with the amplification efficiency ranging from 0 to 1. Assay parameters that may influence reaction efficiency include primers, annealing temperature, and type of polymerase used. Annealing temperature optimization may be used to balance reaction efficiency and specificity. Approaches to the quantification of real-time PCR products have been described,22,24,25 and techniques typically involve the monitoring of fluorescence accumulation as a function of cycle number through specific or nonspecific dsDNA binding dyes. The threshold cycle, CT, is the fractional cycle at which enough fluorescence has accumulated to rise above the background signal and may be used for quantification. Absolute quantification is possible with unknown samples by running reactions of known template copy numbers to obtain a relationship between the threshold cycle number and the amount of initial template in the reaction. A mathematical model for relative quantification purposes has also been described.26 1.2.2.1.1 Practical Considerations for PCR-based Detection The strength of PCR is its weakness; the assay is incredibly sensitive to the detection of nucleic acids. Since PCR products serve as substrates for subsequent reactions, extremely large numbers of target copies may be generated. As a result
care must be taken in reaction setup and amplicon handling following a reaction to prevent carry-over contamination. Kwok and Higuchi27 list important steps to avoid the occurrence of false positive results, including physically separating the preparation of PCR reagents and the handling of PCR products, as well as frequently changing disposable gloves. While technique is paramount in the ability to generate reproducible results, a brilliant enzymatic approach has also been used to avoid false positive results. Longo et al.28 used a strategy that involved using dUTP in place of dTTP for PCR. All subsequent reactions were treated with uracil DNA glycosylase (UDG), followed by thermal inactivation of this enzyme prior to starting thermal cycling. As a result, any carry-over contaminating DNA would contain uracil and ultimately be rendered unamplifiable through the action of UDG, while simultaneously leaving target DNA intact. Nonspecific amplification arises from primers that bind to unintended targets such as themselves (primer dimers) or other unintended sequences present in the reaction mixture (e.g., DNA sequences from the natural microbiota present in foods). Methods to minimize nonspecific amplification include proper primer design, optimization of assay conditions, and the use of a hotstart DNA polymerase. Wittwer et al.29 studied the influence of annealing time on product specificity. Tests indicated that as annealing time increased, so did the tendency of primer sets to form nonspecific products. Although specificity was generally improved with short annealing times, in some cases there was a tradeoff in the amount of product formed and the specificity of the products formed. Other techniques for optimizing PCR conditions include varying the concentrations of primers and MgCl2, and evaluating two and three step thermal cycling formats. The ultimate test of a primer set’s specificity is in evaluating the performance with target and nontarget DNA sequences. Although it is possible to generate millions of amplicon copies in an hour or less, one complicating factor with PCR testing of food samples is that the level of inhibition is a function of the type of food tested.30 PCR inhibitors may hamper cell lysis, making it difficult to extract DNA, degrade or sequester nucleic acids, or they may act on DNA polymerase.6 In an effort to increase the likelihood of detection when pathogens are present in a sample, separation methods, enrichment procedures, and the extraction of DNA have been used. A negative PCR result could indicate that the target sequence was not present in the reaction or that the reaction itself failed. In order to avoid the uncertainty of such a result in diagnostic PCR, it has been proposed that PCRs contain an internal amplification control.31 Internal amplification controls are nontarget DNA sequences that will be amplified regardless of whether or not the target sequence was present in the reaction. If the internal amplification control is not amplified, then the reaction failed, and it is not possible to know if the target sequence was present in the failed reaction, so the detection step must be repeated.
5
Molecular Detection: Principles and Methods
The amplification of nucleic acids for detection purposes is usually just one step of a procedure that involves assay design and sample preparation prior to amplification, followed by specificity and sensitivity analysis. Some steps prior to and after amplification are shown in Figure 1.1.
using a technique such as agarose gel electrophoresis to compare the mobility of standard DNA ladder to the mobility of the amplified DNA (Figure 1.2). Comparison of the known standards to the PCR products can be used to estimate the size of the products formed. This step may be followed by performing a Southern blot to evaluate sequence specificity. Two potential drawbacks to traditional PCR are that (i) endpoint quantification is challenging and (ii) it is necessary to open the reaction tube to verify reaction product specificity,
1.2.2.1.2 Traditional PCR Traditional PCR techniques involve amplification of a target sequence of interest followed by product size verification
Assay design
Sample preparation
• target selection • software aided oligo design
• enrichment • extraction • separation
Specificity analysis
Target amplification • thermal cycling • isothermal incubation
Quantification • CT analysis
• gel electrophoresis • sequence specific probes – Southern blotting – labeled probes – microarray hybridization • complementary sequence Tm • sequencing
Figure 1.1 Steps used for the detection of nucleic acids by amplification. Quantification is not essential to verify specificity.
Melt, anneal primers
Repeat multiple cycles
Extend
Millions of copies of original template
Traditional PCR with gel
Real-time PCR with nonspecific detection
Real-time PCR with sequence-specific detection TaqMan
Molecular Beacon
Unbound probe with reporter and quencher
PCR products
Probe binds Primer binds
PCR proceeds Probe displaced Fluorescent reporter separated from quencher
DNA ladder
Unbound, unactive SYBR green
ssDNA
Bound, active SYBR green
dsDNA
Unbound molecular beacon Target
Probe binds, Beacon unfolds, Reporter activated Reporter, quenched Quencher Reporter, activated
Figure 1.2 Representation of PCR and detection protocols. The principle of PCR is illustrated in the top part of the figure. On the bottom are detection techniques. These include gel electrophoresis after traditional PCR. Real-time PCR with nonspecific fluorescent dye is shown where the dye only fluoresces when associated with double stranded DNA. Real-time PCR with probe-based detection with TaqMan and Molecular Beacon technologies is illustrated where the fluorescent reporter must be physically separated from the quencher in order to fluoresce.
6
increasing the opportunity for carry-over contamination. Traditional PCR therefore requires separate instrumentation for the amplification and evaluation of dsDNA products. However, provided that PCR products are handled carefully and that real-time quantification is not necessary, traditional PCR techniques can be used with great success for the detection of food pathogens. A single enrichment, thermal cycling protocol, set of PCR reagent components and concentrations were used for the detection of 13 foodborne pathogens by Wang et al.32 Agarose gel electrophoresis on 2% agarose gels stained with ethidium bromide was used for separation of PCR products. The PCR detection limits reported ranged from two cells to 5 × 104 cells for E. coli O157:H7 and Shigella spp., respectively. 1.2.2.1.3 Real-time PCR The ability to monitor amplicon accumulation as a reaction proceeds has drastically improved the field of nucleic acid detection. In addition to facilitating the quantification of initial target copy numbers, real-time PCR allows an operator to evaluate product specificity without opening the reaction chamber, saving time, and reducing carry-over contamination risk. Real-time PCR systems offer a wide range of capabilities. These include the ability to handle thousands of samples per day, perform 35 thermal cycles in under 40 minutes, and detect initial target copy numbers over a range from 10 to 1010.33 The design of real-time PCR assays has been aided by commercially available software packages that can determine optimal primer, probe, and reaction conditions, given a specific sequence of interest. Real-time PCR assays are typically designed to target short DNA fragments using primers specifically selected to avoid the formation of primer dimers. The increase in fluorescence in response to amplicon formation is generally accomplished in one of two ways: through the use of a nonspecific dsDNA binding, or by sequence specific probes that generate a signal only in the presence of the target DNA sequence. Realtime PCR techniques and applications have been reviewed extensively,14,34–37 and experimental comparisons among instrumentation and assay formats have been performed to compare sensitivities.38 1.2.2.1.4 Real-time PCR—Nonspecific Detection Nonspecific dsDNA binding dyes have been used for realtime PCR fluorescence based detection systems for target quantification and specificity evaluation. Over the course of thermal cycling, an increase in the amount of fluorescence generated is recorded. The earlier this increase in fluorescence occurs, the larger the initial target copy number present in the reaction. Following thermal cycling, product specificity is verified by slowly raising the reaction temperature through a broad temperature range that includes the expected product melting temperature, while simultaneously recording fluorescence in order to determine the melting temperature (Tm) of any dsDNA products that have formed (Figure 1.2). The melting temperature of a dsDNA
Molecular Detection of Foodborne Pathogens
product is the temperature at which half of the product has become ss. This melting temperature is a function of the dsDNA length, GC content, solution salt concentration, and dye concentration. Advantages of using nonspecific ds binding dyes as compared to probe based systems include cost and ease of assay design. As a result, this approach may be used as a less expensive alternative for initial testing with a primer set. However, this technique does not provide information regarding the length or sequence of the amplified product, and GC rich regions within a single amplicon may create complex melting profiles with multiple peaks.39 SYBR Green is a nonspecific dsDNA binding dye that is frequently used in real-time PCR assays. This dye binds to the minor grove of dsDNA and does not give strong fluorescence when free in solution. SYBR Green real-time PCR assays have been successfully used for the detection of foodborne pathogens, with specificity verification performed by melting curve analysis.40,41 1.2.2.1.5 Real-time PCR—Sequence Specific Detection A large number of real-time PCR strategies that are based on fluorescene increases in response to sequence specific detection have also been developed. Probe based real-time PCR techniques are advantageous over the use of nonspecific dsDNA binding dyes in that they may not require analysis of PCR amplicon melting temperatures for product specificity—fluorescence generation is a function of the probe binding to a specific sequence of DNA. In the case of real-time PCR development with probe based systems, excitation and emission wavelengths of the fluorophores selected must be kept in consideration.34 Sequence specific chemistries that have been incorporated into real-time PCR assays include those based on a sequence specific probe and DNA polymerase exonuclease activity, molecular beacons, and self-quenched hairpin primers. One real-time PCR chemistry (TaqMan®) that has been used extensively for the detection of foodborne pathogens relies upon the 5′ exonuclease activity of Taq polymerase. A probe containing a reporter and quencher in close proximity to one another binds to a target region between the two primers which define the ends of the discrete fragment ultimately formed. This probe is cleaved by the 5′ exonuclease activity of a DNA polymerase, separating the fluorophore and quencher, generating increases in fluorescence as a direct result of specific probe binding and target fragment extension (Figure 1.2). Numerous assays have been developed with this chemistry.42–45 Molecular beacons are stem and loop oligonucleotide structures used for sequence specific detection. The loop portion contains a sequence that is complementary to a chosen target, while the stem portion contains a short sequence of bases at the 3′ and 5′ ends that are complementary to one another but not the target.46 Fluorescence and quenching moieties are attached to the ends of the beacon. The beacons are designed such that with no loop complementary sequence present the stem structure is stable, but in the presence of a
Molecular Detection: Principles and Methods
complementary target sequence the arms of the stem separate. This separation changes the conformation of the beacon to a more stable structure, allowing simultaneous separation of the fluorophore and quencher, leading to fluorescence generation (Figure 1.2).46 Molecular beacons have been used in numerous applications,47 outside of monitoring specific amplicon formation in real-time PCR. Molecular beacons have been used in multiplex PCR applications for the simultaneous detection of four pathogenic retroviruses48 and four V. cholerae genes.49 Hairpin primers have also been used to monitor product formation as a function of cycle number. Blunt end hairpin primers using fluorophores with no quencher molecules were used with great success in a real-time PCR assay.50 Nazarenko et al.50 also demonstrated that these blunt end hairpin primers reduced the formation of primer dimers without PCR template present, thereby showing the outstanding specificity of the system. Nordgren et al.51 used this type of chemistry to detect norovirus (NV) genogroups I and II. Using hairpin primers it was possible to distinguish between genogroups in a duplex PCR through melting curve analysis. 1.2.2.1.6 Reverse Transcriptase PCR Enrichment procedures have successfully been used for the sensitive detection of viable foodborne pathogens, but this technique is time consuming, as it is a function of the target organisms growth. While PCR is capable of detecting low levels of target DNA, DNA detection does not provide information regarding the viability of a cell; food processing may destroy bacteria while leaving behind DNA and this DNA may be present even if its host cell is no longer alive.52 On the other hand, RNA is easily destroyed, which makes it suitable for determining organism viability.30 Reverse transcriptase PCR of mRNA targets has demonstrated that these molecules are indicators of cell viability.53,54 Following RNA purification and degradation of contaminating DNA from a sample of interest, RNA is reverse transcribed and the synthesized complementary DNA or cDNA may be amplified as is typically done for any DNA target. Reverse transcriptase PCR has been used successfully for the detection of foodborne bacterial pathogens55 and viruses.56 A real-time reverse transcription PCR assay using a TaqMan minor grove binding probe was implemented for the quantitative detection of H5 avian influenza down to 100 target copies.57 1.2.2.1.7 Multiplex PCR The amplification of several target sequences in a single reaction tube can be accomplished by optimized multiplex PCR assays. The motivation for such an approach includes cost efficiency58 and a reduction in laboratory effort and time.59 Conditions such as annealing temperature and reagent concentrations must be adjusted to allow for the simultaneous amplification of more than one target. Multiplex PCR optimization may be complicated, resulting in preferential amplification, poor sensitivity, and poor specificity59 if satisfactory conditions for all primer and template combinations cannot
7
be met. In comparison with single PCR reactions, multiplex PCR assay design considerations include designing long primers with higher melting temperatures and using elevated MgCl2 concentrations.60 Additionally, design considerations should include a method to distinguish between amplicons following thermal cycling. Methods may include designing target sequences of different sizes or melting temperatures for discrimination using gel electrophoresis or dissociation analysis with nonspecific dsDNA binding dyes, respectively. Using real-time PCR probes with different excitation and emission wavelengths may also be used to accomplish this goal. Mutliplex PCR has been used to detect multiple gene targets for speciation and virulence determination in Listeria monocytogenes.61 Other multiplex assays have been aimed at detecting food or waterborne pathogens of differing genera.58,62–65 Lee et al.64 simultaneously amplified sequences from Salmonella enterica, Salmonella typhimurium, Vibrio vulnificus, Vibrio cholerae, and Vibrio parahaemolyticus with multiplex PCR from seeded oyster homogenates. Following enrichment and DNA purification, it was possible to detect each pathogen at a level of 102 cells/g of oyster homogenate. Kong et al.63 were able to simultaneously detect Aeromonas hydrophila, Shigella flexneri, Yersinia enterocolitca, Salmonella typhimurium, Vibrio cholerae, and Vibrio parahaemolyticus in marine water with detection limits ranging from 100 to 102 CFU in a total assay time of less than 12 hours. Molecular beacons were used for the simultaneous detection of four retroviral target molecules in the same reaction tube.48 Using different colored fluorophores with emission maxima separated over the visible range and target sequences less than 130 bp, Vet et al.48 detected as few as ten retroviral genomes. 1.2.2.2 Isothermal Amplification Within the last 20 years, many techniques have been developed that allow for amplification of nucleic acids under isothermal conditions. These techniques include loop mediated amplification (LAMP),66 nucleic acid sequence based amplification (NASBA),67 rolling circle amplification (RCA),68 and strand displacement amplification (SDA).69 Isothermal amplification simplifies hardware requirements as compared to PCR in that they do not require a system for thermal cycling, and may even work with a simple water bath setup. These techniques may use several sets of primers or more than one enzyme to carry out amplification of the target product without thermal cycling. NASBA is an isothermal amplification process developed shortly after PCR began gaining widespread attention.67 NASBA is a sensitive detection method for the detection of RNA or DNA. The reaction typically consists of three enzymes including T7 RNA polymerase, deoxyribonucleoside triphosphates, two specific primers, and buffering reagents and takes place at approximately 40°C. One major advantage of the procedure is that contaminating genomic DNA does not create problems with the assay as it will not be
8
amplified due to the fact that there is no thermal denaturation step involved with the process.67 NASBA has been used for the detection of Hepatitis A virus (HAV) using primers targeting major capsid proteins.70 Jean et al. used Northern blotting and dot blot hybridization to verify the specificity of their reaction and found a detection limit of 0.4 ng RNA/ml as compared to a reverse transcriptase PCR assay used that yielded a detection limit of 4 ng RNA/ml. Other NASBA published methods for the detection of pathogens in foods have been listed by Rodríguez-Lázaro et al.71 Real-time NASBA has also been used to show product formation as a function of time. Molecular beacons were used to generate fluorescence signals with NASBA assays for the detection of Vibrio cholerae72 and HAV.73 LAMP is a procedure using four primers that have a total of six binding sites on the target DNA sequence. The isothermal reaction allows for the generation of 109 target sequences in less than one hour.66 A LAMP assay targeting the invA gene of Salmonella was developed by Wang et al.74 using an amplification time of approximately 60 minutes and run at 65°C. The detection limit of the LAMP assay was 100 fg of DNA per reaction, whereas a PCR approach gave a detection limit of 1 pg of DNA per reaction tube. 1.2.2.3 Microarray Detection In addition to Southern blots, gel electrophoresis, melting temperature analysis with nonspecific dsDNA binding dyes, and probe based amplification detection, microarrays have been used to analyze the specificity of PCR products. DNA microarray technology (aka DNA chips or gene chips) involves the placement of user defined oligonucleotide probes in specific locations on a solid substrate such as glass. Following hybridization of target DNA sequences to probes anchored on a chip’s surface, fluorescence detection can be used to monitor binding events. Depending on the sensitivity required, microarrays can be used with or without upstream amplification steps. Software analysis of large data sets that are generated greatly facilitates the process of data analysis. The advantages and limitations of several microarray software packages have been reviewed.75 Microarrays may be an effective way of distinguishing between nonspecific and target product formation and therefore this detection strategy may allow the use of more primers in a multiplex PCR assay than would normally be possible.76 Amplification methods have been used in combination with microarray technology for the detection of E. coli O157:H7.77 Wilson et al.78 were able to specifically detect 18 pathogenic microorganisms including, prokaryotes, eukaryotes, and viruses using PCR in combination with a microarray containing over 50,000 probes and with a detection limit as low as 10 fg of DNA.
1.2.3 Fluorescence in situ Hybridization (FISH) Fluorescence in situ hybridization (FISH) is a technique for the probe-based identification of nucleic acids without
Molecular Detection of Foodborne Pathogens
amplification. The technique can be used to specifically identify microbial cells in environmental samples and rRNA molecules are frequently targeted.79 Fluorescently labeled probes can be used to generate signals in the presence of specific target sequences, seen with fluorescence microscopy. Typical steps include sample preparation by fixation and permeabilisation, probe binding, removal of unhybridized probes by washing, and flow cytometry or microscopy detection.79 A FISH technique for the detection of Listeria monocytogenes showed specific detection of the target microorganism and detection was possible in sheep milk samples.80
1.2.4 Immunological Detection Methods At the core of all immunological assays is an antibody and antigen interaction. Numerous formats have been used to detect these binding events and immunological assays have been widely used for the detection of foodborne pathogens. Assay specificity and sensitivity is a function of the quality and type of antibodies used in binding to specific antigen epitopes. Many immunoassay formats are based on the enzyme linked immunosorbent assay (ELISA).81 ELISAs are commercially available for the detection of foodborne pathogens, and the method can be used for the detection of antibodies or antigens. The technique involves coating an antibody to a solid support surface, adding a sample of interest and incubating, and washing to remove nonspecific interactions. This step is followed by the addition of a second antibody to create a sandwich structure between the primary bound antibody, the target of interest, and this secondary antibody. The secondary antibody may be conjugated with an enzyme or fluorophore for detection and quantification with a plate reader. In this assay format, the target antigen must have at least two antibody binding sites.82 Muhammad-Tahir and Alocilja83 used a sandwich immunoassay with lateral flow disposable membranes and polyaniline-conjugated antibodies, and conductance measurements yielded detection limits of less that 100 CFU/ml. Other methods for evaluating immunological binding events include fluorescence microscopy and surface plasmon resonance (SPR). Fluorescence microscopy has been used to evaluate antibodies against protozoan parasites Giardia and Cryptosporidium.84 SPR sensors measure refractive index changes that result from surface plasmon excitation at the interface between a thin metal film and a dielectric material.85 SPR is attractive because it is a label-free technique, but has sensitivity limitations in terms of the size range of molecules that can be detected. An SPR system was used to detect Salmonella enteritidis and Listeria monocytogenes using antibodies against the pathogens on a gold sensor surface.86 The lower limit of detection was 106 CFU/ml for the pathogens, and it was noted that this sensitivity was comparable to an ELISA using the same antibodies. Immunoassay sensitivity and potential cross reactivity should be carefully considered in comparing detection methods. Another consideration in using immunoassay based systems is that antibodies must be raised against antigens. As a result, immunological methods typically must be used
9
Molecular Detection: Principles and Methods
with microorganisms that have been sufficiently characterized.87 The long development times associated with monoclonal antibodies and requirement of in vivo generation makes the widespread application of this technology complicated.88 Also, in some cases it may be difficult to confirm the identity of a microorganism through immunological testing alone. On occasion, reference laboratories found that serotyping could not be used to verify the identity of strains that were initially identified as Salmonella sp.89 Additionally, another nucleic acid based technology may be a suitable alternative for a range of molecular targets traditionally detected by antibodies. Aptamers, single stranded ss DNA or RNA that fold into conformations allowing specific binding to targets, have been proposed as alternative recognition molecules to antibodies.88
1.2.5 Combined Detection Methods Due to limitations of individual detection methods, the combination of two or more techniques has been used for verification purposes, ensuring adequate specificity and sensitivity of results. In a study examining 244 stool samples from an outbreak of gastroenteritis, transmission electron microscopy (TEM), PCR, and ELISA formats were used for the detection of NV.90 The results indicated that at least two of the methods should be used in order to increase the level of confidence in the diagnosis. Combining methods has also been used to enhance the performance of individual assays. Immuno PCR (IPCR) was introduced in 199291 and is a method that can dramatically increase the sensitivity of immunoassays such as the commonly used ELISA. IPCR involves the use of an antibody-DNA conjugate to bind specifically to a target antigen. The antibody is bound to DNA that can then be amplified by PCR. The system is designed such that the presence of PCR product in a reaction means that the target antigen has been detected. One advantage of this technique over other types of PCR methods is that the sequence of DNA to be amplified can be entirely selected by the user.92 An overview of IPCR applications, including pathogen protein detection assays, along with detection limits and sensitivity increases compared to ELISA results, is given by Niemeyer et al.92 A real-time IPCR assay to detect NV capsid proteins in food and fecal samples was developed by Tian and Mandrell.93 They found that PCR inhibitors had a minimal impact on the antigen capture and were removed by wash steps. The real-time IPCR system was the first report to detect NV in contaminated foods without virus purification or concentration. Using a tri-antibody system, the results showed a greater than 1000 fold improvement in sensitivity in comparison to an ELISA assay alone.
1.2.6 Foodborne Pathogen Typing Molecular typing can be used to determine variability within a population of closely related microorganisms and has been
valuable in epidemiological investigations. It is especially important when distinguishing between multiple isolates of the same species. Frequently used methods for studying molecular genetics of bacterial pathogens include pulsedfield gel electrophoresis (PFGE), PCR, and PCR-RFLP (restriction fragment length polymorphism).94 Schwartz and Cantor95 developed PFGE for the separation of large DNA fragments on a 1.5% agarose gel. By alternating the direction of the electrical field across a gel in a perpendicular fashion and varying the pulse length of the different field orientations in a nonuniform fashion from 1 to 90 seconds, it was possible to separate fragments as large as 2000 kb. By changing the direction of the electric field across a gel over short time intervals, it was possible to separate much larger fragments of DNA than was originally possible with standard gel electrophoresis. Whole bacterial chromosomes may be cut by rare digestion enzymes, generating a moderate number of DNA fragments suitable for gel analysis, essentially creating a genetic fingerprint of banding patterns for comparison between strains of the same species.94 PFGE is a technique often used for typing of many bacterial foodborne pathogens and the technique has applicability in studying strain population variability. A typing scheme was created by Wong et al.96 using over 500 strains of Vibrio parahaemolyticus collected from 15 countries and 115 PFGE patterns were identified. It was also found that the restriction enzyme SfiI resulted in clearly separated bands, as opposed to the use of other restriction enzymes.
1.2.7 Microfabrication and Microfluidics Advances in microfluidics along with development of integrated lab-on-a-chip or micro total analysis systems (µTAS) have generated platforms capable of small scale sample preparation, fluid transport, and biological detection.97 Advantages of these microsystems over amplifications on larger scales are that reduced reagent volumes are required, and it may be possible to reduce the amount of time required for the reaction to take place.98 Disadvantages of some microsystems include increased nonspecific binding and the reduction of signal intensity.98 Microchip PCR systems offer advantages of low power consumption as well as rapid heating and cooling. Belgrader et al.99 developed the Advanced Nucleic Acid Analyzer using ten silicon reaction chambers, and detection limit ranges between 102 and 104 organisms/ml were achieved. Neuzil et al.100 obtained heating and cooling rates in excess of 100°C/s using a 100 nl PCR volume with a silicon micromachined chip in a system was able to complete 40 cycles in 5 minutes and 40 seconds.
1.2.8 Other Molecular Detection Approaches Manipulation of nanomaterial properties for targeting biomolecules has created the potential for new techniques that are competitive with ELISA and PCR methods.101 The applications of nanostructures in biodiagnostics has been reviewed.101
10
Many silver and gold nanoparticle based methods have been used to detect DNA. A label-free platform using silver nanoparticles and smooth silver films was used for the detection of ssDNA by surface-enhanced Raman scattering (SERS).102 In another system, gold nanoparticles were functionalized with thiolated oligonucleotides to detect DNA hybridization by transmission SPR spectroscopy.103 Aptamers are ss nucleic acids that can be generated by a process known as systematic evolution of ligands by exponential enrichment (SELEX), by using libraries of synthetic nucleic acids.88 After folding into a particular conformation, the resulting nucleic acid ligands are capable of specifically binding to a wide range of targets including proteins, making these molecules a potential alternative to antibody based detection. Aptamers are beginning to emerge as molecules that can contend with antibodies in the fields of diagnostics and therapeutics.104 Specific advantages of aptamers over antibodies include their ability to reform their structure following denaturation, an in vitro as opposed to animal or cell based selection process, and chemical synthesis of the selected sequence, making it possible to produce the selected ligand in a very repeatable fashion.104,105 Electrochemical nucleic acid detection techniques have emerged that are label-free and therefore do not require fluorescent dyes and optical components. A disposable electrode system has been used for sensing fM quantities of specific ssDNA sequences, and it was possible to verify hybridization specificity down to a single base pair mismatch by using melting curves.106 Other electrochemical DNA systems have shown promising results in detecting DNA in blood serum107 and PCR products amplified from the gyrB gene of Salmonella typhimurium.108
1.2.9 Assay Design and Data Analysis Software Nucleic acid based detection techniques have grown at a staggering rate due to the availability of target sequence data, powerful methods for nucleic acid amplification, and the ability to easily design suitable nucleic acid sequences for a particular assay. The design of a sensitive, specific PCR assay includes many considerations, and some of the most important are selecting appropriate primers and target DNA sequences. Computer aided PCR assay design systems began appearing not long after the amplification technique was introduced. One such program provided the ability to evaluate DNA duplex stability, oligonucleotide specificity, and oligonucleotide self-complementarity.109 Significant empirical optimization with poorly designed primers can be costly, time consuming, and may not yield adequate results. PCR assay design software can aid in finding primers that have minimal tendency to form secondary structures, closely match primer melting temperatures, find a suitable amplicon size, and predict its melting temperature, all in less time than it takes to select parameter constraints. Additionally, user defined criteria allow primer sets to be rated in terms of their ability to match desired characteristics. Many packages can
Molecular Detection of Foodborne Pathogens
be found online at no charge by using keywords phrases such as “PCR design software” and range in available features from displaying oligonucleotide secondary structure formation to design aides for multiplex real-time PCR assays.
1.3 Detection Targets Just as important as the selection of a suitable method for detection is the selection of an appropriate target to detect. Targets for detection must be unique to the organism of interest. The ideal target would be a gene or a noncoding region with a unique sequence present only in the organism of interest. While unique genes exist, most detection systems take advantage of sequence variations in genes that are shared by many different organisms. Only by studying these organisms, comparing sequence data, and determining specificity have researchers elucidated targets suitable for detection systems in foods. While specificity is an issue, the target should not be so specific that it fails to detect most strains of a species. The detection sequence should be relatively stable within the species. Genes that undergo high rates of recombination, such as some surface antigens that change often to evade immune systems, are not desirable targets. The most common detection sequences are in genetic regions that share some common traits. These loci are common to most if not all the isolates of a species, and they have a high level of sequence conservation, but enough variability in sequence and/or length to distinguish them from similar loci in other genera and sometimes species within genera. Good candidates are genetic loci that are somewhat constrained in sequence because the gene products encode products of essential function but still display some amount of variability (e.g., ribosomal RNA or cytoskeletal proteins). Technical considerations play a role in the choice of detection targets as well. Some high G + C regions may not have high PCR efficiency. This is something to keep in mind if universal primers are being used in a food with a large amount of natural microflora (such as produce or raw meat) when testing for a pathogen that may be present in low numbers. If the template for detection is present in very low numbers, it could be missed if PCR amplifies competing targets with higher efficiency. This is why targets should be tested in laboratory situations with food samples contaminated with pathogens. This allows for assessment not only of the target but the potential inhibition of PCR by components of the food matrix.
1.3.1 Viral Targets The limited genetic information in viruses in relation to the rest of the organisms discussed in this book necessitates a separate discussion of viral detection targets. Viruses consist of genetic material within a proteinaceous capsid and sometimes a surrounding lipoglycoprotein envelope. They are completely dependent on host cells for the expression of their genetic material, their reproduction, and their assembly. Since they have neither organelle structures nor ribosomes,
11
Molecular Detection: Principles and Methods
protocols using those targets for detection are useless for viruses. They have very small genomes in comparison with other classes of foodborne pathogens, meaning that there is not a lot of variety in genes to choose for detection purposes. While some concepts of viral detection are shared by other pathogens, some detection targets are unique to viruses. 1.3.1.1 RNA Targets Some of the viruses involved in foodborne outbreaks carry their genetic information as RNA, so reverse transcriptasePCR is used for detection of them. Some RNA viruses contain a gene for an RNA dependent RNA polymerase, which is used for duplication of the viral genetic information. The mutation rate in RNA viruses is much higher than in DNA viruses because of the lack of proofreading ability in RNA dependent RNA polymerase.110,111 This makes it difficult to find stable regions of the genome to use as sequence markers. The polymerase gene itself is one of the few regions of the RNA genome that is relatively conserved. It is an example of a gene that serves an essential function to the virus, so broad changes in sequence that may affect its function are not tolerated. It is used as a detection target for some RNA viruses including hepatitis A, Norwalk virus, and others.112–115 DNA viruses lack such an accommodating gene to use for detection. 1.3.1.2 Viral Structural Genes Capsid proteins are the viral components on display to the environment. They are the major antigenic determinants in viruses, and as such are unique to each virus. These sequence differences among structural proteins present in all viruses is probably the most exploited target for viral detection.113 Capsid genes are used for detection of both DNA and RNA viruses. The V2 and V3 capsid genes in hepatitis A116 have been used for detection of the virus in spiked food samples.117,118 Similarly, primers to rotavirus conserved genome region 9, which contains genes for capsid structure have also been used as targets for detection.118 Strain variability among the different strains of the same virus group results in divergence of capsid gene sequences, and in some viruses the capsid gene sequences are highly mutable. As a result some isolates are not detected by some capsid-directed primer targets. This has been reported for different varieties of Norwalk virus and others.119 Therefore, capsid-designed primers work for detection as long as they target conserved regions in the capsid sequence.120,121 1.3.1.3 Other Viral Targets Noncoding regions in viral genomes, as long as they are conserved and therefore usable between different isolates, have also been used as detection targets for several viruses.122–124 This is the case with the 5′ noncoding region of HAV.125 In other cases unique genes, such as hemagglutinin in avian influenza virus,126 are detection targets. Additionally, since viruses have small genomes multiple isolates of the
same virus type can be sequenced to find unique regions shared among them. Whether or not they are coding regions, these unique sequences can then be used for detection targets for that virus. This procedure was used to find detection targets for Astroviruses.127
1.3.2 Nonviral Targets 1.3.2.1 Ribosomal RNA Genes The most common target for molecular detection is the DNA encoding ribosomal RNA (rRNA). All organisms except for viruses contain these loci. These genetic loci are uniquely suited for diagnostic purposes because they have regions that are very highly conserved in sequence, as well as regions that are divergent. Depending on which regions of the rRNA are targeted they can give different levels of identification from kingdom through genus and species, as well as sometimes differentiating strains within a species.128,129 These regions are also desirable for identification purposes because they share similar physical chromosomal structures (Figure 1.3). Ribosomal RNA in both prokaryotes and eukaryotes is synthesized as one precursor molecule which is then processed to make ribosomes. In prokaryotes the 16S, 23S, and 5S rRNAs are transcribed as one unit also containing a tRNA. In eukaryotes the 18S, 5.8S, and 28S rRNAs are also transcribed as a single unit. In both cases mature rRNAs are made by processing of the primary transcript. Because ribosomes perform an exact function in all living cells the sequence diversity among functional areas of rRNA is highly constrained, but some variation is tolerable. On the other hand, the nonfunctional regions of rRNA loci are under minimal selective pressure, and their sequences and lengths can vary greatly. These differences in rRNA sequence have been used to determine evolutionary relationships between organisms.128 Another benefit of rRNA loci is that they are often present in multiple copies since many ribosomes are necessary for the functioning of growing cells. This means multiple copies of the template sequence for amplification. Beyond the sequence variability in the nonfunctional regions of the rRNA, variable regions are contained within each of the rRNA subunits that provide targets for detection
16S
4S
23S
5S
16S–23S spacer region
28S
5.8S
18S (SSU) ITS
ITS
Figure 1.3 Basic physical map of ribosomal DNA loci in prokaryotes (top) and eukaryotes (bottom). ITS, internal transcribed spacer region, SSU, small subunit RNA.
12
of many foodborne pathogens. The 16S, 23S, 18S and 28S subunits have been utilized for detection in most cases. The 16S and 18S RNAs, sometimes referred to as the small subunit RNAs (SSU RNA) in protozoa, have more sequence diversity than the larger subunits (23S and 28S), and as a result the smaller RNAs are used more often for detection.130,131 SSU RNA is a popular target among the protozoa and helminths.132–134 The 16S rRNA sequences have defined bacterial phylogenetic relationships;128 however, for differentiation between species in the same genus the 16S rRNA region is often not discriminating enough because of its low rate of mutation. Even greater diversity in sequence can be obtained by using the spacer regions between the structural subunits. These regions get transcribed as part of the preribosomal RNA, but are cut away later. Since they are not functional RNAs, the spacer regions are not under selective pressure to retain their sequence, but closely related species share similarities in these regions. Because these spacer regions are bound on either side by conserved regions (Figure 1.3), universal primers exist that will bind to the conserved regions and allow their amplification. Specific probes are then used to detect pathogens. Among prokaryotes this spacer region is called the 16S–23S intergenic spacer region (ISR). In eukaryotes, the analogous region is called the internal transcribed spacer region (ITS). ITSs are present in high copy number, and display phylogenetic divergence such that they can show species differentiation.135 The 16S–23S spacer region is widely used to probe for foodborne pathogenic bacteria,131,136 and ITSs are used quite often for detection of fungi and for some helminths.135,137–139 While very useful, sometimes rRNA is not a preferred target. Since all prokaryotes and eukaryotes contain rRNA, primers will amplify regions from many different organisms. If a pathogen is present in low number among normal microflora in foods, then the pathogen target must compete with other templates present in a sample. If the target of interest has a lower PCR efficiency than others present, then the organism of interest may be missed. rRNA has met with mixed results in amplifications from Giardia, for example, because of a high G + C ratio in its 18S rRNA sequence.140 Also, for differentiation of a pathogenic species from nonpathogenic relatives in the same genus, rRNA may not be discriminating enough. 1.3.2.2 Cytoskeleton Proteins Similar to ribosomal DNA, gene sequences for cytoskeletal proteins have been conserved in eukaryotes. These proteins control vital functions such as growth and division of cells, motility, endocytosis, exocytosis, and maintenance of the cell structure. Because these genes arose early in eukaryotic evolution and their sequences have a slow rate of change, they are useful for phylogenetic comparison of species.141,142 These same traits make them useful detection targets, especially if amplification of ITS regions is problematic. Actin and β-tubulin have been used as targets to distinguish between different species in genres of various fungi.143 Giardin, a
Molecular Detection of Foodborne Pathogens
protein associated with the cytoskeleton in Giardia has been used as a detection target.144,145 These proteins, as such, do not exist in prokaryotes, so cytoskeletal targets are limited to detection of eukaryotic pathogens. 1.3.2.3 Virulence and Toxin Genes Among bacteria and fungi there are many cases where a genus consists of pathogenic and nonpathogenic species. Examples are Listeria, Aeromonas, Aspergillus, and Penicillium, to name a few. Often rRNA is not suitable to distinguish between the pathogen and their closely related nonpathogen in the same genus. One way to distinguish them is by assaying for virulence or toxin genes, which are unique to the pathogen genomes. In bacteria, virulence genes are often grouped together on the genome at discrete loci called pathogenicity islands. The altered G + C content of the DNA in many of the pathogenicity islands in relation to the rest of the genome, and repeated sequences on their edges hint that they arrived in these organisms by horizontal transfer.146 Often the pathogens are genetically similar to their sister species except for the pathogenicity islands and other virulence genes. In order to ensure detection of the pathogen in the food sample, and not the innocuous species in the genus, it makes sense to screen directly for the virulence genes or toxins. Virulence gene sequences can be used as specific targets if the gene is unique enough, and the sequence does not vary much between different isolates of a pathogenic species. Hemolysins are a popular target, and they have been used for detection in foods of Shigella, Vibrio, Listeria, Yersinia, Aeromonas, and others.55,147–154 In addition to virulence genes which are involved in the infection process, some organisms produce toxins which are released from the cells. Sometimes these toxins are released as a part of the disease process; however, many organisms release toxins while growing in a food product. Food poisoning is actually caused by reactions to toxins present in food that are made by organisms that grew there. Toxin genes are usually of unique sequence, and so they are used as detection targets. Examples of using toxin genes as detection targets in foods are cereulide, the emetic toxin of Bacillus cereus in rice, botulinum toxin made by Clostridium botulinum in meat and canned corn, enterotoxin made by Staphylococcus aureus in dairy products, and an array of mycotoxins made by fungi such as Alternaria, Aspergillus, Pennicillium, and Fusarium in apples and grains.137,155–162 Other organisms make toxins as part of the disease process once the organism has already grown in the individual, and these types of toxins are also used as detection targets in foods. Examples of these toxins are cytolethal distending toxin in Campylobacter sp. in poultry, and the shiga toxins in Shigella some E. coli strains in meat and dairy products.163–165 1.3.2.4 Unique Genes and Sequences The best detection targets are genes that are absolutely unique to the organism of interest. Failing that, a gene that has unique sequences is desirable. In this section are several examples of unique gene sequences that are neither
Molecular Detection: Principles and Methods
rRNA nor related to virulence and toxicity, but have been found by studies of the physiology of the organisms in question. In Staphylococcus aureus, the nuc gene is a thermostable nuclease.166 While it is not unique to S. aureus, it has sequences in it that will distinguish it from other similar genes. Therefore, it has been used as a detection target for S. aureus.167 The per gene, which encodes perosamine synthetase, has a sequence that is highly conserved among Brucella species, and primers were designed to take advantage of that specificity for detection.168 A unique region in an open reading frame encoding part of the Type III secretion system was utilized as a target to differentiate Burkholderia pseudomallei strains from other bacteria as well as other Burkholderia spp.169 The genus Pseudomonas encompasses a large number of species, some of which are very closely related, so rRNA can be problematic in distinguishing the pathogens from the nonpathogens. The carA gene which encodes carbamoyl phosphate synthase in Pseudomonas sp. was used to distinguish between different species in the genus in meats.170 In order to differentiate between different strains of E. coli sequences in gadA and gadB, which encode glutamate decarboxylase, have been used in artificially contaminated wheat grain.171,172 For the detection of Salmonella in poultry houses the iroB gene, which is absent in the closely related E. coli, was used.173,174 The cpn60 gene (also known as groEL or hsp60), which encodes a heat shock protein in bacteria, contains within it a fragment that has been useful for determining phylogenetic relationships among bacteria. A database of sequences exists to identify organisms found by using this gene as a detection target.175 The rpsU- dnaG- rpoD region is another locus has been used to differentiate between different bacteria. This region encodes proteins involved in the initiations of protein, DNA, and RNA synthesis, and is another example of a locus that has regions that are highly conserved and others that are variable. It has been found to vary between bacteria genera, but to be relatively conserved between species within a genus.176,177 This region was used to distinguish the foodborne pathogen Enterobacter sakazakii from other Enterobacter sp. in infant formula.178 The Toxoplasma B1 gene, which is highly repetitive (35 copies) and highly conserved among various Toxoplasma spp. has been used as a detection target.179,180 The cytoskeletal protein giardin is a major antigenic determinant that is unique Giardia.181 It is also conserved between the different species of Giardia, and as such is a useful detection target. Among the helminths complete genome sequences are not available for many of the genera. However, sequences have been identified by researchers that are unique to some, and these have been used as detection probes. Organisms that have been detected in this fashion include Clonorchis, Opisthorchis, Paragonimus, Taenia, and Fasciola.182–186 1.3.2.5 Insertion Elements In many cases rRNA gene is a fine target for differentiating between genera. However, it is sometimes not discriminating
13
enough for the differentiation of species or subspecies. In the case of Mycobacterium avium subsp. paratuberculosis,187,188 IS900 used. This insertion sequence in the genomes of M. avium subsp. paratuberculosis strains allows discretion down to the subspecies level between different M. avium subspecies.189 If simple detection of genus and species is required for the Mycobacterium genus then 16S rRNA is used. Another insertion sequence, IS711 is used as a species specific detection target for Brucella abortus.190 Primers specific for IS407A have been used to differentiate Burkholderia mallei from B. pseudomallei. 1.3.2.6 Mitochondrial Genes In cases where a whole genome sequence is not available for a eukaryotic organism, mitochondrial genome sequences often are available. These organelles, which are present in almost all eukaryotes, contain genomes on the order of 12–20 kb in length that can provide useful targets for detection. For the most part mitochondrial genomes contain the same complement of genes including those coding for proteins needed for oxidative phosphorylation, rRNA, tRNA, as well as noncoding spacer regions. The mitochondrial genome replicates on its own separate from the nucleus, and the coding regions differ at the rate at which they acquire mutations. The noncoding regions have the most variable sequences. Comparisons of mitochondrial genomes have been used to determine phylogenetic relationships between organisms.191,192 Mitochondrial genes are used often for the molecular detection of helminths and some fungi in foods. The mitochondrial gene COX2, which encodes one of the subunits of cytochrome oxidaise, was used as a target for detection of Saccharomyces cerevisiae.193 Cytochrome oxidase and NADH dehydrogenase genes from the mitochondrial DNA is also a popular target for the detection of helminths such as Clonorchis, Opisthorchis, Fasciola, and Diphyllobothrium.194–196 Mitochondrial sequences can be used to differentiate between closely related species in a genus based on size differences in noncoding regions.195 1.3.2.7 Genes for Surface Expressed Markers Similar to the genes that encode capsid proteins in viruses, genes that encode surface markers in other organisms have been used as detection targets. These surface markers are often antigenic determinants, meaning that their coding regions are sufficiently unique for use in detection. However, a problem with surface markers lies in strain variation. In organisms that change surface markers to evade the immune system, detection based on those markers is not useful. Yet bacterial capsule genes are sometimes used to detect Streptococcus species.197 Streptococcus suis contains an extracellular protein factor encoded by the epf gene that is a specific marker for these strains.198 Among Gram-negative bacteria genes encoding lipopolysaccharide markers were used for detection of E. coli, Salmonella, and Vibrio.199 Flagellar genes in bacteria also fall into this category. Many of the flagellar components are expressed on the surface of the cell. They demonstrate unique signatures, so they are also antigenic. In
14
some instances flagella serve as virulence factors for bacteria when they are involved in attachment to animal host cells. Several bacterial detection target strategies utilize flagellar genes to detect and differentiate species of Campylobacter,200 E. coli.201 The eap gene in Staphylococcus aureus encodes a cell-surface associated protein that allows adherence of the bacterium to host cells. This gene was described as a potential detection target.202 In Brucella the BCSP-31 gene encodes a cell surface antigen specific to Brucella spp. BCSP-31, and other outer membrane protein encoding genes have been used as Brucella-specific detection targets.203,204 The gene for the oncosphere-specific protein tso31 has been used as a detection target for the helminth Taenia.205 The oocyst wall protein gene CpR1 from Cryptosporidium is also a target for food detection systems.134,206,207
1.3.3 Using Multiple Targets The best way to screen for a particular pathogen in foods is to use multiple targets for detection. If a combination of rRNA, virulence, and other relevant target genes are used, then there can be a fair amount of confidence that most or all strains of any pathogen can be detected. The most efficient ways of detecting these multiple targets at the same time would be either with a multiplex procedure or with microarray analysis.60,76,199 Panicker et al.149 used both microarrays and multiplex PCR to detect Vibrio spp. in shellfish. Beyond multiple targets and methods, the chances of detection are enhanced with a pre-enrichment step before molecular analysis. This can take the form of a microbiological enrichment, a capture and concentration with immunomagnetic beads that bind to specific pathogens, or both. Just as multiple targets are used for detection of one pathogen, they are also used to detect several pathogens in one test. Screening for several potential pathogens with one protocol saves both time and money. E. coli, L. monocytogenes, and Salmonella typhimurium were each detected in contaminated wheat in one protocol utilizing a microbiological enrichment step followed by multiplex PCR using primers specific to all three bacteria.171 Multiplex PCR was also used for simultaneous detections of Salmonella and Vibrio in shellfish,62 and Yersinia, Staphylococcus, and Shigella in lettuce.65 A microarray was used to detect the mycotoxin biosynthetic genes of Fusarium, Penicillium, and Aspergillus.137 Wilson et al.78 developed a microarray to detect eighteen prokaryotic, eukaryotic, and viral pathogens at once including Brucella, Clostridium, Staphylococcus, Vibrio, Yersinia, and Fusarium.
1.4 Validation Before widespread use of detection methods, they should be validated to make sure that they will detect most or all isolates of a species. False negatives can lead to disastrous consequences, and false positives can lead to costly, unnecessary recalls by manufacturers. A detection target is not very useful
Molecular Detection of Foodborne Pathogens
if a subset of strains of that organism do not possess it. The best methods have been validated by use in multiple laboratories to make sure they work with different sets of workers. This type of interlaboratory validation is routinely done. For example, 12 laboratories recently validated a Campylobacter detection protocol in spiked chicken carcass rinses,208 and several labs were involved in detection of hepatitis A from spiked food samples.117 Experiments within the food matrix are very important as they will not only assess the detection method within in the presence of potential inhibitors, but also determine how well the target organism competes with natural microbiota in the food. The competition aspect is important to test if an enrichment is involved prior to actual detection. Targets should be screened to make sure they do not react with unwanted organisms. Potential primers and probes should be tested against multiple, closely related species for cross-reactivity. Also during these validations, sensitivity of the method can be determined with known levels of organisms added to foods.
1.5 Conclusions Molecular biology has rapidly revolutionized food diagnostics, driven by biotechnology advances fueled by basic science.209 Numerous molecular detection techniques have emerged that are rapid, sensitive, and specific in detecting nucleic acid sequences of foodborne pathogens. Several factors have led to an explosive growth in methods available for the detection and quantification of foodborne pathogens including the ready availability of synthetic oligonucleotide sequences of approximately 100 bp or less, the ability to modify these sequences at their 3′ or 5′ ends with fluorescence labels or conjugation chemistries, the development of extremely sensitive DNA amplification techniques such as PCR, software tools for molecular assay design and data evaluation, and DNA sequence databases to allow for the search for efficient target sequences. Rapid and simple sample preparation techniques, simplification of data analysis, standardization of molecular testing procedures, and identification of suitable detection targets will lead to the more widespread acceptance of molecular techniques. Additionally, cost effective solutions to pathogen detection and systems for on-site analysis that require minimal operator interface would benefit many industries. Microfabrication, microfluidics, and nanoparticle conjugation chemistries are likely to play significant roles in future systems. The extent to which foodborne pathogen detection solutions will converge upon widely accessible integrated instrumentation solutions that merge preparation, detection, and data interpretation capabilities in a seamless platform remains to be seen. However, molecular detection techniques will likely continue to simplify and increase the speed of detection procedures while simultaneously improving the sensitivity and specificity required for tracking pathogens in environmental, clinical, and food matrices.
Molecular Detection: Principles and Methods
Acknowledgments The authors wish to thank J. Barak, M. Borucki, D. Flaherty, W. Miller and J. Palumbo for helpful discussions and advice.
References
1. WHO, Food safety and foodborne illness, http://www.who. int/mediacentre/factsheets/fs237/en/index.html) 2007. 2. Mead, P.S. et al. Food-related illness and death in the United States. Emerg. Infect. Dis., 5, 607, 1999. 3. Stein, C. et al. The global burden of disease assessments— WHO is responsible? PLoS Neg. Trop. Dis., 1, 1, 2007. 4. Todd, E.C.D. Challenges to global surveillance of disease patterns. Mar. Poll. Bull., 53, 569, 2006. 5. Batt, C.A. Food pathogen detection. Science, 316, 1579, 2007. 6. Wilson, I.G. Inhibition and facilitation of nucleic acid amplification. Appl. Environ. Microbiol., 63, 3741, 1997. 7. Rossen, L. et al. Inhibition of PCR by components of food samples, microbial diagnostic assays and DNA-extraction solutions. Int. J. Food Microbiol., 17, 37, 1992. 8. Powell, H.A. et al. Proteinase inhibition of the detection of Listeria monocytogenes in milk using the polymerase chain reaction. Lett. Appl. Microbiol., 18, 59, 1994. 9. Kreader, C.A. Relief of amplification inhibition in PCR with bovine serum albumin or T4 gene 32 protein. Appl. Environ. Microbiol., 62, 1102, 1996. 10. Al-Soud, W.A. and Rådström, P. Capacity of nine thermostable DNA polymerases to mediate DNA amplification in the presence of PCR-inhibiting samples. Appl. Environ. Microbiol., 64, 3748, 1998. 11. Lantz, P.-G., Hahn, H.B. and Rådström, P. Sample preparation methods in PCR-based detection of food pathogens. Trends Food Sci. Technol., 5, 384, 1994. 12. Lampel, K.A., Orlandi, P.A. and Kornegay, L. Improved template preparation for PCR-based assays for detection of foodborne bacterial pathogens. Appl. Environ. Microbiol., 66, 4539, 2000. 13. Csako, G. Present and future of rapid and/or high-throughput methods for nucleic acid testing. Clin. Chim. Acta, 363, 6, 2006. 14. Olsen, J.E. et al. Probes and polymerase chain reaction for detection of food-borne bacterial pathogens. Int. J. Food Microbiol., 28, 1, 1995. 15. Monis, P.T. and Giglio, S. Nucleic acid amplification-based techniques for pathogen detection and identification. Inf. Gen. Evol., 6, 2, 2006. 16. Harris, L.J. and Griffiths, M.W. The detection of foodborne pathogens by the polymerase chain reaction (PCR). Food Res. Int., 25, 457, 1992. 17. Saiki, R.K. et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science, 230, 1350, 1985. 18. Mullis, K. et al. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harbor Symp. Quant. Biol., 51, 263, 1986. 19. Saiki, R.K. et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239, 487, 1988. 20. Kellogg, D.E. et al. TaqStart antibody: “Hot Start” PCR facilitated by a neutralizing monoclonal antibody directed against Taq DNA polymerase. Biotechniques, 16, 1134, 1994.
15 21. Higuchi, R. et al. Simultaneous amplification and detection of specific DNA sequences. Biotechniques, 10, 413, 1992. 22. Higuchi, R. et al. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechniques. 11, 1026, 1993. 23. Ririe, K.M., Rasmussen, R.P. and Wittwer, C.T. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal. Biochem., 245, 154, 1997. 24. Rutledge, R.G. and Côté, C. Mathematics of quantitative kinetic PCR and the application of standard curves. Nucleic Acid. Res., 31, e93, 2003. 25. Ginzinger, D.G. Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream. Exp. Hematol., 30, 503, 2002. 26. Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acid Res., 29, 2002, 2001. 27. Kwok, S. and Higuchi, R. Avoiding false positives with PCR. Nature, 339, 237, 1989. 28. Longo, M.C., Berninger, M.S. and Hartley, J.L. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reaction. Gene, 93, 125, 1990. 29. Wittwer, C.T., Reed, G.B. and Ririe, K.M. Rapid cycle DNA amplification. In The Polymerase Chain Reaction, Mullis, K.B., Ferré, F. and Gibbs, R.A. (eds.). Birkhauser, Boston, 1994. 30. Glynn, B. et al. Current and emerging molecular diagnostic technologies applicable to bacterial food safety. Int. J. Dairy Technol., 59, 126, 2006. 31. Hoorfar, J. et al. Diagnostic PCR: making internal amplification control mandatory. J. Appl. Microbiol., 96, 221, 2003. 32. Wang, R.-F., Cao, W.-W. and Cerniglia, C.E. A universal protocol for PCR detection of 13 species of foodborne pathogens in foods. J. Appl. Micorbiol., 83, 727, 1997. 33. Logan, J.M.J. and Edwards, K.J. An overview of real-time PCR platforms. In Real-Time PCR An Essential Guide, Edwards, K., Logan, J. and Saunders, N. (eds.). Horizon Bioscience, London, 2004. 34. Kubista, M. et al. The real-time polymerase chain reaction. Mol. Asp. Med., 27, 97, 2006. 35. Levin, R.E. The application of real-time PCR to food and agricultural systems. A review. Food Biotechnol., 18, 97, 2004. 36. Mackay, I.M. Real-time PCR in the microbiology laboratory. Clin. Microbiol. Infect., 10, 190, 2004. 37. Zhang, T. and Fang, H.H.P. Applications of real-time polymerase chain reaction for quantification of microorganisms in environmental samples. Appl. Microbiol. Biotechnol., 70, 281, 2006. 38. Reynisson, E. et al. Evaluation of probe chemistries and platforms to improve the detection limit of real-time PCR. J. Microbiol. Methods, 66, 2006, 2006. 39. Li, W. et al. Complex DNA melting profiles of small PCR products revealed using SYBR Green I. Biotechniques, 35, 702, 2003. 40. Alarcón, B., Vicedo, B. and Aznar, R. PCR-based procedures for detection and quantification of Staphylococcus aureus and their application in food. J. Appl. Microbiol., 100, 352, 2006. 41. Delibato, E. et al. Development of a SYBR green real-time PCR and a multichannel electrochemical immunosensor for specific detection of Salmonella enterica. Anal. Lett., 39, 1611, 2006.
16 42. Hsu, C.-F., Tsai, T.-Y. and Pan, T.-M. Use of the duplex TaqMan PCR system for detection of shiga-like toxinproducing Escherichia coli O157:H7. J. Clin. Microbiol., 43, 2668, 2005. 43. Liu, Y. et al. Real time PCR using TaqMan and SYBR green for detection of Enterobacter sazakii in infant formula. J. Microbiol. Methods, 65, 21, 2006. 44. Vishnubhatla, A. et al. Rapid 5′-nuclease (TaqMan) assay for detection of virulent strains of Yersinia enterocolitica. Appl. Enviorn. Microbiol., 66, 4131, 2000. 45. Wu, V., Fung, D. and Oberst, R. Evaluation of a 5′-nuclease (TaqMan) assay with the thin layer oxyrase method for the detection of Yersinia enterocolitica in ground pork samples. J. Food Prot., 67, 271, 2004. 46. Tyagi, S. and Kramer, F.R. Molecular beacons: probes that fluoresce upon hybridization. Nat. Biotechnol., 14, 303, 1996. 47. Goel, G. et al. Molecular beacon: a multitask probe. J. Appl. Microbiol., 99, 435, 2005. 48. Vet, J.A.M. et al. Multiplex detection of four pathogenic retroviruses using molecular beacons. Proc. Natl. Acad. Sci. USA, 96, 6394, 1999. 49. Gubala, A.J. and Proll, D.F. Molecular-beacon multiplex real-time PCR assay for detection of Vibrio cholerae. Appl. Environ. Microbiol., 72, 6424, 2006. 50. Nazarenko, I. et al. Multiplex quantitative PCR using selfquenched primers labeled with a single fluorophore. Nucleic Acids Res., 30, e37, 2002. 51. Nordgren, J. et al. Novel light-upon-extension real-time PCR assays for detection and quantification of genogroup I and II noroviruses in clinical specimens. J. Clin. Microbiol., 46, 164, 2008. 52. Hanna, S.E., Connor, C.J. and Wang, H.H. Real-time polymerase chain reaction for the food microbiologist: technologies, applications, and limitations. J. Food Sci., 70, R49, 2005. 53. Bleve, G. et al. Development of reverse transcription (RT)-PCR and real-time RT-PCR assays for rapid detection and quantification of viable yeasts and molds contaminating yogurts and pasteurized food products. Appl. Envrion. Microbiol., 69, 4116, 2003. 54. Sheridan, G.E.C. et al. Detection of mRNA by reverse transcription-PCR as an indicator of viability of E. coli cells. Appl. Environ. Microbiol., 64, 1313, 1998. 55. Klein, P.G. and Juneja, V.K. Sensitive detection of viable Listeria monocytogenes by reverse transcription-PCR. Appl. Environ. Microbiol., 63, 4441, 1997. 56. Cliver, D.O. Detection and control of foodborne viruses. Trends Food Sci. Technol., 6, 353, 1995. 57. Lu, Y.Y. et al. Rapid detection of H5 avian influenza virus by TaqMan-MGB real-time RT-PCR. Lett. Appl. Microbiol., 46, 20, 2008. 58. Gilbert, C. et al. Development of a triplex PCR assay for the specific detection of Campylobacter jejuni, Salmonella spp., and Escherichia coli O157:H7. Mol. Cell. Probes, 17, 135, 2003. 59. Markoulatos, P., Siafakas, N. and Moncany, M. Multiplex polymerase chain reaction: a practical approach. J. Clin. Lab. Anal., 16, 47, 2002. 60. Settanni, L. and Corsetti, A. The use of multiplex PCR to detect and differentiate food- and beverage-associated microorganisms: a review. J. Microbiol. Methods, 69, 1, 2007. 61. Liu, D. et al. A multiplex PCR for species- and virulencespecific determination of Listeria monocytogenes. J. Microbiol. Methods, 71, 133, 2007.
Molecular Detection of Foodborne Pathogens 62. Brasher, C.W. et al. Detection of microbial pathogens in shellfish with multiplex PCR. Curr. Microbiol., 37, 101, 1998. 63. Kong, R.Y.C. et al. Rapid detection of six types of bacterial pathogens in marine waters by multiplex PCR. Wat. Res., 36, 2802, 2002. 64. Lee, C.-Y., Panicker, G. and Bej, A.K. Detection of pathogenic bacteria in shellfish using multiplex PCR followed by CovaLinkTM NH microwell plate sandwich hybridization. J. Microbiol. Methods, 53, 199, 2003. 65. Park, S.-H., Kim, H.-J. and Kim, H.-Y. Simultaneous detection of Yersinia enterocolitica, Staphylococcus aureus, and Shigella spp. in lettuce using multiplex PCR method. J. Microbiol. Biotechol., 16, 1301, 2006. 66. Notomi, T. et al. Loop-mediated isothermal amplification of DNA. Nucleic Acid. Res., 28, e63, 2000. 67. Compton, J. Nucleic acid based sequence amplification. Nature, 350, 91, 1991. 68. Fire, A. and Xu, S.-Q., Rolling replication of short DNA circles. Proc. Natl. Acad. Sci. USA, 92, 4641, 1995. 69. Walker, T.G. et al. Isothermal in vitro amplification of DNA by a restriction enzyme/DNA polymerase system. Proc. Natl. Acad. Sci. USA, 89, 392, 1992. 70. Jean, J. et al. Detection of hepatitis A virus by the nucleic acid sequence-based amplification technique and comparison with reverse transcription-PCR. Appl. Environ. Microbiol., 67, 5593, 2001. 71. Rodríguez-Lázaro, D. et al. Application of nucleic acid sequence-based amplification for the detection of viable foodborne pathogens: progress and challenges. J. Rapid Methods Auto. Microbiol., 14, 218, 2006. 72. Fyske, E.M. et al. Detection of Vibrio cholerae by real-time nucleic acid sequence-based amplification. Appl. Environ. Microbiol., 73, 1457, 2007. 73. El Galil, K.H.A. et al. Real-time nucleic-acid sequence based amplification assay for detection of hepatitis A virus. Appl Environ Microbiol., 71, 7113, 2005. 74. Wang, L. et al. Specific and rapid detection of foodborne Salmonella by loop-mediated isothermal amplification method. Food Res. Int., 41, 69, 2008. 75. Liu, D.K. et al. Comparative evaluation of microarray analysis software. Mol. Biotech. 26, 225, 2004. 76. Call, D.R., Borucki, M.K. and Loge, F.J. Detection of bacterial sample in environmental samples using DNA microarrays. J. Microbiol. Methods, 53, 235, 2003. 77. Vora, G.J. et al. Nucleic acid amplification strategies for DNA microarray-based pathogen detection. Appl. Environ. Microbiol., 70, 3047, 2004. 78. Wilson, W.J. et al. Sequence-specific identification of 18 pathogenic microorganisms using microarray technology. Mol. Cell. Probes, 16, 119, 2002. 79. Amann, R., Fuchs, B.M. and Behrens, S. The identification of microorganisms by fluorescene in situ hybridization. Curr. Op. Biotechol., 12, 231, 2001. 80. Oliveira, M. et al. Development of a fluorescent in situ hybridization protocol for the rapid detection and enumeration of Listeria monocytogenes in milk. J. Food Safety, 98, 119, 2003. 81. Bonwick, G.A. and Smith, C.J. Immunoassays: their history, development and current place in food science and technology. Int. J. Food Sci. Technol., 39, 817, 2004. 82. Notermans, S. and Wernars, K. Immunological methods for detection of foodborne pathogens and their toxins. Int. J. Food Microbiol., 12, 91, 1991.
Molecular Detection: Principles and Methods 83. Muhammad-Tahir, Z. and Alocilja, E.C., A conductometric biosensor for biosecurity. Biosens. Bioelect., 18, 813, 2003. 84. Rose, J.B. et al. Evaluation of immunofluorescence techniques for detection of Cryptosporidium oocysts and Giardia cysts from environmental samples. Appl. Environ. Microbiol., 55, 3189, 1989. 85. Homola, J. and Piliarik, M. Surface plasmon resonance based sensors. In Springer Series on Chemical Sensors and Biosensors, Homola, J. (ed). Springer-Verlag, Berlin, 2006. 86. Koubová, V. et al. Detection of foodborne pathogens using surface plasmon resonance biosensors. Sensors Actuators B: Chemical, 74, 100, 2001. 87. Veal, D.A. et al. Fluorescence staining and flow cytometry for monitoring microbial cells. J. Immunol. Methods, 243, 191, 2000. 88. Proske, D. et al. Aptamers—basic research, drug development, and clinical applications, Appl. Microbiol. Biotechol., 69, 367, 2005. 89. Hoorfar, J., Baggesen, D.L. and Porting, P.H. A PCR based strategy for simple and rapid identification of rough presumptive Salmonella isolates. J. Microbiol. Methods, 35, 77, 1999. 90. Rabenau, H.F. et al. Laboratory diagnostics of Norovirus: which method is the best? Intervirology, 46, 232, 2003. 91. Sano, T., Smith, C.L. and Cantor, C.R. Immuno-PCR: very sensitive antigen detection by means of specific antibodyDNA conjugates. Science, 258, 120, 1992. 92. Niemeyer, C.M., Adler, M. and Wacker, R. Immuno-PCR: High sensitivity detection of proteins by nucleic acid amplification. Trends Biotechol., 23, 208, 2005. 93. Tian, P. and Mandrell, R. Detection of Norovirus capsid proteins in faecal and food samples by a real-time immuno PCR method. J. Appl. Microbiol., 100, 564, 2006. 94. Lukinmaa, S. et al. Application of molecular genetic methods in diagnostics and epidemiolgoy of food-borne bacterial pathogens. APMIS, 112, 908, 2004. 95. Schwartz, D.C. and Cantor, C.R. Separation of yeast chromosome-sized DNAs by pulsed field gel electrophoresis. Cell, 37, 67, 1984. 96. Wong, H.-C. et al. A pulsed-field gel electrophoresis typing scheme for Vibrio parahaemolyticus isolates from 15 countries. Int. J. Food Microbiol., 114, 280, 2007. 97. Hardt, S. and Schönfeld, F. Microfluidics: fundamentals and engineering concepts. In Microfluidic Technologies for Miniaturized Analysis Systems, Hardt, S. and Schönfeld, F. (eds). Springer, New York, 2007. 98. Münchow, G. and Drese, K.-S. Nucleic acid amplification in microsystems. In Microfluidic Technologies for Miniaturized Analysis Systems, Hardt, S. and Schönfeld, F. (eds). Springer, New York, 2007. 99. Belgrader, P. et al. Rapid pathogen detection using a microchip PCR array instrument. Clin. Chem., 44, 2191, 1998. 100. Neuzil, P. et al. Ultra fast miniaturized real-time PCR: 40 cycles in less than six minutes. Nucleic Acid. Res., 34, e77, 2006. 101. Rosi, N.L. and Mirkin, C.A. Nanostructures in biodiagnostics. Chem. Rev., 105, 1547, 2005. 102. Braun, G. et al. Surface-enhanced Raman spectroscopy for DNA detection by nanoparticle assembly onto smooth metal films. J. Am. Chem. Soc., 129, 6378, 2007. 103. Hutter, E. and Pileni, M.-P. Detection of DNA hybridization by gold nanoparticle enhanced transmission surface plasmon resonance spectroscopy. J. Phys. Chem., 107, 6497, 2003.
17 104. Jayasena, S.D. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem., 45, 1628, 1999. 105. Tombelli, S., Minunni, M. and Mascini, M. Aptamers-based assays for diagnostics, environmental and food analysis. Biomol. Eng., 24, 191, 2007. 106. Jenkins, D.M. et al. Hybridization probe for femtomolar quantification of selected nucleic acid sequences on a disposable electrode. Anal. Chem., 78, 2314, 2006. 107. Xiao, Y. et al. Label-free electrochemical detection of DNA in blood serum via target-induced resolution of an electrodebound DNA pseudoknot. J. Am. Chem. Soc.,129, 11896, 2007. 108. Lai, R.Y. et al. Rapid, sequence-specific detection of unpurified PCR amplicons via a reusable, electrochemical sensor. Proc. Natl. Acad. Sci. USA, 103, 4017, 2006. 109. Rychlik, W. and Rhoads, R.E. A computer program for choosing optimal oligonucleotides for filter hybridization, sequencing, and in vitro amplification of DNA. Nucleic Acids Res., 17, 8543, 1989. 110. Drake, J.W. and Holland, J.J. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. USA, 96, 13910, 1999. 111. Elena, S.F. and Sanjuán, R. Adaptive value of high mutation rates of RNA viruses: separating causes from consequences. J. Virol., 79, 11555, 2005. 112. Day, J.M., Spackman, E. and Pantin-Jackwood, M. A multiplex RT-PCR test for the differential identification of turkey astrovirus type 1, turkey astrovirus type 2, chicken astrovirus, avian nephritis virus, and avian rotavirus. Avian Dis., 51, 681, 2007. 113. Pina, S. et al. Viral pollution in the environment and in shellfish: human Adenovirus detection by PCR as an index of human viruses. Appl. Environ. Microbiol., 64, 3376, 1998. 114. Jiang, X., Wang, J. and Estes, M.K. Characterization of SRSVs using RT-PCR and a new antigen ELISA. Arch. Virol., 140, 363, 1995. 115. Chan, M.C.W. et al. Sapovirus detection by quantitative realtime RT-PCR in clinical stool specimens. J. Virol. Methods, 134, 146, 2006. 116. Jansen, R.W., Siegl, G. and Lemon, S.M. Molecular epidemiology of human hepatitis A virus defined by an antigencapture polymerase chain reaction method. Proc. Natl. Acad. Sci. USA, 87, 2867, 1990. 117. Papafragkou, E. et al. Rapid and sensitive detection of hepatitis A virus in representative food matrices. J. Virol. Methods, 147, 177, 2008. 118. Jean, J. et al. Simultaneous detection and identification of hepatitis A virus and rotavirus by multiplex nucleic acid sequence-based amplification (NASBA) and microtiter plate hybridization system. J. Virol. Methods, 105, 123, 2002. 119. Saito, H. et al. Application of RT-PCR designed from the sequence of the local SRSV strain to the screening in viral gastroenteritis outbreaks. Microbiol. Immunol., 42, 439, 1998. 120. Jonassen, C.M. et al. Comparison of capsid sequences from human and animal astroviruses. J. Gen. Virol., 82, 1061, 2001. 121. Jiang, B. et al. Sequence conservation and expression of the gene encoding the outer capsid glycoprotein among human group C rotaviruses of global distribution. Arch. Virol., 141, 381, 1996. 122. Atmar, R.L. et al. Detection of enteric viruses in oysters by using the polymerase chain reaction. Appl. Environ. Microbiol., 69, 631, 1993.
18 123. Sánchez, G. et al. Hepatitis A virus. In Methods in Molecular Biology, Spencer, J.F.T. and Ragout de Spencer, A.L. (eds). Humana Press, Inc., Totowa, NJ, 2004. 124. Kämmerer, U., Kunkel, B. and Korn, K. Nested PCR for specific detection and rapid identification of human Picornaviruses. J. Clin. Microbiol., 32, 285, 1994. 125. Rivera, V.M., Welsh, J.D. and Maizel, J.V. Jr. Comparative sequence analysis of the 5′ noncoding region of the Enteroviruses and Rhinoviruses. Virology, 165, 42, 1988. 126. Ng, L.F.P. et al. Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay. BMC Infect. Dis., 6, 40, 2006. 127. Royuela, R., Negredo, A. and Sánchez-Fauquier, A. Development of a one step real-time RT-PCR method for sensitive detection of human astrovirus. J. Virol. Methods, 133, 14, 2006. 128. Woese, C. Bacterial evolution. Microbiol. Rev., 51, 221, 1987. 129. Sogin, M.L. and Silberman, J.D. Evolution of the protists and protistan parasites from the perspective of molecular systematics. Int. J. Parasitol., 28, 11, 1998. 130. Rudi, K. et al. Rapid identification and classification of bacteria by 16S rDNA restriction fragment melting curve analyses. Food Microbiol., 24, 474, 2007. 131. Jensen, M.A., Webster, J.A. and Straus, N. Rapid identification of bacteria on the basis of polymerase chain reaction-amplified ribosomal DNA spacer polymorphisms. Appl. Environ. Microbiol., 59, 945, 1993. 132. Santín, M., Trout, J.M. and Fayer, R. Prevalence of Enterocytozoon bieneusi in post-weaned dairy calves in the eastern United States. Parasitol. Res., 93, 287, 2004. 133. Dzikowski, R. et al. Use of rDNA polymorphism for identification of Heterophyidae infecting freshwater fishes. Dis. Aquat. Organ., 59, 35, 2004. 134. Gómez-Couso, H. et al. Detection of Cryptosporidium and Giardia in molluscan shellfish by multiplexed nested-PCR. Int. J. Food Microbiol., 91, 279, 2004. 135. Nazar, R.N. et al. Potential use of PCR-amplified ribosomal intergenic sequences in the detection and differentiation of verticillium wilt pathogens. Physiol. Mol. Plant Pathol., 39, 1, 1991. 136. Molander, A. et al. A protocol for polymerase chain reaction detection of Entercoccus faecalis and Enterococcus faecium from the root canal. Int. Endodon. J., 35, 1, 2002. 137. Schmidt-Heydt, M. and Geisen, R. A microarray for monitoring the production of mycotoxins in foods. Int. J. Food Microbiol., 117, 131, 2007. 138. Kusaba, M. and Tsuge, T. Phylogeny of Alternaria fungi known to produce host-specific toxins on the basis of variation in internal transcribed spacers of ribosomal DNA. Curr. Genet., 28, 491, 1995. 139. Zur, G. et al. Detection of Alternaria fungal contamination in cereal grains by a polymerase chain reaction-based assay. J. Food Prot., 65, 1433, 2002. 140. Rochelle, P.A. et al. Comparison of primers and optimization of PCR conditions for detection of Cryptosporidium parvum and Giardia lamblia in water. Appl. Environ. Microbiol., 63, 106, 1997. 141. Fletcher, L.D. et al. Structure, expression and phylogenetic analysis of the gene encoding actin I in Pneumocystic carinii. Genetics, 137, 743, 1994. 142. Schroeder, S. et al. The β-tubulin gene is a useful target for PCR-based detection of an albino Ophiostoma piliferum used in biological control of sapstain. Eur. J. Plant Pathol., 108, 793, 2002.
Molecular Detection of Foodborne Pathogens 143. Morello, L.G. et al. Detection and quantification of Aspergillus westerdijkiae in coffee beans based on selective amplification of β-tubulin gene by using real-time PCR. Int. J. Food Microbiol., 119, 270, 2007. 144. Mahbubani, M.H. et al. Detection of Giardia in environmental waters by immuno-PCR amplification methods. Curr. Microbiol., 36, 107, 1998. 145. Guy, R.A. et al. Real-time PCR for quantification of Giardia and Cryptosporidium in environmental water samples and sewage. Appl. Environ. Microbiol., 69, 5178, 2003. 146. Hacker, J. and Kaper, J.B. Pathogenicity islands and the evolution of microbes. Ann. Rev. Microbiol., 54, 641, 2000. 147. Gasanov, U., Hughes, D. and Hansbro, P.M. Methods for the isolation and identification of Listeria spp. and Listeria monocytogenes: a review. FEMS Microbiol. Rev., 29, 851, 2005. 148. Villalobo, E. and Torres, A. PCR for detection of Shigella spp. in mayonnaise. Appl. Environ. Microbiol., 64, 1242, 1998. 149. Panicker, G. et al. Detection of pathogenic Vibrio spp. in shellfish by using multiplex PCR and DNA microarrays. Appl. Environ. Microbiol., 70, 7436, 2004. 150. Panicker, G., Myers, M.L. and Bej, A.K. Rapid detection of Vibrio vulnificus in shellfish and Gulf of Mexico water by real-time PCR. Appl. Environ. Microbiol., 70, 498, 2004. 151. Bej, A.K. et al. Detection of total and hemolysin-producing Vibrio parahaemolyticus in shellfish using multiplex PCR amplification of tl, tdh, and trh. J. Microbiol. Methods, 36, 215, 1999. 152. Kingombe, C.I.B. et al. PCR detection, characterization, and distribution of virulence genes in Aeromonas spp. Appl. Environ. Microbiol., 65, 5293, 1999. 153. Wannet, W.J.B. et al. Detection of pathogenic Yersinia enterocolitica by a rapid and sensitive duplex PCR assay. J. Clin. Microbiol., 39, 4483, 2001. 154. Wang, G. et al. Detection and characterization of the hemoloysin genes in Aeromonas hydrophila and Aeromonas sobria by multiplex PCR. J. Clin. Microbiol., 41, 1048, 2003. 155. Blaiotta, G. et al. PCR detection of staphylococcal enterotoxin genes in Staphylococcus spp. strains isolated from meat and dairy products. Evidence for new variants of seG and seI in S. aureus AB-8802. J. Appl. Microbiol., 97, 719, 2004. 156. Fricker, M. et al. Diagnostic real-time PCR assays for the detection of emetic Bacillus cereus strains in foods and recent foodborne outbreaks. Appl. Environ. Microbiol., 73, 1892, 2007. 157. Yoon, S.-Y. et al. Application of real-time PCR for quantitative detection of Clostridium botulinum type A toxin gene in food. Microbiol. Immunol., 49, 505, 2005. 158. Andersen, B. et al. Real-time PCR quantificaton of the AM-toxin gene and HPLC qualification of toxigenic metabolites from Alternaria species from apples. Int. J. Food Microbiol., 111, 105, 2006. 159. Shapira, R. et al. Detection of aflatoxigenic molds in grains by PCR. Appl. Environ. Microbiol., 62, 3270, 1996. 160. Mayer, Z. et al. Quantification of the copy number of nor-1, a gene of the aflatoxin biosynthetic pathway by real-time PCR, and its correlation to the cfu of Aspergillus flavus in foods. Int. J. Food Microbiol., 82, 143, 2003. 161. Bluhm, B.H., Cousin, M.A. and Woloshuk, C.P. Multiplex real-time PCR detection of fumonisin-producing and trichothecene-producing groups of Fusarium species. J. Food Prot., 67, 536, 2004. 162. Geisen, R. et al. Development of a real time PCR system for detection of Penicillium nordicum and for monitoring ochratoxin A production in foods by targeting the ochratoxin polyketide synthase gene. System. Appl. Microbiol., 27, 501, 2004.
Molecular Detection: Principles and Methods 163. Samosornsuk, W. et al. Evaluation of a cytolethal distending toxin (cdt) gene-based species-specific multiplex PCR assay for the identification of Campylobacter strains isolated from poultry in Thailand. Microbiol. Immunol., 51, 909, 2007. 164. Chen, S. et al. An automated fluorescent PCR method for detection of shiga toxin-producing Escherichia coli in foods. Appl. Environ. Microbiol., 64, 4210, 1998. 165. Cebula, T.A., Payne, W.L. and Feng, P. Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR. Appl. Environ. Microbiol., 33, 248, 1995. 166. Alarcón, B., Vicedo, B. and Aznar, R. PCR-based procedures for detection and quantification of Staphylococcus aureus and their application in food. J. Appl. Microbiol., 100, 352, 2006. 167. Barkstad, O.G., Aasbakk, K. and Maeland, J.A. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J. Clin. Microbiol., 30, 1654, 1992. 168. Bogdanovich, T. et al. Validated 5’ nuclease PCR assay for rapid identification of the genus Brucella. J. Clin. Microbiol., 42, 2261, 2004. 169. Novak, R.T. et al. Development and evaluation of a realtime PCR assay targeting the type III secretion system of Burkholderia pseudomallei. J. Clin. Microbiol., 44, 85, 2006. 170. Ercolini, D. et al. Simultaneous detection of Pseudomonas fragi, P. lundensis, and P. putida from meat by use of a multiplex PCR assay targeting the carA gene. Appl. Environ. Microbiol., 73, 2354, 2007. 171. Kim, J. et al. Simultaneous detection by PCR of Escherichia coli, Listeria monocytogenes, and Salmonella typhimurium in artificially inoculated wheat grain. Int. J. Food Microbiol., 111, 21, 2006. 172. McDaniels, A.E. et al. Confirmational identification of Escherichia coli, a comparison of genotypic and phenotypic assays for glutamate decarboxylase and β-D-glucuronidase. Appl. Environ. Microbiol., 62, 3350, 1996. 173. Bäumler, A.J., Heffron, F. and Reissbrodt, R. Rapid detection of Salmonella enterica with primers specific for iroB. J. Clin. Microbiol., 35, 1224, 1997. 174. Soumet, C. et al. An immunoconcentration-PCR assay to detect Salmonella in the environment of poultry houses. Int. J. Food Microbiol., 48, 221, 1999. 175. Hill, J.E., Town, J.R. and Hemmingsen, S.M. Improved template representation in cpn 60 polymerase chain reaction (PCR) product libraries generated from complex templates by application of a specific mixture of PCR primers. Environ. Microbiol., 8, 741, 2006. 176. Erickson, B.D. et al. Nucleotide sequence of the rpsU-dnaGrpoD operon from Salmonella typhimurium and a comparison of this sequence with the homologous operon of Escherichia coli. Gene, 40, 67, 1985. 177. Versalovic, J. et al. Conservation and evolution of the rpsUdnaG-rpoD macromolecular synthesis operon in bacteria. Mol. Microbiol., 8, 343, 1993. 178. Seo, K.H. and Brackett, R.E. Rapid, specific detection of Enterobacteri sakazakii in infant formular using a real-time PCR assay. J. Food Prot., 68, 59, 2005. 179. Lin, M.-H. et al. Real-time PCR for quantitiative detection of Toxoplasma gondii. J. Clin. Microbiol., 38, 4121, 2000. 180. Burg, J.L. et al. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J. Clin. Microbiol., 27, 1787, 1989.
19 181. Faubert, G. Immune response to Giardia duodenalis. Clin. Microbiol. Rev., 13, 35, 2000. 182. Wonratanacheewin, S. et al. Development of a PCR-based method for the detection of Opisthorchis veverrini in experimentally infected hamsters. Parasitology, 122, 175, 2001. 183. Parvathi, A. et al. Clonorchis sinensis: development and evaluation of a nested polymerase chain reaction (PCR) assay. Exp. Parasitol., 115, 291, 2007. 184. Kaplan, R.M. et al. A repetitive DNA probe for the sensitive detection of Fasciola hepatica in infected snails. Int. J. Parasitol., 25, 601, 1995. 185. Maleewong, W. et al. Detection of Paragonimus heterotremus in experimentally infected cat feces by antigen captureELISA and by DNA hybridization. J. Parasitol., 83, 1075, 1997. 186. González, L.M. et al. Differential diagnosis of Taenia saginata and Taenia solium infection by PCR. J. Clin. Microbiol., 38, 737, 2000. 187. Pillai, S.R. and Jayarao, B.M. Application of IS900 PCR for detection of Mycobacterium avium subsp. paratuberculosis directly from raw milk. J. Dairy Sci., 85, 1052, 2002. 188. Ravva, S.V. and Stanker, L. H. Real-time quantitative PCR detection of Mycobacterium avium subsp. paratuberculosis and differentiation from other mycobacteria using SYBR green and TaqMan assays. J. Microbiol. Methods, 63, 305, 2005. 189. Bull, T.J. et al. Characterization of IS900 loci in Mycoba cterium avium subsp. paratuberculosis and development of multiplex PCR typing. Microbiology 146, 2185, 2000. 190. O’Leary, S., Sheahan, M. and Sweeney, T. Brucella abortus detection by PCR assay in blood, milk and lymph tissue of serologically positive cows. Res. Vet. Sci., 81, 170, 2006. 191. Boore, J.L. Animal mitochondrial genomes. Nucleic Acid Res., 27, 1767, 1999. 192. Le, T.H., Blair, D. and McManus, D.P. Mitochondrial DNA sequences of human schistosomes: the current status. Int. J. Parasitol., 30, 283, 2000. 193. López, V. et al. A simplified procedure to analyse mitochondrial DNA from industrial yeasts. Int. J. Food Microbiol., 68, 75, 2001. 194. Le, T.H. et al. Clonorchis sinensis and Opisthorchis viverrini: development of a mitochondiral-based multiplex PCR for their identification and discrimination. Exp. Parasitol., 112, 109, 2006. 195. Kim, K.-H. et al. Characterization of the complete mitochondrial genome of Diphyllobothrium nihonkaiense (Diphyllobothriidae: Cestoda) and development of molecular markers for differentiating fish tapeworms. Mol. Cells, 23, 379, 2007. 196. Cucher, M.A. et al. PCR diagnosis of Fasciola hepatica in field-collected Lymnaea columella and Lymnaea viatrix snails. Vet. Parasitol., 137, 74, 2006. 197. Marois, C. et al. Multiplex PCR assay for detection of Streptococcus suis species serotypes 2 and 1/2 in tonsils of live and dead pigs. J. Clin. Microbiol., 42, 3169, 2004. 198. Wisselink, H.J., Joosten, J.J. and Smith, H.E. Multiplex PCR assays for simultaneous detection of six major serotypes and two virulence-associated phenotypes of Streptococcus suis in tonsillar specimens from pigs. J. Clin. Microbiol., 40, 2922, 2002. 199. Morin, N.J., Gong, Z. and Li, X.-F. Reverse transcription-multiplex PCR assay for simultaneous detection of Escherichia coli O157:H7, Vibro cholerae O1, and Salmonella typhi. Clin. Chem., 50, 2037, 2004.
20 200. Harmon, K.M., Ransom, G.M. and Wesley, I.V. Differentiation of Campylobacter jejuni and Campylobacter coli by polymerase chain reaction. Mol. Cell. Probes, 11, 195, 1997. 201. Gannon, V.P.J. et al. Use of the flagellar H7 gene as a target in multiplex PCR assays and improved specificity in identification of enterhemorrhagic Escherichia coli strains. J. Clin. Microbiol., 35, 656, 1997. 202. Hussain, M. et al. eap gene as novel target for specific identification of Staphylococcus aureus. J. Clin. Microbiol., 46, 470, 2008. 203. Imaoka, K. et al. Simultaneous detection of the genus Brucella by combinatorial PCR. Jpn. J. Infect. Dis., 60, 137, 2007. 204. Tantillo, G.M., Di Pinto, A. and Buonavoglia, C. Detection of Brucella spp. in soft cheese by semi-nested polymerase chain reaction. J. Dairy Res., 70, 245, 2003.
Molecular Detection of Foodborne Pathogens 205. Mayta, H. et al. Nested PCR for specific diagnosis of Taenia solium taeniasis. J. Clin. Microbiol., 46, 286, 2008. 206. Laberge, I. et al. Detection of Cryptosporidium parvum in raw milk by PCR and oligonucleotide probe hybridization. Appl. Environ. Microbiol., 62, 3259, 1996. 207. Wiedenmann, A., Krüger, P. and Botzenhart, K. PCR detection of Cryptosporidium parvum in environmental samples--a review of published protocols and current developments. J. Ind. Microbiol. Biotechnol., 21, 150, 1998. 208. Josefsen, M.H. et al. Validation of a PCR-based method for detection of food-borne thermotolerany Campylobacters in a multicenter collaborative trial. Appl. Environ. Microbiol., 70, 4379, 2004. 209. Feng, P. Impact of molecular biology on the detection of foodborne pathogens. Mol. Biotechnol., 7, 267, 1997.
Section I Foodborne Viruses
2 Adenoviruses Charles P. Gerba
University of Arizona
Roberto A. Rodríguez
University of North Carolina
Contents 2.1 Introduction......................................................................................................................................................................... 23 2.1.1 Classification and Morphology................................................................................................................................ 23 2.1.2 Biology, Pathogenesis, and Medical Importance..................................................................................................... 24 2.1.2.1 Gastroenteritis........................................................................................................................................... 25 2.1.2.2 Respiratory Infections............................................................................................................................... 25 2.1.2.3 Pharyngoconjunctival Fever (PCF)........................................................................................................... 25 2.1.2.4 Eye Infections............................................................................................................................................ 25 2.1.2.5 Obesity...................................................................................................................................................... 25 2.1.2.6 Morbidity and Mortality............................................................................................................................ 25 2.1.2.7 Impact on the Immunocompromised........................................................................................................ 25 2.1.2.8 Water- and Foodborne Outbreaks............................................................................................................. 25 2.1.2.9 Occurrence in Water................................................................................................................................. 26 2.1.2.10 Occurrence in Shellfish............................................................................................................................. 26 2.1.2.11 Survival in the Environment and Shellfish............................................................................................... 26 2.1.3 Identification and Diagnosis.................................................................................................................................... 27 2.1.3.1 Culture-Based Techniques........................................................................................................................ 27 2.1.3.2 Antibody-Based Methods.......................................................................................................................... 27 2.1.3.3 Nucleic Acid Probes.................................................................................................................................. 27 2.1.3.4 PCR-Based Techniques............................................................................................................................. 27 2.1.3.5 Integrated Techniques............................................................................................................................... 27 2.2 Methods............................................................................................................................................................................... 28 2.2.1 Sample Preparation.................................................................................................................................................. 28 2.2.2 Detection Procedures............................................................................................................................................... 29 2.3 Conclusions and Future Perspectives.................................................................................................................................. 30 References.................................................................................................................................................................................... 31
2.1 Introduction The potential for the transmission of adenoviruses by foods has only recently received attention and has been almost entirely focused on shellfish. Transmission of adenovirus eye and respiratory infections by recreational waters, however, has been well documented. Recent outbreaks have suggested that adenoviruses can also be transmitted by drinking water. Association of adenoviruses with water and food outbreaks is difficult because of the wide variety of illnesses that the viruses can cause, and of large number of asymptomatic cases. This is exacerbated by the fact that being a nonreportable disease, adenovirus infection is often associated with illnesses not considered foodborne (respiratory infections). Still occurrence of these viruses in food and water should be taken as an indication of their potential to be transmitted by
these routes. The application of molecular methods has been key in our understanding of exposure by food and water.
2.1.1 Classification and Morphology The human adenoviruses belong to the genus Mastadenovirus in the family Adenoviridae and consist of at least 51 serotypes. These serotypes are divided into six subgenera labeled A through F. Each serotype is distinguished by its resistance to neutralization by antisera to other known adenovirus serotypes.1 Table 2.1 outlines the current classification scheme for human adenovirus serotypes. Adenoviruses have a nonenveloped, icosahedral virion that consists of a core containing linear double-stranded DNA (26–45 kb) enclosed by a capsid.2 The capsid is composed of 252 capsomers, 240 of which are hexons and 12 of which 23
24
Molecular Detection of Foodborne Pathogens
are pentons. Each penton projects a single fiber that varies in length for each serotype, an exception being the pentons of the enteric adenoviruses (serotypes 40 and 41) that project two fibers.1 Adenoviruses are approximately 70–100 nm in diameter.
2.1.2 Biology, Pathogenesis, and Medical Importance Due to their physical, chemical, and structural properties, adenoviruses may survive extended periods of time outside host cells. They are stable in the presence of many physical and chemical agents, as well as adverse pH conditions. For example, adenoviruses are resistant to lipid solvents due to the lack of lipids within their structure.4 Infectivity is optimal between pH 6.5 and 7.4; however, the viruses can withstand pH ranges between 5.0 and 9.0. Adenoviruses are heat resistant (particularly type 4) and may remain infectious after freezing.5 Table 2.1 Human Adenovirus Serotype Classification Subegenera A B C D E F
Serotypes 12, 18, 31 3, 7, 11, 14, 16, 21, 34, 35, 50 1, 2, 5, 6 8–10, 13, 15, 17, 19, 20, 22–30, 32, 33, 36–39, 42–49, 51 4 40, 41
Source: Adapted from Shenk, T., Adenoviridae: The viruses and their replication. In Fields Virology, 4th edn. Knipe, D.M. et al. (Eds.), Lippincott Williams and Wilkins, Philadelphia, PA, 2001, and van Regenmortel, M.H.V. et al., Virus Taxonomy: Seventh Report of the International Committee on Taxonomy of Viruses, Academic Press, San Diego, CA, 2000.
Routes of infection include the mouth, nasopharynx and the ocular conjunctiva. Less frequently, the virus can become systemic and affect the bladder, liver, pancreas, myocardium or central nervous system.6 Of the 51 currently recognized human serotypes (a serotype 52 has been proposed), only onethird are associated with a specific human disease (Table 2.2). Other infections remain largely asymptomatic. Adenoviruses are associated with a variety of types of clinical illnesses involving almost every human organ system. Illnesses include upper (pharyngitis and tonsillitis) and lower (bronchitis, bronchiolitis, and pneumonia) respiratory illnesses, conjunctivitis, cystitis, and gastroenteritis. Several studies have found that the enteric adenoviruses are second only to rotaviruses as the causative agents of acute gastroenteritis in infants and young children.7,8 Most illnesses caused by adenoviruses are acute and self-limiting. Although the symptomatic phase may be short, all adenoviruses can remain in the gastrointestinal tract and continue to be excreted for an extended period of time. Species within subgenera C may continue to be excreted for months or even years after disease symptoms have resolved. Adenoviruses can remain latent in the body (in tonsils, lymphocytes and adenoidal tissues) for years and be reactivated under certain conditions, such as a change in immune status. The long-term effect of such a latent infection is unknown.5 Adenovirus infections may be accompanied by diarrhea, though the virus can be excreted even if diarrhea is not present.7 A large proportion of infections caused by subgenera A and D tend to be asymptomatic, whereas the species within subgenera B and E tend to result in a higher rate of symptomatic respiratory illnesses. Immunity is species-specific. The presence of pre-existing antibodies resulting from a previous infection is usually protective. It is difficult to confidently link all adenoviruses to specific illnesses because many infections may be asymptomatic, healthy people can shed viruses.5 Occurrence studies comparing infection in healthy and ill people have found
Table 2.2 Common Illnesses Associated with Human Adenoviruses Disease Acute febrile pharyngitis Pharyngoconjunctival fever Acute respiratory disease Pneumonia Epidemic keratoconjunctivitis Follicular conjunctivitis Gastroenteritis/diarrhea Urinary tract Colon Hepatitis
Individual at Risk Infants, young children School-aged children Military recruits Infants, young children, military recruits Any Infants, young children Infants, young children Bone marrow, liver or kidney transplant recipients, AIDS victims or immunosuppressed
Serotypes 1–3, 5–7 3, 7, 14 3, 4, 7, 14, 16, 21 1–3, 4, 6, 7, 14, 16 8–11,13, 15, 17, 19, 20, 22–29, 37 3, 7 18, 31, 40, 41 34,35 42–49 1, 2, 5
Source: Adapted from Horwitz, M.S., Adenoviruses. In Fields Virology, 4th edn. Knipe, D.M. et al. (Eds.), Lippincott, Williams and Wilkins, Philadelphia, PA, 2001; and Enriquez, C.E., Adenoviruses. In Encyclopedia of Environmental Microbiology, Bitton, G. (Ed.), John Wiley and Sons, New York, 2002.
Adenoviruses
25
between 0 and 20% of asymptomatic people can shed adenovirus.
complete recovery. Ad3 and Ad7 are the most commonly isolated species.6
2.1.2.1 Gastroenteritis Estimates of the incidence of adenovirus gastroenteritis in the world have ranged from 1.5 to 12%. Enteric adenoviruses are second only to rotaviruses as the leading causes of childhood gastroenteritis.7,9 Diarrhea is usually associated with fever and can last for up to two weeks. Though diarrhea can occur during infection by any type of adenovirus, Ad40 and Ad41 of subgenus F specifically cause gastroenteritis and diarrhea. Adenovirus type 31 (Ad31) is also suspected of causing infantile gastroenteritis. Some estimate that Ad40/41 contribute from 5 to 20% of hospitalizations for diarrhea in developed countries.10
2.1.2.5 Obesity There is accumulating evidence that several viruses may be involved in obesity in animals and humans.14 Studies in chickens, mice and nonhuman primates indicate that Ad36 can cause obesity.15 Obese humans have a higher prevalence of serum antibodies to Ad36 than lean humans.16 Other adenoviruses are capable of causing obesity in animals, but no correlation with antibodies has been demonstrated.16 The metabolic and molecular mechanisms of how adenovirus infections cause obesity are not precisely understood; however, increases in food intake alone cannot explain the observed increases in adiposity (tendency to store fat), suggesting that Ad36 induces metabolic changes.17 One mechanism appears to be that Ad36 influences the differentiation of preadipocyte.17
2.1.2.2 Respiratory Infections Over 5% of respiratory illnesses in children younger than 5 years of age are due to adenovirus infections.11 The initial transmission of adenoviruses is through the nasopharynx. Secondary transmission in households can be as high as 50% due to fecal-oral transmission from children shedding virus in the feces. Adenoviruses can be recovered from the throat or stool of an infected child for up to three weeks.6 Adenovirus respiratory infections are also well documented in adults. 2.1.2.3 Pharyngoconjunctival Fever (PCF) Pharyngoconjunctival fever (PCF) refers to a syndrome of pharyngitis, conjunctivitis, and spiking fever.5 Symptoms of this syndrome include unilateral or bilateral conjunctivitis, mild throat tenderness, and fever. The illness usually lasts from 5 to 7 days, with no permanent eye damage.4 The most commonly isolated adenovirus serotype is 3, although 7 and 14 have also been associated.6 The disease is best known for centering on summer camps, pools, and small lakes.12,13 Transmission of the agent appears to require direct contact with the water, allowing the virus direct contact with the eyes or upper respiratory tract. Secondary spread is common, although adults contracting the disease tend to have milder symptoms, usually only conjunctivitis. 2.1.2.4 Eye Infections Epidemic keratoconjunctivitis (EKC) is a syndrome which causes inflammation of the conjunctiva and cornea. EKC was once referred to as “Shipyard Eye,” as it was first described in shipyard workers.6 EKC is considered highly contagious and begins with edema of the eyelids, pain, shedding tears, and photophobia. Serotypes 8, 11, 19, and 37 can cause EKC. Transmission occurs through direct contact with eye secretions from an infected person as well as through contact with contaminated surfaces, eye instruments, ophthalmic solutions, towels, or hands of medical personnel. Outbreaks have involved mostly adults. Follicular conjunctivitis is often contracted by swimming in inadequately chlorinated swimming pools or in lakes during the summer.6 Most cases result in only mild illness and
2.1.2.6 Morbidity and Mortality Since adenovirus is not a reportable disease agent, there are no national or population-based morbidity and mortality figures available; most of the epidemiological data come from the study of select populations who appear to be most affected by adenovirus exposure. These include children in institutions such as hospitals and daycare centers, military recruits, immunocompromised individuals, and groups of families. Enteric infection in children results in disease 50% of the time. This percentage is greater when the infection is centered in the respiratory tract.5 Attack rates for waterborne outbreaks have been as high as 67% in children, with secondary attack rates (person-to-person transmission) of 19% for adults and 63% for children.5 2.1.2.7 Impact on the Immunocompromised Although adenovirus infection may result in mild or asymptomatic infections in the immuno competent in the immunocompromised, the virus can disseminate into any body system and cause pneumonitis, meningoencephalitis, hepatitis (especially in liver and bone marrow transplant patients), and hemorrhagic cystitis (especially in kidney transplant patients).5 According to Hierholzer18 over 11% of transplant recipients become infected with adenoviruses, with an 18% case fatality rate. The enteric adenoviruses are rarely isolated from immunocompromised patients with gastroenteritis or diarrhea and are generally not associated with serious illness in the immunocompromised. 2.1.2.8 Water- and Foodborne Outbreaks Although adenoviruses have been detected in shellfish no foodborne outbreaks have been documented to date. This may be a simple reflection that the virus is never considered a cause and thus no testing is perform to assess if adenoviruses could be involved. However, contact with recreational water has been associated with numerous adenovirus outbreaks over the years. Adenoviruses are the most reported cause of swimming pool outbreaks associated with viruses. Many outbreaks of PCF from nonenteric adenoviruses have come from people
26
swimming in pools and lakes. Ad3, Ad4, Ad7, and Ad14 have been associated with outbreaks in swimming pools19,20 and the adenoviruses have been detected in pool waters after outbreaks.12 It is clear that nondisinfected or inadequately disinfected recreational water is a source of adenovirus infection in swimmers. A routine monitoring of chlorinated swimming pools in South Africa demonstrated the presence of adenovirus by polymerase chain reaction (PCR) in 26 of 93 (15.4%) samples.20 While the detection method did not assess virus viability, it did demonstrate the widespread occurrence of adenoviruses in swimming pools. There have been three drinking water outbreaks reported in Europe in which enteric adenoviruses may have been a cause of gastroenteritis.21–23 Multiple viral agents were involved and the water had not been adequately disinfected. 2.1.2.9 Occurrence in Water Limited data has been available on the occurrences of adenoviruses in water. Only since the development of molecular methods for the direct detection of adenoviruses in water with confirmation tests performed in cell culture has data become available. Adenoviruses have been isolated from wastewater and river water, often more frequently and at higher concentrations than the enteroviruses.24–27 Adenoviruses have also been detected in sewage, rivers, oceans, swimming pools. Adenoviruses are commonly detected in raw and nondisinfected secondary sewage discharges, although little published data is available for the U.S. In Spain, monthly samples of raw sewage, effluent, river water, and seawater were tested using nested PCR amplification. Adenovirus was detected in 14 of 15 sewage, two of three effluent, 15 of 23 river water, and seven of nine seawater samples. Samples that were positive for enterovirus or hepatitis A were also positive for adenovirus, but there was no correlation between the fecal coliform level and adenovirus occurrence.26 In Greece, 36 samples of sewage effluent were tested over a 15-month period using cell culture. Adenovirus was detected in all samples with concentrations ranging from 70 to 3200 cytopathic units (CPU)/l. In Australia,24 raw sewage, primary effluent, and secondary effluent were sampled over a year using cell culture; 25 of 26 raw sewage, 23 of 26 primary effluent and 23 of 26 secondary effluent samples were positive for adenovirus.28 The mean concentrations in sewage, primary effluent, and secondary effluent were 1950, 1350, and 250 infectious units (IU)/l, respectively. Enteroviruses were removed to a greater extent than adenoviruses by activated sludge treatment.24 Both respiratory and enteric adenoviruses have been isolated from surface waters worldwide. Nevertheless, survey data is limited in the U.S. An evaluation of 29 surface water samples in the U.S. yielded 38% positive for infectious Ad40 and Ad41.29 The concentration of Ad40/41 ranged from 1.03 to 3.23 per 100 l. In this study, adenoviruses were more common in surface waters than enteroviruses and astroviruses. Likewise, when comparative studies have been conducted, adenoviruses usually outnumber enteroviruses in surface waters. Infectious adenoviruses have been detected in conventionally treated and disinfected drinking water in Africa and Asia
Molecular Detection of Foodborne Pathogens
using genome detection with PCR in cell culture.30,31 In both of these studies, adenoviruses were commonly detected in the raw, untreated surface water. In one study, adenoviruses were found in 4.4% of the finished drinking water samples that met the current acceptable bacteriological standards. In the other study, adenoviruses were detected at concentrations ranging from 0 to 0.9 most probable number (MPN)/100 l. In the van Heerden et al. study it was noted that none of the adenoviruses growing in cell culture produced cytopathic effects (CPE). 2.1.2.10 Occurrence in Shellfish Interest in the occurrence of adenoviruses in shellfish largely stems from their potential as indicators of other enteric viruses and fecal pollution.26 As with sewage and surface waters adenoviruses appear to be in greater numbers or at least isolated more commonly in shellfish than other enteric viruses, which may be a reflection of their greater stability in the environment.32 In addition, being a DNA virus eliminates the added steps for detection enteric RNA viruses needed for reverse transcription-PCR (RT-PCR). Although cell culture has been used to a limited degree PCR has been the method of choice, because of the long incubation times required for production of cytopathogenic effects in cell culture required for adenoviruses. Adenoviruses have been reported from every continent where shellfish are harvested. In Spain reported that of the mussels and oysters tested 47% contained adenoviruses, 19% enteroviruses, and 24% hepatitis A virus.33 In a multilaboratory study of virus contamination of shellfish in Europe human adenoviruses detected by PCR where found to correlate with the presence of other human enteric viruses and suggested they could be useful as a molecular index of viral contamination of shellfish.34 In a study in Korea adenoviruses was detected in 89% of the oysters collected from several locations.35 In India adenoviruses were detected in 17% of the oysters and 27% of clam samples, but noroviruses and hepatitis A virus were detected.36 However, enteroviruses were isolated with a greater frequency, 37% for oysters and 46% for clams. 2.1.2.11 Survival in the Environment and Shellfish Limited data suggests that adenoviruses survive longer in water than enteroviruses and hepatitis A virus.37 Adenoviruses also exhibit greater thermal stability than enteroviruses. This may explain their longer survival in water. They are capable of surviving for months in water, especially at low temperatures. The double-stranded DNA that comprises the genome of the virus may provide more stability in the environment. In addition, adenoviruses may use host cell repair enzymes to repair damaged DNA. This may also prolong their survival in the environment and enhance their resistance to inactivation by ultraviolet light. Qualitative PCR analyses of adenovirus DNA in oysters and mussels demonstrated that Ad35 could be detected for 6–8 weeks.38 In contrast the virus was detected in cell culture for 4–6 weeks.
Adenoviruses
2.1.3 Identification and Diagnosis 2.1.3.1 Culture-Based Techniques Adenovirus subgenera A through E can be cultured in human cell lines, albeit slowly,39,40 and thus may be overgrown by other faster growing viruses. They also require more than one passage in cell culture for expression of CPE. For this reason usually TCID50 or MPN methods are used for their quantification in environmental samples27 Guanidine can be added to cultures to selectively suppress enteroviruses while allowing adenoviruses to grow.25 A variety of cell lines have been used to grow and/or detect adenovirus such as HeLa cells,24,41 HEp-2 cells,28,41 293 cells,42 Chang conjunctival cells,43 CaCo-2 cells,44 and PLC/PRF/5 cells.43 Hurst et al.25 found that the number of infectious adenoviruses obtained by observing CPE in the 293 cell line was five-fold greater than the number detected via CPE in HEp-2 cells with sewage samples. Based on these findings and those of Takiff et al.45 they suggested that HEp-2 cells might not be as appropriate for detecting Ad40 and Ad41 as 293 cells. The use of HEp-2 cells might miss the enteric adenoviruses that may constitute up to 80% of the adenoviruses found in raw sewage. This might explain the findings of Tani et al.41 who, unlike other researchers, detected adenoviruses at much lower numbers than the enteroviruses in sewage, but relied on the use of the HeLa and HEp-2 cell lines. Grabow et al.43 determined that the PLC/PRF/5 liver cell line was more sensitive for detecting Ad41 and also exhibited CPE earlier than 293 cells and Chang conjunctival cells; however, while Ad40 may be grown using the PLC/PRF/5 cell line, CPE is not observed.43 This cell line has been used to study the survival and recovery, respectively, of Ad40 and Ad41 in water.19,37 also reported that the PLC/PRF/5 cell line was at least as sensitive as the HEp-2 cell line for isolating the lower-numbered serotypes (i.e., Ad1, Ad2, Ad3, Ad5, Ad6, and Ad7). Although BGM is the most common cell line used for isolation of enteric viruses from environmental samples adenoviruses will not produce CPE in this cell line although they can be detected by ICC-PCR.27,35 2.1.3.2 Antibody-Based Methods Antibody-based techniques have been developed for detecting and identifying adenoviruses in clinical samples, but have rarely been used with environmental samples. Both groupspecific techniques (e.g., detecting all human or primate adenoviruses only) and species-specific techniques (e.g., detecting Ad40 or Ad41 only) have been developed. A group-specific indirect immunofluorescence technique has been used to observe nongrowing (do not replicate or produce CPE) adenoviruses obtained from stool samples in tissue cultures.46 Only two studies have used antibody techniques for adenovirus detection in environmental samples. One used a group-specific immunofluorescence assay to detect adenoviruses in primary sludge from wastewater treatment plants.47 The viruses were visualized in HEp-2 cell cultures in which primary sludge concentrate had been added. The second study compared cell
27
culture, immunofluorescence, and in situ DNA hybridization methods for the detection of the enteric adenoviruses in raw sewage.25 While one of the cell-culture methods (using HEp-2 cells) and the immunofluorescence method (using groupspecific antibodies) yielded nearly equivalent results, the average levels detected using the in situ DNA hybridization technique were approximately 40% greater. 2.1.3.3 Nucleic Acid Probes Gene probes have been developed to detect enteric adenoviruses in clinical and environmental samples, but have thus far seen limited use because they are not as sensitive or as easy to use as PCR methods. Genthe et al.48 used Ad40 and Ad41 specific digoxigenin (DIG)-labeled DNA probes for enteric adenovirus detection in both raw and treated water. Nevertheless, the viability of the adenoviruses detected using this method was questionable since they were still detectable after exposure to 20 mg/l chlorine. 2.1.3.4 PCR-Based Techniques The advent of PCR techniques has provided faster, more sensitive and more specific methods to detect adenoviruses in both clinical and environmental samples. These techniques do not demonstrate infectivity, however. Allard et al.49,50 used PCR to detect adenoviruses in untreated domestic sewage via nested PCR. Puig et al.39 compared cell culture, one-step PCR and nested PCR using sewage and river water samples. Nested PCR was found to be the most sensitive technique, allowing for the detection of < 10 particles. This is 100–1000 times more sensitive than traditional cell culture-based detection methods. Using similar techniques, Pina et al.26 were able to detect human adenoviruses in sewage, river water, seawater, and shellfish. They suggested that the detection of human adenoviruses by PCR be used as an indicator of human viral contamination of the environment. A nested multiplex PCR for detection of human enteric adenoviruses, hepatitis A virus and enteroviruses in sewage and shellfish was reported by Formiga-Cruz et al.51 The limit of detection was approximately one genome copy for adenovirus and ten copies for enterovirus and hepatitis A virus per PCR reaction using cell cultured viruses. The lower detection of enteroviruses may reflect the addition steps to perform RT-PCR for the detection of the RNA viruses. 2.1.3.5 Integrated Techniques A combination of cell culture and PCR has been used as a method to assess the viability of viruses and to increase the speed of identification (i.e., reduce the need for another passage in cell culture). In such methods, PCR is used to detect the presence of viruses growing in cell culture.51 Chapron et al.29 employed this method to detect Ad40 and Ad41 in surface water samples in BGM cells. The viruses did not produce CPE, yet could be detected by PCR. Ko et al.52 developed an RT-PCR method for the detection of Ad2 and Ad41 mRNA in cell culture. Only infectious adenoviruses are detected using this method because only viable viruses are able to produce mRNA during replication in cell culture.
28
Choo and Kim35 compared the detection of adenoviruses in oysters by ICC-PCR in BGM and human lung epithelial cells (A549) along with direct detection in the oyster samples by PCR. They found 23.6%, 50.9%, and 89.1% of all oysters positive by cell culture, ICC-PCR, and direct PCR, respectively. This suggests that not all of the adenoviruses in the oysters were viable. Rigotto et al.53 also reported the greater sensitivity of nested PCR over IC-PCR. Nested PCR was capable of detecting 1.2 plaque forming units (PFU) of Ad5 per gram of tissue vs. 120 CFU/g by ICC-PCR.
2.2 Methods Virus detection in foods usually involves an extraction step followed by a concentration step. To date the only published methods for adenovirus detection in foods have been aimed at its isolation from shellfish. Shellfish extracts and concentrates can be toxic to cell cultures used in virus detection and may have more substances than other foods which may interfere with detection by molecular methods (PCR). No method for the extract/concentration or molecular detection is 100% efficient and should not be expected to be so because of variability in the individual genomes resistance to reagents used in extraction and processing. Another issue is that the volume of the extract may be large relative to the volumes used in the molecular assay limiting the sensitivity of the assay. All of these factors should be taken into consideration when reporting results.
2.2.1 Sample Preparation Due to the low number of viruses found in most surface and ground water samples, viruses are first concentrated from volumes ranging from 10 to 1000 l. Methods commonly used are adsorption to positively or negatively charged microporous filters in a pleated cartridge format, adsorption to positively charged glass wool and ultrafiltration. Viruses are then desorbed or eluted in small volumes of liquid. Fields and Metcalf54 first reported the concentration of adenoviruses using negatively charged filters. Enriquez and Gerba19 demonstrated the use of positively and negatively charged filters for the concentration of Ad40 from tap, sea and waste waters. Jiang and Chu55 used ultrafiltration to concentrate adenoviruses from surface waters and Van Heerden et al.30 used positively charged glass wool to isolate adenoviruses from conventionally treated drinking water. Methods have only been developed for the detection of adenoviruses from shellfish. This usually involves an extraction step from the shellfish, a concentration step and then preparation for PCR. These methods are identical to what is used for other enteric viruses. Methods for used isolating enteroviruses from other foods would likely be useful for adenoviruses.56 The only consideration is that adenoviruses tend to be more sensitive to inactivation at pH levels above 9 than enteroviruses. After shucking usually several shellfish are pooled for processing. Sometimes certain organs such as the gills, digestive gland, or versa are extracted and then pooled. Since viruses may occur in the shellfish meat usually the shellfish
Molecular Detection of Foodborne Pathogens
are processed whole after removal from the shell. The shellfish meat is them homogenized in a blender or stomacher. This is followed by centrifugation to pellet the solids and virus. The supernatant is then discarded. Ultracentifugation can be used to ensure pelleting of the virus26 or the pH lowered to 5.0 and conductivity adjusted to ensure adsorption of the virus to the tissue.57 The virus is then eluted from the homogenized tissues by addition of glycine buffer at pH 9.5–10.0 or with glycine buffer at pH 7.5 and the salt concentration increased to 8000 mg/l and the solids discarded. The eluate is then concentrated further by ultracentrifugation, ultrafiltration, or acid precipitation at pH 4.5. The method reported by Pina et al.26 involving glycine buffer elution and ultracentrifugation or minor modifications appears to be the most commonly used method at present for adenoviruses.33,34,51 The following methods described the processing of shellfish sample prior the analysis by PCR for the detection of adenovirus. This method consists of the use of an alkaline glycine solution (0.25 M pH 10.00) to promote the detachment of viruses from meat. Then the sample is clarified by centrifugation and the viruses are concentrated from the elution solution by polyethylene glycol (PEG) precipitation (8% PEG and 0.3 M of NaCl). The elution of the viruses from shell fish meet was described by Formiga-Cruz et al.34 and Pina et al.26 The conditions for PEG precipitation were described by Lewis and Metcalf.58 Materials: (1) Blender (2) 500 ml Erlenmeyer flask (3) 0.25 M glycine solution: for 1 l distilled water, add 18.75 g of glycine and adjust the pH to 10.00 with 1 N NaOH (4) 250 ml conical centrifuge bottle (5) PEG 6000 (6) Sodium chloride (7) Floor swing bucked refrigerated centrifuge (8) Horizontal shaker (9) 1 N HCl solution (10) 1 N NaOH solution Virus extraction procedure: (1) Homogenize 33 g of shell fish meat with 167 ml of 0.25 M glycine solution in a blender at maximum speed for 30 sec (2) Decant the homogenize solution in a 500 ml Erlenmeyer flask and stir for 15 min (3) Adjust the pH of the solution to 7.3 with 1 N HCl solution (4) Centrifuge at 2500 × g for 30 min (5) Keep the supernatant. Measure the volume of the solution Concentration of virus by PEG precipitation: (1) For 200 ml of eluted sample, add 16 g of polyethylene glycol, and 3.5 g of NaCl (2) Decant the solution in a 250 ml conical bottle
29
Adenoviruses
(3) Put the bottle horizontally in the orbital shaker, shake at 100 revolutions/min overnight at 4°C (4) Centrifuge at 4200 rpm for 1 h (5) Add 5 ml of phosphate buffer, using the pipette, break the pellet and agitate the bottle with a voltex for 1 min (6) Measure the volume on the reconstituted concentrated sample (7) Store the sample at –20°C until further analysis
2.2.2 Detection Procedures For the nucleic acids extraction, we describe a modification of the guanidine thiocianated extraction method described by Boom et al.59 However, any commercial kit for the DNA extraction from plasma or stool sample would work. The described nested-PCR is specific for the hexon gene for all human adenovirus which includes the groups A through F. These set of primers were previously described by Avellon et al.67 Nested PCR consists of two rounds of amplification: the first amplifies the target region from the viral genome and the second round amplifies a smaller region inside the product of the first round amplification. The PCR products are analyzed by agarose gel electrophoresis. Materials: (1) Guanidine lysis buffer: 120 g guanidine thiocyanate in 100 ml TE buffer, 11 ml of 5 M NaCl, 11 ml 3 M sodium acetate (NaOAc) pH 5.5, and 3.5 ml of poplyadenylic acid 5′ potassium salt (1 mg/ml) (2) 100% proof ethanol (3) 70% ethanol solution (4) Sterile nuclease free water (5) Silica spin minicolumns (high-bind RNA minicolumns, Promega Biotek, others manufacturers columns such as Qiagen will work) (6) 2 ml collection tubes (7) 1.5 ml microcentrifuge tubes (8) 5 U/µl hot start taq polymerase (qiagen hotstart or Applied Biosystems gold Taq) (9) 10 × PCR buffer (provided with Taq polymerase) (10) 25 mM MgCl2 (provided with the Taq polymerase) (11) 25 pmoles/µl stock primers (12) 2.5 mM each dNTPs solution (10 mM total) (13) Sterile nuclease free water (14) Micropipets (0.5–10 µl, 10–100 µl, 100–1000 µl sizes) (15) Barrier sterile tips (16) 10% bleach solution (50 ml commercial bleach solution, 450 ml of water) (17) First round PCR primers are: ADHEX1F 5′-AACACCTAYGASTACATGAAC-3′ ADHEX2R 5′-KATGGGGTARAGCATGTT-3′ Fragment size of 473 bp (18) Second round PCR primers are: ADHEX2F 5′-CCCMTTYAACCACCACCG-3′ ADHEX1R 5′-ACATCCTTBCKGAAGTTCCA-3′ Fragment size of 168 bp
Nucleic acid extraction: (1) Add 100 µl of lysis buffer to a 1.5 ml microcentrifuge tubes (2) Add 100 µl of sample to the tubes and mix then with a voltex for 15 sec (3) Incubate at room temperature for 10 min (4) Remove the drops from the lip by a brief centrifugation (5) Add 200 µl of 100% proof ethanol (6) Mix with a voltex for 15 sec (7) Load the 400 µl of sample mixture into the silica minicolumns (8) Centrifuge for 1 min at 16000 × g (9) Place the column in a new collection tube (10) Add 500 µl of 70% ethanol and centrifuge at max speed for 1 min (11) Repeat the wash steps 9 and 10 one more time (12) Place the column in a collection tube. Dry the column by centrifugation at 16000 × g for 1 min (13) Put the column in a sterile 1.5-ml tube (14) Add 50 µl of sterile nuclease free water in the center of the column without touching the walls (15) Let incubate for 1 min and then centrifuge 16000 × g for 1 min (16) Keep the flow through store at –20°C for future PCR analysis Nested PCR procedure: (1) Prepare first round PCR mixture (50 µl) consisting of 1 × PCR buffer, 2.0 mM of MgCl2, 200 µM of each dNTP, 25 pmoles of each primers (ADHEX1F and ADHEX2R) for the first PCR, 1.5 U of Taq polymerase, 2 µl extracted virus DNA, and nuclease free water for a final volume of 50 µl. Prepare a master mixture for multiple reactions and adjust by increasing the volume 5% (to consider the lost of mixture during handling). Specifically, the following calculation is for a master mixture for ten reactions: (i) In a sterile 1.5 ml Eppendolf tube add: 52.5 µl of 10 × PCR buffer 42 µl of 25 mM MgCl2 solution 10.5 µl of Primer F (ADHEX1F) 10.5 µl of Primer R (ADHEX2R) 2.1 µl of Taq polymerase 260 µl of water (ii) Aliquot 40 µl of PCR mixture into each PCR tube and add 10 µl of sample (2) Conduct PCR amplification in a thermal cycler using the following program: one cycle of 94°C for 10 min; 35 cycles of 94°C for 30 sec, 50°C for 30 sec, and 72°C for 30 sec; one cycle of 72°C for 10 min. Use the heated lip option. (Note: If this option is not available then add a drop of mineral oil to the reaction to avoid the vaporization.) (3) Prepare second round PCR mixture (50 µl) consisting of 1 × PCR buffer, 2.0 mM MgCl2, 200 µM of each dNTP, 0.5 µM each primers (ADHEX2F
30
and ADHEX1R) for the second round of PCR, 1.5 U of Taq polymerase, 2 µl of first round PCR, and nuclease free water for a final volume of 50 µl. Specifically, the following calculation is for a master mixture for ten reactions: (i) In a sterile 1.5 ml eppendolf tube add: 52.5 µl of 10 × PCR buffer 42 µl of 25 mM MgCl2 solution 10.5 µl of nested Primer F (ADHEX2F) 10.5 µl of nested Primer R (ADHEX1R) 2.1 µl of Taq polymerase 328 µl of sterile nuclease free water (ii) Aliquot 48 µl of PCR mixture into each PCR tube and add 2 µl of first round PCR product. The cycling conditions of the second round PCR are the same used for first round PCR. (4) Agarose gel electrophoresis (i) Prepare a 2% agarose gel in 0.5 × TBE in a 250-ml Erlenmeyer flask adding 2 g agarose and 100 ml 0.5 × TBE buffer (ii) Heat the gel in a microwave oven until the agarose dissolves. Add 5 µl of 10 mg/ml ethidium bromide stock solution (50 µg/ml working solution) after the agarose cools down (~45°C) and before pouring. (iii) Pour the gel slowly, trying to reduce the formation of bubbles. Put the well comb in its correct position. Let the gel stand for at least 30 min. (iv) Locate the gel wells in the negative side of the electrophoresis chamber. Add 0.5 × TBE buffer until the lever reaches more than 2 mm above the gel. (v) Mix 10 µl of the sample with 2 µl of 6 × loading buffer. (vi) Using a pipette with a fine tip, load the sample into the well. Load at step DNA ladder every six samples (amount recommended by manufacturer). (vii) Check that the polarity is in the correct orientation (well in the negative side, running to positive side). (viii) Applied as follows: 5 V per cm gel length. (ix) Stop the electrophoresis when it reached 70% of the gel length. Use as reference the faster dye of the loading buffer. (x) Visualize the PCR products using a UV transilluminator. (xi) The PCR product size is estimated by comparing it with the step ladder and with the positive control. The 100 bp step ladder has step increases from 100 bp to 1000 bp. A positive sample for adenovirus should show a band between 100 bp and 200 bp with 168 bp. Also, a positive sample should have the same running distance as the positive control.
Molecular Detection of Foodborne Pathogens
Comment on quality control: (1) All the areas for the analysis should be separate in different rooms: one room exclusive for mixing PCR reagents, one room for handling the samples, one for the nested PCR, and another for gel electrophoresis. (2) We recommend using a different PCR workstation/ hood with UV lamp for preparing the master mix and another for the addition of the first round PCR product to the second round PCR mixture. Use a biological hood type 2 for handling the samples. Before and after uses, the hoods should be cleaned with 10% bleach solution and turn on the UV light for 30 min. The bleach can be inactivated with 2% sodium thiosulfate solution and washed with water. (3) Open the reagents only inside the workstation, and the samples and PCR products are only opened in their respective workstation. (4) Keep the equipment in each respective room and not used then in other areas (i.e., pipets, tips, and different lab coats are exclusively used in each room). (5) The PCR product is only opened in the workstation for samples and in the electrophoresis room (negative pressure from the main laboratory).
2.3 Conclusions and Future Perspectives Adenoviruses, like the enteroviruses, cause a wide range of illness many of which are not thought of as being food or waterborne. This, combined with the long time needed to produce cytopathogenic effects in cell culture previously resulted in few studies on their occurrence in the environment and role in food and waterborne diseases. While waterborne transmission is well documented, the role of food in their transmission is unknown. Certainly documenting their presence in food, especially shellfish suggests foodborne transmission is possible. Human adenoviruses are more common in sewage contaminated waters and it has been suggested by several groups of investigators that they may be useful indicators of other enteric viruses in water and shellfish. Adenoviruses also have the added advantage of unlike most human enteric viruses, they have a DNA genome, eliminating the need for RT-PCR. However, recent research on the occurrence of adenoviruses in areas remote from human sewage contamination suggests that other sources besides humans or exceptionally long survival times in the environment.61 Clearly additional research is needed to assess the usefulness of human adenoviruses as indicators of human viral contamination. The application of PCR makes possible for the first time low cost and simple methods for the detection of adenoviruses in food and water. This will help us better understand the role of these vehicles in their transmission. Currently all molecular methods suffer from inability to determine viability without the use of cell culture, small assay volumes, quantification at low numbers of genome copies, interference with substances in concentrates, and the loss of virus during sample processing. These are major challenges that need to
Adenoviruses
be overcome to take full advance of molecular approaches for virus detection in foods.
References
1. Shenk, T. Adenoviridae: the viruses and their replication. In Fields Virology, 4th edn. Knipe, D.M. et al. (Eds.). pp. 2265– 2300. Lippincott Williams and Wilkins, Philadelphia, PA, 2001. 2. Enriquez, C.E. Adenoviruses. In Encyclopedia of Environ mental Microbiology. Bitton, G., (Ed.). Vol. 1, pp. 92–100. John Wiley and Sons, New York, 2002. 3. van Regenmortel, M.H.V. et al. Virus Taxonomy: Seventh Report of the International Committee on Taxonomy of Viruses. pp. 227–238. Academic Press, San Diego, CA, 2000. 4. Liu, C. Adenoviruses. In Textbook of Human Virology, 2nd edn. Belshe, R.B. (Ed.). pp.791–803. Mosby Year Book, St. Louis, MO, 1991. 5. Foy, H.M. Adenoviruses. In Viral Infections of Humans: Epidemiology and Control, 4th edn. Evans, A.S. and Kaslow, R.A. (Eds.). pp. 119–138. Plenum Publishing Corporation, New York, NY, 1997. 6. Horwitz, M.S. Adenoviruses. In Fields Virology, 4th edn. Knipe, D.M. et al. (Eds.). pp. 2301–2326. Lippincott, Williams and Wilkins, Philadelphia, PA, 2001. 7. Wadell, G. Molecular epidemiology of human adenoviruses. Curr. Top. Microbiol. Immunol., 110, 191, 1994. 8. Scott-Taylor, T.H., and Hammond, G.W. 1995. Local succession of adenovirus strains in pediatric gastroenteritis. J. Med. Virol. 45, 331–338. 9. Shinozaki, T. et al. Epidemiology of enteric adenoviruses 40 and 41 in acute gastroenteritis in infants and young children in the Tokyo area. Scand. J. Infect. Dis., 23, 543, 1991. 10. LeBaron, C.W. et al. Viral agents of gastroenteritis. Public health importance and outbreak management. MMWR, 39, 1, 1990. 11. Brandt, C.D., Kim, H.W. and Vargosdo, A.J. Infections in 18,000 infants and children in a controlled study of respiratory tract disease. Am. J. Epidemiol., 90, 484, 1972. 12. D’Angelo, L.J. et al. Pharyngoconjunctival fever caused by adenovirus type 4: report of a swimming pool-related outbreak with recovery of virus from pool water. J. Infect. Dis., 140, 42, 1979. 13. Harley, D. et al. A primary school outbreak of pharyngoconjunctival fever caused by adenovirus type 3. Commun. Dis. Intell., 25, 9, 2001. 14. Jaworowska, A. and Barylak, G. Obesity development associated with viral infections. Postepy. Hig. Med. Dosw., 60, 227, 2006. 15. Atkinson, R.L. et al. Human adenovirus -36 is associated with increased body weight and paradoxical reduction of serum lipids. Int. J. Obes., 29, 281, 2005. 16. Greenway, F. Virus-induced obesity. Am. J. Physiol. Regul. Comp. Physiol., 290, R188, 2006. 17. Vangipuram, S.D. et al. A human adenovirus enhances preadiocytes differentiation, Obes. Res., 12, 77, 2004. 18. Hierholzer, J.C. Adenoviruses in the immunocompromised host. Clin. Microbiol. Rev., 5, 262, 1992. 19. Gerba, C.P. and Enriquez, C.E. Virus-associated outbreaks in swimming pools. Proceedings of the 1st Annual Chemistry Symposium. pp. 31–45. National Spa and Pool Institute, National Spa and Pool Institute, Alexandria, VA, 1997. 20. Van Heerden, J., Ehlers, M.M. and Grabow, W.O.K. Detection and risk assessment of adenoviruses in swimming pool water. J. Appl. Microbiol., 99, 1256, 2005. 21. Kukkula, M. et al. Waterborne outbreak of viral gastroenteritis. Scand. J. Infect. Dis., 29, 415, 1997.
31 22. Villena, C. et al. A large infantile gastroenteritis outbreak in Albania caused by multiple emerging rotavirus genotypes. Epidemiol. Infect., 131, 1105, 2003. 23. Divizia, M. et al. Waterborne gastroenteritis outbreak in Albania. Water Sci. Technol., 50, 57, 2004. 24. Irving, L.G. and Smith, F.A. One-year survey of enteroviruses, adenoviruses, and reoviruses isolated from effluent at an activated-sludge purification plant. Appl. Environ. Microbiol., 41, 51, 1981. 25. Hurst, C.J., McClellan, K.A. and Benton, W.H. Comparison of cytopathogenicity, immunofluorescence and in situ DNA hybridization as methods for the detection of adenoviruses. Water Res., 22, 1547, 1988. 26. Pina S. et al. Viral pollution in the environment and in shellfish: human adenovirus detection by PCR as an index of human viruses. Appl. Environ. Microbiol., 64, 3376, 1998. 27. Rodriguez, R.A., Gundy, P.M. and Gerba, C.P. Comparison of BGM and PLC/PRC/5 cell lines for total culturable viral assay of treated sewage. Appl. Environ. Microbiol., 74, 2583, 2008. 28. Krikelis, V. et al. Seasonal distribution of enteroviruses and adenoviruses in domestic sewage. Can. J. Microbiol., 31, 24, 1985. 29. Chapron, C.D. et al. Detection of astroviruses, enteroviruses, and adenovirus types 40 and 41 in surface water collected and evaluated by the information collection rule and an integrated cell culture-nested PCR procedure. Appl. Environ. Microbiol., 66, 2529, 2000. 30. Van Heerden, J. et al. Incidence of adenoviruses in raw and treated water. Water Res., 37, 3704, 2003. 31. Lee, H.K. and Jeong, Y.S. Comparison of total culturable virus assay and multiplex integrated cell culture-PCR for reliability of waterborne virus detection. Appl. Environ. Microbiol., 70, 3632, 2004. 32. Enriquez, C.E. and Gerba, C.P. Concentration of enteric adenovirus 40 from tap, sea, and waster water. Water Res., 95, 2554, 1995. 33. Munianin-Mujika, I. et al. Comparative analysis of viral pathogens and potential indicators in shellfish. Int. J. Food Microbiol., 83, 75, 2003. 34. Formiga-Cruz, M. et al. Distribution of human virus contamination in shellfish from different growing areas in Greece, Spain, Sweden, and the United Kingdom. Appl. Environ. Microbiol., 68, 5990, 2002. 35. Choo, Y.J. and Kim, S.J. Detection of human adenoviruses and Enteroviruses in Korean oysters using cell culture, integrated cell culture-PCR, and direct PCR. J. Microbiol., 44, 1662, 2006. 36. Umesha, K.R. et al. Prevalence of human pathogenic enteric viruses in bivalue molluscan shellfish and cultured shrimp in south west coast of India. Int. J. Food Microbiol., 122, 279, 2008. 37. Enriquez, C. E., Hurst, C.J. and Gerba, C.P. Survival of the enteric adenoviruses 40 and 41 in tap, sea, and waste water. Water Res., 29, 2548, 1995. 38. Hernroth, B. and Allard, A. The persistence of infectious adenovirus (type 35) in mussels (Mytilus edulis) and oysters (Ostrea edulis). Int. J. Food Microbiol., 113, 296, 2007. 39. Puig, M. et al. Detection of adenoviruses and enteroviruses in polluted waters by nested PCR amplification. Appl. Environ. Microbiol., 60, 2963, 1994. 40. Echavarria, M. et al. PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virusinfected individuals. J. Clin. Microbiol., 36, 3323, 1998.
32 41. Tani, N. et al. Seasonal distribution of adenoviruses, enteroviruses and reoviruses in urban river water. Microbiol. Immunol., 39, 577, 1995. 42. Brown, M. Laboratory identification of adenoviruses associated with gastroenteritis in Canada from 1983 to 1986. J. Clin. Microbiol., 28, 1525, 1990. 43. Grabow, W.O., Puttergill, D.L. and Bosch, A. Propagation of adenovirus types 40 and 41 in the PCL/PRF/5 primary liver carcinoma cell line. J. Virol. Methods, 37, 201, 1992. 44. Pintó, R.M. et al. Detection of fastidious infectious enteric viruses in water. Environ. Sci. Technol., 29, 2636, 1995. 45. Takiff, H.E., Straus, S.E. and Garon, C.F. Propagation and in vitro studies of previously non-culturable enteral adenoviruses in 293 cells. Lancet, 2, 832, 1981. 46. Retter, M. et al. Enteric adenoviruses: detection, replication and significance. J. Clin. Microbiol., 10, 574, 1979. 47. Williams, F.P. and Hurst, C.J. Detection of environmental viruses in sludge: enhancement of enterovirus plaque assay titers with 5-iodo-2′-deoxyuridine and comparison to adenovirus and coliphage titers. Water Res., 22, 847, 1988. 48. Genthe, B. et al. Detection of enteric adenoviruses in South African water using gene probes. Water Sci. Technol., 31, 345, 1995. 49. Allard, A. et al. Polymerase chain reaction for detection of adenovirus in stool samples. .J Clin. Microbiol., 28, 2659, 1990. 50. Formiga-Cruz, M. et al. Nested multiplex PCR assay for detection of human enteric viruses in shellfish and sewage. J. Virol. Methods, 125, 111, 2005. 51. Reynolds, K.A., Gerba, C.P. and Pepper, I.L. Detection of infectious enteroviruses by an intergrated cell culture-PCR procedure. Appl. Environ. Microbiol., 62, 1424, 1996.
Molecular Detection of Foodborne Pathogens 52. Ko, G., Cromeans, T.L. and Sobsey, M.D. UV inactivation of adenovirus type 41 measured by cell culture mRNA RT-PCR. Water Res., 39, 3643, 2005. 53. Rigotto, C. et al. Detection of adenoviruses in shellfish by means of conventional-PCR, nested-PCR, and integrated cell culture PCR (ICC/PCR). Water Res., 39, 297, 2005. 54. Fields, H.A., and Metcalf, T.G. Concentration of adenovirus from seawater. Water Res., 9, 357, 1975. 55. Jiang, S., and Chu, W. PCR detention of pathogenic viruses in southern California urban rivers. J. Appl. Microbiol., 97, 17, 2004. 56. Goyal, S.M. Methods of virus detection in foods. In Viruses in Foods, Goyal, S.M. (Ed.). pp. 101–119. Springer, New York, NY, 2006. 57. Sobsey, M.D., Carrick, R.J. and Jensen, H.R. Improved methods enteric viruses in oysters. Appl. Environ. Mirobiol., 36, 121, 1978. 58. Lewis G.D. and Metcalf, T.G. Polyethylene glycol precipitation for recovery of pathogenic viruses, including hepatitis A virus and human rotavirus, from oyster, water, and sediment samples. Appl. Environ. Microbiol., 54:1983, 1988. 59. Boom, R., C.J.A. et al. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol., 28, 495, 1990. 60. Avellón, A.P. et al. Rapid and sensitive diagnosis of human adenovirus infections by a generic polymerase chain reaction. J. Virol. Methods, 92, 113, 2001. 61. Lipp, E.R., Futch, J.C. and Griffin, D.W. Analysis of multiple enteric viral targets as sewage markers in coral reefs. Mar. Pollut. Bull., 54, 1897, 2007.
3 Astroviruses
Edina Meleg and Ferenc Jakab University of Pécs
Contents 3.1 Introduction......................................................................................................................................................................... 33 3.1.1 History, Virion Structure and Classification............................................................................................................ 33 3.1.1.1 History....................................................................................................................................................... 33 3.1.1.2 Genome Structure..................................................................................................................................... 34 3.1.1.3 Classification............................................................................................................................................. 35 3.1.2 Pathogenesis and Pathology..................................................................................................................................... 35 3.1.2.1 Physical Features....................................................................................................................................... 35 3.1.2.2 Propagation of Human Astroviruses......................................................................................................... 35 3.1.2.3 Propagation of Animal Astroviruses........................................................................................................ 36 3.1.2.4 Transmission............................................................................................................................................. 36 3.1.2.5 Pathogenesis.............................................................................................................................................. 36 3.1.3 Clinical Features . ................................................................................................................................................... 36 3.1.3.1 Characteristics of Human Illness.............................................................................................................. 36 3.1.3.2 Role in Immunocompromised Hosts......................................................................................................... 37 3.1.3.3 Immunity................................................................................................................................................... 37 3.1.4 Epidemiology........................................................................................................................................................... 38 3.1.4.1 Role in Disease.......................................................................................................................................... 38 3.1.4.2 Antibody Acquisition and Prevalence....................................................................................................... 38 3.1.5 Laboratory Diagnosis............................................................................................................................................... 38 3.1.6 Treatment and Prevention........................................................................................................................................ 40 3.2 Methods............................................................................................................................................................................... 40 3.2.1 Sample Preparation ................................................................................................................................................. 40 3.2.3 Detection Procedures............................................................................................................................................... 40 3.3 Conclusions and Future Perspectives.................................................................................................................................. 43 References.................................................................................................................................................................................... 44
3.1 Introduction
3.1.1 History, Virion Structure and Classification
Astroviruses are the members of Astroviridae family, which include both human and animal nonenveloped viruses possessing a plus-sense, ssRNA genome. In humans, astroviruses mainly produce gastroenteritis together with a broad spectrum of symptoms such as malaise, vomiting, diarrhea, fever and abdominal pain. Besides being one of the most common causes of viral gastroenteritis in young children in developed countries, astrovirus is the culprit for viral diarrhea in young children in some other parts of the world.1 Although foodborne illness resulting from viral infections is a large and growing public health problem, most countries do not have good reporting systems; therefore realistic estimation of the true burden of foodborne diseases is difficult. Based on a recent study, astroviruses account for less than 1% of foodborne illnesses in the United States.2
3.1.1.1 History Astroviruses were first identified by Madeley and Cosgrove in 1975 in the feces of hospitalized infants with diarrhea.3 Based on direct electron microscopy (EM) studies of fecal samples, astroviruses were observed as 28–30 nm particles in diameter with a distinctive five-six pointed star-like surface (Figure 3.1). This morphology distinguished astroviruses from other small, round viruses with similar size, such as picornaviruses and caliciviruses. In some preparations, bridging structures, which may be surface extensions of the virus, have been observed between adjacent astrovirus particles.4 The term “astrovirus” was named after the star morphology (astron = star; Greek), although this surface structure can only be identified in approximately 10% of the particles by EM. Interestingly, particles isolated from infected rhesus
33
34
Molecular Detection of Foodborne Pathogens
5´UTR Non-structural proteins
3´UTR
?
A(n) Structural proteins ORF 1a
ORF 1b
ORF 2
Frameshift site
Figure 3.2 Genome arrangement of astroviruses. www.tulane. edu/~dmsander/WWW/335/Diarrhoea1.gif 50 nm
Figure 3.1 Image of human astroviruses by electron microscopy. http://www.virology.net/Big_Virology/BVRNAastro.html
monkey kidney epithelial (LLCMK2) cells lack the star-like morphology, but it can be induced by a brief exposure to pH = 10 environment. Later, based on high-resolution EM5 and electron cryomicroscopy studies astroviruses seemed to be icosahedral particles with spikes or knob-like projections, and 41–43 nm in total diameter. Studies on purified cell culture-adopted HAstV-1 particles evaluated by cryo-electron microscopy and image analysis revealed a rippled solid capsid shell structure (330 Å in diameter) decorated with 30 dimeric spikes extending 50 Å from the virion surface.6 These particles, however, have not been characterized by protein composition, which is a key factor for the virus-specific infectivity and may have an effect on virion structure.7,8 A few months before naming astroviruses, in 1975 Appleton and Higgins9 reported an outbreak of mild diarrhea and vomiting among infants in a maternity ward. In their study, astroviruses particles were 29–30 nm in diameter, and did not display the special surface features, however by EM these viruses were distinct in size and morphology from the previously identified Norwalk viruses and rotaviruses. One year later specific immunologic reagents proved that these viruses were really astroviruses.10 Subsequently, viral particles, that were similar size and had the star-like surface features, were observed in gastroenteritis cases in several young mammals and birds, including mice,11 kittens,12 dogs,13,14 lambs,15 calves,16 deer,17 piglets,18 minks19 as well as turkeys.20 Gough et al.21 observed fatal hepatitis in ducklings due to astrovirus infection, and virus particles were found in liver of these animals in addition to feces. Astrovirus appears to cause species-specific infections.22 In 1981, Lee and Kurtz23 published the successful isolation of human astroviruses in the presence of trypsin in human embryonic kidney (HEK) cells and passage in LLCMK2 cells, which definitely distinguished them from noncultivatable small, round viruses, such as caliciviruses. In the late 1980s, Herrmann et al.24,25 developed an enzyme immunoassay (EIA) that detects viral antigen. Although, the virus was well known since 1975, the real medical importance was only recognized in 1991.26 Reverse-transcription polymerase chain reaction (RT-PCR) assays were first use in 1995 to detect human astroviruses. These techniques contributed
to more detailed characterization of astrovirus strains by the analysis of nucleotide sequence information.27–29 In the past few years spreading of RT-PCR technique could be observed in studies of the prevalence of astrovirus among children with diarrhea to detect and genotype strains. 3.1.1.2 Genome Structure Astroviruses have a plus-sense, single-stranded RNA genome, which is approximately 6800 nucleotides (nt) (varies from 6.4 to 7.3 kb) in length. It is polyadenylated at the 3′ end, and surrounded by an isocahedral capsid. The genomial RNA includes 5′ and 3′ nontranslated region (UTR), and three open reading frames (ORFs), each encoding polyprotein that is proteolytically processed to yield smaller proteins (Figure 3.2). The two ORF located toward the 5′ end of the genome, designated ORF 1a (~2700 nt) and ORF 1b (~1550 nt), encode nonstructural proteins, such as an RNAdependent RNA polymerase and a 3C-like serine protease that are involved in RNA transcription and replication. ORF 1a also encodes overlapping immunogenic epitopes that are recognized by antibodies produced to intact astroviruses.30 An overlap of 60–70 nt is found between ORF 1a and ORF 1b of mammalian astroviruses (this region is only 12–45 nt long in avian viruses). This overlapping region contains signals which are essential for translation of the viral RNA polymerase through a frameshift mechanism.31,32 This region is completely conserved among human and animal astroviruses in two characteristics: a heptameric AAAAAAC sequence, and the potential to form a downstream stem-loop structure. These features are critical for the ribosomal-1 frameshifting event during the translation of the genome.31,32 The third ORF is located at the 3′ one-third of the genome, designated ORF 2, which has the greatest sequence variability in the astrovirus genome, and encodes the 90 kDa protein that is the precursor of the three capsid proteins that have been described for human astroviruses.33,34 Structural proteins encoded by ORF 2 are translated from the so-called subgenomic (sg) RNA.33,34 The more conserved amino-terminal region of the astrovirus capsid protein has an important function in assembly of the capsid core, while the hypervariable carboxy-terminal form the spikes of the virion and participate in the early interactions between the virus and the host cells.35 ORF 1b and ORF 2 overlap in eight nt. The 3′ UTR of HAstV genome, which is located between ORF 2 and the polyA tail is 80–85 nt long (this sequence can be longer [130–305 nt] in avian viruses).36
35
Astroviruses
The final 19 nt of ORF 2 and the 3′ UTR are thought to be important for interacting with the viral RNA replicase and cellular proteins. These regions are highly conserved among all known HAstV serotypes.37 During infection of susceptible cells, two RNA species have been observed: the full-length genomic RNA (gRNA), and an sgRNA (~2.4 kb in length).38,39 Both RNA species are initially observed at 12 hours postinfection in LLCMK2 cells.39 Synthesis of the negative-sense RNA of astrovirus has not been well studied. By all means, the gRNA is probably a template to synthesize the full-length negative-sense RNA, which is a template to produce both the full-length gRNA and the sgRNA. The synthesis of sgRNA probably requires an internal sequence in the full-length negative sense RNA to serve as promoter for the virus transcriptase. However, the identity of this promoter in astrovirus has not been defined; it is thought that about 120 nt of the ORF 2 region might be an important sequence of the promoter.40 Part of this region includes the sequence AUUUGGAGNGGNACCNAAN5-8 AUGNC (the ORF 2 start codon is underlined; N can be any of the four nucleotides), which is highly conserved among all members of Astroviridae.41 After astrovirus entry, the gRNA is used as a template to synthesize the virus nonstructural proteins. The primary protein product coded by ORF 2 is observed abundantly 12 hours after infection39 (nonstructural proteins are initially detected 6 hours postinfection42). 3.1.1.3 Classification Genome arrangement of astroviruses is similar to the genome of Picornaviridae and Caliciviridae,43 but the size, number, and processing of polyproteins, the lack of an RNA-helicase domain in astroviruses, and the use of a ribosomal frameshifting mechanism distinguish them from similar viruses. Therefore astroviruses are classified into a separate family, the Astroviridae.44 Astroviruses have been isolated from both humans and several animal species. According to the origin of the virus and the genome structure, two genera have been distinguished within the family: mamastrovirus (infect mammals) and avastrovirus (including viruses from avian species). Viruses in the genus mamastrovirus are more closely related to each other than those viruses within the avastrovirus genus.36,45 Serologic relatedness between viruses isolated from different species, even within the same genus has not been identified.46,47 Human astroviruses have been grouped into eight serotypes (HAstV-1 to HAstV-8) according to immunfluorescence and neutralization assays, as well as immunelectron microscopy that use hyperimmune sera to raise different culture adapted strains.23,48–52 Common epitopes of the capsid protein in cases of all known HAstV serotypes were identified. These epitopes are widely used in many different diagnostic assays.24,25 Recently, more sensitive molecular methods are used, that enabled the classification of human astroviruses on the basis of the sequence similarity of specific genome regions. Nowadays, different regions of the genome, obtained
by RT-PCR, have been widely used to group HAstVs into different genotypes; though depending on the specific region of the analyzed genome (ORF 1a, 1b or ORF 2), strains can be grouped differently.53 Several animal serotypes of astroviruses have been identified. At least two, but probably three serotypes are found among bovine astroviruses (BAstVs) based on the crossreactivity to specific sera. Two serotypes have been identified among turkey (TAstVs)36 and chicken astroviruses (CAstVs).46 Many serotypes of astroviruses have been identified in consequence of different serological studies, suggesting that additional types of astrovirus might exist.47,54
3.1.2 Pathogenesis and Pathology 3.1.2.1 Physical Features Astroviruses are one of the most resistant viruses. They show resistance against different physical and chemical agents, such as chloroform, a variety of nonionic, anionic as well as zwitterionic detergents, even lipid solvents; they are able to maintain their infectivity at 60°C for 5 min (HAstV)5,22 or 10 min (TAstV), and at ultralow temperature (–70 to –85°) for 6–10 years, but repeated freezing and thawing is detrimental55 to them, particles are resistant to treatment from pH 3 to 10.5,22 The extreme stability of astroviruses against environmental factors suggests that traditional pasteurization procedures cannot completely inactivate them. Furthermore, astroviruses are able to persist under severe environmental conditions, they endure on inanimate surfaces, on human hands, in dried human and animal fecal materials, in water, on kitchen surfaces, food preparation areas, hospital as well as cruise ship cafeterias, on carpets and hospital lockers.56 There is a lack of information on the survival of astrovirus on foods. Information is also lacking on the efficiency of current washing and decontamination procedures for the removal of astrovirus. It was already demonstrated that traditional disinfection procedures do not eliminate astroviruses by water treatment. 3.1.2.2 Propagation of Human Astroviruses Serial passage of astrovirus in HEK cells requires incorporation of 10 μg/ml trypsin in the serum-free growth media.23 Higher levels of typsin do not improve the viral yield, while lower levels (for example the 0.5 μg/ml necessary for rotavirus growth) are not sufficient to maintain astrovirus in cell culture. After several passages of HEK-293 cells, viruses were able to grow in primary baboon kidney (PBK) cells and in a continuous cell line of LLCMK2 cells. Attempts to establish serial passage by direct inoculation of PBK or LLCMK2 cells with fecally derived astrovirus were unsuccessful. Willcocks et al.57 could propagate the virus in a continuous cell line of human colon adenocarcinoma (CaCo-2) cells using 5 μg/ml trypsin in the culture medium. With this method, the first cytopathic effect (CPE) appeared after 2 days of infection. Nowadays, this cell line is commonly used to grow wild-type astrovirus strains.
36
However, adenocarcinoma cell lines (CaCo-2, T-84, HT-29, SK-CO-1 cells) are the most efficient cells to isolate HAstV, the virus are also able to grow in human liver hepatoma cells (PLC/PRF/5) and in monkey kidney-derived (MA104, Cos-1, vero) cells as well.52,58–60 CaCo-2, T-84 and PLC/PRF/5 cell lines are the most efficient to directly isolate HAstV strains from fecal suspensions.52,58–60 Adaptation of field HAstV strains to grow in cell culture has low efficiency because different astrovirus strains have different susceptibility to trypsin. Although, 10 μg/ml of trypsin has been regularly used to activate virus infectivity; recent isolation of HAstV type-8 in CaCo-2 cells required much higher (200–400 μg/ml) trypsin concentration.8 In consequence, the optimal concentration of trypsin to obtain completely activated virus can depend on the HAstV strain. 3.1.2.3 Propagation of Animal Astroviruses To date bovine,61 porcine62 and avian astroviruses have been propagated in cell culture. Bovine astrovirus was isolated by Aroonprasert et al. in primary neonatal bovine kidney (NBK) cells in the presence of 50 μg/ml trypsin. This amount of trypsin in the culture media was necessary both for direct isolation from fecal samples and for serial passage of the virus in NBK cells. Primary bovine embryo kidney (BEK) cells were also efficient in growing bovine astroviruses using feces and cell culture adopted viruses as the starting material.61 A porcine astrovirus was isolated in embryonic swine kidney cells using 50 μg/ml trypsin in the culture medium. Fecal samples from infected pigs were filtrated and used directly for infection. However, maximal CPE was evident 4–5 days after inoculation of cell monolayers, the CPE was not formed if trypsin was removed from the medium or if the virus inoculum was mixed with convalescent phase serum.62 Chicken astroviruses were successfully adapted to both chicken embryo liver (CEL) and chicken hepatocellular carcinoma (LMH) cells. Tracheal swabs, lymphocytes, and intestine homogenates from infected chickens were particularly used as a source of the virus. Duck astroviruses were also adapted to these cells (CEL and LMH) without the addition of trypsin to the medium.46 Adaptation of turkey astrovirus to avian (as turkey and chicken embryo-derived cells) and mammalian (e.g. CaCo-2, vero) cell lines was unsuccessful, although they could be replicated in turkey embrionated eggs.63–65 Astroviruses from other vertebrates, like lambs,15 red deer,17 cats26 and dogs13,14 have also been isolated in cell cultures, but serial passage of the virus has not been performed. 3.1.2.4 Transmission Astrovirus can be transmitted through the fecal-oral route, by person-to-person contact, from fecally contaminated fingers to foods or to work surfaces and door handles. There is a significant risk of contamination from field workers who do not have adequate on-site toilet and hand-washing facilities.56 Astroviruses can be disseminated over a wide area in aerosol droplets (produced by vomiting), which is a particular hazard for exposed food or surfaces with subsequent transfer to foods.
Molecular Detection of Foodborne Pathogens
Astroviruses can be transferred with contaminated food and water from different origins.52,66–70 Sequence analysis of HAstV strains detected from both clinical samples and water supplies verified that water could be an important source for HAstV contamination, because virus strains from both origins were identical, at least in the specific genome region analyzed.69 It was shown, that poliovirus can infiltrate into the roots and body of plants from the soil,71 and consequently it is probable, that astroviruses also have the same feature. 3.1.2.5 Pathogenesis Pathogenesis of human astrovirus infections has been extensively studied. Recent histopathologic examinations show that astrovirus infects the mature epithelial cells of the small intestine, especially in the jejunum and in the duodenum.72 Severe diarrhea caused by villus atrophy in the intestine suggests that the inflammatory response does not play an important role in the pathogenesis of astrovirus.72 Other mammalian astroviruses can infect epithelial cells (OAstV, BAstV), subepithelial macrophages (OAstV), as well as M cells (BAstV) of the small intestine.73,74 OAstV particles were also observed in vacuoles of the enterocytes.73 OAstV infection was characterized by transient villus atrophy and crypt hypertrophy, which resulted in severe diarrhea after 2–4 days of infection. BAstV was unable to induce diarrhea in gnotobiotic animals, nevertheless, inflammatory mononuclear cells above the dome villi were observed on infection with this virus.74 In addition, the lamina propria was infiltrated with neutrophils and cells with degenerate nuclei were present. Lymphoid cell depletion was noted in the central region of germinal centers beneath the infected dome villi. In the case of turkey astrovirus 2 (TAstV-2) infection, mild crypt hyperplasia was observed after 1 day of infection in the proximal jejunum, while after 3–5 days of infection the same manifestation was observed in the distal jejunum and ileum, as well as in the duodenum.75 Electron microscopy studies revealed intracytoplasmic astrovirus aggregates in enterocytes on the sides and base of villi in the ileum and distal jejunum on day 3 postinfection. Astrovirus infection do not cause inflammation in humans72 and turkeys,65 but induce apoptosis in cultured cells,76 which suggest that this form of programmed cell death, could contribute to diarrhea in some species. Several other mechanisms could also contribute to the gastroenteritis due to astroviruses.
3.1.3 Clinical Features 3.1.3.1 Characteristics of Human Illness HAstV are the causative agents of viral gastroenteritis worldwide mainly in children (under the age of 5). Within the four childhood gastroenteritis virus (rotavirus, enteric adenovirus, astrovirus and calicivirus) HAstV is the second most common viral agent that causes diarrhea in young children evaluated in outpatient settings.26 Astrovirus infections have also been recognized in elderly, institutionalized patients77,78 and
37
Astroviruses
immunocompromised individuals. HAstV type 1 has been detected as the predominant strain in most countries.22,51 However, the incubation period in most HAstV infections is 3–4 days; a shorter incubation time of 24–36 hours was also documented during an outbreak of gastroenteritis in a Japanese kindergarten.79–81 Generally, human astroviruses induce a mild, watery diarrhea that typically lasts for 2–3 days, associated primarily with vomiting, fever, anorexia, abdominal pain and a variety of constitutional symptoms lasting no more than 4 days.22,82 Dehydration also can occur in patients with underlying gastrointestinal disease, poor nutritional status, or mixed infections83 (Table 3.1). Prolonged lactose intolerance and sensitivity to cow’s milk have been described.84,85 Persistent gastroenteritis due to astrovirus has been associated with serotype 3.86 Deaths related to astrovirus infection are extremely rare, although have been reported.87 Severe intussusception caused by HAstV infection was also documented in a child hospitalized with gastroenteritiss.88 In an Argentinean outpatient study with children under 36 months of age, astrovirus was associated with 12.4% of the diarrhea episodes; fever was present in 41.6%, and 16.7% of the patients required hospitalization.89 In Egypt among children under the age of 3 years, the total incidence of diarrhea due to astrovirus was equal to rotavirus; and severe dehydration arose out of 17% of astrovirus infected patients.90 Astroviruses cause infection at relatively low doses in humans, and appear in food which are usually obtainable in easy-to-use form, and therefore are not subjected to cooking conditions that kill them. Infected food workers may shed virus for longer periods of time, and for that reason may remain infectious even after full recovery.92 In children it may be difficult to distinguish diarrhea caused by astrovirus from that caused by rotavirus on clinical grounds alone.22,26 However, in general astrovirus diarrhea is less severe when compared to symptomatic rotavirus infection, as it does not cause significant dehydration and patients are less likely to require hospitalization.26,45,85 3.1.3.2 Role in Immunocompromised Hosts HAstVs cause chronic diarrhea among immunosuppressed patients in all age groups. HAstVs cause infection more frequently in patients with several immune diseases, such as chronic lymphocytic leukemia, congenital T-cell immunodeficiency, human immunodeficiency, combined immunodeficiency, Waldenstrom’s macroglobulinaemia and immunodeficiency polyendocrinopathy.93–96 Depletion of CD4 + T-cells by disease or iatrogenic means (for example chemotherapy) develops prolonged astrovirus diarrhea.93,97,98 Among HIV-infected patients, several viruses (for example astroviruses, adenoviruses, picobirnaviruses) were found more often in the stools of those with diarrhea (n = 65) than those without diarrhea (n = 65).95 HAstVs have been associated with outbreaks in bone marrow transplant patients.99 Chronic astrovirus diarrhea has been published in a child, who received a bone marrow transplant for combined immunodeficiency.22 The infection persisted until the child’s death, but no antibodies to astroviruses were detected in the serum.
Table 3.1 Clinical Symptoms Associated with Human Astrovirus Infection Diarrhea
Incidence 72–100% Duration 2–3 days (average) Maximum number of stools 4/24 hours Incidence of bloody diarrhea 0% Abdominal pain Incidence 50% Vomiting Incidence 20–70% Duration 1 day (average) Maximum number of vomiting 1/24 hours Fever Incidence 20–25% Maximum 37.9°C Dehydration Incidence to a degree 24–30% Incidence of severe dehydration 0–5% Hospitalization Incidence 6% Duration 6 days (average) Bronchiolitis Incidence 33% Otitis Incidence 13% Severity score (1–20)* 5 (average) Admission diagnosis of gastroenteritis 18.7–48% Source: Adopted from Walter, J.E., Mitchell, D.K., Curr. Opin. Infect. Dis., 16, 247, 2003. *20 points scoring system according to Ruuska and Vesikari.91
3.1.3.3 Immunity At present the determining factors of immunity to astrovirus are not well understood. Astroviruses primarily infect two age groups (young children and the elderly) and institutionalized patients. The age distribution of symptomatic infection suggests that antibodies to astrovirus acquired in childhood provide a certain protection from illness through adult life and that immunity decreases late in life. Studies revealed that in volunteers with detectable serum astrovirus antibody, diarrhea did not manifest clinically after virus challenge.79 Indirect evidence suggests that astrovirus-specific antibodies play a role in limiting infection in the host. Gamma globulin pools in the USA and Japan contain antibodies to human astroviruses, suggesting that astrovirus infection is common.81,100 Studies in the UK have shown that antibodies to astrovirus are acquired in early childhood; 70% have antibody by school age, 75% by 10 years of age, and 77% by early adulthood.101 The normal mucosal immune system is important in the protection of individuals from repeated human astrovirus infections.102 CD4 + T-cells that recognize human astrovirus antigens in a human leukocyte antigen (HLA)-restricted manner have been found in the lamina propria of intestinal tissue of healthy adults.102 Upon activation, these human astrovirus CD4 + T-cells may play a role in preventing repeated astrovirus infections by production of helper T-cell subtype 1-type cytokines, interferon gamma and tumor necrosis factor, providing a defense barrier at the portal of entry.
38
The role of the humoral immune response in animals to restrict astrovirus infection is not clear. It was demonstrated, that virus replication in small turkeys infected with TAstV was limited, however the infection did not induce significant adaptive immune response. No protection was observed against TAstV on secondary challenge; and the restricted virus replication was attributed to an inherent response, cured by production of nitric oxide.103
3.1.4 Epidemiology Human astrovirus infections have been detected worldwide, principally in young children suffering from diarrhea.9,77,95,104,105 Human astroviruses cause disease in (i) infants and young children, (ii) elderly institutionalized patients, (iii) immunocompromised hosts, and (iv) otherwise healthy individuals that come into contact with astrovirus-contaminated food or water. Studies in Australia,106 Thailand26 and Guatemala83 have revealed HAstV as the second most common cause of gastroenteritis in children, after rotavirus, with incidences varying from 4.2% to 8.6%. Large outbreaks caused by astroviruses through contaminated food, which affect thousands of persons in Japan, have been reported among otherwise normal school-age children and adults.107,108 Age distribution of HAstV can vary. In a Spanish study, 80% of children under 3 years of age were infected with astroviruses.109 In Egypt age-specific HAstV and rotavirus incidences were similar (0.38 for infants under 6 months, 0.40 for infants between 6 and 11 months, and 0.16 for children 12–23 months).90 Astrovirus infections occur primarily in the winter months in temperate regions and in the rainy seasons in more tropical climates.45,83 HAstV type 1 has been detected as the predominant strain in most countries,48,69,106,110 and the circulation of other types in a given period is probably less frequent throughout the year in any single geographic area, but the most common serotype can vary with time and location. Hence, in the UK 72% of the community-acquired astroviruses, detected between 1975 and 1987 were serotype 1,22 while in Australia serotypes 1, 3, and 4 were most frequently found in an 18-year period.111 In Mexico, astrovirus type 2 was the predominant strain (35%).112 Although in a study in 2004, where samples were analyzed from different regions of Mexico, types 1, 2, 3, 4, 6, 7, and 8 were found, and in a region, frequency of serotype 8 and type 1 was the same.113 Both community-acquired26,85 and nosocomial9,84 infections have been described. 3.1.4.1 Role in Disease Until recently it was complicated to determine the real incidence of astrovirus infection and its role in disease, partly due to the frequency of coinfections with other pathogens.45 Development of more sensitive detection methods has clarified their role in gastroenteritis in different populations. Astroviruses frequently cause outbreaks of diarrhea in child care centers, and children less than 36 months of age attending child care settings are at the greatest risk of developing
Molecular Detection of Foodborne Pathogens
diarrhea.114 In several parts of the world astroviruses are known to be the main cause of viral diarrhea in young children.1 Astroviruses were identified as a foodborne pathogen only within the last 30 years, though they have probably been causing foodborne infections for centuries. Astroviruses are estimated to participate in less than 1% of all foodborne illness, similar to rotaviruses,2 which mean 39000 cases per year out of 3.9 million total cases due to viruses.2 Although, weaknesses and variations in foodborne disease surveillance systems (where such programmes exist at all), make the global estimation of foodborne diseases difficult. Symptoms of astroviral foodborne infection range from mild gastroenteritis to severe life-threatening syndromes. The seriousness of foodborne illness caused by astroviruses is dependant on the number of infective virus particles, moreover the age, genetic background, and general immune, health and nutrition status of the infected person, as well as the efficiency of sanitation systems. Thus foodborne diseases most seriously affect children, pregnant women, the elderly, and people already suffering from other diseases causing severe illness. Any food that has been handled manually and not at all or insufficiently heated is a possible source of astrovirus infection.115 Contamination of fresh produce by the astrovirus-containing fecal material frequently causes foodborne illnesses. The source of this contamination can vary from an infected person that has contact with food, to an entire harvesting area subjected to inefficiently or even untreated sewage or sludge (which is commonly used as fertilizer), and polluted water for irrigation.56 Bivalve molluscan shellfish can concentrate astroviruses from large volumes of water, allowing accumulation of virus from fecally contaminated water. 3.1.4.2 Antibody Acquisition and Prevalence Antibodies to astrovirus are generally acquired in early childhood. In 1978, an examination of 87 children under 10 years of age in the Oxford region of the UK demonstrated a rapid increase in antibody prevalence from 7% in 6–12-month-old babies, to 70% by school age.101 Astrovirus antibodies could be detected in 75% of the 10-year-old children. Young adults were also examined, and 77% had antibodies to astrovirus. In this study HAstV antibodies were detected by immunofluorescence of astrovirus infected cells; consequently, the prevalence of astrovirus in the population was likely underestimated. In a seroprevalence study among hospitalized children in the UK rates of 86% for serotype 1, 1% for type 2, 8% for serotype 3, and 6% for serotype 4 were reported.116
3.1.5 Laboratory Diagnosis Table 3.2 summarizes the current diagnostic methods for astroviruses. Most studies of astrovirus detection in food have focused on shellfish. Different protocols have been developed for the detection of astroviruses from foodstuffs; and comparative studies are needed to determine which assays should be recommended.117 The detection of astroviruses from any type of food sample without an effective concentration
39
Astroviruses
Table 3.2 The Current Diagnostic Techniques for Astroviruses Method Electron microscopy (EM)
Specimen
Sensitivity
Reagents
Negative stained fecal 106 to 107 virus specimens particles per gram of feces119 105 to 106 particles per gram of stool
• Organic solvents, resin, • Aqueous (or alcoholic) solutions of heavy metal stains
Enzyme immunoassay (EIA)
Clinical samples25
Molecular techniques (molecular probes, reverse transcriptionpolymerase chain reaction/RT-PCR/)
Both clinical and environmental samples69,118,120–125
• A group reactive monoclonal antibody (8E7) • Viral antigen • A polyclonal antiserum as the detector antibody • Commercial kit is available (DAKO Corporation,Carpenteria, CA) • Probe (fragment of astrovirus genome) in the case of molecular probes • Extracted astrovirus nucleic acid • Primers (oligonucleitodes from different regions of the genome)29,53,126,127 • Deoxinucleotides • Reverse transcriptase • Polymerase
Cell culturing
Both clinical and environmental samples
Immunoelectron microscopy (IEM)
Comparable sensitivity (91%) and specificity (98%) to IEM (105 to 106 particles per gram of stool)
• Molecular probes: 105 to 106 particles per gram of stool119 • RT-PCR: ten to 100 particles per gram of feces119
Media, trypsin
Limitations/Requirements • A lack of specific antibodies to every serotype119 • Experienced microscopist • Only 10% of the astroviral particles in a given specimen display the distinctive surface star-like structure54 • Cannot be used for looking for the lower concentration of virus particles present in contaminated food or water
• Knowledge of human astrovirus genomes • The high variability in the genomic sequence does not allow the use of universal primers for all members of the family, Astroviridae36 • Fail to distinguish between infectious and noninfectious virus particles • Diagnostic methods for the detection of astroviruses or viral RNA in food and water have not been adopted to routine laboratories in most parts of the world • Naturally occurring inhibitors can hamper the PCR reaction. Therefore, the incorporation of an internal nucleic acid standard into each RT-PCR tube is important to identify inhibitors and eliminate false negatives • Requires the extraction of the viral RNA from the sample (e.g. with borate buffer, glycine solution, saline beef, proteinase K digestion, washing of food samples with guanidinium thiocyanate, adding PBS to the food sample, then extract with Freon) • More sensitive real-time RT-PCR has been developed • Have also been used to confirm the presence of astrovirus in EIA-positive samples28,95,104. Good correlation between EIA and RT-PCR has been observed, although it was demonstrated that in some cases RT-PCR has a higher sensitivity than EIA in detecting astrovirus28 • Have also been used to detect astrovirus genome in animals, such as minks128 and turkeys129 • Time-consuming, unreliable, expensive • Requires trypsin for isolation from primary specimens • Polluted water and shellfish samples are usually toxic for cell cultures
40
procedure and appropriate virus detection method is difficult and frequently unsuccessful. Several concentration methods have been developed in recent years. Concentration and purification of virions from shellfish rely on physicochemical procedures,118 such as polyethylene glycol (PEG) 6000 or 8000 precipitation, organic flocculation, or application of positively-charged virosorb filters. In addition, many different viral detection techniques have been used, ranging from tissue culture methods to nucleic acid hybridization. It is important to apply a method, which is flexible, inexpensive and can be used without extensive pH treatment or use of multiple reagents. Furthermore, it can be used in a minimally equipped laboratory and by staff with a minimal level of training. The traditional technique for detection of astroviruses is to isolate them in tissue culture. The isolation of astroviruses from food samples is not an easy task. Bacterial contaminations from shellfish also create difficulties in virus propagation in cell cultures. Treating samples with large amounts of antibiotics or chloroform might be effective, but toxic effects cannot be excluded. Therefore, at present, molecular techniques (such RT-PCR, real-time PCR, or immunomagnetic beads-PCR) offer the best alternative to develop sensitive and specific methods for the detection of astroviruses from environmental samples.130 Unfortunately, molecular techniques fail to distinguish between infectious and noninfectious virus particles, which may be a critical point in environmental virology and infection control.131 Although, the RNA genome does not remain intact without the protective capsid in an RNase-rich environment; therefore, if the genomic RNA could be detected by amplification, there is a good reason to suppose that viruses are infective. Virus detection in other foods, such as lettuce, strawberry, deli meats (ham, turkey, and roast beef), and green onion is not general.132
3.1.6 Treatment and Prevention Astrovirus gastroenteritis is generally characterized as a mild, self-limiting diarrhea with or without nausea and vomiting. The infection can strike down the individual for a few days, but does not require specific therapy. Although, more severe disease can develop in patients who have other medical problems, such as underlying gastrointestinal disease, malnutrition, immunodeficiency, coinfection with other pathogens(s) or prolonged illness. In addition, dehydration in young children may demand oral or intravenous fluid resuscitation. Intravenous immunoglobulin may be a beneficial adjunct in patients with severe immunodeficiency who have no response to conservative therapies,93 however, subsequent studies are required to determine effectiveness and to ascertain indications. Determinant of prevention of astrovirus infection is to break transmission, particularly in hospitals and other institutions, day-care centers, and families where person-to-person transmission is probable. Immunization against astroviruses is the ideal solution to prevent outbreaks, considering that
Molecular Detection of Foodborne Pathogens
astrovirus is a medically important pathogen.26,83 Vaccine development is not current, because the actual importance of astroviruses, as well as key factors of immunity are not well understood. Nevertheless, a prophylactic vaccine can play a remarkable role in reducing the incidence of food- and waterborne infections caused by astrovirus. Until then, general hygienic procedures, such as hand washing, disinfection of probably contaminated areas, surfaces (associated with feces or vomits containing astrovirus) with chlorine-based detergents, wearing of gloves for all points in the food chain where foodstuffs are handled manually, and appropriate treatment of potable water can prevent foodborne outbreaks and diseases due to astroviruses. It is also essential to not grow or wash foodstuffs in fecally contaminated water. Moreover, pasteurization procedures, disease control in animals, better regulation of shellfish beads, improvement in the safety of animals own feed and water supply, and protection from manure can prevent outbreaks; primarily because general hygienic procedures are not always sufficient to reduce astroviral infections and contamination.
3.2 Methods 3.2.1 Sample Preparation Frequently used virus concentration methods are summarized in Table 3.3, and general sample preparation and detection procedures of astroviruses from food samples are shown in Table 3.4. Food samples are usually obtained from cafeterias, coastal waters, as well as shellfish growing areas, and stored at 4°C, for a maximum of 24 hours until further processing. Generally, cold storage temperatures (2–8°C) delay senescence, product browning and growth of microorganisms in minimally processed fruits as well as vegetables, however promote the survival of astroviruses. Although, most studies of astrovirus detection in food have focused on shellfish. Shellfish are generally shucked, and the stomach and digestive verticula are removed by dissection, and frozen (–20°C) until analysis. For analysis, 20–25 g tissues need to be thawed on ice, then homogenized (e.g. in tryptose phosphate broth (TPB)-glycine buffer) and—in some cases—sonicated before virus concentration and nucleic acid extraction. In order to prevent cross-contamination, it is recommended to sterilize the homogenizing part of the blender with ethanol (70%) and to heat for 1 min after each sample. Some detailed sample preparation procedures are introduced in Section 3.2.3. Here we provide three step-wise protocols (Figures 3.3 through 3.5) for preparation of mussel, food and shellfish for RT-PCR detection of astroviruses.
3.2.3 Detection Procedures (i) Extraction of viral RNA: Viral RNA is prepared with one of the methods outlined in Figures 3.3 through 3.5. (ii) RT-PCR: The type-common primer pair Mon2/ PRBEG (Mon2, 5′ GCT TCT GAT TAA ATC AAT
41
Astroviruses
Table 3.3 Frequently used Virus Concentration Techniques from Foods Method
Reagents and Equipment
Underlying Priniciples
Hydroextraction
Homogenized sample in dialysis bag surrounded by polyethylene glycol
Viruses remain inside the bag, at 4°C, complete within 18–24 hours
Ultracentrifugation
Homogenized sample
Ultrafiltration
Homogenized sample, membrane
Adsorption to membrane filters Precipitation
Homogenized sample, positive/ negative filter Homogenized sample, PEG
Centrifuge at speeds above 50000 rpm Sample is driven through a membrane by applying pressure, viruses and macromolecules are retained Membrane filters retain viruses Add 8% PEG
Advantages/Disadvantages –Low recovery –Viruses are sometimes adsorbed to the dialysis membrane, –Toxic substances present in food may inactivate viruses during the 24-hour incubation period –Ultracentrifuge is very expensive –Good recovery, –Clogging of the filter
–Clogging, –Membrane coating components –Simple, cheap, –Good recovery
Table 3.4 General Sample Preparation and Detection Procedures of Astroviruses from Food Samples Concentration Homogenization, centrifugation Homogenization, sonification, centrifugation Homogenization in 1:7 (wt/vol) 10% TPB-0.05 M glycine (pH 9), centrifugation Homogenization, ultracentrifugation
Viral extraction or elution PEG 6000 centrifugation Freon TF centrifugation
Viral nucleic acid extraction Proteinase K, phenol-chloroform extraction, ethanol precipitation Mix of glass powder matrix and guanidine isothiocyanate
Detection
Reference
RT-PCR, hybridization
124
Nested RT-PCR
133
Chloroform extraction, PEG 6000 precipitation
Proteinase K digestion , phenolchloroform extraction, ethanol precipitation
RT-PCR, cell culture
33
Glycine buffer, PBS, centrifugation,
Guanidinium thiocyanate-silica particles
(nested) RT-PCR
134
TTT 3′; PRBEG, 5′ ACC GTG TAA CCC TCC TCT C 3′) targeting the hypervariable 3′ end of ORF2 region of astrovirus types 1–3 to 5–8, as well as Mon2/JWT4 (JWT4, 5′ GCA GAG AGC TTG TTA TTA AC 3′) for HAstV-4 are used for detection of HAstV by RT-PCR. These primers yield amplicons from 296 to 332 bp depending on the different HAstV types.136 (1) Prepare reverse transcription mixture (25 μl per tube) containing 0.1% bovine serum albumin, 0.4 mM dNTP mix (Promega, Madison, WI), 2 U AMV-RT (avian myeloblastosis virus RT, Promega, Madison, WI), 4 U RNasine (RNase inhibitor, Promega, Madison, WI), 0.05 μM dithiothreitol (Promega, Madison, WI), 2 μM
negative-strand primer (Mon2) and 5 μl RNA suspension in the reaction buffer (10 mM Tris, 50 mM KCl, 3 mM MgCl2, pH 8.3). (2) Incubate the tubes for 1 hour at 42°C. (3) Prepare PCR mixture (25 μl per tube) containing 10% dimethyl sulfoxide (Sigma, St. Louis, MO), Taq polymerase and 1 μM positive-strand primer (PRBEG, JWT4 or DM4 [DM4, 5′ CTA CAG TTC ACT CAA ATG AA 3′]) in the reaction buffer (same as the RT). (4) Transfer the total volume (25 μl) of cDNA from step 2 into each tube containing 25 μl PCR mixture. Perform PCR amplification with an initial denaturation at 94°C for 3 min, followed by 40 cycles of amplification; denaturation at 94°C for
42
Molecular Detection of Foodborne Pathogens
Homogenize (1 min, 9,500 rpm), then stir on magnetic stirrer (15 min) Sonicate (1 min, 100 W), centrifuge (10,000 × g, 90 min, 4°C)
Virus extraction
Grind the mussel tissue (3 min, 10,000 rpm), then add 100 ml 1 M borate-3% beef extract buffer pH 9
Adjust the pH to 7.3, then supplement the extract with 10% (final concentration) PEG 6000
Centrifuge (10,000 × g, 90 min, 4°C) Resuspend the pellet in 12 ml Na2HPO4 (pH 9) with vigorous magnetic stirring
Concentration
Incubate overnight at 4°C
Centrifuge (1,500 × g, 20 min, 4°C), then adjust the pH to 7.2 Extract RNA (RNA-PLUS purification kit; Bioprobe Systems, Montreuil, France or phenolchloroform extraction), resuspend the RNA pellet in 25 µl diethyl pyrocarbonate-treated water RT-PCR
Figure 3.3 Protocol I: preparation of mussel sample for RT-PCR detection of astroviruses (based on Traore et al., Appl. Environ. Microbiol., 64, 3118, 1998.) Wash the food (20–40 g) 3× with 40 ml PBS, mix for 5 min Freon extract (add 70 ml Freon, for 5 min, centrifugation [5,000 × g, 10 min, 4°C]) PEG precipitate (add 10% PEG 6000 and 0.3 M NaCl, incubate: 2 h, 4°C; centrifugation [7000 × g, 30 min, 4°C]) Extract the pellet with 8 ml TRIzol Clarification (centrifugation [8000 x g, 20 min, 4°C] Phenol/chlorophorm extract (add 1.6 ml chloroform to the aqueous phase, mix for 15 sec; incubation: 3 min, room temperature; centrifugation: 8000 × g, 20 min, 4°C; mix the aqueous layer with 4 ml isopropanol for 30 sec; incubation: 10 min, room temperature; centrifugation: 8000 × g, 20 min, 4°C) Precipitate viral RNA (wash the pellet with 8 ml 70 % ethanol; centrifugation: 7000 × g, 5 min, 4°C; air dry the pellet; suspend in 100 µl RNase-free water; store at –80°C RT-PCR amplification
Figure 3.4 Protocol II: preparation of food sample for RT-PCR detection of astroviruses (according to Schwab et al., Appl. Environ. Microbiol., 66, 213, 2000.) Homogenize 25 g shellfish in TPB-0.05 M glycine (pH 9.0–9.5) (5 min), then sonicate (2 min, 100 W) Concentration: centrifugation (3000 × g, 30 min, 4°C), adjust supernatants pH to 7.2–7.4 add PEG 6000 (8%;wt/vol), stir: 2 h, 4°C, then repeat centrifugation Detoxification: resuspend pellet in 5 ml 0.15 M Na2HPO4 (pH 9.0–9.5), sonicate 2 times (30 sec, 100 W) centrifugation (10000 × g, 30 min, 4°C), adjust supernatants pH to 7.4 Purification: add PBS to 15 ml final volume, then extract 5 times with Freon TF centrifugation (3000 × g, overnight, 4°C) over membrane filter Nucleic acid extraction: lyse with 6.6 M guanidine isothiocyanate, bind nucleic acid to silica particles, wash with guanidine isothiocyanate, ethanol and acetone Elution: TE buffer at 56°C, ethanol precipitate: add 0.1 vol. sodium acetate and 2 volume ethanol, leave at –70°C, 30 min, centrifuge at 20000 × g, 20 min, 4°C RT-PCR assay
Figure 3.5 Protocol III: preparation of shellfish for RT-PCR detection of astroviruses (based on Lees et al., Appl. Environ. Microbiol., 60, 2999, 1994.)
Astroviruses
1 min, annealing at 50°C for 1 min, and elongation at 72°C for 1 min. The final extension is at 72°C for 10 min. (5) Separate PCR products by agarose gel (3%) electrophoresis in Tris–boric acid EDTA buffer, pH 8.0, containing ethidium bromide (0.5 μg/ml), and visualize amplicons by UV-transillumination at 320 nm. (iii) Sequencing and phylogenetic analysis: The amplicons from the 3′ end of ORF2 obtained above are cloned into pGEM-T vector (Promega, Madison, WI) following the manufacturer’s instructions. Two different clones of the same RT-PCR amplicon are sequenced using fluorescein-labeled primers and commercial sequencing kit (SequiTerm EXCEL II Long-Read DNA Sequencing Kit-ALF, Epicentre Technologies, Madison, WI) on an automated sequencer (ABI 310, Applied Biosystems, Foster City, CA) following the manufacturer’s recommendations. Basic sequence manipulation and verification are performed using OMIGA software (v.2.0 Accelrys Co., San Diego, CA). Nucleotide sequences of the Hungarian strains are compared to available reference strains and a genotype is assigned based upon similarity scores. Viruses with 97–100% nucleotide identity in the 3’ end of ORF2 region of the genome are considered the same strain. In order to obtain a more accurate and reliable comparison, phylogenetic analysis is performed on representative strains using a longer, approximately 1.2-kb region (Mon2/DM4) of the 3’ end of ORF2. ClustalW v1.7 (http://evolution.genetics.washington.edu) is used to create multiple alignments of the amino acid sequences of the selected partial capsid sequences. The nucleotide sequences are added and aligned by GeneDoc v2.3 (http://www.psc. edu/biomed/genedoc) using the corresponding amino acid sequences as template, resulting in a consensus length of 1183 nucleotides terminating at the 3’ end of ORF2. A phylogenetic tree is constructed from the nucleotide sequence alignment using the maximum-likelihood algorithm in the program DNAML of PHYLIP v3.52c (http://evolution.genetics.washington.edu/phylip) running in a UNIX environment. The global rearrangement option is invoked and the order of the sequence input is randomized 50 times. The analysis is performed unrooted.
3.3 Conclusions and Future Perspectives Since astrovirus is one of the main four viruses that cause foodborne infections, studies are needed to estimate the burden and cost of illness caused by foodborne astroviral infections, especially among susceptible individuals. Therefore, better surveillance systems are required. Molecular investigation of astroviruses throughout the whole food chain and through populations is also essential. The burden of
43
foodborne illnesses due to astrovirus is highest in the elderly, and as a result of aging populations it will probably increase in the following years.137 The extreme stability of astroviruses in the environment and their highly infectious nature contribute to the ease of foodborne transmission. Infected foodhandlers play a well known role in transmission of astrovirus. Nevertheless, virus contamination may occur anywhere in the food chain, consequently the role of the infected agricultural laborer should be taken into consideration. The use of sludge as fertilizer and wastewater for irrigation increase the risk for viral contamination. There is a need to develop quick and simple molecular methods for detection of astroviruses from foodstuffs, and to urge rapid exchange of typing information between food laboratories and countries. New methods should be comparable and need to be standardized. Further studies are needed to evaluate the applicability of these methods in food microbiology.137 Molecular methods may play an important role to better understand foodborne astroviral outbreaks. Further studies are needed both to evaluate the mechanism of emergence of epidemic strains and the plausible link with animal astrovirus infections. There is a need for international cooperation as well as a well-organized public health system with the involvement of researchers to find solutions for foodborne astroviral outbreaks. Development of rapid detection methods to combine epidemiological and virological information is also necessary in the limitation of foodborne outbreaks. Contaminated products usually have a normal look, smell and taste, which present difficulties in the identification of astrovirus. Also, appropriate astrovirus detection methods are in general, not routinely available in food microbiology laboratories. While routine cell culture methods isolate astroviruses easily from blood or other sterile sites, specific methods are necessary to identify them from foodstuffs. A primary obstacle of linking epidemic outbreaks with foods is to detect the small amount of viruses that may be present in foodstuffs. In addition, by the time the infection is clinically manifest, the food under discussion has been consumed or discarded. In most countries the surveillance infrastructure for foodborne diseases of microbiological (or chemical) etiology, is weak or nonexistent. Moreover, in many countries, principally in the developing world, laboratory resources and skills to identify astroviruses are inadequate, and etiology-specific surveillance is often not possible. Even in the developed countries, laboratory-based surveillance is not well advanced. Absence of a simple and reliable diagnostic test to detect astroviruses in food makes surveillance difficult. Currently available routine monitoring systems focus on bacterial pathogens. Nowadays, directives establish no specific microbiological criteria concerning the presence of enteric viruses in food or water; nonetheless it has clearly been shown, that no correlation between the presence of HAstVs and indicators of fecal pollution was found. Further investigations are needed to establish possible correlations between fecal contamination and HAstVs as viral
44
contaminants.138 Nevertheless, the shortcomings of standard indicator organisms: fecal coliform bacteria, Escherichia coli, and Salmonellae as generally accepted indicators of fecal contamination of food, have been highlighted in several studies,139,140 and this has led to calls for a reassessment of quality guidelines based on these indicator organisms. The food industry and the scientific community should work together to develop an integrated plan of action to address foodborne astroviral infections.
References
1. Matsui, S.M., Greenberg, H.B. Astroviruses. In: Field’s Virology, 4th ed. Knipe, D.M. and Howley, P.M. (eds.). Lippincott Williams & Wilkins, Philadelphia, PA, 875–894, 2001. 2. Mead, P.S., Slutsker, L., Dietz, V., McCaig, L.F., Bresee, J.S., Shapiro, C., Griffin, P.M., Tauxe, R.V. Food-related illness and death in the United States. Emerg. Infect. Dis. 5, 607, 1999. 3. Madeley, C.R., Cosgrove, B.P. 28 nm particles in faeces in infantile gastroenteritis. Lancet 2, 451, 1975. 4. Madeley, C.R. Comparison of the features of astroviruses and caliciviruses seen in samples of feces by electron microscopy. J. Infect. Dis. 139, 519, 1979. 5. Risco, C., Carrascosa, J.L., Pedregosa, A.M., Humphrey, C.D., Sánchez-Fauquier, A. Ultrastructure of human astrovirus serotype 2. J. Gen. Virol. 76(Pt 8), 2075, 1995. 6. Matsui, S.M., Kiang, D., Ginzton, N., Chew, T., GeigenmüllerGnirke, U. Molecular biology of astroviruses: selected highlights. Novartis Found Symp. 238, 219, 2001. 7. Bass, D.M., Qiu, S. Protelolytic processing of the astrovirus capsid. J. Virol. 74, 1810, 2000. 8. Méndez, E., Fernandez-Luna, T., Lopez, S., Méndez-Toss, M., Arias, C.F. Proteolytic processing of a serotype 8 human astrovirus ORF2 polyprotein. J. Virol. 76, 7996, 2002. 9. Appleton, H., Higgins, P.G. Viruses and gastroenteritis in infants. Lancet 1, 1297, 1975. 10. Caul, E.O., Appleton, H. The electron microscopical and physical characteristics of small round human fecal viruses: an interim scheme for classification. J. Med. Virol. 9, 257, 1982. 11. Kjeldsberg, E., Hem, A. Detection of astroviruses in gut contents of nude and normal mice. Arch. Virol. 84, 135, 1985. 12. Hoshino, Y., Zimmer, J.F., Moise, N.S, Scott, F.W. Detection of astroviruses in faeces of a cat with diarrhoea. Arch. Virol. 70, 373, 1981. 13. Marshall, J.A., Healey D.S., Studdert, M.J., Scott, P.C., Kennett, M.L., Ward, B.K., Gust, I.D. Viruses and viruslike particles in the faeces of dogs with and without diarrhea. Aust. Vet. J. 61, 33, 1984. 14. Williams, F.P. Jr. Astrovirus-like, coronavirus-like, and parvovirus-like particles detected in the diarrheal stools of beagle pups. Arch. Virol. 66, 216, 1980. 15. Snodgrass, D.R., Gray, E.W. Detection and transmission of 30 nm virus particles (astroviruses) in faeces of lambs with diarrhoea. Arch. Virol. 55, 287, 1977. 16. Woode, G.N., Bridger, J.C. Isolation of small viruses resembling astroviruses and caliciviruses from acute enteritis of calves. J. Med. Microbiol. 11, 441, 1978. 17. Tzipori, S., Menzies, J.D., Gray, E.W. Detection of astroviruses in the faeces of red deer. Vet. Rec. 108, 286, 1981.
Molecular Detection of Foodborne Pathogens 18. Bridger, J.C. Detection by electron microscope of caliciviruses, astroviruses and rotavirus-like particles in the faeces of piglets with diarrhoea. Vet. Rec. 107, 532, 1980. 19. Englund, L., Chriel, M., Dietz. H.H., Hedlund, K.O. Astrovirus epidemiologically linked to pre-weaning diarrhoea in mink. Vet. Microbiol. 85, 1, 2002. 20. McNulty, M.S., Curran, W.L., McFerran, J.B. Detection of astroviruses in turkey faeces by direct electron microscopy. Vet. Rec. 106, 561, 1980. 21. Gough, R.E., Collins, M.S., Borland, E., Keymer, I.F. Astrovirus-like particles associated with hepatitis in ducklings. Vet. Rec. 114, 279, 1984. 22. Kurtz, J.B., Lee, T.W. Astroviruses: human and animal. In: Novel Diarrhoea Viruses. Bock, G., Whelan, J. (eds.). Ciba Foundation Symposium. Wiley, Chichester, UK, 92–107, 1987. 23. Lee, T.W., Kurtz, J.B. Serial propagation of astrovirus in tissue culture with the aid of trypsin. J. Gen. Virol. 57, 421, 1981. 24. Herrmann, J.E., Hudson, R.W., Perron-Henry, D.M., Kurtz, J.B., Blacklow, N.R. Antigenic characterization of cell cultivated astrovirus serotypes and development of astrovirus-specific monoclonal antibodies. J. Infect. Dis. 158, 182, 1988. 25. Herrmann, J.E., Nowak, N.A., Perron-Henry, D.M., Hudson, R.W., Cubitt, W.D., Blacklow, N.R. Diagnosis of astrovirus gastroenteritis by antigen detection with monoclonal antibodies. J. Infect. Dis. 161, 226, 1990. 26. Herrmann J.E., Taylor, D.N., Echeverria, P., Blacklow, N.R. Astroviruses as a cause of gastroenteritis in children. N. Engl. J. Med. 324, 1757, 1991. 27. Jonassen, T.O., Monceyron, C., Lee, T.W., Kurtz, J.B., Grinde, B. Detection of all serotypes of human astrovirus by the polymerase chain reaction. J. Virol. Methods 52, 327, 1995. 28. Mitchell, D.K., Monroe, S.S., Jiang, X., Matson, D.O., Glass, R.I., Pickering, L.K. Virologic features of an astrovirus diarrhea outbreak in a day care center revealed by reverse transcriptase-polymerase chain reaction. J. Infect. Dis. 172, 1437, 1995. 29. Saito, K., Ushijima, H., Nishio, O., Oseto, M., Motohiro, H., Ueda, Y., Takagi, M., Nakaya, S., Ando, T., Glass, R. Detection of astroviruses from stool samples in Japan using reverse transcription and polymerase chain reaction amplification. Microbiol. Immunol. 39, 825, 1995. 30. Matsui, S.M., Kim, J.P., Greenberg, H.B., Young, L.M., Smith, L.S., Lewis, T.L., Herrmann, J.E., Blacklow, N.R., Dupuis, K., Reyes, G.R. Cloning and characterization of human astrovirus immunoreactive epitopes. J. Virol. 67, 1712, 1993. 31. Lewis, T.L., Matsui, S.M. Astroviral ribosomal frameshifting in an infection-transfection transient expression system. J. Virol. 70, 2869, 1996. 32. Lewis, T.L., Matsui, S.M. Studies of the astrovirus signal that induces (-1) ribosomal frameshifting. Adv. Exp. Med. Biol. 412, 323, 1997. 33. Monroe, S.S., Jiang, B., Stine, S.E., Koopmans, M., Glass, R.I. Subgenomic RNA sequence of human astrovirus supports classification of Astroviridae as a new family of RNA viruses. J. Virol. 67, 3611, 1993. 34. Willcocks, M.M., Carter, M.J. Identification and sequence determination of the capsid protein genojme of human astrovirus serotype 1. FEMS Microbiol. Lett. 114, 1, 1993. 35. Krishna, N.K. Identification of structural domains involved in astrovirus capsid biology. Viral Immunol. 18, 17, 2005. 36. Koci, M.D., Schultz-Cherry, S. Avian astroviruses. Avian Pathol. 31, 213, 2002.
Astroviruses 37. Monceyron, C., Grinde, B., Jonassen, T.O. Moleculrar characterisation of the 3’-end of the astrovirus genome. Arch. Virol. 142, 699, 1997. 38. Koci, M.D., Seal, B.S., Schultz-Cherry, S. Molecular characterization of an avian astrovirus. J. Virol. 74, 6173, 2000. 39. Monroe, S.S., Stine, S.E., Gorelkin, L., Herrmann, J.E., Blacklow, N.R., Glass, R.I. Temporal synthesis of proteins and RNAs during human astrovirus infection of cultured cells. J. Virol. 65, 641, 1991. 40. Walter, J.E., Briggs, J., Guerrero, M.L., Matson, D.O., Pickering, L.K., Ruiz-Palacios, G., Berke, T., Mitchell, D.K. Molecular characterization of a novel recombinant strain of human astrovirus associated with gastroenteritis in children. Arch. Virol. 146, 2357, 2001. 41. Jonassen, C.M., Jonassen, T.T.Ø, Sveen, T.M., Grinde, B. Complete genomic sequences of astroviruses from sheep and turkey: comparison with related viruses. Virus Res. 91, 195, 2003. 42. Guix, S., Caballero, S., Bosch, A., Pintó, R.M. C-terminal nsP1a protein of human astrovirus colocalizes with the endoplasmic reticulum and viral RNA. J. Virol. 78, 13627, 2004. 43. Green, K.Y., Ando, T., Balayan, M.S., Berke, T., Clarke, I.N., Estes, M.K., Matson, D.O., Nakata, S., Neill, J.D., Studdert, M.J., Thiel, H.J. Taxonomy of the caliciviruses. J. Infect. Dis. 181(suppl 2), S322, 2000. 44. Monroe, S.S., Carter, M.J., Herrmann, J.E., Kurtz, J.B., Matsui, S.M. Family Astroviridae. In: Virus Taxonomy: Classification and Nomenclature of Viruses. Murphy, F.A., Fauquet, C.M., Bishop, D.H.L., Ghabrial, S.A., Jarvis, A.W., Martelli, G.P., Mayo, M.A., Summers, M.D. (eds). SpringerVerlag, Vienna, Austria, 364, 1995. 45. Walter, J.E., Mitchell, D.K. Astrovirus infection in children. Curr. Opin. Infect. Dis. 16, 247, 2003. 46. Baxendale, W., Mebatsion, T. The isolation and characterisation of astroviruses from chickens. Avian Pathol. 33, 364, 2004. 47. Woode, G.N., Gourley, N.E., Pohlenz, I.F., Liebler, E.M., Mathews, S.L., Hutchinson, M.P. Serotypes of bovine astrovirus. J. Clin. Microbiol. 22, 668, 1985. 48. Koopmans, M.P., Bijen, M.H., Monroe, S.S., Vinje, J. Agestratified seroprevalence of neutralizing antibodies to astrovirus types 1 to 7 in humans in The Netherlands. Clin. Diagn. Lab. Immunol. 5(1), 33, 1998. 49. Kurtz, J.B., Lee, T.W. Human astrovirus serotypes Lancet 2(8416), 1405, 1984. 50. Lee, T.W., Kurtz, J.B. Human astrovirus serotypes. J. Hyg. (Camb.) 89, 539, 1982. 51. Lee, T.W., Kurtz, J.B. Prevalence of human astrovirus serotypes in the Oxford region 1976–92, with evidence for two new serotypes. Epidemiol. Infect. 112, 187, 1994. 52. Taylor, M.B., Cox, N., Vrey, M.A., Grabow, W.O. The occurrence of hepatitis A and astroviruses inselected river and dam waters in South Africa. Water Res. 35, 2653, 2001. 53. Belliot, G., Laveran, H., Monroe, S.S. Detection and genetic differentiation of human astroviruses: phylogenetic grouping varies by coding region. Arch. Virol. 142, 1323, 1997. 54. Monroe, S.S. Molecular epidemiology of human astroviruses. In: Perpectives in Medical Virology. Viral Gastroenteritis. Desselberger, U., Gray, J.J. (eds.). Elsevier, Amsterdam, The Netherlands, 607–616, 2003.
45 55. Williams, F.P. Jr. Electron microscopy of stool-shed viruses: retention of characteristic morphologies after long-term storage at ultralow temperatures. J. Med. Virol. 29, 192, 1989. 56. Seymour, I.J., Appleton, H. Foodborne viruses and fresh produce. J. Appl. Microbiol. 91, 759, 2001. 57. Willcocks, M.M., Carter, M.J., Laidler, F.R., Madeley, C.R. Growth and characterisation of human faecal astrovirus in continuous cell line. Arch. Virol. 113, 73, 1990. 58. Brinker, J.P., Blacklow, N.R., Herrmann, J.E. Human astrovirus isolation and propagation in multiple cell lines. Arch. Virol. 145, 1847, 2000. 59. Taylor, M.B., Grabow, W.O., Cubitt, W.D. Propagation of human astrovirus in the PLC/PRF5 hepatoma cell line. J. Virol. Methods 67, 13, 1997. 60. Taylor, M.B., Marx, F.E., Grabow, W.O. Rotavirus, astrovirus and adenovirus associated with an outbreak of gastroenteritis in a South African child care centre. Epidemiol. Infect. 119, 227, 1997. 61. Aroonprasert, D., Fagerland, J.A., Kelso, N.E., Zheng, S., Woode, G.N. Cultivation and partial characterization of bovine astrovirus. Vet. Microbiol. 19, 113, 1989. 62. Shimizu, M., Shirai, J., Narita, M., Yamane, T. Cytopathic astrovirus isolated from porcine acute gastroenteritis in an established cell line derived from porcine embryonic kidney. J. Clin. Microbiol. 28, 201, 1990. 63. Guy, J.S., Miles, A.M., Smith, L., Fuller, F.J., Schultz-Cherry, S. Antigenic and genomic characterization of turkey enteroviruslike virus (North Carolina, 1988 isolate): identification of the virus as turkey astrovirus 2. Avian Dis. 48, 206, 2004. 64. Koci, M.D., Kelley, L.A., Larsen, D., Schultz-Cherry, S. Astrovirus induced synthesis of nitric oxide contributes to virus control during infection. J. Virol. 78, 1564, 2004. 65. Koci, M.D., Moser, L.A., Kelley, L.A., Larsen, D., Brown, C.C., Schultz-Cherry, S. Astrovirus induces diarrhea in the absence of inflammation and cell death. J. Virol. 77, 11798, 2003. 66. Appleton, H. Small round viruses: Classification and role in food-borne infections. In: Novel Diarrhoea Viruses. Bock, G., Whelan, J. (eds.). Ciba Foundation Symposium 128. Wiley, Chichester, UK, 108–125, 1987. 67. Le Cann, P., Ranarijaona, S., Monpoeho, S., Le Guyader, F., Ferré, V. Quantification of human astroviruses in sewage using real-time RT-PCR. Res. Microbiol. 155, 11, 2004. 68. Maunula, L., Kalso, S., Von Bonsdorff C.H., Pönkä, A. Wading pool water contaminated with both noroviruses and astroviruses as the source of gastroenteritis outbreak. Epidemiol. Infect. 132, 737, 2004. 69. Nadan, S., Walter, J.E., Grabow, W.O., Mitchell, D.K., Taylor, M.B. Molecular characterization of astroviruses by reverse transcriptase PCR and sequence analysis: comparison of clinical and environmental isolates from South Africa. Appl. Environ. Microbiol. 69, 747, 2003. 70. Push, D., Oh, D.Y., Wolf, S., Dumke, R., Schröter-Bobsin, U., Höhne, M., Röske, I., Schreier, E. Detection of enteric viruses and bacterial indicators in German environmental waters. Arch. Virol. 150, 929, 2005. 71. Oron, G., Goemans, M., Manor, Y., Feyen, J. Poliovirus distribution in the soil-plant system under reuse of secondary wastewater. Water Res. 29, 1069, 1995. 72. Sebire, N.J., Malone, M., Shah, N., Anderson G, Gaspar HB, Cubitt WD. Pathology of astrovirus associated diarrhoea in a paediatric bone marrow transplant recipient. J. Clin. Pathol. 57, 1001, 2004.
46 73. Snodgrass, D.R., Angus, K.W., Gray, E.W., Menzies, J.D., Paul, G. Pathogenesis of diarrhoea caused by astrovirus infections in lambs. Arch. Virol. 60(3–4), 217, 1979. 74. Woode, G.N., Pohlenz, J.F., Gourley, N.E., Fagerland, J.A. Astrovirus and Breda virus infections of dome cell epithelium of bovine ileum. J. Clin. Microbiol. 19, 623, 1984. 75. Thounevelle, M.L., Haynes, J.S., Reynolds, D.L. Astrovirus infection in hatchling turkeys: histologic, morphometric, and ultrastructural, findings. Avian Dis. 39, 328, 1995. 76. Guix, S., Bosch, A., Ribes, E., Dora Martínez, L., Pintó, R.M. Apoptosis in astrovirus-infected CaCo-2 cells. Virology 319, 249, 2004. 77. Gray, J.J., Wreghitt, T.G., Cubitt, W.D., Elliott, P.R. An outbreak of gastroenteritis in a home for the elderly associated with astrovirus type 1 and human calicivirus. J. Med. Virol. 23, 377, 1987. 78. Lewis, D.C., Lightfoot, N.F., Cubitt, W.D., Wilson, S.A. Outbreaks of astrovirus type 1 and rotavirus gastroenteritis in a geriatric in-patient population. J. Hosp. Infect. 14, 9, 1989. 79. Kurtz, J.B., Lee, T.W., Craig, J.W., Reed, S.E. Astrovirus infection in volunteers. J. Med. Virol. 3, 221, 1979. 80. Midthun, K., Greenberg, H.B., Kurtz, J.B., Gary, G. W., Lin, F. C., Kapikian, A.Z. Characterization and seroepidemiology of a type 5 astrovirus associated with an outbreak of gastroenteritis in Marin County, California. J. Clin. Microbiol. 31, 955, 1993. 81. Konno, T., Suzuki, H., Ishida, N, Chiba, R., Mochizuki, K., Tsunoda, A. Astrovirus-associated epidemic gastroenteritis in Japan. J. Med. Virol. 9, 11, 1982. 82. Greenberg, H.B., Matsui, S.M. Astroviruses and caliciviruses: emerging enteric pathogens. Infect. Agents Dis. 1, 71, 1992. 83. Cruz, J.R., Bartlett, A.V., Herrmann, J.E., Cáceres, P., Blacklow, N.R., Cano, F. Astrovirus-associated diarrhea among Guatemalan ambulantory rural children. J. Clin. Microbiol. 30, 1140, 1992. 84. Esahli, H., Breback, K., Bennet, R., Ehrnst, A., Eriksson, M., Hedlund, K-O. Astroviruses as a cause of nosocomial outbreaks of infant diarrhea. Pediatr. Infect. Dis. 10, 511, 1991. 85. Nazer, H., Rice, S., Walker-Smith, J.A. Clininal associations of stool astrovirus in childhood. J. Pediatr. Gastroenterol. Nutr. 1, 555, 1982. 86. Caballero, S., Guix, S., El-Senousy, W.M., Calicó, I., Pintó, R.M., Bosch, A. Persistent gastroenteritis in children infected with astrovirus: association with serotype-3 strains. J. Med. Virol. 71, 245, 2003. 87. Singh, P.B., Sreenivasan, M.A., Pavri, K.M. Viruses in acute gastroenteritis in children in Pune, India. Epidemiol. Infect. 102, 345, 1989. 88. Jakab, F., Péterfai, J., Verebély, T., Meleg, E., Bányai, K., Mitchell, D.K., Szücs, G. Human astrovirus infection associated with childhood intussusception. Pediatr. Inter. 49, 103, 2007. 89. Giordano, M.O., Martinez, L.C., Isa, M.B., Paez Rearte, M., Nates, S.V. Childhood astrovirus-associated diarrhea in the ambulantory setting in a Public Hospital in Cordoba city, Argentina. Rev. Inst. Med. Trop. Sao Paulo 46, 93, 2004. 90. Naficy, A.B., Rao, M.R., Holmes, J.L., Abu-Elyazeed, R., Savarion, R., Wierzba, T.F., Frenck, R.W., Monroe, S.S., Glass, R.I., Clemens, J.D. Astrovirus diarrhea in Egyptian children. J. Infec. Dis. 182, 685, 2000.
Molecular Detection of Foodborne Pathogens 91. Ruuska, T., Vesikari, T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand. J. Infect. Dis. 22, 259, 1990. 92. Parashar, U.D., Dow, L., Fankhauser, R.L., Humphrey, C.D., Miller, J., Ando, T., Williams, K.S., Eddy, C.R., Noel, J.S., Ingram, T., Bresee, J.S., Monroe, S.S., Glass, R.I. An outbreak of viral gastroenteritis associated with consumption of sandwiches: implications for the control of transmission by food handlers. Epidemiol. Infect. 121, 615, 1998. 93. Björkholm, M., Celsing, F., Runarsson, G., Waldenström, J. Successful intravenous immunoglobulin therapy for severe and persistent astrovirus gastroenteritis after fludarabine treatment in a patient with Waldenstrom’s macroglobulinemia. Int. J. Hematol. 62, 117, 1995. 94. Gallimore, C.I., Taylor, C., Gennery, A.R., Cant, A.J., Galloway, A., Lewis, D., Gray, J.J. Use of a heminested reverse transcriptase PCR assay for detection of astrovirus in environmental swabs from an outbreak of gastroenteritis in a pediatric primary immunodeficiency unit. J. Clin. Microbiol. 43, 3890, 2005. 95. Grohmann, G.S., Glass, R.I., Pereira, H.G., Monroe, S.S., Hightower, A.W., Weber, R., Bryan, R.T. Enteric viruses and diarrhea in HIV-infected patiens. Enteric Opportunistic Infections Working Group. N. Engl. J. Med. 329, 14, 1993. 96. Wood, D.J., David, T.J., Chrystie, I.L., Totterdell, B. Chronic enteric infection in two T-cell immunodeficient children. J. Med. Virol. 24, 435, 1988. 97. Bergmann, L., Fencehl, K., Jahn, B., Mitrou, P.S., Hoelzer, D. Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia. Ann. Oncol. 4, 371, 1993. 98. Coppo, P., Scieux, C., Ferchal, F., Clauvel, J-P., Lassoued, K. Astrovirus enteritis in a chronic lymphocytic leukemia patient treated with fludarabine monophosphate. Ann. Hematol. 79, 43, 2000. 99. Cubitt, W.D., Mitchell, D.K., Carter, M.J., Willcocks, M.M., Holzel, H. Application of electronmicroscopy, enzyme immunoassay, and RT-PCR to monitor an outbreak of astrovirus type 1 in a paediatric bone marrow transplant unit. J. Med. Virol. 57, 313, 1999. 100. LeBaron, C.W., Furutan N.P., Lew, J.F., Allen, J.R., Gouvea, V., Moe, C., Monroe, S.S. Viral agents of gastroenteritis. Morbid. Mortal. Wkly. Rept. 39(RR-5), 1, 1990. 101. Kurtz, J.B., Lee, T.W. Astrovirus gastroenteritis age distribution of antibody. Med. Microbiol. Immunol. 166(1–4), 227, 1978. 102. Molberg, Ø., Nilsen, E.M., Sollid, L.M., Scott, H., Brandtzaeg, P., Thorsby, E., Lundin, K.E.A. CD4 + T cells with specific reactivity against astrovirus isolated from normal human small intestine. Gastroenterology 114, 115, 1998. 103. Mendez, E., Arias, C.F. Astroviruses. In: Field’s Virology, 5th ed. Knipe, D.M. and Howley, P.M. (eds.). Lippincott Williams & Wilkins, Philadelphia, PA, 981–1000, 2007. 104. Cox, G.J., Matsui, S.M., Lo, R.S., Hinds, M., Bowden, R.A., Hackman, R.C., Meyer, W.G., Mori, M., Tarr, P.I., Oshiro, L.S., Ludert, J.E., Meyers, J.D., McDonald, G.B. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology 107, 1398, 1994. 105. Moe, C.L., Allen, J.R., Monroe, S.S., Gary, Jr., H.E., Humphrey, C.D., Herrmann, J.E., Blacklow, N.R., Carcamo, C., Koch, M., Kim, K-H., Glass, R.I. Detection of astrovirus in pediatric stool samples by immunoassay and RNA probe. J. Clin. Microbiol. 29, 2390, 1991.
Astroviruses 106. Palombo, E.A., Bishop, R.F. Annual incidence, serotype distribution, and genetic diversity of human astrovirus isolates from hospitalized children in Melbourne, Australia. J. Clin. Microbiol. 34, 1750, 1996. 107. Oishi, I., Yamazaki, K., Kimoto, T., Minekawa, Y., Utagawa, E., Yamazaki, S., Inouye, S., Grohmann, G.S., Monroe, S.S., Stine, S.E., et al. A large outbreak of acute gastroenteritis associated with astrovirus among students and teachers in Osaka, Japan. J. Infect. Dis. 170, 439, 1994. 108. Utagawa, E.T., Nishizawa, S., Sekine, S., Hayashi, Y., Ishihara, Y., Oishi, I., Iwasaki, A., Yamashita, I., Miyamura, K., Yamazaki, S., Inouye, S., Glass, R.I. Astrovirus as a cause of gastroenteritis in Japan. J. Clin. Microbiol. 32, 1841, 1994. 109. Guix, S., Caballero, S., Villena, C., Bartolome, R., Latorre, C., Rabella, N., Simo, M., Bosch, A., Pintó, R.M. Molecular epidemiology of astrovirus infection is Spain, Barcelona. J. Clin. Microbiol. 40, 133, 2002. 110. Mitchell, D.K., Matson, D.O., Cubitt, W.D., Jackson, L.J., Willcocks, M.M., Pickering, L.K., Carter, M.J. Prevalence of antibodies to astrovirus types 1 and 3 in children and adolescents in Norfolk, Virginia. Pediatr. Infect. Dis. J. 18, 249, 1999. 111. Schnagl, R.D., Belfrage, K., Farrington, R., Hutchinson, K., Lewis, V., Erlich, J., Morey, F. Incidence of human astrovirus in central Australia (1995 to 1998) and comparison of deduced serotypes detected from 1981 to 1998. J. Clin. Microbiol. 40, 4114, 2002. 112. Guerrero, M.L., Noel, J.S., Mitchell, D.K., Calva, J.J., Morrow, A.L., Martinez, J., Rosales. G., Velázquez, F.R., Monroe, S.S., Glass, R.I., Pickering, L.K., RuizPalacios, G.M. A prospective study of astrovirus diarrhea of infancy in Mexico City. Pediatr. Infect. Dis. J. 17, 723, 1998. 113. Méndez-Toss, M., Griffin, D.D., Calva, J., Contreras, J.F., Puerto, F.I., Mota, F., Guiscafré, H., Cedillo, R., Muñoz, O., Herrera, I., López, S., Arias, C.F. Prevalence and genetic diversity of human astroviruses in Mexican children with symptomatic and asymptomatic infections. J. Clin. Microbiol. 42, 151, 2004. 114. Mitchell, D.K., Van, R., Morrow, A.L., Monroe S.S., Glass, R.I., Pickering, L.K. Outbreaks of astrovirus gastroenteritis in day care centers. J. Pediatr. 123, 725, 1993. 115. Djuretic, T., Wall, P.G., Ryan, M., Evans, H.S., Adak, G.K., Cowden, J.M. General outbreaks of infectious intestinal disease in England and Wales 1992 to 1994. CDR Rev. 6, R57, 1996. 116. Noel, J., Cubitt, D. Identification of astrovirus serotypes from children treated at the Hospitals for Sick Children, London 1981–1993. Epidemiol. Infect. 113, 153, 1994. 117. Lees, D. Viruses and bivalve shellfish. Int. J. Food Microbiol. 59, 81, 2000. 118. Traore, O., Arnal, C., Mignotte, B., Maul, A., Laveran, H., Billaudel, S., Schwartzbrod, L. Reverse transcriptase PCR detection of astrovirus, hepatitis A virus, and poliovirus in experimentally contaminated mussels: comparison of several extraction and concentration methods. Appl. Environ. Microbiol. 64, 3118, 1998. 119. Glass, R.I., Noel, J., Mitchell, D., Herrmann, J.E., Blacklow, N.R., Pickering, L.K., Dennehy, P., Ruiz-Palacios, G., De Guerrero, M.L., Monroe, S.S. The changing epidemiology of astrovirus-associated gastroenteritis: a review. Arch. Virol. (Suppl.) 12, 287, 1996.
47 120. Chapron, C.D., Ballester, N.A., Fontaine, J.H., Frades, C.N., Margolin, A.B. Detection of astroviruses, enteroviruses, and adenovirus types 40 and 41 in surface waters collected and evaluated by the information collection rule and an integrated cell culture-nested PCR procedure. Appl. Environ. Microbiol. 66, 2520, 2000. 121. Elamri, D.E., Aouni, M., Parnaudeau, S., Le Guyader, F.S. Detection of human enteric viruses in shellfish collected in Tunisia. Lett. App. Microbiol. 43, 399, 2006. 122. Gabrieli, R., Macaluso, A., Lanni, L., Di Giamberardino, F., Cencioni, B., Petrinca, A.R., Divizia, M. Enteric viruses in molluscan shellfish. New Microbiol. 30, 471, 2007. 123. Grimm, A.C., Cashdollar, J.L., Williams, F.P., Fout, G.S. Development of an astrovirus RT-PCR detection assay for use with conventional real-time, and integrated cell culture/ RT-PCR. Can. J. Microbiol. 50, 269, 2004. 124. Le Guyader, F., Haugarreau, L., Miossec, L., Dubois, E. and Pommepuy, M. Three-year study to assess human enteric viruses in shellfish. Appl. Environ. Microbiol. 66, 3241, 2000. 125. Pintó, R.M., Villena, C., Le Guyader, F., Guix, S., Caballero, S., Pommepuy, M., Bosch, A. Astrovirus detection in wastewater samples. Water Sci. Technol. 43, 73, 2001. 126. Noel, J.S., Lee, T.W., Kurtz, J.B., Glass, R.I., Monroe, S.S. Typing of human astroviruses from clinical isolates by enzyme immunoassay and nucleotide sequencing. J. Clin. Microbiol. 33, 797, 1995. 127. Walter, J.E., Mitchell, D.K., Guerrero, M.L., Berke, T., Matson, D.O., Monroe, S.S., Pickering, L.K., Ruiz-Palacios, G. Molecular epidemiology of human astrovirus diarrhea among children from a periurban community of Mexico City. J. Infect. Dis. 183, 681, 2001. 128. Mittelholzer, C., Englund, L., Hedlund, K.O., Dietz, H.H., Svensson, L. Detection and sequence analysis of Danish and Swedish strains of mink astrovirus. J. Clin. Microbiol. 41, 5192, 2003. 129. Koci, M.D., Seal, B.S., Schultz-Cherry, S. Development of an RT-PCR diagnostic test for avian astrovirus. J. Virol. Methods 90, 79, 2000. 130. Tsai, Y-L., Tran, B., Sangermano, L.R. and Palmer, C.J. Detection of poliovirus, hepatitis A virus, and rotavirus from sewage and ocean water by triplex reverse transcriptase PCR. Appl. Environ. Microbiol. 60, 2400, 1994. 131. Abad, F. X., Pintó, R. M., Villena, C., Gajardo, R. and Bosch, A. Astrovirus survival in drinking water. Appl. Environ. Microbiol. 63, 3119, 1997. 132. Schwab, K.J, Neill, F.H., Fankhauser, R.L., Daniels, N.A, Monroe, S.S., Bergmire-Sweat, D.A., Estes, M.K., Atmar, L.R. Development of methods to detect “norwalk-like viruses” (NLVs) and hepatitis A virus in delicatessen foods: application to a food-borne NLV outbreak. Appl. Environ. Microbiol. 66, 213, 2000. 133. Green, J., Henshilwood, K., Gallimore, C.I., Brown, D.W.G., Lees, D.N. A nested reverse transcriptase PCR assay for detection of small round-structured viruses in environmentally contaminated molluscan shellfish. Appl. Environ. Microbiol. 64, 858, 1998. 134. Pina, S., Puig, M., Lucena, F., Jofre, J., Girones, R. Viral pollution in the environment and in shellfish: human adenovirus detection by PCR as an index of human viruses. Appl. Environ. Microbiol. 64, 3376, 1998. 135. Lees, D.N., Henshilwood, K., Doré, W.J. Development of a method for detection of enteroviruses in shellfish by PCR with poliovirus as a model. Appl. Environ. Microbiol. 60, 2999, 1994.
48 136. Meleg, E., Jakab, F., Kocsis, B., Bányai, K., Melegh, B., Szücs, Gy. Human astroviruses in raw sewage samples in Hungary. J. Appl. Microbiol. 101, 1123, 2006. 137. Koopmans, M., von Bonsdorff, C-H., Vinjé, J., de Medici, D., Monroe, S. Foodborne viruses. FEMS Microbiol. Rev. 26, 187, 2002. 138. Macaluso, A., Gabieli, R., Lanni, L., Saccares, S., Pana, A., Divizia, M. Enteric viruses and bacteriological parameters in molluscs. Ann Ig. 16(1–2), 237, 2004.
Molecular Detection of Foodborne Pathogens 139. Croci, L., De Medici, D., Scalfaro, C., Fiore, A., Divizia, M., Donia, D., Cosentino, A.M., Moretti, P., Costantini, G. Determination of enterovirus, hepatitis A virus; bacteriophages and E. coli in Adriatic sea mussels. J. Appl. Microbiol. 88, 293, 2000. 140. Le Guyader, F., Apaire-Marchais, V., Brillet, J., Billaudel, S. Use of genomic probes to detect hepatitis A virus and enterovirus RNA in wild shellfish and relationships of viral contamination and bacterial contamination. Appl. Environ. Microbiol. 59, 3963, 1993.
4 Avian Influenza Virus Giovanni Cattoli and Isabella Monne
Istituto Zooprofilattico Sperimentale delle Venezie
Contents 4.1 Introduction......................................................................................................................................................................... 49 4.1.1 Classification of AI Virus........................................................................................................................................ 49 4.1.2 Biology and Pathogenesis........................................................................................................................................ 50 4.1.3 Medical Importance and Zoonotic Implication of AI Viruses................................................................................ 50 4.1.4 Diagnosis of AI Viruses........................................................................................................................................... 51 4.1.4.1 Virus and Antigen Detection..................................................................................................................... 51 4.1.4.2 Serology for AI Diagnosis......................................................................................................................... 52 4.1.4.3 Molecular Tests......................................................................................................................................... 52 4.2 Methods............................................................................................................................................................................... 55 4.2.1 Sample Collection and Handling............................................................................................................................. 55 4.2.1.1 Selection of Samples to be Collected........................................................................................................ 55 4.2.1.2 Transportation and Storage of Specimens................................................................................................. 55 4.2.1.3 Handling of Specimens............................................................................................................................. 56 4.2.2 Samples Preparation for PCR Testing..................................................................................................................... 56 4.2.3 Detection Procedures............................................................................................................................................... 56 4.2.3.1 One Step RT-PCR for the Detection of Type A Influenza Viruses........................................................... 56 4.2.3.2 One Step RT-PCR for the Detection of AI Viruses Belonging to the H5 Subtype................................... 57 4.2.3.3 Two Step RT-PCR for the Subtype Specific Detection of H7 AI Virus.................................................... 57 4.2.3.4 Detection of Type A Influenza Virus by Qualitative Real Time PCR (M gene)...................................... 58 4.2.3.5 Detection of Type A Influenza Viruses of H5 HA Subtype by Qualitative One Step Real Time RT-PCR..................................................................................................................................................... 58 4.2.3.6 Detection of Type A Influenza Viruses of H7 HA Subtype by Qualitative Real Time PCR......................................................................................................................................... 59 4.3 Conclusions and Future Perspectives.................................................................................................................................. 59 References.................................................................................................................................................................................... 60
4.1 Introduction Recent outbreaks of avian influenza (AI) in birds occurring in Europe, in the Americas, Asia, and Africa, have provided field evidence of how challenging could it be to control this infection, particularly in densely populated poultry areas or in areas where free-range rural village poultry and backyard flocks are present.1–3 The early detection of AI in domestic and wild bird populations as well as in poultry commodities has been recognized as crucial to the implementation of timely and adequate prevention and control strategies. In the last decade, an increasing number of novel molecular technologies have become available to aid diagnosis of infectious diseases of animals and many of these have been applied to improve and accelerate the diagnosis of AI. In addition, more traditional diagnostic protocols, mainly based on classical viral culture methods and
i mmuno-enzymatic assays, have been revisited or improved in the recent years. The increased availability of diagnostic tests in conjunction with improved knowledge on the epidemiology and the pathogenesis of AI, is resulting in a modified approach to surveillance and diagnosis of this infection, with a wider application of the molecular-based technologies.4
4.1.1 Classification of AI Virus Influenza viruses have segmented, negative sense, single strand RNA genomes. The viruses are classified in the family Orthomyxoviridae. At present the Orthomyxoviridae family consists of five genera, only viruses of the Influenzavirus A genus are known to infect birds. Influenza A viruses are subdivided into subtypes based on the antigenic relationships in the surface glycoproteins, hemagglutinin (HA), and neuraminidase (NA). At present, 16 HA subtypes have been recognized
49
50
(H1–H16) and nine NA subtypes (N1–N9).5 Each virus has one type of HA and one type of NA antigen, apparently in any combination.
4.1.2 Biology and Pathogenesis Type A AI viruses are very widespread in nature; up to now they have been detected in more than 105 different species of wild birds from 26 families.6 Wild aquatic birds are natural reservoirs of these viruses and they can become infected by viruses of all HA and NA subtypes without showing signs of disease. In domesticated poultry AI viruses can be grouped in two pathotypes based on the clinical signs they may cause mainly in gallinaceous species: low pathogenic AI (LPAI) viruses and highly pathogenic AI (HPAI) viruses. LPAI viruses mostly cause infections of the respiratory and the enteric tract and the infection is subclinical in most avian species. Infections may be characterized by mild respiratory signs, some depression and reduced egg production. HPAI viruses not only replicate in the respiratory and enteric tract but also in endothelial cells throughout the body with spillover to adjacent parenchymal cells. Disease signs involve the respiratory and enteric tracts and many other organ systems, such as the central nervous system. Lesions are characterized by multiple haemorrhages in visceral organs and the skin, and mortality rates approach 100%. Infection with HPAI viruses thus leads to wide dissemination in the body and virus presence in many organs and edible tissues.7 To date, only viruses of H5 and H7 subtype have been shown to cause HPAI in susceptible species, but not all H5 and H7 viruses can be classified as HPAI. It appears that H5 and H7 HPAI viruses arise by mutation after an AI virus precursor of low pathogenicity (LPAI) has been introduced into poultry. It follows that all HPAI viruses should have a LPAI progenitor, although the latter have only been identified in a limited number of cases.8 For all influenza A viruses the HA glycoprotein is produced as a precursor, HA0, which requires post translational cleavage by host proteases before it is functional and virus particles are infectious.9 The HA0 precursor proteins of AI viruses of low virulence for poultry (LPAI viruses) have a single arginine at the cleavage site and another basic amino acid at position -3 or -4 from the cleavage site. These viruses are limited to cleavage by extracellular host proteases such as trypsin-like enzymes and thus restricted to replication at sites in the host where such enzymes are found, i.e., the respiratory and intestinal tracts. HPAI viruses possess multiple basic amino acids (arginine and lysine) at their HA0 cleavage sites, either as a result of apparent insertion or apparent substitution, and appear to be cleavable by an intracellular ubiquitous proteases. HPAI viruses are able to replicate throughout the bird, damaging vital organs and tissues, which results in disease and death.10,11 The factors that bring about mutation from LPAI to HPAI are not known. In some instances mutation seems to have taken place rapidly (at the primary site) after introduction in
Molecular Detection of Foodborne Pathogens
poultry possibly through the wild birds,12,13 in others the LPAI virus has circulated in poultry for months before mutating.14 Therefore, it is impossible to predict if and when this mutation will occur. However, it can be reasonably assumed that the wider the circulation of LPAI in poultry, the higher the chance that mutation to HPAI will occur. HPAI viruses are not necessarily virulent for all species of birds and the severity of the clinical signs may vary with bird species, age of the host and virus strain.15,16 In particular, ducks rarely show clinical signs as a result of HPAI infections although there are reports that some of the Asian H5N1 viruses have caused disease and the HPAI viruses A/duck/Italy/2000 H7N1 and A/chicken/Germany/34 (H7N1) have been reported to cause disease and death in naturally and experimentally infected waterfowl.15,17 Bird to bird transmission of AI viruses is complex and it largely depends on the virus strain, host species and environmental factors.18 LPAI viruses are mainly excreted with feces, through the cloaca. Viral shedding through the respiratory tract is also considered important, at least for some species or some strains, as the Asian HPAI H5N1. For this virus, and similarly for other HPAI viruses, transmission from poultry to humans is supposed to occur primarily through direct contact with secretions of the upper respiratory tract, infected feces, feathers, organs, and blood of infected animals. Inhalation of contaminated dust or droplets can be an alternative transmission route.19
4.1.3 Medical Importance and Zoonotic Implication of AI Viruses Until recently, direct infection of humans with AI viruses had not been considered significant. Human cases were sporadically reported between 1959 and 1996 with only three documented cases, two in the USA (HPAI and LPAI H7N7) and one, likely to be of laboratory exposure-origin, in Australia (HPAI H7N7). In all cases the patients recovered and the main clinical sign was characterized by self-limiting conjunctivitis.3,8 However, starting from 1996, a series of events has raised the concerns on the zoonotic potential of AI infections. With some exceptions, since 1996 almost all the reported cases of AI virus infection in humans have been caused by HPAI viruses belonging to the H5 or H7 subtypes directly transmitted from infected birds to humans. Among the LPAI viruses, the first documented case of avian to human transmission was described in 1996 and caused by a LPAI H7N7 virus. The virus was isolated in England from the eye of a woman suffering from conjunctivitis. This person had ducks and the virus was shown to be genetically 100% of avian origin.20,21 In 1999, LPAI viruses belonging to the H9N2 subtype were isolated from two young girls in Hong Kong.22 They were suffering from an influenza-like syndrome and fortunately they recovered with no serious consequences. Subsequently, isolation of H9N2 viruses in human beings was reported in the Peoples Republic of China on five occasions during 1998.23 In 2003, LPAI H7N2 was isolated from a patient with respiratory symptoms in the US. Also in this case, the patient recovered.3
Avian Influenza Virus
In two other circumstances, evidence of contacts between LPAI viruses and humans were only detected serologically. A serological survey in human beings potentially at risk of exposure during the 2002–2003 LPAI H7N3 epidemic in Italy revealed the presence of specific antibodies in 3.8% of serum samples collected in poultry workers.24 Serological prevalence with regard to H9N2 was also revealed by the hemagglutination inhibition test in the human population at risk of exposure in Iran.25 However, this latter finding needs confirmation by means of other serological tests. Certainly, more significant and severe are the human infections caused by HPAI viruses. The first documented evidence on how serious could be the consequences of avian to human transmission of HPAI viruses occurred in 1997 in Hong Kong. In that year, the HPAI H5N1 circulating in the domestic poultry was capable of infecting 18 people, causing the death of six of them.26 Viruses belonging to the same antigenic subtype, H5N1, and genetically related to the 1997 viruses re-emerged in Hong Kong in 2003.27 In that year, this HPAI virus circulating in poultry in South East China began to spread westward among wild and domestic birds throughout Asia, reaching Europe and Africa in 2005 and 2006. Since then, the continued infections of humans and other mammals, such as felines, caused by this virus have caused great concern over the capabilities of H5N1 to cross the species barrier and to potentially become easily transmissible among humans. To date (2nd February 2009), a total of 404 confirmed cases of HPAI H5N1 infections in humans and 254 human deaths have been reported to the World Health Organization (WHO) (available at http://www.who.int/csr/disease/avian_influenza/ country/cases_table_2008_04_17/en/index.html). Other HPAI viruses belonging to the H7 subtype were reported as etiological agents of severe human infections to a minor extent compared to HPAI H5N1. During the 2003 outbreak caused by the H7N7 HPAI virus in poultry in The Netherlands, 82 cases were reported in humans. Generally, symptoms were described as influenza-like illness and/or conjunctivitis, but one fatality also occurred.28 In Canada, persons involved in outbreaks management suffered from conjunctivitis, headache, and flu-like syndrome. The H7N3 HPAI virus, responsible for the outbreak in poultry, was confirmed to be the causative agent of the disease. Fortunately, no fatal cases occurred.29 While such human infections generally result from direct and intensive contact with infected or diseased poultry, other routes of infection such as consumption of edible tissues from infected avians or contact with contaminated water have been suggested as possible sources of infection.
4.1.4 Diagnosis of AI Viruses Surveillance and monitoring programmes have been implemented in many countries around the world as a result of the global spread of AI viruses and of the subsequent implications on public perception and animal health issues. These programmes are mainly targeting the wild birds—considered as the main reservoirs—and the poultry population. The main aims of these
51
programmes are to detect and control AI viruses in the poultry compartment, thus preventing their spread to human beings. Therefore, nowadays laboratory testing is mainly applied to trace viral circulation in a given area or in a susceptible population in order to implement an early warning system, in addition to diagnose the presence of the virus in a diseased flock or animal or in poultry derived products. This implies the use of rapid, sensitive and, possibly, cost-effective laboratory tests adaptable to very high throughputs.4 4.1.4.1 Virus and Antigen Detection Traditionally, laboratory protocols for the detection and the identification of AI viruses were based on virus isolation (VI) in SPF eggs or in cell cultures. The application of these methods of laboratory investigation is mainly limited by the fact that they are not flexible to a sudden increase in demand, are not cost-effective and often require a long processing time. In fact, these methods are time-consuming and require a minimum of 12 days before a negative result may be issued. Office International des Epizooties (OIE) and EU official methods require two blind passages in eggs of 6 days, before the sample is considered negative.30,31 At present, there seems to be only limited space for improving the time-efficiency of these methods. What appears to be a major bottleneck is the obtainment of suitable substrates for VI. The primary cell cultures and the continuous cell lines tested so far provide variable results, mainly strain to strain dependant and, in general, they are less sensitive than SPF eggs. These are expensive and not always easily available. The use of eggs derived from AI and Newcastle disease virus (NDV) specific antibody negative (SAN) parent stocks are considered as an alternative method in the OIE manual30 and, more recently, in the EU manual.31 VI implies the replication in laboratory of viable viral particles to a significant concentration thus, biosafety, and biocontainment should be regarded as a priority for laboratories in which AI VI is performed. Despite these major difficulties, VI in fowl’s eggs still remains the gold standard for AI virus detection. Its sensitivity is equal or often superior to many alternative tests. In addition, genetic or antigenic variation of the viruses, as well as the presence of contaminants or PCR inhibitors in the samples, can impair the efficiency of molecular and immunoassays, but they have minor impact on VI. Under certain circumstances, it might be desirable to test a certain number of samples in a short period of time. In this case, antigen capture immunoassays can be considered a very useful diagnostic tool. They are very easy to use, do not require sophisticated or expensive equipment and, in many instances, they can be applied on-site, thus avoiding the time-consuming and delicate phase of sample preparation and shipment. In many cases, test results can be available within minutes. To date, most of the antigen capture tests available on the market target the type A influenza virus nucleoprotein (NP), thus detecting any type A influenza virus. With the exception of one H5 subtype specific test for veterinary use, this kind of
52
Molecular Detection of Foodborne Pathogens
assay does not provide any indication on the subtype involved. Furthermore, no indication on the pathotype (i.e., HPAI vs LPAI) can be obtained. Their main limitations consist in the unsatisfactory sensitivity compared to VI and molecular tests, and their unit cost.32,33 Due to their low sensitivity, sampling numbers should be increased before the presence of viral circulation in a given population can be ruled out. For the same reason, excessive dilution of the samples by pooling of swabs should be avoided. These features make this kind of assay unsuitable for monitoring and early detection programmes, where large number of samples must be cost-effectively screened with sensitive testing procedures. 4.1.4.2 Serology for AI Diagnosis Serology represents a relatively inexpensive and practical methodology to assess the circulation and the prevalence of influenza viruses in poultry. It does not provide direct evidence on the presence of the virus but, in the framework of a surveillance effort in domesticated birds, serological diagnosis is considered a suitable approach to monitor the AI-free status of a given region or farm. On the contrary, the application of the serological methods available today in wild bird surveillance may generate information of very limited use, particularly for HPAI surveillance.34 In fact, serology does not provide information concerning the pathotype and wild birds, specifically wild waterfowl, which are commonly infected by LPAI viruses, therefore serologically positive. During monitoring or surveillance programmes, large numbers of animals have to be tested in order to guarantee acceptable statistical significance. In recent times the agar gel immuno-diffusion (AGID) test has been superseded by commercial ELISA tests. Both systems detect antibodies to
the group antigen of influenza A viruses, and therefore are unable to give any indication on the virus subtype causing infection. These tests find their primary application in monitoring poultry flocks, although most of them lack validation data for minor species (ducks, geese, quails etc). In addition, AGID is not suitable for testing sera of waterfowl as the latter do not produce precipitating antibodies.35 The hemagglutination inhibition test is a simple, robust, and fully validated test that generates qualitative and quantitative information on antibodies that are a result of vaccination or of infection in most avian species. It is more labor-intensive than ELISA or AGID tests, but it yields information that under certain circumstances is more valuable and useful for managing field situations. 4.1.4.3 Molecular Tests In implementation of surveillance and monitoring programmes for AI, cost-effective testing procedures capable of facing high and constant workflows are necessary. During AI outbreaks the main problems encountered by a diagnostic laboratory are represented by a sudden increase in sample testing and an increased pressure for faster turn-around-time (TAT), both combined with high quality test performances and cost effectiveness.36 In this respect, the possibility of diagnosing AI by using molecular methods offers important advantages compared to other protocols, such as VI and ELISA. For this reason, in the recent past there has been a significant increase in the development and application of testing procedures for the detection of AI viral RNA. Several RT-PCR and real time PCR protocols have been published in scientific journals (see Table 4.1 for references) and the most recent methodologies such as NASBA,37,38 LAMP-PCR39,40 and pyrosequencing41,42
Table 4.1 Main Representative PCR-Based Protocols for the Detection of AI Viruses Published Since 2000 in International Scientific Journals Target End point RT-PCR Type A influenza virus Type A influenza virus, H5 and H7 subtypes Type A influenza virus, H5 and H7 subtypes Type A influenza virus and Newcastle Disease virus Type A influenza virus, avian pneumovirus and Newcastle Disease virus Type A influenza virus, H5, H7, H9 subtypes Type A influenza virus, H5, H7 and H9 H5 AI subtypes H7 AI subtypes H5 and H7 subtypes
Assay
One step RT-PCR Two step RT-PCR
Notes
Reference
82 83
One step RT-PCR-ELISA Two step duplex RT-PCR
Positive samples confirmed by dot-blot hybridisation. Emi-nested PCR for H7 subtype. Laboratory evaluation. Partially validated on Eurasian lineage. Validated assay.
One step multiplex RT-PCR
Laboratory evaluation.
85
One step type A RT-PCR and one step multiplex RT-PCR (H5, H7, H9) Two step, multiplex RT-PCR One step RT-PCR Two step RT-PCR One step multiplex RT-PCR
Laboratory evaluation.
86
Laboratory evaluation. Ring test evaluation on Eurasian strains. Ring test evaluation on Eurasian strains. Limited clinical validation.
87 56 56 88
44 84
(Continued)
53
Avian Influenza Virus
Table 4.1 (Continued) Target
Assay
Notes
H5 subtype of the H5N1 HPAI virus H1-H16 AI subtypes H1-H16 AI subtypes H1-H15
One step RT-PCR RT-PCR and sequencing RT-PCR and sequencing RT-PCR and sequencing
Limited clinical validation. Limited validation. Laboratory evaluation. Laboratory evaluation.
Real time RT-PCR (rRT-PCR) Type A influenza virus
One step rRT-PCR
Type A influenza virus Type A influenza virus
One step rRT-PCR One step rRT-PCR
Type A influenza virus
Two step rRT-PCR
Type A influenza virus, H5 and N1 Type A influenza virus, H5 and H9
One step multiplex rRT-PCR One step multiplex rRT-PCR
Type A influenza virus, H9 and N2
One step multiplex rRT-PCR
Type A and B influenza virus, H5
One step multiplex rRT-PCR
Type A and B influenza virus, H5 and N1
One step multiplex rRT-PCR
H5, H7, H9 AI subtypes
One step rRT-PCR
H5 and H7 subtypes
One step multiplex rRT-PCR
H5 AI subtypes
One step rRT-PCR
H5N1 HPAI virus of the Qinghai lineage
One step rRT-PCR
H5 subtype of the H5N1 HPAI virus
Two step rRT-PCR
H5 subtype of the H5N1 HPAI virus
Two step multiplex rRT-PCR
H5 subtype of the H5N1 HPAI virus
One step rRT-PCR
N1 subtype
One step rRT-PCR
Hydrolysis probe. Validated assay. MGB-hydrolysis probe. Laboratory evaluation. Light upon extension fluorogenic primers. Laboratory evaluation. SybrGreen chemistry. Limited field evaluation. MGB-hydrolysis probes. Laboratory evaluation. Hydrolysis probe. Laboratory evaluation. SybrGreen 1 dye. Validated assay Discrimination between type A and B not possible. Laboratory evaluation. Hydrolysis probes. Limited clinical validation on human specimens. Hydrolysis probes. Validated assay for Eurasian lineage. Hydrolysis probe. Validated assay for American lineage. Hydrolysis probes. Validated assay for Eurasian lineage. Hydrolysis probe. Validated assay. MGB-hydrolysis probes. Laboratory evaluation on one human specimen. Hydrolysis probes targeting two distinct regions of the HA molecule. Validated on human specimens of Hong Kong and Vietnam origin. Hydrolysis probe. Limited clinical validation on human specimens. MGB-hydrolysis probes. Validated assay on N1 subtypes pf the Eurasian lineage
have been applied, in many cases successfully, for the detection and typing of AI viruses. However, the use of these latter techniques is limited to research purposes at the moment. With reference to the application of nucleic acid amplification protocols, sample processing appears less cold-chain dependant, as the preservation of cellular integrity and virus viability is not essential for these assays. The possibility to detect AI viral RNA in samples containing inactivated viral particles due to prolonged storage or shipment, or in samples treated to eliminate viral infectivity increases the chances to diagnose the disease in specimens collected in remote area of the world and addresses the biosafety issues. Reagents are also available to better preserve the integrity of a fragile molecule as the RNA at environmental temperatures.43 Thus,
Reference 89 61 60 59
45, 56 90 91 92 93 94 95 96 97 46 45 54 57 98 99
42 100
unlike VI, molecular techniques can also be applied in small laboratories, providing that the basic equipment is available. This can contribute to the extension of a diagnostic laboratory network in the affected area and to the reduction of the TAT by avoiding the submission of the samples to a distant central and fully equipped laboratory of virology. In terms of analytical and diagnostic sensitivity and specificity, the data available concerning the molecular tests for AI can be considered as optimal for their application in large scale diagnosis during an outbreak, showing values of diagnostic sensitivity, and specificity close to or above 90%.32,44,45 An excellent agreement with the VI was reported during a LPAI outbreak investigation32 and in clinical validation of real time protocols.46 Data derived from experimental study32
54
indicate that RT-PCR based methods are capable of revealing viral RNA in tracheal swabs of experimentally infected birds for 10–15 days after challenge, similarly to VI. This period of time covers the first 7–10 days post-infection, when serology is not of diagnostic aid due to an undetectable immune response. Similarly, other studies provided experimental evidence of the usefulness of PCR-based techniques as an alternative to qualiquantitative VI methodologies.47,48 Molecular techniques can provide a variety of data useful for surveillance, monitoring, and outbreak investigation. Once the RNA is extracted, it is possible to gain information not only concerning the presence of virus in the clinical specimen, but also about the HA and NA gene segments, the pathotype (LPAI vs HPAI virus) and other genomic sequencing data that can be used for molecular epidemiology. Most importantly, expensive, and time consuming in vivo tests for pathogenicity can be avoided, preserving animal welfare. However, the recent and extensive applications of these kinds of molecular assays in the field of AI diagnosis have highlighted some drawbacks. The costs related to the equipment and reagents needed for PCR and real time PCR testing are still significant, although they decreased in recent times, mainly as a result of the widespread use of these technologies and the subsequent marketing competition. Nucleic acids amplification methodologies are generally extremely sensitive assays, making them prone to easily reveal cross contamination of samples, leading to false positive results. Mishandling of the extracted RNA, improper use of reagents or use of nonsterile, non RNAse-free disposables, or inadequate reference controls, may result in false negative test response. AI viruses exhibit a significant degree of genetic variability, particularly in certain important regions of the genome, as for segment 4 (HA) and 6 (NA). This might lead to diagnostic failures of some molecular tests based on primers and probes targeting these hyper variable regions when applied on mutated or new emerging viruses. A recent example for this is the PCR detection failure of viruses belonging to the H7 subtypes occurred during wild bird surveillance program in the US. In this case, a few nucleotides mismatches in the PCR probe targeting the HA molecule were the likely cause of failure.49 Consequently, the recent initiatives concerning AI sequence data sharing50 are crucial in the understanding of viral evolution and in updating probes and other molecular diagnostic tools as long as the viruses mutate. Considering the extreme sensitivity of many nucleic acid amplification assays, some samples tested positive by a given molecular test might not be confirmed by any other test applied on the same sample, including VI.51 Therefore, the adoption of fully validated protocols and harmonized test is mandatory. Examples of unexpected false positive results may indeed occur after extensive field application.52 Since AI is now threatening almost every continent, these considerations should seriously be taken into account when planning official guidelines and diagnostic protocols. Public institutions and private biotechnology companies are currently investing resources in research and development of
Molecular Detection of Foodborne Pathogens
more stabilized PCR reagents, robust molecular protocols and easy-to use, flock-side molecular tests.53 Currently, the most common types of molecular tests used for AI detection are RT-PCR or real time RT-PCR (rRT-PCR)based protocols (Table 4.1). Schematically, these can be further subdivided in protocols for the so-called “generic” detection of type A influenza viruses and protocols for the detection and identification of specific type A influenza virus subtypes. The common genomic targets of the first type of molecular tests are well conserved segments of the viral genome located in the genes encoding for the matrix proteins (M1 and 2) or the NP. Since these proteins are antigenically and genetically conserved regardless of the virus subtype, these types of tests are virtually capable of detecting type A influenza viruses belonging to subtypes H1–H16. Based on the available literature, these protocols exhibit high sensitivity and specificity, with higher performances of the rRT-PCR tests compared to the RT-PCR tests. For these reasons, these type A influenza tests are used as screening tests to evaluate the infectious status of an animal, flock or area (see Table 4.1 for references). Infections caused by AI viruses belonging to the H5 and H7 subtype are of major concern for public health and economic impact. Regardless of their pathogenicity, which may vary, they are notifiable diseases of animals, according to the current international legislation for animal health.30 Therefore, their occurrence must be detected promptly and immediately reported to the national and international veterinary authorities. As a consequence, all the samples tested positive in the screening for type A influenza virus should be PCR tested for the identification of these two subtypes and/or immediately submitted for VI attempts.31,36 Several protocols have been described for the specific PCR detection of H5 and H7 directly in clinical specimens (Table 4.1) and some of them properly validated.45,46,54 Phylogenetic studies55 demonstrated that H5 and H7 sequences could be divided into two major groups, related to the geographical origin of the viruses. Thus, so called “American” and “Eurasian” lineages were described among avian H5 and H7 viruses. These groups reflect the genetic variation observed in the targeted genes and this has also influence in the development and application of specific diagnostic assays. In fact, molecular tests designed on viruses belonging to the American lineage generally exhibit poor performances, in term of sensitivity, when applied on the Eurasian strains and vice versa.45,56 The major public health and veterinary concern raised by the spread of the Asian H5N1 HPAI also contributed to the development of several molecular tests specifically targeting this dangerous virus (Table 4.1). In many instances, these protocols are duplex RT-PCR or rRT-PCR tests targeting the H5 and the N1 gene segments of this specific virus, but sometimes they result in poor performances when applied on different H5 strains. One protocol has been described targeting one specific H5N1 HPAI genetic sublineage.57 LPAI viruses belonging to the H9 subtype are also of major interest for the economic losses they can cause to the
Avian Influenza Virus
poultry industries58 in addition to their sporadic capabilities to be transmitted to humans, fortunately without serious consequences.22 These reasons have also led to the development of rapid molecular tests for its detection in clinical specimens (see Table 4.1 for references). In some instances, there is the need to determine the specific subtype of type A PCR positive samples, once the involvement of the H5, H7, and H9 subtypes has been ruled out. RT-PCR protocols designed on conserved regions of the HA molecule were developed and subsequent sequence analysis of the PCR product should enable the identification of the H1–H16 subtype.59,60,61 These protocols are useful for rapid subtyping of viral isolates, but the lower sensitivity of these methods may represent a limit for their direct application on clinical specimens. Currently, none of the published molecular tests have been specifically validated for AI detection in poultry-derived products such as meat, feathers, etc. Recently, a protocol describing the RNA extraction procedure and the subsequent RT-PCR protocol for the detection of AI RNA from manure has been described.62
4.2 Methods 4.2.1 Sample Collection and Handling 4.2.1.1 Selection of Samples to be Collected Protocols concerning sample collection for AI are mainly focused on the detection of the virus in holdings suspected to be infected, thus, in living, moribund or recently dead birds. As a reference, the EU diagnostic manual for AI, adopted in 2006 by the EU31 or the OIE Manual for Diagnostic Tests and Vaccines for Terrestrial Animals30 provide concise but practical guidelines concerning sample collection and transportation. For molecular testing, viable viruses are not requested. However, the target RNA molecule is extremely fragile and its degradation due to improper sample handling and storage may result in false negative results. The targeted replication sites of LPAI viruses are the respiratory (mainly trachea and lungs) and the digestive (intestines) tract. HPAI viruses are disseminated throughout the whole body tissues. Both, LPAI and HPAI viruses, are shed via the upper respiratory tract and feces but the quantity of shed viral particles and the duration of shedding may vary according to host species, host immune status, and virus strains.63,64 Thus, tissue specimens from trachea, lungs, and intestines or oropharyngeal, tracheal, or cloacal swabs are suitable samples for AI detection in carcasses and/or living birds. In addition, for HPAI viruses, specimens from brain and other internal organs, such as spleen, heart and kidney, can be collected. Intestinal contents of fresh feces also may contain high viral loads.65–67 However, presence of potential PCR inhibitors, bacterial or fungal contaminations and proteases impose particular attention when dealing with this type of material as false PCR results (positives or negatives) may occur. In case of HPAI infections, the virus causes viremia and therefore can be present also in the blood of recently infected birds.68–70 Data on the duration and intensity of the
55
viremic period are scarce and these parameters can vary greatly according to the virus strain, its pathotype or the host involved. For example, virus titres in experimentally infected chickens varied from 101.4 EID50/ml for H5N2 HPAI69 to 108 EID50/ml for H5N1 HPAI.68 In another study, ducks experimentally inoculated with A/H5N1 HPAI revealed virus titers in blood ranging from 100.7 EID50/ml to 102.3 EID50/ml.71 For LPAI viruses, replication occurs at the epithelial surfaces of the respiratory and intestinal tracts; therefore viremia is not expected for this pathotype. However, in a few occasions H9 or H7 LPAI virus genomes have been detected in blood and viable viruses were isolated.72,73 Based on the above mentioned data, blood does not represent an ideal sample for AI detection but it can be considered as a potential source of environmental contamination during handling and processing of blood samples collected from suspected HPAI infected animals or during slaughtering of poultry in the pre-clinical phase of the disease. Viremia and viral replication in endothelial cells occurring in HPAI infections contribute to the colonization of muscles and other edible tissues (i.e., liver) in infected birds. Muscles and meat of domestic birds were found to be HPAI infected during field investigations on imported poultry products74 as well as experimental infections.69,75 Incomplete evisceration or contamination from lungs and intestine during slaughtering procedures may lead to LPAI or HPAI contaminated meat or carcasses, as recently demonstrated.76 Therefore, muscles (particularly breast and tight muscles) or respiratory and intestinal tissues still present in poultry carcasses represent suitable specimens for the detection of both HPAI and LPAI viruses. 4.2.1.2 Transportation and Storage of Specimens Swabs, tissue specimens, or feces should be immediately submitted to the laboratory for testing. Soon after their collection, samples should be refrigerated on ice or with frozen gel packs. In case a submission delay (>24 h) to the laboratory is expected, samples should be frozen in dry ice, liquid nitrogen or -80°C. Repeated cycles of freezing and thawing must be avoided to prevent reduction of the viral load, cell lysis, and consequent RNA degradation. Storage of allantoic fluids of eggs inoculated with H5 and H7 HPAI, and LPAI viruses in the guanidine-based lysis buffer included in two commercial RNA extraction kits preserved the suitability of the original RNA template for real time PCR amplification up to 7 days at + 4°C; ambient temperature and at + 37°C.77 Importantly, the same lysis buffers were able to inactivate both the HPAI and LPAI viruses tested after 4 h, thus increasing the biosafety of the handled specimens. In one other investigation,78 end point RT-PCR amplification was still possible after 2 weeks storage at ambient temperature of bird fecal samples spiked with influenza A viruses using guanidine buffer, commercial preservative or alcohols (ethanol or isopropanol) as preservatives. PCR products up to 521 bp were obtained in samples preserved with guanidine or commercial buffers and up to 206 bp in samples
56
preserved with alcohols. Obviously, all these procedures will make parallel VI attempts impossible. In case VI is necessary to confirm results of molecular testing or to assess viral infectivity, viral transport medium (VTM) should be used. VTM are generally based on phosphate saline buffered solutions (PBS, pH 7.0–7.4) or protein-based media, such as brain heart infusion (BHI) or tris-buffered tryptose bacteriological media supplemented with antibiotics and/or antifungals.31 VTM supplementation with glycerol (10–20%) contributes to better preserve sample stability and integrity, particularly during prolonged storage at low temperatures. 4.2.1.3 Handling of Specimens Probably only one documented case of human infection caused by an AI virus following laboratory exposure has been reported so far in the scientific literature.79 The case occurred in Australia and consisted of conjunctivitis caused by an H7N7 HPAI virus. In contrast, several cases of conjunctivitis, influenza-like illness and one fatal case of acute lung infection were reported during the H7N7 HPAI poultry outbreaks in 2003 in The Netherlands.28 People confirmed to be infected were somehow involved in the outbreak management. Adequate protective measures should therefore be adopted during collection and handling of samples suspected to contain AI viruses, at the farm level, at the slaughterhouse and within the laboratory. Personal protective items (PPI), such as lab-coats, goggles, disposable gloves, should be properly worn during necropsies and collection of samples from animals suspected to be AI-infected. Orthomyxoviruses are identified as biological agents of biohazard class 2.80,81 According to the WHO recommen dations,81 they should be manipulated in a BSL2 laboratory, adopting BSL3 work practices. Good laboratory practices should be applied during the whole process of sample testing at laboratory level. Useful and practical guidelines and comprehensive information on biosafety-related issues in the laboratory can be found in the EU manual for AI and on the WHO website.31,80,81
4.2.2 Samples Preparation for PCR Testing The following procedures for sample preparation can be followed prior to submitting the specimen for RNA extraction and subsequent RT-PCR amplification. Organs and tissues (brain, trachea, lungs, intestine): extract the RNA from tissue homogenate. Using sterile scissors or surgical blades, cut small blocks (approximately 2–5 mm × 2–5 mm) of tissues. If possible, tissues blocks should be frozen in liquid nitrogen to better preserve RNA integrity and to facilitate tissue disruption. Animal tissues can then be disrupted simply by sterile pestle and mortar. Fiber-rich tissues (e.g., lung and trachea) may require the addition of sterile quartz powder or sand to better disrupt tissue cells. To facilitate the disruption and the homogenization process, 300–500 µl of sterile PBS can be added. This will make also possible the preparation of aliquots for other types of test (i.e., VI),
Molecular Detection of Foodborne Pathogens
starting exactly from the same homogenate. Homogenization is carried out simply using a syringe and needle. Alternatively, a commercially available, automatic homogenizer can be used. Add the requested amount of this suspension to the lysis buffer of the RNA extraction kit according to the manufacturer’s instructions. Cloacal swabs, tracheal, or oro-pharyngeal swabs: dilute swabs in PBS (max 1 ml) and extract the RNA from this suspension. It is possible to pool the samples (up to ten tracheal swabs/pool or five cloacal swabs/pool). Vortex briefly. Add the requested amount of this suspension to the lysis buffer of the RNA extraction kit according to the manufacturer’s instructions. Feces: a suspension is prepared by adding one volume of feces to four volumes of sterile PBS. Add the requested amount of this suspension to the lysis buffer of the RNA extraction kit according to the manufacturer’s instructions. Allantoic fluid: simply add the requested amount of sample (allantoic fluid) to the lysis buffer of the RNA extraction kit according to the manufacturer’s instructions. RNA extraction: several methods for the manual or robotic extraction of the RNA exist. Many commercial kits are available, some of them developed and optimized for the extraction of the nucleic acids on specific matrixes, such as tissues, blood, and stool. However, to facilitate the organization of sample processing within the laboratory and make it more cost-effective and practical, only some kits are presented in this chapter, which can be used on different matrixes with satisfactory results. The kits listed should be considered as examples, representatives of the most common types used in different laboratories or described in several scientific journals. They have been evaluated in many laboratories working on AI. The use of other kits not included in the list is possible, providing their performances are methodically evaluated. Kits widely used for RNA extraction: NucleoSpin® RNA II (Macherey-Nagel GmbH & Co., Germany); RNeasy® MiniKit (Qiagen Gmbh, Germany); High pure RNA isolation kit (Roche Applied Science, Germany), not recommended for feces; MagMax (Ambion/Applied Biosystems), for swabs or other liquid matrix. Not recommended for tissues and organs. Useful for robotic extractions. Extraction protocol follows the manufacturer’s instructions.
4.2.3 Detection Procedures 4.2.3.1 One Step RT-PCR for the Detection of Type A Influenza Viruses This protocol is a modification of the method developed and described by Fouchier et al.82 for the detection of type A influenza viruses in samples of human and animal origin, including birds. According to previous field investigation on swabs of avian origin, the relative sensitivity was 95.6% (CI95 = 93.1–98.0) and the relative specificity was 96.3% (CI95 = 94.4–98.1) when compared to VI.32 In one other study on experimentally infected ducks48 the protocol provided 100% of relative sensitivity and 94% of
57
Avian Influenza Virus
relative specificity. In some cases, unspecific bands can be visualized on gel.52 Careful examination of the gel and use of proper controls and size-markers are therefore extremely important. Target: M gene Sample: RNA 5 µl in 25 µl of total reaction volume Reagents: One step RT-PCR (Applied Biosystems GeneAmp® Gold RNA PCR Core Kit Part No 4308207) Primers:82 Forward M52 C: 5′-CTT CTA ACC GAG GTC GAA ACG-3′ Reverse M253 R: 5′-AGG GCA TTT TGG ACA AAG/T CGT CTA-3′
a given thermocycler. The protocol has been tested mainly on H5 AI viruses belonging to the “Eurasian” lineage. Target: HA gene Sample: RNA 5 µl in 50 µl of total reaction volume Reagents: One step RT-PCR (Qiagen OneStep RT-PCR Kit cat # 210212) Primers:56 H5-kha-1: CCT CCA GAR TAT GCM TAY AAA ATT GTC H5-kha-3: TAC CAA CCG TCT ACC ATK CCY TG Note the inclusion of degenerate nucleotides indicated above in bold.
Reagent (Conc. Stock Solution)
Reagent
Final Concentration
Volume Required for one Reaction
/
4.7 µl
RNase-free water PCR buffer 5 × MgCl2 25 mM
1 × 2.5 mM
5 µl 2.5 µl
dNTPs mix 10 mM
1 mM
2.5 µl
DTT 100 mM
10 mM
2.5 µl
Primer M52 C 10 mM
0.3 mM
0.75 µl
Primer M253 R 10 mM
0.3 mM 10 U
0.75µl
Reverse transcriptase 50 U/µl
15 U
0.3 µl
Ampli Taq GOLD 5 U/µl Total volume Vortex the mix for few seconds. Aliquote 20 µl in 0.2-ml PCR tubes. RNA
2.5 U
0.5 µl
RNase inhibitor 20 U/µl
Final reaction volume
}
0.5 µl
20 µl 5 µl
RNase-free water PCR buffer 5 × from Qiagen OneStep RT-PCR Kit dNTPs mix 10 mM each (from Qiagen Kit)
Final Concentration
Volume Required for one Reaction (50 µl)
/
28.8 µl
1 ×
10 µl
0.4 mM each
2 µl
Primer H5-kha-1: 50 pmol/µl (50 µM)
1 µM
1 µl
Primer H5-kha-3: 50 pmol/µl (50 µM)
1 µM
1 µl
RNase inhibitor 40 U/µl (Promega) One Step RT-PCR Enzyme Mix (Qiagen Kit) Volume minus target
8U
0.2 µl 2 µl 45 µl
Volume extracted RNA
5 µl
Final reaction volume
50 µl
25 µl
Cycling conditions: One cycle of 42°C for 20 min; one cycle of 95°C for 5 min; 40 cycles of 94°C for 1 min, 55°C for 1 min, 72°C for 1 min; one cycle of 72°C for 10 min. Detection: Agarose gel 2 % or silver stained SDSPAGE 7% Expected amplified fragment: 244 bp.
Cycling conditions: One cycle of 50°C for 30 min; one cycle of 94°C for 15 min; 40 cycles of 94°C for 30 sec, 58°C for 1 min, and 68°C for 2 min; one cycle of 68°C for 7 min. Detection: Agarose gel 2 % or silver stained SDSPAGE 7% Expected amplified fragment: 300–320 bp.
4.2.3.2 One Step RT-PCR for the Detection of AI Viruses Belonging to the H5 Subtype This one step RT-PCR protocol has been partially validated in two consecutive ring trials performed in the EU and the results were published.56 According to the ring trials results, the protocol appears to be sensitive and useful for H5 AI virus detection in clinical specimens. Since the targeted region encompass the cleavage site segment of the HA gene segment, the subsequent sequence of the resulted amplified products will allow the determination of the pathotype. However, some results have revealed possible specificity problems. These include false positives with non-H5 AI specimens and/or multiple bands of similar size to the predicted amplicon. This may relate to the precise cycling conditions which are employed on
4.2.3.3 Two Step RT-PCR for the Subtype Specific Detection of H7 AI Virus This protocol consists in a two step RT-PCR first developed in The Netherlands and then selected for its good results among different tests during the AVIFLU European project.56 By this protocol, amplicon is detected conventionally by agarose gel electrophoresis with ethidium bromide staining or by SDS-PAGE with silver staining. The amplicon span the HA cleavage site so sequencing can provide pathotyping information, i.e., LPAI or HPAI. Target: HA gene Sample: RNA 5 µl in 50 µl of total reaction volume Primers:56 GK 7.3 5′-ATG TCC GAG ATA TGT TAA GCA-3′ GK 7.4 5′-TTT GTA ATC TGC AGC AGT TC-3′
58
Molecular Detection of Foodborne Pathogens
Step 1. Preparation of cDNA
Reagent
Final Concentration
RNA
/
Volume Required for one Reaction 10 µl
Primer GK 7.3 50 µM 2.5 µM 1 µl Heat to 95°C for 2 min and put the mix immediately on ice; then add the following reagents: RNase-free water / 3 µl
1 ×
M-MLV RT Buffer 5 × dNTPs mix 10 mM
0.5 mM each
RNase inhibitor 40 U/µl MMLV-RT 200 U/µl Final reaction volume
Probe:45 FAM M + 64 : FAM-5′-tca ggc ccc ctc aaa GCC GA-3′-TAMRA
Final Concentration
Volume Required for one Reaction
Probe FAM M + 64 1 µM
100 nM
2.5 µl
2 × QuantiTect Multiplex RT-PCR Master Mix
1 ×
12.5 µl
Reagent
4 µl
Primer M + 25F 5 µM
300 nM
1.5 µl
1 µl
Primer M-124R 5 µM QuantiTect Multiplex RT Mix
300 nM
1.5 µl
/
0.2 µl
/
1.8 µl
20 U
0.5 µl
100 U
0.5 µl 20 µl
Reverse transcriptase thermal parameters: 15 min at 37°C; 45 min at 42°C.
RNase-free water Total volume Vortex the mix for few seconds. Aliquote 20 µl per tube RNA Final reaction volume
Step 2. cDNA PCR amplification This protocol has been evaluated using the reagents contained in the AB Gene Kit cat#AB-0575/DC/LD/A:
Final Concentration
Volume Required for one Reaction
/
18 µl
1 ×
25 µl
Primer GK 7.3 50 µM
1 µM
1 µl
Primer GK 7.4 50 µM Total volume
1 µM
1 µl
Reagent RNase-free water 2 × Reddy Mix PCR Master Mix with dNTPs
cDNA Final reaction volume
}
45 µl 5 µl 50 µl
Cycling conditions: one cycle of 94°C for 30 min; 35 cycles of 94°C for 30 sec, 52°C for 30 sec, 72°C for 45 sec; one cycle of 72°C for 4.15 min. Detection: agarose gel 2% or silver stained SDSPAGE 7% Expected amplified fragment: 200–220 bp. 4.2.3.4 Detection of Type A Influenza Virus by Qualitative Real Time PCR (M gene) The protocol uses the probe-primer set previously evaluated by Spackman et al.45 The basic procedure has been previously evaluated by different authors.45,56 In the one step rRT-PCR protocol described below the QuantiTect Multiplex RT-PCR Kit (Qiagen Cod. 204643) has been adopted. Reagents: QuantiTect Multiplex RT-PCR Kit (Qiagen Cod. 204643) Primers:45 Forward M + 25: AGA TGA GTC TTC TAA CCG AGG TCG Reverse M-124: TGC AAA AAC ATC TTC AAG TCT CTG
}
20 µl 5 µl 25 µl
Cycling conditions: This protocol was developed on AB7300 (Applied Biosystems) and Rotorgene 6000 (Corbett) real time platforms. Other laboratories using different instrumentation platforms should first critically and carefully examine these cycling conditions as they may not perform optimally on other instruments. Hence cycling temperatures, times and ramp speeds may all need to be modified. Thermal parameters: one cycle of 50°C for 20 min; one cycle of 95°C for15 min; 40 cycles of 94°C for 45 sec, 60°C for 45 sec. 4.2.3.5 Detection of Type A Influenza Viruses of H5 HA Subtype by Qualitative One Step Real Time RT-PCR Similarly to the H7 real time PCR protocol (Section 4.2.3.6), this protocol has been developed and properly validated recently.46 The procedure can be coupled with H7 detection within the same real time PCR run, providing a fast and sensitive method for the detection of notifiable AI subtypes in poultry. The protocol has been validated on a wide variety of H5/H7 isolates of the Eurasian lineage, including the recent H5/H7 LPAI viruses circulating in poultry and wild birds as well as the H5N1 HPAI viruses circulating in Eastern and Central Asia, Middle East, Europe and Africa. The protocol was developed using the QuantiTect Multiplex RT-PCR Kit (Qiagen Cod. 204643). Reagents: QuantiTect Multiplex RT-PCR Kit (Qiagen Cod. 204643). Primers:46 Forward H5 F : TTA TTC AAC AGT GGC GAG Reverse H5 R: CCA KAA AGA TAG ACC AGC Note degenerate nucleotides indicated in bold. Probe:46 FAM H5: FAM-5′-ccc tag cac tgg caa tca tg-3′-TAMRA
59
Avian Influenza Virus
Reagent (Conc. Stock Solution)
Final Concentration
Probe FAM H5 1 µM
150 nM
2 × QuantiTect Multiplex RT-PCR Master Mix
1 ×
Volume Required for one Reaction 3.75 µl 12.5 µl
Primer H5F 5 µM
300 nM
1.5 µl
Primer H5Rnew 5 µM QuantiTect Multiplex RT Mix
300 nM
1.5 µl
RNase-free water Total volume Vortex the mix for few seconds. Aliquote 20 µl per tube RNA
0.2 µl /
}
0.55 µl 20 µl 5 µl 25 µl
Final reaction volume
Cycling conditions: This protocol was evaluated on AB7300 (Applied Biosystems) and Rotorgene 6000 (Corbett) real time platforms. Other laboratories using different instrumentation platforms should first critically and carefully examine these cycling conditions as they may not perform optimally on other instruments. Hence cycling temperatures, times and ramp speeds may all need to be modified. Thermal parameters: one cycle of 50°C for 20 min; one cycle of 95°C for 15 min; 40 cycles of 94°C for 45 sec, 54°C for 45 sec. 4.2.3.6 Detection of Type A Influenza Viruses of H7 HA Subtype by Qualitative Real Time PCR 46 Primers: Forward H7 F: TTT GGT TTA GCT TCG GG Reverse H7 R: GAA GAM AAG GCY CAT TG Note degenerate nucleotides indicated in bold. Probe:46 VIC H7: VIC-5′-CAT CAT GTT TCA TAC TTC TGG CCA T-3 ′-TAMRA
Reagent Probe VIC H7 1 µM 2 × QuantiTect Multiplex RT-PCR Master Mix
Final Concentration
Volume Required for one Reaction
150 nM
3.75 µl
1 ×
12.5 µl
Primer H7F 10 µM
300 nM
0.75 µl
Primer H7R 10 µM QuantiTect Multiplex RT Mix
900 nM
2.25 µl
/
0.55 µl
RNase-free water Total volume Vortex the mix for few seconds. Aliquote 20 µl per tube RNA Final reaction volume
real time platforms. Other laboratories using different instrumentation platforms should first critically and carefully examine these cycling conditions as they may not perform optimally on other instruments. Hence cycling temperatures, times and ramp speeds may all need to be modified. Thermal parameters: one cycle of 50°C for 20 min; one cycle of 95°C for 15 min; 40 cycles of 94°C for 45 sec, 54°C for 45 sec.
0.2 µl
}
20 µl 5 µl 25 µl
Cycling conditions: This protocol was evaluated on AB7300 (Applied Biosystems) and Rotorgene 6000 (Corbett)
4.3 Conclusions and Future Perspectives The increasing importance of AI viruses for the veterinary and medical sciences in the last decade has contributed to a tremendous increase in actions related to this infection with the aim to better understand the pathogenicity and virulence mechanisms of these viruses and to develop better diagnostic tools for their detection. Taking advantages of the new technologies available nowadays for the diagnosis of infectious diseases, an impressive number of scientific papers has been published describing the application of technologies, such as NASBA, LAMP-PCR, or microarrays, to the detection of the viruses. Further, well established technologies, such as RT-PCR or real time PCR have been improved and applied for this infection. As for many other infectious and contagious diseases, it has been realized that rapidity in the detection and characterization of the responsible microorganism is essential for the disease control. The key issues related to the major changes in the field of AI diagnosis in the last 10–15 years, can be summarized into two main points: improved rapidity and flexibility. If compared to the classical VI and typing methods, molecular technologies have probably not improved significantly the diagnostic sensitivity or specificity. Rather, they have allowed the detection of the causative agent, in association with its typing, subtyping, and with the characterization of its molecular determinant of pathogenicity in a more time-effective and flexible manner. Importantly, the molecular tests have made the screening of large susceptible populations, such as poultry or wild birds, sustainable and cost-effective for many countries. Many molecular protocols are currently available for AI testing, but only few of these have been fully and properly validated at present. Provision and harmonization of molecular test validation procedures is therefore necessary to expand the number of validated protocols, getting to more standardized laboratory results. With very few exceptions, the vast majority of the available protocols have been developed and tested for the detection of AI viruses in clinical specimens, from alive or dead animals. To better perform epidemiological investigations, as well as to better address public health and food safety issues, it would be desirable to expand the application of the molecular tests to environmental specimens, such as water, soil, surfaces, etc., and to poultry-derived products such as meat, feathers, and eggs. Thus, the development of new protocols or the validation of the existing testing procedures on these materials appears to be necessary.
60
References
1. Perroncito, E. Epizoozia tifoide nei gallinacei. Ann. Accad. Agric. Torino, 21, 87, 126, 1878. 2. Capua, I. and Marangon S. Control of avian influenza in poultry. Emerg. Infect. Dis., 12, 1319, 2006. 3. Perdue, M.L. and Swayne, D.E. Public health risk from avian influenza viruses. Avian Dis., 49, 317, 2005. 4. Cattoli, G. and Terregino, C. New perspectives in avian influenza diagnosis. Zoonoses Public Health, 55, 24, 2008. 5. Fouchier, R.A.M. et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from blackheaded gulls. J. Virol., 79, 2814, 2005. 6. Olsen, B. et al. Global patterns of influenza A virus in wild birds. Science, 312, 384, 2006. 7. EFSA (European Food Safety Authority), Scientific report of the scientific panel on biological hazards on “Food as a possible source of infection with highly pathogenic avian influenza viruses for humans and other mammals”.. EFSA J., 74, 1, 2006. Also available online at www.efsa.eu.int 8. Capua, I. and Alexander, D.J. Human implications of avian influenza viruses and Paramyxoviruses. Eur. J. Clin. Microbiol. Infect. Dis., 23, 1, 2004. 9. Rott, R. The pathogenic determinant of influenza virus. Vet. Microbiol., 33, 303, 1992. 10. Vey, M. et al. Haemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the recognition motif R-X-R/K-R. Virology, 188, 408, 1992. 11. Senne D.A. et al. Survey of the haemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the cleavage site as a marker of pathogenicity potential. Avian Dis., 40, 425, 1996. 12. Suarez, D.L. et al. Recombination resulting in virulence shift in avian influenza outbreak. Emerg. Infect. Dis., 10, 1, 2004. 13. Pasick, J., Handel, K. and Robinson, J. Intersegmental recombination between the haemagglutinin and matrix genes was responsible for the emergence of a highly pathogenic H7N3 avian influenza virus in British Columbia. J. Gen. Virol., 86, 727, 2005. 14. Banks, J. et al. Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy. Arch. Virol., 146, 963, 2001. 15. Alexander, D.J. et al. The pathogenicity of four avian influenza viruses for chickens, turkeys and ducks. Res. Vet. Sci., 24, 242, 1978. 16. Alexander, D.J., Parsons, G. and Manvell, R.J. Experimental assessment of the pathogenicity of eight avian influenza A viruses of H5 subtype for chickens, turkeys, ducks and quails. Avian Pathol., 15, 647, 1986. 17. Capua, I. and Mutinelli, F. Mortality in Muscovy ducks and domestic geese associated with natural infection with a highly pathogenic avian influenza virus of H7N1 subtype. Avian Pathol., 30, 179, 2001. 18. Alexander, D.J. An overview of the epidemiology of avian influenza. Vaccine, 25, 5637, 2007. 19. Mumford, E. et al. Avian influenza H5N1: risks at the humananimal interface. Food Nutr. Bull., 28, 357, 2007. 20. Kurtz, J., Manvell, R.J. and Banks, J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet, 348, 901, 1996. 21. Banks, J. et al. Phylogenetic analysis of H7 haemagglutinin subtype influenza A viruses. Arch. Virol., 145, 1047, 2000. 22. Peiris, M. Human infection with influenza H9N2. Lancet, 354, 916, 1999.
Molecular Detection of Foodborne Pathogens 23. Guo, Y., Li, J. and Cheng, X. Discovery of men infected by avian influenza A (H9N2) virus. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 13, 105, 1999. 24. Puzelli, S. et al. Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. J. Infect. Dis., 192, 1318, 2005. 25. Hosseini, M. et al. Seroprevalence of H9N2 antibody in poultry farm and slaughter house workers of Iran using HI test. Proceedings of the 13th World Association of Veterinary Diagnosticians Symposium, 11–14 November 2007, Melbourne, Australia. 26. Subbarao, K. et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science, 279, 393, 1998. 27. Peiris, J.S et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet, 21, 363, 617, 2004. 28. Koopmans, M. et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet, 363, 587, 2004. 29. Tweed, S.A. et al. Human illness from avian influenza H7N3, British Columbia. Emerg. Infect. Dis., 10, 2196, 2004. 30. OIE (World Organization for Animal Health), Highly pathogenic avian influenza. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 5th Edition. Office International des Epizooties, Paris, France, 258, 2004. 31. EC (European Commission), Commission Decision 2006/437/ EC of 4 August 2006 approving a diagnostic manual for avian influenza as provided for in Council Directive 2005/94/EC [notified under document number C (2006) 3477], 2006. Available at: http://eur-lex.europa.eu/LexUriServ/site/en/oj/2006/l_237/ l_23720060831en00010027.pdf 32. Cattoli, G. et al. Comparison of three rapid detection systems for type A influenza virus on tracheal swabs of experimentally and naturally infected birds. Avian Pathol., 33, 432, 2004. 33. Woolcock, P.R. and Cardona, C.J. Commercial immunoassay kits for the detection of influenza virus type A: evaluation of their use with poultry. Avian Dis., 49, 477, 2005. 34. Cattoli, G. and Capua, I. Diagnosing avian influenza in the framework of wildlife surveillance efforts and environmental samples. J. Wildlife Dis., 43, S35, 2007. 35. Higgins, D.A. Precipitating antibodies of the duck (Anas plathyrhyncos). Comp. Biochem. Physiol., 93B, 135, 1989. 36. Cattoli, G. and Capua, I. Molecular diagnosis of avian influenza during an outbreak. Dev. Biol. (Basel), 124, 99, 2006. 37. Collins, R.A. et al. A NASBA method to detect high- and lowpathogenicity H5 avian influenza viruses. Avian Dis., 47, 1069, 2003. 38. Lau, L.T. et al. Nucleic acid sequence-based amplification methods to detect avian influenza virus. Biochem. Biophys. Res. Commun., 313, 336, 2004. 39. Imai, M. et al. Development of H5-RT-LAMP (loop-mediated isothermal amplification) system for rapid diagnosis of H5 avian influenza virus infection. Vaccine, 24, 6679, 2006. 40. Jayawardena, S. et al. Loop-mediated isothermal amplification for influenza A (H5N1) virus. Emerg. Infect. Dis., 13, 899, 2007. 41. Pourmand, N. et al. Rapid and highly informative diagnostic assay for H5N1 influenza viruses. PLoS One, 20,1e95, 2006. 42. Ellis, J.S. et al. Design and validation of an H5 TaqMan real-time one-step reverse transcription-PCR and confirmatory assays for diagnosis and verification of influenza A virus H5 infections in humans. J. Clin. Microbiol., 45, 1535, 2007.
Avian Influenza Virus 43. Forster, J.L. et al. The effect of sample type, temperature and RNAlater trade mark on the stability of avian influenza virus RNA. J. Virol. Methods, 149, 190, 2008. 44. Dybkaer, K., et al. Application and evaluation of RT-PCRELISA for the nucleoprotein and RT-PCR for detection of low-pathogenic H5 and H7 subtypes of avian influenza virus. J. Vet. Diagn. Invest., 16, 51, 2004. 45. Spackman, E. et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J. Clin. Microbiol., 40, 3256, 2002. 46. Monne, I. et al. Development and validation of a one step real time PCR assay for the simultaneous detection of H5, H7 and H9 subtype avian influenza viruses. J. Clin. Microbiol., 46, 1769, 2008. 47. Lee, C.W. and Suarez, D.L. Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus. J. Virol. Methods, 119, 151, 2004. 48. Foni, E. et al. Detection of influenza A virus by RT-PCR and standard methods in experimental infection of Ducks. New Microbiol., 28, 31, 2005. 49. Xing, Z. et al. Realtime RT-PCR assay unable to detect H7 subtype avian influenza viruses isolated from wild birds. J. Clin. Microbiol., 46,1844, 2008. 50. Bogner, P. et al. A global initiative on sharing avian flu data. Nature, 442, 981, 2006. 51. OIE (World Organization for Animal Health). Quality Standard and Guidelines for Veterinary Laboratories: Infectious Diseases, 2nd Edition. Office International des Epizooties, Paris, France, 2008, Available online at http://www.oie.int. 52. Martì, N.B. et al. False positive results obtained by following a commonly used reverse transcription-PCR protocol for detection of Influenza A virus. J. Clin. Microbiol., 44, 3845, 2006. 53. Das, A. et al. Development of an internal positive control for rapid diagnosis of avian influenza virus infections by real time reverse transcription-PCR with lyophilized reagents. J. Clin. Microbiol., 44, 3065, 2006. 54. Slomka, M.J. et al. Validated real time reverse transcriptasepolymerase chain reaction and its application in H5N1 outbreaks in 2005–2006. Avian Dis., 50, 373, 2007. 55. Suarez, D.L. Evolution of avian influenza viruses. Vet. Microbiol., 74, 15, 2000. 56. Slomka, M.J. et al. Identification of sensitive and specific avian influenza polymerase chain reaction methods through blind ring trials organized in the European Union. Avian Dis., 51, 227, 2007. 57. Hoffmann, B. et al. Rapid and highly sensitive pathotyping of avian influenza A H5N1 virus by using real-time reverse transcription-PCR. J. Clin. Microbiol., 45, 600, 2007. 58. Banks, J. et al. Phylogenetic analysis of influenza A viruses of H9 haemagglutinin subtype. Avian Pathol., 29, 353, 2000. 59. Lee, M-S. et al. Identification and subtyping of avian influenza viruses by reverse transcription-PCR. J. Virol. Methods, 97, 13, 2001. 60. Phipps, L.P., Essen, S.C. and Brown, I.H. Genetic subtyping of influenza A viruses using RT-PCR with a single set of primers based on conserved sequences within the HA2 coding region. J. Virol. Methods, 122, 119, 2004. 61. Wang, R. et al. Examining the hemagglutinin subtype diversity among wild duck-origin influenza A viruses using ethanol-fixed cloacal swabs and a novel RT-PCR method. Virology, 375, 182, 2008.
61 62. Guan, J. et al. Development of methods for detection and quantification of avian influenza and newcastle disease viruses in compost by real-time reverse transcription polymerase chain reaction and virus isolation. Poultry Sci., 87, 838, 2008. 63. Capua, I. et al. Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virus. Avian Pathol., 33, 158, 2004. 64. Keawcharoen, J. et al. Wild ducks as long-distance vectors of highly pathogenic avian influenza virus (H5N1). Emerg. Infect. Dis., 14, 600, 2008. 65. Webster, R.G., et al. Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology, 84, 268, 1978. 66. Tian, G. et al. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology, 341, 153, 2005. 67. Rimmelzwaan, G.F., Osterhaus, A.D. and Kuiken, T. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am. J. Pathol., 168, 176, 2006. 68. Mase, M. et al. Experimental assessment of the pathogenicity of H5N1 influenza A viruses isolated in Japan. Avian Dis., 49, 582, 2005. 69. Swayne, D.E. and Beck, J.R. Experimental study to determine if low-pathogenicity and high-pathogenicity avian influenza viruses can be present in chicken breast and thigh meat following intranasal virus inoculation. Avian Dis., 49, 81, 2005. 70. Muramoto, Y. et al. Highly pathogenic H5N1 influenza virus causes coagulopathy in chickens. Microbiol. Immunol., 50, 73, 2006. 71. Kishida, N. et al. Pathogenicity of H5 influenza viruses for ducks. Arch. Virol., 150, 1383, 2005. 72. Kishida, N. et al. Co-infection of Staphylococcus aureus or Haemophilus paragallinarum exacerbates H9N2 influenza A virus infection in chickens. Arch. Virol., 149, 2095, 2004. 73. Toffan, A. et al. Conventional inactivated bivalent H5/H7 vaccine prevents viral localisation in muscles of turkeys infected experimentally with LPAI and HPAI H7N1 isolates. Avian Pathol., 37, 407, 2008. 74. Tumpey, T.M. et al. Characterization of highly pathogenic H5N1 avian influenza A virus isolated from duck meat. J. Virol., 76, 6344, 2002. 75. Beato, M.S. et al. A conventional, inactivated oil emulsion vaccine suppresses shedding and prevents viral meat colonisation in commercial (Pekin) ducks challenged with HPAI H5N1. Vaccine, 25, 4064, 2007. 76. Beato, M.S. et al. Isolation and characterization of an H10N7 avian influenza virus from poultry carcasses smuggled from China into Italy. Avian Pathol., 35, 400, 2006. 77. Beato, M.S. et al. Inactivation of avian influenza viruses by nucleic acid extraction reagents. Proceedings of the 13th World Association of Veterinary Diagnosticians Symposium, 11–14 November 2007, Melbourne, Australia. 78. Evers, D.L., Slemons, R.D. and Taubenberger, J.K. Effect of preservative on recoverable RT-PCR amplicon length from influenza A virus in bird feces. Avian Dis., 51, 965, 2007. 79. Taylor, H.R. and Turner A.J. A case report of fowl plague keraconjunctivitis. Brit. J. Ophthalmol., 61, 86, 1977. 80. WHO Laboratory Biosafety Manual, 3rd Edition, 2004. Available online at http://www.who.int/csr/resources/ publications/biosafety/WHO_CDS_CSR_LYO_2004_11/en/. 81. WHO Laboratory Biosafety Guidelines for Handling Specimens Suspected of Containing Avian Influenza A Virus, 2005. Available online at http://www.who.int/csr/disease/ avian_influenza/guidelines/handlingspecimens/en/.
62 82. Fouchier, R.A.M. et al. Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J. Clin. Microbiol., 38, 4096, 2000. 83. Starick, E., Römer-Oberdörfer, A. and Werner, O. Type- and subtype-specific RT-PCR assays for avian influenza A viruses (AIV). J. Vet. Med. B. Infect. Dis. Vet. Public Health, 47, 295, 2000. 84. Farkas, T. et al. Rapid and simultaneous detection of avian influenza and newcastle disease viruses by duplex polymerase chain reaction assay. Zoonoses Public Health., 54, 38, 2007. 85. Malik, Y.S., Patnayak, D.P. and Goyal, S.M. Detection of three avian respiratory viruses by single-tube multiplex reverse transcription-polymerase chain reaction assay. J. Vet. Diagn. Invest., 16, 244, 2004. 86. Chaharaein, B. et al. Detection of H5, H7 and H9 subtypes of avian influenza viruses by multiplex reverse transcriptionpolymerase chain reaction. Microbiol. Res., doi:10.1016/j. micres.2007.01.001. 87. Xie, Z. et al. A multiplex RT-PCR for detection of type A influenza virus and differentiation of avian H5, H7, and H9 hemagglutinin subtypes. Mol. Cell. Probes, 20, 245, 2006. 88. Thontiravong, A. et al. The single-step multiplex reverse transcription- polymerase chain reaction assay for detecting H5 and H7 avian influenza A viruses, Tohoku. J. Exp. Med., 211, 75, 2007. 89. Ng, L.F. et al. Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay. BMC Infect. Dis., 2, 6, 2006. 90. Di Trani, L. et al. A sensitive one-step real-time PCR for detection of avian influenza viruses using a MGB probe and an internal positive control. BMC Infect. Dis., 6, 87, 2006.
Molecular Detection of Foodborne Pathogens 91. Kiss, I. et al. Application of real-time RT-PCR utilising lux (light upon extension) fluorogenic primer for the rapid detection of avian influenza viruses. Acta Vet. Hung., 54, 525, 2006. 92. Karlsson, M. et al. A real-time PCR assay for the monitoring of influenza A virus in wild birds. J. Virol. Methods, 144, 27, 2007. 93. Payungporn, S. et al. Single step multiplex real-time RT-PCR for H5N1 influenza A virus detection. J. Virol. Methods, 131, 143, 2006. 94. Li, P.Q. et al. Development of a multiplex real-time polymerase chain reaction for the detection of influenza virus type A including H5 and H9 subtypes. Diagn. Microbiol. Infect. Dis., 61, 192, 2008. 95. Ong, W.T. et al. Development of a multiplex real-time PCR assay using SYBR Green 1 chemistry for simultaneous detection and subtyping of H9N2 influenza virus type A. J. Virol. Methods, 144, 57, 2007. 96. Rossi, J., Cramer, S. and Laue, T. Sensitive and specific detection of influenza virus A subtype H5 with real-time PCR. Avian Dis., 51, 387, 2007. 97. Wu, C. et al. A multiplex real-time RT-PCR for detection and identification of influenza virus types A and B and subtypes H5 and N1. J. Virol. Methods, 148, 81, 2008. 98. Lu, Y.Y et al. Rapid detection of H5 avian influenza virus by TaqMan-MGB real-time RT-PCR. Lett. Appl. Microbiol., 46, 20, 2008. 99. Ng, K.O.E., et al. Influenza A H5N1 detection. Emerg. Infect. Dis., 11, 1303, 2005. 100. Agüero, M. et al. A real-time TaqMan RT-PCR method for neuraminidase type 1 (N1) gene detection of H5N1 Eurasian strains of avian influenza virus. Avian Dis., 51 (Suppl 1), 378, 2007.
5 Hepatitis A and E Viruses Hiroshi Ushijima, Pattara Khamrin Aino University
Niwat Maneekarn
Chiang Mai University
Contents 5.1 Introduction ........................................................................................................................................................................ 63 5.1.1 Hepatitis A Virus (HAV)......................................................................................................................................... 63 5.1.1.1 Overview of Hepatitis A Virus Infection and Pathogenesis..................................................................... 63 5.1.1.2 Hepatitis A Virion, Genome Organization, and Proteins......................................................................... 63 5.1.1.3 HAV Classification and Genetic Diversity................................................................................................ 64 5.1.1.4 Foodborne and Waterborne HAV.............................................................................................................. 64 5.1.1.5 Diagnosis of HAV..................................................................................................................................... 64 5.1.2 Hepatitis E Virus (HEV)......................................................................................................................................... 65 5.1.2.1 Overview of Hepatitis E Virus Infection and Pathogenesis...................................................................... 65 5.1.2.2 Hepatitis E Virion, Genome Organization, and Proteins.......................................................................... 66 5.1.2.3 HEV Classification and Genetic Diversity................................................................................................ 66 5.1.2.4 Foodborne and Waterborne HEV............................................................................................................. 66 5.1.2.5 Diagnosis of HEV..................................................................................................................................... 66 5.2 Methods............................................................................................................................................................................... 67 5.2.1 Reagents and Equipments........................................................................................................................................ 67 5.2.2 Sample Collection and Preparation ........................................................................................................................ 68 5.2.2.1 HAV Specimen Collection and RNA Extraction ..................................................................................... 68 5.2.2.2 HEV Specimen Collection and RNA Extraction ..................................................................................... 68 5.2.3 Detection Procedures . ............................................................................................................................................ 68 5.2.3.1 Detection of HAV . ................................................................................................................................... 68 5.2.3.2 Detection of HEV . ................................................................................................................................... 70 5.3 Conclusions and Future Perspectives.................................................................................................................................. 71 References.................................................................................................................................................................................... 71
5.1 Introduction 5.1.1 Hepatitis A Virus (HAV) 5.1.1.1 Overview of Hepatitis A Virus Infection and Pathogenesis Viral hepatitis is a major health concern worldwide with higher incidence in developing countries than in the developed countries.1,2 Hepatitis A virus (HAV) is one of the etiologic agents of acute viral hepatitis. Most infection occur in children and generally are self-limiting.1 Transmission of HAV is primarily via the fecal-oral route, either by contact with an infected person or by ingestion of contaminated food and water.1 In the industrialized countries, due to improvements of public health and socioeconomic conditions, there has been a shift of HAV infection toward a higher age with an increase of hospitalized and severe cases associated with outbreaks.3 The illness severity is age-dependent. Generally,
HAV infection in children is asymptomatic and rarely develops jaundice, whereas in older children and adults are symptomatic infection with a wide range of clinical manifestations from mild and anicteric infection to severe and fulminant hepatic failure (FHF).1 Infected people can excrete HAV in feces for about 3 months or longer, and viremia is detectable by reverse transcription-polymerase chain reaction (RT-PCR) in the majority of patients at the onset of symptoms and can persist for several weeks after aminotransferase peak.4 Viral replication occurs primarily within hepatocytes, and then the viruses are secreted into bile through the bile ducts which results in large amount of virus being shed in the feces.5 5.1.1.2 Hepatitis A Virion, Genome Organization, and Proteins HAV is classified as the only member of the genus Hepatovirus within the Picornaviridae family.6,7 It is a 63
64
spherical, icosahedral symmetry, nonenveloped RNA virus. The virus particle is 27–32 nm in diameter with a positive single-stranded RNA genome of 7.5 kb.1 The viral genome composed of 5′ nontranslated region (NTR), structural protein regions, nonstructural protein regions, 3′ NTR, and followed by a short poly(A) tail.8 A single large open reading frame (ORF) of HAV genome can be divided into three distinct functional protein-encoded regions termed P1, P2, and P3. The P1 region encodes the capsid polypeptides VP1–VP4. The P2 and P3 regions encode the nonstructural polypeptides which are necessary for virus replication.8 5.1.1.3 HAV Classification and Genetic Diversity The HAV strains isolated from various parts of the world constitute a single serotype. However, genetic variability between strains allows the classification of HAV into six different genotypes based on phylogenetic analysis of nucleotide sequences in the VP1/P2A region.9,10 Based on this region, the HAV strains that differ from each other at least 15% of nucleotide sequences are considered to be different genotypes, while the strains that their nucleotide sequence differ over 7–7.5% belong to different HAV subgenotypes.9 Of six HAV genotypes, genotype I, II, and III are associated with human infections, and are further divided into subgenotype IA, IB, IIA, IIB, IIIA, and IIIB, respectively. The remaining three genotypes IV, V, and VI are represented by strains of simian HAV.9,10 From the epidemiological data, HAV genotypes I and III are the vast majority of human strains which comprise more than 80% of strains circulating worldwide.1,9,11 5.1.1.4 Foodborne and Waterborne HAV Foodborne and waterborne viral infections are increasingly recognized as the causes of illness in humans. HAV is one of the leading causes of foodborne and waterborne viral infections. It can be transmitted from person-to-person, or indirectly via food and water contaminated with virus-containing feces. HAV has previously been isolated directly from food or environmental sources. Salad vegetables, soft fruits, green onion, strawberry, lettuce, clam, shellfish, and oyster samples have been reported to be the sources of HAV infections.12–17 A large epidemic outbreak of HAV, reported in 1988, was attributed to the ingestion of raw clams and caused illness in 300,000 persons in Shanghai, China.18 Moreover, waterborne outbreaks of HAV associated with HAV contamination in water supply have also been reported from several countries. HAV has also been detected in river, canal, ground/tap water and sewage.12,16,19–21 5.1.1.5 Diagnosis of HAV For the detection of HAV genomic RNA, several genome segments have been amplified by different sets of primer pairs. The genomic regions which have been used widely to detect
Molecular Detection of Foodborne Pathogens
and to define HAV genotypes, included the junction of VP3/ VP1 region.17,22–25 the junction of VP1/P2A region,4,24–28 the entire VP1 region,29 and the junction of 3C/3D region.30 The primers used for the detection of HAV are summarized in Table 5.1. Currently, the genomic region that most commonly used for the detection and identification of HAV genotypes is the VP1/P2A junction region. To facilitate the molecular analysis of HAV, the amplification of their genomic RNA and sequencing of DNA amplicon should be performed and HAV genotypes are identified based on sequence analysis. Sequence variation within the VP1/P2A junction has defined six HAV genotypes and two subtypes within genotypes I, II, and III.9–11 In contrast to most picornaviruses, HAV of human origin replicates poorly in cell cultures with a relatively low concentration of viruses and viral antigen being produced into the cultured supernatant. For these reasons, development of a number of RT-PCR-based assays that enable the rapid and specific detection of small amount of viral nucleic acid in environmental sources, food samples, and clinical specimens have been developed recently. Several kinds of clinical samples have been used for the detection of HAV genome, including stool, serum, saliva, and liver suspension.9,26,31 In addition, HAV has also been detected by other sensitive molecular techniques such as restriction fragment length polymorphism (RFLP),32 Southern blotting,33 real-time RT-PCR,34 and reverse transcription loop-mediated isothermal amplification assay (RT-LAMP).35 Currently, the amplification of viral RNA by RT-PCR is the most sensitive and widely used method for the detection of foodborne HAV RNA.15,16,21,25,36 The efficiency of the extraction methods for HAV RNA from clinical specimens is of great important for molecular diagnosis. Therefore, choosing appropriate RNA extraction methods is a critical step for a successful and valid use of PCR amplification of viral genome in clinical samples. Traditionally, proteinase K digestion and guanidinium isothiocyanate (GTC)-phenol-chloroform extraction method followed by ethanol precipitation has been widely used to extract RNA from serum or stool samples.37 Recently, numerous protocols for RNA extraction, i.e., GTC-silica method, antigen-capture method, and magnetic beads coated with anti-HAV have been used for the isolation of HAV RNA and to separate viral genome from the potential inhibitors of RT-PCR reaction that might exist in the clinical samples.9,22,31,37–41 The total genomic RNA of HAV can also be easily isolated from clinical samples with high sensitivity and reproducibility by using commercially available RNA extraction kits, i.e., Trizol LS® Reagent (Invitrogen Life Technology, Carlsbad, CA)30,41 or QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany).27,31,35,42 Recently, the use of the QIAamp Viral RNA Mini Kit (Qiagen) has been reported to be an efficient method for extraction of HAV genomic RNA with a detection limit of 6 × 103 copies/ml in clinical samples.31
65
Hepatitis A and E Viruses
Table 5.1 Oligonucleotide Primers for the Detection and Sequencing of HAV from Clinical Specimens Primer Name
Region
Sequence 5′–3′
Position
Sense
VP1-4
VP3/VP1
First PCR
CGT TGC TTC CCA TGT CAG AG
2115–2135
+
VP1-5
VP3/VP1
First PCR
GAC CTT CCC ATA AAC TTG TAG
2483–2462
–
VP1-2
VP3/VP1
Second PCR
GTT TTG CTC CTC TTT ATC ATG CTA TG
2168–2194
+
VP1-1
VP3/VP1
Second PCR
GGA AAT GTC TCA GGT ACT TTC TTT G
2415–2390
–
BR-5
VP1/P2A
First PCR
TTG TCT GTC ACA GAA CAA TCA G
2950–2972
+
BR-9
VP1/P2A
First PCR
AGT CAC ACC TCT CCA GGA AAA CTT
3310–3286
–
RJ-3
VP1/P2A
Second PCR
TCC CAG AGC TCC ATT GAA
2984–3002
+
BR-6
VP1/P2A
Second PCR
AGG AGG TGG AAG CAC TTC ATT TGA
3217–3193
–
–
VP3/VP1
First PCR
GTG AAT GTT TAT CTT TCA GCA AT
2133–2155
+
–
VP3/VP1
First PCR
GAT CTG ATG TAT GTC TGG ATT CT
2429–2451
–
–
VP3/VP1
Second PCR
GCT CCT CTT TAT CAT GCT ATG GAT
2172–2195
+
–
VP3/VP1
Second PCR
CAG GAA ATG TCT CAG GTA CTT TCT
2392–2415
–
–
VP1/P2A
First PCR
GAC AGA TTC TAC ATT TGG ATT GGT
2870–2893
+
–
VP1/P2A
First PCR
CCA TTT CAA GAG TCC ACA CAC T
3360–3381
–
–
VP1/P2A
Second PCR
CTA TTC AGA TTG CAA ATT ACA AT
2896–2981
+
–
VP1/P2A
Second PCR
AAC TTC ATT ATT TCA TGC TCC T
3268–3289
–
+2897
VP1/P2A
First PCR
CTA TTC AGA TTG CAA ATT AYA AT
2897–2819
+
–3288
VP1/P2A
First PCR
AAY TTC ATY ATT TCA TGC TCC T
3267–3288
–
+2949
VP1/P2A
Second PCR
TAT TTG TCT GTY ACA GAA CAA TCA G
2949–2973
+
–3192
VP1/P2A
Second PCR
AGG RGG TGG AAG YAC TTC ATT TGA
3169–3192
–
A
VP3/VP1
First PCR
GTT TTG CTC CTC TTT ATC ATG CTA TG
2167–2192
+
B
VP3/VP1
First PCR
GGA AAT GTC TCA GGT ACT TTC TTT G
2389–2414
–
A
VP3/VP1
Second PCR
GTT TTG CTC CTC TTT ATC ATG CTA TG
2167–2192
+
C
VP3/VP1
Second PCR
TCC TCA ATT GTT GTG ATA GC
2358–2377
–
HA027
3C/3D
First PCR
TTT GGW GTT GGD GAG AAR AAT GG
5318–5340
+
HA030
3C/3D
First PCR
AAG CGT TTT GGA GAC YAC ATT C
5969–5989
–
HA028
3C/3D
Second PCR
GTG TKA GRT GGG TYA TGA ATG C
5343–5364
+
HA029
3C/3D
Second PCR
GAC YAC ATT CAT TGA ACA YTG AG
5955–5977
–
5.1.2 Hepatitis E Virus (HEV) 5.1.2.1 Overview of Hepatitis E Virus Infection and Pathogenesis HEV is widely spread in many tropical and subtropical countries where sanitary infrastructure remains inadequate.43 Clinical manifestations of HEV infection are similar to those of HAV infection and encompass a wide spectrum of symptoms. Typical HEV symptoms include jaundice, hepatomegaly, dark- or tea-colored urine, anorexia, diarrhea, vomiting, and fever.44,45 The illness is usually self-limiting and typically lasts for about 1–4 weeks and infection does not progress to chronicity. The disease is slightly more severe than HAV infection, but still has a low mortality in the general population with the rate of about 1–4%.44,46 However, a few patients develop a prolonged clinical illness
PCR Product
Reference
369 bp
24
247 bp
24
360 bp
24, 26, 27
234 bp
24, 26, 27
319 bp
25
244 bp
25
512 bp
25
394 bp
25
392 bp
4, 28
244 bp
9, 28
248 bp
23
211 bp
23
672 bp
30
635 bp
30
24 24
24, 26, 27 24, 26, 27
25 25
25 25
4, 28 9, 28
23 23
30 30
and severe complications with a high mortality rate associated with infection of pregnant women (15–20%), particularly in the third trimester of pregnancy. Causes of death among pregnant women with HEV infection include hepatic encephalopathy and disseminated intravascular coagulation.43,47–50 Incubation period of HEV infection ranges from 15 to 60 days.51–53 HEV antigen first appears in the liver and this is typically followed by viremia.54 Virus accumulates at a relatively high concentration in bile and is subsequently shed in the feces. Viremia and fecal shedding are detected prior to liver abnormalities. Liver function tests are indicative of hepatic inflammation. Laboratory tests of enzyme level abnormalities including, high peak of alanine aminotransferase (ALT), aspartate aminotransferase (AST), gammaglutamyl aminotransferase (GGT), and serum alkaline phosphatase (SAP). Experimental studies
66
of HEV infections in human volunteers demonstrated that liver enzyme elevations occurred at 4–5 weeks after oral ingestion and persisted for 3–13 weeks.51,53 Virus excretions in feces occurred approximately at 2–4 weeks. In addition, HEV RNA could be detected in serum around the first 2–3 weeks after exposure. Antibodies to HEV were first detected at about 6 weeks after infection and remained detectable up to 2 years.51,53 The HEV pathogenesis is not well understood. Several studies demonstrated that HEV is transmitted through fecal-oral contact or consumption of contaminated food or water.43,55–57 The site of the primary replication has not been identified, but it is presumed to be in the intestinal tract. The route and mechanism by which the virus reaches the liver from the intestinal tract after consumption of the virus remain unclear. However, possible mechanism of HEV associated disease may be due to (i) liver cell injury caused by either an immunologic mechanism and/or direct cytopathic effects of the virus on the liver cells, and (ii) viral antigenantibody complex mediated vasculitis/glomerulonephritis.47 HEV particle is almost certainly resistant to the change of pH between alkaline and acidic. Therefore, it can survive in the gastrointestinal tract and cause infection, but does not seem to tolerate exposure to high salt concentration, including cesium chloride. Since the main mode of transmission of HEV is the fecal-oral route, prevention of HEV infection, therefore, relies primarily on the provision of clean drinking water, improving personal hygiene, and avoiding consumption of raw, uncooked meat, and vegetables. Study of thermal stability of HEV suggests that it is less stable than HAV.58 5.1.2.2 Hepatitis E Virion, Genome Organization, and Proteins Initially, HEV had been classified as a member of the Picornaviridae family. Later, it was shown that HEV was antigenically and biophysically unrelated to the picornaviruses. For these reasons, HEV has been reclassified as the only member of the genus Hepevirus in the new family Hepeviridae.43 HEV has been characterized as a nonenveloped 27–34 nm particle with a positive sense single-stranded RNA genome. Its genome is approximately 7.2 kb in length, and contains a short 5′ NTR, three ORFs (ORF1, ORF2, ORF3), 3′ NTR, and followed by a poly(A) tail.59–61 ORF1 is the largest among the three ORFs and encodes a nonstructural protein containing methyltransferase, helicase, and replicase domains. ORF2 encodes the major capsid protein of the virus, while ORF3 encodes a small protein that appears to serve as a viral regulatory protein rather than a structural protein.43,62,63 5.1.2.3 HEV Classification and Genetic Diversity Only a single known serotype of HEV is recognized to date. However, based on sequence analysis, several HEV isolates
Molecular Detection of Foodborne Pathogens
identified from different parts of the world have been classified into five genotypes.43,64,65 Of these, genotypes 1–4 are found in humans, genotypes 3 and 4 are restricted mainly in pigs, whereas genotype 5 has been isolated from chickens in the US.65 Data of global distribution of HEV in humans demonstrated that genotype 1 has been circulated in the developing countries in Asia and Africa, and is responsible mainly for waterborne outbreaks in these areas. Genotype 2 has been reported from outbreaks of HEV in Mexico and Nigeria. On the other hand, genotypes 3 and 4 are sometimes found to be associated with zoonotic infection and have been reported from sporadic cases of an acute HEV infection and/or domestic pigs in America, Europe, and Asia.43,47 5.1.2.4 Foodborne and Waterborne HEV HEV is spread mainly through the fecal-oral route via fecal contamination in water and food products. The growing data on the epidemiological studies of HEV indicated that HEV may be a zoonotic virus. Detections of HEV RNA from feces and anti-HEV from sera of swine have recently been documented.66–68 In addition, a number of studies reported the evidence of zoonotic foodborne transmission of HEV from animals to humans, such as, detection of HEV from pig livers sold in Japan and the US.57,69 Direct evidence for zoonotic foodborne transmission of HEV has also been confirmed in Japan where consumption of uncooked deer and wild-boar meat resulted in HEV infection in humans.70,71 In addition, waterborne outbreaks of HEV disease have been reported in association with contaminated water supply in several countries worldwide.72–76 5.1.2.5 Diagnosis of HEV For diagnosis of HEV infection, several methods are available. These include immune electron microscopy (IEM), enzyme immunoassay (EIA), immunochromatography (IC), RT-PCR, real-time PCR, and nucleic acid sequence analysis. Among these methods, RT-PCR and nucleic acid sequence analysis are widely used methods for the detection and genotype identification of foodborne HEV (food/water contaminations) and zoonotic HEV infections.77–80 These techniques have replaced the traditional immunological tests and become the gold standard for diagnosis of HEV infection. Recently, molecular techniques based on RT-PCR for the detection of viral genomic RNA have been developed for both epidemiological study and diagnosis of HEV infection. The most reliable marker for diagnosis of HEV infection is the presence of HEV RNA in serum or fecal samples. Therefore, several protocols of nested RT-PCR have been reported for direct detection of HEV from clinical specimens.77,81–88 The oligonucleotide primers used for the detection of HEV from clinical specimens are summarized in Table 5.2.
67
Hepatitis A and E Viruses
Table 5.2 Oligonucleotide Primers for the Detection and Sequencing of HEV From Clinical Specimens Primer Name
Region
Sequence 5′–3′
Position
Sense
HE361 HE364 HE366 HE363
ORF2/3 ORF2/3 ORF2/3 ORF2/3
First PCR First PCR Second PCR Second PCR
GCR GTG GTT TCT GGG GTG AC CTG GGM YTG GTC DCG CCA AG GYT GAT TCT CAG CCC TTC GC GYM TGG TCD CGC CAA GHG GA
5302–5321 5446–5465 5325–5344 5442–5461
+ – + –
ConsORF2-s1 ConsORF2-a1 ConsORF2-s2 ConsORF2-a2
ORF2 ORF2 ORF2 ORF2
First PCR First PCR Second PCR Second PCR
GAC AGA ATT RAT TTC GTC GGC TGG CTT GTT CRT GYT GGT TRT CAT AAT C GTY GTC TCR GCC AAT GGC GAG C GTT CRT GYT GGT TRT CAT AAT CCT G
6298–6321 6470–6494 6347–6368 6467–6491
+ – + –
E1 E5 E2 E4-1
ORF2 ORF2 ORF2 ORF2
First PCR First PCR Second PCR Second PCR
CTG TTT AAY CTT GCT GAC AC WGA RAG CCA AAG CAC ATC GAC AGA ATT GAT TTC GTC G TGY TGG TTR TCR TAA TC
6260–6279 6551–6568 6298–6316 6467–6486
+ – + –
F1 R1 F2 R2
ORF2 ORF2 ORF2 ORF2
First PCR First PCR Second PCR Second PCR
GCC GAG TAT GAC CAG TCC A ACA ACT CCC GAG TTT TAC CC AAT GTT GCG ACC GGC GCG C TAA GGC GCT GAA GCT CAG C
6577–6595 7107–7127 6649–6668 7079–7098
+ – + –
Forward (ex) Backward (ex) Forward (in) Backward (in)
ORF1 ORF1 ORF1 ORF1
First PCR First PCR Second PCR Second PCR
CAT GGT CGA GAA GGG CCA GG GCG GAA GTC ATA ACA GTG GG ATG ACT TTG CTG AGT TTG ACT CAT ATT CCA GAC AGT ATT CC
4089–4108 4631–4650 4403–4423 4601–4620
+ – + –
3156N 3157N 3158N 3159N
ORF2 ORF2 ORF2 ORF2
First PCR First PCR Second PCR Second PCR
AAT TAT GCY CAG TAY CGR GTT G CCC TTR TCY TGC TGM GCA TTC TC GTW ATG CTY TGC ATW CAT GGC T AGC CGA CGA AAT CAA TTC TGT C
5711–5732 6419–6441 5996–6017 6322–6343
+ – + –
PCR Product
Reference 77 77 77 77
164 bp 137 bp
82 82 82 82
197 bp 145 bp
88 88 88 88
309 bp 189 bp
84 84 84 84
551 bp 450 bp
86 86 86 86
562 bp 218 bp
85 85 85 85
731 bp 348 bp
5.2 Methods 5.2.1 Reagents and Equipments Reagents DEPC-treated water Ethanol Phosphate buffered saline (PBS), pH 7.4 Chloroform Isopropanol TRIzol® LS reagent QIAamp Viral RNA Mini Kit 5× First-Strand RT Buffer DTT Deoxynucleotide triphosphate (dNTP) Mix (2.5 and 10 mM) SuperScript III Reverse Transcriptase (200 units/µl) Random primer (1 µg/µl) RNase Inhibitor (40 units//µl) Mineral oil 5× Colorless GoTaq PCR buffer
Supplies and Equipments 0.2, 0.5, 1.5-ml tubes (RNase-free) Micropipetters and aerosol barrier filter tips (10, 100, 1000 µl) Disposable protective gloves Appropriate tube racks Suitable containers for ice Disposable plastic pipets Freezer –20, –80°C High speed microcentrifuge Class II biological safety cabinet Speed-vacuum Heat box Vortex mixer PCR thermal cycler Laboratory balances Agarose gel electrophoresis apparatus Timers (Continued)
68
Molecular Detection of Foodborne Pathogens
Reagents
Supplies and Equipments
Specific primers for HAV and HEV GoTaq DNA polymerase (5 units/µl) TAE (Tris-acetate-EDTA) buffer Agaro Loading dye 100 bp DNA ladder marker Ethidium bromide Wizard SV Gel and PCR Clean-Up System or QIAquick PCR purification kit BigDye Terminator v3.1 Cycle Sequencing Kit
5.2.2 Sample Collection and Preparation 5.2.2.1 HAV Specimen Collection and RNA Extraction Although feces, serum, saliva, and liver suspension can be used for diagnosis of foodborne HAV infection, the specimens of choice are feces and serum. The fecal specimen should be collected within 1 week after the onset of dark urine and stored at –20°C until tested.89 The 10% stool suspension is prepared in phosphate-buffered saline (pH 7.4) and clarified by centrifugation at 4,800 × g for 15 min to eliminate larger debris. Serum sample should be collected during the first month after presentation of clinical signs or symptoms (jaundice, dark urine, or the level of serum ALT/AST are higher than 20 UI/L) The obtained serum should be stored at –20°C or below until use for RNA extraction. For the TRIzol® LS extraction method, 100 µl of serum or 10% (w/v) fecal supernatant is mixed with 800 µl of TRIzol® LS reagent and 200 µl of chloroform. After centrifugation at 8,000 × g for 20 min at 4°C, the upper phase is precipitated with 600 µl of isopropanol at –20°C for 18–24 h. Then, follows by centrifugation, and the pellet is washed with 70% ethanol, air dry, and finally resuspended in 10 µl of DEPCtreated water. For QIAamp Viral RNA Mini Kit, the RNA is extracted from the fecal supernatant or serum according to the manufacturer’s instructions. Briefly, 140 µl of 10% (w/v) fecal supernatant or serum is mixed with 560 µl of AVL viral lysis buffer. The mixture is incubated at room temperature for 10 min and 560 µl of ethanol is added. Then, the mixture is applied onto the spin column, centrifuge at 6000 × g for 1 min, and 500 µl of AW1 buffer is added. The column is centrifuged at 6,000 × g for 1 min to remove unbound materials, and washed by addition of 500 µl of AW2 buffer. Then, the column is centrifuged at full-speed for 3 min, and placed into a new 1.5-ml microcentrifuge tube. Finally, 60 µl of AVE buffer is added directly onto the column to elute HAV genomic RNA. After incubation at room temperature for 1 min, the column is centrifuged at 6,000 × g for 1 min. The obtained RNA is used as a template for PCR amplification. The genomic RNA can be stored at –80°C until nested RT-PCR assay is performed. 5.2.2.2 HEV Specimen Collection and RNA Extraction The specimens of choice for the diagnosis of HEV infection are serum and stool samples. Specimens should be collected
Ultraviolet transilluminator Syringe and needle Sterile Pasteur piptes DNA sequencer (ABI 3100 Applied Biosystems)
in an early acute phase of the disease and stored at –20°C until tested. Long-term storage should be kept at –70°C. Several methods have been used for the extraction of HEV RNA from clinical specimens prior to RT-PCR. These include the use of glass powder RNA extraction, antigencapture method by the use of anti-HEV antibody to capture the virus particle, microspin columns for HEV RNA extraction, and conventional RNA separation by using GTCphenol-chloroform extraction method.90–92 Recently, highly sensitive and reproducible RNA extraction kits, which are commercially available, have been introduced and widely used for HEV genomic RNA isolation, including Trizol LS® Reagent (Invitrogen Life Technology) and QIAamp Viral RNA Mini Kit (Qiagen).77,80–83 The details of specimen collection and RNA extraction methods are similar to those of the protocols described above for HAV detection.
5.2.3 Detection Procedures 5.2.3.1 Detection of HAV (i) Reverse-transcription PCR (RT-PCR): The following RT-PCR protocol has been modified from previously published reports.24,26,27 The RT reaction is carried out in a total volume of 15 µl. Note: Vortex and spin down all microcentrifuge tubes of RT-PCR components before use. (1) Prepare the reverse transcription mix (RT-mix) as follows (volumes indicated as per specimen): Component DEPC-treated water 5× First-strand buffer 0.1 M DTT dNTP mix (10 mM) SuperScript III reverse transcriptase Random primer (hexa-deoxyribonucleotide mixture; 1 µg/µl) RNase inhibitor Total
Volume (µl) 3.3 3.0 0.8 0.8 0.8 0.8 0.5 10.0
(2) Add 10 µl RT-mix to each 0.5 ml tube followed by addition of 5.0 µl of individual RNA sample. (3) Spin the tubes briefly to ensure that no reagent droplets remain on the side of the tubes. (4) Overlay the reaction mixture with one drop of mineral oil to prevent evaporation during the RT process.
69
Hepatitis A and E Viruses
(5) Transfer the reaction tubes to a 50°C heat box for 1 h, and then increase temperature to 95°C for 5 min. (6) Rapidly chill the tubes on ice for 5 min. (7) The cDNA can be used directly in the PCR, or stored at –20°C for future use. (ii) Nested PCR for HAV detection: For nested PCR amplification, two different PCR reactions (first and second PCR) are performed separately in a total volume of 25 µl. The cDNA is amplified for the detection of HAV genome. A forward primer BR-5 is used in combination with a reverse primer BR-9 (Table 5.1) to specifically generate a PCR amplicon of 360 bp.24 (1) Remove all aliquots of PCR reagents (DEPCtreated water, 5 × Colorless GoTaq PCR buffer, 2.5 mM dNTP mix, primers, GoTaq DNA polymerase) from the –20°C freezer. Vortex and spin down all reagents before opening the tubes. (2) Prepare the first PCR reaction mix as follows (volumes indicated as per specimen) : Component
Volume (µl)
DEPC-treated water
13.9 5.0
5 × Colorless GoTaq PCR buffer (containing MgCl2) dNTP mix (2.5 mM) Primer BR-5 (20 pmol/µl)
2.0 0.5
Primer BR-9 (20 pmol/µl)
0.5 0.1
GoTaq DNA polymerase (5 units/µl) Total
22.0
(3) Add 22.0 µl of first PCR mix and 3.0 µl of cDNA into a 0.2-ml PCR tube. (4) Turn on a thermocycler and preheat the block to 93°C. (5) Spin the sample tubes in a microcentrifuge at 14,000 × g for 30 sec at room temperature. (6) Place the sample tubes in the thermal cycler for 30 cycles of 93°C for 30 sec, 55°C for 30 sec, 72°C for 50 sec; and one cycle of 72°C for 10 min. (7) Following amplification, pulse-spin the reaction tubes to pull down the condensation droplets at the inner wall of the tubes. The samples are now ready for the second PCR or stored frozen at –20°C. (8) The second PCR is conducted using the first PCR product as a template. Prepare the second PCR reaction mix as follows (volumes indicated as per specimen): Component DEPC-treated water 5 × Colorless GoTaq PCR buffer (containing MgCl2) dNTP mix (2.5 mM)
(9) Add 23.0 µl of second PCR mix and 2.0 µl of first PCR product to a 0.2-ml PCR tube. (10) Then, the PCR is carried out under the same thermal cycling conditions as the first amplification. The expected size of the second PCR product is 234 bp in length. (11) Analyze the PCR products by agarose gel electrophoresis through 2% agarose gel in TAE buffer at 100 volts for 30 min. (12) The gel is stained with ethidium bromide and then visualized under ultraviolet light source. Note: negative control is also concurrently included along with the test samples in order to monitor any possible contamination that might be occur during the PCR procedure. (iii) HAV sequence analysis and genotype identification: To characterize HAV genotypes, a phylogenetic analysis should be carried out by direct sequencing of the nucleotide sequence of VP1/P2A junction. A key step in all sequencing methods is the careful preparation of the template with adequate concentration and purity. Prior to sequencing reaction, the unincorporated nucleotide and primers remaining after the PCR amplification must be removed. This step can be done simply by using a commercial spin column kits (Wizard SV Gel and PCR Clean-Up System; Promega, Madison, WI or QIAquick PCR purification kit; Qiagen). The amount of purified PCR product is once more estimated by electrophoresis through 2% agarose gel in parallel with standard DNA and the purified product is used as a template in cycle sequencing reaction. Nucleotide sequencing is performed using the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA) according to the manufacturer protocol. (1) For each sequencing reaction, mix the following reagents in a labeled tube Component Terminator ready reaction mix (v3.1) 5 × Sequencing buffer Purified PCR product (~100 ng) Sequencing primer (BR-6; 5 pmol/µl) DEPC-treated water Total
Volume (µl) 14.9 5.0
Primer RJ-3 (20 pmol/µl)
2.0 0.5
Primer BR-6 (20 pmol/µl)
0.5
GoTaq DNA polymerase (5 units/µl) Total
0.1 23.0
Volume (µl) 4.0 4.0 1.0 1.0 10.0 20.0
(2) Spin the samples tubes in a microcentrifuge at 14,000 × g for 30 sec at room temperature. (3) Place the sample tubes in a thermocycler for a total of 25 cycles of 96°C for 10 sec, 50°C for 5 sec, and 60°C for 4 min. (4) Then, the DNA sequencing product is purified by ethanol-EDTA precipitation, washed with 70% ethanol, and dry the pellet in a vacuum centrifuge. (5) Finally, analyze the nucleotide sequence of the DNA product using an automated DNA sequencer ABI 3100 Applied Biosystems.
70
Molecular Detection of Foodborne Pathogens
Note: having obtained good-quality sequence data, it is necessary to compare the sequence data with other published sequences. Therefore, the HAV nucleotide sequences of VP1/P2A junction should be compared with those of the reference strains available in the NCBI (National Center for Biotechnology Information) GenBank database, EMBL (The European Molecular Biology Laboratory), or DDBJ (DNA Data Bank of Japan). Phylogenetic and molecular evolutionary analyses are conducted using MEGA version 4.93 The authors strongly recommend that the new sequences obtained should be submitted for deposition in one of the databases mentioned above, in order to make them available to the scientific community. Most journals do not accept manuscripts before deposition of the sequence data in one of those databases. 5.2.3.2 Detection of HEV (i) RT-PCR: The protocols that are routinely used for the detection and genotyping of HEV from clinical specimens have been modified from References 77 and 81. RNA is reverse-transcribed in the presence of random primers and the RT is carried out under the same conditions as those described above for HAV detection. (ii) Nested PCR for HEV detection: To detect the HEV RNA, a part of ORF2/3 is amplified by nested PCR. The oligonucleotide primers for the detection of HEV are described previously by Inoue et al. (Table 5.2).77 The reaction mixture for the first round amplification is similar to that of HAV except for the primers used. (1) Remove all aliquots of PCR reagents (DEPCtreated water, 5 × Colorless GoTaq PCR buffer, 2.5 mM dNTP mix, primers, GoTaq DNA polymerase) from the –20°C freezer. Vortex and spin down all reagents before open the tubes. (2) Prepare the first PCR reaction mix as follow (volumes indicated as per specimen): Component DEPC-treated water 5 × Colorless GoTaq PCR buffer (containing MgCl2) dNTP mix (2.5 mM)
13.9 5.0
Primer HE361 (20 pmol/µl)
2.0 0.5
Primer HE364 (20 pmol/µl)
0.5
GoTaq DNA polymerase (5 units/µl) Total
Volume (µl)
0.1 22.0
(3) Add 22.0 µl of first PCR mix and 3.0 µl of cDNA into a 0.2-ml PCR tube. (4) Turn on a thermal cycler and preheat the block to 94°C. (5) Spin the sample tubes in a microcentrifuge at 14,000 × g for 30 sec at room temperature.
(6) Place the sample tubes in the thermocycler for a total of 35 cycles of 94°C for 30 sec, 58°C for 30 sec, and 72°C for 30 sec; and one cycle of 72°C for 10 min. (7) Following amplification, pulse-spin the reaction tubes to pull down all the solution that may attach to the inner wall of the tubes. The samples are ready for second PCR or stored frozen at –20°C. (8) Then, nested PCR is performed in a total volume of 25 µl with 2 µl of amplification product from the first round PCR. Prepare the second PCR reaction mix as follows (volumes indicated as per specimen): Component DEPC-treated water 5 × Colorless GoTaq PCR buffer (containing MgCl2) dNTP mix (2.5 mM)
Volume (µl) 14.9 5.0
Primer HE366 (20 pmol/µl)
2.0 0.5
Primer HE363 (20 pmol/µl)
0.5
GoTaq DNA polymerase (5 units/µl) Total
0.1 23.0
(9) Add 23.0 µl of second PCR mix and 2.0 µl of first PCR product to a 0.2-ml PCR tube. (10) Then, the nested PCR is carried out under the same thermal cycling conditions as the first amplification. The expected sizes of the amplification products are 164 bp and 137 bp for the first and second round PCR, respectively. (11) The PCR product sizes are determined by electrophoresis through 3% agarose gel in TAE buffer at 100 volts for 30 min. (12) The gel is stained with ethidium bromide and then visualized under ultraviolet light source. Note: negative control is also concurrently included along with the test samples in order to monitor any possible contamination that might occur during the PCR procedure. (iii) HEV sequence analysis and genotype identification: For the detection of genetic variation and genotype identification of HEV, genome sequence and phylogenetic analyses should be performed at least one part of the gene by direct sequencing of PCR products. HEV PCR product purification and sequencing protocol are similar to those described above for the HAV sequence analysis except for sequencing primer HE363 is used. (1) For each sequencing reaction, mix the following reagents in a labeled tube Component Terminator ready reaction mix (v3.1) 5 × Sequencing buffer Purified PCR product (~100 ng) Sequencing primer (HE363; 5 pmol/µl) DEPC-treated water Total
Volume (µl) 4.0 4.0 1.0 1.0 10.0 20.0
71
Hepatitis A and E Viruses
(2) Spin the samples tubes in a microcentrifuge at 14,000 × g for 30 sec at room temperature. (3) Place the sample tubes in a thermocycler for 25 cycles of 96°C for 10 sec, 50°C for 5 sec, and 60°C for 4 min. (4) Then, the DNA sequencing product is purified by ethanol-EDTA precipitation, washed with 70% ethanol, and the pellet is dried in a vacuum centrifuge. (5) Finally, the nucleotide sequence of the DNA product is analyzed using an automated DNA sequencer ABI 3100 Applied Biosystems.
5.3 Conclusions and Future Perspectives Acute viral hepatitis is an important disease caused by a variety of hepatitis viruses. Among them, HAV, and HEV contribute a significant role on the disease. Both are enteric viruses and transmitted by fecal-oral contact or consumption of contaminated food or water. HAV is responsible for acute viral hepatitis, which represents a significant public health problem in many countries due to the persistent circulation of the viruses in the environment. HEV epidemics have also been reported in some developing countries and are associated frequently with contaminated drinking water. In addition, it causes substantial morbidity and mortality, particularly among pregnant women. Recently, the determination and analysis of molecular biomarkers (e.g., nucleic acid sequencing or phylogenetic analysis) have been used to detect and to determine the relatedness of the viruses circulating worldwide. Molecular epidemiology has become a particularly powerful tool for investigation of foodborne and waterborne outbreaks of the diseases. In addition, the availability of a large and growing database of HAV and HEV sequences has allowed the identification of the source of virus contamination and may help to accelerate the public health concern and immediate response to the outbreaks. Although single round PCR is the most familiar molecular assay for the detection and genotyping of pathogens in clinical microbiology, the multiplex PCR assay is also getting much attention and has been developed and widely used to serve these purposes in several viruses. However, multiplex PCR has some inherited limitations, particularly the sensitivity of the method. For future perspective, a more highly sensitive, reliable, and inexpensive method needs to be developed for the detection and genotyping of pathogens. Most recently, DNA microarray technology has been developed and widely applicable in several aspects of infectious diseases, particularly for the detection and identification of infecting pathogens. In some cases, the detection limit of microarray was found to be as little as 10 fg of pathogenic DNA, which is far below the detection limits of other existing technologies. Conceivably, DNA microarray is an ideal tool that needs to be developed for the detection and identification, as well as genotyping and characterizing of HAV and HEV in the future.
References
1. Hollinger, F.B., and Emerson S.U., Hepatitis A Virus. In: Knipe, D.M, and Howley, P.M., (ed.), Fields Virology, 5th ed. pp. 911–947. Lippintcott Williams & Wilkins, Philadelphia, PA, 2007. 2. Acharya, S.K. et al. Viral hepatitis in India. Natl. Med. J. India., 19, 203, 2006. 3. Shapiro, C.N., and Margolis, H.S. Worldwide epidemiology of hepatitis A virus infection. J. Hepatol., 2, 11, 1993. 4. Bower, W.A. et al. Duration of viremia in hepatitis A virus infection. J. Infect. Dis., 182, 12, 2000. 5. Robertson, B. Hepatitis A and E. In: Mahy, B.W.J, and ter Meulen, V. (ed.), Topley & Wilson’s Microbiology & Microbial Infection, 10th ed. pp. 1160–1187. Edward Arnold, London. 6. Minor, P.D. et al. Picornaviridae. Classification and nomenclature of viruses: the fifth report of the international committee on taxonomy of viruses. Arch. Virol. (Suppl.), 2, 320, 1991. 7. Melnick, J.L. Properties and classification of hepatitis A virus. Vaccine, 10, 24, 1992. 8. Cohen, J.I. et al. Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J. Virol., 61, 50, 1987. 9. Robertson, B.H. et al. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J. Gen. Virol., 73, 1365, 1992. 10. Lu, L. et al. Characterization of the complete genomic sequence of genotype II hepatitis A virus (CF53/Berne isolate). J. Gen. Virol., 85, 2943, 2004. 11. Costa-Mattioli, M. et al. Genetic analysis of hepatitis A virus outbreak in France confirms the co-circulation of subgenotypes Ia, Ib and reveals a new genetic lineage. J. Med. Virol., 65, 233, 2001. 12. Dubois, E. et al. Detection and quantification by real-time RT-PCR of hepatitis A virus from inoculated tap waters, salad vegetables, and soft fruits: characterization of the method performances. Int. J. Food. Microbiol., 30, 141, 2007. 13. Chancellor, D.D. et al. Green onions: potential mechanism for hepatitis A contamination. J. Food. Prot., 69, 1468, 2006. 14. Bidawid, S., Farber, J.M., and Sattar, S.A. Rapid concentration and detection of hepatitis A virus from lettuce and strawberries. J. Virol. Methods, 88, 175, 2000. 15. Suñén, E. et al. Comparison of two methods for the detection of hepatitis A virus in clam samples (Tapes spp.) by reverse transcription-nested PCR. Int. J. Food. Microbiol., 91, 147, 2004. 16. Formiga-Cruz, M. et al. Nested multiplex PCR assay for detection of human enteric viruses in shellfish and sewage. J. Virol. Methods, 125, 111, 2005. 17. Sincero, T.C. et al. Detection of hepatitis A virus (HAV) in oysters (Crassostrea gigas). Water. Res., 40, 895, 2006. 18. Halliday, M.L. et al. An epidemic of hepatitis A attributable to the ingestion of raw clams in Shanghai, China. J. Infect. Dis., 164, 852, 1991. 19. de Paula, V.S. et al. Hepatitis A virus in environmental water samples from the Amazon Basin. Water. Res., 41, 1169, 2007. 20. Venter, J.M. et al. Hepatitis A virus in surface water in South Africa: what are the risks? J. Water. Health., 5, 229, 2007. 21. Kittigul, L. et al. Detection and characterization of hepatitis A virus in water samples in Thailand. J. Appl. Microbiol., 100, 1318, 2006. 22. Arnal, C. et al. Comparison of seven RNA extraction methods on stool and shellfish samples prior to hepatitis A virus amplification. J. Virol. Methods, 77, 17, 1999.
72 23. Apaire-Marchais, V. et al. Development of RT-semi-nested PCR for detection of hepatitis A virus in stool in epidemic conditions. Mol. Cell. Probes, 8, 117, 1994. 24. Bruisten, S.M. et al. Molecular epidemiology of hepatitis A virus in Amsterdam, the Netherlands. J. Med. Virol., 63, 88, 2001. 25. Chironna, M. et al. Genetic analysis of HAV strains recovered from patients with acute hepatitis from Southern Italy. J. Med. Virol., 70, 343, 2003. 26. Poovorawan, Y. et al. Clinical features and molecular characterization of hepatitis A virus outbreak in a child care center in Thailand. J. Clin. Virol., 32, 24, 2005. 27. Rodrigues, L. et al. Molecular epidemiology of hepatitis A virus in a group of Portuguese citizens living in Lisbon area. J. Med. Virol., 79, 483, 2007. 28. de Paula, V.S. et al. Detection of hepatitis A virus RNA in serum during the window period of infection. J. Clin. Virol., 29, 254, 2004. 29. Costa-Mattioli, M. et al. Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein. J. Virol., 76, 9516, 2002. 30. Endo, K. et al. Analysis of the full-length genome of a subgenotype IIIB hepatitis A virus isolate: primers for broadly reactive PCR and genotypic analysis. J. Med. Virol., 79, 8, 2007. 31. Amado, L.A. et al. Comparison between serum and saliva for the detection of hepatitis A virus RNA. J. Virol. Methods, 148, 74, 2008. 32. Goswami, B.B., Burkhardt, W., and Cebula, T.A. Identification of genetic variants of hepatitis A virus. J. Virol. Methods, 65, 95, 1997. 33. Buti, M. et al. Assessment of the PCR-Southern blot technique for the analysis of viremia in patients with acute hepatitis A. Gastroenterol. Hepatol., 24, 1, 2001. 34. Shan, X.C., Wolffs, P., and Griffiths, M.W. Rapid and quantitative detection of hepatitis A virus from green onion and strawberry rinses by use of real-time reverse transcriptionPCR. Appl. Environ. Microbiol., 71, 5624, 2005. 35. Yoneyama, T. et al. Rapid and real-time detection of hepatitis A virus by reverse transcription loop-mediated isothermal amplification assay. J. Virol. Methods, 145, 162, 2007. 36. Papafragkou, E. et al. Rapid and sensitive detection of hepatitis A virus in representative food matrices. J. Virol. Methods, 147, 177, 2008. 37. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156, 1987. 38. Boom, R. et al. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol., 28, 495, 1990. 39. Deng, M.Y., Day, S.P., and Cliver, D.O. Detection of hepatitis A virus in environmental samples by antigen-capture PCR. Appl. Environ. Microbiol., 60, 1927, 1994. 40. Jothikumar, N., Cliver, D.O., and Mariam, T.W. Immuno magnetic capture PCR for rapid concentration and detection of hepatitis A virus from environmental samples. Appl. Environ. Microbiol., 64, 504, 1998. 41. de Paula, V.S. et al. Comparison of four extraction methods to detect hepatitis A virus RNA in serum and stool samples. Braz. J. Infect. Dis., 7, 135, 2003. 42. Phan, T.G. et al. A novel RT-multiplex PCR for enteroviruses, hepatitis A and E viruses and influenza A virus among infants and children with diarrhea in Vietnam. Arch. Virol., 150, 1175, 2005. 43. Emerson, S.U., and Purcell R.H. Hepatitis E Virus. In: Knipe, D.M, Howley, P.M., (ed.), Fields Virology, 5th ed. pp. 3047– 3058. Lippintcott Williams & Wilkins, Philadelphia, PA, 2007.
Molecular Detection of Foodborne Pathogens 44. Aggarwal, R., and Krawczynski, K. Hepatitis E: an overview and recent advances in clinical and laboratory research. J. Gastroenterol. Hepatol., 15, 9, 2000. 45. Emerson, S.U., and Purcell, R.H. Hepatitis E virus. Rev. Med. Virol., 13, 145, 2003. 46. Krawczynski, K. Hepatitis E. Hepatology, 17, 932, 1993. 47. Mushahwar, I.K. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J. Med. Virol., 80, 646, 2008. 48. Jilani, N. et al. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J. Gastroenterol. Hepatol., 22, 676, 2007. 49. Tsega, E. et al. Acute sporadic viral hepatitis in Ethiopia: causes, risk factors, and effects on pregnancy. Clin. Infect. Dis., 14, 961, 1992. 50. Khuroo, M.S. and Kamili, S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J. Viral. Hepatol., 10, 61, 2003. 51. Chauhan, A. et al. Hepatitis E virus transmission to a volunteer. Lancet, 16, 149, 1993. 52. Tsarev, S.A. et al. Characterization of a prototype strain of hepatitis E virus. Proc. Natl. Acad. Sci. USA, 15, 559, 1992. 53. Balayan, M.S. et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 20, 23, 1983. 54. Purcell, R.H. and Emerson, S.U. Animal models of hepatitis A and E. ILAR. J., 42, 161, 2001. 55. Okamoto, H., Takahashi, M., and Nishizawa, T. Features of hepatitis E virus infection in Japan. Intern. Med., 42, 1065, 2003. 56. Divizia, M. et al. Waterborne gastroenteritis outbreak in Albania. Water. Sci. Technol., 50, 57, 2004. 57. Yazaki, Y. et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J. Gen. Virol., 84, 2351, 2003. 58. Emerson, S.U., Arankalle, V.A., and Purcell, R.H. Thermal stability of hepatitis E virus. J. Infect. Dis., 192, 930, 2005. 59. Reyes, G.R. et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science, 247, 1335, 1990. 60. Tam, A.W. et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology, 185, 120, 1991. 61. Wang, Y. et al. The complete sequence of hepatitis E virus genotype 4 reveals an alternative strategy for translation of open reading frames 2 and 3. J. Gen. Virol., 81, 1675, 2000. 62. Koonin, E.V. et al. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc. Natl. Acad. Sci. USA, 89, 8259, 1992. 63. Surjit, M., Jameel, S., and Lal, S.K. The ORF2 protein of hepatitis E virus binds the 5' region of viral RNA. J. Virol., 78, 320, 2004. 64. Emerson, S.U., and Purcell, R.H. Hepatitis E. Pediatr. Infect. Dis. J., 26, 1147, 2007. 65. Purcell, R.H., and Emerson, S.U. Hepatitis E: an emerging awareness of an old disease. J. Hepatol., 48, 494, 2008. 66. Clayson, E.T. et al. Detection of hepatitis E virus infections among domestic swine in the Kathmandu Valley of Nepal. Am. J. Trop. Med. Hyg., 53, 228, 1995. 67. Arankalle, V.A. et al. Human and swine hepatitis E viruses from Western India belong to different genotypes. J. Hepatol., 36, 417, 2002.
Hepatitis A and E Viruses 68. Fernández-Barredo, S. et al. Prevalence and genetic characterization of hepatitis E virus in paired samples of feces and serum from naturally infected pigs. Can. J. Vet. Res., 71, 236, 2007. 69. Feagins, A.R. et al. Detection and characterization of infectious Hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J. Gen. Virol., 88, 912, 2007. 70. Tei, S. et al. Consumption of uncooked deer meat as a risk factor for hepatitis E virus infection: an age- and sex-matched case-control study. J. Med. Virol., 74, 67, 2004. 71. Masuda, J. et al. Acute hepatitis E of a man who consumed wild boar meat prior to the onset of illness in Nagasaki, Japan. Hepatol. Res., 31, 178, 2005. 72. Rab, M.A. et al. Water-borne hepatitis E virus epidemic in Islamabad, Pakistan: a common source outbreak traced to the malfunction of a modern water treatment plant. Am. J. Trop. Med. Hyg., 57, 151, 1997. 73. Sarguna, P., Rao, A., and Sudha Ramana, K.N. Outbreak of acute viral hepatitis due to hepatitis E virus in Hyderabad, India. J. Med. Microbiol., 25, 378, 2007. 74. Maila, H.T., Bowyer, S.M., and Swanepoel, R. Identification of a new strain of hepatitis E virus from an outbreak in Namibia in 1995. J. Gen. Virol., 85, 89, 2004. 75. Bile, K. et al. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am. J. Trop. Med. Hyg., 51, 466, 1994. 76. Panda, S.K., Thakral, D., and Rehman, S. Hepatitis E virus. Rev. Med. Virol., 17, 151, 2007. 77. Inoue, J. et al. Development and validation of an improved RT-PCR assay with nested universal primers for detection of hepatitis E virus strains with significant sequence divergence. J. Virol. Methods, 137, 325, 2006. 78. Jothikumar, N. et al. Detection of hepatitis E virus in raw and treated wastewater with the polymerase chain reaction. Appl. Environ. Microbiol., 59, 2558, 1993. 79. Huang, F.F. et al. Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States. J. Clin. Microbiol., 40, 1326, 2002. 80. Garkavenko, O. et al. Detection and characterisation of swine hepatitis E virus in New Zealand. J. Med. Virol., 65, 525, 2001.
73 81. Takahashi, M. et al. Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system. J. Clin. Microbiol., 45, 3671, 2007. 82. Zhao, C. et al. Comparison of real-time fluorescent RT-PCR and conventional RT-PCR for the detection of hepatitis E virus genotypes prevalent in China. J. Med. Virol., 79, 1966, 2007. 83. Mizuo, H. et al. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J. Clin. Microbiol., 40, 3209, 2002. 84. He, J. Molecular detection and sequence analysis of a new hepatitis E virus isolate from Pakistan. J. Viral. Hepatol., 13, 840, 2006. 85. Cooper, K. et al. Identification of genotype 3 hepatitis E virus (HEV) in serum and fecal samples from pigs in Thailand and Mexico, where genotype 1 and 2 HEV strains are prevalent in the respective human populations. J. Clin. Microbiol., 43, 1684, 2005. 86. Zhao, Z.Y. et al. Detection of hepatitis E virus RNA in sera of patients with hepatitis E by polymerase chain reaction. Hepatobiliary Pancreat. Dis. Int., 6, 38, 2007. 87. Aggarwal, R. et al. Genetic variability of hepatitis E virus within and between three epidemics in India. Virus. Res., 59, 35, 1999. 88. Zhang, F. et al. Detection of HEV antigen as a novel marker for the diagnosis of hepatitis E. J. Med. Virol., 78, 1441, 2006. 89. Coulepis, A.G. et al. Detection of hepatitis A virus in the feces of patients with naturally acquired infections. J. Infect. Dis., 141, 151, 1980. 90. McCaustland, K.A. et al. Application of two RNA extraction methods prior to amplification of hepatitis E virus nucleic acid by the polymerase chain reaction. J. Virol. Methods, 35, 331, 1991. 91. Ray, R. et al. Hepatitis E virus genome in stools of hepatitis patients during large epidemic in north India. Lancet, 338, 783, 1991. 92. Aggarwal, R., and McCaustland, K.A. Hepatitis E virus RNA detection in serum and feces specimens with the use of microspin columns. J. Virol. Methods, 74, 209, 1998. 93. Tamura, K. et al. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol., 24, 1596, 2007.
6 Noroviruses Anna Charlotte Schultz
Technical University of Denmark (DTU)
Jan Vinjé
Center for Disease Control (CDC)
Birgit Nørrung
University of Copenhagen
Contents 6.1 Introduction......................................................................................................................................................................... 75 6.1.1 Background and Classification................................................................................................................................ 75 6.1.2 Biology..................................................................................................................................................................... 76 6.1.3 Pathogenesis............................................................................................................................................................. 76 6.1.4 Epidemiology........................................................................................................................................................... 76 6.1.5 Diagnosis.................................................................................................................................................................. 77 6.1.5.1 Issues Concerning Sample Processing...................................................................................................... 77 6.1.5.2 Issues Concerning Amplification, Detection, and Quality Assurance (QA)............................................. 80 6.2 Methods............................................................................................................................................................................... 82 6.2.1 Reagents and Equipment.......................................................................................................................................... 82 6.2.2 Sample Preparation.................................................................................................................................................. 82 6.2.3 Detection of Noroviruses by Real-time RT-PCR.................................................................................................... 85 6.3 Conclusion and Future Perspectives.................................................................................................................................... 85 Acknowledgments........................................................................................................................................................................ 85 References.................................................................................................................................................................................... 85
6.1 Introduction
6.1.1 Background and Classification
Noroviruses (NoVs) have emerged as a major cause of foodborne illness causing an estimated 30–50% of all foodborne outbreaks in the U.S. Because these viruses are highly contagious, have a low infectious dose, and are persistent in the environment, they are classified as group B biodefense pathogens. The source of most foodborne outbreaks is contaminated bivalve shellfish, which are often eaten raw, or infected food handlers. Foods that have been implicated in outbreaks include ready-to-eat (RTE) foods such as salads, celery, melon, sandwiches, lettuce, cold cooked ham, and fresh or frozen raspberries. Detection of NoV in food is limited to molecular methods as the virus cannot be grown in routine cell culture. This chapter describes the history, classification, and biology of NoVs and provides an overview of the published methods for the molecular detection in various food items. Detailed laboratory protocols for the rapid concentration, extraction, and real-time reverse transcriptase-polymerase chain reaction (RT-PCR) detection in bivalve molluscan shellfish and raspberries are provided.
Although outbreaks of nonbacterial gastroenteritis have been recognized as early as the 1930s, a causative viral agent was not discovered until 1972 when 27 nm sized virus particles were detected by immune electron microscopy (EM) in stool samples of human volunteers who had been fed with a bacterial-free filtrate from an individual that was involved in an outbreak of acute gastroenteritis in an elementary school in Norwalk, Ohio in 1968.63 The virus was named Norwalk virus (NV) and this virus has been established as the prototype virus for the group of viruses now called NoVs, but in the literature also referred to as “Norwalk-like viruses” or small round structured viruses (SRSVs) based on the characteristic surface morphology of the virus particles. The classification of NoVs as members of the family Caliciviridae was established after the cloning and sequencing of the complete genome of NV58 and Southampton virus.72 To date, these viruses are grouped into a separate genus Norovirus. Other genera include Sapovirus, Lagovirus, and Vesivirus41,100 and a new fifth genus is pending. Below the genus level naming of NoVs has not been agreed upon and therefore NoV strains 75
76
are often named after the geographic location where the outbreaks first occurred such as Hawaii virus, Snow mountain virus, Bristol virus, and Minerva virus. A more formal naming system similar to influenza has been proposed with: species infected/virus genus/genogroup/virus name/strain designation/year of detection/country.4
6.1.2 Biology NoVs are a group of 27–35 nm nonenveloped viruses with an icosahedral capsid enclosing a single stranded positive sense RNA genome of approximately 7.5–7.7 nucleotides (nt). The NoV genome contains three open reading frames (ORFs) with ORF1 at the 5′-end of the genome which encodes a polyprotein of six nonstructural proteins including p48, NTPase, p22, VPg (binds to 5′ end to initiate translation), 3CLpro (protease), and RdRp (RNA dependent RNA polymerase). ORF2 and ORF3 code for two structural proteins: a major (VP1) and a minor (VP2) capsid protein.40 NoVs are a genetically diverse group of viruses which are currently classified into five genetic groups or genogroups.40,148 Strains that infect humans belong to genogroups I, II, and IV.148 Genogroup II includes also strains that have been detected uniquely in swine whereas viruses belonging to genogroup III and V infect cattle or mice, respectively. These five genogroups can be further divided into genotypes or genoclusters (eight in genogroup I, 19 in genogroup II, two in genogroup III, one in genogroup IV, and one in genogroup V).148 Subgenomic RNA, rather than genomic RNA, is used as the template for the production of the capsid proteins.8 Additionally, the 5′ end of the subgenomic and genomic RNAs contains a highly conserved nucleotide motif up-stream from the first AUG start codon and is therefore thought to be a site for the initiation of transcription.67 Using cryo-immune EM the structure of the NV has been resolved.111 Virus particles are assembled from 90 dimers of VP1 and a few VP2 molecules and form a T=3 icosahedral capsid.111 The exact role of VP2 is not completely known although this protein may be important in the stability of the overall viral capsid (capsid–RNA complex).8 VP1 folds into a shell domain (S) and a protruding domain (P) linked by an amino acid hinge.111 The relatively conserved S domain is essential for the formation of the icosahedral structure of the virion, while the P domain stabilizes the capsid by a dimeric interaction and forms the characteristic protrusions on the virion.46 The P domain is further subdivided into the P1 and P2 subdomains with the P2 subdomain containing both immune and cellular recognition sites.16,89,133
6.1.3 Pathogenesis After an incubation period between 24 and 48 hours but sometimes as short as 15 hours,38 clinical symptoms include acute projectile vomiting, nonbloody diarrhea, abdominal cramps, nausea, chills, myalgia, and headache.64 Fever is rarely reported. In human volunteers, NV has been shown to
Molecular Detection of Foodborne Pathogens
affect epithelial cells of the small intestine resulting in broadening and flattening of the villi. NoVs do not appear to infect the cells of the large intestine.29,120,127 During acute illness, the inflammation of the mucosa of the small intestine reduces the adsorptive capacity of the villi and produce intestinal fluid contributing to diarrhea while vomiting is likely due to delayed gastric emptying and disrupted motility.101 However, the precise mechanism of virus-induced diarrhea and vomiting is currently unknown.135 The disease in healthy individuals is usually mild and resolved after 1–3 days.64,65 However, severe illness has been reported in young children, the elderly, cardiovascular or renal disease patients,98 transplant recipients, and other immunosuppressed patients,55 in which case fluid replacement or additional supportive care may be needed.145 Rates of asymptomatic virus shedding of 32% have been reported in both clinical outbreak studies and studies in human volunteers experimentally infected with NV.38
6.1.4 Epidemiology NoVs are transmitted primarily through the fecal-oral route, either directly from person-to-person via contaminated hands, or indirectly via contaminated food or water. The virus can also persist for several days to weeks on surfaces and fomites which can act as a source of continuing infection during outbreaks. Importantly, airborne droplets of vomitus are infectious and have been strongly implicated in contaminating the environment and in direct transmission of NoV within semiclosed communities such as cruise ships, hospitals, the military and long-term care facilities.97 Human NoVs are estimated to be responsible for up to 95% of nonbacterial epidemic gastroenteritis worldwide in humans of all age groups.40 Recent studies indicate that NoV disease is also associated with a significant number of sporadic cases of gastroenteritis.42,56,94 Most outbreaks throughout the world are caused by strains that belong to GII, whereas <5% of the outbreaks are caused by GI and GIV outbreaks are very rare. In most years, viruses of different genotypes cocirculate but in 1996, 2002, and 2006, viruses of genetic cluster GII.4 were associated with the majority of the outbreaks globally. Molecular analysis of these GII.4 strains demonstrated that older GII.4 strains are being replaced by new GII.4 subtypes every 2–3 years coinciding with an increase in the number of outbreaks. These findings are somewhat similar to the evolution of influenza viruses and it has been hypothesized that herd immunity may contribute to a proposed epochal evolution model for GII.4 NoVs88,126 although there are other possible explanations that could describe these observations (e.g., natural fluctuation). NoVs bind to human histoblood group antigens (HBGAs),52,53,57,87,96,131,132 which are complex carbohydrates present on the surfaces of red blood cells as well as on the mucosal epithelium and in body fluids with important biological functions.95,112 The recognition of HBGAs by the capsid protein of NoVs appear to be highly strain specific,
Noroviruses
and eight distinct receptor-binding patterns have been iden tified.47,48,54 The binding of NV and other NoV genotypes to certain HBGA molecules has also been strongly linked with clinical infection.57,87,113 Recent studies have shown that HBGAs and in particular secretor status controlled by the 1,2-fucosyltransferase FUT2 gene determine susceptibility to NoV infections, with nonsecretors (FUT2−/−), representing 20% of Europeans, being highly resistant to symptomatic infections with major strains of NoV such as GII.4.73,134 Due to the different HBGA specificities of the capsid protein from distinct strains, a host–pathogen coevolution driven by carbohydrate–protein interactions has been suggested. For a comprehensive overview on HBGAs and susceptibility to NoV infection, the reader is referred to a review of LePendu et al.83 NoV outbreaks are often linked to food handlers who infect foods that are eaten raw or not further processed (RTE foods) prior to consumption.138,146 Other sources of NoV contamination are shellfish growing waters (e.g., oysters) and irrigation water (e.g., soft fruits and vegetables). NoVs have also been associated with outbreaks after exposure to contaminated drinking water.50,74,99 The NoVs are very stable in the environment, which greatly contributes to viral spread and disease.40 Studies in human volunteers in the 1970s showed that NV particles remained infectious after the virus had been exposed to pH 2.7 for 3 hours or incubated at 60°C for 30 min.40
6.1.5 Diagnosis Despite numerous attempts, NoV can still not be grown in cell culture32 and although successful passage of NoV in a 3-D cell culture system has been reported,128 this work has not been confirmed by others.139 After the discovery of NV by EM, this method was used for the next 20 years by many research laboratories for the detection of SRSV or NoVs in human fecal samples. Performing EM, however, requires expensive equipment and is a relative insensitive method as it requires at least 106 particles/ml).40 Further developments allowed the visualization of the NoVs by using immune transmission EM63,65,66 or viral antigens by ELISA. Although these refinements in diagnostic procedures increased the sensitivity, broadly reactive antibodies are not widely available.69,123 The cloning and sequencing of several complete NoV genomes (Norwalk and Southampton) followed by numerous reports on partial sequences from other SRSV strains allowed for the development of the first generation of broadly reactive primers to detect NoVs by RT-PCR.2,59,141 These assays allowed detection of NoVs in human fecal samples and using different primer combinations in a nested-PCR format,39 also detection in food matrices such as shellfish. However, since most food matrices contain RT-PCR inhibitors which are coextracted with viral RNA, a critical step in the detection of low-copy number of NoV in foods is the removal of these inhibitors using multi-step elution, concentration, and extraction procedures.6 Over the last 10 years, significant progress
77
has been made in the development of protocols for the improved detection of enteric viruses in shellfish.6,12,23,27,77,125 While different protocols have successfully detected NoVs in other food matrices,69,80 rigorous evaluation of these protocols is needed before standardized protocols can be implemented in laboratories performing routine detection of NoVs in foods. After the initial sampling, most methods for the detection of viruses in food include the following three steps: (1) elution and concentration of the virus particles from the foodstuff, (2) nucleic acid extraction and, (3) detection and confirmation of viral RNA (4). Various strategies for each step have been described15,30,35,86,117,119 and an overview of these methods and their performance characteristics is summarized in Table 6.1. 6.1.5.1 Issues Concerning Sample Processing Sample collection. When salads, soft fruits or whole shellfish are analyzed, generally 10–50 g of sample is analyzed. Since shellfish accumulate viruses in their digestive tissue,103,115 and NV has been shown to bind specifically to carbohydrate structures on this tissue, a number of methods analyzing only this part of shellfish have been published. This approach allows processing of only 1.5–2 g of digestive tissue which has been demonstrated to be sufficient for the recovery and detection of NoV RNA43,77,85 and requires less processing time.6 However, while the dissection of digestive tissue has several advantages for larger shellfish species like oysters and large mussels, this method is technically difficult for small species, such as clams or cockles. As the number of virus particles in each shellfish will often vary, it is important that the sample to be analyzed will represent a number of different shellfish individuals. Elution and concentration of NoV from foods. Elution and concentration of virus particles from the food matrix are the most critical steps of sample processing before RT-PCR detection of viral RNA. Although efforts are aimed to develop horizontal methods applicable to a wide variety of food matrices such as bivalve shellfish, salads, and soft fruits, some specific adjustments of the method may be required to enhance virus elution from a given foodstuff. Therefore, the elution step of virus from food matrices depends on the type of food being analyzed, as well as its state (e.g., fresh, frozen, etc.). In addition, the selection of an elution step needs to be based upon the differences in surface morphology and hydrophobic interactions, internal tissue composition (i.e., RT-PCR inhibitory substances, pH, etc.), whether the virus is present inside (e.g., shellfish flesh) or at the surface of the food (e.g., salads and soft fruit and RTE foods) and conditions of processing to which the food matrix has been subjected previously.1,21,26,45,71 Some methods for shellfish have used acidic adsorption prior to virus elution, but most methods have performed virus elution using a large volume of buffer (two to five times the sample weight). Glycine buffers containing proteins such as beef extract at an alkaline pH (range 8.5–10) have been most commonly used for this purpose. Moreover, when analyzing acidic and pectin containing raspberries or strawberries, the
20 (0.3 g)
8 (0.12 g)
1.5c
1.5c 1.5c 1.5c 1.5c 2c 10c 5c
GuSCN Alkaline
6
4 (0.32 g)
10
50
8
Lettuce
1 (2.5 g) 5 (1.25 g) 5 (0.07 g)
Alkaline Gycine Chlorof-but, CatFloc
Glycine, chlorof Chlorof-but, CatFloc
50 25 1.5c
Glycine, cat-Floc Glycine Glycine Glycine Threonineb Glycine Glycine
Gycine-threonine Chlorof-but, CatFloc Chlorof-but, CatFloc Zirconia beads Proteinase K Trizol ProteinaseK
Clams
20 (1.5 g) 5 (0.1 g)
1 (1 g) 8 (0.8 g)
0.2 (0.04 g)
Viral Elution
Chlorof-but, CatFloc
Glycine Waterb Glycine Sonication Glycine b
20 50 100 10 25 25c 2c
6 (0.1 g) 6 (0.09 g) 0.5 (0.01 g) 0.8 (0.08 g) 1 (0.05 g)
2 (0.4 g)
2 (0.5 g) 1 (0.5 g) 5 (1 g)
Final % Analyzed
25 50 18 50 25
Sample Size (g)
Mussels
Oysters
Food Sample(s)
PEG
Absorbtion to hydroxyapatite PEG
Ultracentrifugation PEG
Ag capture PEG Ultracentrifugation PEG PEG Ultracentrifugation Ultracentrifugation
PEG PEG Ultracentrifugation
PEG
PEG PEG Ultracentrifugation PEG PEG
Concentration
Table 6.1 Selected Methods Used for Virus Detection in Shellfish, Vegetables and Berries
Trizol QIAshedder™ homogeneiser RNEasy kit
CTAB
Poly A Nucleospin RNAkit RNEasy kit
QIAamp Guanidium, CsCl GuSCN RNEasy kit GuSCN Tryzol + Boom GuSCN
GuSCN+ QIAamp Prot. K, CTAB QIAamp kit RNEasy kit GuSCN GuSCN High Pure Viral NA kit
Prot. K, CTAB
QIAamp Boiling GuSCN GuSCN Tri-reagent
RNA Extraction
50 RT-PCRU NoV 10 PFU HAV 10 RT-PCRU NoV
1.2 TCID50/g HAV 600 PCRU/g HAV
102–103 RT-PCRU NoV
<102 genome copies
22 RT-PCR50U NoV 27 PFU HAV 100 RT-PCRU NoV 100 PFU HAV
1.2 PFU/g EV
Detection Limit(s) (Per Quantity of Analyzed Product)
82
119
37
36 129 22
84 24 110 18 105 107 49
9 122 108 91 60 12 43
6
125 19 106 39 68
Reference
78 Molecular Detection of Foodborne Pathogens
25
Vegetables
15
Raspberries Strawberries Blueberries
20 (3 g)
4 (2.4–3.6 g) Tris-glycine. beef extract
Alkaline Sodium bicarbonate+Soya protein Ultra-filtration
Ultracentrifugation
PEG
Ultracentrifugation
PEG
PEG
Immunomagnetic separation, positively charged filters filtration
Immunomagnetic separation
Magnetic capture
PEG
Filtration
PEG
QIAampa (or miniMAGb)
QIAamp
RNEasy Kit
QIAamp
RNEasy kit
Prot. K, Phenolchlorof CTAB
TrizolTM
QIAamp
Trizol-chlorofpoly(dT) magneticbeads
54 RT-PCRU NoV 12 RT-PCRU HAV 26a or 0b RT-PCRU RV
103–104 RT-PCRU or 102-103 TCID50 HAV
102 RT-PCR U NoV
10% recovery
102 RT-PCRU NoV
10 PFU HAV
0.5 PFU HAV
10-2-102 PFU or 10-105 RT-PCRU HAV
13
118
7
117
7
80
10
123
109
31 30
1.2 × 103 PCRU NoV 50 TCID50 HAV
44
50 PFU HAV
1 RT-PCRU NoV 1 TCID50 HAV
Source: Modified from Le Guyader, F.S., and Atmar, R.L., In Human Viruses in Water, Volume 17: Perspectives in Medical Virology, 1st ed., Bosch, A. (Ed.), Elsevier Science. Amsterdam, 2007. a Detection limit in infectious viruses was calculated taking into account the infectious titer of the HAV stock given by ATCC. b Elution performed after acidic adsorption. c Only digestive tissues analyzed Abbreviations: Glycine, glycine buffer; Chlorof, chloroform; but, butanol; PEG, polyethylene glycol precipitation; ultracentri, ultracentrifugation; prot. K, proteinase K; GuSCN, guanidinium thiocyanate; EV: enterovirus, NoV: norovirus, HAV: hepatitis A virus.
60–90
Alkaline Tris glycine beef-extract
50
Raspberries Strawberries
Alkaline
Gycine Chlorof-but, CatFloc
60
2 (0.2 g)
PBS
PBS
Alkaline glycine
Alkaline
PBS
Alkaline Tryptose phosphate-glycine
Alkaline Tris-glycine-beef extract
10
Raspberries
10
0.4 (0.1 g)
10 (2.5 g)
16 (4 g)
50
One piece of food
25
Green onion Strawberry rinses
Lettuce Strawberries
25
Lettuce Green onions Raspberries
100
25
Green onions
Noroviruses 79
80
release of viruses may be favored by the addition of Tris to the elution buffer, hence increasing the buffer capacity followed by pH neutralization and incubation with pectinase in order to prevent jelly formation.13,30,117,118 After elution of viruses from the food matrix, clarification of the water-phase by extracting with a chloroform-butanol mixture is a rapid step before concentrating the viruses using polyethylene glycol (PEG) precipitation,30 ultracentrifugation,117 or ultrafiltration.13 However, analyzing the digestive tissues of shellfish by direct lysis of the virus particles by proteinase K, or Trizol of the shellfish tissues or by beating with Zirconia beads in the presence of denaturing buffer are elution strategies that have been used successfully.43,60,85,92 A disadvantage of this direct lysis approach is that it often limits the quantity of shellfish tissues that can be analyzed and therefore reduces the chances to recover low amounts of the viral RNA. On the other hand, since small amounts of viruses can still be successfully recovered in relatively smaller amount of digested shellfish, it may be due to the simultaneously decrease in amount of inhibitor which are known to interfere with virus recovery in many concentration methods. There is often an inverse relationship between the recovery of NoV from shellfish tissue and the increasing complexity of the recovery method.43 RNA extraction. Based on the type of food, a variety of methods to extract viral RNA while concurrently reducing the level of PCR inhibitors have been reported4,43 and they are all dependant on the characteristics of the priory concentrated virus suspension. Lysis of the concentrated viruses pellet by proteinase K, followed by purification of nucleic acid using phenol-chloroform and cethyl trimethyl ammonium bromide (CTAB) precipitation was one of the first successful methods described for detection of NoV in shellfish.5 Although this method is quite labor-intensive the efficiency to detect viruses in shellfish has been confirmed in several studies.6,77,78 However, most methods today are based on guanidium extraction either using a variation of the method described by Boom et al.11 or using commercially available kits, based on similar chemistry (QIAamp or RNeasy kit by Qiagen®, or NucliSens magnetic kit by bio-Mérieux). All these RNA extraction methods have proven to be successful for NoV detection in naturally contaminated shellfish, berries, and other food matrices.13,60,80,81,90,114,116 6.1.5.2 Issues Concerning Amplification, Detection, and Quality Assurance (QA) Amplification and detection. The first generation of NoV primers104,144 were not broadly reactive due to the limited knowledge of the tremendous genetic diversity among NoVs. With the availability of more NoV sequences, broadlyreactive RT-PCR assays were designed based on a highly conserved region (region A) within the RdRp.3,12,28,34,76,77,107,141 Although sequences obtained from these assays can be used to distinguish NoV strains, far more reliable genotyping is achieved by amplifying partial regions of the 5′-end of ORF2 (region C) or 3′-end (region D).70,140 While most of the above mentioned RT-PCR assays utilize a virus-specific primer in the RT reaction, random hexamers have also been used successfully to generate cDNA.17,20,39,60 Although nested PCR
Molecular Detection of Foodborne Pathogens
or boosted PCR protocols can increase the sensitivity up to 10–1,000 times12,28,34,39,75,107 extreme care needs to be taken for performing such assays on a routine basis because of the high risk of cross-contamination. Although most RT-PCR assays to detect NoV RNA have been successfully used, no assay which detects all strains has been reported. As a consequence multiplex approaches involving several primer sets and probes are required to address the diversity of these viruses, and no single assay stands out as the best by all criteria.4,143 For example, several outbreak investigations report the use of different primer sets targeting different areas of the genome to be able to amplify the strain in both clinical or environmental samples.79,81,124 Confirmation of RT-PCR amplicons. Although still used in some laboratories, detection of RT-PCR products in ethidium bromide stained agarose gels (i.e., a band having a similar size to that of the positive control) is not considered as an appropriate method for the confirmation of conventional RT-PCR assay results.4 Either probe hybridization assays including dot blot hybridization, liquid hybridization, and Southern blot hybridization have been used for confirmation but the limitation is the genetic variability of NoVs which makes it difficult to select a panel of probes to detect most if not all possible NoV strains.76,78 To resolve this and also to attempt to genotype strains, reverse line blot (RLB) assays have been developed for the confirmation of NoV amplicons derived from the polymerase region142 and capsid region.102 These methods are very useful in large-scale epidemiological studies for the initial NoV confirmation of amplicons. To date, most laboratories use TaqMan realtime RT-PCR assay for the detection and confirmation of NoV (see below) and sequencing of region C or region D amplicons is used to determine the genotype or to link geographical different clusters of NoV illness to the same source (e.g., batch of contaminated oysters). Based on analyzing the complete genomic sequence of 18 NoV strains,67 the ORF1–ORF2 junction region has been identified as the most conserved region of the NoV genome. Consequently, GI, and GII specific real-time (Q)RT-PCR assays targeting this region have been developed.61,130,136 These assays have been refined and have been shown to detect NoV in both clinical and environmental samples robustly.25,60,93,108 A selection of primers and probes and different combinations in which they have been used are shown in Table 6.2. Compared to conventional RT-PCR assays, Q-RT-PCR assays is more sensitive, faster, and quantitative if RT-PCR inhibitors are not present in the sample.93 Q-RT-PCR assays also avoid post RT-PCR confirmation steps, such as gel electrophoresis and hybridization or sequencing because positive products can be confirmed by melting curve analysis (in SYBR green Q-RT-PCR) or by probes (in Taqman Q-RT-PCR). In one study, broadly reactive NoV GI and GII TaqMan RT-PCR assays were developed and evaluated on a panel of 84 archived stool samples representing 19 different NoV genotypes and on cDNA from 38 naturally contaminated shellfish samples.60 The sensitivity of these assays is <10 copies of viral genome per reaction. Replacing the degenerated
81
Noroviruses
Table 6.2 Selected Real-Time RT-PCR Primers and Probes Targeting the ORF1-ORF2 Junction for the Detection of Noroviruses in Foods NoV Genogroup NoV GI
NoV GII
NoV IV
a b c
d e
Primers and Probea
Sequence (5’–3’)b
Positionc
Reference
QNIF4 (+) NV1LCR (–) NVGG1p (+)
CGCTGGATGCGNTTCCAT ccttagacgccatcatcatttac FAM-TGGACAGGAGAYCGCRATCT-TAMRAd
5291–5308 5354–5376 5321–5340
25 130
COG1F (+) COG1R (–) Ring 1(a)-TP (–) Ring 1(b)-TP (–)
CGYTGGATGCGNTTYCATGA CTTAGACGCCATCATCATTYAC FAM-AGATYGCGATCYCCTGTCCA-TAMRAd FAM-AGATCGCGGTCTCCTGTCCA-TAMRAd
5291–5310 5354–5375 5321–5340 5321–5340
61
JJV1F (+) JJV1R (–) JJV1P (+)
GCC ATG TTC CGI TGG ATG TCC TTA GAC GCC ATC ATC AT FAM-TGT GGA CAG GAG ATC GCA ATC TC-BHQ
5282–5299 5377–5358 5319–5341
60
Cog 1F (+) Cog 1R (–) Ring 1A (–) Ring 1B (-)
cgYtggatgcglttYcatga cttagacgccatcatcattYac FAM-agatYgcgatcYcctgtcca-BHQe FAM-agatcgcggtctcctgtcca-BHQe
5291–5310 5354–5375 5321–5340 5321–5340
136
QNIF2 (+) COG2R (–) QNIFs (+)
ATGTTCAGRTGGATGAGRTTCTCWGA TCGACGCCATCTTCATTCACA FAM-AGCACGTGGGAGGGCGATCG-TAMRAd
5012–5037 5080–5100 5042–5061
93 61
COG2F (+) COG2R (–) RING2-TP (+)
CARGARBCNATGTTYAGRTGGATGAG TCGACGCCATCTTCATTCACA FAM-TGGGAGGGCGATCGCAATCT-TAMRAd
5003–5028 5080–5100 5048–5067
61
NV2LCF (+) NV2LCR (–) NV2LCpr (+)
GARYCIATGTTYAGRTGGATG TCGACGCCATCTTCATTCAC FAM-TGGGAGGGSGATCGCRATCT-TAMRAd
5006–5026 5081–5100 5048–5067
130
COG2Fex (+) COG2R (–) RING2(a)+RING2 (b) (+)
MRSTGGATGMGRTTYTCWGA TCGACGCCATCTTCATTCACA FAM-TGGGAGGGYGATCGCAATCT (15 pmol)+ TGGGAGGGGGATCGCGATCT (5 pmol)-TAMRAd
5018–5037 5080–5100 5048–5067
62
COG2F (+) NV117 (–) TM3probe (+)
CAR GAR BCN ATG TTY AGR TGG ATG AG TCG ACG CCA TCT TCA TTC AC FAM -TGG GAG GGC GAT CGC AAT CTG GC-TAMRAd
5003–5028 5081–5100 5048–5070
61 51
JJV2F (+) COG2R (-) RING2-TP (+)
CAAGAGTCAATGTTTAGGTGGATGAG TCGACGCCATCTTCATTCACA FAM-AGCACGTGGGAGGGCGATCG-TAMRAd
5003–5028 5080–5100 5048–5067
60
Mon 4F (+) Mon 4R (–) Ring 4 (+)
tttgagtcYatgtacaagtggatgc tcgacgccatcttcattcaca FAM-tgggagggggatcgcgatct-BHQe
718–742 795–815 763–783
136
+, virus sense; −, antivirus sense. Mixed bases in degenerate primers and probes are as follows: Y = C or T; R = A or G; M = A or C; W = A or T; S = C or G; B = not A; I = inosine; N = any. Nucleotide position are based on the Norwalk (GI); accession number M87661, Camberwell virus (GII); accession number AF145896 and the Fort Lauderdale virus (GIV); accession number AF414426. TAMRA, 6-carboxytetramethylrhodamine quencher dye; FAM, 6-carboxyfluorescein reporter dye. BHQ, black hole quencher dye; FAM, 6-carboxyfluorescein reporter dye.
forward primer61 with a nondegenerated primer made this assay significantly more sensitive and at least as sensitive as the nested PCR.60 In another study, a one-step real-time RT-PCR assay was developed for GII and evaluated with the previously described
GI assay61 on an archived panel of 150 naturally contaminated shellfish samples.93 While the GII assay allowed detection of a large range of different strains circulating in France since 1995, the GI strains were detected infrequently. The detection limit as determined on artificially contaminated oysters
82
were found to be 70 and seven RT-PCR detectable units of GI and GII reference NoV strains, respectively.93 Quality assurance (QA)/quality control (QC). QA/QC measures include the use of positive and negative controls to identify false negative or false positive results, respectively. Most false negative results are a consequence of inefficient virus and/or nucleic acid extraction or the presence of inhibitors. Most false positives results are due to crosscontamination. Process extraction controls. Although numerous methods for the detection of viruses in shellfish have been published, it is difficult to compare assay performance between methods. Reasons for this include the use of different virus strains, different foods or species of shellfish, different RT-PCR methods, and the absence of reports of direct comparisons of different methods. The different methods described in Table 6.1 accomplish inhibitor removal to varying degrees, although no systematic evaluation of the efficiency of inhibitor removal has been performed. In order to facilitate the comparison of methods, a universal standard is needed. For this purpose, Costafreda et al.22 proposed the use of Mengo virus as an extraction control to evaluate virus concentration and nucleic acid extraction efficiency. With the accumulating knowledge of the recent cultivable Murine NoV showing similar environmental and chemical resistance as human NoV14 this could be a well suited and perhaps better candidate to be used as an extraction control for NoV. RT-PCR internal controls (IC). Since the concentration of RT-PCR inhibitors varies depending on the type of samples (e.g., species of shellfish, season of harvesting),125 the addition of an internal control like a viral RNA sequence in NoV RT-PCR reactions is critical to realize false negative results as well as providing data on the extraction efficiency of the assay.6,121 Known quantities of RNA transcripts have been spiked into nucleic acid extracts to allow quantitative22,43 or qualitative81,121 assessment of amplification efficiency. Dilution of the viral RNA is another approach to minimize and assess the potential problem of inhibitors.93 However, this approach also affects the assay sensitivity since a smaller amount of shellfish tissue is analyzed. Amplification inhibition seems to be caused by an imbalance between the amount of inhibitors, the amount of virus present in the sample, and the efficiency of the RNA extraction method coupled with its ability to remove inhibitors. Different IC have been used to generate a PCR product with a different size than the target product making it possible to distinguish between the two during gel electrophoresis. However limitations are often the lack of versatility due to amplification by primers that are not broadly reactive. An internal standard was created by cloning a 319 nt sequence of the polymerase gene containing a 156 nt cDNA insert, resulting in a 475 nt RT-PCR product that was amplified by the broadly reactive primer-pair 289/290 that can detect both NoV and sapovirus strains.33 In another study, synthetic short RNA fragments corresponding to the real-time RT-PCR sequence of the primers and probes targeting the ORF1-ORF junction were created based on NoV GI and GII
Molecular Detection of Foodborne Pathogens
reference strains. In each RNA sequence, a restriction site (BamHI) was included to discriminate the sequence from sample RNA if contamination was suspected.25 When using a competitive IC RNA, there are three possible outcomes of RT-PCR assays: (i) no product (the assay has failed, inhibition may be present); (ii) the IC RNA, but not the virus fragment is obtained (the assay has worked, and the sample is most likely negative or viral RNA is below the detection limit); (iii) the virus fragment, with or without the IC RNA fragment, is obtained (the assay has worked, and the sample is positive). EU legislation requires the inclusion of virus controls in standardized methods for the detection of viruses in foods. To harmonize this aspect, efforts are made within the CEN/ TC275/WG6/TAG4 (virus detection in foods) to develop standardized viral RNA extraction and detection protocols, However it becomes essential to gain more information about the practical application of this method to product safety assessment within the EU.
6.2 Methods 6.2.1 Reagents and Equipment Reagents and equipments for the sample preparation and RNA extraction are listed in Table 6.3. Reagents for real-time RT-PCR are listed in Table 6.4 and reactions can be carried out in a MX3000 Real-time PCR thermal cycler (Stratagene, France), or equivalent equipment.
6.2.2 Sample Preparation Based on epidemiological outbreak investigation, food items that have most often been associated with NoV outbreaks include bivalve molluscs especially oysters, mussels, and clams, salad crops such as lettuce and green onions and soft fruits such as raspberries, strawberries, and blackberries. All these food have been implicated in foodborne outbreaks and should be considered as primary targets for virological analysis. A positive result of such analysis may prevent the outbreak to continue by helping the risk management during outbreak investigations to take the proper action which may be immobilization or withdrawal of food stocks, or prohibition of harvest. However, RTE foods served in restaurants or institutions and subsequently implicated in outbreaks due to improper care during handling are less meaningful to be analyzed for viruses as they are often not well preserved and most often the causative agent cannot be identified. A comprehensive epidemiological investigation may be able to find the risk food and possible actions may include a recall of a certain batch of foods. Although bottled mineral water never has been identified as the source of NoV infection, contamination of mineral water with pathogenic bacteria has been reported.137,147 As mentioned in the introduction of this chapter, virus detection in food includes the following steps: sampling, viral elution, concentration, viral RNA amplification, and
83
Noroviruses
Table 6.3 Reagents and Equipments Used for Sample Preparation RNA Extraction of Shellfish and Soft Fruits Matrix Soft fruit
Reagent, Equipment and Consumables
Composition and Concentration of Reagent/Supplier
Elution buffer 1
Glycine, Tris, 1% [wt/vol] beef extract pH 9.5±0.2.
HCL Pectinase Elution buffer 2
Pectinex/Sigma. Glycine, Tris, 1% [wt/vol] beef extract pH 7.0±0.2.
Shellfish
Proteinase K solution
3 U/ml; add 20 mg proteinase K (30 U/mg) to 200 ml molecular grade water and shake to mix/Finnzymes, cat no. F-202S.
Soft fruits and shellfish
Lysis buffer Magnetic extraction reagents Magnetic silica
NucliSens/Bio-Mérieux, cat no. 200292, 280134. NucliSens/Bio-Mérieux, cat no. 200293. NucliSens/Bio-Mérieux, cat no. 280133; magnetic silica is included in the magnetic extraction reagents (cat no. 200293). However, additional silica will be needed due to the increased amount (250 µl per sample) used in this method.
Soft fruit
Falcon tube containing a nylon cell strainer of 40-µm pore size
BD Falcon.
Centricon Plus-70 centrifugal filter device
100K NMWL; Millipore.
Shellfish
Sterile shucking knife and heavy duty safety glove Scissors and forceps Pipettes and pipette tips Sterile petri dishes and sterile razor blades Centrifuge tubes (15 ml)
For the opening of shellfish. For the dissection of shellfish.
Soft fruits and shellfish
Centrifuge NucliSens miniMAG instrument Thermoshaker Waterbath Aspirator or equivalent apparatus Shaking incubator or equivalent Vortex mixer (or pulse vortexer) Micro-tubes (1.5 ml) Eppendorf tubes (1.5 ml) or equivalent
For the chopping of digestive tissue.
Bio-Mérieux, cat no. 200305. Operating at 60°C, 1,400 rpm. Operating at 65°C. For removal of supernatant Operating at 37°C. Bio-Mérieux, cat no. 200294.
Source: Butot, S., Putallaz, T., and Sanchez, G., Appl. Environ. Microbiol., 73, 186, 2007; Greening, G.E. and Hewitt, J., Food Anal. Methods, 1, 109, 2008; and Jothikumar, N. et al., Appl. Environ. Microbiol., 71, 1870, 2005.
detection. Since there is no standard horizontal method to detect NoV in food matrices, we describe here a method for shellfish and a method for soft fruits. For shellfish, sample preparation is based on analyzing the digestive glands which after carefully chopping into very small pieces are subsequently lysed in a proteinase K solution to digest the tissue and release the viral RNA from the virus particles.60 This procedure has been used successfully to detect NoV in many shellfish samples epidemiologically linked to outbreaks and can also be used to quantitatively determine the virus concentration in oysters within a working day.43 For soft fruits, the sample preparation is based on elution of viruses from the fruits by alkaline buffer followed by virus concentration by ultra-filtration.13 The procedure can be applied for different types of vegetables, herbs, and fresh or frozen berries. Evaluation of two commercially available kits (Viral RNA minikit and NucliSens magnetic kit) for viral RNA extraction from the soft fruit concentrate showed
similar recoveries.11 Since the NucliSens magnetic kit has also been demonstrated to work well for RNA extraction on the proteinase K suspension of shellfish, this kit is used here for both matrices. For detection of NoV RNA, two monoplex RT-PCR assays using specific primers and probes targeting the ORF1–ORF2 junction region have been used successfully.25,93 Both assays have been evaluated on a comprehensive panel of stool samples and have been applied effectively to detect NoV GI or GII in naturally contaminated water or shellfish samples.25,93 The overall sample processing scheme is outlined in Figure 6.1. For each sample preparation set-up, it is crucial to include a suitable internal extraction control in order to assure that no cross-contamination has occurred and to monitor the efficiency of the extraction. As a negative control water can be used, while a positive control should be an aliquot of an RNA virus with known concentration and which can be detected by real-time RT-PCR.
84
Molecular Detection of Foodborne Pathogens
Table 6.4 TaqMan Real-Time Protocol for Detection of NoV GI and GII in Shellfish and Soft Fruits Reagent UltraSense reaction mix* UltraSense enzymes mix* ROX* RNase inhibitor QNIF4 GI forward primer NV1LCR GI reverse primer NV1LCpr GI probe QNIF2d GII forward primer COG2R GII reverse primer QNIFS GII probe PCR qualified water Total volume/reaction before RNA addition
Concentration/Reaction
Concentration Stock Solution
Volume/Reaction (µl)
1× – 1× – 500 nM 900 nM 250 nM 500 nM 900 nM 250 nM – –
5× – 50× – 50 µM 50 µM 50 µM 50 µM 50 µM 50 µM – –
5.00 1.25 0.50 2U 0.25 0.45 0.13 0.25 0.45 0.13 12.42 20
Source: da Silva, A.K. et al., Appl. Environ. Microbiol., 73, 7891, 2007; and Loisy, F. et al., J. Virol. Methods, 123, 1, 2005. * RNA UltraSense™ One-Step Quantitative RT-PCR System. Invitrogen, cat. no. 11732927.
15 g of soft fruit or vegetables
1.5 g of chopped digestive gland representing at least six shellfish
Lyse with 2 ml proteinase K at 37˚C for 60 min with shaking
Elute by agitating for 15 min in 60 ml elution buffer (50 mM Glycine, 100 mM Tris, 1% (w/v) beef extract pH 9.5) Filtrate through cell stainer Pectinase treatment at neutral pH (for pectin containing berries only)
Centrifugation at 10,000 × g for 10 min
Centrifugation at 3500 × g for 15 min
Ultra-filtration of supernatant at 3500 × g for 15–45 min
Lyse viral capsid and remaining tissue by transferring the entire virus suspension to 4 ml lysis buffer.
Viral RNA extraction using magnetic silica NoV RNA detection by TaqMan real-time RT-PCR
Figure 6.1 Flow chart of norovirus detection in soft fruits and shelfish. (From Butot, S., Putallaz, T., and Sanchez, G., Appl. Environ. Microbiol., 73, 186, 2007; da Silva, A.K. et al., Appl. Environ. Microbiol., 73, 7891, 2007; Jothikumar, N. et al., Appl. Environ. Microbiol., 71, 1870, 2005; Loisy, F. et al., J. Virol. Methods, 123, 1, 2005; Svraka, S. et al., J. Clin. Microbiol., 45, 1389, 2007.)
Soft fruits.13 Weight 15 g of soft fruits into a stomacher bag and add 60 ml of elution buffer 1 (Table 6.3). Shake gently for 15 min at room temperature (Figure 6.1). Transfer the eluate to a Falcon tube containing a nylon cell strainer (Table 6.3) to remove particulate debris. Rinse the berries and the cell strainer with 6 ml and 2 ml of elution buffer 1,
respectively. Adjust the pH of the transferred eluate to pH 7.0 with 9.5 M HCl and add 300 µl of pectinase. Incubate while gently shaking for 30 min at room temperature. Centrifuge the extract at 3,500 × g for 15 min. and transfer the supernatant to a Centricon Plus-70 centrifugal filter device (Table 6.3) and centrifuge at 3,500 × g to concentrate
85
Noroviruses
the virus particles to ca. 400 µl. The centrifugal filter device is subsequently rinsed with 200 µl of elution buffer 2 (Table 6.3 and Figure 6.1). Shellfish. 43,60 Select a suitable number (preferably a minimum of six) of live oysters or mussels. Wash off any mud from the shell and open the shellfish with a clean shucking knife. Ensure the hand holding the shellfish is protected with a heavy duty safety glove. Dissect out the digestive glands using scissors and forceps (or equivalent tools). Transfer the glands to a clean petri dish and chop finely with a razor blade. During preparation the shellfish must be placed on ice. Transfer a 1.5 g portion of chopped glands into a 15 ml centrifuge tube. Add 2 ml of proteinase K solution (Table 6.3) and mix well. Incubate at 37°C in a shaking incubator (or equivalent) for 60 min. Transfer the tube to a water bath at 65°C for 15 min as a second incubation. Centrifuge at 10,000 × g for 10 min, decant the supernatant, measure, and record the volume and retain the sample (supernatant) for nucleic acid extraction. RNA extraction. Add the entire sample obtained from the shellfish (proteinase K suspension) or soft fruits (ultrafiltrate) sample preparation to a tube containing 4.5 ml of NucliSens lysis buffer and vortex briefly. Continue the procedure according to the manufactures instructions except for using 250 µl of well-mixed magnetic silica solution. Resuspend the extracted RNA in 100 µl elution buffer and use this for real-time RT-PCR.
6.2.3 Detection of Noroviruses by Real-time RT-PCR Amplification and inhibition controls. A negative amplification control (water) and positive amplification controls (e.g., GI and GII reference RNA in low copy numbers) should be included in each amplification series in order to monitor for cross contamination, and amplification efficiencies. In addition the inhibitor removal during the nucleic acid extraction and potential amplification inhibition should be assessed by e.g., testing each sample in duplicates of undiluted and 1/10 diluted RNA. Mastermix and RT-PCR conditions. The mastermixes for real-time RT-PCR should be prepared fresh immediately prior to use. A separate mastermix should be prepared for each of the NoV genogroups. Add the ingredients in the order listed in Table 6.4 and prepare enough mastermix for at least one reaction more than required. Dispense 20 µl mastermix to each well plus 5µl of the RNA sample to be tested (giving a total volume of 25 µl in each well). RT should be carried out for 30 min at 50°C, and denaturation for 5 min at 95°C, followed by 45 cycles of PCR amplification (denaturation at 95°C for 15 s, annealing, and extension at 60°C for 1 min).25 Reporting of results. Analyze the amplification plot using the approach recommended by the manufacturer. Given that all the controls are as expected, a sample is considered positive if the curve giving a Ct value has a proper shape. A sample is considered “not positive” if there is no Ct value or
if the curve does not have the proper shape regardless of the Ct value.
6.3 Conclusion and Future Perspectives NoVs are now recognized as the most important foodborne pathogens contributing to more outbreaks than all other known bacterial, viral, and protozoan pathogens combined. Therefore, efforts to prevent and control viral foodborne illnesses should be primarily directed toward NoVs. Foodborne transmission of NoV involves RTE food items contaminated with fecal material or vomit. Another important source of NoV contamination is water used for food washing or irrigation as well as shellfish growing waters contaminated by sewage infiltration or direct fecal contact. Which foods are implicated in a NoV outbreak is typically identified based on an epidemiological outbreak investigation where the relative risk of exposure to different food items is calculated. Standardized methods for the detection of viruses in foods other than shellfish are not yet available because until recently the methods used to recover and detect viruses from these foods were inadequate. However, the recent development of sensitive TaqMan-based real-time RT-PCR methods have greatly improved the sensitivity and specificity of the detection of NoVs but standardized upstream methods such as concentration and extraction methods have not been established. Using a cocktail of HBGAs that have been recognized as potential receptors of NoVs, or specific monoclonal antibodies to pre-enrich the virus particles regardless of the type of food, may lead to robust standardized protocols to detect one of the most important groups of foodborne pathogens.
Acknowledgments This work was supported by the Danish Veterinary and Food Administration (DVFA), the European Union Project BIOTRACER (FOOD-2006-CT-036272) and the National Food Institute, Technical University of Denmark (DTU). The authors would like to thank Soizick Le Guyader, Laboratoire de Microbiologie, IFREMER, Nantes, France for helpful discussions.
References
1. Allwood, P.B. et al. Occurrence of Escherichia coli, noroviruses, and F-specific coliphages in fresh market-ready produce. J. Food Prot., 67, 2387, 2004. 2. Ando, T. et al. Epidemiologic applications of novel molecular methods to detect and differentiate small round structured viruses (Norwalk-like viruses). J. Med. Virol., 47, 145, 1995. 3. Ando, T. et al. Detection and differentiation of antigenically distinct small round-structured viruses (Norwalk-like viruses) by reverse transcription-PCR and southern hybridization. J. Clin. Microbiol., 33, 64, 1995. 4. Atmar, R.L. and Estes, M.K. Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses. Clin. Microbiol. Rev., 14, 15, 2001. 5. Atmar, R.L. et al. Detection of enteric viruses in oysters by using the polymerase chain reaction. Appl. Environ. Microbiol., 59, 631, 1993.
86
6. Atmar, R.L. et al. Detection of Norwalk virus and hepatitis A virus in shellfish tissues with the PCR. Appl. Environ. Microbiol., 61, 3014, 1995. 7. Baert, L., Uyttendaele, M., and Debevere, J. Evaluation of viral extraction methods on a broad range of Ready-To-Eat foods with conventional and real-time RT-PCR for Norovirus GII detection. Int. J. Food Microbiol., 123, 101, 2008. 8. Bertolotti-Ciarlet, A. et al. The 3′ end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J. Virol., 77, 11603, 2003. 9. Beuret, C., Baumgartner, A., and Schluep, J. Virus-contaminated oysters: a three-month monitoring of oysters imported to Switzerland. Appl. Environ. Microbiol., 69, 2292, 2003. 10. Bidawid, S., Farber, J.M., and Sattar, S.A. Rapid concentration and detection of hepatitis A virus from lettuce and strawberries. J. Virol. Methods, 88, 175, 2000. 11. Boom, R. et al. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol., 28, 495, 1990. 12. Boxman, I.L. et al. Detection of noroviruses in shellfish in the Netherlands. Int. J. Food Microbiol., 108, 391, 2006. 13. Butot, S., Putallaz, T., and Sanchez, G. Procedure for rapid concentration and detection of enteric viruses from berries and vegetables. Appl. Environ. Microbiol., 73, 186, 2007. 14. Cannon, J.L. et al. Surrogates for the study of norovirus stability and inactivation in the environment: a comparison of murine norovirus and feline calicivirus. J. Food Prot., 69, 2761, 2006. 15. Cashdollar, J.L. and Dahling, D.R. Evaluation of a method to re-use electropositive cartridge filters for concentrating viruses from tap and river water. J. Virol. Methods, 132, 13, 2006. 16. Chen, R. et al. Inter- and intragenus structural variations in caliciviruses and their functional implications. J. Virol., 78, 6469, 2004. 17. Cheng, P.K. et al. Norovirus contamination found in oysters worldwide. J. Med. Virol., 76, 593, 2005. 18. Chironna, M. et al. Detection of hepatitis A virus in mussels from different sources marketed in Puglia region (South Italy). Int. J. Food Microbiol., 75, 11, 2002. 19. Chung, H., Jaykus, L.A., and Sobsey, M.D. Detection of human enteric viruses in oysters by in vivo and in vitro amplification of nucleic acids. Appl. Environ. Microbiol., 62, 3772, 1996. 20. Chung, H., Jaykus, L.A., and Sobsey, M.D. Detection of human enteric viruses in oysters by in vivo and in vitro amplification of nucleic acids. Appl. Environ. Microbiol., 62, 3772, 1996. 21. Cliver, D., Ellender, R.D., and Sobsey, J. Methods to detect viruses in foods: testing and interpretation of results. J. Food Prot., 46, 345, 1983. 22. Costafreda, M.I., Bosch, A., and Pinto, R.M. Development, evaluation, and standardization of a real-time TaqMan reverse transcription-PCR assay for quantification of hepatitis A virus in clinical and shellfish samples. Appl. Environ. Microbiol., 72, 3846, 2006. 23. Croci, L. et al. Detection of hepatitis A virus in shellfish by nested reverse transcription-PCR. Int. J. Food Microbiol., 48, 67, 1999. 24. Croci, L. et al. Determination of enteroviruses, hepatitis A virus, bacteriophages and Escherichia coli in Adriatic Sea mussels. J. Appl. Microbiol., 88, 293, 2000. 25. da Silva, A.K. et al. Evaluation of removal of noroviruses during wastewater treatment, using real-time reverse transcription-PCR: different behaviors of genogroups I and II. Appl. Environ. Microbiol., 73, 7891, 2007.
Molecular Detection of Foodborne Pathogens 26. Dalton, C. Commentary. An outbreak of Norwalk virus gastroenteritis following consumption of oysters. Commun. Dis. Intell., 21, 321, 1997. 27. De Medici, D. et al. Detecting the presence of infectious hepatitis A virus in molluscs positive to RT-nested-PCR, Lett. Appl. Microbiol., 33, 362, 2001. 28. De Medici, D. et al. Reverse transcription-booster PCR for detection of noroviruses in shellfish. Appl. Environ. Microbiol., 70, 6329, 2004. 29. Dolin, R. and Baron, S. Absence of detectable interferon in jejunal biopsies, jejunal aspirates, and sera in experimentally induced viral gastroenteritis in man. Proc. Soc. Exp. Biol. Med., 150, 337, 1975. 30. Dubois, E. et al. Modified concentration method for the detection of enteric viruses on fruits and vegetables by reverse transcriptase-polymerase chain reaction or cell culture. J. Food Prot., 65, 1962, 2002. 31. Dubois, E. et al. Intra-laboratory validation of a concentration method adapted for the enumeration of infectious F-specific RNA coliphage, enterovirus, and hepatitis A virus from inoculated leaves of salad vegetables. Int. J. Food Microbiol., 108, 164, 2006. 32. Duizer, E. et al. Laboratory efforts to cultivate noroviruses. J. Gen. Virol., 85, 79, 2004. 33. Escobar-Herrera, J. et al. Construction of an internal RT-PCR standard control for the detection of human caliciviruses in stool. J. Virol. Methods, 137, 334, 2006. 34. Formiga-Cruz, M. et al. Distribution of human virus contamination in shellfish from different growing areas in Greece, Spain, Sweden, and the United Kingdom. Appl. Environ. Microbiol., 68, 5990, 2002. 35. Gassilloud, B. et al. Recovery of feline calicivirus infectious particles and genome from water: comparison of two concentration techniques. Water Sci. Technol., 47, 97, 2003. 36. Goswami, B.B. et al. A polymerase chain reaction-based method for the detection of hepatitis A virus in produce and shellfish. J. Food Prot., 65, 393, 2002. 37. Gouvea, V. et al. Identification of Norwalk virus in artificially seeded shellfish and selected foods. J. Virol. Methods, 48, 177, 1994. 38. Graham, D.Y. et al. Norwalk virus infection of volunteers: new insights based on improved assays. J. Infect. Dis., 170, 34, 1994. 39. Green, J. et al. A nested reverse transcriptase PCR assay for detection of small round-structured viruses in environmentally contaminated molluscan shellfish. Appl. Environ. Microbiol., 64, 858, 1998. 40. Green, K.Y. Fields reference: Caliciviridae: The Noroviruses. In Fields Virology, 5th ed., Lippincott Williams & Wilkins. Phildelphia, PA., 2007. 41. Green, K.Y. et al. Taxonomy of the caliciviruses J. Infect. Dis., 181 Suppl 2, S322–S330, 2000. 42. Green, K.Y. et al. A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly. J. Infect. Dis., 185, 133, 2002. 43. Greening, G.E. and Hewitt, J. Norovirus detection in shellfish using a rapid, sensitive virus recovery and real-time RT-PCR detection protocol. Food Anal. Methods, DOI 10. 1007/ s12161-008-9018-3, 1, 109, 2008. 44. Guevremont, E. et al. Development of an extraction and concentration procedure and comparison of RT-PCR primer systems for the detection of hepatitis A virus and norovirus GII in green onions. J. Virol. Methods, 134, 130, 2006. 45. Gulati, B.R. et al. Efficacy of commonly used disinfectants for the inactivation of calicivirus on strawberry, lettuce, and a food-contact surface. J. Food Prot., 64, 1430, 2001.
Noroviruses 46. Hardy, M.E. Norovirus protein structure and function. FEMS Microbiol. Lett., 253, 1, 2005. 47. Harrington, P.R. et al. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J. Virol., 76, 12335, 2002. 48. Harrington, P.R. et al. Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. J. Virol., 78, 3035, 2004. 49. Hernroth, B.E. et al. Environmental factors influencing human viral pathogens and their potential indicator organisms in the blue mussel, Mytilus edulis: the first Scandinavian report. Appl. Environ. Microbiol., 68, 4523, 2002. 50. Hewitt, J. et al. Gastroenteritis outbreak caused by waterborne norovirus at a New Zealand ski resort. Appl. Environ. Microbiol., 73, 7853, 2007. 51. Hohne, M. and Schreier, E. Detection and characterization of norovirus outbreaks in Germany: application of a one-tube RT-PCR using a fluorogenic real-time detection system. J. Med. Virol., 72, 312, 2004. 52. Huang, P. et al. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J. Infect. Dis., 188, 19, 2003. 53. Huang, P. et al. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol., 79, 6714, 2005. 54. Huang, P.W. et al. Norovirus and histo-blood group antigens: Demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol., 79, 6714, 2005. 55. Huffman, D.E., Nelson, K.L., and Rose, J.B. Calicivirus An emerging contaminant in water: State of the art. Environ. Engineer. Sci., 20, 503, 2003. 56. Hutson, A.M., Atmar, R.L., and Estes, M.K. Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol., 12, 279, 2004. 57. Hutson, A.M. et al. Norwalk virus infection and disease is associated with ABO histo-blood group type. J. Infect. Dis., 185, 1335, 2002. 58. Jiang, X. et al. Norwalk virus genome cloning and characterization. Am. Soc. Adv. Sci., 1580, 1990. 59. Jiang, X. et al. Design and evaluation of a primer pair that detects both Norwalk- and Sapporo-like caliciviruses by RT-PCR. J. Virol. Methods, 83, 145, 1999. 60. Jothikumar, N. et al. Rapid and sensitive detection of noroviruses by using TaqMan-based one-step reverse transcriptionPCR assays and application to naturally contaminated shellfish samples. Appl. Environ. Microbiol., 71, 1870, 2005. 61. Kageyama, T. et al. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J. Clin. Microbiol., 41, 1548, 2003. 62. Kageyama, T. et al. Coexistence of multiple genotypes, including newly identified genotypes, in outbreaks of gastroenteritis due to Norovirus in Japan. J. Clin. Microbiol., 42, 2988, 2004. 63. Kapikian, A.Z. et al. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J. Virol., 10, 1075, 1972. 64. Kaplan, J.E. et al. Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann. Intern. Med., 96, 756, 1982. 65. Kaplan, J.E. et al. Gastroenteritis due to Norwalk virus: an outbreak associated with a municipal water system. J. Infect. Dis., 146, 190, 1982.
87 66. Kaplan, J.E. et al. An outbreak of acute nonbacterial gastroenteritis in a nursing home. Demonstration of person-toperson transmission by temporal clustering of cases. Am. J. Epidemiol., 116, 940, 1982. 67. Katayama, K. et al. Phylogenetic analysis of the complete genome of 18 Norwalk-like viruses. Virology, 299, 225, 2002. 68. Kingsley, D.H. and Richards, G.P. Persistence of hepatitis A virus in oysters. J. Food Prot., 66, 331, 2003. 69. Kobayashi, S. et al. Immunomagnetic capture rt-PCR for detection of norovirus from foods implicated in a foodborne outbreak. Microbiol. Immunol., 48, 201, 2004. 70. Kojima, S. et al. Genogroup-specific PCR primers for detection of Norwalk-like viruses. J. Virol. Methods, 100, 107, 2002. 71. Kurdziel, A.S. et al. Survival of poliovirus on soft fruit and salad vegetables. J. Food Prot., 64, 706, 2001. 72. Lambden, P.R. et al.. Sequence and genome organization of a human small round-structured (Norwalk-like) virus. Science, 259, 516, 1993. 73. Larsson, M.M. et al.. Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J. Infect. Dis., 194, 1422, 2006. 74. Lawson, H.W. et al. Waterborne outbreak of Norwalk virus gastroenteritis at a southwest United-States resort – role of geological formations in contamination of well water. Lancet, 337, 1200, 1991. 75. Le Guyader F. et al. Detection of hepatitis A virus, rotavirus, and enterovirus in naturally contaminated shellfish and sediment by reverse transcription-seminested PCR. Appl. Environ. Microbiol., 60, 3665, 1994. 76. Le Guyader F. et al. Evaluation of a degenerate primer for the PCR detection of human caliciviruses. Arch. Virol., 141, 2225, 1996. 77. Le Guyader F. et al. Three-year study to assess human enteric viruses in shellfish. Appl. Environ. Microbiol., 66, 3241, 2000. 78. Le Guyader F. et al. Detection and analysis of a small roundstructured virus strain in oysters implicated in an outbreak of acute gastroenteritis. Appl. Environ. Microbiol., 62, 4268, 1996. 79. Le Guyader, F.S. et al. Detection of multiple noroviruses associated with an international gastroenteritis outbreak linked to oyster consumption. J. Clin. Microbiol., 44, 3878, 2006. 80. Le Guyader, F.S. et al. Detection of noroviruses in raspberries associated with a gastroenteritis outbreak. Int. J. Food Microbiol., 97, 179, 2004. 81. Le Guyader, F.S. et al. A semiquantitative approach to estimate Norwalk-like virus contamination of oysters implicated in an outbreak. Int. J. Food Microbiol., 87, 107, 2003. 82. Le Guyader, F.S. et al. Round-robin comparison of methods for the detection of human enteric viruses in lettuce. J. Food Prot., 67, 2315, 2004. 83. Le Pendu, J. et al. Mendelian resistance to human norovirus infections. Semin. Immunol., 18, 375, 2006. 84. Lee, T. et al. Occurrence of hepatitis A virus in green-lipped mussels (Perna viridis). Water Res., 33, 885, 1999. 85. Lees, D.N. et al. Detection of small round structured viruses in shellfish by reverse transcription-PCR. Appl. Environ. Microbiol., 61, 4418, 1995. 86. Leggitt, P.R. and Jaykus, L.A. Detection methods for human enteric viruses in representative foods. J. Food Prot., 63, 1738, 2000. 87. Lindesmith, L. et al. Human susceptibility and resistance to Norwalk virus infection. Nat. Med., 9, 548, 2003.
88 88. Lindesmith, L.C. et al. Mechanisms of GII.4 norovirus persistence in human populations. Plos Med., 5, 269, 2008. 89. Lochridge, V.P. et al. Epitopes in the P2 domain of norovirus VP1 recognized by monoclonal antibodies that block cell interactions. J. Gen. Virol., 86, 2799, 2005. 90. Lodder, W.J. and de Roda Husman, A.M. Presence of noroviruses and other enteric viruses in sewage and surface waters in The Netherlands. Appl. Environ. Microbiol., 71, 1453, 2005. 91. Lodder-Verschoor, F. et al. Year-round screening of noncommercial and commercial oysters for the presence of human pathogenic viruses. J. Food Prot., 68, 1853, 2005. 92. Lodder-Verschoor, F. et al. Year-round screening of noncommercial and commercial oysters for the presence of human pathogenic viruses. J. Food Prot., 68, 1853, 2005. 93. Loisy, F. et al. Real-time RT-PCR for norovirus screening in shellfish. J. Virol. Methods, 123, 1, 2005. 94. Lopman, B. et al. Laboratory capability in Europe for foodborne viruses. Euro. Surveill, 7, 61, 2002. 95. Marionneau, S. et al. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie, 83, 565, 2001. 96. Marionneau, S. et al. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology, 122, 1967, 2002. 97. Marks, P.J. et al. A school outbreak of Norwalk-like virus: evidence for airborne transmission. Epidemiol. Infect., 131, 727, 2003. 98. Mattner, F. et al. Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin. Microbiol. Infect., 12, 69, 2006. 99. Maunula, L., Miettinen, I.T. and von Bonsdorff, C.H. Norovirus outbreaks from drinking water. Emerg. Infect. Dis., 11, 1716, 2005. 100. Mayo, M.A. A summary of taxonomic changes recently approved by ICTV. Arch. Virol., 147, 1655, 2002. 101. Meeroff, J.C. et al. Abnormal gastric motor function in viral gastroenteritis. Ann. Intern. Med., 92, 370, 1980. 102. Menton, J.F., Kearney, K. and Morgan, J.G. Development of a real-time RT-PCR and Reverse Line probe Hybridisation assay for the routine detection and genotyping of Noroviruses in Ireland. Virol. J., 4, 86, 2007. 103. Metcalf, T.G., Moulton, E. and Eckerson, D. Improved method and test strategy for recovery of enteric viruses from shellfish. Appl. Environ. Microbiol., 39, 141, 1980. 104. Moe, C.L. et al. Application of PCR to detect Norwalk virus in fecal specimens from outbreaks of gastroenteritis. J. Clin. Microbiol., 32, 642, 1994. 105. Mullendore, J.L., Sobsey, M.D. and Shieh, Y.C. Improved method for the recovery of hepatitis A virus from oysters. J. Virol. Methods, 94, 25, 2001. 106. Muniain-Mujika, I. et al. Comparative analysis of viral pathogens and potential indicators in shellfish. Int. J. Food Microbiol., 83, 75, 2003. 107. Myrmel, M. et al. Detection of enteric viruses in shellfish from the Norwegian coast. Appl. Environ. Microbiol., 70, 2678, 2004. 108. Nishida, T. et al. Detection, quantitation, and phylogenetic analysis of noroviruses in Japanese oysters. Appl. Environ. Microbiol., 69, 5782, 2003. 109. Papafragkou, E. et al. Rapid and sensitive detection of hepatitis A virus in representative food matrices. J. Virol. Methods, 147, 177, 2008. 110. Pina, S. et al. Viral pollution in the environment and in shellfish: human adenovirus detection by PCR as an index of human viruses. Appl. Environ. Microbiol., 64, 3376, 1998.
Molecular Detection of Foodborne Pathogens 111. Prasad, B.V. et al. X-ray crystallographic structure of the Norwalk virus capsid. Science, 286, 287, 1999. 112. Ravn, V. and Dabelsteen, E. Tissue distribution of histo-blood group antigens. APMIS, 108, 1, 2000. 113. Rockx, B.H. et al. Association of histo-blood group antigens and susceptibility to norovirus infections. J. Infect. Dis., 191, 749, 2005. 114. Roda de Husman, A.M. et al. Rapid virus detection procedure for molecular tracing of shellfish associated with disease outbreaks. J. Food Prot., 70, 967, 2007. 115. Romalde, J.L. et al. In-situ detection of hepatitis-A virus in cell-cultures and shellfish tissues. Appl. Environ. Microbiol., 60, 1921, 1994. 116. Rutjes, S.A. et al. Detection of noroviruses in foods: a study on virus extraction procedures in foods implicated in outbreaks of human gastroenteritis. J. Food Prot., 69, 1949, 2006. 117. Rzezutka, A. et al. A centrifugation-based method for extraction of norovirus from raspberries. J. Food Prot., 68, 1923, 2005. 118. Rzezutka, A., D’Agostino, M., and Cook, N.. An ultracentrifugation-based approach to the detection of hepatitis A virus in soft fruits. Int. J. Food Microbiol., 108, 315, 2006. 119. Sair, A.I. et al. Improved detection of human enteric viruses in foods by RT-PCR. J. Virol. Methods, 100, 57, 2002. 120. Schreibe, D.S., Blacklow, N.R. and Trier, J.S. Small intestinal lesion induced by Hawaii agent acute infectious nonbacterial gastroenteritis. J. Infect. Dis., 129, 705, 1974. 121. Schwab, K.J. et al. Distribution of norwalk virus within shellfish following bioaccumulation and subsequent depuration by detection using RT-PCR. J. Food Prot., 61, 1674, 1998. 122. Schwab, K.J. et al. Development of a reverse transcriptionPCR-DNA enzyme immunoassay for detection of “Norwalklike” viruses and hepatitis A virus in stool and shellfish. Appl. Environ. Microbiol., 67, 742, 2001. 123. Shan, X.C., Wolffs, P. and Griffiths, M.W. Rapid and quantitative detection of hepatitis A virus from green onion and strawberry rinses by use of real-time reverse transcription-PCR. Appl. Environ. Microbiol., 71, 5624, 2005. 124. Shieh, Y. et al. Detection of norwalk-like virus in shellfish implicated in illness. J. Infect. Dis., 181 (Suppl 2), S360, 2000. 125. Shieh, Y.C., Calci, K.R. and Baric, R.S. A method to detect low levels of enteric viruses in contaminated oysters. Appl. Environ. Microbiol., 65, 4709, 1999. 126. Siebenga, J.J. et al. Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J. Virol., 81, 9932, 2007. 127. Sshreibe, D.S., Blacklow, N.R., and Trier, J.S.. Mucosal lesion of proximal small-intestine in acute infectious nonbacterial gastroenteritis. N. Engl. J. Med., 288, 1318, 1973. 128. Straub, T.M. et al. In vitro cell culture infectivity assay for human noroviruses. Emerg. Infect. Dis., 13, 396, 2007. 129. Sunen, E. et al. Comparison of two methods for the detection of hepatitis A virus in clam samples (Tapes spp.) by reverse transcription-nested PCR. Int. J. Food Microbiol., 91, 147, 2004. 130. Svraka, S. et al. Etiological role of viruses in outbreaks of acute gastroenteritis in The Netherlands from 1994 through 2005. J. Clin. Microbiol., 45, 1389, 2007. 131. Tan, M. et al.. Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. J. Virol., 77, 12562, 2003. 132. Tan, M. and Jiang, X. Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol., 13, 285, 2005.
Noroviruses 133. Tan, M. and Jiang, X. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J. Virol., 79, 14017, 2005. 134. Thorven, M. et al. A homozygous nonsense mutation (428G-->A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J. Virol., 79, 15351, 2005. 135. Treanor, J. and Dolin, R. Noroviruses and other caliciviruses. In Mandell, G.L., Bennett, J.E. and Dolin, R. (eds.) Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 6th ed. p. 2195. Philadelphia: Churchill Livingstone, 2005. 136. Trujillo, A.A. et al. Use of TaqMan real-time reverse transcription-PCR for rapid detection, quantification, and typing of norovirus. J. Clin. Microbiol., 44, 1405, 2006. 137. Tsai, G.J. and Yu, S.C. Microbiological evaluation of bottled uncarbonated mineral water in Taiwan. Int. J. Food Microbiol., 37, 137, 1997. 138. Vasickova, P. et al. Viruses as a cause of foodborne diseases: a review of the literature. Veterinarni Medicina, 50, 89, 2005. 139. Vinjé, J. Personal Communication. 2008. 140. Vinje, J., Hamidjaja, R.A. and Sobsey, M.D. Development and application of a capsid VP1 (region D) based reverse transcription PCR assay for genotyping of genogroup I and II noroviruses. J. Virol. Methods, 116, 109, 2004.
89 141. Vinje, J. and Koopmans, M.P. Molecular detection and epidemiology of small round-structured viruses in outbreaks of gastroenteritis in the Netherlands. J. Infect. Dis., 174, 610, 1996. 142. Vinje, J. and Koopmans, M.P. Simultaneous detection and genotyping of “Norwalk-like viruses” by oligonucleotide array in a reverse line blot hybridization format. J. Clin. Microbiol., 38, 2595, 2000. 143. Vinje, J. et al. International collaborative study to compare reverse transcriptase PCR assays for detection and genotyping of noroviruses. J. Clin. Microbiol., 41, 1423, 2003. 144. Wang, J. et al.. Sequence diversity of small, round-structured viruses in the Norwalk virus group. J. Virol., 68, 5982, 1994. 145. Widdowson, M.A. et al. Detection of serum antibodies to bovine norovirus in veterinarians and the general population in the Netherlands. J. Med. Virol., 76, 119, 2005. 146. Widdowson, M.A. et al. Norovirus and foodborne disease, United States, 1991–2000. Emerg. Infect. Dis., 11, 95, 2005. 147. Wilkinson, F.H. and Kerr, K.G. Bottled water as a source of multi-resistant Stenotrophomonas and Pseudomonas species for neutropenic patients. Eur. J. Cancer Care (Engl. ), 7, 12, 1998. 148. Zheng, D.P. et al. Norovirus classification and proposed strain nomenclature. Virology, 346, 312, 2006.
7 Rotaviruses
Dongyou Liu, Larry A. Hanson, and Lesya M. Pinchuk Mississippi State University
Contents 7.1 Introduction......................................................................................................................................................................... 91 7.1.1 Classification and Biology....................................................................................................................................... 91 7.1.1.1 Rotaviruses................................................................................................................................................ 91 7.1.1.2 Structural and NSPs.................................................................................................................................. 91 7.1.1.3 Serogroups, Serotypes, and Genotypes..................................................................................................... 92 7.1.1.4 Biology...................................................................................................................................................... 92 7.1.2 Clinical Manifestation, Pathogenesis, and Epidemiology....................................................................................... 93 7.1.2.1 Clinical Manifestation............................................................................................................................... 93 7.1.2.2 Pathogenesis.............................................................................................................................................. 93 7.1.2.3 Epidemiology............................................................................................................................................ 94 7.1.3 Diagnosis.................................................................................................................................................................. 94 7.1.3.1 Phenotypic Techniques.............................................................................................................................. 94 7.1.3.2 Molecular Techniques............................................................................................................................... 95 7.2 Methods............................................................................................................................................................................... 95 7.2.1 Sample Preparation ................................................................................................................................................. 95 7.2.2 Detection Procedures............................................................................................................................................... 96 7.2.2.1 RT-PCR Detection of Rotavirus G and P Genotypes............................................................................... 96 7.2.2.2 Real-time RT-PCR Detection of Rotaviruses Groups A and C................................................................ 96 7.3 Conclusion........................................................................................................................................................................... 97 References.................................................................................................................................................................................... 98
7.1 Introduction 7.1.1 Classification and Biology 7.1.1.1 Rotaviruses The genus Rotavirus encompasses a group of nonenveloped, segmented, double-stranded (ds) RNA viruses in the family Reoviridae. Being spherical particles measuring about 72 nm in diameter with a smooth outer edge, the rotaviruses are so named because their icosahedral shell or capsid (with 32 capsomers) forms a rim round the nucleic acid core, giving a wheel-like appearance.1 The rotavirion capsid is composed of three concentric protein layers encasing a genome of 11 unique dsRNA segments (amounting to 16–21 kb in total), with each segment usually coding for a single structural or nonstructural protein (NSP) (with the exception of segments 9 and 11, which each code for two proteins). The inner (core) capsid protein layer encasing dsRNA comprises structural protein VP2 and small numbers of structural proteins VP1 and VP3. The middle capsid protein layer consists of structural protein VP6, which defines rotavirus serogroup (A–G) specificity and is the most immunogenic protein in rotavirus infection. The outer capsid layer is made up of structural protein VP7 (a glycoprotein) in which the protease-sensitive structural protein VP4 spikes are embedded. Accounting
for rotavirus serotype (neutralization)–specificity, the VP4 protein (encoded by segment 4) is P serotype antigen, while the VP7 protein (encoded by segment 7) is G serotype antigen.2,3 7.1.1.2 Structural and NSPs In total, six structural proteins (i.e., VP1, VP2, VP3, VP4, VP6, and VP7) and six NSPs (i.e., NSP1, NSP2, NSP3, NSP4, NSP5, and NSP6) are encoded by rotaviruses. Specifically, rotavirus VP1, VP2, VP3, VP4, VP6, and VP7 are encoded by their corresponding gene segments, NSP1, NSP2, NSP3, NSP4, NSP5, and NSP6 are encoded by segments 8, 7, 10, 11, and 11, respectively. In other words, NSP5, and NSP6 are encoded in overlapping reading frames of a single segment 11.2,4 Located in the inner capsid layer linked to the dsRNA core, VP1, VP2, and VP3 along with other NSPs play a key role in viral transcription. Specifically, being an RNA polymerase enzyme, VP1 is responsible for producing mRNA transcripts for the synthesis of viral proteins and for replicating the rotavirus genome RNA segments for new virus particles inside the infected host cells. VP2 binds the RNA genome; and VP3 is a guanylyl transferase that catalyses the formation of the 5′ cap in the post-transcriptional modification of mRNA. This 91
92
process stabilizes viral mRNA by protecting it from nucleases of the host cell. Situated in the middle capsid layer, VP6 forms the bulk of the capsid with a role in transcription. Being common to all rotaviruses, and highly antigenic, VP6 has been targeted for classification and serological identification of rotaviruses, helping separate them into serogroups A, B, C, D, E, F, and G. Protruding as a spike on the surface of the virion, VP4 binds to molecules on the surface of host receptor cells, and thus facilitates the viral entry into the cell. Prior to the virus turning infectious, VP4 needs to undergo modification (into VP5 and VP8) with the help of a protease enzyme found in the gut. Neutralizing antibodies to VP4 can be used to determine the P-type (P for protease-sensitive) and this protein helps determine the virulence of the virus. The outer layer of the virion is formed by VP7. This is a glycoprotein that is targeted by some neutralizing antibodies and is used to provide the antigenic G-type classification (G for glycoprotein) of the strain. Together with VP4, VP7 generates neutralizing, and protective antibodies against subsequent infections.3 NSP1 (encoded by segment 5), NSP2 (encoded by segment 8), and NSP3 (encoded by segment 7) are RNA-binding proteins that are required either for genome replication, shutdown of cellular protein synthesis, or translational regulation. NSP4 is a viral enterotoxin that increases the intracellular Ca2+ concentration and disturbs the cellular homeostasis of the host, a main factor contributing to malabsorption and diarrhea. NSP5 is (encoded by segment 11) accumulates in the viroplasm, and NSP6 (also encoded by segment 11) is a nucleic acid binding protein. 7.1.1.3 Serogroups, Serotypes, and Genotypes Rotaviruses in the genus Rotavirus can be divided into seven serogroups (A–G) in accordance with serological reactions between the structural protein VP6 (located in the middle capsid layer) and corresponding antisera. Further, rotaviruses are differentiated into 16 G-genotypes and at least 27 P genotypes based on assessment of the outer capsid layer structure proteins VP7 (which defines G-serotypes/genotypes as it is glycoprotein) and VP4 (which defines P-serotypes/genotypes as it is a protease sensitive protein) as well as their underlying genes.3 To designate a P-genotype, a number in square brackets is added after “P” (e.g., P[8]); and to indicate a P-serotype, a serotype number (without bracket) is attached to “P” followed by the genotype in brackets (e.g., P2A[6]). Because there are greater numbers of P-type genotypes than serotypes, P-type antigens are denoted with their genotype referenced in brackets (e.g., P[4], P[8]). G-serotypes are numbered similarly, and the G-genotype number is the same as the G-serotype. Thus, rotavirus G-serotypes are often referred to by their serotypes alone (e.g., G1, G2, G3, etc). Given that the VP4 and VP7 proteins are encoded by separate gene segments, new rotavirus P–G serotype antigen combinations may be generated through reassortment after dual (or mixed) infection of single cells. In human
Molecular Detection of Foodborne Pathogens
infections, rotavirus strains of G–P combinations G1P[8], G2P[4], G3P[8], G4P[8], G9P[6], and G9P[8] are routinely detected, although those bearing rare or unusual G- and/or P-genotypes (e.g., G5, G8, G10, G11, G12, P[11], P[14], and P[25]) have also been described.5 Due to the ubiquitous presence of rotaviruses in the animal kingdom, interspecies transmission and genetic reassortment events make the emergence of novel rotavirus strains from existing animal and human strains a common event.6 In another scheme of classification, the 11 segments of rotaviruses are separated by polyacrylamide gel electrophoresis (PAGE), and a characteristic visual pattern known as RNA electropherotype is generated for individual serogoups.7–9 For example, serogroup A rotaviruses displays a 4–2–3–2 segment migration pattern (indicating the number of rotavirus gene segments of similar sizes that migrate at similar speed on acrylamide gels); serogroup B rotaviruses show a 4–2–2–3 pattern and serogroup C rotaviruses have a 4–3–2–2 pattern.8 This information is valuable since detection of different electropherotypes during an outbreak may indicate the possible emergence of novel or recurring virus strains. Further, on the basis of the migration rate of segment 11 on acrylamide gels in relation to segment 10, long or short electropherotype of rotaviruses can be distinguished. That is, while the standardsized segment 11 of long-electropherotype strains moves faster than segment 10, the short-electropherotype phenotype with a partial duplication in segment 11 causes it to migrate more slowly than gene segment 10.4,10,11 Sequencing is being used more frequently in recent years with VP4, VP6, and VP7 initially used for genotyping. Later the enterotoxin gene NSP4 was added and most recent classification scheme is the use of sequence data from all 11 gene segments.9 Although all rotavirus serogroups (A–G) are infective to animals, only serogroups A–C are found in human infections. Indeed, the majority of human rotavirus isolates share a common group antigen A, which is further divided into at least seven serotypes, and is the single most important cause of severe acute gastroenteritis among infants and young children worldwide. Serogroups B–G rotaviruses are morphologically identical but serologically unrelated to serogroup A. Rotavirus B causes diarrhea in adults (thus called adult diarrhea rotavirus or ADRV) as well as in individuals of other age groups Rotavirus C is responsible for sporadic cases of diarrhea in children. Group D, F, and G mainly infect poultry and Group E may infect swine.8 7.1.1.4 Biology Rotaviruses are tolerant of a range of humidity and pH (3–9), and are unaffected by ether, chloroform, quaternary ammonium disinfectants, and sodium hypochlorite.8 However, they show a reduced infectivity at higher temperatures and are vulnerable to ethanol, phenol, formalin, 37% formaldehyde (1:10), 0.75% hexachlorophene (1:3), and 67% chloramine-T (1:5).8 Thus, rotaviruses are resistant to sanitary measures which are adequate for eliminating bacteria and parastes, and they are stable in the environment. It is no surprise
Rotaviruses
therefore that rotaviruses are able to remain infectious under the inclement and hostile conditions associated with mammalian gastrointestinal tract prior to entry into the epithelial cells of small intestinal villi and subsequent replication in the cytoplasm of these cells. Rotaviruses are capable of undergoing constant genetic changes via sequential point mutations, genetic reassortment, genomic rearrangement, or intragenic recombination.5,12–26 As rotaviruses possess 11 dsRNA segments encoding distinct structural and NSPs, different strains of human and/ or animal origins often exchange genetic materials through reassortment and evolve into new viral species, serotypes, and genotypes.27–33 This is demonstrated by the observations that the common genotype P[8] strains with serotype G1, G3, G4, or G9 VP7 genes have the same genome constellation (Wa genogroup), and except VP7, all other genes are able , to cross-hybridize with other genotype members. The generation of new P–G genotype combinations by the introduction of genes from novel serotypes represents another useful way to generate rotavirus diversity. Another major source of human rotavirus diversity involves the introduction of animal rotavirus genes either through transmission of whole viruses or through reassortment.34 Coinfections with two different or more rotavirus serotypes may also contribute to a great degree of strain diversity among rotaviruses.
7.1.2 Clinical Manifestation, Pathogenesis, and Epidemiology 7.1.2.1 Clinical Manifestation Rotavirus enters the host via fecal-oral route, and upon survival in the acidic environment of the host’s gastrointestinal tract, it infects the epithelial cells of small intestine villi and secretes an enterotoxin, which is responsible for gastroenteritis with diarrhea and sometimes dehydration-related death as a consequence.35 The clinical symptoms of rotavirus gastroenteritis often appear two days after infection, starting with vomiting followed by four to eight days of profuse, watery diarrhea accompanied with low grade fever, headache, malaise, nausea, or cramping. Although rotavirus gastroenteritis is considered as a self-limiting disease, without appropriate intervention, a combination of watery diarrhea, vomiting, and fever often can lead to rapid dehydration and ultimately death. While rotavirus infection in newborn children is often associated with mild or asymptomatic disease, it causes the most severe symptoms in children six months to two years of age, the elderly, and those with suppressed immune functions. Most adults are not susceptible to rotavirus infection due to immunity acquired in childhood, and gastroenteritis in adults may be attributable to nonrotavirus infection. However symptomatic reinfections may occur with a different rotavirus A serotype. Upon resolution of gastroenteritis symptoms, rotavirus antigen may be shed in the stools for approximately one week but for many months in immunocompromised individuals. In fact, the number of infectious rotavirus particles in the stool of an infected person can be higher than
93
10 trillion per gram; and only ten to 100 of these particles are sufficient to transmit infection to another person. 7.1.2.2 Pathogenesis Principally transmitted by the fecal-oral route via contact with contaminated hands, surfaces, objects, food, and water and possibly by the respiratory route, rotavirus relies on its triple capsid layers of proteins to avoid elimination by the acidic pH of the stomach and the proteolytic enzymes in the gut. At the same time, cleavage, and removal of its outer capsid layer by intestinal proteases such as chymotrypsin facilitates its efficient colonization and enhances its infectivity.3 The virus first enters the epithelial cells of the villi in the duodenum by receptormediated endocytosis and forms an endosome. Sialic acid or galactose-based receptors as well as coreceptors like integrins may be involved in endocytosis.3 In addition, the virus may also gain entry into the absorptive enterocytes by direct penetration.3 Then, through the coordinated action of the outer capsid layer proteins (VP7 and the VP4 spike), the virus disrupts the membrane of the endosome, resulting in intracellular calcium imbalance, breakdown of VP7 trimers into single protein subunits and formation of a double-layered particle (DLP) by the remaining capsid layer proteins VP2 and VP6 covering viral dsRNA in the core. In doing so, the viral RNA in the core avoid triggering innate host immune responses called RNA interference. Once outside the endosome, the virus multiplies in the epithelial cells of the small intestinal villi and causes structural and functional changes.1 The viral RNA-dependent RNA polymerase generates mRNA transcripts of the double stranded viral genome, and assembles into DLPs in viroplasm (made by NSP5 and NSP2) around the cell nucleus where most of the rotavirus proteins accumulate. After migrating to the endoplasmic reticulum, DLPs acquire their outer capsid layer (formed by VP7 and VP4) and become infectious viruses which are released from the cell upon lysis.37 As one of the two main types of enterocytes lining the small intestine (the other being crypt cells) villus enterocytes are mature, nonproliferating cells covering the villi with either digestive or absorptive functions. The absorptive enterocytes express disaccharidases, peptidases, and other enzymes on the apical surface to carry out their digestive functions. This is achieved by both passive diffusion of solutes along electrochemical or osmotic gradients and active transport, which employs sodium-glucose cotransporter 1 (SGLT1) to transport water along with solute in addition to passive transportation along osmotic gradients. The crypt cells covering the crypts are the progenitors of the villus enterocytes. Without the well-defined microvilli and absorptive functions, crypt cells secrete Cl− ions into the intestinal lumen. Thus, the absorptive villi and secretive crypts maintain a constant bidirectional flux of electrolytes and water across the epithelium. When rotavirus begins to replicate in the nondividing mature enterocytes near the tips of the villi, it secretes a viral enterotoxin, NSP4, which alters calcium-dependent cell permeability, elevates the chloride secretion and causes cell lysis.1,3,37 The viral NSP4 is then released to extracellular area
94
where it binds to adjacent cells. Thus, together with enterocyte destruction, rotavirus infection decreases absorption of Na+, water, and mucosal disaccharidases, and this malabsorption causes undigested mono- and disaccharides, carbohydrates, fats, and proteins to remain in the colon, which are discharged with unabsorbed water. Thus, a decrease in the absorptive functions of villus enterocytes, an increase in the secretive functions of crypt enterocytes and subsequent destruction of villus entorocytes contribute to malabsorption, leading to diarrhea. In the later stages of rotavirus infection, enterocytes in the villi regenerate and the patient regain normal body weight within ten to 28 days after infection. Thus, rotavirus infection is considered a self-limiting disease as long as the dehydration is not severe as to causing death of young ones.8 It has been shown that the CD8+ cytotoxic T lymphocytes (CTL) as well as CD4+ helper T cells (TH) are instrumental in helping clear the rotavirus infection.37,38 7.1.2.3 Epidemiology Group A rotavirus is a ubiquitous pathogen that accounts for >90% of rotavirus gastroenteritis in humans, resulting in millions of cases of diarrhea, almost 2 million in hospitalization and an estimated 611,000 in death.39–63 It is the leading single cause of severe diarrhea among infants and children (from six months to five years old), with boys being twice as likely to be admitted to hospital as girls. However, group A rotavirus is not considered to cause any significant degree of disease in adults. By contrast nongroup A rotaviruses (i.e., B and C) are much less common and only cause sporadic family and community outbreaks of gastroenteritis in all age groups.64 Primary infections with group A rotavirus peak between nine and 23 months of age, with infants of six to 23 months of age having the greatest risk for being hospitalized. By five years of age, most children have exposure to the virus with or without symptoms, as evidenced by the presence of specific serum antibodies against the pathogen.65 Although adults with exposure to the virus are frequently asymptomatic, they may still shed the viral particles in their stools, which can be transmitted to children. The elderly and individuals with compromised immune functions are at significant risk of developing severe diarrhea and showing extended period of viral dissemination, for whom medical intervention is often required. Other factors that may affect the severity of rotavirus infections in humans include host variations, geographic/seasonal differences, and emergence of new virus strains, etc. For example, malnutrition in humans often increases the severity of rotavirus diarrhea, delays small intestinal recovery, and modifies intestinal inflammatory responses. Rotavirus infections occur primarily in the winter in temperate areas, but they occur throughout the year in the tropics; due possibly to the seasonal changes in temperature and humidity. The close contact between humans and domestic animals promotes the emergence of novel virus strains and varieties, as rotaviruses have the capacity to exchange genetic materials via reassortment, leading to novel viral identities that are more potent and are unrecognized by host immune network. Additionally, the increased consumption of ready-to-eat or raw food products
Molecular Detection of Foodborne Pathogens
(e.g., seafood and vegetables) also facilitates transmission of animal rotaviruses to humans, as group A rotaviruses are shed in large numbers in stools (>1012 particles/g feces), which may pollute waters used for farming and bivalve shellfish culture.66,67
7.1.3 Diagnosis 7.1.3.1 Phenotypic Techniques Rotaviruses are capable of growing in cell culture in primary calf kidney cells as well as in established cell lines such as MA104, MDBK or PK-15, which facilitate their identification and characterization. Other phenotypic procedures include electron microscopy, PAGE-based electropherotyping, enzyme linked immunosorbent assay (ELISA), dot-immunoblotting, immuno-fluorescence test, immunoperoxidase test, passive hemagglutination assay (HA), latex agglutination test, and dot blot hybridization, etc.68 Rotavirus serogroups A–G are determined by serological assays with antibodies raised against structural protein VP6 located in the middle capsid layer; and rotavirus group A serotypes are similarly assessed by using antibodies to structural proteins from outer capsid layers (i.e., a glycoprotein VP7 defining G serotypes/genotypes and a protease sensitive protein VP4 defining P serotypes/genotypes). As a consequence, four common serotypes (designated as serotypes G1–G4), corresponding to antigenic determinants located on the VP7 protein, have been identified in rotavirus group A. These four serotypes (G1–G4) represent at least 90% of rotavirus group A strains circulating globally. Other 12 human rotavirus G serotypes (e.g., G8, G9, and G12) are considered rare. Given that about 30% of rotavirus-positive stool specimens have nontypeable (NT) strains, which cannot be typed with existing monoclonal antibodies, use of culture and other techniques (e.g., molecular analysis) is essential to characterize these NT strains. Laboratory diagnosis of human rotavirus infections is possible by enzyme immunoassay for detection of antibodies against rotavirus VP6 group A-specific antigen in diarrheal stools. Another approach is to employ anti-VP6specific antibodies immobilized onto latex (reverse passive latex agglutination test), nitrocellulose, or nylon (rapid chromatographic assays) for the immunological capture of rotavirus VP6 antigen in feces, and subsequent detection with a second labeled, types-specific anti-VP6 antibody, and chromatographic assays, or by visible agglutination of latex particles. On the whole, rotavirus-specific immunoglobulin (Ig) A or IgG antibodies are more readily detected than rotavirus antigen in fecal specimens. Thus, the antigen detection techniques often result in an underestimation of rotavirus disease and asymptomatic infection. Nonetheless, immunological assays such as ELISA are dependent on the presence of significant amounts of intact rotavirus proteins in stool samples for consistent detection. Due to the frequent digestion or degradation of these proteins by endogenous and exogenous proteolytic enzymes, together with the possibility of the rotavirus
Rotaviruses
strains bearing point mutation particles, application of typespecific monoclonal antibodies in immunological assays for rotaviruses in stool may not always give reliable account on the true status of human rotavirus gastroenteritis.69 7.1.3.2 Molecular Techniques Molecular procedures including reverse-transcription PCR (RT-PCR), nested/multiplex RT-PCR, restriction fragment length polymorphism (RFLP) and real-time reversetranscription PCR provide a much specific, sensitive, and rapid approach for detection and genotyping of rotaviruses.70–77 Other molecular methods such as nucleotide sequencing and oligonucleotide microarray hybridization offer the opportunity to discriminate mixed rotavirus infections.78–80 PCR assays have been applied since the early 1990s for the detection and identification of human and animal rotavirus VP4 and VP7.81,82 Apart from showing the predominance of only four common rotavirus G serotypes (G1–G4) among children, these techniques facilitated the identification of at least 43 distinct P–G type combinations among the ten human rotavirus G serotypes and 11 rotavirus HRV P serotypes and subtypes. Use of a multiplexed, seminested RT-PCR method permitted the detection of both the common G serotypes (G1–G4) and the rare serotypes (e.g., G5, G8, and G9), and the genotyping of common P types (P[4] and P[8]) and rare P types (P[6], P[9], and P[10]). Given that large numbers of rotaviruses are shed in stools (>1012 particles/g feces), and discharged in sewage, it is no surprise that rotavirus is one of the common viruses present in waters and shellfish. Although food- or waterborne outbreaks of rotavirus gastroenteritis are infrequent, the presence of rotaviruses in water, vegetables, and seafood imply a health risk to humans.83 Due to the fact that a relative low density of rotavirus is found in water and shellfish specimens, various sample processing procedures are needed to concentrate the virus and to remove of natural inhibitors to DNA polymerase.83 Direct alkaline elution84 and acid adsorption– neutral elution85 are examples of the common and efficient methods used to concentrate viruses from whole shellfish. Using the acid adsorption–alkaline elution and reconcentration using speedVac centrifugation together with an expanded rotavirus microarray assay of Chizhikov et al.78 Honma et al.86 identified from (i) five clinically relevant human rotavirus VP4 genotypes (P[4], P[6], P[8], P[9], and P[14]) and (ii) five additional human rotavirus VP7 genotypes (G5, G6, G8, G10, and G12) on one chip. Use of a microtiter plate hybridization-based ELISA coupled with PCR (PCRELISA) also facilitated the identification of clinically relevant G (G1–G6, G8–G10, G12) and P (P[4], P[6], P[8], P[9], and P[14]) genotypes of group A rotavirus.
7.2 Methods 7.2.1 Sample Preparation Oysters. Oyster samples often contain low levels of rotaviruses, which need to be concentrated before RT-PCR
95
detection. A useful technique to prepare oyster samples is the acid adsorption-alkaline elution method.83,85 Briefly, oyster samples are transported to the laboratory in chilled containers. On arrival, the oysters are washed, scrubbed, and the shells opened with a sterile shucking knife. The liquor or mantle fluid is drained into a discard container. The oyster meat, except the adductor muscle that was left attached to the shell, is collected, cut into small pieces, and trimmed to 25 g for analysis of rotavirus. Seven volumes of chilled, sterilized distilled water are added to 25 g of oyster flesh and homogenized at high speed twice using a blender (Hamilton Beach, Southern Pines, NC). The conductivity of the homogenate is reduced to less than 2000 μS/cm by adding sterilized distilled water. The homogenate of oyster is adjusted to pH 4.8 with 1 N HCl, shaken for 15 min, and centrifuged at 2000 × g for 20 min at 4°C. The supernatant is discarded and the pellet is suspended in 25 ml of 2.9% tryptose phosphate broth (TPB) containing 6% glycine, pH 9.0 for elution of the virus, shaken for 15 min, and centrifuged at 10,000 × g for 15 min at 4°C. The supernatant (S1) is collected and the pellet is reeluted with 25 ml of 0.5 M arginine–0.15 M NaCl, pH 7.5. The suspension is shaken for 15 min and centrifuged. The supernatant (S2) is collected, combined with S1 and adjusted to pH 7.2 with 1 N HCl. The virus in the supernatant is precipitated by adding 12.5% PEG 8000 and 0.3 M NaCl. The mixture is refrigerated overnight at 4°C. The pellet is dissolved in 15 ml of 0.05 M phosphate-buffered saline (PBS), pH 7.5 and precipitated again with PEG–NaCl. The mixture is stirred for 2 h at 4°C and then centrifuged at 10,000 × g for 10 min. The pellet is dissolved in 5 ml of PBS. The virus is extracted with chloroform at a final concentration of 30%. After centrifugation at 3000 × g for 10 min, the top layer of the aqueous phase is collected (S3). The pellet at the interface between the solvent and the aqueous phase is re-extracted with 0.5 volume of arginine–NaCl, pH 7.5. After centrifugation, the top layer (S4) is collected and combined with S3. The sample is reconcentrated using speedVac centrifugation to reduce the volume of the concentrate to approximate 1 ml and stored at −80°C until nucleic acid extraction. Viral RNA from oyster samples is then extracted using RNeasy® mini kit (Qiagen AG, Basel, Switzerland). In brief, 200 μl of the concentrated oysters is lysed and RNA is purified on the silica-based column according to the manufacturer’s protocol. RNA bound to the membrane in the column is eluted in 60 μl of warm RNase-free water.87 Another method for preparation of oyster samples is by direct alkaline elution.84 Briefly, seven volumes of chilled, sterilized, distilled water are added to the oyster flesh and homogenized using a blender (Hamilton Beach, Southern Pines, NC). The virus is eluted from oyster tissues with 10% TPB containing 0.05 M glycine, pH 9.0 and re-eluted with 0.5 M arginine–0.15 M sodium chloride (NaCl), pH 7.5. The pooled eluates are precipitated twice by adding polyethylene glycol (PEG 8000) and NaCl to a final concentration of 12.5% PEG–0.3 M NaCl. After dissolving the pellet, the virus is extracted with chloroform to a final concentration of 30% and re-extracted with 0.5 volume of arginine–NaCl, pH 7.5.
96
Molecular Detection of Foodborne Pathogens
The aqueous phase is collected and kept at −80°C prior to RNA extraction. Stool. The viral ds RNA is extracted from stools or infected cell culture lysates using the TRIzol method (Invitrogen, Carlsbad, CA). Alternatively, total nucleic acids can be extracted from stool samples using a single protocol.74 Briefly, fecal specimens are prepared as 10% suspensions with STAR buffer (stool transport and recovery buffer; Roche Diagnostics). Chloroform aliquots of 0.1× volume are added, and following mixing, the samples are centrifuged at 8000 × g for 10 min. The aqueous layer (stool extract) is removed to a fresh tube and stored at −80°C, or the extraction is completed before freezing. Stool extracts of 200 μl are further purified with the Qiagen QIAamp DNA Total, and nucleic acids are eluted from the spin columns using 50 μl of nuclease-free water. Extracted nucleic acids are stored at −80°C.74
7.2.2 Detection Procedures 7.2.2.1 RT-PCR Detection of Rotavirus G and P Genotypes Santos et al.88 described a RT-PCR for detection of group A rotavirus G and P genotypes. The viral dsRNA is extracted from stools or infected cell culture lysates using the TRIzol method and subjected to reverse transcription followed by RT-PCR. The cDNA of the rotavirus VP7 or VP4 gene is synthesized by RT-PCR using primers that are biotin labeled at their 5′ ends. Four different VP7 gene-specific primer pairs are selected to increase the efficiency of VP7 gene amplification (Table 7.1). Initially, the Beg9–End9 primer pair, which amplifies the entire VP7 segment of most of rotavirus strains, is used. When the VP7 gene is not amplified with this primer pair, one of the following three primer pairs is used: sBeg9– RVG9, 9Con2–G922, or LID1–G922. The sBeg9–RVG9 primer pair is used as the first choice because it provides the best amplification. For VP4 gene amplification, two different primer pairs are selected (Table 7.2). The first primer pair used is Con3–Con2. For those strains for which the VP4 gene is negative with this primer pair, the primer pair F4–C8 is used for amplification (Table 7.2).
Table 7.2 VP4 Primers for RT-PCR Detection of Rotavirus P Genotypes Primer
Sequence
Positions
Con3
5′-TGGCTTCGCTCATTTATAGACA-3′
Con2
5′-ATTTCGGACCATTTATAACC-3′
11–32
F4
5′-TATAAAATGGCTTCIYTVAT-3′
4–23
C8
5′-ATTGGIGTYTGATAITCRTC-3′
1446–1467
868–887
Procedure: (1) Prepare RT-PCR mixture (50 µl) containing 1 × reaction mix (a buffer containing 0.2 mM of each deoxynucleoside triphosphate (dNTP), 2 mM MgSO4), SuperScript™ III RT/Platinum® Taq Mix (Invitrogen, Life Technologies, Carlsbad, CA), 0.25 µM each primer pair, distilled water to 48 µl and 2 µl extracted RNA. (2) Subject the genomic RNAs to one cycle of reverse transcription (25°C at 5 min followed by 42°C at 45 min). (3) Perform PCR amplification for 30 cycles of 94°C for 30 sec, 40°C for 1 min and 72°C for 1.5 min; and a cycle of 72°C for 5 min. (4) Analyze the PCR products by agarose gel electrophoresis and visualize by staining with ethidium bromide. Note: application of the VP7 and VP4 primers in RT-PCR permits detection of rotavirus G and P genotypes. To further distinguish among rotavirus G–P combinations, specific probes can be then utilized in a PCR-ELISA system.88 7.2.2.2 Real-time RT-PCR Detection of Rotaviruses Groups A and C Logan et al.89 described a real-time RT-PCR for detection of rotavirus A, and rotavirus C from stool specimens, with primers and probes targeting rotavirus group A structural protein VP6 gene and rotavirus group C structural protein VP7 gene (Table 7.3). Procedure:
Table 7.1 VP7 Primers for RT-PCR Detection of Rotavirus G Genotypes Primer Sequence Positions Beg9 1–28 5′-GGCTTTAAAAGAGAGAATTTCCGTCTGG-3′ End9 1036–1062 5′-GGTCACATCATACAATTCTAATCTAAG-3′ sBeg9
5′-GGCTTTAAAAGAGAGAATTTC-3′
1–21
RVG9
1044–1062
5′-GGTCACATCATACAATTCTAATCTAAG-3′
LID1
5′-ATGTATGGTATTGAATATACCA-3′
48–70
9Con1
5′-TAGCTCCTTTTAATGTATGG-3′
37–56
G922
5′-GTRTARAAIACTTGCCACCA-3′
922–941
(1) Prepare reverse transcription mixture (40 μl) containing 1 × RT buffer, 5.5 mM MgCl2, 0.5 mM each dNTP, 2.5 μM random hexamer, 0.4 U/μl RNase inhibitor, 1.25 U/μl Multiscribe reverse transcriptase (TaqMan reverse transcription kit, Applied Biosystems), and 17.5 μl of extracted nucleic acids. (2) Immediately before testing, remove extracted nucleic acids (prepared by Qiagen QIAamp DNA kit, see above) from −80°C storage and add to 200μl thin-walled PCR tubes containing the RT buffer, dNTPs, and MgCl2.
97
Rotaviruses
Table 7.3 Primers and Probes for Real-Time RT-PCR Detection of Rotavirus Groups A and C Target gene
Primer or probe
Concentration (μM)
Position
Rotavirus A (VP6)
RotaA-fwd1
5′-GGATGTCCTGTACTCCTTGTCAAAA-3′
0.60
26–50
RotaA-fwd2
5′-GGAGGTTCTGTACTCATTGTCAAAAA-3′
0.60
26–51
RotaA.rev1
5′-TCCAGTTTGGAACTCATTTCCA-3′
0.60
170–149
RotaA.rev2
5′-TCCAGTTTGAAAGTCATTTCCATT-3′
0.60
170–147
5′-(VIC)-ATAATGTGCCTTCGACAAT-3′
0.25
93–75 93–72
RotaA.probe1 RotaA.probe2 Rotavirus C (VP7)
Sequence
5′-(VIC)-AATATAATGTACCTTCAACAAT-3′
0.25
RotaC.fwd
5′-TTAGATACTACAAGTAATGGAATCGGATGT-3′
0.60
655–684
RotaC.rev
5′-TGGGTGTCATTTGATACAACTTCA-3′
0.60
731–708
RotaC.probe
5′-(FAM)-CAGCTAGTACAGAAACTT-3′
0.20
689–706
(3) Denature the reaction components by heating at 95°C for 5 min on a GeneAmp 9700 thermocycler (Applied Biosystems) and then snap-chill on ice for 5 min. Add random hexamer, RNase inhibitor, and Multiscribe reverse transcriptase to the reaction tube. (4) Conduct reverse transcription on a GeneAmp 9700 thermocycler as follows: one cycle of 25°C for 10 min; one cycle of 42°C for 30 min; one cycle of 48°C for 20 min; and one cycle of 95°C for 5 min. Store the completed RT products at −20°C until use. (5) Prepare real-time PCR mixture (25-μl) containing 1 × TaqMan Universal Mastermix (containing AmpErase uracil-N-glycosylase, with dTTP partially replaced by dUTP), the appropriate forward and reverse primer(s) and MGBNFQ probe(s) at concentrations as detailed in Table 7.3 and 2 μl of template RT products. (6) Perform real-time PCR on an ABI 7000 sequence detector (Applied Biosystems) using universal thermal cycling conditions: one cycle of 50°C for 2 min (dUTP glycosylase step); one cycle of 95°C for 10 min; and 40 cycles of 95°C for 15 sec, 60°C for 1 min. Use sequence detection software version 1.2 for all data analysis. Note: rotaviruses serogroups A, B, and C are known to cause gastrointestinal infections in humans. Group A rotaviruses are predominant and result in severe diarrheal diseases in infants and young children. Group B rotaviruses cause adult diarrhea and are reportedly geographically confined, having been first identified in a large waterborne epidemic in China. Group C rotaviruses, an emerging cause of gastroenteritis in children over two years old and in adults, have now been identified as causative agents of gastroenteritis in both sporadic cases and outbreaks worldwide. Use of this real-time RT-PCR permits simultaneous detection of rotaviruses serogroups A and C in stool specimens.89
7.3 Conclusion Rotaviruses are dsRNA viruses that are separated into seven groups (A–G) based on serological reactions bet ween the structural protein VP6 (located in the middle capsid layer) and corresponding antisera. While serogroups A–G are infective to animals, only serogroups A, B, and C are known to cause gastrointestinal infections in humans. Group A rotaviruses are predominant and result in severe diarrheal diseases in infants and young children. Group A rotaviruses can be classified into at least 27 P genotypes on the basis of their VP4 protein and 16 G genotypes on the basis of their VP7 protein. Group B rotaviruses cause adult diarrhea and are reportedly geographically confined. Group C rotaviruses, an emerging cause of gastroenteritis in children over two years old and in adults, have now been identified as causative agents of gastroenteritis in both sporadic cases and outbreaks worldwide. Due to their distinct genetic structures (with 11 gene segments) and their ability to undergo genetic changes via sequential point mutations, genetic reassortment, genomic rearrangement, or intragenic recombination, new rotaviruses may emerge constantly. This has necessitated the development and application of rapid and accurate laboratory assays for detection and typing of rotaviruses. While immunological assays such as ELISA have proven valuable for the diagnosis of rotavirus infections, these phenotypic procedures suffer from poor sensitivity and inability to detect rotaviruses secreting mutated target proteins. Application of molecular procedures such as PCR and microarray has made rapid, sensitive, and precise detection and typing of rotaviruses feasible. Indeed, these new generation techniques facilitate the characterization of rotavirus strains not commonly found in humans and animals. Considering the existence of large number of genotypes within group A rotavirus, use of standard RT-PCR is cumbersome as multiple individual reaction tubes may have to be set up for determining genotypes that are very close to other similar genotypes. By combining RT-PCR with microarray or ELISA, it is possible to type all rotavirus G and P genotypes in an efficient manner. Further adoption of these RT-PCR
98
assays into real-time platforms will enhance laboratory detection and identification of disease-causing rotaviruses.
References
1. Estes, M.K. and Kapikian, A.Z. Rotaviruses. In: Fields Virology, 5th edn., vol 2. pp. 1917–1974. Knipe, D.M. et al. (eds.). Lippincott Williams & Wilkins, Philadelphia, PA, 2007. 2. Desselberger, U. Rotavirus: basic facts. In: Rotaviruses Methods and Protocols, pp. 1–8. Gray, J. and Desselberger, U. (eds.). Humana Press, 2000. 3. Desselberger, U., Gray, J. and Estes, M.K. Rotaviruses. In: Topley and Wilson’s Microbiology and Microbial Infections, pp. 946–958. Mahy, B.W.J. and Meulen, V.T. (eds.). ASM Press, USA, 2005. 4. Mohan, K.V. and Atreya, C.D. Nucleotide sequence analysis of rotavirus gene 11 from two tissue culture-adapted ATCC strains, RRV and Wa. Virus Genes, 23, 321, 2001. 5. Griffin, D.D. et al., Surveillance of rotavirus strains in the United States: identification of unusual strains. J. Clin. Microbiol., 38, 2784, 2000. 6. Gentsch, J.R. et al. Serotype diversity and reassortment between human and animal rotavirus strains: implication for rotavirus vaccine programs. J. Infect. Dis., 192, S146, 2005. 7. Maunula, L. and von Bonsdorff, C.H. Short sequences define genetic lineages: phylogenetic analysis of group A rotaviruses based on partial sequences of genome segments 4 and 9. J. Gen. Virol., 79, 321, 1998. 8. Steele, A.D., Geyer, A. and Gerdes, G.H. Rotavirus infections. In: Infectious Diseases of Livestock, pp. 1256–1264. Coetzer, J.A.W. and Tustin, R.C. (eds.). Oxford University Press, Southern Africa, 2004. 9. Matthijnssens, M. et al. Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch. Virol., 153, 1621, 2008. 10. Kobayashi, N. et al. Unusual human rotavirus strains having subgroup I specificity and “long” RNA electropherotype. Arch. Virol., 109, 11, 1989. 11. Matsui S.M. et al. Sequence analysis of gene 11 equivalents from “short” and “super short” strains of rotavirus. J. Virol., 64, 120, 1990. 12. Adah, M.I. et al. Nigerian rotavirus serotype G8 could not be typed by PCR due to nucleotide mutation at the 3′ end of the primer binding site. Arch. Virol., 142, 1881, 1997. 13. Gouvea, V. and Brantly, M. Is rotavirus a population of reassortants? Trends Microbiol., 3, 159, 1995. 14. Desselberger, U. Genome rearrangements of rotavirus. Adv. Virus Res., 49, 69, 1996. 15. Alfieri, A.A. et al. Characterization of human rotavirus genotype P[8]G5 from Brazil by probe-hybridization and sequence. Arch. Virol., 141, 2353, 1996. 16. Suzuki, Y., Gojobori, T. and Nakagomi, O. Intragenic recombination in rotaviruses. FEBS Lett., 427, 183, 1998. 17. Diwarkarla, C. and Palombo, E. Genetic and antigenic variation of capsid protein VP7 of serotype G1 human rotavirus isolates. J. Gen. Virol., 80, 341, 1999. 18. Unicomb, L.E. et al. Evidence of high-frequency genomic reassortment group A rotavirus strains in Bangladesh: emergence of type G9 in 1995. J. Clin. Microbiol., 37, 1885, 1999. 19. Griffin, D.D. et al. Characterization of nontypeable rotavirus strains from the United States: identification of a new rotavirus reassortant (P2A[6], G12) and rare P3[9] strains related to bovine rotaviruses. Virology, 294, 256, 2002.
Molecular Detection of Foodborne Pathogens 20. Iturriza-Gómara, M. et al. Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J. Virol., 75, 3696, 2001. 21. Iturriza-Gómara, M., Kang, G. and Gray, J. Rotavirus genotyping: keeping up with an evolution population of human rotaviruses. J. Clin. Virol., 31, 259, 2004. 22. Arista, S. et al., G2 rotavirus infections in an infantile population of the South of Italy: variability of viral strains over time. J. Med. Virol., 77, 587, 2005. 23. Awachat, P.S. and Kellar, S.D. Unexpected detection of simian SA-11-human reassortant strains of rotavirus G3P[8] genotype from diarrhea epidemic among tribal children of Western India. J. Med. Virol., 77, 128, 2005. 24. Rahman, M. et al. Typing of human rotaviruses: nucleotide mismatches between the VP7 gene and primer are associated with genotyping failure. Virol. J., 2, 24, 2005. 25. Parra, G.I. and Espinola, E.E. Nucleotide mismatches between the VP7 gene and the primer are associated with genotyping failure of a specific lineage from G1 rotavirus strains. Virol. J., 3, 35, 2006. 26. Chan-it, W. et al. Multiple combinations of P[13]-like genotype with G3, G4, and G5 in porcine rotaviruses. J. Clin. Microbiol., 46, 1169, 2008. 27. Isegawa, Y. et al. Determination of bovine rotavirus G and P serotypes by polymerase chain reaction. Mol. Cell. Probes, 7, 277, 1993. 28. Gouvea, V., Santos, N. and Timenetsky, M.C. VP4 typing of bovine and porcine group A rotaviruses by polymerase chain reaction. J. Clin. Microbiol., 32, 1333, 1994. 29. Gouvea, V. et al., Identification of two lineages (Wa-like and F45-like) within the major rotavirus genotype P[8]. Virus Res., 59, 141, 1999. 30. Gosh, S. et al. Molecular characterization of a porcine group A rotavirus strain with G12 genotype specificity. Arch. Virol., 151, 1329, 2006. 31. Gulati, B.R. et al. Diversity in Indian equine rotaviruses: identification of genotype G10, P6[1] and G1 strains and a new VP7 genotype (G16) strain in diarrheic foals in India. J. Clin. Microbiol., 45, 972, 2007. 32. Martella, V. et al. Identification of a novel VP4 genotype carried by a serotype G5 porcine rotavirus strain. Virology, 346, 301, 2006. 33. Martella, V. et al. Identification of group A porcine rotavirus strains bearing a novel VP4 (P) genotype in Italian swine herds. J. Clin. Microbiol., 45, 577, 2007. 34. Mascarenhas, J.D. et al. Detection of a neonatal human rotavirus strain with VP4 and NSP4 genes of porcine origin. J. Med. Microbiol., 56, 524, 2007. 35. Parashar, U.D. et al. Rotavirus and severe childhood diarrhea. Emerg. Infect. Dis., 12, 304, 2006. 36. Chauhan, R.S., Dhama, K. and Mahendran, M. Pathobiology of rotaviral diarrhea in calves and its diagnosis and control: a review. J. Immunol. Immunopathol., 10, 1, 2008. 37. Ramig, R.F. Pathogenesis of intestinal and systemic rotavirus infection. J. Virol., 78, 10213, 2004. 38. Hoshino, Y. and Kapikian, A.Z. Rotavirus serotypes: classification and importance in rotavirus epidemiology, immunity and vaccine development. J. Health Popul. Nutr., 18, 5, 2000. 39. Guanasena, S. et al. Relative frequency of VP4 gene alleles among human rotaviruses recovered over a 10-year period (1982–1991) from Japanese children with diarrhea. J. Clin. Microbiol., 31, 2195, 1993.
Rotaviruses 40. Das, B. K. et al. Characterization of rotavirus strains from newborns in New Delhi, India. J. Clin. Microbiol., 32, 1820, 1994. 41. Cunliffe, N.A. et al. Rotavirus G and P-types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6] G8 strains. J. Med. Virol., 57, 308, 1999. 42. Cunliffe, N.A. et al. Rotavirus strain diversity in Balantyre, Malawi, from 1997 to 1999. J. Clin. Microbiol., 39, 839, 2001. 43. Iturriza-Gómara, M. et al. Molecular epidemiology of human group A rotavirus infections in the UK between 1995 and 1998. J. Clin. Microbiol., 38, 4094, 2000. 44. Ramachandran, M. et al. Molecular characterization of serotype G9 rotavirus strains from a global collection. Virology, 278, 436, 2000. 45. Banyai, K. et al. Detection of human rotavirus serotype G6 in Hungary. Epidemiol. Infect., 130, 107, 2003. 46. Banyai, K. et al. Eight-year survey of human rotavirus strains demonstrates circulation of unusual G and P types in Hungary. J. Clin. Microbiol., 42, 393, 2004. 47. Kirkwood, C. et al. Genetic and antigenic characterization of rotavirus serotype G9 strains isolated in Australia between 1997 and 2001. J. Clin. Microbiol., 41, 3649, 2003. 48. Laird, A.R. et al. Characterization of serotype G9 rotavirus strains isolated in the United States and India from 1993 to 2001. J. Clin. Microbiol., 41, 3100, 2003. 49. Martella, V. et al. Detection of emerging rotavirus G9 serotype at high frequency in Italy. J. Clin. Microbiol., 41, 3960, 2003. 50. Martella, V. et al. Nucleotide variation in the VP7 gene affects PCR genotyping of G9 rotaviruses identified in Italy. J. Med. Virol., 72, 143, 2004. 51. Page, N.A. and Steele, A.D. Antigenic and genetic characterization of serotype G2 human rotavirus strains from South Africa from 1984 to 1998. J. Med. Virol., 72, 320, 2004. 52. Nielsen, N.M. et al. Characterization of rotavirus strains among hospitalized and non-hospitalized children in GuineaBissau, 2002. A high frequency of mixed infections with serotype G8. J. Clin. Virol., 34, 13, 2005. 53. Khamrin, P. et al. Emergence of human G9 rotavirus with an exceptionally high frequency in children admitted to hospital with diarrhea in Chiang Mai, Thailand. J. Med. Virol., 78, 273, 2006. 54. Castello, A.A. et al. Molecular epidemiology of group A rotavirus diarrhea among children in Buenos Aires, Argentina, from 1999 to 2003 and emergence of the infrequent genotype G12. J. Clin. Microbiol., 44, 2046, 2006. 55. Pietruchinski, E. et al. Rotavirus diarrhea in children and adults in a southern city of Brazil in 2003: distribution of G/P types and finding of a rare G12 strain. J. Med. Virol., 78, 1241, 2006. 56. Samajdar, S. et al. Changing pattern of human group A rotaviruses: emergence of G12 as an important pathogen among children in eastern India. J. Clin. Virol., 36, 183, 2006. 57. Uchida, R. et al. Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain. J. Clin. Microbiol., 44, 3499, 2006. 58. Volotão, E.M. et al. Rotavirus surveillance in the city of Rio De Janeiro-Brazil during 2000–2004: detection of unusual strains with G8P[4] or G10P[9] specificities. J. Med. Virol., 78, 263, 2006.
99 59. Duan, Z.-J. et al. A novel human rotavirus of G5P[6] genotype identified from a Chinese girl with diarrhea. J. Clin. Microbiol., 45, 1614, 2007. 60. Fischer, T.K. et al. Characterization of rotavirus strains in a Danish population: high frequency of mixed infections and diversity within the VP4 gene of P[8] strains. J. Clin. Microbiol., 43, 1099, 2005. 61. Fischer, T.K. et al. Hospitalization and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993–2003. J. Infect. Dis., 195, 1117, 2007. 62. Rahman, M. et al. Evolutionary history and global spread of the emerging G12 human rotaviruses. J. Virol., 81, 2382, 2007. 63. Steyer, A.M. et al. Rotavirus genotypes in Slovenia: unexpected detection of G8P[8] and G12P[8] genotypes. J. Med. Virol., 79, 629, 2007. 64. Smith M.J. et al. The clinical and molecular epidemiology of community- and healthcare-acquired rotavirus gastroenteritis. Pediatr. Infect. Dis. J., 27, 54, 2008. 65. Dunn, S.J. et al. Serotypic and genotypic characterization of human serotype 10 rotaviruses from asymptomatic neonates. J. Clin. Microbiol., 31, 165, 1993. 66. Gratacap-Cavallier, B. et al. Detection of human and animal rotavirus sequences in drinking water. Appl. Environ. Microbiol., 66, 2690, 2000. 67. van Zyl, W.B. et al. Molecular epidemiology of group A rotaviruses in water sources and selected raw vegetables in southern Africa. Appl. Environ. Microbiol., 72, 4554, 2006. 68. Malik, S.V.S. et al. Data sheet on rotaviruses (global status of rotavirus infections in man and animals). In: Animal Health and Production Compendium. CAB International, Wallingford, UK, 2005. 69. Coulson, B.S. VP4 and VP7 typing using monoclonal antibodies. Arch. Virol. (Suppl.), 12, 113, 1996. 70. Gouvea, V. et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J. Clin. Microbiol., 28, 276, 1990. 71. Gentsch, J.R. et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J. Clin. Microbiol., 30, 1365, 1992. 72. Taniguchi, K. et al. Identification of human and bovine rotavirus serotypes by polymerase chain reaction. Epidemiol. Infect., 109, 303, 1992. 73. Iturriza-Gómara, M. et al. Comparison of specific and random priming in the reverse transcriptase polymerase chain reaction for genotyping group A rotaviruses. J. Virol. Methods, 78, 93, 1999. 74. O’Neill, H.J. et al. Clinical utility of nested multiplex RT-PCR for group F adenovirus, rotavirus and Norwalk-like viruses in acute viral gastroenteritis in children and adults. J. Clin. Virol., 25, 335, 2002. 75. Santos, N. et al. VP7 gene polymorphism of serotype G9 rotavirus strains and its impact on G genotype determination by PCR. Virus Res., 90, 1, 2002. 76. Santos, N. et al. VP7 gene polymorphism of serotype G9 rotavirus strains and its impact on G genotype determination by PCR. Virus Res., 93, 127, 2003. 77. Fischer, T.K., and Gentsch, J.R. Rotavirus typing methods and algorithms. Rev. Med. Virol., 14, 71, 2004. 78. Chizhikov, V. et al. Detection and genotyping of human group A rotaviruses by oligonucleotide microarray hybridization. J. Clin. Microbiol., 40, 2398, 2002. 79. Lovmar, L. et al. Microarray for genotyping human group A rotavirus by multiplex capture and type-specific extension. J. Clin. Microbiol., 41, 5153, 2003.
100 80. Domingues, A.L.S., Silva, M.H. and Gouvea, V. Biotin-psolaren labeled cDNA amplicons for genotyping rotavirus strains by dot hybridization assay. J. Virol. Methods, 140, 228, 2007. 81. Adler, M. et al. Detection of rotavirus from stool samples using a standardized immuno-PCR (“Imperacer”) method with end-point and real-time detection. Biochem. Biophys. Res. Commun., 333, 1289, 2005. 82. Ahmed, K., Nakagomi, T. and Nakagomi, O. Molecular identification of a novel G1 VP7 gene carried by a human rotavirus with a super-short RNA pattern. Virus Genes, 35, 141, 2007. 83. Kittigul, L. et al. An efficient virus concentration method and RT-nested PCR for detection of rotaviruses in environmental water samples. J. Virol. Methods, 124, 117, 2005. 84. De Medici, D. et al. Detecting the presence of infectious hepatitis A virus in molluscs positive to RT-nested-PCR. Lett. Appl. Microbiol., 33, 362, 2001.
Molecular Detection of Foodborne Pathogens 85. Mullendore, J.L., Sobsey, M.D. and Shieh, Y.C., Improved method for the recovery of hepatitis A virus from oysters. J. Virol. Methods, 94, 25, 2001. 86. Honma, S. et al. Development and validation of DNA microarray for genotyping group A rotavirus VP4 (P[4], P[6], P[8], P[9], and P[14]) and VP7 (G1 to G6, G8 to G10, and G12) genes. J. Clin. Microbiol., 45, 2641, 2007. 87. Kittigul, L. et al. Development of a method for concentrating and detecting rotavirus in oysters. Int. J. Food Microbiol., 122, 204, 2008. 88. Santos, N. et al. Development of a microtiter plate hybridization-based PCR-enzyme-linked immunosorbent assay for identification of clinically relevant human group A rotavirus G and P genotypes. J. Clin. Microbiol., 46, 462, 2008. 89. Logan, C., O’Leary, J.J. and O’Sullivan, N. Real-time reverse transcription-PCR for detection of rotavirus and adenovirus as causative agents of acute viral gastroenteritis in children. J. Clin. Microbiol., 44, 3189, 2006.
8 Sapoviruses Grant S. Hansman
National Institute of Infectious Diseases
Contents 8.1 Introduction........................................................................................................................................................................101 8.1.1 Genetic Classification ............................................................................................................................................101 8.1.2 Serological Studies................................................................................................................................................. 103 8.1.3 Cross-Reactive Studies.......................................................................................................................................... 103 8.1.4 Diagnostic Techniques........................................................................................................................................... 103 8.2 Methods............................................................................................................................................................................. 103 8.2.1 Reagents and Equipment........................................................................................................................................ 103 8.2.2 Sample Preparation................................................................................................................................................ 105 8.2.2.1 Primary-treated Domestic Wastewater (Method 1)................................................................................ 105 8.2.2.2 Secondary-treated Effluent (Method 1) and River Water (Method 1)..................................................... 105 8.2.2.3 Influent and Effluent Water (Method 2).................................................................................................. 105 8.2.2.4 River Water (Method 2)........................................................................................................................... 106 8.2.2.5 Seawater.................................................................................................................................................. 106 8.2.2.6 Oysters..................................................................................................................................................... 106 8.2.2.7 Shellfish................................................................................................................................................... 106 8.2.2.8 Stool......................................................................................................................................................... 106 8.2.3 Detection Procedures............................................................................................................................................. 106 8.2.3.1 EM........................................................................................................................................................... 106 8.2.3.2 ELISA Detection..................................................................................................................................... 107 8.2.3.3 RNA Extraction....................................................................................................................................... 107 8.2.3.4 Reverse Transcription.............................................................................................................................. 107 8.2.3.5 Nested PCR............................................................................................................................................. 108 8.2.3.6 Real-time RT-PCR.................................................................................................................................. 108 8.2.3.7 Phylogenetic Analysis............................................................................................................................. 109 8.3 Conclusions and Future Perspectives................................................................................................................................ 109 References.................................................................................................................................................................................. 109
8.1 Introduction Viruses can infect animals, plants, and bacteria. Viruses are composed of either single-stranded or double-stranded nucleic acid, which can be either DNA or RNA. Viral infections in humans usually result in an immune response and disease. In this chapter, we utilize human sapovirus, a cause of gastroenteritis, as a model to illustrate the various ways to prepare viral samples for molecular detection and identification. In recent years, a number of important findings concerning human sapovirus were discovered, which were likely, in part, due to improved detection techniques and increased surveillance. Human sapovirus strains were detected in water samples, which included untreated wastewater specimens, treated wastewater samples, and river samples;1,2 human sapovirus strains were detected in clams destined for human consumption in Japan;3 porcine sapovirus was detected in oysters destined for human consumption in the USA;4 and the number of sapovirus-associated outbreaks of gastroenteritis,
especially involving adults, appears to be steadily increasing, suggesting that sapovirus virulence and/or prevalence may be increasing.5–8
8.1.1 Genetic Classification The virus family Caliciviridae contains four genera Sapovirus, Norovirus, Lagovirus, and Vesivirus, which include Sapporo virus, Norwalk virus, Rabbit hemorrhagic disease virus, and Feline calicivirus, respectively. Human sapovirus is an etiological agent of gastroenteritis. The prototype strain of human sapovirus, the Sapporo virus, was originally discovered from an outbreak in an orphanage in Sapporo, Japan, in 1977.9 In that study, Chiba et al. identified viruses with the typical animal calicivirus morphology, the Star-of-David structure, by electron microscopy (EM). Besides having this classical structure, sapovirus particles are typically 41–46 nm in diameter and have a cup-shaped depression and/or ten spikes on the outline. The sapovirus 101
102
Molecular Detection of Foodborne Pathogens
genome is a single-stranded, positive sense RNA molecule of approximately 7.5 kb that is polyadenylated at the 3′ end. Sapovirus can be divided into five genogroups (GI–GV) Figure 8.1), among which GI, GII, GIV, and GV are known to infect humans, whereas sapovirus GIII infects porcine species (Figure 8.1). The sapovirus GI, GIV, and GV genomes are each predicted to contain three main open reading frames (ORFs), whereas sapovirus GII and GIII have two ORFs. Sapovirus ORF1 encodes for nonstructural proteins, including the VPg, protease, and RNA dependent RNA polymerase (RdRp), and a major capsid protein (VP1). Sapovirus ORF2 and ORF3 encoded proteins of yet unknown functions. Recently, naturally occurring intragenogroup recombinant sapovirus strains were identified (i.e., strains Mc10 and C12).10 When polymerase-based grouping was performed, Mc10 and C12 strains clustered together, but when capsid-based grouping
was performed, these two strains belonged in two distinct genotypes. In a more recent study, intergenogroup recombinant sapovirus strains were identified (i.e., strains SW278 and Ehime1107).11 Phylogenetic analysis of the nonstructural region (i.e., genome start to capsid start) grouped SW278 and Ehime1107 strains into GII, while the structural region (i.e., capsid start to genome end) grouped these strains into GIV. By comparing the sequence similarity across the length of the genomes using SimPlot software,12 a potential recombination site was discovered, at a point where the similarity analysis showed a sudden drop in nucleotide identity after the RdRp region, indicating that a recombination event occurred at the RdRp-capsid junction. Since the discovery of these intragenogroup and intergenogroup recombinant sapovirus strains classification numbering schemes have conflicted between the different research groups. Ideally, both polymerase and
1000
1000 943
Mc114 Manchester Sapporo
1000
Dresden
805
Chiba000496 Ehime643 1000
1000
1000
Parkville Houston27 Stockholm Chiba010658
999
Syd3
Arg39 1000 963
Mc2 Bristol SK15
1000
1000 1000 410
GI/2
GI/3
GIV/1
SW278 NK24
1000
469
GI/5
Ehime1107
1000
916
GI/4
Potsdam
1000
918
0.02
Yokote1
1000
536
GI/1
Syd53 C12
GV/1 GII/1 GII/6 GII/3
Mc10
GII/2
Mex340
GII/4
Cruise ship
GII/5
PEC
GIII
Figure 8.1 Phylogenetic tree of sapovirus based upon the entire VP1 nucleotide sequences. Different genogroups and genotypes are indicated. The numbers on each branch indicate the bootstrap values for the genotype. Bootstrap values of 950 or higher were considered statistically significant for the grouping. The scale represents nucleotide substitutions per site. GenBank accession numbers for the reference strains are as follows: Arg39, AY289803; Bristol, HCA249939; C12, AY603425; Chiba000496, AJ412800; Chiba010658, AJ606696; Cruise ship, AY289804; Dresden, AY694184; Ehime643, DQ366345; Ehime1107, DQ058829; Houston27, U95644; Manchester, X86560; Mc2, AY237419; Mc10, AY237420; Mc114, AY237422; Mex340, AF435812; NK24, AY646856; Parkville, U73124; PEC, AF182760; Potsdam, AF294739; Sapporo, U65427; SK15, AY646855; Stockholm, AF194182; SW278, DQ125333; Syd3, DQ104357; Syd53, DQ104360; and Yokote1 AB253740.
103
Sapoviruses
capsid genes should be analyzed. However, this is not always practical, due to amplification difficulties, time and cost of reagents. Therefore, many phylogenetic studies have used the 5′ terminus of the capsid gene.
8.1.2 Serological Studies Most studies agree that sapovirus infection is more frequent in young children than adults and that infection in children almost always occurs by 5 years of age. In addition, children at daycare centers and institutions are at greatest risk of sapovirus-associated infection and transmission. In an early study of sapovirus antibody prevalence in the general community,13 Sakuma et al. indicated that sapovirus infections were acquired more readily after 2 years of age than before 2 years of age, and especially in infants attending nurseries and children attending kindergarten or primary schools. Grohmann et al.14 also found that infants under 6 months of age had the highest rate of sapovirus-associated gastroenteritis. Sapovirus also causes sporadic cases of acute gastroenteritis requiring hospitalization as well as symptomatic and asymptomatic infections not requiring hospitalization in the community.8,14–28 However, only a limited number of sapovirus studies have been conducted, therefore it has been difficult to check for correlations between or to draw conclusions about rates of incidence, detection, and overall prevalence. Epidemiological studies have been conducted in a number of countries, including Australia, Canada, Finland, France, Japan, Mexico, Mongolia, Spain, Sweden, Taiwan, Thailand, UK, US, and Vietnam. The rates of incidence, detection, and overall prevalence of sapovirus infections vary in each country and setting, and are likely affected by the diagnostic techniques used.29
8.1.3 Cross-Reactive Studies Human sapovirus is noncultivable, but expression of a subgenomic-like construct (i.e., VP1 to genome end) or VP1 alone in insect or mammalian cells can result in the formation of virus-like particles (VLPs) that are morphologically and antigenically similar to native sapovirus.30–36 Recently, we compared the antigenic relationships among all human sapovirus genogroups.37–39 Hyperimmune antisera that were raised against the VLPs reacted strongly against the homologous VLPs. However, several antisera weakly cross-reacted against heterologous VLPs using an antibody ELISA. On the other hand, an antigen ELISA showed that the sapovirus VLPs belonging to all human genogroups were antigenically distinct. These findings provide evidence of a likely correspondence between the sapovirus antigenicity and VP1 genogrouping and genotyping.
8.1.4 Diagnostic Techniques Several groups have used enzyme immunoassays (EIAs) to screen for sapovirus antibodies.20,25,40–42 ELISA assays
can screen for specific antibodies or virus particles and are useful for screening a large number of samples.40–42 Recently, we developed a sapovirus ELISA that was based on hyperimmune rabbit and guinea pig antisera raised against sapovirus VLPs.36,38 After a number of optimization steps, the ELISA was prepared for clinical testing. Our results also showed a low sensitivity, although we found that the sapovirus ELISA was useful in detecting sapovirus GI antigens in clinical stool samples collected two days after the onset of illness. We are currently developing a new ELISA based on monoclonal antibodies that have broad range cross-reactivities. Several groups have designed RT-PCR primers that can detect a broad range of sapovirus strains (Table 8.1 and Figure 8.2A).19,21,23,24,43 One set of primers (sense p289 primer and antisense p290 primer) were designed to detect both norovirus and sapovirus (Table 8.1).19 In an earlier study, we detected sapovirus from stool specimens from hospitalized infants with sporadic gastroenteritis in Chiang Mai, Thailand, between July 2000 and July 2001.23 We used a single round PCR with primers (sense SV5317 primer and antisense SV5749 primer) directed against capsid gene.23 In this Thailand study, we detected three different sapovirus genotypes belonging to GI and GII, showing the usefulness of these primers. Following this study, we performed a second molecular epidemiological study using stool specimens collected from hospitalized infants with acute gastroenteritis in Thailand, between November 2002 and April 2003. However, we used a new set of nested RT-PCR primers designed by Okada et al.44 (Table 8.1). For the first PCR we used sense SV-F11 primer and antisense SV-R1 primer. For the nested PCR, we used sense SV-F21 primer and antisense SV-R2 primer. In this second Thailand study, we detected four different sapovirus genotypes, including a newly identified GV strain. A second generation set of RT-PCR primers were designed by Okada et al.45 with higher sensitivity and is currently used in our laboratory (Table 8.1). Recently, several real-time RT-PCR methods that could detect human sapovirus were developed.46–48 The advantage of real-time RT-PCR over traditional RT-PCR is that it can give a rapid result and can be used to determine the number of copies of cDNA per gram of stool sample. Two of these methods used primers and probes that targeted the capsid region, whereas the other report used primers and probes that targeted the polymerase-capsid junction. Oka et al. method was proven to detect all human sapovirus genogroups46 and is described in detail below.
8.2 Methods 8.2.1 Reagents and Equipment The essential reagents and equipment needed for sapovirus molecular detection using RT-PCR and identification by sequence analysis are listed in Table 8.2.
104
Molecular Detection of Foodborne Pathogens
Table 8.1 Primers for Sapovirus Nested RT-PCR and Primers and Probes for Sapovirus Real-Time PCR Application
Target
Primer
Polarity
Location
GATTACTCCAAGTGGGACTCCAC TGACAATGTAATCATCACCATA
Sequence (5′ to 3′)
+ –
4568a 4886a
PCR
GI and GII (other genogroups?)
p290 p289
PCR
GI and GII (other genogroups?)
SV5317 SV5749
CTCGCCACCTACRAWGCBTGGTT TGGGGVGGTASBTTTGARGYCCG
+ –
5083b 5516b
GI, GII, GIV, GV
SV-F11 SV-R1 SV-F21 SV-R2
GCYTGGTTYATAGGTGGTAC CWGGTGAMACMCCATTKTCCAT ANTAGTGTTTGARATGGAGGG GWGGGRTCAACMCCWGGTGG
+ –
5098b 5878b 5157b 5591b
PCR
PCR
a b c d e
SV-F13
GAYYWGGCYCTCGCYACCTAC
+
5074b
SV-F14 SV-R13 SV-R14 SV-F22 SV-R2
GAACAAGCTGTGGCATGCTAC GGTGANAYNCCATTKTCCAT GGTGAGMMYCCATTCTCCAT SMWAWTAGTGTTTGARATG GWGGGRTCAACMCCWGGTGG
+ – – + –
5074b 5861b 5861b 5154b 5572b
GI, GII, GIV
SaV124F
GAYCASGCTCTCGCYACCTAC
+
5078c
GI
SaV1F
TTGGCCCTCGCCACCTAC
+
700d
GV GI, GII, GIV, GV GI, GII, GIV GV
SaV5F SaV1245R SaV124TP SaV5TP
TTTGAACAAGCTGTGGCATGCTAC CCCTCCATYTCAAACACTA FAM-CCRCCTATRAACCA-MGB-NQF FAM-TGCCACCAATGTACCA-MGB-NQF
+ – – –
5112e 5163c 5105c 5142e
GI, GII, GIV, GV
Real-time PCR
+ –
NK24 virus (AY646856). Manchester virus (X86560). Mc10 virus (AY237420). Parkville virus (U73124; partial sequence). Norwalk virus (X86560). FAM, 6-carboxyfluorescein (reporter dye); MGB, minor groove binder; NQF, nonfluorescent quencher.
A
SV-F22 (5,154)
Nested PCR
SV-F13 (5,074) SV-F14 (5,074)
B
5'
SV-R13 (5,876) SV-R14 (5,876)
first PCR
Manchester/93 genome (GI) 1
SV-R2 (5,591)
5,180
13
5,666
(5,170) RdRp
N
6,855 VP1
6,852 C 5'
7,431 A(n) 3'
C
ORF2
7,349
ORF3
Bristol/98 genome (GII) 1
14
(5,174) RdRp
N
6,853 VP1
C 6,856
ORF1
7,490 A(n) 3'
N
N-terminal of VP1
C
C-terminal of VP1
7,347
Figure 8.2 Detection of sapovirus by nested RT-PCR. The location of the primers in the RdRp/capsid junction.
105
Sapoviruses
Table 8.2 Reagents and Equipment for RT-PCR and Sequencing Reagents QIAamp Viral RNA kit (Qiagen) Alcohol (80–100%) Reverse transcription reagents (e.g., SuperScript II; Invitrogen) DNA Taq polymerase reagents (e.g., Ex Taq; Takara) Random hexamers (Takara) RNase inhibitor (Toyobo) dNTPs (Roche) Terminator cycle sequence kit (e.g., BigDye; Applied Biosystems) Primers (listed in Table 8.1) Agarose Ethidium bromide Tris-acetate-EDTA (TAE) buffer DNA marker Distilled water QIAquick gel extraction kit (Qiagen)
Equipment Pipettes and tips (10 µl, 100 µl and 1000 µl) Tubes (1.5 ml, 15 ml and 50 ml) Disposable gloves Thermocycler (e.g., 2700 thermocycler; Applied Biosystems) DNA sequencer (e.g. ABI 3100 Avant sequencer; Perkin-Elmer ABI) Centrifuge (up to 10,000 × g) Heating block Vacuum manifold and pump Refrigerators (4°C and –20°C or –80°C) Vortex Measuring scale Electrophoresis tank and power supply Knife for cutting gels Beakers or flasks (600 ml) Microwave Transilluminator (an ultraviolet lightbox) Gel casting trays and combs
8.2.2 Sample Preparation A number of researchers have found that storing clinical stool samples for extended periods of time may result in RNA degradation and viral instability.19,49,50 In this regard, different research laboratories have adopted a range of different storage conditions. For example, raw stool samples, 10% stool suspensions, 10% clarified stool suspensions and extracted RNA have all been stored at such widely divergent temperatures as –20°C, –60°C, –70°C, or –80°C prior to molecular applications. In general, we keep raw stool samples at 4°C prior to diagnostic work and then store raw stool samples long term at –30°C or –80°C. Little is known about the stability of sapovirus in food or water samples, however in the case of noroviruses, samples are usually stored at 4°C or lower. Sapovirus was recently detected in untreated wastewater, treated wastewater, and a river in Japan.1,51 The methods used to concentrate the virus were different for each sample site (see below). 8.2.2.1 Primary-Treated Domestic Wastewater (Method 1)1 Viruses in 400 ml of primary-treated domestic wastewater are recovered by using the enzymatic virus elution (EVE) method.52 Primary-treated domestic wastewater is centrifuged at 9,000 × g for 15 min and the supernatant decanted. The pellet is resuspended in the EVE buffer (10 g/l of each of the following enzymes: mucopeptide N-acetylmuramoylhdrolase, carboxylesterase, chrymotrypsin, and papain) and stirred for 30 min. The suspension is centrifuged at 9,000 × g for 30 min and then the supernatant is collected and stored at –20°C until further analysis. The viruses in the supernatant are concentrated using a polyethylene glycol (PEG) precipitation method.53
PEG 6000 is added to the supernatant at a concentration of 8% and stirred at 4°C overnight. The sample is centrifuged at 9,000 × g for 90 min, and the pellet is resuspended in 4 ml of 20 mM phosphate-buffered solution (PBS; pH 8.0) and briefly agitated using a vortex. The resuspended sample is centrifuged at 9,000 × g for 10 min, and the supernatant was collected and stored at –20°C until RNA extraction. 8.2.2.2 Secondary-Treated Effluent (Method 1) and River Water (Method 1)1 Viruses in 1 l of secondary-treated effluent and river water are concentrated by PEG precipitation as follows. 100 g of PEG 6000 and 23.4 g of NaCl are added to 1 l of sample and stirred at 4°C overnight. The sample is then centrifuged at 10,000 × g for 60 min and the pellet resuspended in 4 ml of distilled water. The resuspended sample is centrifuged at 10,000 × g for 10 min and then the supernatant is collected and stored at –20°C until further analysis. The viruses in the supernatant are concentrated using the PEG precipitation method described above. Samples are stored at –20°C until RNA extraction. 8.2.2.3 Influent and Effluent Water (Method 2)2 Influent and effluent water samples are treated similarly, except that effluent samples are initially treated with sodium thiosulfate for the purpose of decholorination. Then, 2.5 M/l MgCl2 is added to the water samples to give a final concentration of 25 mM/l. 100 ml of influent and 1000 ml of effluent are passed through an HA negatively charged membrane (Nihon Millipore, Tokyo, Japan) with a 0.45-µm pore size attached to a glass filter holder. Then, 200 ml of 0.5 mmol/1 H2SO4 (pH 3) is passed through the filter (to remove magnesium ions and electropositive substances), followed by
106
10 ml of 1 mmol/1 of NaOH (pH 11) (to elute the viruses). To neutralize the filtrate, 50 µl of 100 mmol/1 H2SO4 (pH 1) and 100 µl of 100 × Tris-EDTA buffer pH 8 is added. The concentrated sample is centrifuged in a Centriprep YM-50 (Nihon Millipore) according to the manufacturer’s instructions; 1,000 × g for 10 min, removal of the sample that passed through the ultrafiltration membrane and then further centrifugation at 1,000 × g for 5 min to obtain a final volume of 0.7 ml.54 Samples are stored at –20°C until RNA extraction. 8.2.2.4 River Water (Method 2)54 Another method that is used to detect sapovirus in river water was developed.1,54 5 ml of 250 mM/l AlCl3 is initially passed through an HA filter to form a cation (Al3 + )-coated filter. 500 ml of river water sample was passed through the filter, followed by successive steps using H2SO4 and NaOH as described above for influent and effluent water (method 2). The concentrated sample is centrifuged in a Centriprep YM-50 (Nihon Millipore) according to the manufacturer’s instructions to obtain a final volume of 0.7 ml and stored at –20°C until RNA extraction. 8.2.2.5 Seawater1 Viruses in 20 l of seawater are concentrated according to the method of Katayama et al.55 Seawater is filtered with an HA negatively charged membrane (Nihon Millipore) with a 0.45-µm pore size. Then, 200 ml of 0.5 mM H2SO4 is passed through the membrane to rinse out cations. Next, 10 ml of 1 mM NaOH is poured onto the membrane and the filtrate was recovered in a tube containing 0.1 ml of 50 mM H2SO4 and 0.1 ml of 100 × TE buffer. Viruses in the filtrate are further concentrated with a Centriprep Concentrator 50 system (Nihon Millipore) according to the manufacturer’s instructions to obtain a final volume of 1 ml and stored at –20°C until RNA extraction. 8.2.2.6 Oysters Unlike norovirus, human sapovirus has not yet been detected in oysters. Several methods have been developed, which are usually evaluated with a spiked virus in order to determine the efficiency of the RNA recovery. Recently, a Japanese group developed a more efficient method.56 Fresh oysters are shucked and their stomachs and digestive tracts are removed by dissection. The samples are weighed and homogenized in 10 mM PBS (pH 7.4; without magnesium or calcium) and made into a 10% suspension. The suspension is added to 0.1 ml antifoam B (Sigma, St Louis, MO) and homogenized twice at 30 sec intervals at maximum speed using an Omni-mixer (OCI Instruments, Waterbury, CT). Next, 6 ml of choloroform:butanol (1:1 vol) is added, the suspension was homogenized for 30 sec, and 170 ml Cat-Floc T (Calgon, Elwood, PA) is added. The sample is centrifuged at 3,000 × g for 30 min at 4°C and the supernatant is layered onto 1 ml of 30% sucrose solution and ultracentrifuged at 154,000 × g for 3 h at 4°C. Finally, the pellet is resuspended in 140 µl of distilled water DDW and stored at –80°C until RNA extraction.
Molecular Detection of Foodborne Pathogens
8.2.2.7 Shellfish Recently, we detected sapovirus in clam samples designated for human consumption.3 Clams are shucked and their stomachs and digestive diverticula are removed by dissection on the day of harvest. Then 1 g of the stomachs and digestive diverticulum (approximately 10–15 clams per package are pooled) are homogenized with an Omni-mixer in nine times their weight (approximately 9 ml) of PBS (pH 7.4; without magnesium or calcium). After centrifugation at 10,000 × g for 30 min at 4°C, all of the supernatant is layered onto 1 ml of 30% sucrose solution and ultracentrifuged at 154,000 × g for 3 h at 4°C. The supernatant is then carefully removed, and the pellet is resuspended in approximately 140 µl of distilled water and stored at –80°C until RNA extraction. 8.2.2.8 Stool Stool samples are usually diluted and clarified before RNA can be extracted using the commercial and in-house RNA extraction methods. In our laboratory, a 10% (wt/vol) stool suspension is prepared with sterilized water and centrifuged at 10,000 × g for 10 min at 4°C. However, other research laboratories have prepared the clarified supernatant in different ways. Yuen et al. prepared 10% (w/v) stool suspensions in Hanks’ complete balanced salt solution, clarified the solution by centrifuging the sample at 3,500 × g for 15 min at room temperature, followed by 7,000 × g for 30 min at 4°C.57 Drier et al. prepared 10% (wt/vol) stool suspension in PBS and clarified the solution by centrifuging the sample at 3,500 × g for 15 min.58 Houde et al. prepared 20% (wt/vol) stool suspension in PBS and clarified the solution by centrifuging the sample 2,000 × g for 3 min, followed by 16,000 × g for 5 min.59
8.2.3 Detection Procedures The rates of incidence and overall prevalence of sapovirus infections vary in each country and setting, and are likely affected by the diagnostic techniques used. Different laboratories employ different detection techniques for various reasons, including costs, equipment, time, and personnel. 8.2.3.1 EM Sapovirus was first detected by EM.9 However, this technique is tedious, since virus particles are difficult to correctly identify and the number of particles is generally low.27 To obtain a positive result by EM, approximately 106 particles per g of stool are needed as well as a skilled expert who can differentiate between a “VLP” and an actual virion. The sample preparation is straightforward although time-consuming. A 10% stool suspension is usually prepared in PBS or distilled water and then centrifuged. It is important to thoroughly vortex the suspension prior to centrifuging in order to separate the virus particles from the organic and inorganic material in the stool. The stool suspension is centrifuged at low speed (3,000 × g for 10 min) and then the supernatant collected and centrifuged at medium speed (10,000 × g for 30 min). The supernatant is then collected and centrifuged at high speed
Sapoviruses
in a 10–20% sucrose cushion (50,000 × g for 2 h) and then the pellet is resuspended in a small volume (20–50 µl) of PBS or distilled water and stored below –30°C. The method of negative staining can vary and can include (2–4%) uranyl acetate or (2–4%) phosphotungstic acid. Various kinds of EM grids can also be used, although carbon-coated grids usually provide the best resolution for sapovirus (personal communication). The virus integrity and morphology are usually stable for a certain amount of time; however, freshly prepared samples should be examined and freeze thawing may disrupt the virus morphology. The methodology for applying the sample to the grid can also vary between laboratories. In our laboratory, 10–20 µl of 1:10 sample is placed on Para film, 20 µl of water is placed on the Para film next to the sample, and then 20 µl of stain is placed on the Para film next to the water. A grid is placed in lockable forceps. The grid is touched to the sample (on the carbon side) and left to dry for 15 sec, and then the excess sample is removed from the grid with filter paper. This is repeated for the water and then the stain. Finally, the grid is left to dry for 20 min and then examined by EM at 30,000–40,000 × magnification. The resuspended pellet can also be used for molecular biology techniques, including RT-PCR and ELISA as described below. 8.2.3.2 ELISA Detection We developed an antigen ELISA detection system that was based on hyperimmune rabbit and guinea pig antisera raised against sapovirus VLPs.36 Wells of 96-well microtiter plates are coated with 100 µl of a 1:8,000 dilution of either hyperimmune rabbit (P) or preimmune rabbit (N) antisera diluted in PBS, and the plates are incubated overnight at 4°C. Wells are washed three times with PBS containing 0.1% Tween 20 (PBS-T), and then blocked with PBS containing 5% skim milk (PBS-SM) for 1 h at room temperature. After washing the wells four times with PBS-T, 100 µl of each clinical stool specimen (10% stool suspension is prepared in PBS, vortexed, centrifuged at 3,000 × g for 5 min, the supernatant is collected and further centrifuged at 10,000 × g for 30 min, and then the final supernatant collected and diluted 1:1 with PBS-T containing 1% SM [PBS-T-SM]) is added to duplicate hyperimmune rabbit and duplicate preimmune rabbit wells, and the plates are incubated for 1 h at 37°C. After washing the wells four times with PBS-T, 100 µl of a 1:8,000 dilution of hyperimmune guinea pig antiserum diluted in PBS-T-SM is added to each well, and the plates are incubated for 1 h at 37°C. Wells are washed four times with PBS-T, and then 100 µl of a 1:1,000 dilution of horseradish peroxidase (HRP)conjugated rabbit anti-guinea pig immunoglobulin G (IgG) (Cappel, West Chester, PA) diluted in PBS-T-SM is added to each well and the plates are incubated for 1 h at 37°C. Wells are washed four times with PBS-T, and then 100 µl of substrate o-phenylenediamine and H2O2 is added to each well and left in the dark for 30 min at room temperature. The reaction is stopped with the addition of 50 µl of 2 N H2SO4 to each well, and the absorbance is measured at 492 nm (A492). The cutoff value is defined as the mean plus three
107
standard deviations, and P/N ratios over the cutoff value are considered significantly positive.36,38 8.2.3.3 RNA Extraction RNA for RT-PCR should be free from DNA contamination, as this can generate false positives during the PCR step. Moreover, many substances found in stool samples can inhibit PCR, because the Taq polymerases require optimal conditions, including optimal pH and reagent concentrations.60 Several groups have suggested using a competitive internal control RNA to monitor inhibition of RT-PCR.61–63 Today, commercial extraction methods have replaced the earlier extraction methods and effectively remove RT-PCR inhibitors. One of the most popular methods for extracting RNA from stool samples, environmental samples or food samples is the QIAamp Viral RNA Mini Protocol (Qiagen, Hilden, Germany). The QIAamp Viral RNA Protocol is actually designed to purify viral RNA from plasma, serum, cellfree body fluids and cell-culture supernatants. However, the method can be modified to purify viral RNA from other samples as well, including stool samples and environmental samples. For a stool sample, a 10% stool suspension is prepared with sterilized water and centrifuged at 10,000 × g for 10 min at 4°C. For water samples, we use 140 µl of the concentrated water sample. For the shellfish samples, we prepare a 10% (vol/vol) of the resuspended pellet (described above). In our laboratory, this extraction method has been used to successfully detect norovirus, sapovirus, astrovirus, HEV, and Aichi virus in stool samples. It can be carried out in a standard centrifuge or a vacuum manifold, with the vacuum manifold being more useful for 24–48 samples, and the centrifuge more appropriate for a handful of samples. The entire procedure takes approximately 60–90 min (for 24 samples using a vacuum manifold). Briefly, 560 µl of 100% ethanol is added to the sample and vortexed for 15 sec. Then, 600 µl of sample is added to the QIAamp spin column and the vacuum turned on. The remaining sample (approximately 660 µl) is added to the column. After the entire sample is passed through the QIAamp spin column, the column is washed with 750 µl of buffer AW1, and then washed with 750 µl of buffer AW2. The spin column is then centrifuged at 10,000 × g for 2 min at 4°C in order to remove the residual reagents. Then, 60 µl of buffer AVE is added, the QIAamp spin column is centrifuged at 10,000 × g for 2 min at 4°C, and the RNA is collected in a clean tube. This method extracts both RNA and cellular DNA. In order to remove the DNA from the sample, it is recommended that the RNA preparation be digested with DNase, followed by heat treatment to inactivate the DNase. The RNA can be stored at –20°C or –70°C and may remain stable for up to 1 year, although we have found it to be stable for up to 2 years when stored at –80°C. 8.2.3.4 Reverse Transcription (RT) Reverse transcription (RT) can be performed using random primers, poly(T) primers or gene specific primers. A number of different reverse transcriptases are available, each with a
108
different sensitivity. Our reverse transcriptase of choice is Invitrogen Superscript III. (1) Prepare RT mixture in a final volume of 20 µl containing 10 µl of RNA in 50 ρmol random hexamer (Takara, Tokyo, Japan), 1 × Superscript III RT buffer (Invitrogen, Carlsbad, CA), 10 mM DTT (Invitrogen), 0.4 mM of each dNTP (Roche, Mannheim, Germany), 1 U RNase inhibitor (Toyobo, Osaka, Japan), and 10 U Superscript RT III (Invitrogen). (2) Perform RT at 50°C for 1 h, followed by deactivation of RT enzyme at 72°C for 15 min. Note: This standard RT method is useful for epidemiological studies, but a modified RT method is utilized for preparing high quantity cDNA for other molecular methods, i.e., amplification of long PCR fragments. Briefly, (i) prepare an RT mix in a PCR tube (1 × Superscript III RT buffer, 10 mM DTT, 0.4 mM of each dNTP, 1 U RNase inhibitor and 10 U Superscript RT III) and put on ice; (ii) add poly(T) reverse primer to another PCR tube with 10 µl of RNA and then add two drops of PCR oil; (iii) centrifuge the tube briefly, and put in the 94°C block for 2 min; (iv) take this tube out of the block, placed between the thumb and index finger to cool briefly (15 sec); (iv) add the RT master mix (9 µl) quickly to the bottom of this tube, centrifuge briefly and put in the 55°C block for 2–3 h; (v) deactivate the RT at 94°C for 15 min, place on ice and store the cDNA at –20°C. This cDNA is useful for producing long DNA fragments (over 3 kb) for fulllength genome analyses, expression of the capsid protein and replication studies. However, the ability to determine the fulllength norovirus genome sequence relies on the knowledge of partial sequences and degenerate primers, and on knowledge of the fact that the 5′ untranslated region (UTR) of the norovirus genome is usually conserved at the ORF2 start. 8.2.3.5 Nested PCR Numerous PCR primers that detect different regions (polymerase or capsid) have been designed and improved. Okada et al. designed a second generation of RT-PCR primers (for nested PCR) that could detect strains from all human genogroups as well as many of the different genotypes [45]. This modified primer set has also detected novel genotypes. (1) Prepare the first PCR mixture containing 5 µl of cDNA, 20 ρmol of each primer, 1 × Taq DNA polymerase buffer B, 0.2 mM of each dNTP, 2.5 U Taq polymerase, and up to 50 µl of distilled. For the first PCR, F13, F14, R13, and R14 primers are used45 (Figure 8.2 and Table 8.3). (2) Perform PCR at 94°C for 3 min followed by 35 cycles of 94°C for 30 sec, 48°C for 30 sec, 74°C for 45 sec, and a final extension of 5 min at 74°C. (3) Carry out the nested PCR using 5 µl of the first PCR in a second reaction mixture (identical to the first except for the primers) and the same PCR conditions. For the nested PCR, F22 and R2 primers are used45 (Figure 8.2 and Table 8.2).
Molecular Detection of Foodborne Pathogens
Table 8.3 Sapovirus First-Round and Nested RT-PCR Mixtures First PCR (µl)
× _____
Second PCR (µl)
10 × ExTaq buffer
5
5
2.5 mM dNTP
4
4
SV-F13 (20 ρmol/ µl)
1
–
SV-F14 (20 ρmol/ µl)
1
–
SV-R13 (20 ρmol/ µl)
1
–
SV-R14 (20 ρmol/ µl)
1
–
SV-F22 (20 ρmol/ µl)
–
1
SV-R2 (20 ρmol/ µl)
–
1
cDNA or 1st PCR product ExTaq DNA polymerase
5
–
2
0.25
0.25
Distilled water
31.75
36.75
Total per tube
50
50
× _____
–
Note: For molecular methods that require high fidelity, we used KOD DNA polymerase, which has a unique proofreading ability and is faster and more accurate than conventional DNA polymerases. The proofreading ability results in a lower PCR mutation frequency and considerably higher elongation rates than those achieved by conventional DNA polymerases. 8.2.3.6 Real-time RT-PCR The real-time RT-PCR method presented below was reported recently for detection of all human sapovirus genogroups.46 (1) Extract RNA with the Qiagen method. (2) Add viral RNA (10 µl) to a reaction mixture (5 µl) containing DNase I buffer (150 mM Tris-HCl, pH 8.3, 225 mM KCl, 9 mM MgCl2) and 1 U of RQ1; incubate the reaction mixture first at 37°C for 30 min to digest DNA and then at 75°C for 5 min to inactivate the enzyme. (3) Add DNase I-treated RNA (15 µl) to 15 µl of another mixture containing RT buffer, 1 mM of each dNTP, 10 mM dithiothreitol, 50 pmol of random hexamers, 30 units of RNase OUT and 200 units of SuperScript III RNaseH (–) reverse transcriptase DNase; perform RT at 37°C for 15 min followed by 50°C for 1 h, and store the solution at –20°C. (4) Prepare quantitative real-time RT-PCR in a 25 µl of a reaction volume using a QuantiTect Probe PCR Kit containing 2.5 µl of cDNA, 12.5 µl of Quantitect Probe PCR Master Mix, 400 nM of each primer (SaV124F, SaV1F, SaV5F, and SaV1245R), and 5 ρmol of TaqMan MGB probes (SaV124TP and SaV5TP) (Table 8.4). The four primers (SaV124F, SaV1F, SaV5F, and SaV1245R) and two TaqMan MGB probes (SaV124TP and SaV5TP) are designed
109
Sapoviruses
8.3 Conclusions and Future Perspectives
Table 8.4 Sapovirus Real-Time PCR Mixture µl 2 × real-time PCR Master mix
12.5
SaV124F (10 ρmol/ µl)
1
SaV1F (10 ρmol/ µl)
1
SaV5F (10 ρmol/ µl)
1
SaV1245R (10 ρmol/ µl)
1
SaV124TP (10 ρmol/ µl)
1
SaV5TP (10 ρmol/ µl)
1
cDNA or plasmid
× _____
2.5
Distilled water
5
Total per well
25
–
(using multiple alignment analysis of 27 sapovirus sequences) to hybridize against the highly conserved nucleotides between 5078 and 5181 with respect to Mc10 virus, and used here to detect sapovirus GI, GII, GIV, and GV sequences in a single reaction tube. (5) Perform PCR amplification with a 7500 Fast RealTime PCR System (Applied Biosystems, Foster City, CA) under the following conditions: initial denaturation at 95°C for 15 min to activate DNA polymerase, followed by 40 cycles of amplification with denaturation at 94°C for 15 sec, and annealing and extension at 62°C for 1 min. (6) Collect and analyze amplification data with Sequence Detector software version 1.3 (Applied Biosystems); use a ten-fold serial dilution of standard cDNA plasmid (2.5 × 107–2.5 × 101 copies) to quantify the viral copy numbers in reaction tubes. The detection limit of the real-time RT-PCR is approximately 1.3 × 105 copies of sapovirus RNA per gram of stool sample. 8.2.3.7 Phylogenetic Analysis (1) Excise the PCR-generated amplicons from the gel and purify by the QIAquick gel extraction kit (Qiagen). (2) Sequence the PCR products directly with the terminator cycle sequence kit (version 3.1) and determined with the ABI 3100 Avant sequencer (Perkin-Elmer ABI, Boston, MA); or (3) Clone the PCR products into plasmid vector (e.g., pCR2.1; Invitrogen) in case foodborne outbreaks due to multiple strains are suspected. Four or more colonies should be sequenced. (4) Align nucleotide sequences using Clustal X and calculate the distances by Kimura’s two-parameter method.64 Generate phylogenetic trees with bootstrap analysis from 1000 replicas by the neighborjoining method as described previously.64
New methods and technologies are continuously been developed and tested. More rapid, reliable, and sensitive detection systems will benefit diagnostic laboratories and may improve outbreak management. Methods that can reduce the time needed for complete analysis will allow for more samples to be processed, which in turn will provide better information on these viruses. Reliable and highly sensitive methods that can be used worldwide, will improve surveillance and reporting. A number of companies have developed kits that can extract RNA from up to 96 samples at one time. Ambion developed a rapid high throughput (96 samples) viral RNA isolation kit (MagMax-96 Viral RNA Isolation Kit; Ambion, Austin, TX) that captures both viral RNA and DNA onto microspherical paramagnetic beads. Promega developed an automated system that can extract total RNA from 96 samples (SV 96 Total RNA Isolation System; Promega, Madison, WI) and capture the extracted RNA onto glass fibers. Beckman CoulterQiagen developed at kit that can extract DNA and RNA (96 samples) from plasma, serum, and other cell-free body fluids (QIAamp Virus BioRobot 9604 Kit; Qiagen) and capture the nucleic acid onto a silica-gel membrane. Recently other detection methods have been developed for norovirus, including isothermal nucleic acid sequencebased amplification (NASBA), real-time RT-loop mediated isothermal amplification (LAMP) and real-time LightCycler RT-PCR.65–67 Immunochromatography (IC) is another rapid detection method, and a method to detect norovirus by IC was recently developed by a company in Japan (Immuno-Probe Company, Saitama, Japan). Recently, a microarray assay was also developed for the detection and typing of noroviruses.68 These methods have yet to be developed for sapovirus, but since the number of sapovirus-associated outbreaks of gastroenteritis appears to be steadily increasing, more rapid and reliable methods will be sought after.
References
1. Hansman, G.S. et al. Sapovirus in water, Japan. Emerg. Infect. Dis., 13, 133, 2007. 2. Haramoto, E. et al. Quantitative detection of sapoviruses in wastewater and river water in Japan. Lett. Appl. Microbiol., 46, 408, 2008. 3. Hansman, G.S. et al. Human sapovirus in clams, Japan. Emerg. Infect. Dis., 13, 620, 2007. 4. Costantini, V. et al. Human and animal enteric caliciviruses in oysters from different coastal regions of the United States. Appl. Environ. Microbiol., 72, 1800, 2006. 5. Hansman, G.S. et al. An outbreak of gastroenteritis due to Sapovirus. J. Clin. Microbiol., 45, 1347, 2007. 6. Hansman, G.S. et al. Recombinant Sapovirus gastroenteritis, Japan. Emerg. Infect. Dis., 13, 786, 2007. 7. Johansson, P.J. et al. A nosocomial sapovirus-associated outbreak of gastroenteritis in adults. Scand. J. Infect. Dis., 37, 200, 2005. 8. Noel, J.S. et al. Parkville virus: a novel genetic variant of human calicivirus in the Sapporo virus clade, associated with an outbreak of gastroenteritis in adults. J. Med. Virol., 52, 173, 1997.
110
9. Chiba, S. et al. An outbreak of gastroenteritis associated with calicivirus in an infant home. J. Med. Virol., 4, 249, 1979. 10. Katayama, K. et al. Novel recombinant sapovirus. Emerg. Infect. Dis., 10, 1874, 2004. 11. Hansman, G.S. et al. Intergenogroup recombination in sapoviruses. Emerg. Infect. Dis., 11, 1916, 2005. 12. Lole, K.S. et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol., 73, 152, 1999. 13. Sakuma, Y. et al. Prevalence of antibody to human calicivirus in general population of northern Japan. J. Med. Virol., 7, 221, 1981. 14. Grohmann, G. et al. Outbreak of human calicivirus gastroenteritis in a day-care center in Sydney, Australia. J. Clin. Microbiol., 29, 544, 1991. 15. Hedlund, K.O. et al. Epidemiology of calicivirus infections in Sweden, 1994-1998. J. Infect. Dis., 181 (Suppl 2), S275, 2000. 16. Schuffenecker, I. et al. Genetic classification of “Sapporo-like viruses”. Arch. Virol., 146, 2115, 2001. 17. Nakata, S. et al. Members of the family caliciviridae (Norwalk virus and Sapporo virus) are the most prevalent cause of gastroenteritis outbreaks among infants in Japan. J. Infect. Dis., 181, 2029, 2000. 18. Robinson, S. et al. Epidemiology of human Sapporo-like caliciviruses in the South West of England: molecular characterisation of a genetically distinct isolate. J. Med. Virol., 67, 282, 2002. 19. Jiang, X. et al. Design and evaluation of a primer pair that detects both Norwalk- and Sapporo-like caliciviruses by RT-PCR. J. Virol. Methods, 83, 145, 1999. 20. Wolfaardt, M. et al. Incidence of human calicivirus and rotavirus infection in patients with gastroenteritis in South Africa. J. Med. Virol., 51, 290, 1997. 21. Vinje, J. et al. Molecular detection and epidemiology of Sapporo-like viruses. J. Clin. Microbiol., 38, 530, 2000. 22. Buesa, J. et al. Molecular epidemiology of caliciviruses causing outbreaks and sporadic cases of acute gastroenteritis in Spain. J. Clin. Microbiol., 40, 2854, 2002. 23. Hansman, G.S. et al. Genetic diversity of norovirus and sapovirus in hospitalized infants with sporadic cases of acute gastroenteritis in Chiang Mai, Thailand. J. Clin. Microbiol., 42, 1305, 2004. 24. Okada, M. et al. Molecular epidemiology and phylogenetic analysis of Sapporo-like viruses. Arch. Virol., 147, 1445, 2002. 25. Farkas, T. et al. Prevalence and genetic diversity of human caliciviruses (HuCVs) in Mexican children. J. Med. Virol., 62, 217, 2000. 26. Pang, X.L. et al. Human caliciviruses in acute gastroenteritis of young children in the community. J. Infect. Dis., 181 Suppl 2, S288, 2000. 27. Matson, D.O. et al. Human calicivirus-associated diarrhea in children attending day care centers. J. Infect. Dis., 159, 71, 1989. 28. Matson, D.O. et al. Asymptomatic human calicivirus infection in a day care center. Pediatr. Infect. Dis. J., 9, 190, 1990. 29. Lopman, B.A. et al. Viral gastroenteritis outbreaks in Europe, 1995–2000. Emerg. Infect. Dis., 9, 90, 2003. 30. Guo, M. et al. Expression and self-assembly in baculovirus of porcine enteric calicivirus capsids into virus-like particles and their use in an enzyme-linked immunosorbent assay for antibody detection in swine. J. Clin. Microbiol., 39, 1487, 2001.
Molecular Detection of Foodborne Pathogens 31. Chen, R. et al. Inter- and intragenus structural variations in caliciviruses and their functional implications. J. Virol., 78, 6469, 2004. 32. Jiang, X. et al. Expression and characterization of Sapporolike human calicivirus capsid proteins in baculovirus. J. Virol. Methods, 78, 81, 1999. 33. Numata, K. et al. Molecular characterization of morphologically typical human calicivirus Sapporo. Arch. Virol., 142, 1537, 1997. 34. Oka, T. et al. Expression of sapovirus virus-like particles in mammalian cells. Arch. Virol., 151, 399, 2005. 35. Hansman, G.S. et al. Antigenic diversity of human Sapoviruses. Emerg. Infect. Dis., 13, 1519, 2007. 36. Hansman, G.S. et al. Development of an antigen ELISA to detect sapovirus in clinical stool specimens. Arch. Virol., 151, 551, 2006. 37. Hansman, G.S. et al. Cross-reactivity among sapovirus recombinant capsid proteins. Arch. Virol., 150, 21, 2005. 38. Hansman, G.S. et al. Characterization of polyclonal antibodies raised against sapovirus genogroup five virus-like particles. Arch. Virol., 150, 1433, 2005. 39. Hansman, G.S. et al. Antigenic diversity of human sapoviruses. Emerg. Infect. Dis., 13, 1519, 2007. 40. Nakata, S. et al. Microtiter solid-phase radioimmunoassay for detection of human calicivirus in stools. J. Clin. Microbiol., 17, 198, 1983. 41. Chiba, S. et al. Sapporo virus: history and recent findings. J. Infect. Dis., 181 Suppl 2, S303, 2000. 42. Nakata, S. et al. Detection of human calicivirus antigen and antibody by enzyme-linked immunosorbent assays. J. Clin. Microbiol., 26, 2001, 1988. 43. Okada, M. et al. The detection of human sapoviruses with universal and genogroup-specific primers. Arch. Virol., 151, 2503, 2006. 44. Okada, M. et al. Molecular epidemiology and phylogenetic analysis of Sapporo-like viruses. Arch. Virol., 147, 1445, 2002. 45. Hansman, G.S. et al. Genetic diversity of Sapovirus in children, Australia. Emerg. Infect. Dis., 12, 141, 2006. 46. Oka, T. et al. Detection of human sapovirus by real-time reverse transcription-polymerase chain reaction. J. Med. Virol., 78, 1347, 2006. 47. Gunson, R. N. et al. The real-time detection of sapovirus. J. Clin. Virol., 35, 321, 2006. 48. Chan, M. C. et al. Sapovirus detection by quantitative realtime RT-PCR in clinical stool specimens. J. Virol. Methods, 134, 146, 2006. 49. Vinje, J. et al. International collaborative study to compare reverse transcriptase PCR assays for detection and genotyping of noroviruses. J. Clin. Microbiol., 41, 1423, 2003. 50. Trujillo, A.A. et al. Use of TaqMan real-time reverse transcription-PCR for rapid detection, quantification, and typing of norovirus. J. Clin. Microbiol., 44, 1405, 2006. 51. Ueki, Y. et al. Norovirus pathway in water environment estimated by genetic analysis of strains from patients of gastroenteritis, sewage, treated wastewater, river water and oysters. Water Res., 39, 4271, 2005. 52. Sano, D. et al. Detection of enteric viruses in municipal sewage sludge by a combination of the enzymatic virus elution method and RT-PCR. Water Res., 37, 3490, 2003. 53. Lewis, G.D. and Metcalf, T.G. Polyethylene glycol precipitation for recovery of pathogenic viruses, including hepatitis A virus and human rotavirus, from oyster, water, and sediment samples. Appl. Environ. Microbiol., 54, 1983, 1988.
Sapoviruses 54. Haramoto, E. et al. Application of cation-coated filter method to detection of noroviruses, enteroviruses, adenoviruses, and torque teno viruses in the Tamagawa River in Japan. Appl. Environ. Microbiol., 71, 2403, 2005. 55. Katayama, H. et al. Development of a virus concentration method and its application to detection of enterovirus and norwalk virus from coastal seawater. Appl. Environ. Microbiol., 68, 1033, 2002. 56. Nishida, T. et al. Genotyping and quantitation of noroviruses in oysters from two distinct sea areas in Japan. Microbiol. Immunol., 51, 177, 2007. 57. Yuen, L. K. et al. Heminested multiplex reverse transcriptionPCR for detection and differentiation of Norwalk-like virus genogroups 1 and 2 in fecal samples. J. Clin. Microbiol., 39, 2690, 2001. 58. Dreier, J. et al. Enhanced reverse transcription-PCR assay for detection of norovirus genogroup I. J. Clin. Microbiol., 44, 2714, 2006. 59. Houde, A. et al. Comparative evaluation of RT-PCR, nucleic acid sequence-based amplification (NASBA) and real-time RT-PCR for detection of noroviruses in faecal material. J. Virol. Methods, 135, 163, 2006. 60. Hale, A.D. et al. Comparison of four RNA extraction methods for the detection of small round structured viruses in faecal specimens. J. Virol. Methods, 57, 195, 1996.
111 61. Atmar, R.L. and Estes, M.K. Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses. Clin. Microbiol. Rev., 14, 15, 2001. 62. Wang, Q.H. et al. Development of a new microwell hybridization assay and an internal control RNA for the detection of porcine noroviruses and sapoviruses by reverse transcriptionPCR. J. Virol. Methods, 132, 135, 2006. 63. Schwab, K.J. et al. Use of heat release and an internal RNA standard control in reverse transcription-PCR detection of Norwalk virus from stool samples. J. Clin. Microbiol., 35, 511, 1997. 64. Katayama, K. et al. Phylogenetic analysis of the complete genome of 18 Norwalk-like viruses. Virology, 299, 225, 2002. 65. Fukuda, S. et al. Rapid detection of norovirus from fecal specimens by real-time reverse transcription-loop-mediated isothermal amplification assay. J. Clin. Microbiol., 44, 1376, 2006. 66. Greene, S.R. et al. Evaluation of the NucliSens Basic Kit assay for detection of Norwalk virus RNA in stool specimens. J. Virol. Methods, 108, 123, 2003. 67. Pang, X. et al. Evaluation and validation of real-time reverse transcription-pcr assay using the LightCycler system for detection and quantitation of norovirus. J. Clin. Microbiol., 42, 4679, 2004. 68. Jaaskelainen, A.J. and Maunula, L. Applicability of microarray technique for the detection of noro- and astroviruses. J. Virol. Methods, 136, 210, 2006.
9 Slow Viral Diseases Takashi Onodera, Guangai Xue University of Tokyo
Akikazu Sakudo Osaka University
Gianluigi Zanusso University of Verona
Katsuaki Sugiura
Food and Agricultural Materials Inspection Center
Contents 9.1 Introduction........................................................................................................................................................................113 9.1.1 Definition and Classification of Slow Viral Diseases.............................................................................................113 9.1.2 Biology, Pathogenesis, and Medical Importance....................................................................................................114 9.1.3 Laboratory Diagnosis of Slow Viral Diseases........................................................................................................116 9.2 Methods............................................................................................................................................................................. 120 9.2.1 Reagents and Equipment........................................................................................................................................ 120 9.2.2 Sample Collection and Preparation....................................................................................................................... 120 9.2.3 Detection Procedures............................................................................................................................................. 120 9.3 Conclusions and Future Perspectives................................................................................................................................ 122 References.................................................................................................................................................................................. 123
9.1 Introduction 9.1.1 Definition and Classification of Slow Viral Diseases Prion diseases or transmissible spongiform encephalopathies (TSEs) are fatal neurological disorders that include Creutzfeldt–Jakob disease (CJD) in humans, scrapie in sheep and goats, bovine spongiform encephalopathy (BSE) in cattle, and chronic wasting disease (CWD) in cervids. A key event in prion diseases is the conversion of the cellular, hostencoded prion protein (PrPC) to its abnormal isoform (PrPSc) predominantly in the central nervous system of the infected host.1 There is increasing evidence that the major and possibly only component of the infectious agent is PrPSc or a prion protein (PrP) folding intermediate.2 PrPC is a cell surfaceanchored glycoprotein whose function is not well characterized.3 PrPSc is derived from PrPC in a post-translational process that appears to involve PrPC–PrPSc molecular interactions.4 The crucial role of PrPC expression in prion infection and PrPSc formation has been demonstrated in transgenic mice with an ablated PrP murine gene.5 Transgenic animals have since been used extensively to unravel the influence
of specific PrP amino acid residues or domains on prion susceptibility.6–11 Kuru and the transmissible agents in dementias have been classified in a group of virus-induced slow infections that we have described as sub-acute spongiform virus encephalopathies because of the strikingly similar histopathological lesions they induce (Table 9.1). Slow virus diseases that we have been variously designated as sub-acute spongiform encephalopathies, transmissible amyloidoses of the brain, or transmissible cerebral amyloidoses (TCA) will be discussed individually below. Kuru was the first chronic or sub-acute degenerative disease in humans that was shown to be provoked by a slow virus infection, and as such has attracted worldwide attention and stimulated the search for similar virus infections as the possible cause of other sub-acute and chronic diseases in humans.12–17 Such a slow progressive infection in humans, with an incubation period of many years and an absence of any inflammatory responses to the slow destruction of brain cells, was previously unknown. In veterinary medicine, Sigurdsson17 had shown such slow virus infection in sheep. The elucidation of the etiology of kuru has led to the discovery that worldwide pre-senile dementias, CJD and its variants, with basically 113
114
Table 9.1 Transmissible Spongiform Encephalopathies with Mutations Responsible for Inherited Genetic forms of the Disease In humans Kuru Creutzfeldt–Jakob disease Sporadic Iatrogeric (human growth hormone, pituitary gonadotropin, dura mater and corneal transplants, stereotactic electrodes) Familial (178asn, 200lys, 210ile, octapeptide inserts 2, 4–9) Variant Gerstmann–Sträussler–Scheinker syndrome (GSS is only genetic. Mutations are classified according to disease phenotype) Spastic paraparesis with dementia (105leu) Familial, Alzheimer-like (145stop, 198ser, 217arg) Atypical dementia (octapeptide repeat insertions 6, 7) Fatal familial insomnia (178asn) In animals Scrapie (sheep, goats) Transmissible mink encephalopathy Chronic wasting disease (mule, deer, elk) Bovine spongiform encephalopathy Exotic ungulate spongiform encephalopathy (nyala, gemsbok, Arabian oryx, greater kudu, eland, moufflon) Feline spongiform encephalopathy (cats, albino tigers, puma, cheetah)
Molecular Detection of Foodborne Pathogens
Table 9.2 Conventional Virus-Induced Slow Infections of Man Virus
Picornaviridae Poliovirus Echovirus Paramyxoviridae Measles Togaviridae Rubella Flaviviridae Tick-borne encephalitis (RSSE) Hepatitis C
Diseases RNA viruses Chronic meningoencephalitis In immunodeficient patients Sub-acute postmeasles leuco-encephalitis Sub-acute sclerosing panencephalitis Progressive congenital rubella Progressive panencephalitis Epilepsia partialis continua (Kozhevnikov’s epilepsy) and progressive bulbar palsy in Russia Chronic hepatitis C (non-A, non-B hepatitis)
Retroviridae Lentivirus HIV-1, HIV-2 HIV neuromyeloencephalopathy Oncovirus HTLV-1, HTLV-2 Adult T-cell leukemia and mycosis fungoides, HAM/TSP neuromyeloencephalopathy Jamaican neuropathy, tropical spastic paraparesis Rhabdoviridae Rabies lyssavirus Rabies encephalitis DNA viruses
similar cellular lesions, are also transmissible and caused by a very similar, unconventional “virus” or prion.18 In all of TCA in humans, infectious amyloids are formed from the TCA amyloid precursor protein (PrP) specified on the short arm of chromosome 20 in human and chromosome 2 in mouse. There are other slow infections of the CNS in humans that are caused by conventional viruses, including measles virus, papovaviruses (JCV and SV40-PML), rubella virus, cytomegalovirus, herpes simplex virus, adenovirus types 7 and 32, Russian spring–summer encephalitis (RSSE) viruses, and the human retroviruses (human T-cell lymphotropic viruses-I: HTLV1, and human immunodeficiency viruses: HIV) (Table 9.2). However, unlike these conventional viruses, the “unconventional viruses” of the sub-acute spongiform encephalopathies are truly slow in their replication, with long doubling times. Moreover, these alone appear to be viruses that have made it necessary to alter our conceptions of the possible range of virus structure. The process of infection appears to be a seeding by a “virus,” which is a nucleating agents inducing and then automatically accelerating the conformational transition in the amyloid submit protein. In that process host-specified precursor protein (PrPC) is converted to an insoluble cross-β-plated configuration (PrPSc).19–21 Oligomers of microfilaments of this amyloid submit protein nucleate its own polymerization, crystallization, and precipitation as insoluble arrays of amyloid fibrils. Thus, proteolytic cleavage and conformational change of the precursor and oligomeric
Adenoviridae Adenovirus 7 and 32 Papovaridae JC virus SV40 Hepadnoviridae Hepatitis B Herpesviridae Herpes Simplex Cytomegalovirus Epstein-Barr virus Varicella-Zoster virus Herpes saimiri (B-virus)
Sub-acute encephalitis Progressive multifocal leucoencephalopathy Progressive multifocal leucoencephalopathy Homologous serum jaundice Sub-acute encephalitis Cytomegalovirus brain infection Chronic infectious mononucleosis Herpes zoster (sub-acute encephalitis) Chronic herpes B encephalitis
assembly of this structurally altered polypeptide produces a fibril amyloid enhancing factor22 with apparent infectious properties (Table 9.2).
9.1.2 Biology, Pathogenesis, and Medical Importance Several features distinguish prions from viruses. First, prions can exist in multiple forms, whereas viruses exist in a single form with distinct ultrastructural morphology. Second, prions are non-immunogenic in contrast to viruses, which almost always provoke an immune response. Third, there is no evidence for an essential nucleic acid within the infectious prion particle, whereas viruses have a nucleic acid genome that serves as the template for the synthesis of viral progeny. Forth, the only known component of the prion is PrPSc, which
115
Slow Viral Diseases
is encoded by a chromosomal gene, whereas viruses are composed of nucleic acid, proteins, and often other constituents. PrPSc is derived from PrPC by a post-translational process. The molecular events in the conversion are unknown but may involve only a change in the conformation of the protein. PrPSc may be distinguished from PrPC by its different biochemical and biophysical properties.22–26 Limited proteolysis of PrPSc produces a smaller, protease-resistant molecule of about 140 amino acids, designated PrP.27–30 Under the same conditions PrPC is completely protease-digested. The amino acid sequence of PrPSc that has been established by protein sequencing and mass spectrometry is identical to that deduced from the genomic DNA sequence. No proteins other than PrPSc have been consistently found in fractions enriched for prion infectivity. Prion diseases are a group of neurodegenerative disorders affecting mammals (Table 9.1). The diseases are transmissible under some circumstances, but unlike other transmissible disorders prion diseases they can also be caused by mutations in the host PrP gene. The mechanism of prion spread among sheep and goats developing natural scrapie is unknown. CWD, transmissible mink encephalopathy (TME), BSE, feline spongiform encephalopathy (FSE), and exotic ungulate encephalopathy (EUE) are all thought to occur after the consumption of prion-infected materials. Similarly, kuru of New-Guinea Fore people is thought to have resulted from the consumption of brain tissue during ritualistic cannibalism. Familial CJD, Gerstmann–Sträussler–Scheinker (GSS), and Fatal familial insomnia (FFI) are all dominant, inherited prion diseases have been show to be genetically linked to mutations in the PrP gene, while iatrogenic CJD cases can be traced to inoculation of prions through human pituitary derived growth hormone, cornea transplants, dura mater grafts, or cerebral electrode implants; although the number of cases recorded to date is small. Most cases of CJD are sporadic, probably the result of somatic mutation of the PrP gene or the spontaneous conversion of PrPC into PrPSc. About 10–15% of CJD cases and virtually all cases of GSS and FFI appear to be caused by germline mutations in the PrP gene. Twelve different PrP genes have been shown to segregate with human prion diseases (Table 9.3 and Figure 9.1). Variant CJD (vCJD) was identified by the CJD Surveillance Unit in Great Britain,27 followed by a report of a similar case in France.28 The patients in these reports differed from typical cases of sporadic CJD in terms of the relatively young age at disease onset (average 26.3 years), the prolonged duration of illness (average 14 months), and the clinical features with psychiatric symptoms, then with ataxia and the pain at the extremities, with myoclonus or chorea occurring late in the illness. Dementia was not evident until the final stages of the illness, when it was often accompanied by cortical blindness and akinetic mutism (Table 9.4). None of these patients showed changes in electroencephalogram readings that are characteristic of sporadic CJD, and all were methionine homozygous at codon 129 with no pathogenic mutations in the human prion protein gene (PRNP).
Table 9.3 Prion Diseases and Gene Mutations Disease PrP
Gene Mutation
Gerstmann–Sträussler–Scheinker syndrome Gerstmann–Sträussler–Scheinker syndrome Gerstmann–Sträussler–Scheinker syndrome Gerstmann–Sträussler–Scheinker syndrome Familial Creutzfeldt–Jakob disease
(PrP P102L) (PrP P105L, 129V) (PrP A117V) (PrP G131V, 129M)
Fatal Familial Insomnia Familial Creutzfeldt–Jakob disease Familial Creutzfeldt–Jakob disease Familial Creutzfeldt–Jakob disease Familial Creutzfeldt–Jakob disease Familial Creutzfeldt–Jakob disease Gerstmann–Sträussler–Scheinker syndrome Familial Creutzfeldt–Jakob disease Familial Creutzfeldt–Jakob disease Familial Creutzfeldt–Jakob disease Familial Creutzfeldt–Jakob disease Familial Creutzfeldt–Jakob disease Gerstmann–Sträussler–Scheinker syndrome Gerstmann–Sträussler–Scheinker syndrome Familial Creutzfeldt–Jakob disease Familial Creutzfeldt–Jakob disease or Gerstmann–Sträussler–Scheinker syndrome
(PrP D178N, 129M) (PrP D178N, 129V) (PrP V180I, 129M) (PrP T183A, 129M) (PrP T188A, 129M) (PrP E196K) (PrP F198S, 129V) (PrP E200K, 129 M or V) (PrP V203I, 129M) (PrP R208H, 129M) (PrP V210M, 129M) (PrP E211Q, 129M) (PrP Q212P, 129M) (PrP Q217R, 129V) (PrP M232R, 129M) (PrP octapeptide repeat insertions)
The neuropathological features in these cases were remarkably similar and presented a spectrum of changes that were highly unusual for sporadic CJD. Although spongiform changes were present in all cases in the cerebral cortex, the most striking abnormality was the presence of multiple kurutype PrP plaques, many of which were surrounded by a halo of spongiform change. Similar plaques were present in other regions of the cerebrum and cerebellum. Spongiform change was most evident in the basal ganglia and thalamus, with severe thalamic astrocytosis. Immunocytochemistry showed widespread accumulation of PrP in the brain, particularly in the cerebellar cortex and occipital cortex. The relationship of these cases to sporadic CJD in older patients is unclear and further studies are required to characterize this unusual phenotype and investigate the possibility that these cases are usually related to the BSE agent via the human food chain. Epidemiological studies have not shown increased risk in particular occupations that may be exposed to human or animal prions, although individual CJD cases in two histopathology technicians, a neuropathologist, and a neurosurgeon have been documented. While there have been concerns that CJD may be transmitted by blood transfusion, extensive epidemiological analysis in the UK has found that the frequency of blood transfusion and donation was not different over 200 cases of CJD and a matched control population.29 Recent reports show that vCJD may be transmitted by blood. One case of probable transfusion-transmitted vCJD infection has been reported,
116
Molecular Detection of Foodborne Pathogens
A
B
C
6C4
D
E
F
T2
Type-1 CJD
Type-2 CJD
Figure 9.1 Immunohistochemical staining with monoclonal antibodies in human brain tissue with CJD. Type-1 (synaptic type) CJD specimen were intensively stained with mAbs 6C4 (Panel A) and T2 (Panel D) in the molecular layer of the cerebellum, with findings showing granular (Type-1; synapsis type) staining. Type-2 (Kuru type) spherical plaques (Panel B, C, E, F) in the cerebellum from a CJD patient with Met/Val polymorphism at codon 129 were differently stained with mAbs 6C4 and T2. The former was characterized by negative staining in the core of plaques, while the latter portrayed homogeneous staining of the central area (Panel C, F). (From Hosokawa, T., et al., Microbiol. Immunol., 52, 25, 2008.)
Table 9.4 Diagnostic Criteria for vCJD I
Progressive neuropsychiatric disorder Duration of illness > 6 months Routine investigations do not suggest an alternative diagnosis No history of potential iatrogenic exposure
II
Early psychiatric symptoms Persistent painful sensory symptoms Ataxia Mycolonus or chorea or dystonia Dementia
III
IV
Electroencephalogram does not show the typical appearance of sporadic CJD (or no electroencephalogram done) Bilateral pulvnar high signal on MRI scan Positive tonsil biopsy
and one case of subclinical infection has been detected.30,31 On February 9, 2006, a third case was announced by the UK Health Protection Agency. Each of the three patients had received a blood transfusion from a donor who subsequently developed clinical vCJD, which indicates that transfusion caused the infection. However, a policy to exclude potential donors who had received a fusion would not have prevented at least the first two cases because the corresponding donors had not received any blood transfusion. Diagnostic tools to
detect prions in blood are under development,32 but no routine test for the presence of the infectious agents of vCJD is available at present. Therefore, questions arise as to whether an infection like vCJD could spread endemically through blood donation alone and to what extent the exclusion of potential donors with a history of transfusion would influence the transmission of such an infection (i.e., how many deaths due to the infection could be prevented?). Transmission of CJD to rodents following intracerebral inoculation with buffy coat from CJD cases has been reported.33 The transmission study on rodents or chimpanzee have been done with blood from sporadic or genetic CJD, indicating that the transmissibility of sporadic CJD do not occur by transfusion.34 In addition, differently from vCJD this transmitted strain is not lymphotrophic.
9.1.3 Laboratory Diagnosis of Slow Viral Diseases A specific diagnosis of prion diseases relies on the detection of PrPSc (Table 9.5). However, the diagnostic methods currently used such as immunohistochemistry, western blotting, and enzyme-linked immunosorbent assay (ELISA) techniques apparently lack sufficient specificity to detect PrPSc in cerebrospinal fluid although transmission studies indicate the presence of some infectivity in some species.35 PrPSc can be distinguished from PrPC by its high beta-sheet content,36 its partial resistance to protease digestion,37 and its tendency to form large aggregates both in vivo and in vitro.38 The formation of multimeric aggregates can be assumed to be closely
117
Slow Viral Diseases
Table 9.5 Diagnostic Methods for Prion Infections Method
Principle
Western blotting ELISA
PK-resistant PrP PK-resistant PrP
Immunohistochemistry Bioassay Cell culture assay Histoblot
PK-resistant PrP PK-resistant PrP, incubation time or infectivity titer PK-resistant PrP or infectivity titer PK-resistant PrP
Cell blot
PK-resistant PrP
Slot blot
PK-resistant PrP
PET blot
PK-resistant PrP
PMCA
PK-resistant PrP
CDI DELFIA
PrP conformation Insoluble PrP
Capillary gel electrophoresis
PK-resistant PrP
FCS
Aggregation of PrP
Aptamer
PrP conformation
FT-IR spectroscopy MUFS Flow microbead immunoassay Surrogate marker
Alterations of spectral feature Alterations of spectral feature PK-resistant PrP Change of expression level of 14-3-3 protein, erythroid-specific marker or plasminogen
Procedural Detail Detect PK-resistant PrP on the membrane Detect PK-resistant PrP adsorbed on microtiter plates by anti-PrP antibody Immunostain of tissue sections Transmission to mice Transmission to cells Cryosection is blotted onto membrane before PK-treatment and immunolabeling with anti-PrP antibody Grow the cells on cover slip, directly transfered to membrane, and detect the PK-resistant PrP using anti-PrP antibody. Filter the cell lysate through nitrocellulose membrane, and detect the PK-resistant PrP using anti-PrP antibody. Paraffin-embedded tissue section is collected on membrane, and PK-resistnt PrP is immunolabeled with anti-PrP antibody Amplfication of misfolding protein by cycles of incubation and sonication Specific antibody binding to denatured and native forms of PrP Measure a percentage of the insoluble PrP extracted by two concentrations of guanidine hydrochloride Competition between fluorescein labeled synthetic PrP peptide and PrP present in samples is assayed by separation of free and antibodypeptide peaks using capillary electrophoresis PrP aggregates were labeled by anti-PrP antibody tagged with fluorecent dyes, resulting in intensity fluorescent target, which were measured by dual-color fluorescence intensity distribution analysis Use RNA aptamers that specifically recognize PrPC and/or PrPSc conformation. Analyze FT-IR spectra with statistical analysis Analyze spectra of emission excited by ultraviolet radiation Detect PK-resistant PrP using flowcytometer with anti-PrP antibody coupled with microbeads Detect the change by two-demensional gel electrophoresis, differential display reverse-transcriptase PCR or Western blotting of surrogate marker proteins for prion diseases
References [108] [109] [110] [111] [112] [78] [54] [56] [43,77] [81] [57] [113] [78,88]
[41,91]
[104] [92] [93] [79] [114–117]
Source: Modified from Sakudo, A. et al., J. Vet. Med. Sci., 69, 329, 2007. With permission from The Japanese Society of Veterinary Science. Notes: PET: Paraffin-embedded tissue, PMCA: Protein misfolding cyclic amplification, CDI: Conformation-dependent immunoassay, DELFIA: Dissociationenhanced lanthanide fluorescent immunoassay, FCS: Fluorescence correlation spectroscopy, FT-IR: Fourier transformed infrared, ELISA: Enzymelinked immunosorbent assay, MUFS: Multi-spectral ultraviolet fluorescence spectroscopy, PCR: Polymerase chain reaction, PK: Proteinase K, PrP: Prion protein, PrPC: Cellular isoform of PrP, PrPSc: Abnormal isoform of PrP.
related to the infection process.39,40 Since the ultimate detection limit should be the PrPC aggregate within a given sample volume, Bieschke et al. established a diagnostic test capable of detecting single aggregates of PrPSc.41 It was estimated that in the UK during the years from 1985 to 1995, tissue from more than 700,000 cattle carrying BSE entered the human food chain, while at the same time BSE was identified in 180,000 carcasses that were destroyed.42 This shows the necessity for sensitive methods that are able to identify BSE at an early stage. A sensitive paraffinembedded tissue (PET) blot method that detects prion PrPSc deposits in formalin-fixed and PET after blotting on a nitrocellulose membrane has been developed.43 Its sensitivity has
been compared with that of the histological and immunohistochemical (IHC) methods and the western blot method used in Prionics. With the PET blot method, four clinically less conspicuous cases showed the same PrPSc deposition pattern as was seen in clinical BSE. In these cases, the results of histological examination and western blotting were negative.43 Western blotting shows the presence and absence of protein production and also provides information on the molecular weight of peptides from the mobility shift of bands. Originally the application of a western blot technique for screening large numbers of cattle was considered difficult. Oesch et al. developed a rapid western blotting procedure (named Prionics Check or PWB), which has undergone
118
odifications by the Swiss and British Veterinary Authorities m as well as the European Commission. Samples of brain stem from officially confirmed BSE or scrapie cases and samples from healthy New Zealand adult bovines could be diagnosed with 100% specificity and sensitivity.44,45 Furthermore, autolyzed samples could still be diagnosed correctly leading to the development of a unique surveillance program in Switzerland to test fallen stock for hidden cases of BSE. The routine application of the Prionics western blotting technique has also revealed unrecognized BSE cases that would have gone into the food chain. When peptides are modified with aberrant glycosylation, a different electrophoretic mobility is observed. Therefore, the mobility is influenced by the host genotype and also by prion strains.46,47 In other words, a mobility index is used to differentiate sCJD subtype (i.e., type 1 or type 2A), or iatrogenic CJD (iCJD) and sCJD to vCJD because of the different PrPSc glycoform profile.48–53 Recently, a modified western blotting method has been developed for prion detection. Cell blot54 is a method whereby cells grown on cover-slips are transferred to a nitrocellulose membrane where the PK-resistant PrP is then detected by western blotting.54 In addition, slot blotting55 is a method whereby cell lysates are filtered through a nitrocellulose membrane using a slot-blot device before the PK-resistant PrP in the membrane is detected by western blotting.55 The sensitivity of western blotting can be also enhanced by centrifugation56 or the development of an extraction method. An example of a modified extraction method is the sodium phosphotungstic acid (PTA) method.57,58 PTA can precipitate PrPSc from solutions. Guanidine hydrochloride has also been used to extract PrPSc. Western blotting has disadvantages in terms of processing time, the limited number of samples that can be processed, and the need for experienced personnel. These problems are at least in part overcome by the ELISA, although ELISA also has disadvantages (e.g., false-positive results and low cost-effectiveness), which western blotting does not have. Meanwhile, Grassi et al. chose to develop a conventional two-site immunometric assay (sandwich immunoassay) based on the use of two different monoclonal antibodies recognizing two distinct epitopes on the PrP molecule. In this category of immunoassay, the first antibody (capture antibody) is immobilized on a solid phase (e.g., a microtiter plate) while a second antibody, covalently labeled with an enzyme (e.g., acetylcholine esterase, AchE), is used as a tracer.59,60 PrP in a sample is detected by measuring enzyme activity bound to the solid phase through the intermediary of capture antibodyPrP-tracer antibody reactions. A two-site immunometric assay was chosen because it has been clearly demonstrated that this kind of immunoassay provides more sensitive, more specific, and faster measurement than other tests.61 With the ELISA method, PK-resistant PrP is directly absorbed on a microtiter plate or captured by the anti-PrP antibody coated on a microtiter plate, and detected or sandwiched by other anti-PrP antibodies. This mechanism of action is commercially exploited in Prionics Check EIA (Prionnics/Roche, Switzerland), Roche Applied Science PrionScreen (Roche, Switzerland), the Bio-Rad Platelia BSE purification kit and
Molecular Detection of Foodborne Pathogens
Bio-Rad BSE detection kit (Bio-Rad, France), the FRELISA BSE Kit (FUJIREBIO inc., Japan), the IDEXX HerdChek BSE antigen test kit (IDEXX Laboratories, USA), and Institut Pourquier Speed’it BSE (Institut Pourquier, France). Modified versions of this method are also commercially available such as VMRD CWD dbELISA (VMRD, Inc., USA), Enfer-TSE kit (Abbott Laboratories, USA), Prionics-Check LIA (Prionics, Switzerland), and CediTect BSE test (Eurofins Analytico Food, Netherlands). Although the extensively employed ELISA method is sensitive with high throughput and does not require sophisticated techniques, the high frequency of falsepositive results remains a problem. Another common method to diagnose prion diseases is the IHC analysis of brain sections (Figure 9.2).62,63 In IHC analysis, typical features of prion diseases such as the accumulation of PrP amyloid plaques, astroglyosis, and neuronal
BSE DMV F99-IHC 20x
BSE DMV 6C4-IHC 20x
BSE DMV T2-IHC 20x
Scrapie DMV F99 – IHC 20x
Scrapie DMV 6C4 – IHC 20x
Scrapie DMV T2 - IHC 20x
Figure 9.2 Immunohistochemistry of brain tissues from Italian cases of sheep scrapie and BSE. Diffuse particulate deposition of PrPSc was portrayed with mAbs 6C4 and T2 in the neuropil. The commercial mAb (F99/97) used as a control produced analogous results.(From Hosokawa, T. et al., Biochem. Biophys. Res. Commun. 366, 657, 2008. With permission from Dr. Casalone.)
Slow Viral Diseases
cell loss are examined by light microscopy. Although vacuolation is also sometimes used as an index of prion infection, many combinations of prion strains and host species portray PrPSc accumulation without vacuolation in brain sections after prion infection.64,65 Furthermore, the region of the brain where PrPSc is accumulated is dependent on the prion strain.66 Recently, the histopathological analysis of organs/ tissues other than the brain has been studied for the diagnosis of prion diseases. For example, the tonsils seem to be applicable in humans, deer, and sheep,58,67–72 while the appendix has been used for the preclinical diagnosis of vCJD in humans.58,73–76 Lesion profiles are often used for the discrimination of prion strains, which induces strain-specific patterns of vacuolation and PrPSc accumulation in the brain. In addition, IHC analysis has been improved with modified histoblotting or PET blotting. Such improvements further enable the detection of PrPSc in cryosections.43,77,78 There are several newly developed methods using antiPrP antibody for the detection of PrP or PrP isoforms. Conformation-dependent immunoassay (CDI) is a method employed to detect conformational differences between PrP isoforms by measuring the relative binding of antibodies to denatured and native proteins.57 CDI is commercially used for the CDI test in InPro Biotechnology, Inc. (USA). In other cases, using anti-PrP antibody-coupled microbeads and a flowcytometer, the flow microbead-immunoassay (FMI) method, detected 7-pmol/7-nmol recombinant PrP and PrPSc spiked in bovine meat and bone meal at concentrations higher than 0.3%.79 It should be emphasized that the novel PMCA technology amplifies cyclically the misfolding and aggregation process in vitro.80 It is conceptually analogous to DNA amplification by polymerase chain reaction (PCR). In this system, sequential cycles of incubation and sonication in the presence of seed PrPSc supplied with PrPC. Importantly, the PMCA method amplifies not only PrPSc but also prion infectivity titers.81 Furthermore, this method enables prion detection in blood from not only terminally diseased hamsters but also prion-infected presymptomatic hamsters.82 Five cycles of PMCA reaction achieved 97% conversion of PrPC to PrPSc in brain homogenate.83 This sensitivity is the highest among the detection methods for prion proteins reported so far. PrPSc detection is possible at >10,000-fold dilution, though the sensitivity could be increased if a more highly sensitive modified western blotting method was to be combined with this method. However, it should be noted that the protocol for PrPSc amplification depends on prion strain, species, and sample source (e.g., brain homogenate, blood, etc.). At present, the application of this method for vCJD, CWD, and hamster and mouse scrapie has been reported.83–86 Recently, the development of modified PMCA such as recombinant PrP-PMCA (rPrP-PMCA) has been studied.87 These developments will help to expand the use of this method in the field of prion biology. To date, this method has been mainly restricted to the study of prion conversion mechanisms and diagnosis of prion diseases. Capillary gel-electrophoresis is an approach that takes advantage of competitive antibody-binding between a
119
fluorescein labeled synthetic PrP peptide and PrP present in tissue samples.88,89 The free peptide and antibody-peptide peaks are separated by capillary electrophoresis. The sensitivity of this method is high; only 50 amol/l (10 –18 mol/l) of fluorescent marker was used,89 while the specificity of this method remains unclear. For example, a recent report from Brown et al.90 has shown the difficulty in reproducing the results presented in a previous report by Schmerr et al.89 Fluorescence correlation spectroscopy (FCS) is also a highly sensitive method that detects single fluorescently labeled molecules in solutions.49,91 PrPSc can be labeled by the anti-PrP antibody or by conjugation with a labeled recombinant PrP. Fourier transformed infrared spectroscopy is a diagnostic method that incorporates the multivariate analysis of infrared spectra discriminating between prion-infected and uninfected animals.92 Such a spectroscopy-based assay is also used in multi-spectral ultraviolet fluorescence spectroscopy (MUFS).93 MUFS identifies changes in the spectral pattern of emission excited by ultraviolet radiation. The advantages of these methods are lack of pretreatment steps to eliminate PrPC (such as PK treatment) and anti-PrP antibody. However, the practical use of MUFS has not been reported so far. As similar spectral analysis, visible, and near-infrared (Vis-NIR) spectroscopy could be promising for noninvasive diagnosis94 because VisNIR radiation is transmissible into the body. Overall, discriminatory analysis of spectra between infected and uninfected animals could be useful for the diagnosis of prion diseases. A tool for detecting PrPSc has been developed recently. Although some antibodies and aptamers are able to distinguish PrPSc from PrPC, they have not had extensive practical applications. Antibodies with a conformational epitope of PrPSc were obtained by immunization of Tyr-Tyr-Arg peptide.95 Antibodies 15B3 and V5B2 can also recognize PrPScspecific epitopes.96,97 However, these antibodies have not been practically exploited and their applications in experiments have been limited. PrPC and/or PrPSc-specific binding RNA or DNA aptamers have also been reported.98–100 Although the use of animal bioassays has been considered the most sensitive way to detect infectivity, a recently developed western blot test is said to match or surpass the bioassays in reliability/accuracy.58 Although PrP-expressing transgenic mice inoculated with fibrils consisting of recombinant PrP or PMCA-amplified PrPSc exhibit a similar neuropathology similar to that found in prion diseases,2 it remains to be established whether PrPSc is completely identical in these cases or is the only entity of prions. Therefore, the determination of infectivity with a reliable animal bioassay is the gold standard, although the assay may require a longer time and many more animals to confirm this finding. Furthermore, the characteristics of this assay may occasionally demand sophisticated techniques.1 It should be also noted that the volume of inoculum is critical for reducing standard errors of the results in animal bioassays. Certain animal bioassays for prion diagnosis are time-consuming and economically nonviable. However, transmission of prions to their natural host is very informative and helpful for understanding the clinical phenotype of diseases. However, cell culture systems that
120
specifically and reliably detect prion have been developed to certain strains of prion.101 Prion diseases can usually be diagnosed only by a postmortem analysis with an ELISA, western blotting, IHC means, and animal bioassays using brain samples.102 A premortem diagnostic method for prion diseases remains to be established. Recently, dramatic improvements to highly sensitive diagnostic methods such as PMCA have been achieved, some of which raise the possibility of a premortem diagnosis using blood samples, though the further development of analytical methods to specifically and reliably detect prions is more important with increasing emphasis on reducing prionrelated risks recognized in terms of public health and the safety of food and blood supplies. We still have the old questions for currently available immunological methods: (i) Which animal and in vitro models are currently available for the detection and quantification of prion infectivity? (ii) Which diagnostic techniques allow the reliable investigation and confirmation of suspect cases in animals and humans?
9.2 Methods 9.2.1 Reagents and Equipment Reagents: Dithiothreitol (DTT, Promega, Madison, WI) N-tetradecyl 1-N, N-dimethyl-3-ammonio-1-propanesulfonate, sulfobetaine, (SB 3-14, Calbiochem or Sigma) N-lauryl-sacrosine (Sigma), protease inhibitors were from Roche RNAse A (from bovine pancreas, protease-free) and DNAse I were from Calbiochem or Roche Protein concentration assay kit (BCA) from Pierce Others listed in Table 9.6. Equipment: To avoid cross contamination between different scrapie strains, we recommend the use of new glassware and instruments or single use materials for animal inoculations, dissection of brains from affected animals, and during the purification of PrPSc. This is especially important if the isolates are to be used in animal bioassays. Avoid blood contamination during dissection of brains, rinse excised brains in PBS, flash freeze in liquid nitrogen, and store at –70°C. All solutions must be filtered (0.2 μm) and placed in lint-free vessels previously rinsed with distilled or deionized water. All procedures are performed in a laminar flow biosafety cabinet in an appropriate laboratory according to governmental regulations. Use personal protection equipment (lab coat, gloves, and face mask) and change gloves frequently.
9.2.2 Sample Collection and Preparation PrPSc was prepared using a modified version of the procedure described by Shinagawa et al.103 PrPSc from TSE-affected brain tissue has been successfully purified in several species
Molecular Detection of Foodborne Pathogens
including humans with CJD and vCJD, sheep with scrapie, cattle with BSE, and cervids with CWD. Numerous experiments have used PrPSc isolates purified by this procedure allowing detailed analyses of several different aspects of TSE diseases. Typically the PrPSc yield from the hamster 263K strain is 50–100 μg per gram of brain. The method described yields PrPSc preparations with a total protein content of between 60 and 90%. Non-proteinase K (PK) digested preparations are usually less pure than PK-digested preparations since nearly all other proteins are digested by PK. However, a significant protein contaminant identified in these preparations is ferritin, which survives even PK treatment.104 Variations in purity may depend on the TSE strain, the stage of the disease, the manner in which the brain is excised and stored, and the expediency of the purification. In addition to contamination by other proteins, the final PrPSc sample most likely contains trace quantities of lipids, nucleic acids, carbohydrates, and ions (copper, iron, calcium, etc). Preparations not treated with PK are characterized by the presence of truncated and nontruncated PrPSc forms (Figure 9.3). This is likely due to in situ proteolysis that occurs in infected brains; however, additional proteolysis may occur during the excision and/or purification procedure even though steps such as rapid freezing, careful temperature control, and the use of protease inhibitors during the purification are used in an attempt to prevent proteolysis. Since PrPSc itself is thought to be the infectious agent of TSEs, it would be of interest to achieve its purification to homogeneity in order to test this hypothesis.
9.2.3 Detection Procedures PrPSc is the most reliable biomarker for prion diseases and also the main component of prions. Therefore, most of the methods used for the diagnosis of prion infections rely on the presence of PrPSc (Table 9.5). Following PK digestion PrPC is completely degraded, whereas the C-terminal of fragment PrPSc is partially resistant. This feature is used to distinguish PrPSc from PrPC.37,105 As PrPSc is highly accumulated in brain in the clinical phase of diseases, brain samples are appropriate for these methods, which are required for post-mortem analysis. One of the most reliable methods of detecting prions is western blotting. Western blotting is used to detect PK-resistant PrP in extracts from the brain and other tissues. PK-digested samples are first subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by transfer of the separated peptides blotted onto the membrane with the anti-PrP antibody. A western blotting kit (Prionics Check Western Test) is commercially available from Prionics AG (Switzerland). To cite a case, a representative simple step-wise protocol of western blotting for prion-noninfected HpL3-4-PrP cells106 and persistently prion-infected ScN2a cells with anti-PrP antibody SAF83 (SPI Bio., Montigny le Bretonneux, France) has been shown as follows:
121
Slow Viral Diseases
Table 9.6 Solutions, Reagents, and Buffers Buffer
Component
Volume
10 × PBS pH 6.9
26.8 g Na2HPO4-7H2O 14.8 g NaH2PO4-H2O 75.9 g NaCl
1000 ml
1 × PBS, pH 7.4
100 ml 10× PBS, pH 6.9 900 ml de-ionized water 340.5 ml M Na2HPO4 159.5 ml M NaH2PO4 10 ml 1 M Tris-Cl, pH 8.0 2 ml 0.5 M EDTA 26.2 ml 5 M NaCl 0.002 ml 1 M DTT 50 g Na N-lauryl-sacrosine 100 ml 5× TEND 171 ml 5 M NaCl 100 ml 5× TEND 5 g SB 3–14 1 ml 1 M Tris-Cl 0.5 ml 1 M MgCl2 2 ml 5 M NaCl 68.5 g sucrose 4 ml 5 M NaCl 1 g SB 3–14 2 ml 1 M Tris-Cl 0.5 g SB 3–14 10 ml 10× PBS
1000 ml
1 M NaPO4, pH 6.9 5 × TEND (50 mM Tris-HCl, pH 8.0 at 4°C; 5 mM EDTA; 5 mM EDTA; 665 mM NaCl; 1 mM DTT, added immediately before use) 10% Sarcosine (TEND) 10% NaCl, 1% SB 3-14 (TEND)
TMS (10 mM Tris-HCl, pH 7.0 at 20°C; 10 mM Tris-HCl, pH 7.0 at 20°C; 100 mM NaCl) 1 M Sucrose; 100 mM NaCl; 0.5% SB 3–14; 10 mM Tris-CI, pH 7.4 at 20°C
0.5% SB 3–14/1× PBS
500 ml 500 ml
500 ml
100 ml
200 ml
100 ml
1 M DTT (1000 ×) Protease inhibitors Pls (1000 ×)
0.5 mg/ml Leupeptin = 1 μM (in H2O) 1 mg/ml Aprotinin = 0.15 μM (in H2O) 1 mg/ml Pepstatin = 1 μM (in methanol) 24 mg/ml Pefabloc = 0.1 M (in 0.05 M Tris-HCl, pH 6.5) at 20°C
Note: DTT and PI solutions are freshly diluted into buffers.
(1) For preparation of the cell lysate, detach cells with a scraper and wash twice with ice-cold PBS. (2) Solubilize the washed cells in radio-immunoprecipitation assay (RIPA) buffer containing 10 mM TrisHCl (pH 7.4), 1% deoxycholate, 1% Nonidet P-40, 0.1% sodium dodecyl sulfate (SDS), and 150 mM NaCl and then sonicated at 4°C for 10 min. (3) Remove the cellular debris by centrifugation at 5,000 × g for 1 min. (4) Measure the protein concentration of the supernatants using a Bio-Rad DC protein assay (Bio-Rad, Hercules, CA). (5) Treat the sample (120 μg protein) with proteinase K at 20 μg/ml for 30 min at 37°C. (6) Add an equal volume of 2× SDS gel-loading buffer (90 mM Tris/HCl pH 6.8, 10% mercaptoethanol, 2% SDS, 0.02% bromophenol blue, and 20% glycerol) and heat the samples at 100°C for 10 min to terminate the reaction before western blotting. Cells treated as above except for the digestion by PK should be also included as control.
(7) Separate the proteins by conventional SDS-PAGE (12%) as described elsewhere. (8) Transfer the proteins to polyvinylidene difluoride (PVDF) membranes (Amersham Biosciences, Piscataway, NJ) using a semidry blotting system (Bio Rad, Cambridge, MA). (9) Block the membranes with 5% skim milk for 1 h at room temperature. (10) Further incubate the blocked membranes for 1 h at room temperature with anti-PrP antibody SAF83 (SPI bio), which recognizes residues 126–164 of PrP, in PBS-Tween (0.1% Tween 20) containing 0.5% skim milk. Note: anti-PrP antibodies recognizing the C-terminal half of PrP such as SAF83 and 6H4 (Prionics AG) can be used for the detection of PrPSc in this western blotting system, whereas those recognizing the N-terminal half of PrP such as SAF32 (SPI bio) cannot be used. This is because the C-terminal half of PrPSc is resistant to PK, whereas the N-terminal half is susceptible to PK.
122
Molecular Detection of Foodborne Pathogens
1
2
3
Uninfected PK
–
+
4
Infected –
+
5
6
7
Uninfected –
8
Infected
+
–
+
HpL3-4-PrP (Prion non-infected cells) (kDa) 51
PK
(–)
ScN2a (Persistently prion infected cells)
(+)
PK
(–)
(+)
75 50 37
35 29
25 20
Anti-PrP Ab (SAF83)
15
10 21 6H4
P8
Figure 9.3 Detection of PrPSc in the brains of terminally diseased mice. PrP from the brain membrane fraction (30 μg protein per lane) of uninfected mice (lanes 1, 2, 5, 6) and terminally diseased mice intracerebrally inoculated with Obihiro-1 prions (lanes 3, 4, 7, 8) was detected by western blotting with anti-PrP 6H4 (lanes 1–4) and P8 (lanes 5–8). Each fraction was treated (+)(lanes 2, 4, 6, 8) with proteinase K (PK), or left untreated (–) (lanes 1, 3, 5, 7). (From Inoue, Y. et al., Jpn J. Infect. Dis., 58, 78, 2005. With permission from the National Institute of Infectious Diseases, Japan.)
(1) Wash the membranes three times for 10 min in PBSTween and incubated with horseradish peroxidase (HRP)-labeled anti-mouse immunoglobulin secondary antibody in PBS-Tween containing 0.5% skim milk for 1 h at room temperature before being washed three times in PBS-Tween for 10 min. (2) Further develop the membranes with an enhanced chemiluminescence (ECL) reagent (Amersham) for 5 min. Blots were exposed to ECL Hypermax film (Amersham). Films were processed in an X-ray film processor. The results obtained by western blotting using HpL3-4-PrP and ScN2a cells with SAF83 are shown in Figure 9.4. HpL34-PrP cells106 generate PrPC but not PrPSc, while ScN2a cells produce both PrPC and PrPSc. Therefore, PrP in HpL3-4-PrP cells is digestible with PK, whereas PrP in ScN2a is partially resistant to PK. Therefore, it is obvious that western blotting of PrP using the anti-PrP antibody detects PrP in ScN2a but not in HpL3-4-PrP after digestion by PK (Figure 9.4).
9.3 Conclusions and Future Perspectives The chain reaction of BSE epidemics in the UK and Europe and subsequent emergence of vCJD in young adults and teenagers have raised concerns and highlighted the importance of risk assessment in the food chain. Recently, several highly
Figure 9.4 Detection of the abnormal isoform of prion protein (PrPSc) in cell cultures. Detection of prion protein (PrP) in lysates from HpL3-4 cells (PrP gene-deficient neuronal cells retransformed with a PrP-expressing vector) and ScN2a cells (persistently prion-infected neuroblastoma) with (+) and without (–) proteinase K (PK) treatment was performed by western blotting with anti-PrP antibody SAF83 (SPI Bio, Montigny le Bretonneux, France). PK digested the cellular isoform of prion protein (PrPC) without affecting PrPSc. Therefore, PK-resistant PrP is usually used as an index of prion infection. A relevant example of PK-resistant PrP detected in ScN2a cells but not in HpL3-4-PrP cells is shown.
sensitive methods for detecting prions have been developed. Representative of these is PMCA. Originally developed by Claudio Soto and his colleagues, PMCA has been a hot topic of debate in prion meetings all over the world. A broad spectrum of PrPSc species have now been successfully amplified using PMCA, including CWD, mouse-adapted scrapie, and BSE. Studies with human sporadic and variant CJD cases show that PMCA amplification efficiency is tightly controlled by the PrPC substrate genotype at codon 129. PMCA appears to overcome the species barrier encountered during cross-species transmission more rapidly than in vivo. By “forcing” the technique with lower dilutions of the PrPSc seed and more amplification rounds, mouse Chandler PrPSc can now convert hamster PrPC or cervid PrPC, a conversion that might be observable in vivo but only with extremely long incubation periods. Castilla J. showed that using PMCA, PrPSc was generated from the healthy brains of 11 different species, including bank voles, mice, cattle, humans, sheep, and rabbits, generating a variety of electrophoretic profiles.107 PMCA was able to detect PrPSc in as little as 1 μl of blood from an asymptomatic prion-infected mouse. Given the increasing evidence of human to human transmission via blood products, scientists are waiting for PMCA to be incorporated into a reliable test with the ability to identify blood donors that are asymptomatic carriers. Further advances in amplification technology are to be expected and the replacement of PrPC by recombinant PrP as a substrate as well as the use of intermittent shaking rather than sonication should circumvent some of the difficulties in the near future.
Slow Viral Diseases
References
1. Aguzzi A. and Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell, 116, 313, 2004. 2. Legname G. et al. Synthetic mammalian prions. Science, 305, 673, 2004. 3. Harris D.A. Trafficking, turnover and membrane topology of PrP. Br. Med. Bull., 66, 71, 2003. 4. Horiuchi M. and Caughey B. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J., 18, 3193, 1999. 5. Bueler H. et al. Mice devoid of PrP are resistant to scrapie. Cell, 73, 1339, 1993. 6. Scott M. et al. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell, 73, 979, 1993. 7. Shmerling D. et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell, 93, 203, 1998. 8. Barron R.M. et al. Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J., 20, 5070, 2001. 9. Perrier V. et al. Dominant-negative inhibition of prion replication in transgenic mice. Proc. Natl. Acad. Sci. USA, 99, 13079, 2002. 10. Chiesa R. et al. Molecular distinction between pathogenic and infectious properties of the prion protein. J. Virol., 77, 7611, 2003. 11. Chesebro B. et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science, 308, 1435, 2005. 12. Gajdusek D.C. et al. Kuru: clinical pathological and epidemiological study of an acute progressive disease of the central nervous system among natives of the Eastern Highland of New Guinea. Am. J. Med., 26, 442, 1959. 13. Gajdusek D.C. et al. Degenerative diseases of the central nervous systems in New Guinea: the endemic occurrence of “kuru” in the native population. N. Engl. J. Med., 257, 974, 1959. 14. Hadlow, W.J. Scrapie and kuru. Lancet, 2, 289, 1959. 15. Prusiner, S.B. et al. Kuru with incubation periods exceeding two decades. Ann. Neurol., 12, 1, 1982. 16. Zigas, V. et al. Kuru: clinical study of a new syndrome resembling paralysis agitants in natives of the Eastern Highlands of Australian New Guinea Med. J. Aust., 2, 745, 1957. 17. Sigurdsson, B. Rida, a chronic encephalitis of sheep: with general remarks of infections which develop slowly and some of their characteristics. Brit. Vet. J., 110, 341, 1954. 18. Gadjusek, D.C. Unconventional viruses and the origin and disappearance of kuru. Science, 197, 943, 1977. 19. Come, J.H. et al. A kinetics model for amyloid formation in the prion diseases: Importance of seeding. Proc. Natl. Acad. Sci. USA, 99, 5959, 1993. 20. Hendrix, J.C. et al. A convergent synthesis of the amyloid protein of Alzheimer’s disease. J. Amer. Chem. Soc., 114, 7930, 1992. 21. Jarett, J.T. et al. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: Implication for the pathogenesis of Alzheimer’s disease. Biochemistry, 32, 4693, 1993. 22. Aiken, J.M. et al. The search for scrapie agent nucleic acid. Microbiol. Rev., 54, 242, 1990. 23. Brown, P. et al. The new biology of spongiform encephalopathy: Infectious amyloidosis with a genetic twist. Lancet, 337, 1019, 1991.
123 24. Prusiner, S.B. Molecular biology of prion diseases. Science, 252, 1515, 1991. 25. Weissmann, C. A “unified theory” of prion propagation. Nature, 352, 679, 1991. 26. Gabizon, R. et al. Prion liposome. Biochem. J., 266, 1, 1990. 27. Will, R.G. et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet, 347, 921, 1996. 28. Chazot, G. et al. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet, 347, 1181, 1996. 29. Esmonde, T.F.G. et al. Creutzfeldt-Jakob disease and blood transfusion. Lancet, 341, 205, 1993. 30. Llewelyn, C.A. et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet, 363, 417, 2004. 31. Peden, A.H. et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet, 364, 527, 2004. 32. Castilla, J. et al. Detection of prions in blood. Nat. Med., 11, 982, 2005. 33. Tateishi, J. Transmission of Creutzfeldt-Jakob disease from human blood and urine into mice. Lancet, 2 (8463), 1074, 1985. 34. Gajdusek, D.C. Subacute spongiform encephalopathies: transmissible cerebral amyloidosis caused by unconventional viruses. In: Virology, B.N. Fields and D.M. Knipe (eds). pp. 2289–2324. Raven Press, New York, 1990. 35. Brown, P. et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol., 35, 513, 1994. 36. Pan, K.M. et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA, 90, 10962, 1993. 37. Meyer, R.K. et al. Separation and properties of cellular and scrapie prion proteins. Proc. Natl. Acad. Sci. USA, 83, 2310, 1986. 38. Prusiner, S.B. et al. Scrapie prions aggregate to form amyloidlike birefringent rods. Cell, 35, 349, 1983. 39. Eigen, M. Prionics or the kinetic basis of prion diseases. Biophys Chem, 63, A1, 1996. 40. Caughey, B. et al. Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem. Biol., 2, 807, 1995. 41. Bieschke, J. et al. Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc. Natl. Acad. Sci. USA, 97, 5468, 2000. 42. Anderson, R.M. et al. Transmission dynamics and epidemiology of BSE in British cattle. Nature, 382, 779, 1996. 43. Schulz-Schaeffer, W.J. et al. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am. J. Pathol., 156, 51, 2000. 44. Schaller, O. et al. Validation of a western immunoblotting procedure for bovine PrP(Sc) detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE). Acta Neuropathol., 98, 437, 1999. 45. Schimmel, H. and Moynagh, J. Preliminary report concerning the evaluation of test for the diagnosis of transmissible spongiform encephalopathy in bovines. Available at http:// ec.europa.eu/food/fs/bse/bse12 en.html 46. Pan, T. et al. Novel differences between two human prion strains revealed by two-dimensional gel electrophoresis. J. Biol. Chem., 276, 37284, 2001. 47. Thuring, C.M. et al. Discrimination between scrapie and bovine spongiform encephalopathy in sheep by molecular size, immunoreactivity, and glycoprofile of prion protein. J. Clin. Microbiol., 42, 972, 2004.
124 48. Collinge, J. et al. Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature, 383, 685, 1996. 49. Head, M.W. et al. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991–2002. Ann. Neurol., 55, 851, 2004. 50. Notari, S. et al. Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J. Biol. Chem., 279, 16797, 2004. 51. Parchi, P. et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol., 46, 224, 1999. 52. Schoch, G. et al. Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med., 3, e14, 2006. 53. Wadsworth, J.D. et al. Molecular and clinical classification of human prion disease. Br. Med. Bull., 66, 241, 2003. 54. Bosque, P.J. and Prusiner, S.B. Cultured cell sublines highly susceptible to prion infection. J. Virol., 74, 4377, 2000. 55. Winklhofer, K.F., Hartl, F.U. and Tatzelt, J. A sensitive filter retention assay for the detection of PrP(Sc) and the screening of anti-prion compounds. FEBS Lett., 503, 41, 2001. 56. Fujita, R. et al. Efficient detection of PrPSc (263K) in human plasma. Biologicals, 34, 187, 2006. 57. Safar, J. et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med., 4, 1157, 1998. 58. Wadsworth, J.D. et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet, 358, 171, 2001. 59. Ekins, R.P. and Jackson, T. Non isotopic immunoassays. In: Monoclonal Antibodies and New Trends in Immunoassay. An Overview, C.A. Bizollon (Ed.). p. 129. Elsevier, Amsterdam, 1984. 60. Grassi, J. et al. Production of monoclonal antibodies against interleukin-1 alpha and -1 beta. Development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media. J. Immunol. Methods, 123, 193, 1989. 61. Moynagh, J. et al. Tests for BSE evaluated. Bovine spongiform encephalopathy. Nature, 400, 105, 1999. 62. Armstrong, R.A. et al. Quantification of vacuolation (“spongiform change”), surviving neurones and prion protein deposition in eleven cases of variant Creutzfeldt-Jakob disease. Neuropathol. Appl. Neurobiol., 28, 129, 2002. 63. Ironside, J.W. et al. Pathological diagnosis of variant Creutzfeldt-Jakob disease. APMIS, 110, 79, 2002. 64. Iwata, N. et al. Distribution of PrP(Sc) in cattle with bovine spongiform encephalopathy slaughtered at abattoirs in Japan. Jpn J. Infect. Dis., 59, 100, 2006. 65. Orge, L. et al. Identification of putative atypical scrapie in sheep in Portugal. J. Gen. Virol., 85, 3487, 2004. 66. Hirogari, Y. et al. Two different scrapie prions isolated in Japanese sheep flocks. Microbiol. Immunol., 47, 871, 2003. 67. Hill, A.F. et al. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet, 349, 99, 1997. 68. Hill, A.F. et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet, 353, 183, 1999. 69. Schreuder, B.E. and Somerville, R.A. Bovine spongiform encephalopathy in sheep? Rev. Sci. Tech., 22, 103, 2003. 70. Schreuder, B.E. et al. Preclinical test for prion diseases. Nature, 381, 563, 1996. 71. van Keulen, L.J. et al. Pathogenesis of natural scrapie in sheep. Arch. Virol. Suppl., 57, 2000.
Molecular Detection of Foodborne Pathogens 72. Wild, M.A. et al. Preclinical diagnosis of chronic wasting disease in captive mule deer (Odocoileus hemionus) and white-tailed deer (Odocoileus virginianus) using tonsillar biopsy. J. Gen. Virol., 83, 2629, 2002. 73. Hilton, D.A. et al. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease Lancet, 352, 703, 1998. 74. Hilton, D.A. et al. Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ, 325, 633, 2002. 75. Hilton, D.A. et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J. Pathol., 203, 733, 2004. 76. Ironside, J.W. et al. Retrospective study of prion-protein accumulation in tonsil and appendix tissues. Lancet, 355, 1693, 2000. 77. Ritchie, D.L., Head, M.W. and Ironside, J.W. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting. Neuropathol. Appl. Neurobiol., 30, 360, 2004. 78. Taraboulos, A. et al. Regional mapping of prion proteins in brain. Proc. Natl. Acad. Sci. USA, 89, 7620, 1992. 79. Murayama, Y. et al. Specific detection of prion antigenic determinants retained in bovine meat and bone meal by flow microbead immunoassay. J. Appl. Microbiol., 101, 369, 2006. 80. Soto, C., Saborio, G.P. and Anderes, L. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond. Trends Neurosci., 25, 390, 2002. 81. Castilla, J. et al. In vitro generation of infectious scrapie prions. Cell, 121, 195, 2005. 82. Saa, P., Castilla J. and Soto, C. Presymptomatic detection of prions in blood. Science, 313, 92, 2006. 83. Saborio, G.P., Permanne, B. and Soto, C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature, 411, 810, 2001. 84. Jones, M. et al. In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J. Pathol., 213, 21, 2007. 85. Kurt, T.D. et al. Efficient in vitro amplification of chronic wasting disease PrPRES. J. Virol., 81, 9605, 2007. 86. Murayama, Y. et al. Efficient in vitro amplification of a mouse-adapted scrapie prion protein. Neurosci. Lett., 413, 270, 2007. 87. Atarashi, R. et al. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Methods, 4, 645, 2007. 88. Jackman, R. and Schmerr, M.J. Analysis of the performance of antibody capture methods using fluorescent peptides with capillary zone electrophoresis with laser-induced fluorescence. Electrophoresis, 24, 892, 2003. 89. Schmerr, M.J. et al. Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy. J. Chromatogr. A, 853, 207, 1999. 90. Brown, P., Cervenakova, L. and Diringer, H. Blood infectivity and the prospects for a diagnostic screening test in CreutzfeldtJakob disease. J. Lab. Clin. Med., 137, 5, 2001. 91. Giese, A. et al. Putting prions into focus: application of single molecule detection to the diagnosis of prion diseases. Arch. Virol. Suppl., 161, 2000. 92. Schmitt, J. et al. Identification of scrapie infection from blood serum by Fourier transform infrared spectroscopy. Anal. Chem., 74, 3865, 2002.
Slow Viral Diseases 93. Rubenstein, R. et al. Detection and discrimination of PrPSc by multi-spectral ultraviolet fluorescence. Biochem. Biophys. Res. Commun., 246, 100, 1998. 94. Sakudo, A. et al. Near-infrared spectroscopy: promising diagnostic tool for viral infections. Biochem. Biophys. Res. Commun., 341, 279, 2006. 95. Paramithiotis, E. et al. A prion protein epitope selective for the pathologically misfolded conformation. Nat. Med., 9, 893, 2003. 96. Curin Serbec, V. et al. Monoclonal antibody against a peptide of human prion protein discriminates between CreutzfeldtJacob’s disease-affected and normal brain tissue. J. Biol. Chem., 279, 3694, 2004. 97. Korth, C. et al. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature, 390, 74, 1997. 98. Rhie, A. et al. Characterization of 2’-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J. Biol. Chem., 278, 39697, 2003. 99. Sayer, N.M. et al. Structural determinants of conformationally selective, prion-binding aptamers. J. Biol. Chem., 279, 13102, 2004. 100. Weiss, S. et al. RNA aptamers specifically interact with the prion protein PrP. J. Virol., 71, 8790, 1997. 101. Sakudo, A. et al. Recent developments in prion disease research: diagnostic tools and in vitro cell culture models. J. Vet. Med. Sci., 69, 329, 2007. 102. Gavier-Widen, D. et al. Diagnosis of transmissible spongiform encephalopathies in animals: a review. J. Vet. Diagn. Invest., 17, 509, 2005. 103. Onodera, T. et al. Isolation of scrapie agent from the placenta of sheep with natural scrapie in Japan. Microbiol. Immunol., 37, 311, 1993. 104. Bolton, D.C. et al. Isolation and structural studies of the intact scrapie agent protein. Arch. Biochem. Biophys., 258, 579, 1987. 105. McKinley, M.P., Bolton, D.C. and Prusiner, S.B. A proteaseresistant protein is a structural component of the scrapie prion. Cell, 35, 57, 1983. 106. Sakudo, A. et al. Octapeptide repeat region and N-terminal half of hydrophobic region of prion protein (PrP) mediate PrP-dependent activation of superoxide dismutase. Biochem. Biophys. Res. Commun., 326, 600, 2005.
125 107. Castilla, J. et al. De novo generation of prions in a cell-free system. Presented at Prion2007, Edinburgh, September 26–28, 2007, 16. 108. Inoue, Y. et al. Infection route-independent accumulation of splenic abnormal prion protein. Jpn J. Infect. Dis., 58, 78, 2005. 109. Grathwohl, K.U. et al. Sensitive enzyme-linked immunosorbent assay for detection of PrP(Sc) in crude tissue extracts from scrapie-affected mice. J. Virol. Methods, 64, 205, 1997. 110. McBride, P.A., Bruce, M.E. and Fraser, H. Immunostaining of scrapie cerebral amyloid plaques with antisera raised to scrapie-associated fibrils (SAF). Neuropathol. Appl. Neurobiol., 14, 325, 1988. 111. Prusiner, S.B. et al. Measurement of the scrapie agent using an incubation time interval assay. Ann. Neurol., 11, 353, 1982. 112. Klohn, P.C. et al. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc. Natl. Acad. Sci. USA, 100, 11666, 2003. 113. Barnard, G. et al. The measurement of prion protein in bovine brain tissue using differential extraction and DELFIA as a diagnostic test for BSE. Luminescence, 15, 357, 2000. 114. Fischer, M.B. et al. Binding of disease-associated prion protein to plasminogen. Nature, 408, 479, 2000. 115. Kenney, K. et al. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Ann. Neurol., 48, 395, 2000. 116. Miele, G., Manson, J. and Clinton, M. A novel erythroidspecific marker of transmissible spongiform encephalopathies. Nat. Med., 7, 361, 2001. 117. Zerr, I. et al. Diagnosis of Creutzfeldt-Jakob disease by twodimensional gel electrophoresis of cerebrospinal fluid. Lancet, 348, 846, 1996. 118. Hosokawa, T., et al. Distinct immunohistochemical localization of Kuru plaques using novel anti-PrP antibodies. Microbiol. Immunol., 52, 25, 2008. 119. Hosokawa, T. et al. A monoclonal antibody (1D12) defines novel distribution pattern of prion protein (PrP) as granules in nucleus: implication for mechanisms of nuclear localization of PrP. Biochem. Biophys. Res. Commun. 366, 657, 2008.
Section II Foodborne Gram-Positive Bacteria
10 Bacillus
Noura Raddadi, Aurora Rizzi, Lorenzo Brusetti, Sara Borin, Isabella Tamagnini, and Daniele Daffonchio University of Milan
Contents 10.1 Introduction ................................................................................................................................................................... 129 10.1.1 Classification..................................................................................................................................................... 129 10.1.2 The Genetic Baseline of the B. cereus Group Ecotypes................................................................................... 130 10.1.3 Species Discrimination in the B. cereus Group................................................................................................ 130 10.1.4 Emetic and Diarrheal Illnesses Caused by Foodborne B. cereus......................................................................131 10.1.5 Other Foodborne Virulent Bacillus spp............................................................................................................ 133 10.1.6 Detection of B. cereus Toxins........................................................................................................................... 133 10.1.7 Detection of B. cereus Cells in Food and Environmental Samples.................................................................. 134 10.2 Methods.......................................................................................................................................................................... 135 10.2.1 Sample Preparation........................................................................................................................................... 135 10.2.1.1 B. cereus Isolation and Enumeration............................................................................................... 135 10.2.1.2 DNA Isolation.................................................................................................................................. 136 10.2.2 Detection Procedures........................................................................................................................................ 136 10.2.2.1 Detection of B. anthracis by RSR-PCR ......................................................................................... 136 10.2.2.2 Detection of B. cereus Toxin Genes by Multiplex PCR.................................................................. 137 10.2.2.3 Detection of B. cereus Toxin Genes by RT-PCR............................................................................. 138 10.2.2.4 Detection of Emetic B. cereus Strains by RT-PCR......................................................................... 138 10.3 Conclusions and Future Perspectives............................................................................................................................. 139 References.................................................................................................................................................................................. 140
10.1 Introduction 10.1.1 Classification The genus Bacillus includes Gram-positive spore-forming rod-shaped bacteria that are very diverse, from physiology to the ecological niche, from DNA sequence to gene regulation. Several species within the genus Bacillus have been associated with foodborne diseases, or carrying toxin determinants: among others, B. weihenstephanenesis, B. pumilus, B. mojavensis, B. licheniformis, and B. subtilis.1–5 However, the best-known foodborne pathogen within the genus is B. cereus. All Bacillus species, owing to endospore formation, can survive heat treatment and in the absence of a competitive microbiota, can multiply in cooked food during storage, producing toxins under suitable conditions.6–8 Consumption of such contaminated food might lead to intoxication with acute symptoms shortly after ingestion. Bacterial cells and/or spores in the food can survive the passage through the acidic environment of the stomach and infect the intestine with subsequent toxin production and symptoms, which last hours to days after food consumption.5 In this chapter, we will focus on the food-poisoning implications of Bacillus species. Before giving details on the food poisoning potential, the type of toxins and the method
of detection, we will briefly introduce the complex ecology and the identification challenges that characterize several Bacillus species. We will use as a paradigm the B. cereus group that shows a ‘bivalent face’ as far as its important impact on human activity.9,10 B. cereus is the most important foodborne pathogen in this group and will be the major subject of this chapter. This bacterium has been associated with food-poisoning illnesses11–13 as well as other kinds of clinical infections.14–18 B. thuringiensis is an insect pathogen widely used as biopesticide and differently from B. cereus has a very useful impact on human activities being widely used in agriculture for insect pest biocontrol. B. anthracis is the etiological agent of anthrax, a fatal disease for human and animals and has been sometimes associated with foodborne anthrax cases.19–21 Three forms of anthrax can be distinguished depending on the route of infection: cutaneous, gastrointestinal, and inhalational (pulmonary). Each form may progress to fatal systemic anthrax. The gastrointestinal form is extremely rare and occurs frequently after the ingestion of undercooked meat from animals with B. anthracis. The means by which B. anthracis crosses membrane barriers to establish infection remains unknown. B. anthracis probably invades the mucosa through 129
130
preexisting lesions, or, in the absence of mucosal damage, through the Peyer’s patch due to the uptake by M cells or dendritic cells. The disease is characterized by fever, nausea, vomiting, abdominal pain, and bloody diarrhea.19,22 B. weihenstephanensis, a psychrotolerant species capable of growing at temperatures as low as 4–6°C is implicated in food spoilage.23,24 In addition to B. cereus, B. thuringiensis, B. anthracis, and B. weihenstaephanenesis, the B. cereus group encompasses two other species, B. mycoides and B. pseudomycoides that are typically isolated from soil and plant rhizosphere. The six species are known to be strictly related phylogenetically, as has been shown by DNA-DNA hybridization studies23,25–27 and the sequencing of the ribosomal RNA genes.23,28–30 However, a marked variability is always observed when large collections of strains are examined by DNA fingerprinting methods that target the whole genome31–35 and/or discrete genes.36–40 Hence, the phylogenetic and taxonomic relationship among these species is still open to debate. It has been proposed previously that B. anthracis, B. cereus, and B. thuringiensis represent a single species, this conclusion having been reached through genome sizing and mapping,32–35 multilocus enzyme electrophoresis (MEE),41 multilocus sequence typing (MLST),42,43 and genome sequencing.44 The genetic variability observed within/between these species has raised several interesting questions and posed a challenge to microbiologists: (i) What is the evolutionary pathway of these species and how are they differentiated during evolution? (ii) What is the genetic baseline driving the different ecotypes and the virulence?
10.1.2 The Genetic Baseline of the B. cereus Group Ecotypes The ecology of these bacteria is still far to be clear, despite several analyses have recently shown that a major environmental niche for these bacteria is the invertebrate intestinal tract.45–47 In a general model, these species commonly live associated to the intestine of invertebrates assuming a symbiotic life style, but occasionally they escape such an ecotype becoming invasive for other animal hosts, that are in specific insects, arthropods, and nematodes for B. thur ingiensis, mammals, and humans for B. anthracis and B. cereus.46 Apart from this general scheme, the ecology of these species outside the invertebrate host is not completely clear, and several environments where these bacteria have been commonly associated to, have been questioned to be really able to continuously support the life cycle of these bacteria. It has been shown that with respect to other soil inhabiting bacteria, like those of the B. subtilis group that have genomes harboring many genetic determinants for the metabolism of plant-derived sugars, B. cereus group bacteria are rich in genes for protein metabolism. This suggests that they evolved in relation to nutrient rich environments like animal guts or animal tissues and fluids rather than the plant-environment.44,48 Specialization on different “animal” niches has lead to different evolution of the species in the
Molecular Detection of Foodborne Pathogens
B. cereus group. For instance, B. anthracis has been proposed to diverge from the other members of the group by specializing as a lethal mammal pathogen. It has been supposed that B. anthracis has evolved along two possible pathways:49 (i) in the first pathway, one considers B. anthracis to be a relatively ancient organism with a low growth rate, determined by the previously mentioned ecological constraints and evolving separately from a common ancestor with B. cereus and other relatives; (ii) in the second pathway, it has been supposed to be derived relatively recently from B. cereus, through the acquisition and rearrangement of plasmids resulting in the actual pXO plasmid pattern responsible of lethal virulence. Such a divergence from the B. cereus ancestor has been proposed to occur rather recently, between 13,000 and 26,000 years ago.50 A recent divergence from B. cereus is supported by (i) the very marked similarity between B. anthracis and certain strains of B. cereus;41,51 (ii) the presence in B. anthracis genome of several B. cereus-typical virulence genes that are, however, not expressed.52 The lack of gene expression in B. anthracis has been shown to be due to a nonsense mutation in PlcR, a pleiotrophic regulator driving the transcription of several B. cereus virulence factors (such as phospholipase C, proteases and enterotoxins) except cereulide.53–55 Recently, it has been shown that under anaerobiosis, at least two separate pathways, i.e., the PlcR-dependent and the Fnr-dependent pathways, control the expression of enterotoxin genes.56–58 The activity of PlcR depends on PapR, a secreted signaling peptide reimported into the bacterial cell through the oligopeptide permease (Opp) system59 while the activity of Fnr depends on the availability of O2 and NO. In B. anthracis, a nonfunctional PlcR is the result of counter selection, due to its disadvantageous effects on the overall fitness of the cell. Mignot et al.52 showed that a functional PlcR is incompatible with the plasmid borne AtxA-controlled virulence regulon, determining a dramatic effect on the sporulation. When the two regulators are simultaneously transcribed B. anthracis cells loose the ability to sporulate, a feature that heavily affects the overall survival capacity of the bacterium in the environment.
10.1.3 Species Discrimination in the B. cereus Group The similarity among such closely related bacteria as the species of the B. cereus group posed serious challenges for the species discrimination. This is an important point to be addressed, considering the differences in the virulence potential of these microorganisms. While B. anthracis can be differentiated by biochemical tests from most of B. cereus and B. thuringiensis, a problem still exists for isolates borderline between species such as, for instance, the pathogenic B. cereus G9241, for which these tests fail to recognize its pathogenic potential.60 This strain has been confirmed to be a B. cereus harboring a virulence plasmid very similar to plasmid pXO1 of B. anthracis, and a second plasmid encoding for a capsule synthesis. However, such a second plasmid and the capsule coding genes were completely different from the pXO2 plasmid and the typical capsule of B. anthracis.60
131
Bacillus
Thus, considering such a virulence potential of strains genetically near neighbor of B. anthracis, approaches that might rapidly identify these strains are of great interest. Indeed the characterization of these strains is actually providing useful clues for the understanding of the evolution pattern of these species and the mechanisms they have adopted for regulating the virulence by the way of plasmid/chromosome interaction.52 From a safety perspective, these strains could represent alternative hosts for B. anthracis toxin genes.60 Several B. cereus strains resulted strictly related to B. anthracis. For example, Keim et al.49 and Radnedge et al.61 individuated by amplified fragment length polymorphism (AFLP), B. cereus and B. thuringiensis strains closely related to B. anthracis. Radnedge et al.61 tried to identify by suppression subtractive hybridization genomic regions of B. anthracis absent in these closely related strains. Apart from AFLP, several other methods based on whole genome fingerprinting have been used for typing B. anthracis and the identification of species borderline strains, like, among others, rep-PCR10 and multi locus sequence typing (MLST),42 or, recently, comparative genomics62 and microarray analysis.63 Alternative approaches have been based on length or sequence polymorphisms in variable number tandem repeats in multiple loci (multi locus VNTR analysis, MLVA64) or on signature single nucleotide polymorphisms (SNPs) in the genome.65 MLVA has been used as a gold standard for subtyping B. anthracis isolated worldwide (see among others Refs 64, 66–68). Together with MLVA, SNP analysis is greatly contributing in typing and tracing B. anthracis isolates, especially by the whole genome SNP analysis.50 Besides those identified in the whole genome, SNPs in housekeeping genes have been nicely exploited to identify strains related to certain species or genetic types. For example, Prüss et al.69 showed that certain nucleotides in the 16S rRNA gene and their relative prevalence among the different ribosomal operons in the genome correlate with the psychrotolerance of B. cereus strains and hence are signature of the species B. weihenstephanensis. In addition to strain B. cereus G9241, several other isolates have been shown to be borderline between B. cereus or B. thuringiensis and B. anthracis. In population genetic studies among a strain collection of the B. cereus group species it was found MEE and MLST41,42 that the strains could be grouped into two main groups, the first including soil and dairy isolates, while the second those with pathogenic potential. This second group included, besides B. anthracis, most of the strains isolated from patients in clinical environments and, among these strains, the B. cereus strains isolated from periodontitis in humans. Helgason et al.41,42 clearly showed that in the species B. cereus/B. thuringiensis some genetic types exist having a close relationship with B. anthracis. For instance, besides the previously mentioned strain G9241, B. cereus Zebra Killer (ZK) and B. thuringiensis 97–27 (subsp. Konkukian, serotype H34)70 resulted closely related to B. anthracis according to AFLP and MLST.71 The proteome of all these three isolates resulted more similar to that of B. anthracis than to the nonvirulent B. cereus ATCC 14579.72 In a study aiming to determine a strategy for the identification
of B. cereus group isolates near neighbor of B. anthracis,43 two B. cereus and one B. thuringiensis strains resulted closely related to B. anthracis, according to restriction site insertion (RSI)-PCR36 patterns of the 16S–23S rRNA gene spacers, rep-PCR profiles and MLST analysis.43 Despite several approaches based on comparative genome sequencing and SNPs analysis by microarray applications, have been recently proposed for the identification of strains close to B. anthracis and other virulent strains in the B. cereus group, the gold standard is actually represented by MLST. This approach is rather simple and straightforward and take advantage from the availability of databases for the comparison of new isolates with historical or well characterized strains.42,73 Several MLST schemes based on sequencing of different gene sets have been proposed.42,43,73–77 However, most of the published studies are referring to that developed by Priest et al.74 From this MLST scheme, B. anthracis fall within the clade 1 that also includes many virulent B. cereus near neighbors of B. anthracis including emetic strains.
10.1.4 Emetic and Diarrheal Illnesses Caused by Foodborne B. cereus This bacterium is a common soil inhabitant that has been recognized as a food poisoning species since the beginning of the century. The first confirmed outbreak of B. cereus food poisoning occurred in Norway in 1950 after the consumption of a contaminated vanilla sauce, which had been prepared a day in advance before consumption and stored at room temperature.78 B. cereus is widespread in the environment including soil, water, and phylloplane.79 It is also often present in a variety of foods including rice, cereals, spices, vegetables, meat, milk, and pasteurized milk products.80–87 Toxins produced by vegetative cells of B. cereus can be the causative agents of two types of gastrointestinal diseases, respectively associated to emesis and diarrhea. In general, both types of foodborne illnesses are relatively mild and usually do last not more than 24 h. Nevertheless, more severe forms have occasionally been reported, including two deaths after the ingestion of food contaminated with high amounts of the emetic toxin and three deaths caused by the diarrheal necrotic enterotoxin CytK1.12,55,88,89 The emetic syndrome has been frequently associated with cereal foods including rice and pasta. Diarrheal toxins have been found in many foods, including milk, vegetables, and meat products.90 The minimal cell density required to provoke both types of diseases is estimated in the range 105–108 CFU/g of ingested food (CFU=colony-forming units). However, there are some reports of emetic syndrome associated with foods containing only 103 CFU/g food.91,92 The diarrheal syndrome is caused by heat-labile hydrophilic enterotoxins produced during the vegetative growth of B. cereus in the small intestine, and is characterized by abdominal pain and diarrhea that are manifested after 8–16 h incubation. Five chromosome-encoded enterotoxins have been characterized: two protein complexes hemolysin BL (HBL) and nonhemolytic enterotoxin (NHE), and three
132
enterotoxic proteins: cytotoxin K (CytK), enterotoxin T (BcET) and enterotoxin FM/S (EntMF/S).48,55,93–95 CytK is a 34 kDa hemolytic pore-forming toxin with homology to the β-barrel pore-forming toxins, including staphylococcal β-hemolysin. To date, only three strains containing cytk-1 gene, encoding the more toxic variant of the CytK protein, have been identified: B. cereus strains NVH391/98, NVH883/00, and INRAAF2. Phylogenetic analysis showed that these strains comprise a novel cluster of thermophilic strains genetically distant from the other B. cereus group strains.96,97 Strain NVH 391/98, isolated in 1998 in France at a level of 3×105/g from a vegetable puree, has been implicated in bloody diarrhea that caused the death of three persons.55,98 Recently, the complete genome sequence of this strain revealed the presence of two new important diarrheic toxin operons that may have contributed to the toxicity of this strain in the fatal incident.99 HBL and NHE are tripartite toxins, in which all three components are necessary for maximal cytotoxic activity.100,101 NHE consists of three components with molecular masses of 39, 45, and 105 kDa. HBL contains the protein components B (37.5 kDa), L1 (38.2kDa), and L2 (43.5 kDa).102 A previous study indicated that the cytotoxicity of B. cereus strains was dominated by the amount of secreted NHE and suggested that NHE is the most important toxin that contributes to food poisoning.103 Recently, it has been shown that NHE acts as a pore-forming toxin inducing cell lysis; and that HBL and NHE constitute a superfamily of pore-forming cytotoxins.104 It has been suggested that BcET and EntFM have either an unknown type of enterotoxic action or none at all.105 The emetic syndromes characterized by nausea and vomiting, and induced from 1 to 5 h after consumption of the contaminated food, are associated with the 1.2-kDa cereulide toxin.12,88,93,106 Cereulide concentrations ranging from 0.01 to1.28 µg/g were reported in foods implicated in the emetic type of food poisoning.106,107 The chemical structure and characteristics of this toxin have been studied in detail and recently the molecular basis for its synthesis has been described.91,92,107–109 Cereulide is a hydrophobic, non ribosomally synthesized small cyclic dodecadepsipeptide [(D-OLeu-D-Ala-L-OVal-L-Val)3]. The 24-kb (nt 15094–38668) cereulide synthesis gene cluster (ces) encodes seven proteins involved in the synthesis of the cereulide toxin and is located on a 270 kb plasmid.13,109,110 Cereulide is heat- and proteaseresistant and pH-stable. At low K+ concentration, it acts as an ionophore through mitochondrial membranes and interferes with oxidative phosphorylation.111–114 The diversity of the cereulide producers was investigated by Ehling-Schulz et al.,115 who concluded that, like B. anthracis, the cereulide-producing strains represent a recently emerged virulent emetic clone of B. cereus. These emetic toxin-producing B. cereus strains form a distinct cluster within B. cereus and harbor some specific characters, such as inability to hydrolyze starch and to ferment salicin, poor ability to grow at temperatures below 10°C, growth at 48°C, high heat resistance and low ability of their spores to germinate at 30°C. However, individual cereulide-producing strains differed up to 1000-fold
Molecular Detection of Foodborne Pathogens
in their capacity to produce cereulide.116 B. cereus may be differentiated into 18 serotypes based upon flagellar (H) antigens. Serovar H1 was considered the predominant serovar implicated in the emetic food poisoning syndrome.117 However, a recent study showed that strains of serovars H3 and H12 are also sources of emetic-type food poisoning and that emetic toxin producers belong to two phylogenetically distinct B. cereus clusters.118 Taken together with the discovery of emetic B. weihenstephanensis,4 these data suggest that cereulide-producing strains are progressively diversifying. The fact that the capacity for cereulide production is shared by two phylogenetically distinct B. cereus clusters and by B. weihenstephanensis strains, suggests that the 270 kb plasmid carrying the operon responsible for cereulide production, named pCER270,13,109,110 can undergo to lateral transfer. Indeed, plasmid transfer between members of the B. cereus group has been shown to occur.119–122 The true incidence of B. cereus food poisoning is unknown for a number of reasons. These include the differences in reporting procedures between countries and the relatively short duration of both disease syndromes (<24 h). In addition, the frequency at which single people are affected is usually not monitored. Another reason for this underestimation is the misdiagnosis of the disease, which is symptomatically similar to other types of food poisoning. For example, the symptoms caused by emetic B. cereus resemble those caused by Staphylococcus aureus, while those caused by diarrheal B. cereus resemble those caused by Clostridium perfringens.91,92 In some cases, epidemiological investigations of B. cereus outbreak could not be achieved due to delayed notification, which prevented the acquisition of suspected food samples, or to the lack of a reference laboratory and/or specific diagnostic protocols.123 For instance, between 1991 and 2005, 153 outbreaks were caused by B. cereus in Taiwan, representing 11.2% of the total outbreaks of the period.124 In the USA, from 1982 to 1997, 8781 foodborne-disease outbreaks were reported to the Centers for Disease Control and Prevention (CDC). Of these, 2246 (26%) involved at least five individuals and had sufficient clinical information reported to be considered confirmed foodborne outbreaks. A specific etiology was confirmed by laboratory testing in 697 (31%) outbreaks; among which B. cereus accounted for 1% (10 out of 697 outbreaks with a known etiology).125 Between 1980 and 1997, 2715 cases of B. cereus food poisoning in England and Wales were reported to the Public Health Laboratory Service.126 In Italy and Germany few B. cereus foodborne disease outbreaks have been reported. In June 2000, 173 people presented symptoms of intoxication (nausea and watery diarrhea) after they attended banquettes in Pisa, Italy. A microbiological investigation was performed and HBL-producing B. cereus strains were recovered from stool samples of 19 patients (out of 23 who required hospitalization), foods (more than 102 CFU) and from the rolling board of the confectioner’s shop which was hypothesized to be the source of contamination of all food samples analyzed.127 In 2006, 57 persons (out of 149 participants to a wedding banquet) had a foodborne illness in Salerno, Italy. Ricotta cheese contaminated with B. cereus
133
Bacillus
was supposed to be the responsible of this outbreak, although diagnostic certainty was not achieved, as no leftovers were available.123 In June 2006, two emetic food poisoning outbreaks involving 17 children who became sick one hour after eating a rice dish with vegetables, and one student who consumed cooked cauliflower, stored at room temperature for 1.5 days and then reheated, were reported in Germany.128 In France and Belgium, diarrheal and emetic B. cereus fatal food poisoning cases were reported.12,55 In African countries very little is known about the real incidence of B. cereus food poisoning outbreaks, and this could be due to the lack of surveillance data and under-reporting of the disease. In Kenya, 37 food poisoning outbreaks were reported to the Ministry of Health from various parts of the country in the period 1970– 1993. Only 13 of these involving 926 people were confirmed to be due to particular etiological agents, among which B. cereus. However, authors suggested that foodborne disease outbreaks are many more than those recorded by the Ministry of Health due to under-reporting, inadequate investigation of outbreaks, and inadequate diagnostic facilities.129 The type of illness most commonly encountered in a country is influenced by the average diet type and nutrition habits of the population. For example, while in Japan, the emetic illness is reported more frequently than the diarrheal one, in Europe and North America the diarrheal illness is more frequent.112
ingested, in which the presence of B. subtilis could have been a contributing factor. B. subtilis has been associated with emesis following the consumption of large numbers (2×106) of cells.133 Moreover, the detergent surfactin was shown to be toxic toward boar sperm cells through pore formation and destruction of the cell with subsequent loss of mitochondrial activity.134,135 With regard to the other Bacillus species, toxin production was confirmed and in vitro toxicity toward cell lines was demonstrated. For instance, two emetic B. weihenstephanensis strains were able to grow and produce cereulide at 8°C.4 The complete genome sequencing of strain B. weihenstephanensis KBAB4 revealed the presence of a NHE-like toxin on a 400 kb plasmid.99 To our knowledge, up to now there were no reports on food poisoning cases related to these species. However, the risk of food poisoning from psychrotolerant emetic strains in refrigerated foods, and from cyclic lipopeptides-producing strains needs to be further investigated. The loss of cytotoxicity by B. mojavensis following the abolition of surfactin synthesis5 supports a role of this molecule in potential virulence. It has been shown that strains of B. firmus, B. megaterium, B mojavensis, B. fusiformis and B. simplex2,3 can produce heat-stable toxins with physical characteristics and mode of action similar to those of the B. cereus emetic toxin.
10.1.5 Other Foodborne Virulent Bacillus spp.
10.1.6 Detection of B. cereus Toxins
Besides B. cereus, other species in the genus Bacillus have been implicated in food poisoning. Among these, B. weihenstephanensis, B. subtilis, B. licheniformis, B. pumilus, B. mojavensis, B. firmus, B. megaterium, B. simplex, and B. fusiformis have been shown to produce toxins and should be considered of food safety concerns.2,3,5,7,90 In recent years, several authors reported on food poisoning incidents implicating Bacillus species other than the B. cereus: (i) The baby milk powder containing toxigenic B. licheniformis involved in fatal illness of an infant,1 which were later shown to produce the toxin lichenysin A;130 (ii) a B. pumilus-contaminated rice in a Chinese restaurant intoxicated three individuals. Strain NVH891-05 isolated from the contaminated rice grew well at low temperatures (10–15°C) and produced large amounts of a toxic cyclic acylheptapeptide, named pumilacidin.5 Heat-stable toxin-producing B. licheniformis and B. pumilus were also isolated from mastitic milks. The toxins inhibited mobility of boar sperm cells and disturbed the plasma membrane permeability barrier without affecting the mitochondria.131 The B. licheniformis isolates were shown to have ribopattern similar to strains implicated in the infant fatal case of food poisoning, and harbored three lichenysin A synthetase genes lchAA, lchAB, and lchAC;131 (iii) Duca et al.132 reported on a case of infant emesis resulting from consumption of an infant cereal product contaminated with B. cereus and B. subtilis spores. However, the emetic toxin production was not demonstrated and the B. cereus strain was not isolated from the afflicted infants. The emesis has than been attributed to the high bacterial load
The detection of cereulide in suspected contaminated food samples, or in vomit and fecal samples from ill patients or in the isolates obtained from those samples, represents a necessary clue to confirm B. cereus as the causative agent. At present, different tests exist and are commonly used for the detection of diarrheal toxins like the vascular permeability reaction (VPR), the ligated rabbit ileal loop, and cell cytotoxicity assays. VPR consists in injecting cell-free culture supernatants (0.1 ml) intradermally into rabbits weighting 2.5–3.0 kg. After 3 h, 4 ml of 2% Evans blue dye solution is injected intravenously. Measurements of perpendicular diameters of the zones of light and dark blue, and necrosis when present, are made after 1 h.136 The ligated rabbit ileal loop assay consists in the injection of the material to be tested (e.g., the bacterial culture supernatant) into 5 cm ileal loop of female New Zealand white rabbits. The reaction is considered positive if the ratio of the volume of fluid accumulation to loop length is >0.5.94 In the cytotoxicity assays filtered supernatant is supplemented to a cell line and the effects of the treatment on the cells is evaluated. A number of cell lines are susceptible to the diarrheal toxins. The most commonly used are Vero (monkey kidney) and Chinese hamster ovary (CHO) cell lines, although other cell lines have been used including HeLa S3, Human Embryonic Lung (HEL) and McCoy cell lines.136,137 Gray et al.90 developed an innovative assay using a murine hybridoma Ped-2E9 cell model. Culture supernatants containing enterotoxins are added to a Ped-2E9 cell line and analyzed for cytotoxicity with an alkaline phosphatase release assay. The assay was shown to be rapid (results
134
obtained within 1 h) and to have 25- to 58-fold-higher sensitivity than the CHO assay. Although cell cytotoxicity assays are an inexpensive and convenient method for diarrheal toxin detection, they present many drawbacks. B. cereus produces many extracellular virulence factors such as phospholipases and sphingomyelinase, which may be cytotoxic to the cell lines.38,138,139 The test is time-consuming since it needs an enrichment step and requires the constant maintenance of cell lines. Commercial kits have been developed for the detection of the diarrheal toxins of B. cereus. Two immunological assays are commercially available: the B. cereus Enterotoxin Reverse Passive Latex Agglutination (BCET-RPLA) kit (Oxoid, Basingstoke, UK) and the Tecra Bacillus Diarrheal Enterotoxin Visual Immunoassay (BDE-VIA) kit (Tecra Diagnostics, Frenchs Forest, Australia) for detection of the L2 component of HBL (HblC) and the 41-kDa subunit of NHE, respectively. Both kits require the culture of B. cereus isolates for 6–18 h prior to testing. The culture supernatants are then tested for the enterotoxin-related proteins. To our knowledge, commercial kits are not yet available for the detection emetic toxin of B. cereus. Cereulide is traditionally assessed using a HEp-2 tissue culture assay by observing vacuole formation106,140,141 or colorimetrically, by using the 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) metabolic staining assay.142,143 An assay based on the uncoupling of respiratory activity of rat liver mitochondria has been developed for emetic toxin.112 Another bioassay, based on the loss of motility of boar spermatozoa, has also been developed.144,145 However, this assay has been found to be not enough specific, since other toxins were shown to affect sperm motility.146 Recently, a Computer Aided Semen Analysis (CASA) study of the boar semen motility has been demonstrated to be an appropriate assay for detection of cereulide, which induces motility ceasing at concentrations lower than 20 ng/ml, in comparison with other toxins that have the same effect at much higher concentrations. Since the assay detected cereulide indirectly, the presence of cereulide in positive samples was verified by HPLC-MS.147–149
10.1.7 Detection of B. cereus Cells in Food and Environmental Samples Standard isolation and enumeration of B. cereus from foods, the environment and clinical settings are generally performed by using conventional selective plating media. Two standard media are recommended by food authorities: polymyxinegg yolk-mannitol-bromothymol blue (PEMBA, Oxoid) or mannitol-egg yolk-polymyxin (MEYP, Oxoid) agar.150 When grown on PEMBA, B. cereus produces typical crenated colonies that retain the turquoise blue of the pH indicator (bromothymol blue) due to their inability to produce acid via mannitol fermentation. A zone of egg-yolk precipitation is produced through lecithinase activity, which involves the cleaving of lecithin (phosphatidylcholine) into phosphorylcholine and diglyceride. Polymyxin B is used in the media as a selective agent to suppress Gram-negative bacteria.151
Molecular Detection of Foodborne Pathogens
Recently, two new chromogenic plating media, B. cereus group plating medium (BCM, Biosynth AG, Switzerland) and Chromogenic B. cereus agar (CBC; Oxoid) were developed based on the activity of two different hydrolyzing enzymes: the phosphatidyl inositol phospholipase C (PI-PLC) for BCM, and the β-D-glucosidase for CBC. On BCM, 5-bromo-4chloro-3-indoxylmyoinositol-1-phosphate is cleaved by PIPLC and gives to B. cereus colonies a homogeneous blueturquoise color. The colonies are sometimes surrounded by a blue halo. CBC contains 5-bromo-4-chloro-3-indolylβ-glucopyranoside that is cleaved by β-D-glucosidase and results in white colonies with a blue-green centre. However, in addition to being time-consuming and unable to indicate the toxin production capability of the isolates, the performance of these culture-dependent detection methods are debated. In fact, some B. cereus strains, especially highly toxic strains with atypical growth characteristics, lack one or more of the key characteristics on these media, a feature that could lead to their misidentification.152 In addition, presumptive B. cereus isolates must then be tested by several biochemical and microscopic procedures to confirm whether they are true B. cereus, due to the phylogenetically close relationship between the different species. Crystal formation is one key test that positively identifies B. thuringiensis, while rhizoid colony morphology is a phenotypic character of the species B. mycoides and B. pseudomycoides.27 Thus, acrystalliferous variants of B. thuringiensis or nonrhizoid variants of B. mycoides/B. pseudomycoides may be misidentified as B. cereus. Moreover, the difficulty in clearly identifying isolates within the B. cereus group is also increased by the presence of enterotoxin-producing B. thuringiensis strains (Raddadi et al., unpublished data).153–156 Blood-agar medium could also be used to select HBL-producing B. cereus strains that show discontinuous hemolytic patterns.157 Based on monoclonal antibodies that detect specifically the B component of HBL and the nheA component of NHE, Moravek et al.158 described a colony immunoblot assay (CIA) that enables the identification of HBL and NHE-producing B. cereus isolates grown on blood agar within 24 h. Over years, several biosensor-based techniques for the detection of foodborne pathogens and bioterrorism agents have been developed and reported in the literature. A biosensor is an analytical device that integrates a biological sensing element with an electrical transducer to quantify a biological event into an electrical output. Recently, Pal et al.159 used immunochemical techniques for the development of a B. cereus biosensor. The approach utilizes the concept of a direct charge transfer (DCT) of electrons in a voltage controlled switch format for bacterial detection. The biosensor uses rabbit polyclonal anti-B. cereus antibodies as the biological sensing element and polyaniline nanowires as the electrical transducer. The biosensor was shown to have high sensitivity, being able to detect the presence of B. cereus at concentrations as low as 101 CFU/ml, and rapid with a detection time being only 6 min. In addition to these different detection methods, molecular detection systems for foodborne pathogenic bacteria in
135
Bacillus
general, as well as for diarrheal and emetic B. cereus strains, have been developed along the years. These include PCRs (conventional, multiplex, and real-time) and oligonucleotide DNA microarrays. Jin et al.160 developed DNA microarrays for the detection and identification of intestinal pathogens using two universal PCR primers to amplify two variable regions of bacterial 16S and 23S ribosomal RNA genes. Two oligonucleotide microarrays based on 16S rRNA gene sequences of predominant human intestinal bacterial species were reported for the detection of intestinal bacteria in fecal samples collected from human subjects, and for the detection of foodborne pathogenic bacteria, respectively.161,162 However, these tools could not be useful for the discrimination among the bacteria of the B. cereus group due to the close phylogenetic relationship between the different species that harbor mostly 16S rRNA gene sequences. Recently, Park et al.163 developed a multiplex PCR that targets gyrB and groEL genes as diagnostic markers for the simultaneous detection and identification of the B. cereus group bacteria from food samples. A 400 bp PCR fragment was amplified from the groEL gene for all the bacteria of the B. cereus group, while amplicons of 253, 475, 299, and 604 bp were yielded for the gyrB gene from B. anthracis, B. cereus, B. thuringiensis, and B. mycoides, respectively. PCR has been extensively used to amplify all the diarrheal toxin-producing genes,13,89,127,154,164 and genes encoding the emetic toxin cereulide, after their identification and sequencing.91,92,108,115 However, the presence of a toxin gene does not necessarily indicate that the bacterium is capable of producing the protein in concentrations high enough to determine the disease. For example, different emetic B. cereus strains were shown to have 1000-fold difference in their capacity to express cereulide.116 Another major drawback of conventional PCR is the requirement for post-PCR analysis by gel or capillary electrophoresis that is time-consuming, and bears the risk of false-positive results due to laboratory contamination. Thus, introduction of more rapid and sensitive detection systems, such as quantitative real-time PCR (RT-PCR), is required. In principle, two different chemistries are available for real-time detection of PCR products: fluorescent probes that bind specifically to certain DNA sequences (Taq Man-based RT-PCR) and fluorescent dyes that intercalate in any double-stranded DNA (SYBR green I-based RT-PCR). Based on the sequence of the cereulide synthetase (ces) gene, Fricker et al.128 developed novel diagnostic assays that were applied successfully to identify the causative agent of two recent emetic food-poisoning outbreaks in Germany. The methods developed were a Taq Man-based RT-PCR assay targeting a highly specific sequence of the ces gene, and a duplex SYBR green I-based RT-PCR assay for onestep differentiation between emetic B. cereus and S. aureus. Yang et al.124 developed a SYBR green-based RT-PCR assay for the rapid (analysis is performed in less than 3 h) quantitative detection of B. cereus in food (cooked rice, milk, and chicken meat) and fecal samples, using the nheB gene as target. Combined with the most probable number (MPN) technique (MPN-RT-PCR assay) for the enumeration of low
loads of contamination, the assay was performed in less than 8 h and the detection limit was as low as 1 CFU/ml. The MPN-RT-PCR assay could be used as an alternative method for detecting low levels of contamination. It provides stronger quantification than the traditional enrichment step, allows the dilution of PCR inhibitors and the discrimination of viable and dead cells. In fact, when applying RT-PCR to the detection of pathogens in foods without enrichment, the method usually consistently detects 102–103 CFU or more per gram of sample.124,128,165 This decrease in the sensitivity of RT-PCR, which theoretically can reach one copy of target gene detected per reaction, is mainly due to PCR inhibitors such as lipids, proteases, and divalent cations present in dairy products.166,167 To overcome this problem and enhance the sensitivity of the detection, most available detection systems require selective enrichment steps, especially for low pathogen concentrations. However, this could prevent the appreciation of original pathogen contamination levels. Recently, Fukushima et al.165 developed a method for the rapid separation and concentration of B. cereus cells (and also other foodborne pathogenic bacteria) from food matrices that can be used prior to real-time quantitative PCR and viable-cell counting. Using these combined methods, the target organisms in the food samples can be concentrated up to 250-fold and detected at cell concentrations as low as 101 CFU/g. In the following paragraphs, we will report on procedures that can be adopted for the detection and identification of B. cereus using modern molecular methods. Principles and procedures, from sample preparation to application of detection techniques, are illustrated and discussed.
10.2 Methods 10.2.1 Sample Preparation Bacterial isolation and enumeration from food samples remain an integral component in the sample preparation prior to molecular confirmation of foodborne pathogens concerned. Additionally, bacterial DNA can be extracted directly from food matrices both for microbiological quality evaluation and risk assessment studies of foodborne pathogens of interest, and for epidemiological diagnosis of food poisoning illnesses using molecular detection techniques. In the latter case, the incriminated bacterium is also isolated on selective medium and further identified by biochemical and/ or molecular methods. 10.2.1.1 B. cereus Isolation and Enumeration To enumerate B. cereus spores, 25 g or 25 ml of food samples are homogenized with 225 ml of peptone saline solution (PSS) containing 8.5 g/l NaCl and 1 g/l of neutralized bacteriological peptone. Ten milliliters of the homogenate (diluted 1:10) are transferred into sterile tubes, incubated at 80°C for 10 min, and then cooled in melting ice prior to further serial dilutions in PSS, until 1:1000 dilution. In order to detect and enumerate low levels of B. cereus spores, a three-tube MPN procedure could be performed using as growth medium
136
tryptone soya broth (TSB, Oxoid) supplemented with 100 mg/l of polymyxin B sulfate. After incubation at 30°C for 24 h, tubes are examined visually for turbidity. A loopful of culture from positive MPN tubes is streaked onto one of the chromogenic B. cereus group selective media (MEYP; BCM; CBC) plates and incubated at 30°C for 24–48 h. Colonies with a typical B. cereus morphotype are purified on tryptone soya agar (TSA; Oxoid). In order to detect and enumerate high levels of spores of B. cereus, the spread-plate procedure is carried out as follows: 1 ml volume of the 1:1000 dilution is spread plated in duplicate onto one of the three B. cereus group selective media agar plates and incubated at 30°C for 24–48 h. The plates with 15–150 typical B. cereus colonies are counted. One to five randomly selected typical colonies are purified. The total counts of B. cereus spores are based on percentage of colonies tested that were confirmed as B. cereus, and expressed as CFU/g of sample. The purified isolates are stored in nutrient broth (Oxoid) with 20% glycerol at –80°C until use.84,162 10.2.1.2 DNA Isolation DNA template for PCR reactions can be prepared from the purified isolates by a simple boiling method as following. Cells are collected by centrifugation (5000×g for 2 min) from 1 ml of a 4-h culture grown in nutrient broth at 30°C. The cell pellet is washed once with 500 µl of sterile MilliQ water or TE buffer (pH=8), centrifuged, resuspended in100 µl of sterile MilliQ water or TE buffer and boiled for 10–15 min. The boiled samples are centrifuged at 10000×g for 5 min to precipitate cell debris and the supernatants, which contain nucleic acids, are collected and stored at –20°C until use. There are also several commercial kits available for total DNA extraction from overnight grown pure bacterial cultures such as AquaPure genomic DNA isolation kit (BioRad) or QIAamp DNA stool mini kit (QIAGEN). The phenolchloroform extraction protocol is also useful to obtain pure high molecular weight genomic DNA.168 Total DNA from food samples can be isolated using the AquaPure genomic DNA isolation kit (Bio-Rad), the QIAamp DNA Mini Kit (Qiagen), the Wizard DNA Purification resinbased kit (Promega), the NucleoSpin food kit (MachereyNagel), or a simple boiling method. Yang et al.124 extracted DNA using the QIAamp DNA stool mini kit (Qiagen) with some modifications to the manufacturer’s instructions. For pure cultures, bacteria are placed in brain heart infusion broth and incubated overnight at 30°C. DNA is extracted from 200 µl of each individual culture. For cultures in spiked food or fecal samples, 200 µl or 200 µg of spiked samples are added to 1.4 ml of buffer ASL and heated for 15 min at 99°C. After heating, the manufacturer’s steps are followed up to the proteinase K step. At this time, 30 µl of proteinase K (20 mg/ ml) is placed into a new microcentrifuge tube, and 400 µl of the supernatant obtained from “Inhibit Extreatment” step is added, followed by 400 µl of buffer Al and 400 µl of ethanol. Since the total volume of the resulting lysate exceeds the volume of the spin column, the lysate is applied twice to the
Molecular Detection of Foodborne Pathogens
spin column. Finally, after the washing steps 40 µl of buffer AE is added to elute the DNA.
10.2.2 Detection Procedures The traditional methods for strain identification, looking to metabolism and physiology, can be time consuming and laborious. As well, the culture-dependent techniques for direct isolation and identification of B. cereus suffer the same problems. In addition, these techniques do not allow the differentiation among the B. cereus group isolates due to the close phylogenetic relationship between the species in this group and the presence of borderline isolates between B. cereus and B. anthracis. This could be of high risk from a human safety point of view. In fact, although B. cereus has been implicated in some fatal cases, the illnesses caused by this pathogen are usually mild. On the contrary, up to 40% of people having gastrointestinal anthrax die after antibiotic treatment.21 Although rare (less than 1% of reported anthrax cases), foodborne anthrax cases have been reported after ingestion of B. anthracis-contaminated meat.21 The gastrointestinal anthrax disease is characterized by fever, nausea, vomiting, abdominal pain, and bloody diarrhea,19,22 symptoms that are somehow similar to intoxication with B. cereus. On the other hand, while B. anthracis could be differentiated from B. cereus based on biochemical traits, a problem still exists for the B. cereus/B. thuringiensis borderline strains, which can display disease symptoms similar to B. anthracis. Recently a strain isolated from humans, identified as B. cereus on the basis of phenotypic and molecular data, caused symptoms similar to those of the anthrax disease and it was shown to harbor a virulence plasmid very similar to pXO1, while a capsule plasmid completely different from pXO2.60 These isolates could be discriminated from B. anthracis by different molecular techniques such as RT-PCR assays that target the nonsense mutation in the pleiotrophic regulator gene plcR.53,169–171 However, the approach requires expensive RT-PCR platforms, limiting equipment in most laboratories in developing countries where anthrax is endemic.67 10.2.2.1 Detection of B. anthracis by RSI-PCR Principle: Gierczyn´ ski et al.172 developed a simple and cost effective RSI-PCR-based assay as an alternative to this RT-PCR approach.36 The assay precisely detects the B. anthracis-specific nonsense mutation in plcR gene by restriction digestion with the endonuclease SspI. The requirements of this assay are limited to standard PCR equipment and an agarose or a polyacrylamide gel electrophoresis (PAGE) apparatus, that makes it available for most routine diagnostic laboratories worldwide. The nonsense mutation in the B. anthracis gene plcR generates a termination codon (UAA) in place of glutamic acid (GAA) in position 209 of the amino acid sequence of the functional PlcR.53 In order to detect thymidine (T), the key nucleotide in the plcR nonsense mutation of B. anthracis, an artificial SspI specific cleavage site can be introduced into a PCR
Bacillus
product generated using the 60-bp long AplR primer (5′-AT GTCATACTATTAATTTGACACGATAGTTCAATAGCT TTATTTGCATGACAAAGCGAAT-3′), modified at the 3′ end to specifically introduce the SspI cleavage site in the amplified plcR fragment. At positions 58 and 59 of the AplR primer, two adenine (A) bases determine, when the amplicon is generated, the incorporation in the PCR product of an artificial cleavage site (AATATT) for SspI only in the plcR amplicon deriving from B. anthracis. These two adenines replaced cytosine (C) and thymine (T), which complement G and A at positions 1147 and 1146 (positions referred to sequence accession number AF132086), respectively, of the truncated plcR of B. anthracis strain 9131.53 Primer AplF (5′-GCTCAATCAACAATTGGCAGG-3′) can be used in combination with primer AplR for the amplification of a 278 bp fragment of the plcR gene.172 Procedure: (1) Prepare PCR mixture (25 µl) containing 1× PCR buffer (10 mM Tris-HCl pH 8.9, 2 mM MgCl2, 50 mM KCl), 10 pmol of each primer (AplF and AplR), 0.2 mM of each dNTPs and 5–10 ng of genomic template DNA. (2) Carry out a hot start step at 95°C for 5 min in a PCR cycler before adding Taq DNA polymerase (to avoid formation of primer dimers whose formation could be favored by the 60-bp forward primer used). (3) Add 1 U of Taq DNA polymerase (Polgen), and perform the cycling program consisting of an initial denaturation step at 94°C for 3 min, 35 cycles of denaturation at 94°C for 40 sec, annealing at 58°C for 30 sec and extension at 72°C for 30 sec and a final extension at 72°C for 5 min. (4) Transfer 6 µl of PCR product in a tube containing 5–7 U of restriction enzyme SspI with appropriate reaction buffer (total volume 20 µl) and incubate at specified temperature and time. (5) Separate the digestion products in 4% high resolution agarose (MP Biomedicals) in TAE (40 mM Tris-acetate pH 8.0, 1 mM EDTA) at a constant voltage of 6 V/cm for 3 h. (6) Visualize the specific DNA fragments (about 60 and 220 bp for B. anthracis; 120 and 158 bp for some B. thuringiensis strains that have native SspI restriction site in the plcR gene) with conventional ethidium bromide staining. Note: it is also possible to separate the digestion products onto 8% nondenaturing polyacrylamide gel (Applichem) using a conventional chamber for vertical electrophoresis. In this case, DNA is visualized by either ethidium bromide staining or silver staining. Further details of the procedures to be adopted for RSI-PCR analysis can be found in Daffonchio et al.,36 Daffonchio et al.,43 and Gierczyn´ ski et al.172 This test was applied to 47 strains of B. anthracis that were isolated from four different countries (France, Georgia, Poland, and Russia), including
137
vaccinal strains, and all gave a SspI restriction profile with two fragments of about 60 and 220 bp as expected.172 It is important to notice that some B. thuringiensis strains gave aspecific SspI restriction profile of about 120 and 160 bp. However, these strains were shown to have a native SspI restriction site that splits PCR product into fragments of 120 and 158 bp. In addition, some B. cereus tested in this assay gave a plcR amplified fragment of the expected length (290 bp) but was not cleaved by the restriction enzyme.172 10.2.2.2 Detection of B. cereus Toxin Genes by Multiplex PCR With regard to B. cereus toxins, two commercial kits are available for the detection of the diarrheal HBL and NHE (see Section 10.1.4), while no kits are actually available for the detection of the emetic toxin cereulide, due to its low antigenic characteristics,173 or the necrotic toxin CytK1. Over the years, to allow the rapid detection of the genetic determinants of these toxins, different molecular methods have been developed, including microarray 174 conventional PCR and RT-PCR. Principle: Ngamwongsatit et al.156 developed a multiplex PCR method using new specific PCR primers for detection of eight enterotoxin genes (hblCDA, nheABC, cytK, and entFM) in a single PCR reaction. Procedure: (1) Prepare PCR mixture (in a final volume of 20 µl) containing 5 µl of template DNA prepared by the boiling method, 1× PCR buffer (10 mM Tris-HCl pH 8.3 and 50 mM KCl), 1.5 mM MgCl2, 200 mM of each dNTP, 0.2–0.4 mM of primers (targeting hblD, nheB, hblA, nheA, hblC, nheC, cytK, and entFM genes) and 5 U of Taq DNA polymerase. (2) Carry out the PCR amplification in cycler with an initial denaturation at 95°C for 5 min, 30 cycles of 94°C for 45 sec, 54°C for 1 min, 72°C for 2 min and a final extension at 72°C for 5 min. (3) Separate the amplicons on 1.5% agarose gels and visualize the fragments of predicted size of 1018, 935, 884, 759, 695, 618, 565, and 486 bp for hblD, nheB, hblA, nheA, hblC, nheC, cytK, and entFM genes, respectively, from B. cereus/B. thuringiensis. Note: by using this assay, Ngamwongsatit et al.156 categorized the 616 isolates into four groups. All eight genes were detected in group I. Group II and III lacked hblCDA and cytK, respectively, while in group IV, both hblCDA and cytK were missing. However, the applicability of the method was not tested on food samples, which often contain PCR inhibitors. This multiplex PCR is an informative and easy-to-handle tool for the detection of enterotoxin genes in individual isolates purified from food samples. However its efficiency for the direct
138
Molecular Detection of Foodborne Pathogens
detection of toxin-producing B. cereus/B. thuringiensis in food samples should be tested to be used as a tool for risk assessment. 10.2.2.3 Detection of B. cereus Toxin Genes by RT-PCR Principle: Yang et al.124 developed a SYBR green-based RT-PCR for the detection of B. cereus group cells in different food and fecal samples. They choose the nhe gene that codify for the diarrheal toxin NHE, because this gene was shown to be present in 100% of B. cereus and B. thuringiensis strains.156 Another reason of the choice is related to the fact that NHE toxin is the most important toxin in B. cereus diarrheal food poisoning.103 Procedure: (1) Prepare RT-PCR mixture (25 µl) containing 12.5 µl of SYBR Premix Ex Taq (2×) (TaKaRa Bio Inc.), 0.5 µl of ROX reference dye II (50×), 10 µM of each primer and 2.5 µl of template DNA extracted by boiling, and two primer pairs (consensus primers: SG-F3, 5′-GCACTTATGGCAGTATTTGCAGC-3′, and SG-R3, 5′-GCATCTTTTAAGCCTTCTGGTC-3′; degenerate primers: mSG-F3, 5′-GCACTKATGGC AGTATTTRCR GC-3′, and mSG-R3, 5′-GCATCTT TYARGCCTTCTGGTC-3′) in order to overcome false-negative results due to the sequence polymorphisms characterizing this gene. (2) Perform PCR amplification on a cycler (e.g., an Mx3000P apparatus, Stratagene), with the thermal protocol consisting of in initial denaturation at 95°C for 30 sec, followed by 40 cycles at 95°C for 5 sec and 60°C for 30 sec. (3) Examine the amplified products by gel electrophoresis to confirm that the results reported by the Mx3000P correlated with the amplification of a product with the expected size (152 bp). Note: the performance of the two primer pairs was evaluated by Yang et al.124 with 10 ng of purified DNA from 60 strains of the B. cereus group and was shown to be specific for bacteria of this group. This method was shown to be highly sensitive detecting as less as 102–107 CFU/g of B. cereus in cooked rice and chicken samples, and thus was supposed to be sufficient to be used as a quick and routine technique for the quantification of B. cereus group cells. However, a problem still exists for the detection of low-level contamination. In this case, an enrichment step could be incorporated in order to allow bacterial pathogens to multiply and reach detectable levels. However, this kind of method prevents the quantification of original contamination levels. In order to solve the problem of low-level contamination detection, the RT-PCR can be coupled to a three-tube MPN assay. This method was applied to 30 food samples, and was shown to have a detection
limit of as low as 1 B. cereus CFU/ml, which is more sensitive than an RT-PCR assay without enrichment.124 This MPN RT-PCR assay provides stronger quantification than the traditional enrichment and is important for the discrimination of viable and dead cells. This method is useful for detection and quantification of cells of the B. cereus group and not only of the B. cereus species, since nhe gene is widely distributed among bacteria in this group. 10.2.2.4 Detection of Emetic B. cereus Strains by RT-PCR The first conventional PCR-based assay for the detection of emetic B. cereus strains has been described in 2004.91,92 Primers EM1F (5′-GACAAGAGAAATTTCTACGAGCAA GTACAAT-3′) and EM1R (5′-GCAGCCTTCCAATTACTC CTTCTGCCACAGT-3′) amplify a fragment of 635 bp from emetic B. cereus genomic DNA. The specificity of the assay was assessed using a panel of 178 bacterial strains; neither false-positive nor false-negative signals were detected.91,92 Principle: recently, after the biosynthetic pathway for nonribosomal synthesis of cereulide and the related genes have been deciphered,115,176 a TaqMan-based as well as a SYBR green I-based duplex RT-PCR assays that target a highly specific part of the cereulide synthetase (ces: accession no. DQ360825) genes were developed by Fricker et al.128 for the detection of emetic B. cereus and its differentiation from S. aureus. The target probe for emetic B. cereus was labeled at the 5′ end with the reporter dye 6-carboxyfluorescein (FAM), and the IAC probe was labeled at the 5′ end with 5-hexachloro-6-carboxyfluorescein (HEX). Both probes were labeled at the 3′ ends with tetramethyl-6-carboxyrhodamine (TAMRA). Procedures: (i) TaqMan-based RT-PCR: (1) Prepare PCR mixture (25-µl) containing 12.5 µl Brilliant Q PCR Multiplex Mastermix (Stratagene), 0.5 µM of each primer (ces_TaqMan_ for: 5′-CGCCGAAAGTGATTATACCAA-3′; ces_TaqMan_rev: 5′-TATGCCCCGTTCTCAA ACTG-3′; IAC_for: 5′-GCAGCCACTGGTAA CAGGAT-3′; IAC_rev: 5′-GCAGAGCGCAGAT ACCAAAT-3′), 0.2 µM of each probe (ces_ TaqMa n _ probe: 5′-FA M- G G GA A A ATA ACGAGAAATGCA-TAMRA-3′; IAC_probe: 5′-HEX-AGAGCGAGGTATGTAGGCGGTAMRA-3′), approximately 170 copies of plasmid DNA pUC19 (Fermentas), and 5 µl of DNA template. Controls containing 5 µl of only TrisEDTA buffer were included in each run to detect any contamination. (2) Carry out the amplification in a Stratagene MX3000P PCR system (Stratagene) with the thermal cycling consisting of 95°C for 10 min followed by 40 cycles at 95°C for 15 sec and
139
Bacillus
55°C for 60 sec. The maximum ramp rate of the Stratagene MX3000P RT-PCR system was 2.5°C/sec. (ii) SYBR green I RT-PCR: (1) Prepare PCR mixture (25-µl) containing 12.5 µl SYBR Premix Ex Taq (Takara Bio, Inc.), 1–5 µl of template DNA (depending on extraction method), 0.3 µM for each B. cereus primer (ces_SYBR_F: 5′-CACGCCGAAAGTGATTATACCAA-3′; ces_SYBR_R: 5′-CACGATAAAACCACTGA GATAGTG-3′), and 0.12 µM for each S. aureus primer (sa_SYBR_F: 5′-CGTGTTGA ACGTGGTCAAATCA-3′; sa_SYBR_R: 5′-CA CCTTCGTCTTTTGATAATACG-3′). (2) Perform PCR amplification in a Stratagene MX3000P RT-PCR system with the following cycling program: one cycle of 95°C for 10 sec, and 45 cycles at 95°C for 10 sec and 60°C for 30 sec. Note: the same conditions can be used with the Smart Cycler II system (Cepheid), but with the ramp rate set on maximum (10°C/sec) for the simplex detection of emetic B. cereus strains and altered to 3°C/sec for simplex and duplex detection involving the primers specific for S. aureus. The real-time assays developed were shown to detect 101–103 CFU/g of emetic B. cereus directly from food samples without the need for further enrichment steps. Lower cell numbers (one B. cereus CFU/g) can be detected after a short enrichment time (4–6 h). After 6 h of enrichment, it was possible to detect one B. cereus CFU/g and 103 CFU S. aureus/g of food by the SYBR green duplex assay when emetic B. cereus was present in the same enrichment. Foods incriminated in emetic outbreaks were reported to have 105–108 CFU B.cereus/g or between 105 and 106 S. aureus CFU/g.177 Thus samples from emetic food poisonings can be processed and analyzed within short time (1.5–6 h). However, once the presence of B. cereus is detected by this assay, a further analysis of the emetic toxin cereulide is still needed due to its heat stability, especially in the cases of reheated foods. Three methods for detection of the emetic toxin have been described including a cytotoxicity assay using HEp2 or CHO cells, HPLC-MS analysis, and a spermbased bioassay. The cytotoxicity assay could be performed from pure B. cereus isolates as following: cells are grown in 20 ml of skim milk medium for 18 h, and, after autoclaving, an aliquot of the preparation is serially diluted (two-fold) in 96-well plates by using Earle’s minimal essential cell culture medium supplemented with 1% fetal calf serum, 1% (vol/vol) sodium pyruvate (100 mM), 2% (vol/vol) L-glutamine (200 mM), 0.2% (vol/vol) penicillin-streptomycin (10,000 U/ml), and 2% ethanol as a diluent. Immediately after this, HEp-2 cells (0.15 ml; 105 cells per well) are added, and the plates are incubated for 48 h at 37°C in a 5% CO2 atmosphere. Toxicity titers are determined by using the cell proliferation
reagent WST-1.103,175 The cytotoxicity assay could also be performed directly from food samples. In this case, 5 g (or 5 ml) of food sample are homogenized in 5 ml sterile Milli-Q water and autoclaved (20 min at 121°C). Ten microliters of the cell-free supernatant are then tested in a HEp-2 cell culture assay as described above. Both cytotoxicity assay and sperm-based bioassay are semi-quantitative, and the conclusive identification of cereulide is only provided by HPLC-MS analysis.146,147
10.3 Conclusions and Future Perspectives It is virtually impossible to ensure that foods are free from spore forming bacteria such as the ubiquitous bacterium B. cereus. In most food poisoning cases, illness is associated with the heating of precooked food held for too long at inappropriate storage temperature. However, if food is cooked and stored correctly, B. cereus should not constitute serious problems. Toxin-producing Bacillus spp. seem to be rare among isolates from water, food, and food environments, and none of the toxins detected are similar to the B. cereus enterotoxins or to cereulide. However, although rare, Bacillus spp. outside the B. cereus group might still be involved in food poisoning through foods that are considered safe by the public. Thus, it is interesting to develop detection methods of Bacillus spp. in food ingredients and in the food production plants. Several molecular detection methods are actually available for B. cereus and its toxins. These include conventional PCR, multiplex PCR, and RT-PCR. However, although highly specific and sensitive, these molecular methods have some drawbacks. For example, the conventional PCR could be used for qualitative detection of the presence of the foodborne pathogenic bacterium, but it is not usable for risk assessment evaluation since further confirmation methods, such as DNA hybridization or sequencing, are always needed. This method bears also the risk of false-positive results due to laboratory contamination. The multiplex PCR could be a good alternative to detect different pathogens or different toxins of the same pathogenic bacterial species simultaneously. However, in same cases it is possible to get false negative results due to the presence of different primer pairs in the same reaction mix, or due to different annealing temperatures. In addition, this method is qualitative and do not allow quantification of the pathogenic bacterium or of its toxins. In order to quantify the presence of a specific pathogenic bacterium or its toxins, TaqMan or SYBR green-based RT-PCRs could be applied. However, although highly sensitive, this technique could be biased by the presence of PCR inhibitors in complex matrices (such as foods and fecal samples) and cannot discriminate between DNA originating from alive and dead cells. This method allows the detection of 102–104 CFU/g of sample and thus lower levels of the contaminants cannot be detected, requiring an enrichment step. Enrichment steps are time-consuming and could overestimate the initial level of contamination. Another drawback of RT-PCR is the necessity of expensive and sophisticated real-time platforms and
140
reagents that cannot be available in most laboratories especially in developing countries. The confirmation of B. cereus as the causative agent responsible for foodborne disease is dependent upon a combination of different clues like food consumption history, nature of the symptoms and detection of the bacterium in the implicated food and/or the patient vomit or feces. It is also necessary to demonstrate either that the same serotype isolated from the vomit/feces is also present in the implicated food, or that the isolate is toxigenic. The rapid detection of microbes in food samples is becoming more critical and the development of rapid and sensitive methods is of great interest for human safety. Molecular techniques can be used to confirm the identity and the nature of B. cereus isolates. These include multiplex PCR that allows the detection of the different enterotoxin genes and RT-PCR for both diarrheal and emetic toxin genes. However, there are still some limitations in the application of these methods. For example, the DNA template used for PCR amplification of the genes does not necessary derive from viable cell and thus also dead bacterial cells are quantified by the RT-PCR. Also, the amplification of the genes by PCR could not necessary be a confirmation of the incrimination of a B. cereus strain as a food poisoning agent because the capability of the B. cereus isolates to express emetic toxin genes was shown to vary 1000-fold between the different strains. In addition, several studies showed that, although the diarrheal toxin genes were amplified by PCR from different strains, their expression, or at least the expression of all the subunits of the three component toxins was not always confirmed. On the other hand, it is important to take into account the presence of PCR inhibitors in food matrices which could lead to false-negative results, and that the sensitivity of quantitative RT-PCR is affected by the presence of DNA polymorphisms of the toxin genes. In conclusion, from a food safety perspective, important foodborne pathogens within the genus Bacillus are the species of the B. cereus group and in particular B. cereus. However, other species within the genus should be considered when examining suspected samples, since several strains of Bacillus species other than those of the B. cereus group have been described to produce lipophilic compounds such as surfactants with potential toxicity for humans. As far as the detection of B. cereus, a combination of molecular methods, including PCR amplification of the toxin-encoding genes and cytotoxicity assays represent the major tools necessary for risk assessment evaluation.
References
1. Salkinoja-Salonen, M.S. et al. Toxigenic strains of Bacillus licheniformis related to food poisoning. Appl. Environ. Microbiol., 65, 4637, 1999. 2. Taylor, J.M.W. et al. Heat-stable toxin production by strains of Bacillus cereus, Bacillus firmus, Bacillus megaterium, Bacillus simplex and Bacillus licheniformis. FEMS Microbiol. Lett., 242, 313, 2005. 3. From, C. et al. Toxin-producing ability among Bacillus spp. outside the Bacillus cereus group. Appl. Environ. Microbiol., 71, 1178, 2005.
Molecular Detection of Foodborne Pathogens
4. Thorsen, L. et al. Characterization of emetic Bacillus weihenstephanensis, a new cereulide-producing bacterium. Appl. Environ. Microbiol., 72, 5118, 2006. 5. From, C. et al. Cytotoxicity in Bacillus mojavensis is abolished following loss of surfactin synthesis: implications for assessment of toxicity and food poisoning potential. Int. J. Food Microbiol., 117, 43, 2007. 6. Brown, K.N. Spore resistance and ultra heat treatment processes. J. Appl. Bacteriol., 76, 67, 1994. 7. Østensvik, Ø. et al. Cytotoxic Bacillus spp. belonging to the B. cereus and B. subtilis groups in Norwegian surface waters. J. Appl. Microbiol., 96, 987, 2004. 8. Cronin, U.P. and Wilkinson, M.G. Bacillus cereus endospores exhibit a heterogeneous response to heat treatment and lowtemperature storage. Food Microbiol., 25, 235, 2008. 9. Daffonchio, D., Cherif, A. and Borin, S. Homoduplex and heteroduplex polymorphisms of the amplified ribosomal 16S23S internal transcribed spacers describe genetic relationships in the “Bacillus cereus group”. Appl. Environ. Microbiol., 66, 5460, 2000. 10. Cherif, A. et al. Genetic relationship in the ‘Bacillus cereus group’ by rep-PCR fingerprinting and sequencing of a Bacillus anthracis-specific rep-PCR fragment. J. Appl. Microbiol., 94, 1108, 2003. 11. Slaten, D.D., Oropeza, R.I. and Werner, S.B. An outbreak of Bacillus cereus food poisoning - Are caterers supervised sufficiently? Public Health Rep., 107, 477, 1992. 12. Dierick, K. et al. Fatal family outbreak of Bacillus cereusassociated food poisoning. J. Clin. Microbiol., 43, 4277, 2005. 13. Ehling-Schultz, M. et al. Toxin gene profiling of enterotoxic and emetic Bacillus cereus. FEMS Microbiol. Lett., 260, 232, 2006. 14. Lequin, M.H. et al. Bacillus cereus meningoencephalitis in preterm infants: neuroimaging characteristics. Am. J. Neuroradiol., 26, 2137, 2005. 15. John, A.B. et al. Intractable Bacillus cereus bacteremia in a preterm neonate. J. Trop. Pediatr., 53, 131, 2007. 16. Sue, D. et al. Capsule production in Bacillus cereus strains associated with severe pneumonia, J. Clin. Microbiol., 44, 3426, 2006. 17. Pillai, A., Thomas, S. and Arora, J. Bacillus cereus: the forgotten pathogen. Surg. Infect., 7, 305, 2006. 18. Altiparmak, U.E., et al. Postoperative endophthalmitis caused by Bacillus cereus and Chlamydia trachomatis. J. Cataract. Refract. Surg., 33, 1284, 2007. 19. Beatty, M.E., et al. Gastrointestinal anthrax: review of the literature. Arch. Intern. Med., 163, 2527, 2003. 20. Ichhpujani, R.L. et al. An outbreak of human anthrax in Mysore (India). J. Commun. Dis., 36, 199, 2004. 21. Babamahmoodi, F. et al., Three rare cases of anthrax arising from the same source. J. Infect., 53, 175, 2006. 22. Glomski, I.J. et al. Primary involvement of pharynx and peyer’s patch in inhalational and intestinal anthrax. PLoS Pathog., 3, e76, 2007. 23. Lechner, S. et al. Bacillus weihenstephanensis sp. nov. is a new psychrotolerant species of the Bacillus cereus group. Int. J. Syst. Bacteriol., 48, 1373, 1998. 24. Baron, F. et al. Isolation and characterization of a psychrotolerant toxin producer, Bacillus weihenstephanensis, in liquid egg products. J. Food Prot., 70, 2782, 2007. 25. Nakamura, L.K. DNA relatedness among Bacillus thuringiensis serovars. Int. J. Syst. Bacteriol., 44, 125, 1994. 26. Nakamura, L.K. and Jackson, M.A. Clarification of the taxonomy of Bacillus mycoides. Int. J. Syst. Bacteriol., 45, 46, 1995.
Bacillus 27. Nakamura, L.K. Bacillus pseudomycoides sp. nov. Int. J. Syst. Bacteriol., 48, 1031, 1998. 28. Ash, C. et al. Phylogenetic heterogeneity of the genus Bacillus revealed by comparative analysis of small-subunit-ribosomal RNA sequences. Lett. Appl. Microbiol., 13, 202, 1991. 29. Ash, C. et al. Comparative analysis of Bacillus anthracis, Bacillus cereus, and related species on the basis of reverse transcriptase sequencing of 16S rRNA. Int. J. Syst. Bacteriol., 41, 343, 1991. 30. Ash, C. and Collins, M.D. Comparative analysis of 23S ribosomal RNA gene sequences of Bacillus anthracis and emetic Bacillus cereus determined by PCR-direct sequencing. FEMS Microbiol. Lett., 94, 75, 1992. 31. Brousseau, R. et al. Arbitrary primer polymerase chain reaction, a powerful method to identify Bacillus thuringiensis serovars and strains. Appl. Environ. Microbiol., 59, 114, 1993. 32. Carlson, C.R., Grønstad, A. and Kolstø, A.-B. Physical maps of the genomes of three Bacillus cereus strains. J. Bacteriol., 174, 3750, 1992. 33. Carlson, C.R. and Kolstø, A.-B. A complete physical map of a Bacillus thuringiensis chromosome. J. Bacteriol., 175, 1053, 1993. 34. Carlson, C.R., Caugant, D.A. and Kolstø, A.-B. Genotypic diversity among Bacillus cereus and Bacillus thuringiensis strains. Appl. Environ. Microbiol., 60, 1719, 1994. 35. Carlson, C.R., Johansen, T. and Kolstø, A.-B. The chromosome map of Bacillus thuringiensis subsp. canadensis HD224 is highly similar to that of the Bacillus cereus type strain ATCC 14579. FEMS Microbiol. Lett., 141, 163, 1996. 36. Daffonchio, D. et al. Restriction Site Insertion-PCR (RSIPCR) for rapid discrimination and typing of closely related microbial strains. FEMS Microbiol. Lett., 180, 77, 1999. 37. Daffonchio, D. et al. A randomly amplified polymorphic DNA marker specific for the Bacillus cereus group is diagnostic for Bacillus anthracis. Appl. Environ. Microbiol., 65, 1298, 1999. 38. Kim, Y.R, Czajka, J. and Batt, C.A. Development of a fluorogenic probe-based PCR assay for detection of Bacillus cereus in nonfat dry milk. Appl. Environ. Microbiol., 66, 1453, 2000. 39. Schraft, H. and Griffith, M.W. Specific oligonucleotide primers for detection of lecitinase-positive Bacillus spp. by PCR. Appl. Environ. Microbiol., 61, 98, 1995. 40. Schraft, H. et al. Epidemiological typing of Bacillus spp. isolated from food. Appl. Environ. Microbiol., 62, 4229, 1996. 41. Helgason, E. et al. Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis-one species on the basis of genetic evidence. Appl. Environ. Microbiol., 66, 2627, 2000. 42. Helgason, E. et al. Multilocus sequence typing scheme for bacteria of the Bacillus cereus group. Appl. Environ. Microbiol., 70, 191, 2004. 43. Daffonchio, D. et al. Strategy for identification of Bacillus cereus and Bacillus thuringiensis strains closely related to Bacillus anthracis. Appl. Environ. Microbiol., 72, 1295, 2006. 44. Ivanova, N. et al. Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis. Nature, 423, 87, 2003. 45. Margulis, L. et al. The Arthromitus stage of Bacillus cereus: intestinal symbionts of animals. Proc. Natl. Acad. Sci. USA, 95, 1236, 1998. 46. Jensen, G.B. et al. The hidden lifestyles of Bacillus cereus and relatives. Environ. Microbiol., 5, 631, 2003. 47. Swiecicka, I. and Mahillon J. Diversityof commensal Bacillus cereus sensu latoisolated from the commonsowbug (Porcellio scaber, Isopoda). FEMS Microbiol. Ecol., 56, 132, 2006.
141 48. Gohar, M. et al. A comparative study of Bacillus cereus, Bacillus thuringiensis and Bacillus anthracis extracellular proteomes. Proteomics, 5, 3696, 2005. 49. Keim, P. et al. Molecular evolution and diversity in Bacillus anthracis as detected by amplified fragment length polymorphism markers. J. Bacteriol., 179, 818, 1997. 50. Van Ert, M.N. et al. Global genetic population structure of Bacillus anthracis. PLoS ONE, 2, e461, 2007. 51. Helgason, E. et al. Genetic structure of population of Bacillus cereus and B. thuringiensis isolates associated with periodontitis and other human infections. J. Clin. Microbiol., 38, 1615, 2000. 52. Mignot, T. et al. The incompatibility between the PlcR- and AtxA-controlled regulons may have selected a nonsense mutation in Bacillus anthracis. Mol. Microbiol., 42, 1189, 2001. 53. Agaisse, H. et al. PlcR is a pleiotropic regulator of extracellular virulence factor gene expression in Bacillus thuringiensis. Mol. Microbiol., 32, 1043, 1999. 54. Okstad, O.A. et al. Sequence analysis of three Bacillus cereus loci carrying PIcR-regulated genes encoding degradative enzymes and enterotoxin. Microbiology, 145, 3129, 1999. 55. Lund, T., De Buyser, M.L. and Granum, P.E. A new cytotoxin from Bacillus cereus that may cause necrotic enteritis. Mol. Microbiol., 38, 254, 2000. 56. Duport, C. et al. Control of enterotoxin gene expression in Bacillus cereus F4430/73 involves the redox-sensitive ResDE signal transduction system. J. Bacteriol., 188, 6640, 2006. 57. Zigha, A. et al. Anaerobic cells of Bacillus cereus F4430/73 respond to low oxidoreduction potential by metabolic readjustments and activation of enterotoxin expression. Arch. Microbiol., 185, 222, 2006. 58. Zigha, A. et al. The redox regulator Fnr is required for fermentative growth and enterotoxin synthesis in Bacillus cereus F4430/73. J. Bacteriol., 189, 2813, 2007. 59. Slamti, L. and Lereclus, D. A cell-cell signaling peptide activates the PlcR virulence regulon in bacteria of the Bacillus cereus group. EMBO J., 21, 4550, 2002. 60. Hoffmaster, A.R. et al. Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc. Natl. Acad. Sci. USA, 101, 8449, 2004. 61. Radnedge, L. et al. Genome differences that distinguish Bacillus anthracis from Bacillus cereus and Bacillus thuringiensis. Appl. Environ. Microbiol., 69, 2755, 2003. 62. Read, T.D. et al. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature, 423, 81, 2003. 63. Zwick, M.E. et al. Microarray-based resequencing of multiple Bacillus anthracis isolates. Genome Biol., 6, R10, 2005. 64. Keim, P. et al. Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis. J. Bacteriol., 182, 2928, 2000. 65. Read, T.D. et al. Comparative genome sequencing for discovery of novel polymorphisms in Bacillus anthracis. Science, 296, 2028, 2002. 66. Gierczyn´ ski, R. et al. Intriguing diversity of Bacillus anthracis in eastern Poland - the molecular echoes of the past outbreaks. FEMS Microbiol. Lett., 239, 235, 2004. 67. Merabishvili, M et al. Diversity of Bacillus anthracis strains in Georgia and of vaccine strains from the former Soviet Union. Appl. Environ. Microbiol., 72, 5631, 2006. 68. Ciammaruconi, A. et al. Fieldable genotyping of Bacillus anthracis and Yersinia pestis based on 25-loci multi locus VNTR analysis. BMC Microbiol., 8, 21, 2008.
142 69. Prüss, B.M. et al. Correlation of 16S ribosomal DNA signature sequences with temperature-dependent growth rates of mesophilic and psychrotolerant strains of the Bacillus cereus group. J. Bacteriol., 181, 2624, 1999. 70. Hernandez, E. et al. Super-infection by Bacillus thuringiensis H34 or 3a3b can lead to death in mice infected with the influenza A virus. FEMS Immunol. Med. Microbiol., 29, 177, 2000. 71. Hill, K.K. et al. Fluorescent amplified fragment length polymorphism analysis of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis isolates. Appl. Environ. Microbiol., 70, 1068, 2004. 72. Rasko, D.A. et al. Genomics of the Bacillus cereus group of organisms. FEMS Microbiol. Rev., 29, 303, 2005. 73. Tourasse, N.J. and Kolstø, A.B. SuperCAT: a supertree database for combined and integrative multilocus sequence typing analysis of the Bacillus cereus group of bacteria (including B. cereus, B. anthracis and B. thuringiensis). Nucleic Acids Res., 36, D461, 2007. 74. Priest, F.G. et al. Population structure and evolution of the Bacillus cereus group. J. Bacteriol., 186, 7959, 2004. 75. Candelon, B. Two distinct types of rRNA operons in the Bacillus cereus group. Microbiology, 150, 601, 2004. 76. Ko, K.S. et al. Population structure of the Bacillus cereus group as determined by sequence analysis of six housekeeping genes and the plcR gene. Infect. Immun., 72, 5253, 2004. 77. Sorokin, A., et al. Multiple-locus sequence typing analysis of Bacillus cereus and Bacillus thuringiensis reveals separate clustering and a distinct population structure of psychrotrophic strains. Appl. Environ. Microbiol., 72, 1569, 2006. 78. Haug, S. Food poisoning caused by aerobic spore forming bacilli. J. Appl. Bacteriol., 18, 591, 1955. 79. Altayar, M. and Sutherland, A. D. Bacillus cereus is common in the environment but emetic toxin producing isolates are rare. J. Appl. Microbiol., 100, 7, 2006. 80. in’t Veld, P.H. et al. Detection of genes encoding for enterotoxins and determination of the production of enterotoxins by HBL blood plates and immunoassays of psychrotrophic strains of Bacillus cereus isolated from pasteurised milk. Int. J. Food Microbiol., 64, 63, 2001. 81. Smith, D.P. et al. Detection of Bacillus cereus on selected retail chicken products. J. Food Prot., 67, 1770, 2004. 82. Collier, F.A., Elliot, S.L. and Ellis, R.J. Spatial variation in Bacillus thuringiensis/cereus populations within the phyllosphere of broad-leaved dock (Rumex obtusifolius) and surrounding habitats. FEMS Microbiol. Ecol., 54, 417, 2005. 83. Wijnands, L.M. et al. Prevalence of potentially pathogenic Bacillus cereus in food commodities in The Netherlands. J. Food Prot., 69, 2587, 2006. 84. Reyes, J.E. et al. Prevalence of Bacillus cereus in dried milk products used by Chilean School Feeding Program. Food Microbiol., 24, 1, 2007. 85. King, N. J., Whyte, R. and Hudson, J.A. Presence and significance of Bacillus cereus in dehydrated potato products. J. Food Prot., 70, 514, 2007. 86. Choo, E. et al. Prevalence and genetic diversity of Bacillus cereus in dried red pepper in Korea. J. Food Prot., 70, 917, 2007. 87. Valero, M., Hernández-Herrero, L.A and Giner, M.J. Survival, isolation and characterization of a psychrotrophic Bacillus cereus strain from a mayonnaise-based ready-to-eat vegetable salad. Food Microbiol., 24, 671, 2007. 88. Mahler, H., Pasi, A. and Kramer, J.A. Fulminant liver failure in association with the emetic toxin of Bacillus cereus. New. Engl. J. Med., 336, 1142, 1997.
Molecular Detection of Foodborne Pathogens 89. Guinebretière, M.-H. et al. Rapid discrimination of cytK-1 and cytK-2 genes in Bacillus cereus strains by a novel duplex PCR system. FEMS Microbiol. Lett., 259, 74, 2006. 90. Gray, K.M. et al. Rapid Ped-2E9 cell-based cytotoxicity analysis and genotyping of Bacillus species. J. Clin. Microbiol., 43, 5865, 2005. 91. Ehling-Schulz, M., Fricker, M. and Scherer, S. Identification of emetic toxin producing Bacillus cereus strains by a novel molecular assay. FEMS Microbiol. Lett., 232, 189, 2004. 92. Ehling-Schulz, M. et al. Bacillus cereus, the causative agent of an emetic type of food-borne illness. Mol. Nutr. Food Res., 48, 479, 2004. 93. Agata, N. et al. A novel dodecadepsipeptide, cereulide is an emetic toxin of Bacillus cereus. FEMS Microbiol. Lett., 129, 17, 1995. 94. Beecher, D.J., Schoeni, J.L. and Wong, A.C. Enterotoxic activity of hemolysin BL from Bacillus cereus. Infect. Immun., 63, 4423, 1995. 95. Lund, T. and Granum, P.E. Characterization of a nonhaemolytic enterotoxin complex from Bacillus cereus isolated after a foodborne outbreak. FEMS Microbiol. Lett., 141, 151, 1996. 96. Auger, S. et al. The genetically remote pathogenic strain NVH391-98 of the Bacillus cereus group is representative of a cluster of thermophilic strains. Appl. Environ. Microbiol., 74, 1276, 2008. 97. Fagerlund, A. et al. Toxin production in a rare and genetically remote cluster of strains of the Bacillus cereus group. BMC Microbiol., 7, 43, 2007. 98. Hardy, S.P., Lund, T. and Granum, P.E. CytK toxin of Bacillus cereus forms pores in planar lipid bilayers and is cytotoxic to intestinal epithelia. FEMS Microbiol. Lett., 197, 47, 2001. 99. Lapidus, A. et al. Extending the Bacillus cereus group genomics to putative food-borne pathogens of different toxicity. Chem. Biol. Int., 171, 236, 2008. 100. Beecher, D.J. and Macmillan, J.D. Characterization of the components of hemolysin BL from Bacillus cereus. Infect. Immun., 59, 1778, 1991. 101. Lindbäck, T. et al. Characterization of the Bacillus cereus Nhe enterotoxin. Microbiology, 150, 3959, 2004. 102. Dietrich, R. et al. Production and characterization of monoclonal antibodies against the hemolysin BL enterotoxin complex produced by Bacillus cereus. Appl. Environ. Microbiol., 65, 4470, 1999. 103. Moravek, M. et al. Determination of the toxic potential of Bacillus cereus isolates by quantitative enterotoxin analyses. FEMS Microbiol. Lett., 257, 293, 2006. 104. Fagerlund, A. et al. Bacillus cereus Nhe is a pore-forming toxin with structural and functional properties similar to the ClyA (HlyE, SheA) family of haemolysins, able to induce osmotic lysis in epithelia. Microbiology, 154, 693, 2008. 105. Choma, C. and Granum, P.E The enterotoxin T (BcET) from Bacillus cereus can probably not contribute to food poisoning. FEMS Microbiol. Lett., 217, 115, 2002. 106. Agata, N., Ohta, M. and Yokoyama, K. Production of Bacillus cereus emetic toxin (cereulide) in various foods. Int. J. Food Microbiol., 73, 23, 2002. 107. Agata, N. et al. A novel dodecadepsipeptide, cereulide, isolated from Bacillus cereus causes vacuole formation in HEp-2 cells. FEMS Microbiol., Lett., 121, 31, 1994. 108. Horwood, P.F., Burgess, G.W. and Oakey, H.J. Evidence for non-ribosomal peptide synthetase production of cereulide (the emetic toxin) in Bacillus cereus. FEMS Microbiol. Lett., 236, 319, 2004.
Bacillus 109. Hoton, F.M. et al. The cereulide genetic determinants of emetic Bacillus cereus are plasmid-borne. Microbiology, 151, 2121, 2005. 110. Rasko, D.A. et al. Complete sequence analysis of novel plasmids from emetic and periodontal Bacillus cereus isolates reveals a common evolutionary history among the B. cereus-group plasmids, including Bacillus anthracis pXO1. J. Bacteriol., 189, 52, 2007. 111. Jaaskelainen, E.L. et al. In vitro assay for human toxicity of cereulide, the emetic mitochondrial toxin produced by food poisoning Bacillus cereus. Toxicol. In Vitro, 107, 737, 2003. 112. Kawamura-Satò, K. et al. Quantitative analysis of cereulide, an emetic toxin of Bacillus cereus, by using rat liver mitochondria. Microbiol. Immunol., 49, 25, 2005. 113. Rajkovic, A. et al. Heat resistance of Bacillus cereus emetic toxin, cereulide. Lett. Appl. Microbiol., 46, 536, 2008. 114. Teplova, V.V. et al. The higher toxicity of cereulide relative to valinomycin is due to its higher affinity for potassium at physiological plasma concentration Int. J. Food Microbiol., 109, 132, 2006. 115. Ehling-Schulz, M. et al. Identification and partial characterization of the non-ribosomal peptide synthetase gene responsible for cereulide production in emetic Bacillus cereus. Appl. Environ. Microbiol., 71, 105, 2005. 116. Carlin, F. et al. Emetic toxin-producing strains of Bacillus cereus show distinct characteristics within the Bacillus cereus group. J. Food. Prot., 69, 847, 2006. 117. Gilbert, R.J. and Parry, J.M. Serotypes of Bacillus cereus from outbreaks of food poisoning and from routine foods. J. Hyg. (Lond.), 78, 69, 1977. 118. Vassileva, M. et al. A new phylogenetic cluster of cereulideproducing Bacillus cereus strains. J. Clin. Microbiol., 45, 1274, 2007. 119. Hu, X. et al. Transfer and expression of the mosquitocidal plasmid pBtoxis in Bacillus cereus group strains. FEMS Microbiol. Lett., 245, 239, 2005. 120. Van der Auwera, G.A. et al. Plasmid exchanges among members of the Bacillus cereus group in foodstuffs. Int. J. Food Microbiol., 113, 164, 2007. 121. Van der Auwera, G.A., Timmery, S. and Mahillon, J. Selftransfer and mobilisation capabilities of the pXO2-like plasmid pBT9727 from Bacillus thuringiensis subsp. konkukian 97-27. Plasmid, 59, 134, 2008. 122. Yuan, Y.M. et al. Kinetics of plasmid transfer among Bacillus cereus group strains within lepidopteran larvae. Arch. Microbiol., 187, 425, 2007. 123. Panico, M.G., Caporale, V. and Agozzino, E. Investigating on a foodborne outbreak: analysis of the critical points. Ann. Ig., 18, 191, 2006. 124. Yang, I.C. et al. Development of rapid real-time PCR and most-probable-number real-time PCR assays to quantify enterotoxigenic strains of the species in the Bacillus cereus group. J. Food Prot., 70, 2774, 2007. 125. Hedberg, C.W. et al. The use of clinical profiles in the investigation of foodborne outbreaks in restaurants: United States, 1982-1997. Epidemiol. Infect., 136, 65, 2008. 126. Ripabelli, G. et al. Epidemiological typing of Bacillus cereus by amplified fragment length polymorphism. Lett. Appl. Microbiol., 30, 358, 2000. 127. Ghelardi, E. et al. Identification and characterization of toxigenic Bacillus cereus isolates responsible for two food-poisoning outbreaks. FEMS Microbiol. Lett., 208, 129, 2002. 128. Fricker, M. et al. Diagnostic Real-Time PCR assays for the detection of emetic Bacillus cereus strains in foods and recent foodborne outbreaks. Appl. Environ. Microbiol., 73, 1892, 2007.
143 129. Ombui, J.N. and Nduhiu, J.G. Prevalence of enterotoxigenic Bacillus cereus and its enterotoxins in milk and milk products in and around Nairobi. East. Afr. Med. J., 82, 280, 2005. 130. Mikkola, R. et al. Toxic lactonic lipopeptide from food poisoning isolates of Bacillus licheniformis. Eur. J. Biochem., 267, 4068, 2000. 131. Nieminen, T. et al. Toxinogenic Bacillus pumilus and Bacillus licheniformis from mastitic milk. Vet. Microbiol., 124, 329, 2007. 132. Duca, Le H. et al. Cases of emesis associated with bacterial contamination of an infant breakfast cereal product. Int. J. Food Microbiol., 102, 245, 2005. 133. Kramer, J.M. et al. Identification and characterization of Bacillus cereus and other Bacillus species associated with foods and food poisoning. In: Corry, J.E.L., Roberts, D., and Skinner, F.A. (Eds.), Isolation and Identification Methods for Food Poisoning Organisms, 261. Academic Press, London, 1982. 134. Suominen, I. et al. Toxic Bacillus pumilus from indoor air, recycled paper pulp, Norway spruce, food poisoning outbreaks and clinical samples. Syst. Appl. Microbiol., 24, 267, 2001. 135. Hoornstra, D. et al. A new method for in vitro detection of microbially produced mitochondrial toxins. Toxicol. In Vitro, 17, 745, 2003. 136. Christiansson, A. et al. Toxin production by Bacillus cereus dairy isolates in milk at low temperatures. Appl. Environ. Microbiol., 55, 2595, 1989. 137. Fletcher, P. and Logan, N.A. Improved cytotoxicity assay for Bacillus cereus diarrheal enterotoxin. Lett. Appl. Microbiol., 28, 394, 1999. 138. Gilmore, M.S. et al. A Bacillus cereus cytolytic determinant, cereolysin AB, which comprises the phospholipase C and sphingomyelinase genes: nucleotide sequence and genetic linkage. J. Bacteriol., 171, 744, 1989. 139. Gohar, M. et al. Two-dimensional electrophoresis analysis of the extracellular proteome of Bacillus cereus reveals the importance of the PlcR regulon. Proteomics, 2, 784, 2002. 140. Hughes, S. et al. Potential application of a HEp-2 cell assay in the investigation of Bacillus cereus emetic-syndrome food poisoning. FEMS Microbiol. Lett., 52, 7, 1988. 141. Shinagawa, K. et al. Emesis of rhesusmonkeys induced by intragastric administration with the HEp-2 vacuolation factor (cereulide) produced by Bacillus cereus. FEMS Microbiol. Lett., 130, 87, 1995. 142. Finlay, W.J., Logan, N.A. and Sutherland, A.D. Semiautomated metabolic staining assay for Bacillus cereus emetic toxin. Appl. Environ. Microbiol., 65, 1811, 1999. 143. Rowan, N.J. et al. Putative virulence factor expression by clinical and food isolates of Bacillus spp. after growth in reconstituted infant milk formulae. Appl. Environ. Microbiol., 67, 3873, 2001. 144. Andersson, M.A. et al. A novel sensitive bioassay for detection of Bacillus cereus emetic toxin and related depsipeptide ionophores. Appl. Environ. Microbiol., 64, 1338, 1998. 145. Andersson, M.A. et al. Sperm bioassay for rapid detection of cereulide-producing Bacillus cereus in food and related environments. Int. J. Food Microbiol., 94, 175, 2004. 146. Rajkovic, A., Uyttendaele, M. and Debevere, J. Computer aided boar semen motility analysis for cereulide detection in different food matrices. Int. J. Food Microbiol., 114, 92, 2007. 147. Haggblom, M.M. et al. Quantitative analysis of cereulide, the emetic toxin of Bacillus cereus produced under various conditions. Appl. Environ. Microbiol., 68, 2479, 2002. 148. Rajkovic, A. et al. Influence of type of food on the kinetics and overall production of Bacillus cereus emetic toxin. J. Food Prot., 69, 847, 2006.
144 149. Rajkovic, A. et al. Dynamics of boar semen motility inhibition as a semi-quantitative measurement of Bacillus cereus emetic toxin (Cereulide). J. Microbiol. Methods, 65, 525, 2006. 150. Schulten, S.M. et al. Evaluation of the ISO 7932 standard for the enumeration of Bacillus cereus in foods. Int. J. Food Microbiol., 57, 53, 2000. 151. Evans, M.E., Feola, D.J. and Rapp, R.P. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gramnegative bacteria. Ann. Pharmacoth., 33, 960, 1999. 152. Fricker, M., Reissbrodt, R. and Ehling-Schulz M. Evaluation of standard and new chromogenic selective plating media for isolation and identification of Bacillus cereus. Int. J. Food Microbiol., 121, 27, 2008. 153. Damgaard, P.H. Diarrheal enterotoxin production by strains of Bacillus thuringiensis isolated from commercial Bacillus thuringiensis-based insecticides. FEMS Immun. Med. Microbiol., 12, 245, 1995. 154. Hansen, B.M. and Hendriksen, N.B. Detection of enterotoxic Bacillus cereus and Bacillus thuringiensis strains by PCR analysis. Appl. Environ. Microbiol., 67, 185, 2001. 155. Swiecicka, I. et al. Haemolytic and nonhaemolytic enterotoxin genes are broadly distributed among Bacillus thuringiensis isolated from wild mammals. Microbial. Ecol., 52, 544, 2006. 156. Ngamwongsatit, P. et al. Broad distribution of enterotoxin genes (hblCDA, nheABC, cytK, and entFM) among Bacillus thuringiensis and Bacillus cereus as shown by novel primers. Int. J. Food. Microbiol., 121, 352, 2008. 157. Beecher, D.J. and Wong, A.C.L. Identification and analysis of the antigens detected by two commercial Bacillus cereus diarrheal enterotoxin immunoassay kits. Appl. Environ. Microbiol., 60, 4614, 1994. 158. Moravek, M. et al. Colony immunoblot assay for the detection of hemolysin BL enterotoxin producing Bacillus cereus. FEMS Microbiol. Lett., 238, 107, 2004. 159. Pal, S. et al. Nanowire labeled direct-charge transfer biosensor for detecting Bacillus species. Biosen. Bioelect., 22, 2329, 2007. 160. Jin, D.Z. et al., Detection and identification of intestinal pathogens in clinical specimens using DNA microarrays. Mol. Cell. Probes, 20, 337, 2006. 161. Wang, R.F. et al. Design and evaluation of oligonucleotide-microarray method for the detection of human intestinal bacteria in fecal samples. FEMS Microbiol. Lett., 213, 175, 2006. 162. Wang, R.F. et al. Development and application of an oligonucleotide microarray for the detection of food-borne bacterial pathogens. Appl. Microbiol. Biotechnol., 76, 225, 2007.
Molecular Detection of Foodborne Pathogens 163. Park, S.H. et al. Simultaneous detection and identification of Bacillus cereus group bacteria using multiplex PCR. J. Microbiol. Biotechnol., 17, 1177, 2007. 164. Jackson, S.G. Rapid screening test for enterotoxin-producing Bacillus cereus. J. Clin. Microbiol., 31, 972, 1993. 165. Fukushima, H. et al. Rapid separation and concentration of food-borne pathogens in food samples prior to quantification by viable-cell counting and real-time PCR. Appl. Environ. Microbiol., 73, 92, 2007. 166. Feng, P. Impact of molecular biology on the detection of foodborne pathogens. Mol. Biotechnol., 7, 267, 1997. 167. McKillip, J.L. and Drake, M. Real-time nucleic acid–based detection methods for pathogenic bacteria in food. J. Food Prot., 67, 823, 2004. 168. Sambrook, J., Fritsch, E.F. and Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. 1989. 169. Slamti, L. et al. Distinct mutations in PlcR explain why some strains of the Bacillus cereus group are nonhemolytic. J. Bacteriol., 186, 3531, 2004. 170. Easterday, W.R. et al. Specific detection of Bacillus anthracis using a TaqMan mismatch amplification mutation assay. Biotechniques, 38, 731, 2005. 171. Easterday, W.R. et al. Use of single nucleotide polymorphisms in the plcR gene for specific identification of Bacillus anthracis. J. Clin. Microbiol., 43, 1995, 2005. 172. Gierczyn´ ski, R. et al. Specific Bacillus anthracis identification by a plcR–targeted restriction site insertion-PCR (RSIPCR) assay. FEMS Microbiol. Lett., 272, 55, 2007. 173. Melling, J. and Capel, B.J. Characteristics of Bacillus cereus emetic toxin. FEMS Microbiol. Lett., 4, 133, 1978. 174. Liu, Y. et al. Confirmative electric DNA array-based test for food poisoning Bacillus cereus. J. Microbiol. Methods, 70, 55, 2007. 175. Ngamwongsatit, P. et al. WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line. J. Microbiol. Methods, 73, 211, 2008. 176. Magarvey, N.A., Ehling-Schulz, M. and Walsh, C.T. Characterization of the cereulide NRPS α-hydroxy acid specifying modules: activation of α-keto acids and chiral reduction on the assembly line. J. Am. Chem. Soc., 128, 10698, 2006. 177. Bennett, R.W. Staphylococcal enterotoxin and its rapid identification in foods by enzyme-linked immunosorbent assaybased methodology. J. Food Prot., 68, 1264, 2005.
11 Clostridium
Annamari Heikinheimo, Miia Lindström University of Helsinki
Dongyou Liu
Mississippi State University
Hannu Korkeala
University of Helsinki
Contents 11.1 Introduction.................................................................................................................................................................... 145 11.1.1 Classification..................................................................................................................................................... 145 11.1.2 Pathogenesis...................................................................................................................................................... 148 11.1.3 Diagnosis........................................................................................................................................................... 149 11.1.3.1 Foodborne C. perfringens................................................................................................................ 149 11.1.3.2 Foodborne C. botulinum.................................................................................................................. 150 11.2 Methods.......................................................................................................................................................................... 151 11.2.1 Sample Preparation........................................................................................................................................... 151 11.2.2 Detection Procedures........................................................................................................................................ 152 11.2.2.1 Multiplex PCR for C. perfringens Toxin Genes.............................................................................. 152 11.2.2.2 Multiplex PCR for C. botulinum Toxin Genes................................................................................ 152 11.2.2.3 PCR Assay to Distinguish Between Proteolytic (Mainly Group I) and Nonproteolytic (Mainly Group II) C. botulinum...................................................................................................... 152 11.3 Conclusion...................................................................................................................................................................... 153 References.................................................................................................................................................................................. 153
11.1 Introduction 11.1.1 Classification The genus Clostridium comprises a highly heterogeneous group of Gram-positive, endospore-producing, rod-shaped anaerobes that is ubiquitously distributed in the environment (e.g., soil, sewage, and marine sediments) and exists in the gastrointestinal tract of humans and domestic and feral animals. As obligate anaerobes, clostridia ferment by pathways that generate organic solvents, such as butyric acid, acetic acid, butanol, and acetone, as well as large amounts of gas (CO2 and H2) during fermentation of sugars. In addition, clostridia generate a variety of malodorous compounds during the fermentation of amino acids and fatty acids. The capability of clostridia to degrade large biological molecules (e.g., proteins, lipids, collagen, and cellulose) in the environment into fermentable components is undoubtedly assisted by their production of a wide range of extracellular enzymes. Thus, besides being useful for industrial production of alcohols and commercial solvents, clostridia play an important role in nature in biodegradation and the carbon cycle. Furthermore, a few species (e.g., C. butyricum and C. pasteurianum) are
capable of fixing nitrogen. Under stressful conditions, such as lack of nutrients or unfavorable temperatures, clostridia tend to produce spores that facilitate their persistence in the environment under extreme conditions. Although most Clostridium species are saprophytes, a small number (primarily C. perfringens, C. botulinum, C. tetani, and C. difficile) are pathogens to man and animals. These pathogenic species often secrete an array of invasins, exotoxins, and other extracellular enzymes (e.g., proteases, lipases, collagenase, and hyaluronidase). Various toxins are responsible for such human diseases as tetanus, botulism, and gas gangrene. C. perfringens (formerly called C. welchii) is a known toxin producer. The genome of C. perfringens strain 13 is 3,031,430 bp long, with 2,660 open reading frames and a low overall G + C content of 28.6%.1 Comparison of C. perfringens strain 13, gas gangrene isolate ATCC 13124T, and the enterotoxinproducing food poisoning strain SM101 has revealed considerable genomic diversity, with >300 unique genomic islands.2 Of the over 15 toxins produced by C. perfringens, alpha (CPA), beta (CPB), epsilon (ETX), and iota (ITX) toxins are the four major toxins present in five different toxinotypes (A–E) of the bacterium (Table 11.1).3 In addition, C. perfringens isolates 145
146
Molecular Detection of Foodborne Pathogens
Table 11.1 C. perfringens Toxinotypes and Their Major Toxins Toxinotype A B C D E
Alpha (CPA)
Beta (CPB)
Epsilon (ETX)
+ +
+
+ + + + +
may produce other toxins such as Clostridium perfringens enterotoxin (CPE) and Clostridium perfringens beta2 toxin (CPB2).4,5 These toxins have been also targeted for PCR identification (Table 11.2). CPE causes C. perfringens type A food poisoning as well as antibiotic-associated diarrhea (AAD) and sporadic diarrheas in humans.5 This toxin is also responsible for enteric diseases and enterotoxemias in animals.6 C. botulinum is a diverse species. The taxonomic denominator for C. botulinum is the production of botulinum neurotoxin (BoNT). C. botulinum is subdivided into four distinct groups based on physiological and genetic criteria, with Group I (proteolytic C. botulinum) strains producing one or two toxins of type A, B, or F; Group II (nonproteolytic C. botulinum) strains producing toxins of type B, E, or F; Group III strains producing toxins of type C or D; and Group IV strains producing toxin of type G.7 For the Group IV organisms, the species name Clostridium argentinense has been adopted.8 The genome of C. botulinum Group I (proteolytic) strain Hall A (ATCC 3502) consists of a chromosome of 3,886,916 bp and a plasmid of 16,344 bp, with 3,650 and 19 predicted genes, respectively.9 Clostridium sporogenes is phenotypically and genotypically related to Group I C. botulinum. Nontoxigenic type E-like counterparts of Group II C. botulinum have also been identified.10 C. botulinum secretes BoNT, which causes the deadly botulism food poisoning. BoNTs can be separated into seven distinct serotypes (A–G) on the basis of the immunological characteristics of its botulinum toxin. Moreover, four immunologically or genetically distinct BoNT/A subtypes, five BoNT/B subtypes, and six BoNT/E subtypes have been identified.11,12 While C. botulinum Groups I and II tend to cause foodborne botulism, C. botulinum Group I is often responsible for infant and wound botulism. Interestingly, strains of C. butyricum and C. baratii have also been shown to produce type E and F neurotoxins, respectively. Being adapted to a saprophytic lifestyle in both soil and aquatic environments, C. botulinum relies on the toxins and extracellular enzymes it produces to kill prey species, to gain access to nutrient sources, and to degrade rotting or decayed tissues.9 The strains of Group I C. botulinum are proteolytic and capable of utilizing amino acids as an energy source. The minimum growth temperature of Group I C. botulinum is 13–16°C and the optimum 37–42°C.13 Under otherwise favorable conditions, growth is typically inhibited by a water activity of 0.94, corresponding to approximately 10% NaCl (w:v) in brine. Growth does not occur under a pH of 4.5. Group II C. botulinum is nonproteolytic and saccharolytic. The minimum
Iota (ITX)
+ +
growth temperature is 3°C.14,15 The inhibitory water activity is 0.97, corresponding to 5% NaCl in brine. The spores of Group I C. botulinum possess a very high heat resistance.16 The spores of Group II C. botulinum are less heat-resistant than those of Group I. As Group I and II strains differ in their epidemiologies, discrimination between the two groups should be done whenever an outbreak strain is isolated. C. botulinum spores are widely spread in the environment and may contaminate raw foods. The heat-resistant Group I spores can cause problems in canning and especially in home preservation of vegetables and meat. Group II spores pose a safety hazard in modern food processing. They are able to grow at refrigeration temperatures, and anaerobic packages provide them with favorable conditions for growth and toxin formation. This sets great challenges for the production of modified atmosphere packaged chilled foods.17 C. tetani is the culprit for tetanus (lockjaw) in both humans and animals. C. tetani can be distinguished into 11 groups on the basis of its reaction with flagellar antigens. When C. tetani spores enter the skin via a puncture wound (e.g., stepping on a rusty nail), they germinate and form C. tetani vegetative cells. An exotoxin (called tetanus toxin or tetanospasmin) released by C. tetani cells migrates along neural paths and blocks the release of neurotransmitters (glycine and gamma-amino butyric acid) from the spinal cord and brainstem that regulate muscle contraction. This leads to continuous muscle contraction, primarily in the neck and jaw muscles (lockjaw) and respiratory failure, with mortality rates ranging from 40 to 78%. Being one of the three most poisonous substances known to humans (the other two are BoNT and diphtheria toxin), tetanus toxin (tetanospasmin, name of the gene encoded on a plasmid) comprises up to 5–10% of the bacterial cell weight and is heat-labile (destroyed at 56oC in 5 min) and O2-labile. C. difficile belongs to the normal microbiota of the mammalian gastrointestinal tract. C. difficile proliferation and infection in the human colon often occur after use of broadspectrum antibiotics. Through release of two toxins (A and B), C. difficile destroys the intestinal lining and causes AAD, colitis, and pseudomembranous colitis. C. difficile toxin A is an enterotoxin that induces fluid accumulation in the bowel, and toxin B is a cytopathic toxin that is extremely lethal. Both toxins are highly unstable and tend to degrade at room temperature. Additionally, C. septicum causes fatal traumatic (woundderived) and nontraumatic (endogenous) myonecrosis (malignant edema, gangrene) as well as enteric infections (usually a necrotic enteritis) in humans and animals. C. septicum cells
147
Clostridium
Table 11.2 Multiplex Primers for Determination of C. perfringens Toxinotypes Gene
Product (bp)
Present in Toxinotype
cpa
TGCATGAGCTTCAATTAGGT TTAGTTTTGCAACCTGCTGT
400
A–E
cpb
GCGAATATGCTGAATCATCTA GCAGGAACATTAGTATATCTTC
196
B, C
etx
GCGGTGATATCCATCTATTC CCACTTACTTGTCCTACTAAC
655
B, D
iA
ACTACTCTCAGACAAGACAG CTTTCCTTCTATTACTATACG
446
E
cpe
GGAGATGGTTGGATATTAGG GGACCAGCAGTTGTAGATA AGATTTTAAATATGATCCTAACC CAATACCCTTCACCAAATACTC
233
A–E
567
A–E
cpb2
Primers (probe)(5′–3′)
cpa
GTTGATAGCGCAGGACATGTTAAG CATGTAGTCATCTGTTCCAGCATC
402
A–E
cpb
ACTATACAGACAGATCATTCAACC TTAGGAGCAGTTAGAACTACAGAC
236
B, C
etx
ACTGCAACTACTACTCATACTGTG CTGGTGCCTTAATAGAAAGACTCC
541
B, D
itx
GCGATGAAAAGCCTACACCACTAC GGTATATCCTCCACGCATATAGTC
317
E
cpa
AGTCTACGCTTGGGATGGAA TTTCCTGGGTTGTCCATTTC
900
A–E
cpb
TCCTTTCTTGAGGGAGGATAAA TGAACCTCCTATTTTGTATCCCA
611
B, C
etx
TGGGAACTTCGATACAAGCA TTAACTCATCTCCCATAACTGCAC
396
B, D
iap
AAACGCATTAAAGCTCACACC CTGCATAACCTGGAATGGCT
293
E
cpb2
CAAGCAATTGGGGGAGTTTA GCAGAATCAGGATTTTGACCA
200
A–E
cpe
GGGGAACCCTCAGTAGTTTCA ACCAGCTGGATTTGAGTTTAATG
506
A–E
cpa
AAGAACTAGTAGCTTACATATCAACTAGTGGTG TTTCCTGGGTTGTCCATTTCC (VIC-TTGGAATCAAAACAAAGGATGGAAAAACTCAAG-TAMRA)
124
A–E
cpb
TGGAGCGTGAAAGAAACTGTTATTA GGTATCAAAAGCTAGCCTGGAATAGA (FAM-CTTAATTGGAATGGTGCTAACTGGGTAGGACAA-TAMRA)
85
B, C
etx
TTTGATAAGGTTACTATAAATCCACAAGGA AGAGAGCTTTTCCAACATAAACATCTTC (Cy-5-TAATCCTAAAGTTGAATTAGATGGAGAACCA-BHQ-2)
121
B, D
iap
GCATTAAAGCTCACACCTATTCCA GAGATGTGAGAGTTAATCCAAATTCTTG (FAM-CTAACTTAATTGTATATAGAAGGTCTGGTCC)
85
E
cpe
AGCTGCTGCTACAGAAAGATTAAATTT TGAGTTAGAAGAACGCCAATCATATAA (FAM-ACTGATGCATTAAACTCAAATCCAGCT-TAMRA)
88
A–E
cpb2
TATTTCAAAGTTTACTGTAATTTTTATGTTTTCA CCATTACCTTTCTATAAGCGTCGATT (Cy-5-TGCACTTGCTTTCATTGGACTTATTGCTCC-BHQ-2)
127
A–E
Reference
38–40
41
42
43
148
produces alpha toxin (molecular weight 46.5 kDa), probably via a type II secretion pathway, which is both hemolytic and lethal with 2 × 107 hemolytic units per milligram and an LD50 of approximately 10 μg/kg body weight in experimental mice. Interestingly, the C. septicum alpha toxin appears to be unique, as it is not found in any other clostridial species, although its mechanistic features are remarkably similar to those of the cytolytic toxin, aerolysin, from Aeromonas hydrophila. In addition, C. sordellii has been implicated in the deaths of a small number of women after childbirth. C. spiroforme causes rabbit diarrhea, resulting in significant losses in commercial rabbit farming facilities.18 In this chapter, we focus on two human foodborne pathogenic Clostridium species (i.e., C. perfringens and C. botulinum). Molecular methods for their rapid detection and identification are presented.
11.1.2 Pathogenesis C. perfringens type A is reported to be one of the most common causes of food poisonings throughout the industrialized world. The symptoms are caused by CPE, and although all types of C. perfringens (A–E) may produce CPE, usually food poisonings are caused by C. perfringens type A strains.19 C. perfringens type C occasionally causes enteritis necroticans (pigbel) in humans. The symptoms of this rare but fatal food poisoning are produced by C. perfringens beta toxin. C. perfringens type A food poisoning outbreaks are usually reported in institutionalized settings and involve numerous victims. Cooked meat and poultry are considered the most common vehicles for this food poisoning. After surviving in foods during preparation, C. perfringens type A spores germinate and the cells rapidly replicate in the food during cool-down and storage. The temperature range of 10–54°C allows the growth of the organism. Upon ingestion, C. perfringens cells sporulate in the small intestine and produce large quantities of CPE. As a consequence, severe abdominal cramps and diarrhea occur within 8–12 h, usually with a spontaneous recovery within 24 h. Fatalities are rare but possible in elderly and immunocompromised persons. On the molecular level, the enteropathogenic effects of CPE are based on its pore-forming capability in eukaryotic cells. CPE is a single polypeptide of 35 kDa (containing 319 amino acids). By first binding via protein receptors belonging to the claudin family (proteins involved in tight junction structure and function), CPE forms a large complex of 155 kDa. The continuing presence of CPE in intoxicated cells leads to the formation of another large complex of 200 kDa together with a tight junction protein called occludin. These CPE-containing complexes cause changes in cellular membrane permeability, resulting in death of the cells via either the apoptotic or oncotic pathways due to calcium influx through CPE pores.20 Interestingly, most C. perfringens type A food poisoning strains carry the cpe gene in their chromosome and
Molecular Detection of Foodborne Pathogens
show increased resistance to heating, osmotic stress, and low temperatures, whereas C. perfringens type A strains causing AAD, sporadic diarrhea, and animal diarrheas harbor the cpe gene in a plasmid and possess only moderate resistance to the above-mentioned food processing stresses.21,22 Evidence indicates that different subpopulations of cpe genecarrying (cpe-positive) C. perfringens type A strains exist and that the food poisoning strains seem to be adapted to the kitchen environment. However, recent findings show that also plasmidborne cpe-positive C. perfringens type A strains commonly cause food poisonings.23 Healthy food handlers have been demonstrated to serve as rich reservoirs for cpepositive C. perfringens type A, indicating that humans should be considered a possible source of contamination for C. perfringens type A food poisoning.24 C. botulinum produces BoNT during growth. BoNT is a single polypeptide chain of around 150 kDa. After nicking with bacterial protease (or gastric proteases), it turns into a light chain of 50 kDa and a heavy chain of 100 kDa. Being specific for peripheral nerve endings at the point where a motor neuron stimulates a muscle, BoNT binds to the neuron and prevents the release of acetylcholine across the synaptic cleft. The heavy chain mediates binding to presynaptic receptors via its carboxy terminus and forms a channel through the membrane of the neuron via its amino terminus, facilitating entrance of the light chain. Inside a neuron, the toxin specifically cleaves SNARE complex proteins (soluble NSF-attachment protein receptors [NSF, N-ethylmaleimide-sensitive fusion protein]), synaptobrevin (VAMP),25 synaptosomal protein (SNAP25),26,27 and syntaxin,28 which are involved in neurotransmitter release from synaptic vesicles. This abolishes the ability of affected cells to release a neurotransmitter, thus paralyzing the motor system. In structural and functional terms, BoNT is similar to tetanus toxin, as both are zinc-dependent endopeptidases that cleave a set of proteins in the synaptic vesicles of neurons involved in excretion of neurotransmitters. However, while BoNT displays a preference for stimulatory motor neurons at a neuromuscular junction in the peripheral nervous system, causing weakness or flaccid paralysis, tetanus toxin (tetanospasmin) acts on inhibitory motor neurons of the central nervous system, causing rigidity and spastic paralysis. Clinically, botulism often shows one of the four following manifestations: (i) foodborne botulism, which is caused by the ingestion of foods containing BoNT; (ii) infant botulism, which occurs in infants under one year of age after ingestion of C. botulinum spores that then colonize the intestinal tract and produce BoNT; (iii) wound botulism, which is caused by infection of C. botulinum in a wound, with BoNT being produced and spread to the body via the bloodstream; and (iv) intestinal colonization of C. botulinum in adults, which resembles infant botulism in its etiology. The paralysis typically starts in ocular and facial nerves, then proceeds to the throat, chest, and extremities, potentially leading to respiratory difficulty and death by asphyxia.
Clostridium
11.1.3 Diagnosis 11.1.3.1 Foodborne C. perfringens (i) Phenotypic identification: Being able to produce spores, the genus Clostridium is distinct among other anaerobic Gram-positive bacterial genera. However, this feature is often not discernible in uncultured specimens. Therefore, in vitro culture under strict anaerobic conditions followed by other phenotypic procedures is traditionally undertaken to identify Clostridium to species level. On blood agar plates, C. perfringens colonies are flat, rough, and translucent, with regular or irregular margins, an inner zone of hemolysis (resulting from the activity of perfringolysin O), and an outer zone of less complete clearing (caused by C. perfringens alpha toxin). Occasionally strains without inner zone hemolysis are seen. On Nagler agar containing 5–10% egg yolk, C. perfringens generates a characteristic white precipitate as a result of its alpha toxin (with lecithinase activity) interacting with the lipids in egg yolk. Several solid media have been developed for cultivation and isolation of C. perfringens from different sample materials. These include neomycin blood agar, sulfite polymyxin sulfadiazine (SPS) agar, tryptone sulfite neomycin (TSN) agar, Shahidi Ferguson perfringens (SFP) agar, oleandomycin polymyxin sulfadiazine perfringens (OPSP) agar, and tryptose sulfite cycloserine (TSC) agar with or without egg yolk.29–33 Isolation of typical colonies from media is followed by confirmation of C. perfringens colonies with different tests to reveal phenotypic characteristics. Observation of nitrate reduction, gelatine liquefaction, lactose fermentation, or lack of motility in suspected C. perfringens isolates is usually sufficient to distinguish C. perfringens from other organisms.34 Identification of C. perfringens may be also carried out using biochemical test kits such as API.33 Several international method standards are available for confirmation of C. perfringens in different samples, including methods published by the Association of Official Analytical Chemists (AOAC), the International Standardization Organization (ISO), and the Nordic Committee on Food Analysis (NCFA). Notably, not all C. perfringens isolates present in food or feces produce CPE and are thus capable of causing food poisonings. Therefore, detection of CPE production (or the presence of the cpe gene) in the suspected C. perfringens isolate is warranted when confirming the causative agent of the food poisoning. When detecting CPE production, a widely used technique is the enzyme-linked immunosorbent assay (ELISA).35,36 In addition, a kit based on reverse passive latex agglutination (RPLA) provides a straightforward method for detection of CPE in clinical samples.35,37 (ii) Molecular identification: Assays targeting C. perfringens ribosomal RNA (rRNA) and major toxin genes have been designed and applied in recent decades for improved detection and identification of this bacterium. Being a rapid, highly sensitive, and specific technique, PCR has become the method of choice for molecular confirmation of C. perfringens species and toxinotype
149
identity. Many PCR protocols focusing on individual C. perfringens toxin genes (cpa, cpb, etx, iap, cpe, and cpb2) have been reported. Further refinement has led to the development of multiplex PCR assays that enable simultaneous efficient detection of several C. perfringens toxin genes. For example, Meer and Songer38 described a multiplex PCR test that incorporates primers derived from C. perfringens cpa, cpb, cpe, etx, and iA genes for concurrent amplification of multiple target sequences (Table 11.2). Heikinheimo and Korkeala39 subsequently modified the assay. The subsequent inclusion of primers from C. perfringens cpb2 gene44 further enhanced the utility of this multiplex PCR for laboratory detection of the major toxinotypes of this bacterium.40 Yoo et al.41 also devised a multiplex PCR for C. perfringens major toxin genes cpa, cpb, etx, and itx, which is clearly superior to conventional seroneutralization with mice or guinea pigs. Using another independently developed multiple PCR targeting the alpha, beta, epsilon, and iota toxin genes, Garmory et al.44 effectively examined C. perfringens isolates from a variety of animals, including foals, piglets, and lambs. Augustynowicz et al.45 reported the use of primers for four different genes encoding the alpha, beta, epsilon, and iota toxins in a multiplex PCR for determination of genotype profile of C. perfringens isolates from Poland. The assay showed a sensitivity of 200 fg of DNA extracted from pure culture and a concordance of 94% between toxin phenotype and genotype. In another study, Baums et al.42 developed a reliable species-specific multiplex PCR for the detection of the cpa, cpb, cpb2, cpe, etx, and iap genes of C. perfringens isolates in a single reaction not requiring DNA purification (Table 11.2). With the goal of further speeding up the diagnostic process, Albini et al.43 reported the establishment and validation of three real-time fluorogenic (TaqMan) multiplex PCRs for rapid and precise identification of C. perfringens alpha, beta, beta2, epsilon, entero, and iotatoxin genes. This was achieved by using a combination of probe dyes (FAM/TAMRA, Cy-5/ BHQ-2, and VIC/TAMRA) and chromosome-borne alpha toxin as an internal positive control (Table 11.2). Besides showing total agreement with conventional PCR in identifying C. perfringens toxin genotypes, the newly developed multiplex PCRs provide the option of quantitating the copy numbers of plasmidborne toxin genes in relation to the chromosomally located alpha toxin gene. Similarly, Gurjar et al.46 described a real-time multiplex PCR utilizing a dual-labeled fluorescence hybridization probe (TaqMan®) for detection of C. perfringens toxin genes alpha (cpa), beta (cpb), iota (ia), epsilon (etx), beta2 (cpb2), and enterotoxin (cpe). This assay displayed a minimum detection limit of 5–70 pg of DNA depending on the toxin gene targets. In addition to PCR assays, other methods, such as DNA microarray, have also been reported for detecting cpe and other toxin genes.47,48 Colony hybridization has been used to detect cpe in raw beef.49 The authors developed a hydrophobic grid membrane filter colony hybridization method for the enumeration and isolation of cpe-positive C. perfringens
150
directly from feces by detecting the cpe gene in bacterial colonies with a cpe-specific probe.50 (iii) Genetic typing: Typing is the assessment of the relatedness of a group of bacterial isolates to determine whether or not they originate from a common source. The ability to track C. perfringens type A strains involved in food poisoning outbreaks is vital for the control and prevention of this common illness. An early epidemiological tool in the investigation of C. perfringens type A food poisoning outbreaks was serotyping.51,52 This method is based on phenotypic characteristics of the organism, whereas current techniques rely to a great extent on genetic typing of the organism. A variety of nonamplified and amplified genetic typing techniques have been developed and applied. The nonamplified procedures include pulsedfield gel electrophoresis (PFGE), ribotyping, and plasmid profiling, whereas the amplified procedures include PCR, variable number tandem repeat (VNTR), and amplified fragment length polymorphism (AFLP). Nonamplified genetic typing methods. PFGE relies on gel electrophoresis to separate genomic C. perfringens DNA that has been previously digested with rare-cutting restriction enzymes, and generates a distinctive fingerprint pattern (consisting of five to 15 fragments in the range of 10–1,000 kb) for each strain. In assessing the clonality of 71 C. perfringens strains from 36 separate food poisoning outbreaks, Ridell et al.53 used SmaI and ApaI as restriction endonucleases. After evaluation of six restriction endonucleases (SmaI, ApaI, FspI, MluI, KspI, and XbaI), Maslanka et al.54 also chose SmaI, as this enzyme produced 11–13 well-distributed bands of 40–1,100 kb for effective discrimination of C. perfringens using PFGE. The authors obtained 17 distinct patterns among 62 isolates from seven outbreak investigations or control strains and noted that epidemiologically unrelated isolates had unique patterns, while isolates from different individuals within the same outbreak had similar, if not identical, patterns. Lukinmaa et al.55 reported the use of SmaI and ApaI in PFGE for typing 47 C. perfringens isolates from nine foodborne outbreaks of disease isolated during 1984–1999. Like many other bacterial species, C. perfringens harbors plasmids that can be targeted for genetic typing in a procedure called plasmid profiling.56–58 By isolating plasmid DNA from individual C. perfringens isolates and subjecting them to restriction enzyme digestion followed by electrophoresis, the plasmid profile (and genotype) of individual strains can be ascertained. For example, Eisgruber et al.57 employed plasmid profiling to show that the origin of three disease outbreaks could be clearly confirmed due to identical plasmid profiles in all C. perfringens isolates from food and clinical samples. Schalch et al.58 comparatively assessed plasmid profiling, ribotyping, and PFGE for typing 155 C. perfringens isolates from ten food poisoning outbreaks (with 34 food and fecal isolates) and 121 meat and fish pastes. They noted that although all three methods are suitable for classifying C. perfringens isolates below the species level, ribotyping, and PFGE generate patterns that can be interpreted more easily than plasmid profiling.
Molecular Detection of Foodborne Pathogens
Being a derivative of restriction fragment length polymorphism (RFLP), ribotyping uses a ribosomal DNA (rDNA) probe to detect the restriction fragment patterns of C. perfringens chromosomal DNA digested with appropriate restriction enzymes, providing much simpler and more consistent outcomes. Schalch et al.59 detected 12 ribopatterns with EcoRIdigested C. perfringens DNA from 34 isolates from 10 food poisoning cases and outbreaks over a seven-year period and found that all of the ribotypes of each food and stool isolate were identical in eight food poisoning cases and outbreaks. Amplified genetic typing methods. A key feature of amplified genetic typing methods is that C. perfringensspecific gene(s) of interest are amplified by PCR and analyzed directly by gel electrophoresis (e.g., VNTR) or subjected to other treatments before examination (e.g., AFLP). VNTRs, also known as microsatellites, are a class of short DNA sequence motifs that are tandemly repeated at certain specific locations, which play vital roles in both transcriptional and translational control of gene expression in bacteria and other organisms. Sawires and Songer60 characterized five VNTR loci in 112 C. perfringens isolates and demonstrated its value for rapid, easy, and cost-effective typing of this bacterium. In addition, this technique provides insight into the evolution of C. perfringens virulence.61 Chalmer et al.62 also employed VNTR in combination with capillary electrophoresis for precise and high-throughput typing of C. perfringens isolates. AFLP employs adaptors to restriction enzyme-digested C. perfringens DNA for PCR amplification and electrophoretic detection. McLauchlin et al.63 examined 35 C. perfringens clinical and food isolates from seven outbreaks and showed that AFLP is highly reproducible and provides a rapid, sensitive, and reproducible method for the genotyping of C. perfringens. Keto-Timonen et al.64 applied AFLP to differentiate C. perfringens strains from each other. The advantage of the AFLP method is that it overcomes the problem of extracellular DNAse production, which is often a problem when using, for example, PFGE for typing C. perfringens isolates. PCR genotyping assays are also available to establish whether cpe-positive C. perfringens type A isolates carry chromosomal or plasmidborne cpe. These methods detect different insertion sequence elements attached to cpe.65,66 11.1.3.2 Foodborne C. botulinum (i) Phenotypic identification: The complexity of the diagnostics of C. botulinum arises from the lack of validation of sensitive and specific in vitro methods for the detection of C. botulinum. The only standard method for detection of the neurotoxin is the mouse bioassay, which leads to ethical concerns regarding use of laboratory animals.67 Standard detection and isolation of C. botulinum is based on culture in a liquid medium and subsequent detection of BoNT in the culture supernatant by the mouse bioassay. Culture of C. botulinum requires strict anaerobic conditions. All culture media must be deoxygenated by heating in a boiling water bath or by a continuous flow of an anaerobic gas mixture, and the
151
Clostridium
use of anaerobic jars and anaerobic workstations is required in a C. botulinum laboratory. Due to the extreme potency of BoNT, rigorous precautionary measures must be implemented to protect laboratory workers dealing with C. botulinum. Several sample pre-preparation steps can be utilized to enhance the isolation of C. botulinum from clinical samples (e.g., serum and feces). These include: (i) pretreatment with ethanol to eliminate vegetative bacteria and recover spores; (ii) heating to eliminate nonsporeforming bacteria (i.e., 80°C for 10 min for Group I spores or 60°C for 10–20 min for Group II spores); and (iii) inclusion of lysozyme (5 μg/ml) or other heat-resistant lytic enzymes in the culture medium to facilitate germination of heat-stressed spores.67 Chopped-meat-glucose-starch medium; cooked-meat medium; broths containing various combinations of tryptone, peptone, glucose, yeast extract, and trypsin (e.g., tryptonepeptone-glucose-yeast extract medium); reinforced clostridial medium; and fastidious anaerobe broth are widely used liquid media in cultivation of C. botulinum.68–73 Blood agar and egg yolk agar (EYA)74 are the most common unselective plating media, with EYA enabling the lipase reaction typical of C. botulinum. Group I strains grow optimally at 35–40°C, whereas Group II strains favor lower temperatures of 25–30°C.75 If both groups are being sought in a single sample, a compromise of 30°C has been proposed.75 However, investigating replicate samples at 26–30°C and at 35–37°C is preferable to ensure optimal growth for both groups. The optimal incubation time varies with the sample material and the detection method selected to identify the presence of C. botulinum in the culture tube. (ii) Molecular identification: As with C. perfringens, numerous PCR-based assays targeting the BoNT gene bot have been developed for the detection of C. botulinum. A multiplex PCR assay for C. botulinum botA, botB, botE, and botF genes has shown potential for rapid identification of C. botulinum toxinotypes of human botulism caused by Groups I and II76 (Table 11.3). However, the use of PCR assays targeting the neurotoxin genes does not provide details on the physiological group of C. botulinum isolates. In an attempt to address this issue, Dahlsten et al.77 designed a PCR assay targeting fldB, which is involved in phenylalanine metabolism in proteolytic clostridia, Table 11.3 Primers for C. botulinum Types A, B, E, and F Type A B E F
Primer (5′–3′)
Product Size (bp)
AGC TAC GGA GGC AGC TAT GTT CGT ATT TGG AAA GCT GAA AAG G CAG GAG AAG TGG AGC GAA AA CTT GCG CCT TTG TTT TCT TG CCA AGA TTT TCA TCC GCC TA GCT ATT GAT CCA AAA CGG TGA CGG CTT CAT TAG AGA ACG GA TAA CTC CCC TAG CCC CGT AT
782
Table 11.4 Primers for Differentiation between Group I and Group II C. botulinum Strains Gene fldB 16S rrn
Primer (5′–3′)
Product Size (bp)
GGGGAGAAAAAGTTGGTTGG CGAATCCACTAAATGGTGAAGG CGACCTGAGAGGGTGATCG GAGCTGACGACAACCATGC
552 761
to distinguish between proteolytic and nonproteolytic C. botulinum. The assay involves an internal amplification control targeted to the conserved region of 16S rrn in Group I and II C. botulinum (Table 11.4). This assay correctly identified all 36 Group I and 24 Group II C. botulinum strains, showing a 100% exclusivity and inclusivity. (iii) Genetic typing: Genetic typing of C. botulinum has been performed with various nonamplified and amplified procedures, including PFGE, ribotyping, AFLP, repetitive element sequence-based PCR (Rep-PCR), and VNTR. Lin and Johnson78 described the PFGE method using restriction enzymes MluI, RsrII, and SmaI for typing Group I A toxin-producing C. botulinum strains with encouraging results. Subsequently, Nevas et al.79 showed that use of SacII alone or in combination with SmaI and XhoI provides good discrimination among C. botulinum Group I strains. Others80,81 have demonstrated that restriction enzymes XhoI and SmaI can be employed in PFGE for genotyping of Group II C. botulinum strains. Application of ribotyping of EcoRI-digested C. botulinum DNA also permitted differentiation of C. botulinum strains belonging to Groups I and II.82 Keto-Timonen et al.83 showed that AFLP involving restriction enzymes HindIII and HpyCH4IV offers an excellent typing tool for Group I and II C. botulinum. Repetitive extragenic palindromes (REP) are randomly dispersed, repetitive sequence elements of 35–40 bp with an inverted repeat that exist in a wide range of bacterial genomes and are useful as genotyping targets. Hyytiä et al.84 reported a Rep-PCR protocol for determination of C. botulinum Group II type B and E toxin-producing strains to the strain level, and of C. botulinum Group II type F toxin-producing strains and all Group I strains to the toxinotype level. MacDonald et al.85 identified 10 VNTR regions in C. botulinum strain ATCC 3502 (subtype A1) for characterization of C. botulinum type A strains, resulting in the identification of 38 different genotypes among 59 strains. These markers have proven useful for discrimination among C. botulinum subtype A1 strains in the epidemiological investigations of botulism outbreaks.
205 389 543
11.2 Methods 11.2.1 Sample Preparation DNA extraction. One colony (C. perfringens or C. botulinum) is inoculated into 5 ml of cooked meat broth and
152
incubated at 26–30°C (Group II C. botulinum) or 37°C (C. perfringens and Group I C. botulinum) overnight (14 h). Cells are harvested by centrifugation (1,500 × g) at 4°C, and the pellet is resuspended in 600 μl of TE (10 mM Tris–HCl (pH 7.5), 1 mM EDTA (pH 8.0) containing 164 μg of RNase/ ml (Sigma), 8.3 mg of lysozyme/ml (Sigma), and 167 IU of mutanolysin/ml (Sigma) and incubated at 37°C for 30 min. Then, 9.5 mM EDTA (pH 8.0), 0.24 M NaCl, 49 μg of proteinase K/ml (Finnzymes, Espoo, Finland), and 0.8% (v/v) sodium dodecyl sulfate are added, and the mixture is incubated with gentle shaking at 60°C for 1 h to lyze the cells. Lysis is indicated by an increase in viscosity and a change in the suspension from turbid to opalescent. Subsequent phenol– chloroform–isoamyl alcohol (25:24:1, v/v) and chloroform– isoamyl alcohol (24:1, v/v) extractions are performed, and the DNA is precipitated with ethanol (95%, v/v), washed once with 70% ethanol, air-dried, and resuspended in 100 μl of 1 × TE (10 mM Tris–Cl pH 8.0, 1 mM EDTA pH 8.0) and then quantified with a spectrophotometer. For PCR analyses, the DNA is diluted in 1 × TE to a final concentration of 10 ng/μl. Alternatively, if C. perfringens and C. botulinum DNA are intended for PCR only, they can be prepared by using a boiling method. Namely, one to two colonies are suspended in 100 μl of water, heated at 95°C for 5 min, and centrifuged at 13,000 × g for 5 min, after which 1–5 μl is added to the PCR mixture (μl total volume).
11.2.2 Detection Procedures 11.2.2.1 Multiplex PCR for C. perfringens Toxin Genes Principle: All C. perfringens types (A–E) produce alpha toxin (encoded by the cpa gene). In addition, type B produces beta (encoded by the cpb gene) and epsilon (encoded by the etx gene) toxins, type C produces beta toxin, type D produces epsilon toxin, and type E produces iota toxin (encoded by the iA gene). Below, we present a multiplex PCR targeting C. perfringens cpa, cpb, etx, iA, and cpe genes, which was originally reported by Meer and Songer38 and recently updated by Heikinheimo and Korkeala.39 This assay provides a useful means of identifying C. perfringens toxigenotypes. Procedure: (1) Prepare the PCR mixture (50 µl) containing 10 μl of template, primers (0.34 mM of each cpe primer, 0.36 mM of each cpb primer, 0.46 mM of each etx primer, 0.5 mM of each cpa primer, and 0.52 mM of each iA primer), 1 × PCR buffer (10 mM Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl2, and 0.001% gelatin), 0.1 mM of each dNTP, 5 U Taq DNA polymerase (Fisher Scientific), and distilled water (to 50 µl) (see Table 11.2).38,39 (2) Run the following cycling program in a PCR machine: one cycle of 94ºC for 2 min; 35 cycles of 94ºC for 1 min, 53ºC for 1 min, and 72ºC for 1 min; and one cycle of 72ºC for 10 min.
Molecular Detection of Foodborne Pathogens
(3) Separate the PCR products on a 1.5% agarose gel containing 0.5 μg/ml ethidium bromide and visualize under a UV light box and photograph. Note: the expected products are for C. perfringens type A 400 bp; type B 400, 196, and 655 bp; type C 400 and 196 bp; type D 400 and 655 bp; and type E 400 and 446 bp. C. perfringens cpe-positive strains show an additional 233-bp band. 11.2.2.2 Multiplex PCR for C. botulinum Toxin Genes Principle: C. botulinum causing human botulism belongs to two groups: (i) proteolytic Group I producing toxin A, B, or F or (ii) nonproteolytic Group II producing toxin B, E, or F. C. butyricum and C. baratii, which also produce type E and F toxins, respectively, can be distinguished from C. botulinum by biochemical methods. We present below a multiplex PCR assay for the simultaneous detection of type A1, B, E, and F neurotoxin genes76 (Table 11.3). Procedure: (1) Prepare the PCR mixture (50 μl) containing 0.3 μM concentrations of each primer (A, B, E, and F) (Table 11.3), 220 nM concentrations of each deoxynucleotide triphosphate (dATP, dCTP, dGTP, and dTTP; dNTP), 32 mM Tris-HCl (pH 8.4), 80 mM KCl, 4.8 mM MgCl, and 2 U of DNA polymerase (DynaZyme; Finnzymes), 1 μl of DNA template (see Section 11.2.1), and distilled water (to 50 μl). (2) Run the following cycling program in a PCR thermocycler: 28 cycles of 95ºC for 30 s, 60ºC for 25 s, and 72ºC for 1 min 25 s; and 1 cycle of 72ºC for 3 min. (3) Separate the PCR products on a 2% agarose gel containing 0.5 μg/ml ethidium bromide along with a DNA molecular weight marker (e.g., DNA molecular weight marker VI, Roche Diagnostics) and visualize under a UV light box and photograph. Note: a PCR product of 782 bp is observed with C. botulinum subtype A1 alone, 205 bp for type B alone, 389 bp for type E alone, and 543 bp for type F alone. Other bacterial species, including C. botulinum subtypes A2–A4, C. sporogenes, and the nontoxigenic nonproteolytic C. botulinum-like organisms, do not yield a PCR product. Sensitivity of the PCR for types A, E, and F is 102 cells and for type B ten cells per reaction mixture. With a two-step enrichment, the detection limit in food and fecal samples varied from 102 spore/g for types A, B, and F to 101 spore/g of sample material for type E.76 11.2.2.3 PCR Assay to Distinguish Between Proteolytic (Mainly Group I) and Nonproteolytic (Mainly Group II) C. botulinum Principle: Dahlsten et al.77 developed a multiplex PCR with primers targeted to the fldB gene (associated with
153
Clostridium
phenylalanine metabolism in proteolytic clostridia) for specific recognition of Group I C. botulinum, and to a conserved region of 16S rrn (present in both Group I and Group II C. botulinum) (Table 11.4). The 16S rrn primers act as an internal control for both Group I and II C. botulinum.
Procedure: (1) Prepare the PCR mixture (50 μl) containing 1 × PCR buffer (10 mM Tris–HCl, 1.5 mM MgCl2, 50 mM KCl, 0.1% Triton X-100 (DyNAzyme Reaction Buffer, Finnzymes), 200 μM of each dNTP, 0.5 μM of each fldB primer, 0.1 μM of each 16S rnn primer, 2 U Taq DNA polymerase (Finnzymes), 5 μl of DNA, and distilled water (to 50 μl). (2) Run the following cycling program in a PCR machine: one cycle of 95ºC for 2 min; 28 cycles of 95ºC for 30 s, 53ºC for 30 s, and 72ºC for 1 min; and 1 cycle of 72ºC for 5 min. (3) Separate the PCR products on a 2% agarose gel containing 0.5 μg/ml ethidium bromide at 90 V for 1 h 45 min along with a DNA molecular weight marker (e.g., DNA molecular weight marker VI, Roche Diagnostics) and visualize under a UV light box and photograph. Note: the expected products are for C. botulinum Group I 552 and 752 bp; and for Group II 752 bp.77 The assay is intended for rapid typing (Group I vs. Group II) of pure isolates previously identified as C. botulinum. The assay is not suitable for analysis of mixed cultures.
11.3 Conclusion Besides causing serious nonfoodborne diseases, C. perfringens and C. botulinum contribute to an increasing number of food-related outbreaks worldwide. The ability to correctly identify these bacteria and differentiate between their toxigenotypes is vital to the control and prevention of diseases arising from them. While the conventional culture techniques are useful for isolation and identification of these bacteria, these methods are often time-consuming and sometimes variable. The application of molecular procedures has greatly improved laboratory diagnostics of these important bacterial pathogens. There is no doubt that continuing refinement in the sample processing procedures and automation in the target amplification and detection will make molecular identification of C. perfringens and C. botulinum and their toxinotypes an indispensable tool in food and clinical testing laboratories, and further strengthen our capacity in the tracking and prevention of foodborne illnesses resulting from C. perfringens and C. botulinum infection and contamination.
References
1. Shimizu, T. et al. Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater. Proc. Natl. Acad. Sci. USA, 99, 996, 2002.
2. Myers, G.S. et al. Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. Genome Res., 16, 1031, 2006. 3. Hatheway, C.L. Toxigenic clostridia. Clin. Microbiol. Rev., 3, 66, 1990. 4. Gibert, M., Jolivetrenaud, C. and Popoff, M.R. Beta2 toxin, a novel toxin produced by Clostridium perfringens. Gene, 203, 65, 1997. 5. Smedley, J.G. 3rd et al. The enteric toxins of Clostridium perfringens. Rev. Physiol. Biochem. Pharmacol., 152, 183, 2005. 6. Songer, J.G. and Uzal, F.A. Clostridial enteric infections in pigs. J. Vet. Diagn. Invest., 17, 528, 2005. 7. Peck, M.W. Clostridium botulinum and the safety of minimally heated, chilled foods: An emerging issue? J. Appl. Microbiol., 101, 556, 2006. 8. Suen, J.C. et al. Clostridium argentinense, sp. nov: A genetically homogenous group composed of all strains of Clostridium botulinum type G and some nontoxigenic strains previously identified as Clostridium subterminale or Clostridium hastiform. Int. J. Syst. Bacteriol., 38, 375, 1988. 9. Sebaihia, M. et al. Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. Genome Res., 17, 1082, 2007. 10. Kautter, D.A. et al. Antagonistic effect on Clostridium botulinum type E by organisms resembling it. Appl. Microbiol., 14, 616, 1966. 11. Hill, K.K. et al. Genetic diversity among botulinum neurotoxinproducing clostridial strains. J. Bacteriol., 189, 818, 2007. 12. Chen, Y. et al. Sequencing the botulinum neurotoxin gene and related genes in Clostridium botulinum type E strains reveals orfx3 and a novel type E neurotoxin subtype. J. Bacteriol., 189, 8643, 2007. 13. Hinderink, K., Lindström, M. and Korkeala, H. Group I Clostridium botulinum strains show significant variation in growth at low and high temperature. J. Food Prot, 72(1) In press. 14. Eklund, M.W., Wieler, D.I. and Poysky, F.T. Outgrowth and toxin production of nonproteolytic type B Clostridium botulinum at 3.3 to 5.6°C. J. Bacteriol., 93, 1461, 1967. 15. Graham, A.F., Mason, D.R., and Peck, M.W. Effect of pH and NaCl on growth from spores of nonproteolytic Clostridium botulinum at chill temperature. Lett. Appl. Microbiol., 24, 95, 1997. 16. Stumbo, C.R., Purohit, K.S. and Ramakrishna, T.V. Thermal process lethality guide for low-acid foods in metal containers. J. Food Sci., 40, 1316, 1975. 17. Lindström, M., Kiviniemi, K. and Korkeala, H. Hazard and control of group II (non-proteolytic) Clostridium botulinum in modern food processing. Int. J. Food Microbiol., 108, 92, 2006. 18. Drigo, I. et al. Development of PCR protocols for specific identification of Clostridium spiroforme and detection of sas and sbs genes. Vet Microbiol., 2008. 19. McClane, B.A. Clostridium perfringens. In: Food microbiology: Fundamentals and frontiers, 2nd ed. p. 351. ASM Press, Washington DC, 2001. 20. Smedley, J.G. et al. Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin. Infect. Immun., 75, 2381, 2007. 21. Li, J. and McClane, B.A. Further comparison of temperature effects on growth and survival of Clostridium perfringens type A isolates carrying a chromosomal or plasmid-borne enterotoxin gene. Appl. Environ. Microbiol., 7, 4561, 2006.
154 22. Li J. and McClane, B.A. Comparative effects of osmotic, sodium nitrite-induced, and pH-induced stress on growth and survival of Clostridium perfringens type A isolates carrying chromosomal or plasmid-borne enterotoxin genes. Appl. Environ. Microbiol., 12, 7620, 2006. 23. Lahti, P. et al. Clostridium perfringens type A strains carrying a plasmid-borne enterotoxin gene (genotype IS1151-cpe or IS1470-like-cpe) as a common cause of food poisoning. J. Clin. Microbiol., 46, 371, 2008. 24. Heikinheimo, A. et al. Humans as reservoir for enterotoxin gene-carrying Clostridium perfringens type A. Emerg. Infect. Dis., 12, 1724, 2006. 25. Schiavo, G. et al. Tetanus and botulinum-B neurotoxins block transmitter release by proteolytic cleavage of synaptobrevin. Nature, 359, 832, 1992. 26. Blasi, J. et al. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature, 365, 160, 1993. 27. Schiavo, G. et al. Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett., 335, 99, 1993. 28. Schiavo, G. et al. Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J. Biol. Chem., 270, 10566, 1995. 29. Harmon, S.M., Kautter, D.A. and Peeler, J.T. Improved medium for enumeration of Clostridium perfringens. Appl. Microbiol., 22, 688, 1971. 30. Hauschild, A.H. and Hilsheimer, R. Enumeration of foodborne Clostridium perfringens in egg yolk-free tryptosesulfite-cycloserine agar. Appl. Microbiol., 27, 521, 1974. 31. Hauschild, A.H. and Hilsheimer, R. Evaluation and modifications of media for enumeration of Clostridium perfringens. Appl. Microbiol., 27, 78, 1974. 32. Hauschild, A.H., Hilsheimer, R. and Griffith, D.W. Enumeration of fecal Clostridium perfringens spores in egg yolk-free tryptose-sulfite-cycloserine agar. Appl. Microbiol., 27, 527, 1974. 33. Labbé, R. Clostridium perfringens. In: The microbiological safety and quality of food. Aspen Publishers, Gaithersburg, MD, 2000. 34. Cato, E., George, W.L. and Finegold, S. Genus Clostridium, Bergey’s manual of systematic bacteriology. Vol. 2. Williams and Wilkins, Baltimore, MD, USA, 1986. 35. Berry, P.R. et al. Evaluation of ELISA, RPLA, and Vero cell assays for detecting Clostridium perfringens enterotoxin in faecal specimens. J. Clin. Pathol., 41, 458, 1988. 36. Piyankarage, R.H. et al. Sandwich enzyme-linked immunosorbent assay by using monoclonal antibody for detection of Clostridium perfringens enterotoxin. J. Vet. Med. Sci., 61, 45, 1999. 37. Berry, P.R. and Stringer, M.F. Preliminary investigation on the use of latex agglutination for the detection of Clostridium perfringens enterotoxin. J. Appl. Bacteriol., 59, 14, 1985. 38. Meer, R. and Songer, G. Multiplex polymerase chain reaction assay for genotyping Clostridium perfringens. Am. J. Vet. Res., 58, 702, 1997. 39. Heikinheimo, A. and Korkeala, H. Multiplex PCR assay for toxinotyping Clostridium perfringens isolates obtained from Finnish broiler chickens. Lett. Appl. Microbiol., 40, 407, 2005. 40. Uzal, F.A. and Songer, J.G. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J. Vet. Diagn Invest., 20, 253, 2008. 41. Yoo, H.S. et al. Molecular typing and epidemiological survey of prevalence of Clostridium perfringens types by multiplex PCR. J. Clin. Microbiol., 35, 228, 1997.
Molecular Detection of Foodborne Pathogens 42. Baums, C.G. et al. Diagnostic multiplex PCR for toxin genotyping of Clostridium perfringens isolates. Vet. Microbiol., 100, 11, 2004. 43. Albini, S. et al. Real-time multiplex PCR assays for reliable detection of Clostridium perfringens toxin genes in animal isolates. Vet. Microbiol., 127, 179, 2008. 44. Garmory, H.S. et al. Occurence of Clostridium perfringens β2-toxin amongst animals, determined using genotyping and subtyping PCR assays. Epidemiol. Infect., 124, 61, 2000. 45. Augustynowicz, E., Gzyl, A. and S´lusarczyk, J. Molecular epidemiology survey of toxinogenic Clostridium perfringens strain types by multiplex PCR. Scand. J. Infect. Dis., 32, 637, 2000. 46. Gurjar, A.A. et al. Real-time multiplex PCR assay for rapid detection and toxintyping of Clostridium perfringens toxin producing strains in feces of dairy cattle. Mol. Cell. Probes, 22, 90, 2008. 47. Al-Khaldi, S.F. et al. Genotyping of Clostridium perfringens toxins using multiple oligonucleotide microarray hybridization. Mol. Cell. Probes, 18, 359, 2004. 48. Al-Khaldi, S.F. et al. Identification and characterization of Clostridium perfringens using single target DNA microarray chip. Int. J. Food Microbiol., 91, 289, 2004. 49. Baez, L.A. and Juneja, V.K. Nonradioactive colony hybridization assay for detection and enumeration of enterotoxigenic Clostridium perfringens in raw beef. Appl. Environ. Microbiol., 61, 807, 1995. 50. Heikinheimo, A., Lindström, M. and Korkeala, H. Enumeration and isolation of cpe-positive Clostridium perfringens spores from feces. J. Clin. Microbiol., 42, 3992, 2004. 51. Hauschild, A.H.W. Criteria and procedures for implicating Clostridium perfringens in food-borne outbreaks. Can. J. Public Health, 66, 388, 1975. 52. Lund, B.M., Baird-Parker, T.C. and Gould, G.W. The microbiological safety and quality of food. Aspen Publishers, Gauthersburg, MD, 2000. 53. Ridell, J. et al. Prevalence of the enterotoxin gene and clonality of Clostridium perfringens strains associated with foodpoisoning outbreaks. J. Food Prot., 61, 240, 1998. 54. Maslanka, S.E. et al. Molecular subtyping of Clostridium perfringens by pulsed-field gel electrophoresis to facilitate foodborne-disease outbreak investigations. J. Clin. Microbiol., 37, 2209, 1999. 55. Lukinmaa, S., Takkunen, E. and Siitonen, A. Molecular epidemiology of Clostridium perfringens related to food-borne outbreaks of disease in Finland from 1984 to 1999. Appl. Environ. Microbiol., 68, 3744, 2002. 56. Mahony, D.E., Ahmed, R. and Jackson, S.G. Multiple typing techniques applied to a Clostridium perfringens food poisoning outbreak. J. Appl. Bacteriol., 72, 309, 1992. 57. Eisgruber, H., Wiedmann, M. and Stolle, A. Use of plasmid profiling as a typing method for epidemiologically related Clostridium perfringens isolates from food poisoning cases and outbreaks. Lett. Appl. Microbiol., 20, 290, 1995. 58. Schalch, B. et al. Molecular methods for the analysis of Clostridium perfringens relevant to food hygiene. FEMS Immunol. Med. Microbiol., 24, 281, 1999. 59. Schalch, B. et al. Ribotyping for strain characterization of Clostridium perfringens isolates from food poisoning cases and outbreaks. Appl. Environ. Microbiol., 63, 3992, 1997. 60. Sawires, Y.S. and Songer, J.G. Multiple-locus variable-number tandem repeat analysis for strain typing of Clostridium perfringens. Anaerobe, 11, 262, 2005.
Clostridium 61. Sawires Y.S. and Songer, J.G. Clostridium perfringens: Insight into virulence evolution and population structure. Anaerobe, 12, 23, 2006. 62. Chalmers, G. et al. Typing of Clostridium perfringens by multiple-locus variable number of tandem repeats analysis. Vet. Microbiol., 128, 126, 2008. 63. McLauchlin, J. et al. Amplified fragment length polymorphism (AFLP) analysis of Clostridium perfringens for epidemiological typing. Int. J. Food Microbiol., 56, 21, 2000. 64. Keto-Timonen, R. et al. Identification of Clostridium species and DNA fingerprinting of Clostridium perfringens by amplified fragment length polymorphism analysis. J. Clin. Microbiol., 44, 4057, 2006. 65. Wen, Q.Y., Miyamoto, K. and McClane, B.A. Development of a duplex PCR genotyping assay for distinguishing Clostridium perfringens type A isolates carrying chromosomal enterotoxin (cpe) genes from those carrying plasmid-borne enterotoxin (cpe) genes. J. Clin. Microbiol., 41, 1494, 2003. 66. Miyamoto, K., Wen, Q.Y. and McClane, B.A. Multiplex PCR genotyping assay that distinguishes between isolates of Clostridium perfringens type A carrying a chromosomal enterotoxin gene (cpe) locus, a plasmid cpe locus with an IS1470-like sequence, or a plasmid cpe locus with an IS1151 sequence. J. Clin. Microbiol., 42, 1552, 2004. 67. Lindström, M. and Korkeala, H. Laboratory diagnostics of botulism. Clin. Microbiol. Rev., 19, 298, 2006. 68. Robertson, M. Notes upon certain anaerobes isolated from wounds. J. Pathol. Bacteriol., 20, 327, 1916. 69. Gibbs, B.M. and Hirsch, A. Spore formation by Clostridium species in an artificial medium. J. Appl. Bacteriol., 19, 129, 1956. 70. Lilly, T. et al. An improved medium for detection of Clostridium botulinum type E. J. Milk Food Technol., 34, 492, 1971. 71. Quagliaro, D.A. An improved cooked meat medium for the detection of Clostridium botulinum. J. AOAC, 60, 563, 1977. 72. Centers for Disease Control and Prevention. Botulism in the United States (1899–1996). Handbook for epidemiologists, clinicians, and laboratory workers. U.S. Department of Health, Education, and Welfare, CDC, Atlanta, GA, 1998. 73. Saeed, E.M.A. Studies on isolation and identification of Clostridium botulinum investigating field samples specially from equine grass sickness cases. Doctoral thesis, University of Göttingen, Göttingen, Germany, 2005.
155 74. Hauschild, A.H.W. and Hilsheimer, R. Enumeration of Clostridium botulinum spores in meats by a pour-plate procedure. Can. J. Microbiol., 23, 829, 1977. 75. Smith, L.D.S. and Sugiyama, H. Botulism. The organism, its toxins, the disease. Charles C. Thomas, Springfield, IL, 1988. 76. Lindström, M. et al. Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and faecal material. Appl. Environ. Microbiol., 67, 5694, 2001. 77. Dahlsten, E. et al. PCR assay for differentiating between Group I (proteolytic) and Group II (nonproteolytic) strains of Clostridium botulinum. Int. J. Food Microbiol., 124. 108, 2008. 78. Lin, W.J. and Johnson, E.A. Genome analysis of Clostridium botulinum type A by pulsed-field gel electrophoresis. Appl. Environ. Microbiol. 61, 4441, 1995. 79. Nevas, M. et al. Diversity of proteolytic Clostridium botulinum strains, determined by pulsed-field gel electrophoresis approach. Appl. Environ. Microbiol., 71, 1311, 2005. 80. Hielm, S. et al. Genomic analysis of Clostridium botulinum group II by pulsed-field gel electrophoresis. Appl. Environ. Microbiol., 64, 703, 1998. 81. Hyytiä, E. et al. Biodiversity of Clostridium botulinum type E strains isolated from fish and fishery products. Appl. Environ. Microbiol., 65, 2057, 1999. 82. Hielm, S. et al. Ribotyping as an identification tool for Clostridium botulinum strains causing human botulism. Int. J. Food Microbiol., 47, 121, 1999. 83. Keto-Timonen, R., Nevas, M. and Korkeala, H. Efficient DNA fingerprinting of Clostridium botulinum types A, B, E, and F by amplified fragment length polymorphism analysis. Appl. Environ. Microbiol., 71, 1148, 2005. 84. Hyytiä, E. et al. Characterisation of Clostridium botulinum groups I and II by randomly amplified polymorphic DNA analysis and repetitive element sequence-based PCR. Int. J. Food Microbiol., 48, 179, 1999. 85. MacDonald, T.E. et al. Differentiation of Clostridium botulinum serotype A strains by multiple-locus variable-number tandem-repeat analysis. Appl. Environ. Microbiol., 74, 875, 2008.
12 Enterococcus
Teresa Semedo-Lemsaddek, Rogério Tenreiro University of Lisbon
Paula Lopes Alves, Maria Teresa Barreto Crespo
Institute of Experimental and Technological Biology (IBET)
Contents 12.1 Introduction.................................................................................................................................................................... 157 12.1.1 Taxonomy and General Characteristics of Enterococci................................................................................... 157 12.1.2 Molecular Approaches for Identification and Detection of Enterococci.......................................................... 158 12.1.3 Why Detect and/or Quantify Enterococci?....................................................................................................... 168 12.2 Methods.......................................................................................................................................................................... 168 12.2.1 Sample Collection and Preparation.................................................................................................................. 168 12.2.1.1 Sample Homogenization.................................................................................................................. 168 12.2.1.2 Cell Isolation and Counting without Pre-enrichment...................................................................... 169 12.2.1.3 Pre-enrichment................................................................................................................................ 169 12.2.1.4 DNA Extraction for Conventional PCR........................................................................................... 169 12.2.1.5 DNA Extraction for Real-time PCR.................................................................................................170 12.2.1.6 DNA Extraction from a Fermented Cereal-based Food ................................................................. 172 12.2.2 Detection Procedures.........................................................................................................................................173 12.2.2.1 Genus- and Species-specific Multiplex PCR....................................................................................173 12.2.2.2 Data Analysis....................................................................................................................................174 12.3 Conclusions and Future Perspectives..............................................................................................................................174 Acknowledgments.......................................................................................................................................................................175 References...................................................................................................................................................................................175
12.1 Introduction 12.1.1 Taxonomy and General Characteristics of Enterococci The classification and nomenclature of the genus Enterococcus have attracted interest and constant discussion over the years, since the first proposal of the name “enterocoques” made in 1902 by Thiercelin.1 In 1970, Kalina2 proposed that Streptococcus faecalis and S. faecium should be renamed as Enterococcus faecalis and E. faecium, respectively. These proposals remained unrecognized officially and in 1980 the genus Enterococcus did not appear in the Approved List of Bacterial Names. In the 1980s, Schleifer and Kilpper-Bälz3 resurrected the genus Enterococcus after performing DNA–DNA and DNA–rRNA hybridizations. Other studies carried out in the same decade, including 16S rRNA sequencing,4 also demonstrated that enterococci form a separate genus. Analysis of these molecular data divided the streptococci sensu lato into three genera: (i) S. sensu stricto, comprising the majority of the known species; (ii) Enterococcus, for the enteric group; and (iii) Lactococcus, for the lactic streptococci.
Since then the genus Enterococcus has been accepted as valid and today it comprises 33 species. In 2007 Kohler5 performed an extensive review of the publications that lead to each of the species currently accepted and included in Taxonomic Outline of the Bacteria and Archaea (TOBA), based on a comprehensive taxonomy using 16S rRNA gene phylogeny.6 Members of the genus Enterococcus are Gram-positive ovoid cells that appear single, in pairs or short chains, catalase, and oxidase negative, facultative anaerobes, and homofermentative with lactic acid as the end product of glucose fermentation. The majority of the enterococci grow from 10 to 45ºC, with 6.5% NaCl and at pH 9.6, hydrolyze esculin in the presence of 40% bile salts and the G+C content ranges from 37 to 45%.7,8 However, not all enterococci exhibit these characteristics with several authors analyzing and reporting differences in physiological properties among different species and strains belonging to the same species.9–14 Enterococci encompass a large proportion of the autochthonous gastrointestinal microbiota of humans and animals and can also be found in soil, surface waters, plant material, vegetables and raw, and fermented food.14–18 157
158
Enterococci are known to be hardy microorganisms able to resist to pasteurization temperatures and adapt to different substrates and growth conditions (low and high temperature, wide pH range and salinity). This high adaptability implies that they can be found either in food products manufactured from raw materials (e.g., milk or meat) or in heat-treated food products. Studies performed with cheese from different origins, namely France,19,20 Greece,21,22 Italy,23–26 Portugal,27,28 Slovenia,29 Spain,30 and Ireland31 demonstrated that enterococci are a relevant part of the indigenous microbiota and contribute to the development of sensory characteristics.24,32,33 These bacteria are also associated with fermented meat products,15,34,35 vegetables and olives,35–37 and plants in general.38,39 In meat products the most frequent species to be detected are E. faecalis and E. faecium and less frequently or occasionally found are the species E. durans, E. hirae, E. gallinarum, E. casseliflavus, and E. mundtii. In cheeses the frequency of appearance varies according to the type of milk and country of origin but the most frequently reported species is E. faecium, followed by E. faecalis, E. durans, E. hirae, and E. casseliflavus. Products from plant origin do not differ substantially on the enterococcal species found, namely E. faecium, E. faecalis, E. casseliflavus, and E. flavescens. Another benefit of enterococci in food is that many produce bacteriocins with a broad antimicrobial spectrum against pathogenic bacteria.24,40 However, although enterococci belong to the lactic acid bacteria, they are not “generally recognized as safe” (GRAS) organisms limiting their application as starters or probiotics.13,33,41 Although some desirable metabolic traits turn enterococci essential for the production of many food products, the occurrence of antimicrobial resistance and virulence factors, associated with their highly efficient ability to transfer genetic material, pose enterococci as an emerging threat as human pathogens associated with nosocomial and community acquired infections. Strains with virulence determinants and antimicrobial resistance have been isolated not only from medical wards, human or veterinarian, but also from environmental and food samples. 14,17,33,42–46 Among enterococcal species E. faecalis, and to a lesser extent E. faecium, appear as predominantly associated with human pathogenesis with special incidence of vancomycinresistant strains.47–50 Other enterococcal species such as E. avium, E. casseliflavus, E. durans, E. gallinarum, E. gilvus, E. hirae, E. malodoratus, E. mundtii, E. pallens, E. raffinosus, and E. solitarius have been reported as infrequent causes of human infection.32,51–56 Since the majority of the enterococcal infections are associated with E. faecalis and E. faecium, the accurate identification at the species level becomes important for surveillance of food products, hospitals, and other environments.
12.1.2 Molecular Approaches for Identification and Detection of Enterococci The presence of microorganisms in food is a natural and unavoidable occurrence. Cooking generally destroys
Molecular Detection of Foodborne Pathogens
most harmful bacteria, but undercooked foods, processed ready-to-eat foods and minimally processed foods can contain harmful bacteria that constitute serious health threats. Researchers are continuously searching for tools that are fast, accurate and ultrasensitive to detect the presence of these microorganisms. Conventional culture methods remain the most reliable and accurate techniques for foodborne pathogen detection. Traditionally, enterococcal identification relied on various cultivation procedures associated with the analysis of phenotypic profiles including Gram staining, colony morphology, motility, pigmentation, growth requirements and enzymatic, and/or metabolic activities. However, this culture-based identification is time-consuming and frequently limited by the variability of atypical strains, the lack of sufficient data on recently described species and the low reproducibility of some tests. Since Enterococcus is not a phylogenetically nor phenotypically coherent and homogeneous genus, manual or automated systems based on phenotypic characteristics not always allow the correct strain identification, therefore these problems assume great importance.8 Another disadvantage of the standard culture methods is their lack of ability to detect a substantial proportion of the bacterial population which is nonculturable. These viable but nonculturable (VBNC) microorganisms demonstrate metabolic activity,57,58 maintain their pathogenicity59,60 and their antibiotic resistance traits,61 can express,62 and exchange genes,63 and are able to reestablish division upon restoration of favorable conditions.64,65 It has recently been demonstrated that E. faecalis can enter the VBNC state,62 thus representing a risk for food safety and emphasizing the importance of molecular detection in substitution of standard culture methods. Consequently, the optimization of molecular methods for microbial analysis is becoming more important every day, with special relevance for rapid, easy to implement and reliable procedures that may be applied in routine laboratories to ensure the safety and quality of food. Nucleic acid based identification and detection methods have been developed for nearly all bacterial pathogens.66 Rapid and sensitive DNA-based assays which are applicable for the direct detection of enterococci in food, as well as in clinical or environmental samples, may improve the quickness and the accuracy of the detection of these bacteria. In spite of all the advantages associated with molecularbased methodologies, the detection of microorganisms in food products can come across several problems, such as PCR inhibition by food components, sample cross-contamination in sensitive PCR assays, detection of living as well as dead cells (this specific problem can be solved by using mRNA as amplification target instead of DNA in RT-PCR). Additionally, PCR may be too sensitive for some applications, detecting a microbe that is present at nonpathogenic levels. Although the above mentioned problems, and others, have to be considered when optimizing DNA-based methods, PCR amplification of species-specific targets enables precise identification of known microbial species with short reporting times. However, it is also important
Enterococcus
to highlight that positive amplification only demonstrates the presence of the appropriate target DNA sequences in the sample and does not imply that the target organism is viable. This problem can be overcome by the evaluation of cell viability (mRNA detection by RT-PCR) or visualization of living cells in mixed bacterial populations (in situ PCR/hybridization). Several molecular diagnostic methods based on the detection of bacterial nucleic acids have already been described for enterococci. The majority of these methodologies relies on or includes PCR due to the low amounts of DNA and/or cells needed, as well as the detection of a specific DNA sequence against a large background of prokaryotic and eukaryotic cells and organic material present in mixed samples.67 Under ideal conditions, with 100% efficiency and unlimited resources, a single copy of target gene can be amplified to approximately 3.4 × 1010 copies after 35 cycles of PCR. However, it becomes important to emphasize that the ability to design oligonucleotide primers is limited by our knowledge of a microorganism’s genome, as well as by the representativeness of publicly available sequence databases in terms of all variants of that microbial group. Distinct molecular approaches have already been described for enterococci including broad-range PCR,68 multiplex PCR,69–71 species-specific PCR,72–77 real-time PCR,66,78,79 direct detection of bacteria using fluorescent in situ hybridization (FISH) probes80–82 and amplification of 16S and 23S ribosomal gene sequences for hybridization to a microarray.83,84 Conventional PCR assays detect only the presence or absence, rather than the quantity, of a target microorganism and cannot distinguish between nonviable and viable cells. To deal with these limitations several modifications of standard PCR have recently been developed. Real-time quantitative PCR (qPCR), such as the TaqMan system, relies on the release and detection of a signal after cleavage of a fluorescent-labeled probe by the 5′–3′exonuclease activity of Taq DNA polymerase. A fluorogenic oligonucleotide probe, which specifically binds within the two PCR primer regions, is degraded in each PCR cycle, thereby monitoring the amplification of the target gene by an increasing fluorescence signal in real-time. The signal is related to the amount of amplicon present during each cycle and will increase as the amount of specific amplicon increases.66,78,79,85,86 The specificity of the probe introduces a high level of confidence concerning the detection of target microorganisms in mixed samples. Another approach with known advantages is hybridization of whole bacterial cells with fluorescent oligonucleotides (FISH) targeted to broad-range sequences (16 or 23S rDNA) or specific genes.80–82 This method is rapid and easy-to-perform and allows the in situ observation of the abundance, spatial distribution and morphology of bacterial cells.82 FISH assays can significantly shorten time to retrieve results and to initiate control measures in the food industry. Microarray technology is also a powerful tool that can be used for simultaneous detection of large sets of different genes of DNA (or RNA) targets on a glass slide.66 By
159
processing multiple samples and analyzing up to tens of thousands of genes in a single assay, this method is a promising alternative for monitoring environmental and food bacteria, but it requires expensive microarrayer and laser-scanner apparatus. When applying microarrays for microorganism detection, PCR amplification of target genes it often involved in order to enhance detection sensitivity.66,87–89 Microarray methodology has already been applied for the detection of enterococci in environments such as wastewater66 and artificially contaminated milk samples.84 A summary of available probes that can be used in qPCR, RT-qPCR, hybridization assays, FISH, and microarrays for the detection, and/or quantification of enterococci is presented in Table 12.1. As stated before, a variety of molecular methods have been developed for enterococcal detection and identification at genus or species level. The detected DNA targets include genes encoding for rRNA66,74,78,79,90,91 the alpha subunit of RNA polymerase and the phenylalanyl-tRNA synthase,92 the elongation factor EF-Tu,73 the D-alanine:D-alanine ligase,70 a penicillin binding protein,67 the muramidase,77 the alpha subunit of the bacterial ATP synthase,93 the manganese dependent superoxide dismutase,72,94 and the heat shock proteins (groESL),66,76,95,96 as well as genus or species-specific antimicrobial determinants.70,71,79 A short description of each method is presented below and additional information about broad-range PCR primers (designed for eubacteria and lactic acid bacteria and to be used in positive control reactions) and enterococcal PCR primers (designed for selective amplification at genus and species level) can be found in Table 12.2. Ribosomal RNA. rRNA is a universal component of bacterial ribosomes and 5S, 16S, and 23S rRNAs are present at the small (30S) and large (50S) subunits that comprise the complete active ribosome (70S). Since rRNAs are found in high copy numbers (103–104 molecules) per actively growing cell and their coding genes are usually present in more than two copies so, targeting the rRNAs or their coding genes, has the potential to increase the detection sensitivity compared to assays based on the detection of single-copy genes.97 Small subunit ribosomal RNA (16S rRNA) gene sequences are widely used as target for the development of PCR primers and/or specific hybridization probes due to their phylogenetic informational content and wide availability in databases. By comparison, although the large subunit rRNA (23S rRNA) gene contains more sequence variations than the 16S rRNA gene, and thus may provide more useful targets for microorganism identification at species or infra-species level, it has been less frequently used mainly due to the limited availability of sequence information. Since both 16S rRNA and 23S rRNA are part of the ribosome and due to evolutionary constraints there is a minimal variation within these regions. So, examining the 16S–23S rDNA intergenic noncoding region (ITS) may be necessary to distinguish very similar microorganisms. Due to the universality of rRNA genes the selection of specific primers or probes has to be criteriously performed. The use of such gene targets will be more difficult when analyzing
160
Molecular Detection of Foodborne Pathogens
Table 12.1 Probes for Detection and/or Identification of Enterococci Organism Eubacteria Gram positive bacteria Enterococcus spp. vanA enterococci vanC enterococci E. asini E. avium E. casseliflavus E. cecorum E. columbae E. dispar E. durans
Target 16S rDNA 16S rDNA 16S rDNA 16S rDNA 16S rDNAa 16S rDNA 16S rDNA 16S rDNA 23S rDNA 23S rDNA 23S rRNAb 23S rDNA vanA gene 16S rDNA 16S rDNA 16S rDNA 23S rRNA 16S rDNA ITS region 23S rRNA 23S rRNA 23S rRNA 16S rDNA 16S rDNA ITS region ITS region 23S rRNA 16S rDNA ITS region ITS region 23S rRNA 16S rDNA 16S rDNA ITS region ITS region ITS region 23S rRNA 16S rDNA ITS region ITS region
Sequence (5’–3’) EUB338-GCTGCCTCCCGTAGGAGT GTACAAGGCCCGGGAACGTATTCACC GACATAAGGGGCATGATGATTTGACGT Encl 31-CCCCTTCTGATGGGCAGG Encl 45-GGGATAACACTTGCAAAC Encl 259-GAAGTCGCGAGGCTAAGC ENC221-CACCGCGGGTCCATCCATCA ENF191-GAAAGCGCCTTTCACTCTTATGC TGGTTCTCTCCGAAATAGCTTTAGGGCTA GPL813TQb-TGGTTCTCTCCGAAATAGCTTTAGGGCTA Enc01aV-AGGTTAAGTGAATAAGGG ENC176-CAGTTCTCTGCGTCTACCTC vana3-CAACTAACGCGGCACTGTTTCCCAAT EGAC183-CAACTTTCTTCCATGCGGAAAAT CCGCATAACAATCAAAGTCGC Edil 31-CCCCCGCTTGAGGGCAGG Eas09-CGTAACATCCTATCAAAG GAAACCGCATGGTTTCGGTTTGA TACAGAAACAATTTTAAACAA(T) Eav58i-AAATGCTTACATCTCTAA Eav58-TTAGAGATGTAAGCATTT Eca58-AGCTTGTCCGTACAGGTA CTTGCTACACCGGAAGAAAATGAG Ece92-CCACTCATTTTCTTCCGG Ecec1-TGCTTTATTATTTAAAAGATCTGA(T) Ecec2-ATATTGAAAAGTAATACAAAAAAAC(T) Ece09-CACTTAAAGGTAACATCC COL-CTTGCTACACCGAAAGAAAGTGAG Ecol1-GAAGAGAAACATCAATTAATAAACCG(T) Ecol2-ACAGGWTTTGCTTTTGTTCA(T) Eco09i-GGATATTACCCTTAAGTG DIS-TAACCTACCCTCAAGCGGGGGATA Edil 137-ATGTTATCCCCCGCTTGA Edi1-CTGGATACTTGAAGAAAAGAATCAAA(T) Edi2-TCTTGAGTAAGCTTCTATC(T) Edi3-GAAGAACTGCTCAAAACCAGACC(T) Efs38-ATTCTTCACTTCCAAATT DUR-GTCGTACGCTTCTTTTTCCACC Edu1-TGACATTAGAGGATACTCTCAAGAGAAT(T) Edu2-TAATTGAAGAGTCAGGTTATGACTTTGACA(T)
Method
Reference
FISH Microarrays Microarrays Microarrays Microarrays Microarrays FISH FISH TaqMan PCR (qPCR) TaqMan PCR (qPCR) Microarrays FISH TaqMan PCR (qPCR) FISH Hybridization Microarrays Microarrays Hybridization Hybridization Microarrays Microarrays Microarrays Hybridization Microarrays Hybridization Hybridization Microarrays Hybridization Hybridization Hybridization Microarrays Hybridization Microarrays Hybridization Hybridization Hybridization Microarrays Hybridization Hybridization Hybridization
150 151 151 86 86 86 82 82 78 78 86 82 79 82 152 86 86 152 91 86 84 84 152 86 91 91 86 152 91 91 86 152 86 91 91 91 86 152 91 91
23S rRNA
Edr58-CTTACTCGTGTAGACAGA
Microarrays
84
23S rRNA
Edr58i-TCTGTCTACACGGATAAG
Microarrays
84
E. faecalis
16S rDNA
EFA1-TGATTTGAAAGGCGCTTTCGGGTGTCGCTGATGGATGGAC
Microarrays
74
16S rDNA
EFA2-GAAGAACAAGGATGAGAGTAACTGTTCATCCCTTGACGG
Microarrays
74
16S rDNA
EFA3-GAAGTACAACGAGTTGCGAAGTCGCGAGGCTAAGCTAAT
Microarrays
16S rDNA
CAATTGGAAAGAGGAGTGGCGGACG
TaqMan PCR (qPCR)
74 153
16S rDNA
TGCCGCATGGCATAAGAGTGAAAGGCGCTTTCGGGTGTC
Microarrays
90
16S rDNA
CAAGGACGTTAGTAACTGAACGTCCCCTGACGGTATCTAA
Microarrays
90
16S rDNA
GAAGTACAACGAGTCGTTAGACCGCGAGGTCATGCAAATC
Microarrays
90
16S rDNA
CCTCGCGGTCTAGCAGCTCGTTGTGCTT
Microarrays
151
16S rDNA
Enfl84-UGCACUCAAUUGGAAAGAGG
FISH
81
16S rDNA
efs129-CCCTCTGATGGGTAGGTT
Microarrays
86 (Continued)
161
Enterococcus
Table 12.1 (Continued) Organism
Target
Sequence (5’–3’)
Method
ITS region
Efs1-TATTTATTGATTAACCTTCT(T)
Hybridization
ITS region
Efs2-AAGAAGTGATCAAGACCCA(T)
Hybridization
23S rRNA Efs18i-CGAAATGCTAACAACACC 23S rRNA Efa54-CAAAAACAACTGGTACAG E. faecium 16S rDNA TGATTTGAAAGGCGCTTTCGGGTGTCGCTGATGGATGGAC 16S rDNA GAAGAACAAGGATGAGAGTAACTGTTCATCCCTTGACGG 16S rDNA GAAGTACAACGAGTTGCGAAGTCGCGAGGCTAAGCTAAT ITS region Efm1-TTTTATGAGACGATCGAT(T) ITS region Efm2-TCTTGATCTAACTTCTAT(T) 23S rRNA Efm09i-GGATGTTACGATTGTGTG 23S rRNA Efm09-CACACAATCGTAACATCC 23S rRNA Efi58-TGACTCCTCTCCAGACTT 23S rRNA ATCATACGATCAGCCGCAGTGAATA 23S rRNA ENU140-TTCACACAATCGTAACATCCTA 23S rRNA ENU1470-GACTCCTTCAGACTTACTGCTTGG E. flavescens 23S rRNA Efl58i-TTCTACCTATACGGACAA E. gallinarum ITS region Egal-GAGTGGACAAGTTAAAGA(T) 23S rRNA Ega09-CACAACTGTGTAACATCC 23S rRNA EGA141-ATTCACAACTGTGTAACATCCTAT a not E. dispar/E. asini/E. solitarius/E. columbae/E. cecorum/E. faecalis b not E. solitarius
products with complex mixtures of bacteria making specificity analysis fundamental for validation of the method. Nowadays, several databases compiling full and partial rDNA sequences are available online and updated regularly allowing fast and easy comparison of data from unknown organisms. Among these databases are the Ribosomal Database Project II and ProbeBase. Ribosomal Database Project II Release 9.58 (Release 9, update 58) consists of 481,650 aligned and annotated 16S rRNA sequences, along with seven online analysis tools. Update 58 was released on February 6, 2008 (http://rdp.cme.msu.edu/). ProbeBase (http://www.probebase.net) is a comprehensive database containing 1317 rRNA-targeted oligonucleotide probe sequences and eight microarrays from 288 references (status February 2008), with supporting bibliographic and biological annotation, which is frequently used by researchers worldwide. Amplification of the rRNA genes (e.g., PCR or RT-PCR) and the use of probes directed to these regions (e.g., FISH or microarrays) have been widely applied for the detection and/ or identification of Enterococcus as a genus or for particular species. Since E. faecalis is the most commonly encountered species, the majority of the primers and probes are specific for its identification. RNA polymerase and phenylalanyl-tRNA synthase. In 2005 Naser92 and coworkers reported that all enterococcal species analyzed were clearly differentiated on the basis of their RNA polymerase (rpoA) and phenylalanyl-tRNA synthase (pheS) gene sequences. Strains of the same enterococcal species had at least 99% rpoA and 97% pheS sequence similarity, whereas different enterococcal species had a
Microarrays Microarrays Microarrays Microarrays Microarrays Hybridization Hybridization Microarrays Microarrays Microarrays RT-qPCR FISH FISH Microarrays Hybridization Microarrays FISH
Reference 91 91 modified from 154 86 90 90 90 91 91 modified from 154 86 86 66 82 82 86 91 86 82
maximum of 97% rpoA and 86% pheS sequence similarity, pointing to the usefulness of this gene as a target for specieslevel molecular identification. However, no species-specific primers have yet been developed or applied to this genus. Elongation factor EF-Tu. The tuf gene, encoding elongation factor EF-Tu, is involved in peptide chain formation and is an essential constituent of the bacterial genome73,98 making this region a good target for diagnostic purposes. Ke and coworkers73 reported in 1999 a PCR-based assay that targets the tuf gene and detects most enterococcal species with excellent sensitivity and acceptable specificity. D-alanine:D-alanine ligase. A PCR assay developed by Dutka-Malen and coworkers70 enabling the identification at the species level (species E. faecium and E. faecalis) and targeting the D-alanine:D-alanine ligase (ddl) gene was applied to characterize clinically relevant enterococci. Primers for species-specific PCR of E. durans and E. hirae targeting the ddl gene were also developed and validated by Knijff and coworkers.99 Penicillin-binding proteins. Penicillin-binding proteins (PBPs) are the enzymes involved in terminal stages of peptidoglycan synthesis and PBP1 and PBP5 are the prevalent PBPs. Thus, these proteins are potential targets for bacterial cell detection. The gene coding for PBP5 (pbp5) has previously been used for the development of an E. faecalis species-specific probe100 and was subsequently used in competitive PCR for quantification of nonculturable E. faecalis cells.67 Muramidase. In 2006 Arias and coworkers77 searched the GenBank for sequences to be applied for the identification of E. hirae. During this process an E. durans muramidase gene
Eubacteria
Elongation factor EF-Tu (tuf)
U2 Rev-AYRTTITCICCIGGCATIACCAT
U1 For-AAYATGATIACIGGIGCIGCICARATGGA
803
589
590 For-GGNGACGGNACNACNACNGCAACNGT
590 Rev-TCNCCRAANCCNGGYGCNTTNACNGC
600
~600
900
~1500 ~1000 92
996
16S rDNA+23S rDNA+ITS
Sm785 For+422Rev ENFE+L189
73
96
95
91
156 160 161 66
159
76
69
170 1522
74,90
1554
156 157 158
~1500 676/578 466
Reference
155 Sm785 For+422Rev with Ef according to Aymerich et al.171
Observations
320
Product Size (bp)
Chaperonin 60 H279A For-GAIIIIGCIGGIGA(TC)GGIACIACIAC H280A Rev-(TC)(TG)I(TC)(TG)ITCICC(AG)AAICCIGGIGC(TC)TT
rrn 13B For-GTGAATACGTTCCCGGGCCT 6 Rev-GGGTTYCCCCRTTCRGAAAT
23S rDNA 422 Rev-GGAGTATTTAGCCTT L189 Rev-GGTACTTABATGTTTCAGTTC ECST784 For-AGAAATTCCAAACGAACTTG ENC854 Rev-CAGTGCTCTACCTCCATCATT For-AGGAKGTTGGCTTAGAAGCAG Rev-CGCTACCTTAGGACCGTTATAGTTAC
16S rDNA For-GGATTAGATACCCTGGTAGTCC Rev-TCGTTGCGGGACTTAACCCAAC Sm785 For-GGATTAGATACCCTGGTAGTC For-GCTGGATCACCTCCTTTC Uni331 For-TCCTACGGGAGGCAGCAGT Uni797 Rev-GGACTACCAGGGTATCTAATCCTGTT For-GAGAGTTTGATYCTGGCTCAG Rev-AAGGAGGTGATCCARCCGCA 1020 For-TTAAACTCAAAGGAATTGACGG 1190 Rev-CTCACGRCACGAGCTGACGAC Ef16 For-AGAGTTTGATCCTGGCTCA Ef16 Rev-GGTTACCTTGTTACGACTTC U1 For-CCAGCAGCCGCGGTAATACG U2 Rev-ATCGG(C/T)TACCTTGTTACGACTTC
Primers (5’–3’)
Table 12.2 Broad-Range Control and Enterococcal Genus- and Species-Specific PCR Primers
162 Molecular Detection of Foodborne Pathogens
112
480
Manganese-dependent superoxide dismutase (sodA) d1 For-CCITAYICITAYGAYGCIYTIGARCC d2 Rev-ARRTARTAIGCRTGYTCCCAIACRTC
1609
320+420
Elongation factor EF-Tu (tuf) Ent1 For-TACTGACAAACCATTCATGATG Ent2 Rev-AACTTCGTCACCAACGCGAAC
Chaperonin 60 GroES EntGroES For-TTAAAACCATTAGGCGATCG EntGroES Rev-CCCATNCCCATNGANGGRTCCAT
ITS region For-CAAGGCATCCACCGT Rev-GAAGTCGTAACAAGG
92
115
16S rDNA Ec-ssu1 For-GGATAACACTTGGAAACAGG Ec-ssu1 Rev-TCCTTGTTCTTCTCTAACAA
23S rDNA ECST784 For -AGAAATTCCAAACGAACTTG ENC854 Rev-CAGTGCTCTACCTCCATCATT
733
815
16S rDNA E1 For-TCAACCGGGGAGGGT E2 Rev-ATTACTAGCGATTCCGG
Genus Enterococcus
RNA polymerase a subunit (rpoA) rpoA-21 For-ATGATYGARTTTGAAAAACC rpoA-23 Rev-ACHGTRTTRATDCCDGCRCG
431
72
73
96
162, 163, 164
78
97
149
92
92 92
Phenylalanyl-tRNA synthase (pheS) pheS-21 For-CAYCCNGCHCGYGAYATGC pheS-22 Rev-CCWARVCCRAARGCAAARCC pheS-21 For-CAYCCNGCHCGYGAYATGC pheS-23 Rev-GGRTGRACCATVCCNGCHCC 494
93
1102
atpA-27 Rev-CCRCGRTTHARYTTHGCYTG
atpA-20 For-TAYRTYGGKGAYGGDATYGC
α subunit of ATP synthase (atpA)
Lactic acid bacteria
(Continued)
Enterococcus 163
360
444
430
941
Manganese-dependent superoxide dismutase (sodA) FL1 For-ACTTATGTGACTAACTTAACC FL2 Rev-TAATGGTGAATCTTGGTTTGG
Penicillin binding protein (pbp5) For-CATGCGCAATTAATCGG Rev-CATAGCCTGTCGCAAAAC
vanE EE1 For-TGTGGTATCGGAGCTGCAG EE2 Rev-ATAGTTTAGCTGGTAAC
vanG EG1 For-CGGCATCCGCTGTTTTTGA EG2 Rev-GAACGATAGACCAATGCCTT
105 475
105
105
67
94
76
70
76
66
96
941
650
64
185
168
~1000
167
165 166 153
Reference
69 ENFE + L 189
Observations
138
112
143
360
803
E. faecalis
Product Size (bp)
Iron sulfur binding protein Efis For-ATGCCGACATTGAAAGAAAAAATT Efis Rev-TCAATCTTTGGTTCCATCTCT
D-alanine/D-alanine ligase (ddl) For-ATCAAGTACAGTTAGTCTTTATTAG Rev-ACGATTCAAAGCTAACTGAATCAGT DD13 For-CACCTGAAGAAACAGGC DD13 Rev-ATGGCTACTTCAATTTCACG
Chaperonin 60 GroESL EfGroES For-GGAATTGTTCTTGCATCCGT EfGroES Rev-ACAATTAAGTATTCTACGCC For-TGTGGCAACAGGGATCAAGA Rev-TTCAGCGATTTGACGGATTG Efes For-GTGTTAAAACCATTAGGCGAT Efes Rev-AAGCCTTCACGAACAATGG
16S rDNA Efs130 For-AACCTACCCATCAGAGGG Efs490 Rev-GACGTTCAGTTACTAACG For-CGCTTCTTTCCTCCCGAGT Rev-GCCATGCGGCATAAACTG For-TACTGACAAACCATTCATGATG Rev-AACTTCGTCACCAACGCGAAC 72 For-CCGAGTGCTTGCACTCAATTGG 210 Rev-CTCTTATGCCATGCGGCATAAAC ENFE For-GTCGCTAGACCGCGAGGTCATGA
Primers (5’–3’)
Table 12.2 (Continued)
164 Molecular Detection of Foodborne Pathogens
Muramidase (mur) mur-2ed For-AACAGCTTACTTGACTGGACGC mur-2ed Rev-GTATTGGCGCTACTACCCGTATC
D-alanine/ D-alanine ligase (ddl) DuHi For-TTATGTCCCWGTWTTGAAAAATCAA Du Rev-TGAATCATATTGGTATGCAGTCCG Hi Rev-TTTTGTTAGACCTCTTCCGGA
E. hirae and E. durans
177
377
186
658
Unknown region For-TTGAGGCAGACCAGATTGACG Rev-TATGACAGCGACTCCGATTCC
1091
550
676/578
215
E. faecium
500
297
647
298
Manganese-dependent superoxide dismutase (sodA) FM1 For-GAAAAAACAATAGAAGAATTAT FM2 Rev-TGCTTTTTTGAATTCTTCTTTA
D-alanine/D-alanine ligase (ddl) For-GCAAGGCTTCTTAGAGA Rev-CATCGTGTAAGCTAACTTC FAC1 For-GAGTAAATCACTGAACGA FAC2 Rev-CGCTGATGGTATCGATTCAT
23S rDNA Ef Rev-CACACAATCGTAACATCCTA
vanD ED1 For-TGTGGGATGCGATATTCAA ED2 Rev-TGCAGCCAAGTATCCGGTAA
with 16S For according to 171
E. durans
E. hirae and E. durans E. durans E. hirae
(Continued)
77
99
172
94
105
70
85
105
169 71 105 170
433
vanB For-GTGACAAACCGGAGGCGAGGA Rev-CCGCCATCCTCCTGCAAAAAA For-CATCGCCGTCCCCGAATTTCAAA Rev-GATGCGGAAGATACCGTGGCT EB3 For-ACGGAATGGGAAGCCGA EB4 Rev-TGCACCCGATTTCGTTC For-CATCGCCGTCCCCGAATTTCAAA Rev-GATGCGGAAGATACCGTGGCT
79
64
vanA vana3 For-CTGTGAGGTCGGTTGTGCG vana3 Rev-TTTGGTCCACCTCGCCA
E. faecalis and E. faecium
Enterococcus 165
Manganese-dependent superoxide dismutase (sodA) AS1 For-GCATCATGACAAGCATCACGC AS2 Rev-GGCTTTTTGCCTTCAGATAAA AV1 For-GCTGCGATTGAAAAATATCCG AV2 Rev-AAGCCAATGATCGGTGTTTTT CA1 For-TCCTGAATTAGGTGAAAAAAC CA2 Rev-GCTAGTTTACCGTCTTTAACG CE1 For-AAACATCATAAAACCTATTTA CE2 Rev-AATGGTGAATCTTGGTTCGCA CO1 For-GAATTTGGTACCAAGACAGTT CO2 Rev-GCTAATTTACCGTTATCGACT DI1 For-GAACTAGCAGAAAAAAGTGTG DI2 Rev-GATAATTTACCGTTATTTACC DU1 For-CCTACTGATATTAAGACAGCG DU2 Rev-TAATCCTAAGATAGGTGTTTG FV1 For-GAATTAGGTGAAAAAAAAGTT FV2 Rev-GCTAGTTTACCGTCTTTAACG GA1 For-TTACTTGCTGATTTTGATTCG GA2 Rev-TGAATTCTTCTTTGAAATCAG GI1 For-CTGGCTGGGCTTGGCTAGTGA GI2 Rev-ATAATCGGTGTTTTACCGTCT HI1 For-CTTTCTGATATGGATGCTGTC HI2 Rev-TAAATTCTTCCTTAAATGTTG MA1 For-GTAACGAACTTGAATGAAGTG MA2 Rev-TTGATCGCACCTGTTGGTTTT MU1 For-CAGACATGGATGCTATTCCATCT MU2 Rev-GCCATGATTTTCCAGAAGAAT PA1 For-TGGCACCAAATGCTGGCGGAA PA2 Rev-TGGTGTAGAAGTAATTTCAAG
16S rDNA Ita For-TACCGCATAATACTTTTTCTCT Ita Rev-GTCAAGGGATGAACATTCTCT
Other enterococcal species
mur-2 For-CGTCAGTACCCTTCTTTTGCAGAGTC mur-2 Rev-GCATTATTACCAGTGTTAGTGGTTG copY For-CGAGTTATCTGGACTTTAGGTCAAGC copY Rev-CATTCAATCGTTTCGACTGGCT murG For-GGCATATTTATCCAGCACTAG murG Rev-CTCTGGATCAAGTCCATAAGTGG
Primers (5’–3’)
Table 12.2 (Continued)
E. hirae
521
E. asini E. avium E. casseliflavus E. cecorum E. columbae E. dispar E. durans E. flavescens E. gallinarum E. gilvus E. hirae E. malodoratus E. mundtii E. pallens
365 368 288 371 284 284 295 284 173 98 187 134 98 160
E. italicus
E. hirae
344
323
E. hirae
521
Product Size (bp)
Observations
94
94
94
94
94
94
94
94
94
94
94
94
94
94
173
77
77
77
Reference
166 Molecular Detection of Foodborne Pathogens
PO1 For-TGGTTTCTGATATGGATGCGA
Rev-CGAGCAAGACCTTTAAG
For-CTCCTACGATTCTCTTG
Rev-CGCAGGGACGGTGATTTT
For-CGGGGAAGATGGCAGTAT
vanC2/C3
Rev-CGAGCAAGACCTTTAAG
For-CTCCTACGATTCTCTTG
vanC2
EC8 Rev-TAGCGGGAGTGMCYMGTAA
EC5 For-ATGGATTGGTAYTKGTAT
vanC1/C2
Rev-CTTCCGCCATCATAGCT
For-GGTATCAAGGAAACCTC
Rev-CGGCTTGATAAAGATCGGG
For-GACCCGCTGAAATATGAAG
Rev-CTTCCGCCATCATAGCT
For-GGTATCAAGGAAACCTC
vanC1
Rev-CAGCGGCCATCATACGG
For-GCTATTCAG CTGTACTC
Rev-GGAGTAGCTATCCCAGCATT
For-TCTGCAATAGAGATAGCCGC
Rev-CCCCTTTAACGCTAATACGATCAA
For-CATGAATAGAATAAAAGTTGCAATA
vanA
SU2 Rev-CCAAATGTATCTTCGATCGCT
SU1 For-TCAGTGGAAGACTTAATCGCA
SO2 Rev-AATGGAGAATCTTGGTTTGGCGTC
SO1 For-AAACACCATAACACTTATGTGACG
SA2 Rev-GTAGAAGTCACTTCTAATAAC
SA1 For-AAACACCATAACACTTATGTG
RF2 Rev-AATGGGCTATCTTGATTCGCG
RF1 For-GTCACGAACTTGAATGAAGTT
PV2 Rev-CCGAAAGCTTCGTCAATGGCG
PV1 For-TCTGTTGAGGATTTAGTTGCA
PO2 Rev-GTAATCGCTAATTTCTCTCCA
439
484
430
815/827
822
438
822
783
377
1030
173
371
371
287
173
280
E. gallinarum and E. casseliflavus/E. flavescens
E. gallinarum and E. casseliflavus/E. flavescens
E. gallinarum and E. casseliflavus/E. flavescens
E. gallinarum and E. casseliflavus/E. flavescens
E. gallinarum and E. casseliflavus/E. flavescens
E. gallinarum and E. casseliflavus/E. flavescens
E. gallinarum and E. casseliflavus/E. flavescens
Several enterococcal species
Several enterococcal species
Several enterococcal species
E. sulfureus
E. solitarius
E. saccharolyticus
E. raffinosus
E. pseudoavium
E. villorum
170
103
71
105
170
71
70
170
71
169
94
94
94
94
94
94
Enterococcus 167
168
(mur) with 82% homology to E. hirae was detected, primers were developed for both genes and used for multiplex PCR. This method appears to provide a rapid and accurate identification of these two very similar enterococcal species. ATP synthase. atpA codes for the alpha subunit of the bacterial ATP synthase, which functions in ATP synthesis coupled to proton transport.101 The aim of the study developed by Naser and coworkers93 was to analyze the usefulness of atpA gene sequences for the reliable identification of Enterococcus species. All species were differentiated with a maximum of 92% similarity. The intraspecies atpA sequence similarities for all species varied from 98.6 to 100%, except for E. faecium strains that showed a lower atpA sequence similarity of 96.3%. This study clearly showed that atpA provides an alternative tool for the phylogenetic study and identification of enterococci, but no genus- or species-specific primers have been described to demonstrate this potential. Manganese-dependent superoxide dismutase. In 2000 Poyart and coworkers72 sequenced the manganese-dependent superoxide dismutase gene (sodA) of 19 species of the genus Enterococcus. Since variations in their sequences appeared to be greater between species and lower within species, this gene was used to develop species-specific primers94 that can be applied to identify 21 validly published enterococcal species. Heat shock proteins. The groESL genes (also known as chaperonin 60 genes, cpn10/60 or hsp10/60), which encode 10-kDa (GroES) and 60-kDa (GroEL) heat shock proteins, are ubiquitous and evolutionarily highly conserved among bacteria.102 Goh and coworkers95 demonstrated that reverse checkerboard hybridization methodology, based on an approximately 600-bp region of the chaperonin 60 gene, can be an efficient method for the identification of Enterococcus species. Teng and coworkers96 determined the groESL genes full-length sequence of E. faecalis and used this information to develop primers specific for this species. Antimicrobial resistance. Along the years several authors used multiplex PCR to detect both the presence of vancomycin resistance determinants and identify enterococci to the species level.70,103–106 Glycopeptide resistance has been detected in several species of enterococci with seven glycopeptide resistance genotypes already described. Five of these genotypes (vanA, vanB, vanD, vanE, and vanG) are acquired mechanisms and the other two (vanC1 and vanC2/C3) are intrinsic properties. vanA and vanB are the most common resistance genotypes. The vanA genes encode proteins that confer high-level resistance to vancomycin and teicoplanin107 and have been found in several enterococcal species.108 The vanB genes confer resistance to various concentrations of vancomycin but not teicoplanin;109 vanB-type glycopeptide resistance has been described for E. faecalis and E. faecium. The vanD phenotype is characterized by resistance to moderate levels of vancomycin and to low levels of teicoplanin;110,111 vanD determinants are constitutively expressed in E. faecalis but inducible in E. faecium.110 The vanE gene is induced by low levels of vancomycin112 and has only been detected in one
Molecular Detection of Foodborne Pathogens
strain of E. faecalis. The vanC1 and vanC2/C3 genes are specific of the motile vancomycin resistant enterococci (VRE) species E. gallinarum and E. casseliflavus/E. flavescens, respectively.70 Recently, a new vancomycin resistance locus, vanG, has been detected in four E. faecalis clinical isolates with a moderated level of resistance to vancomycin and full susceptibility to teicoplanin.113
12.1.3 Why Detect and/or Quantify Enterococci? Enterococci occur in a wide variety of food products as reported above. They are very important to achieve the final organoleptic properties of those products and can also be used as probiotics. The problems with these bacteria arise when they are related to food spoilage, in particular in meat products, or because they can act as opportunistic pathogens. Studies on enterococci isolated from food have been carried out in recent years to evaluate the detrimental aspects of their presence in food products, specially in view of their wide known capacity for gene transfer, namely of antibiotic resistances and virulence factors. However, although knowing that the presence of virulence and antimicrobial resistance determinants turns the pathogenicity potential of these bacteria higher, the establishment of a direct correlation between the presence of a known enterococcal species and infection is still a matter of discussion. Concerning enterococci, the differences between clinical and food isolates in terms of the real capacity to cause disease are yet to be disclosed. As morbidity of healthy humans resulting from foodborne enterococcal infections is very low,114 all these aspects have to be carefully balanced. From all this reasoning, and because until now no one can decided if they constitute a risk to healthy consumers, methods to detect their presence and/or quantify them are needed and a review on what can implemented in a food laboratory perspective is presented below.
12.2 Methods 12.2.1 Sample Collection and Preparation 12.2.1.1 Sample Homogenization Preparation of food samples for the analysis of Enterococcus spp. by molecular methods has to start by releasing the microbial cells from the food matrix. Food matrices are very different in nature and the analysis of semi-solid, highly viscous, particulate or solid food products is always more difficult than the analysis of a liquid food product due to matrix effect. Moreover, the presence of microbial growth inhibitors, e.g., in spices or salted fishes, has to be considered. When it comes to the extraction of bacterial DNA, several problems can be encountered like differences in cell wall structure, adhesion properties of microorganisms and chemical and biological food characteristics.115 Food sample preparation has to take into account, when preparing the initial suspension and subsequent decimal dilutions, if resuscitation procedures are needed for improved recovery of stressed microorganisms resulting from food
Enterococcus
processing and storage. The procedure starts by weighing into a sterile bowl or plastic bag a mass m (g) or by measuring a volume V (ml) (minimum of 10 g or 10 ml, unless otherwise stated) representative of the test food. A quantity of diluent equal to 9 × m g or 9 × V ml is then added. The use of buffered peptone water is the most recommended initial dilution solution.116–119 Other diluents can and have been used, not necessarily for the detection of enterococci but similar procedures can envisaged for this genus, like 0.1 M Na2HPO4 buffer (pH 8.0) for fermented food,120 sterile Ringer solution for the homogenization of cheeses29 or trypticase soy broth (TSB) for the homogenization of bread slices, ground beef, green salads, and salad dressings.121 The mixture can be homogenized in peristaltic blenders (stomachers), rotary homogenizers (blenders), vibrational mixers (pulsifiers), or other equivalent systems. In certain cases mixing can be carried out using sterile glass beads.116,119,122 The usual operating time of a peristaltic homogenizer is 1–3 min and the rotary homogenizer shall operate for no more than 2.5 min at a speed between 15,000 and 20,000 rpm. The vibrational mixer should work for 0.5–1 min.123 International standards117–119 give specific instructions for the collection and preparation of samples from meat and meat products, fresh and processed fish, crustaceans, mollusks, and similar products. The use of buffered peptone water as first diluent has the advantage that the same homogenate can be used for the detection of other microorganisms, but selective media can be used as described in pre-enrichment if enterococci are the sole target. Two approaches for the extraction of DNA can be envisaged, working with or without enrichment. If the aim of the work is just to detect the presence of the microorganism in the food sample, a previous step of enrichment can be a solution to avoid false negatives; if the study aims to characterize the microbial composition of a food sample, both at qualitative and quantitative levels, then the step of pre-enrichment has to be skipped since it would change the initial balance of the existing species. 12.2.1.2 Cell Isolation and Counting without Pre-enrichment If the aim is to characterize individual strains of Enterococcus spp. existing in a food product, isolation can be performed directly from the initial dilution prepared above, with or without preparing further dilutions depending on the expected microbial concentration. In any case, 1 ml of the initial dilution or 1 ml or 0.2 ml of further dilutions can be pour plated or spread plated, respectively, into Enterococcus selective media. More than 100 selective media have been reported along the years for the isolation of enterococci from different types of samples. However, due to variation of media composition, no single media can be pointed as the golden standard for the isolation of enterococci. Doming and coworkers12 reviewed the media for isolation and counting of enterococci and reported that some media are more selective or have high recovery rates than others. KF (Streptococcus) agar seems
169
to be a good compromise for nondairy products whereas, for dairy products, citrate azide agar can be used with better results. Kanamycin aesculin azide (KAA) agar has also been a popular choice, as well as citrate azide tween carbonate agar (CATC), aesculin-bile-azide medium (ABA ou Enterococcose), Slanetz and Bartley medium (Enterococcus agar), thallous acetate tetrazolium glucose agar (TITG), streptococcus selective agar (ScS), and crystal violet azide agar (KA).17,124 Several chromogenic media have also been developed for isolation and selection of enterococci from faecal and clinical samples, water, and food samples, like Chromocult® enterococci agar, CHROMagar Orientation, Chromogenic UTI medium, CPS ID2 or Uriselect 4.125–127 For plant material the most widely used medium is SB agar.38,39 When the aim of the work is to isolate VRE, VRE Agar can be used.12,128 Media for the isolation or counting of enterococci from food are usually incubated at 35–37°C. However, when working with milk and dairy products media are usually incubated at 45°C to inhibit the growth of other microbiota. Colony counting of enterococci isolated from the different decimal dilution allows their estimation in food. Isolated colonies can have their DNA extracted after culturing in a suitable liquid media like Man Rogosa and Sharp (MRS), brain heart infusion (BHI) or yeast extract peptone (2YT) broth. 12.2.1.3 Pre-enrichment Since the amount of living cells will considerably exceed the amount of dead cells after the enrichment procedure most PCR methods for detection of foodborne pathogens include an initial step of culture-enrichment to increase target concentration and improve sensitivity. Prior enrichment can be performed with buffered peptone water as mentioned above, or by homogenization of the food sample directly with the selective broths for enterococci such as azide dextrose broth or Chromocult® Enterococci broth. 12.2.1.4 DNA Extraction for Conventional PCR International standards on methods to detect foodborne pathogens by PCR have already been published but no details for specific genus are given, therefore almost all the procedures published are based on research laboratories work.129–131 DNA extraction, before or after enrichment, has to be tested in order to detect possible PCR-inhibitory substances. DNA extraction from isolated colonies is usually easier to perform. If an in-house DNA extraction method is to be developed, it has to take into account the degradation of proteins present in the cell extract with proteases (e.g., proteinase K); precipitation of the resulting peptides with organic solvents (e.g., a mixture of phenol and chloroform) to leave the DNA in the aqueous phase; purification of the DNA solution and further concentration using ethanol precipitation in the presence of monovalent cations; collection of the precipitated DNA by centrifugation; washing of the DNA with ethanol and resuspension in buffer (e.g., Tris-EDTA buffer or Tris buffer.132 Some of the traditional extraction methods such as the guanidium thiocyanate method133 were recently modified.134
170
Molecular Detection of Foodborne Pathogens
PCR inhibitors (e.g., polysaccharides and humic acids) are particularly abundant in food samples and are not completely removed by classical extraction protocols. Several authors have tried to extract bacterial DNA from food using filtration steps (e.g., with a 11-µm nylon filter to separate food particles), centrifugation steps,115,135 food matrix lysis136 prior to classical methods, commercial kits and mixture of both, trying to balance between extraction efficiency, DNA purity and DNA suitability for amplification.115,120,137,138 Milk samples need special treatment85–139 due to their high fat content. A summary of commercial kits that can be used for bacterial DNA extraction from food samples, and as such extract DNA from enterococci, is presented in Table 12.3.
12.2.1.5 DNA Extraction for Real-time PCR Several methods have been used to replace quantification of enterococci by plate counting which is time-consuming. However, methods that have been proposed such as DNA hybridization, enzyme immunoassays and real-time PCR detect 103–104 cfu/ml target pathogen turning culture enrichment essential. Methods that separate bacteria from food matrix and concentrate them have been developed in order to use real-time PCR to estimate the number of bacteria directly from the food homogenate. Sterile dilution of known numbers of target copies can be used to set up a standard curve which is used to determine an unknown amount of DNA (absolute quantitation).
Table 12.3 Some Examples of Kits that can be used to Extract Enterococci DNA from Food Matrixes Company
Product Name
Extraction Method
Sample Type
Omega Bio-Tek, Inc., www. omegabiotek.com Takara Bio Inc., http://www. takara-bio.com Roche Applied Science, www. roche-applied-science.com
EZNA bacterial DNA kit, Omega
Silica based columns
Bacteria
Dr. GenTLE® (from Yeast)
GenTLE solution I lysis cells and forms noncharged complex w. nucleic acids Silica based technology
Yeasts and bacteria
Glass fibers technology
The MagNA Pure LC DNA Isolation Kit III High Pure PCR Template Preparation Kit, PromoKine Genomic DNA Isolation Kit II, Maxwell® 16 Cell DNA Purification Kit,
Various food samples, raw material and processed food Bacteria, Fungi
PromoCell GmbH, www. promocell.com Promega Corporation, www. promega.com Peqlab Biotechnologie GmbH, www.pelab.de Macherey-Nagel GmbH, www. mn-net.com
High pure PCR template preparation kit High Pure Foodproof Kit,
Wizard® SV Genomic Purification Promega System peqGOLD Bacterial DNA Kit
Magnetic based technology Silica adsorption Guanidine-detergent lysing solution Maxwell® 16 Instrument, MagneSil® Paramagnetic Particles Silica membrane technology HiBind® silica based spin-column
NucleoSpin® Tissue
Silica membrane technology
NucleoSpin®Food
Silica based technology
Yeast and bacterial, blood, cultured cells, mouse tail, thymus tissues Human, animal, plant, yeast, bacterial, and viral origin Tissue culture or bacterial cells Blood and blood cells, mammalian tissues, cultured cells, bacteria Bacteria
NucleoBond® AXG
Anion-exchange chromatography
Tissue, bacteria, clinical samples, and forensic samples Food (plant origin), food (animal origin), bacteria Tissue, yeast, and bacteria
NucleoMag Tissue
Magnetic-based technology
Tissue, cells, and bacteria
Invitek GmbH, www.invitek.eu
RTP Bacteria DNA Mini Kit
Membrane absorption based isolation
Bacteria
InviMag® Bacteria DNA Mini Kit
RTP® technology (Extraction Tube containing preformulated solid lysis reagents, carrier nucleic acid, and internal RNA/DNA extraction controls) RTP® technology magnetic beads
Invisorb Genomic DNA Kits
Carrier adsorption based isolation
Bacteria
GE Healthcare Life Sciences, www.gehealthcare.com
Illustra bacteria genomicPrep Mini Spin Kit
Spin columns prepacked with silicamembrane
Bacteria
®
®
Bacteria
(Continued)
171
Enterococcus
Table 12.3 (Continued) Company
Product Name
Extraction Method
Sample Type
Fermentas, www.fermentas. com
Genomic DNA Purification Kit
Lysis of the cells with a subsequent selective DNA precipitation with detergent
Cortex Biochem, Inc., www. cortex-biochem.com
MagaZorb® DNA Isolation Kit
Magnetic separation based technology
Chemicell GmbH, www. chemicell.com
geneMAG-DNA/Bacteria
Magnetic silica beads technology
Whole blood, serum, cell cultures, bacteria, plant, and mammalian tissues, as well as from epithelial samples Whole blood, buffy coat, leukocytes, dried blood spots, cells, tissue, formalin-fixed paraffin-embedded tissue, saliva, urine, stool, hair, swabs, milk, bacteria, seminal fluid Bacteria
geneMAG-RNA/DNA
Magnetic silica beads technology
Blood, cells, bacteria, and viruses
mi-Bacterial Genomic DNA Kit (mi-BD100) MagPrep® Bacterial Genomic DNA Kit, Novagen
Silica-membrane technology
Bacteria
Silica-based resin with magnetic-based separation
Bacteria
MasterPure™ Gram Positive DNA Purification Kit
Ready-Lyse™ and the Gram Positive Cell Lysis Solution
MasterPure™ DNA Purification Kit SoilMaster™ Kit
Rapid desalting process1 to remove contaminating macromolecules Hot detergent lysis process combined with a simple chromatography step that removes organic inhibitors Homogenizer for grinding your sample, a column for straining Silica-based membrane
Merck KGaA, www. merckbiosciences.co.uk EPICENTRE® Biotechnologies, www. epibio.com
Cartagen Molecular, Inc., www.cartagen.com Genetic ID NA, Inc., www. genetic-id.com
BioMasher™
Invitrogen Corporation, www.invitrogen.com
ChargeSwitch® gDNA Mini Bacteria Kit PureLink™ Genomic DNA Kit
Ivitrogen easy dna
ZyGEM Corporation Ltd, www.zygem.com MO BIO Laboratories, Inc., www.mobio.com
PrepGEM™ Bacteria
Fast ID Genomic DNA Extraction Kit
PowerMicrobial™ Midi DNA Isolation Kit/Maxi (for isolation of DNA from 50 ml, 100ml) UltraClean™ Microbial DNA Isolation Kit
Magnetic beads technology
Gram positive bacteria
Wide variety of biological sources Bacterial, plant, or fungal templates
DNA, RNA, and Protein isolation Microorganisms, tissues, plants, and raw commodities to moderately and highly processed foods Gram positive, Gram negative
Silica spin-column
Blood, tissues, cells, bacteria, swabs, and blood spots
EA 1 enzyme, can extract high quality DNA Lysis technology (bead solution, and bead beating)
Gram positive, Gram negative, mycoplasmas, capsuled bacteria Wide range of microorganisms; Gram-positive, Gram-negative, yeast, and fungi Variety of microorganisms including bacterial spores and fungal types Bacteria, fungi, algae, and actinomycetes
Lysis technology (bead solution, and bead beating)
PowerSoil™ DNA Isolation Kit
UltraClean™ Soil DNA Isolation Kit Bacterial Genomic DNA Isolation Kit Milk Bacterial DNA Isolation Kit
Bead beating, a silica membrane technology and a new humic substance/ brown color removal procedure Bead beating technology and an inhibitor removal solution Spin column chromatography using Norgen’s resin Spin column chromatography using resin
Chemagic Food Basic Kit
Magnetic beads technology
Gram negative and Gram positive bacteria Gram negative and Gram positive bacteria Bacteria from food matix
Chemagic DNA Bacteria Kit
Magnetic beads technology
Bacteria
Norgen Biotek Corporation, www.norgenbiotek.com chemagen AG, www. chemagen.de
Microorganisms in the soil
(Continued)
172
Molecular Detection of Foodborne Pathogens
Table 12.3 (Continued) Company
Product Name
Extraction Method
Sample Type
Qiagen, www1.qiagen.com
DNeasy Blood & Tissue Kit
DNeasy membrane
Generation Capture Column Kit
Unique
Bio-Rad Laboratories Inc., www.bio-rad.com
AquaPure Genomic DNA Isolation Kits
Novel salt precipitation reagent
Bio 101, Inc., www.bio101. com
G-NOME® kit
Proprietary “salting out” procedure
FastDNA® Kit
FastDNA® SPIN Kit for Soil
Specific binding of DNA by GLASSMILK® Specific binding of DNA by GLASSMILK®
Ver mobio ultra cean soil kit
GENPOINT® AS, www. genpoint.no
BUGS’n BEADS™
Magnetic beads technology
Wizard® Magnetic DNA Purification System for Food
Magnetic beads
Qbiogene
GNOME® DNA Isolation Kit
Vivantis Technologies Sdn. Bhd.¸www.vivantis.com
GF-1 Food DNA Extraction Kit
Mini-column spin technology
Plant, animal or mixed origins
GF-1 Bacterial DNA Extraction Kit
Mini-column spin technology
Gram negative or Gram positive bacteria
Trifunctional purification matrix and
Animal blood and tissues, and from cells, yeast, bacteria, or viruses Whole blood, bone marrow, buffy coat, body fluids, cultured cells, cell suspensions, and Gram negative bacteria Cultured and fixed cells, gram-negative bacteria, plant and animal tissue, and whole blood and bone marrow cells Bacteria, yeast, and animal cells and tissues of all types Animal tissues and bacteria, plants, and yeast and fungi All bacteria, fungi, plants, and animals
Bacterial DNA from a wide range of materials and complex solutions, namely Enterococcus Food samples; dairy products, FishShrimps, meat and poultry, egg, fruit and vegetable, composite foods Bacteria, plant, yeast, blood cells and other mammalian cells and tissues of all types
No work has been done directly with enterococci in food but several species of bacteria have already been quantified in food and water using real-time PCR. Two step extraction of DNA for real-time PCR separate the target cells from the food matrix prior to isolation of DNA from the capture matrix:140 buoyant density centrifugation (BDC) has been used for the detection of food pathogens, centrifugation for Yersinia enterocolytica and flotation for Campylobacter jejuni,141,142 paramagnetic beads143 or filtration.144 BDC as a sample treatment prior to qPCR diminishes the risk of having false positives due to the detection of dead cells,145 eliminates part of the inhibitory substances from the food matrix, separates the microorganisms from the food particles and allows quantification of a target organism even amongst many others.146 Commercial kits can also be used.137,147 Internal controls have also been tested in PCR-based examination of food samples to monitor the detection method, from DNA extraction throughout amplification and detection.148 12.2.1.6 DNA Extraction from a Fermented Cereal-based Food (1) Food sample (1 g) is mixed with 9 ml of 0.9% NaCl solution and homogenized for 30 sec at maximum speed with a stomacher.
(2) Bacterial cells are recovered by two-step differential centrifugation, first at 800 × g for 1 min (to remove food particles) and then at 13,000 × g for 5 min. (3) DNA extraction starts with the addition of 500 µl of TESL (25 mM Tris, 10 mM EDTA, 20% sucrose, 20 mg/ml lysozyme and 20 U mutanolysin) to the cell pellet, followed by incubation at 37ºC for 60 min with gentle shaking. (4) 100 µl of proteinase K (1 mg/ml) are added and the suspension further incubated at 55ºC for 60 min. (5) 500 µl of GES reagent (5 mM guanidium thiocyanate, 100 mM EDTA, and 0.5% sarkosyl) are added and the lysate cooled on ice for 5 min. (6) 250 µl of cold 7.5 M ammonium acetate are added to the lysate, gentle shaked until the two phases are mixed and held on ice for 10 min. (7) The sample is then purified by one extraction with chloroform:isoamyl alcohol (24:1). (8) Nucleic acids are precipitated by isopropanol, washed with 70% ethanol and dissolved in 50 µl of TE with RNase (20 µg/ml), followed by incubation at 37ºC for 30 min.
173
Enterococcus
(9) The quality and size of the food DNA is checked by electrophoresis on 1% (wt/vol) agarose gel on 0.5% TBE buffer (Tris-Borate EDTA, pH 8.0). The DNA yield is quantified spectrophotometrically.
12.2.2 Detection Procedures For the detection of enterococci in food, several approaches can be applied depending on the food matrix, as well as the enterococcal species present or to be searched in the sample. An example of a suitable procedure, as presented here (see also Figure 12.1 which presents the flowchart of the multiplex-PCR based procedure for the detection and/or identification of enterococci at genus and species level), combines the method applied for the extraction of DNA from fermented cereal-based food according to Abriouel and coworkers120 and the detection/identification of enterococci based on the genus- and species-specific multiplex PCR described by Jackson and coworkers,94 enabling the detection of 21 validly published species of Enterococcus. This procedure can also be applied to other foods, after suitable modifications in the protocol of sample treatment prior to DNA extraction to adequately recover bacterial cells (see Section 12.2.1).
12.2.2.1 Genus- and Species-specific Multiplex PCR Amplification procedure consists on the preparation of seven PCR master mixes containing 3 mM MgCl2, 0.2 mM deoxynucleoside triphosphate mix, 3.5 U of high fidelity DNA polymerase and 1.25 µl (16 µM) of each primer (for sequence see Table 12.2 and for primer combination in each mix see Figure 12.1). For primers FL1, FL2, MA1, MA2, GA1, GA2, SA1, SA2, DI1, and DI2 the use of 2.5 µl of each primer is recommended. In all amplifications a genus-specific positive control primer set (E1/E2) must be added (for sequence see Table 12.2). PCR reactions are performed in a final volume of 22.5 µl (20 µl of master mix+2.5 µl of DNA). The PCR amplification program includes an initial denaturation at 95°C for 4 min, followed by 30 amplification cycles of denaturation at 95°C for 30 sec, annealing at 55°C (Groups 1, 2, 5, and 6) or 60°C (groups 3, 4, and 7) for 1 min, and elongation at 72°C for 1 min; amplification ends with an extension step at 72°C for 7 min. After PCR amplification an aliquot of 10 µl of product is electrophoresed on a 2% 1× Tris-acetate-EDTA agarose gel containing 2 µg/ml ethidium bromide. A DNA molecular size marker (preferably with a 10 bp resolution) should be
Food sample
DNA extraction
Genus-and species-specific multiplex PCR
Target species
Primers
Group 1 E1 + E2 DU1 + DU2 FL1 + FL2 FM1 + FM2 MA1 + MA2
Group 2
Group 3
Group 4
Group 5
Group 6
Group 7
E1 + E2 AV1 + AV2 CO1 + CO2
E1 + E2 CE1 + CE2 HI1 + HI2 RF1 + RF2
E1 + E2 AS1 + AS2 GI1 + GI2 PA1 + PA2 PO1 + PO2
E1 + E2 CA1 + CA2 GA1 + GA2 SO1 + SO2
E1 + E2 DI1 + DI2 PV1 + PV2 SA1 + SA2
E1 + E2 FV1 + FV2 MU1 + MU2 SU1 + SU2
E. durans 295 bp
E. casseliflavus 288 bp
E. dispar 284 bp
E. flavescens 284 bp
E. avium 368 bp
E. cecorum 371 bp
E. asini 365 bp
E. faecalis 360 bp
E. gallinarum 173 bp
E. pseudoavium 173 bp
E. mundtii 98 bp
E. columbae 284 bp
E. hirae 187 bp
E. gilvus 98 bp
E. faecium 215 bp
E. solitarius 371 bp
E. saccharolyticus 371 bp
E. sulfureus 173 bp
E. raffinosus 287 bp
E. pallens 160 bp
E. malodoratus 134 bp
E. villorum 280 bp
Figure 12.1 Flowchart of the multiplex-PCR based procedure for detection and/or identification of enterococci at genus and species level.
174
used as standard. Following electrophoresis, the agarose gels are visualized and photographed under UV light. 12.2.2.2 Data Analysis When coupled with the genus-specific primers described by Deasy and coworkers,149 the multiplex PCR for the superoxide dismutase (sod) gene94 provides a rapid and reliable method for the detection and/or identification of the majority of enterococcal species. Using the molecular size marker included in the agarose gel, the size of the amplicons can be estimated and compared with the expected ones (Table 12.2 and Figure 12.1). If the obtained fragments show the expected molecular size for the genus and species primer set, the presence of the target species is detected in the sample (or the isolate is identified at species level if working with pure cultures isolated from food samples). When only the genus-specific amplicon is visualized, the presence of unidentified enterococci is inferred. If no amplicons are observed, with the exception of the positive control reaction tube (food sample artificially contaminated with enterococci, which demonstrates the absence of PCR inhibitors), this means that either no enterococci are present in the analyzed sample at detectable levels or the existing strains show sequence variations in sod gene that prevent primer annealing (the false negative problem can occur despite the applied methodology and has to be taken in account). Although E flavescens (multiplex group 4) and E. casseliflavus (multiplex group 2) are distinguished, these two species are now considered the same with intraspecific variation of the sodA gene sequence, thus explaining why some strains give positive amplification with both primer sets while others show positive results only for one. For other species more recently described, no primer sets were developed since no sodA gene sequences are yet available in the databases.
12.3 Conclusions and Future Perspectives To start the discussion and the conclusion on the detection and quantification of enterococci in food, and on emerging pathogens, a definition of what is a foodborne emerging pathogen is needed. According to Morse174 and Yasmine and Adams175 an emerging pathogen is an agent “causing illnesses that have recently appeared or been recognized in a population, or that are well recognized but are rapidly increasing in incidence or geographic range.” Thinking about what was presented in the first part of this chapter, the conclusion is that this definition can be applied to Enterococcus genus. Why then the precaution with which this genus is always spoken about, because it is a very important part of some food microbiota, that is responsible for the special organoleptic properties of some fermented foods, and also because if well studied and characterized enterococci can be used as probiotics. Its presence in those food products is indispensable and as such it depends on the laboratories for evaluation of the potential risks of consumption of those microorganisms. A long road
Molecular Detection of Foodborne Pathogens
has yet to be followed to avoid been simplistic and preclude, because of all virulence factors that are detected and the presence the antibiotic resistance factors that are reported, the temptation of avoiding eating the food products that have them, avoiding using them as probiotics or even, in the future, avoiding using them as starter culture for instance for cheese production. Nevertheless, efforts should be done on eliminating antibiotic-resistant enterococci from foods by reducing veterinary use of antibiotics and making a prudent use of antibiotics in humans. The lack of an established congruence between virulence determinants and demonstrated pathogenicity show that research on this subject has to continue and is continuing, especially on the aspects of the relationships between host and microbial agent.176–179 Special attention has to be given to routes of transmission of food products namely the survival of strains to the gastrointestinal traffic and their capacity to establish themselves in the human tract. Other routes of transmission have to be investigated, namely fecal contamination of water and plants by food animals and waste water, especially hospital waste water.114 All these evaluations have to take on board not only healthy people, which seem to be unaffected by enterococcal strains, but also the elderly population, infants and immunecompromised people. The microbiological risk assessment of emerging pathogens has to be performed and global data indicates that epidemiology of foodborne diseases is changing, due to changes in food industry, lifestyles, improved surveillance and recovery/detection methods.180,181 As the emergence of foodborne pathogens depends on the laboratory ability to detect, identify and recognize those agents, therefore for the case of Enterococcus a detailed combination of genus and species more specific method is proposed here based on the work of Abriouel and coworkers120 and Jackson and coworkers.94 PCR methods in general, and real-time PCR methods in particular, are increasingly used for the detection and quantification of pathogens in food samples. Two questions still remain to be answered and constitute the future research needed in this area. The first question is the case of false positive sample detection due to the simultaneous detection of dead and live cells, a nonexisting question in conventional methods using pre-enrichment or not. This question has already been approached by several authors when reporting food sample preparation, but a more detailed study for enterococci is needed, as well as a more consistent study on the effect of the different food matrixes on the capacity of detection of the methods. This question is closed related with quantification problems. Again a sound correlation between enterococcal colony forming units (cfu/ml) and concentrations obtained by real-time PCR have to be developed. In what concerns microbiology laboratories that perform food control, validation of the methods is needed as no international standard is approved for Enterococus detection and/ or quantification. Another aspect that has to be taken in consideration is the constant need to have new methods to detect/quantify, if considered necessary, all the new species that are constantly appearing in the literature. All these
Enterococcus
new routes of needed research only make the area of work with Enterococcus more challenging and on the top of food research priorities.
Acknowledgments The authors acknowledge the partial funding from different projects on Enterococcus or food quality and safety that have financed their research on the subject, namely Fundação para a Ciência e Tecnologia through Program PRAXIS XXI, project 2/2.1/BIO/1121/95 and Program SAPIENS, project POCTI/AGR/36165/99 and EU, through Specific Supported Action projects SELAMAT no CT-2004-506386 and ALCUEFOOD na 007176. T. Semedo-Lemsaddek thanks the financial support of the FCT Pos-Doctoral fellowship SFRH/ BPD/20892/2004.
References
1. Thiercelin, E. and Jouhaud, L. Reproduction de l’entérocoque; taches centrales; granulation périphérques et microblastes. C.R. Soc. Biol., 55, 686, 1903. 2. Kalina, A.P. The taxonomy and nomenclature of enterococci. Int. J. Syst. Bacteriol., 20, 185, 1970. 3. Schleifer, K.H. and Kilpper-Bälz, R. Transfer of Strepto coccus faecalis and Streptococcus faecium to the genus Enterococcus nom. rev. as Enterococcus faecalis comb. nov. and Enterococcus faecium comb. nov. Int. J. Syst. Bacteriol., 34, 31, 1984. 4. Ludwig, W. et al. The phylogenetic position of Streptococcus and Enterococcus. J. Gen. Microbiol., 131, 543, 1985. 5. Köhler, W. The present state of species within the genera Streptococcus and Enterococcus. Int. J. Med. Microbiol., 297, 133, 2007. 6. Garrity, G.M. et al. The bacteria: Phylum Firmicutes: Class “Bacilli”. In Taxonomic Outline of the Bacteria and Archea (TOBA), Release 7.7, 2007, Part 9. 7. Devriese, L.A. et al. Identification of aesculin-hydrolyzing streptococci, lactococci, aerococci and enterococci from subclinical intramammary infections in dairy cows. Vet. Microbiol., 70, 87, 1999. 8. Devriese, L.A., Baele, M. and Butaye, P. The genus Enterococcus. In The Prokaryotes, Dworkin, M. et al., Eds. Springer, Heidelberg, 2002. 9. Holt, J.G. et al. Bergey’s Manual of Determinative Bacteriology, 9th ed. William & Wilkins, Baltimore, MD, 1994. 10. Devriese, L.A. et al. Identification of Enterococcus species isolated from foods of animal origin. Int. J. Food Microbiol., 26, 187, 1995. 11. Facklam, R.R., Carvalho, M.G.S. and Teixeira L.M. History, taxonomy, biochemical characteristics, and antibiotic susceptibility testing of Enterococci. In The Enterococci: Pathogenesis, Molecular Biology, and Antibiotic Resistance, Gilmore, M.S. et al., Eds. ASM Press, Washington, D.C., 2002. 12. Doming, K.J., Meyer, H.K. and Kneifel, W. Methods for the isolation, enumeration, characterization and identification of Enterococcus spp. 2. Pheno- and genotypic criteria. Int. J. Food Microbiol., 88, 165, 2003. 13. Foulquié Moreno, M.R. et al. The role and application of enterococci in food and heath. Int. J. Food Microbiol., 106, 1, 2006.
175 14. Ogier, J.-C. and Serror, P. The Enterococcus genus. Int. J. Food Microbiol., 2007, doi:10.1016/j.ijfoodmicro.2007.08.017. 15. Giraffa, G. Enterococci from foods. FEMS Microbiol. Rev., 26, 163, 2002. 16. Giraffa, G. Functionality of enterococci in dairy products. Int. J. Food Microbiol., 88, 215, 2003. 17. Klein, G. Taxonomy, ecology and antibiotic resistance of enterococci from food and the gastro-intestinal tract. Int. J. Food Microbiol., 88, 123, 2003. 18. Kühn, I. Comparison of enterococcal population in animals, humans, and the environment – a European study. Int. J. Food Microbiol., 88, 133, 2003. 19. Desmasures, N. Bazin, F. and Guegen, M. Microbiological composition of raw milk from selected farms in the Camembert region of Normandy. J. Appl. Microbiol., 83, 53, 1997. 20. Duthoit, F., Godon, J.J. and Montel, M.C. Bacterial community dynamics during production of registered designation of origin Salers cheese as evaluated by 16S rRNA gene singlestrand conformation polymorphism analysis. Appl. Environ. Microbiol., 69, 3840, 2003. 21. Manolopoulou E. et al. Evolution of microbial populations during traditional Feta cheese manufacture and ripening. Int. J. Food Microbiol., 82, 153, 2003. 22. Psoni, L. et al. Genotypic and phenotypic heterogeneity in Enterococcus isolates from Batzos, a raw goat milk cheese. Int. J. Food Microbiol., 109, 109, 2006. 23. Mannu, L. et al. Strain typing among enterococci isolated from home-made Pecorino Sardo cheese. FEMS Microbiol. Lett., 170, 25, 1999. 24. Andrighetto C. et al. Phenotypic and genetic diversity of enterococci isolated from Italian cheeses. J. Dairy Res., 68, 303, 2001. 25. Cosentino, S. et al. Genotypic and technological characterization of enterococci isolated from artisanal Fiore Sardo cheese. J. Dairy Res., 71, 444, 2004. 26. Poznanski, E. et al. Indigenous raw milk microbiota influences the bacterial development in traditional cheese from an alpine natural park. Int. J. Food Microbiol., 92, 141, 2004. 27. Macedo, C.A., Malcata, F.X. and Hogg, T.A. Microbiological profiling in Serra ewe’s cheese during ripening. J. Appl. Bacteriol., 79, 1, 1995. 28. Alves, P.I. et al. Comparison of phenotypic and genotypic taxonomic methods for the identification of dairy enterococci. Antonie van Leewenhoek, 85, 237, 2004. 29. Cˇanžek Majhenicˇ, A., Rogelj, I. and Perko, B. Enterococci from Tolminc cheese: Population structure, antibiotic susceptibility and incidence of virulence determinants. Int. J. Food Microbiol., 102, 239, 2005. 30. Centeno, J.A., Menéndez, S. and Rodríguez-Otero, J.L. Main microbial flora present as natural starters in Cebreiro raw cow’s-milk cheese (northwest Spain). Int. J. Food Microbiol., 33, 307, 1996. 31. Gelsomino, R. et al. Enterococcal diversity in the environment of an Irish Cheddar-type cheesemaking factory. Int. J. Food Microbiol., 71, 177, 2001. 32. Franz, C.M., Holzapfel, W.H. and Stiles, M.E. Enterococci at the crossroads of food safety? Int. J. Food Microbiol., 47, 1, 1999. 33. Franz, C.M. et al. Enterococci in foods–a conundrum for food safety. Int. J. Food Microbiol., 88, 105, 2003. 34. Hugas, M., Garriga M. and Aymerich, M.T. Functionality of enterococci in meat products. Int. J. Food Microbiol., 88, 223, 2003.
176 35. Ben Omar, N. et al. Functional and safety aspects of enterococci isolated from different Spanish foods. Syst. Appl. Microbiol., 27, 118, 2004. 36. Randazzo, C.L. et al. Lactobacillus casei, dominant species in naturally fermented Sicilian green olives. Int. J. Food Microbiol., 90, 9, 2004. 37. Pérez Pulido, R. et al. Microbiological study of lactic acid fermentation of Caper berries by molecular and culture-dependent methods. Appl. Environ. Microbiol., 71, 7872, 2005. 38. Müller T. et al. Identification of plant-associated enterococci. J. Appl. Microbiol., 91, 268, 2001. 39. Ott, E.-M. et al. Population dynamics and antagonistic potential of enterococci colonizing the phyllosphere of grasses. J. Appl. Microbiol., 91, 54, 2001. 40. Sarantinopoulos, P. et al. Bacteriocin production by Enterococcus faecium FAIR-E 198 in view of its application as adjunct starter in Greek Feta cheese making. Int. J. Food Microbiol., 72, 125, 2002. 41. Stompfová, V., Lauková, A. and Ouwehand, A.C. Selection of enterococci for potential canine probiotic additives. Vet. Microbiol., 100, 107, 2004. 42. Semedo, T. et al. Virulence factors in food, clinical and reference Enterococci: a common trait in the genus? Syst. Appl. Microbiol., 26, 13, 2003. 43. Semedo, T. et al. Comparative study using type strains and clinical and food isolates to examine hemolytic activity and occurrence of the cyl operon in enterococci. J. Clin. Microbiol., 41, 2569, 2003. 44. Pérez-Pulido, R. et al. Safety and potential risks of enterococci isolated from traditional fermented capers. Food Chem. Toxicol., 44, 2070, 2006. 45. Młynarczyk, G., et al. Occurrence of glycopeptide-resistant enterococci in transplant medicine internal wards in 2001– 2005. Transpl. Proc., 39, 2886, 2007. 46. Ossiprandi, M. C. et al. Susceptibility to vancomycin and other antibiotics of 165 Enterococcus strains isolated from dogs in Italy. Comp. Immunol. Microbiol. Infect. Dis., 31, 1, 2008. 47. Coque, T.M. et al. Population structure of Enterococcus faecium causing bacteremia in a Spanish university hospital: setting the scene for a future increase in vancomycin resistance? Antimicrob. Agents Chemother., 49, 2693, 2005. 48. Treitman, A.N. et al. Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J. Clin. Microbiol., 43, 462, 2005. 49. Amyes, S.G. Enterococci and streptococci. Int. J. Antimicrob. Agents, 29 Suppl 3, S43, 2007. 50. Witte, W. et al. Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens. Int. J. Med. Microbiol., 2008, doi: 10.1016/j.ijmm.2007.10.005. 51. Dargere, S. et al. Enterococcus gallinarum endocarditis occurring on native heart valves. J. Clin. Microbiol., 40, 2308, 2002. 52. Kayser, F.H. Safety aspects of enterococci from the medical point of view, Int. J. Food Microbiol., 88, 255, 2003. 53. Kurup, A. et al. Infection of central nervous system by motile Enterococcus: first case report. J. Clin. Microbiol., 39, 820, 2001. 54. Malani, P.N., Kauffman, C.A. and Zervos, M.J. Enterococcal disease, epidemiology, and treatment. In The Enterococci: Pathogenesis, Molecular Biology, and Antibiotic Resistance, Gilmore, M.S. et al. Eds. ASM Press, Washington, DC, 2002. 55. Ratanasuwan, W. et al. Bacteremia due to motile Enterococcus species: clinical features and outcomes. Clin. Infect. Dis., 28, 1175, 1999.
Molecular Detection of Foodborne Pathogens 56. Sandoe, J.A., Witherden, I.R. and Settle, C. Vertebral osteomyelitis caused by Enterococcus raffinosus. J. Clin. Microbiol., 39, 1678, 2001. 57. Rahman, I. et al. Methionine uptake and cytopathogenicity of viable but nonculturable Shigella dysenteriae type 1. Appl. Environ. Microbiol., 60, 3573, 1994. 58. Lleo, M.M., Tafi, M.C. and Canepari, P. Nonculturable Enterococcus faecalis cells are metabolically active and capable of resuming active growth. Syst. Appl. Microbiol., 21, 333, 1998. 59. Colwell, R.R. and Huq, A. Vibrios in the environment: Viable but nonculturable Vibrio cholerae. In Vibrio and Cholera and Cholera: Molecular Global Perspectives, Kaye, T., Ed. ASM Press, Washington, D.C., 1994. 60. Pruzzo, C. et al. In vitro adhesion to human cells by viable but nonculturable Enterococcus faecalis. Curr. Microbiol., 45, 105, 2002. 61. Lleo, M.M., Bonat, B. and Canepari, P. Vancomycin resistance is maintained in enterococci in the viable but nonculturable state and after division is resumed. Antimicrob. Agents Chemother., 47, 1154, 2003. 62. Lleo, M.M. et al. mRNA detection by reverse transcription-PCR for monitoring viability over time in an Enterococcus faecalis viable but nonculturable population maintained in a laboratory microcosm. Appl. Environ. Microbiol., 66, 4564, 2000. 63. Arana, I.I. et al. Influence of a survival process in a freshwater system upon plasmid transfer between Escherichia coli strains. Microb. Ecol., 33, 41, 1997. 64. Oliver, J.D. Formation of viable but nonculturable cells. In Starvation in Bacteria, Kjelleberg, S. Ed. Plenum Press, New York, 1993. 65. Lleo, M.M. et al. Resuscitation rate in different enterococcal species in the viable but nonculturable state. J. Appl. Microbiol., 91, 1095, 2001. 66. Lee, D.Y., Shannon, K. and Beaudette, L.A. Detection of bacterial pathogens in municipal wastewater using an oligonucleotide microarray and real-time quantitative PCR. J. Microbiol. Methods, 65, 453, 2006. 67. Lleo, M.M. et al. Competitive polymerase chain reaction for quantification of nonculturable Enterococcus faecalis cells in lake water. FEMS Microbiol. Ecol., 30, 345, 1999. 68. Monstein, H.J. et al. Division of the genus Enterococcus into species groups using PCR-based molecular typing methods. Microbiology, 144, 1171, 1998. 69. Sedgley, C.M. et al. Quantitative real-time PCR detection of oral Enterococcus faecalis in humans. Arch. Oral Biol., 50, 575, 2005. 70. Dutka-Malen, S., Evers, S. and Courvalin, P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol., 33, 1434, 1995. 71. Klare, I. and Witte, W. Glykopeptidresistente enterokokken. Wien Klin. Wochenschr., 09/9, 293, 1997. 72. Poyart, C., Quesnes, G. and Trieu-Cuot, P. Sequencing the gene encoding manganese-dependent superoxide dismutase for rapid species identification of enterococci. J. Clin. Microbiol., 38, 415, 2000. 73. Ke, D. et al, Development of a PCR assay for rapid detection of enterococci. J. Clin. Microbiol., 37, 3497, 1999. 74. Wang, R.F. et al. Development of a membrane-array method for the detection of human intestinal bacteria in fecal samples. Mol. Cell Probes, 16, 341, 2002. 75. Sedgley, C., Buck, G. and Appelbe, O. Prevalence of Enterococcus faecalis at multiple oral sites in endodontic patients using culture and PCR. J. Endod., 32, 104, 2006.
Enterococcus 76. Mahmoudpour, A. et al. Isolation and identification of Enterococcus faecalis from necrotic root canals using multiplex PCR. J. Oral Sci., 49, 221, 2007. 77. Arias, C. A. et al. Rapid identification of Enterococcus hirae and Enterococcus durans by PCR and detection of a homologue of the E. hirae mur-2 Gene in E. durans. J. Clin. Microbiol., 44, 1567, 2006. 78. Frahm, E. and Obst, U. Application of the fluorogenic probe technique (TaqMan PCR) to the detection of Enterococcus spp. and Escherichia coli in water samples. J. Microbiol. Methods, 52, 123, 2003. 79. Volkmann, H., et al. Detection of clinically relevant antibioticresistance genes in municipal wastewater using real-time PCR (TaqMan). J. Microbiol. Methods, 56, 277, 2004. 80. Kempf, V.A., Trebesius, K. and Autenrieth, I.B. Fluorescent In situ hybridization allows rapid identification of microorganisms in blood cultures. J. Clin. Microbiol., 38, 830, 2000. 81. Waar, K. Fluorescent in situ hybridization with specific DNA probes offers adequate detection of Enterococcus faecalis and Enterococcus faecium in clinical samples. J. Med. Microbiol., 54, 937, 2005. 82. Wellinghausen, N. et al. Rapid identification of clinically relevant Enterococcus species by fluorescence in situ hybridization. J. Clin. Microbiol., 45, 3424, 2007. 83. Betzl, D., Ludwig, W. and Schleifer, K.H. Identification of lactococci and enterococci by colony hybridization with 23S rRNA-targeted oligonucleotide probes. Appl. Environ. Microbiol., 56, 2927, 1990. 84. Lehner, A. et al. Oligonucleotide microarray for identification of Enterococcus species. FEMS Microbiol. Lett., 246, 133, 2005. 85. Frahm, E. et al. Application of 23S rDNA-targeted oligonucleotide probes specific for enterococci to water hygiene control. Syst. Appl. Microbiol., 21, 450, 1998. 86. Behr, T. et al. A nested array of rRNA targeted probes for the detection and identification of enterococci by reverse hybridization. Syst. Appl. Microbiol., 23, 563, 2000. 87. Chizhikov, V. et al. Microarray analysis of microbial virulence factors. Appl. Environ. Microbiol., 67, 3258, 2001. 88. Sergeev, N. et al. Multipathogen oligonucleotide microarray for environmental and biodefense applications. Biosens. Bioelectron., 20, 684, 2004. 89. Warsen, A.E. et al. Simultaneous discrimination between 15 fish pathogens by using 16S ribosomal DNA PCR and DNA microarrays. Appl. Environ. Microbiol., 70, 4216, 2004. 90. Wang, R.F. et al. DNA microarray analysis of predominant human intestinal bacteria in fecal samples. Mol. Cell Probes, 18, 223, 2004. 91. Tung, S.K. et al. Array-based identification of species of the genera Abiotrophia, Enterococcus, Granulicatella, and Streptococcus. J. Clin. Microbiol., 44, 4414, 2006. 92. Naser, S.M. et al. Application of multilocus sequence analysis (MLSA) for rapid identification of Enterococcus species based on rpoA and pheS genes. Microbiology, 151, 2141, 2005. 93. Naser, S. Phylogeny and identification of enterococci by atpA gene sequence analysis. J. Clin. Microbiol., 43, 2224, 2005. 94. Jackson, C.R., Fedorka-Cray, P.J. and Barrett, J.B. Use of a genus- and species-specific multiplex PCR for identification of enterococci. J. Clin. Microbiol., 42, 3558, 2004. 95. Goh, S.H. et al. Identification of Staphylococcus species and subspecies by the chaperonin 60 gene identification method and reverse checkerboard hybridization. J. Clin. Microbiol., 35, 3116, 1997.
177 96. Teng, L.J. et al. Determination of Enterococcus faecalis groESL full-length sequence and application for species identification. J. Clin. Microbiol., 39, 3326, 2001. 97. Matsuda, K. et al. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl. Environ. Microbiol., 73, 32, 2007. 98. Grunberg-Manago, M. Regulation of the expression of aminoacyl tRNA synthetases and translation factors. In Escherichia coli and Salmonella: Cellular and Molecular Biology, Neidhardt, F. et al. Eds. 2nd ed. ASM Press, Washington, D.C., 1996. 99. Knijff, E. et al. Rapid identification of Enterococcus durans and Enterococcus hirae by PCR with primers targeted to the ddl genes. J. Microbiol. Methods, 47, 35, 2001. 100. Robbi, C. et al. The gene encoding for penicillin-binding protein 5 of Enterococcus faecalis is useful for development of a species-specific DNA probe. Microb. Drug Resist., 2, 215, 1996. 101. Muller, V. and Gruber, G. ATP synthases: Structure, function and evolution of unique energy converters. Cell. Mol. Life Sci., 60, 474, 2003. 102. Ellis, R.J. Chaperonins: introdutory perspective. In The Chaperonins, Ellis, R.J. Ed. Academic Press, Inc., San Diego, CA, 1996. 103. Satake, S. et al. Detection of vancomycin-resistant enterococci in fecal samples by PCR. J. Clin. Microbiol., 35, 2325, 1997. 104. Kariyama, R. et al. Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. J. Clin. Microbiol., 38, 3092, 2000. 105. Depardieu, F. Perichon, B. and Courvalin, P., Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR. J. Clin. Microbiol., 42, 5857, 2004. 106. Li, S., Zhang, Z. and Mi, Z.H. Vancomycin-resistant enterococci in a Chinese hospital. Curr. Microbiol., 55, 125, 2007. 107. Arthur, M., Reynolds, P. and Courvalin, P. Glycopeptide resistance in enterococci. Trends Microbiol., 4, 401, 1996. 108. Mendéz-Alvarez, S., Pérez-Hernández, X and Claverie-Martin, F. Glycopeptide resistance in enterococci. Int. Microbiol., 3, 71, 2000. 109. Evers, S., Sahm, D.F. and Courvalin, P. The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding D-Ala:D-Ala ligases and glycopeptide-resistance proteins VanA and VanC. Gene, 124, 143, 1993. 110. Perichon, B., Reynolds, P.E. and Courvalin, P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob. Agents Chemother., 41, 2016, 1997. 111. Ostrowsky, B.E. et al. A cluster of VanD vancomycin-resistant Enterococcus faecium: Molecular characterization and clinical epidemiology. J. Infect. Dis., 180, 1177, 1999. 112. Fines, M., et al. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob. Agents Chemother., 43, 2161, 1999. 113. Mckessar, S.J. et al. Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis. Antimicrob. Agents Chemother., 44, 3224, 2000. 114. Franz, C.M.A.P. and Holzapfel, W.H. Enterococci. In Emerging Foodborne Pathogens, Motarjemi, Y. and Adams, M. Eds. Woodhead Publishing Limited and CRC Press LLC, England, 2006. 115. Giacomazzi, S., Leroi, F. and Joffraud J.-J. Comparison of three methods of DNA extraction from cold-smoked salmon and impact on physical treatments. J. Appl. Microbiol., 98, 1230, 2005.
178 116. Anonymous. ISO 6887-1:1999. Microbiology of food and animal feeding stuffs – Preparation of test samples, initial suspension and decimal dilutions for microbiological examination – Part 1: General rules for the preparation of initial suspension and dilutions. 117. Anonymous. ISO 6887-2:2003. Microbiology of food and animal feeding stuffs – Preparation of test samples, initial suspension and decimal dilutions for microbiological examination – Part 2: Specific rules for the preparation of meat and meat products. 118. Anonymous. ISO 6887-3:2003. Microbiology of food and animal feeding stuffs – Preparation of test samples, initial suspension and decimal dilutions for microbiological examination – Part 3: Specific rules for the preparation of fish and fishery products. 119. Anonymous. ISO 6887-4:2003/Cor. 1:2004. Microbiology of food and animal feeding stuffs – Preparation of test samples, initial suspension and decimal dilutions for microbiological examination – Part 4: Specific rules for the preparation of products other than milk and milk products, meat and meat products, and fish and fishery products. 120. Abriouel, H., et al. Culture-independent analysis of the microbial composition of the African traditional fermented foods poto poto and degue by using three different DNA extraction methods. Int. J. Food Microbiol., 111, 228, 2006. 121. Heller, L.C., et al. Comparison of methods for DNA isolation from food samples for detection of Shiga toxin-producing Escherichia coli by real-time PCR. Appl. Environ. Microbiol., 69, 1844, 2003. 122. Anonymous. ISO 8261:2001. Milk and milk products–General guidance for the preparation of test samples, initial suspensions and decimal dilutions for microbiological examination. 123. Anonymous. ISO 7218:2007. Microbiology of food and animal feeding stuffs – General requirements and guidance for microbial examination. 124. Reuter, G. and Klein, G. Culture media for enterococci and group D-streptococci. In Handbook of Culture Media for Food Microbiology, Corry, J.E.L. et al. Eds. Elsevier Sciences B.V, Amsterdam, the Netherlands, 2003. 125. Aspevall, O. et al. Performance of four chromogenic urine culture media after one or two days of incubation compared with reference media. J. Clin. Microbiol., 40, 1500, 2002. 126. Perry, J.D. et al. Evaluation of a new chromogenic medium, Uriselect 4, for the isolation and identification of urinary tract pathogens. J. Clin. Pathol., 56, 528, 2003. 127. Miranda, J.M. et al. Evaluation of Chromocult® enterococci agar for the isolation and selective enumeration of Enterococcus spp. in broilers. Lett. Appl. Microbiol., 41, 153, 2005. 128. Ranucci, D. et al. Microbiologial characteristics’ of hamburgers and raw pork sausages, and antibiotic-resistance of isolated bacteria. Vet. Res. Commun., 28, 269, 2004. 129. Anonymous. ISO 22174:2005. Microbiology of food and animal feeding stuffs – Polymerase chain reaction (PCR) for the detection of food-borne pathogens – General requirements and definitions. 130. Anonymous. ISO 20837:2006. Microbiology of food and animal feeding stuffs – Polymerase chain reaction (PCR) for the detection of food-borne pathogens – Requirements for sample preparation for qualitative detection. 131. Anonymous. ISO 20838:2006. Microbiology of food and animal feeding stuffs – Polymerase chain reaction (PCR) for the detection of food-borne pathogens – Requirements for amplification and detection for qualitative methods.
Molecular Detection of Foodborne Pathogens 132. Sambrook, J., Fritsch, J. and Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989. 133. Pitcher, D.G., Saunders, N.A. and Owen, R.J. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett. Appl. Microbiol., 8, 151, 1989. 134. Björkroth, J., et al. Enterococcus species dominating in fresh modified-packaged, marinated broiler legs are overgrown by Carnobacterium and Lactobacillus species during storage at 6°C. Int. J. Food Microbiol., 97, 267, 2006. 135. Uyttendaele, M., van Boxstael, S. and Debevere, J. PCR assay for detection of the E. coli O157:H7 eae-gene and effect of the sample preparation method on PCR detection of heat-killed E. coli O157:H7 in ground beef. Int. J. Food Microbiol., 52, 85, 1999. 136. Rossmanith, P. et al. Development of matrix lysis for concentration of gram positive bacteria from food and blood. J. Microbiol. Methods, 69, 504, 2007. 137. Klerks, M.M. et al. Comparison of methods of extracting Salmonella enterica serovar enteritidis DNA from environmental substrates and quantification of organisms by using a general internal procedual control. Appl. Environ. Microbial., 72, 3879, 2006. 138. Sculpham, A.J., Jones, J.A. and Wesley, I.V. Comparison of DNA extraction methods for analysis of turkey cecal microbiota. J. Appl. Microbiol., 102, 401, 2007. 139. Cremonesi, P. et al. Technical note: Improved method for rapid DNA extraction of mastitis pathogens directly from milk. J. Dairy Sci., 89, 163, 2006. 140. Malorny, B. et al. Enumeration of Salmonella bacteria in food and feed samples by real-time PCR for quantitative microbial risk assessment. Appl. Environ. Microbiol., 74, 1299, 2008. 141. Wollfs, P. et al. Quantification of Campylobacter spp. in chicken rinse samples by using flotation prior to real-time PCR. Appl. Environ. Microbiol., 71, 5759, 2005. 142. Wollfs, P.F. et al. Simultaneous quantification of pathogenic Campylobacter and Salmonella in chicken rinse by a flotation and real-time multiplex PCR. Int. J. Food Microbiol., 117, 50, 2007. 143. Rudi, K., et al. Direct real-time PCR quantification of Campylobacter jejuni inchicken fecal and caecal samples by integrated cell concentration and DNA purification, Appl. Environ. Microbiol., 70, 790, 2004. 144. Wollfs, P.F.G. et al. Quantitation and detection of salmonellae in biological samples without enrichment, using two-step filtration and real-time PCR. Appl. Environ. Microbiol., 72, 3896, 2006. 145. Wollfs, P., Norling, B. and Rådström, P. Risk assessment of false-positive quantitative real-time PCR results in food, due to the detection of DNA originating from dead cells. J. Microbiol. Methods, 60, 315, 2005. 146. Fukushima, H. et al. Rapid separation and concentration of food-borne pathogens in food samples prior to quantification by viable-cell counting and real-time PCR. Appl. Environ. Microbiol., 73, 92, 2007. 147. Flekna, G. et al. Real-time PCR method with statistical analysis to compare the potential of DNA isolation methods to remove PCR inhibitors from samples for diagnostic PCR. Mol. Cell Probes, 21, 282, 2007. 148. Murphy, N.M. et al. Construction and evaluation of a microbiological positive process internal control for PCR-based examination of food samples for Listeria monocytogenes and Salmonella enterica. Int. J. Food Microbiol., 120, 110, 2007. 149. Deasy, B.M. et al. A rapid PCR based method to distinguish between Lactococcus and Enterococcus. Syst. Appl. Microbiol., 23, 510, 2000.
Enterococcus 150. Amann, R.I., Krumholz, L. and Stahl, D.A. Fluorescentoligonucleotide probing of whole cells for determinative, phylogenetic, and environmental studies in microbiology. J. Bacteriol., 172, 762, 1990. 151. Jin, L.Q. et al. Detection and identification of intestinal pathogenic bacteria by hybridization to oligonucleotide microarray., World J. Gastroenterol., 11, 7615, 2005. 152. Manero, A. and Blanch, A.R. Identification of Enterococcus spp. based on specific hybridisation with 16S rDNA probe. J. Microbiol. Methods, 50, 115, 2002. 153. Santo Domingo, J.W., Siefring S.C. and Haugland, R.A. Realtime PCR method to detect Enterococcus faecalis in water. Biotechnol. Lett., 25, 261, 2003. 154. Betzl, D., Ludwig, W. and Schleifer, K.H. Identification of lactococci and enterococci by colony hybridization with 23S rRNA-targeted oligonucleotide probes. Appl. Environ. Microbiol., 56, 2927, 1990. 155. van De Klundert, J.A.M. and Vliegenthart, J.S. PCR detection of genes coding for aminoglycoside-modifying enzymes. In Diagnostic Molecular Microbiology, Persing, D.H., et al. Eds. ASM Press, Washington, D.C., 1993. 156. McClellan, D.L. Griffen, A.L. and Leys, E.J. Age and prevalence of Porphyromonas gingivalis in children. J. Clin. Microbiol., 34, 2017, 1996. 157. Berthier, F. and Ehrlich, S.D. Rapid species identification within two groups of closely related lactobacilli using PCR primers that target the 16S/23S rRNA spacer region. FEMS Microbiol. Lett., 161, 97, 1998. 158. Nadkarni, M.A. et al. Determination of bacterial load by realtime PCR using a broad-range (universal) probe and primers set. Microbiol., 148, 257, 2002. 159. Lu, J. et al. Use of PCR with universal primers and restriction endonuclease digestions for detection and identification of common bacterial pathogens in cerebrospinal fluid. J. Clin. Microbiol., 38, 2076, 2000. 160. Kumar, P.S. et al. New bacterial species associated with chronic periodontitis. J. Dent. Res., 82, 338, 2003. 161. Volkmann, H., et al. Evaluation of inhibition and crossreaction effects on real-time PCR applied to the total DNA of wastewater samples for the quantification of bacterial antibiotic resistance genes and taxon-specific targets. Mol. Cell Probes, 21, 125, 2007. 162. Barry, T. The 16S/23S ribosomal spacer region as a target for DNA probes to identify eubacteria. PCR Methods Appl., 1, 51, 1991. 163. Jensen, M.A., Webster, J.A. and Straus, N. Rapid identification of bacteria on the basis of polymerase chain reaction-amplified ribosomal DNA spacer polymorphisms. Appl. Environ. Microbiol., 59, 945, 1993. 164. Molander, A. et al. A protocol for polymerase chain reaction detection of Enterococcus faecalis and Enterococcus faecium from root canal. Int. Endodont. J., 35, 1, 2002. 165. Meier, H. et al. Detection of enterococci with rRNA targeted DNA probes and their use for hygienic drinking water control. Water Sci. Technol., 35, 437, 1997.
179 166. Bartosch, S. et al. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl. Environ. Microbiol., 70, 3575, 2004. 167. Siqueira, J.F. and Rocas, I.N. Polymerase chain reaction-based analysis of microorganisms associated with failed endodontic treatment. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 97, 85, 2004. 168. Gomes, B.P.F.A. et al. Enterococcus faecalis in dental rroot canals detected by culture and by polymerase chain reaction analysis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 102, 247, 2006. 169. Clark, N.C. et al. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob. Agents Chem other., 37, 2311, 1993. 170. Miele, A., Bandera, M. and Goldstein, B.P. Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates. Antimicrob. Agents Chemother., 39, 1772, 1995. 171. Aymerich, T. et al. Microbial quality and direct PCR identification of lactic acid bacteria and nonpathogenic Staphylococci from artisanal low-acid sausages. Appl. Environ. Microbiol., 69, 4583, 2003. Erratum in: Appl. Environ. Microbiol., 71, 1674, 2005. 172. Cheng, S. et al. A PCR assay for identification of Entero coccus faecium. J. Clin. Microbiol., 35, 1248, 1997. 173. Fortina, M.G. Rapid identification of Enterococcus italicus by PCR with primers targeted to 16S rRNA gene. Lett. Appl. Microbiol., 44, 443, 2007. 174. Morse, S.S. Factors and determinants of disease emergence. Rev. Sci. Tech., 23, 443, 2004. 175. Motarjemi, Y. and Adams, M. Introduction. In Emerging Foodborne Pathogens, Motarjemi, Y. and Adams, M., Eds. Woodhead Publishing Limited and CRC Press LLC, England, 2006. 176. Park, S.Y. et al. Extracellular gelatinase of Enterococcus faecalis destroys a defense system in insect hemolymph and human serum. Infect. Immun., 75, 1861, 2007. 177. Brinster, S. et al. Enterococcal leucine-rich repeat containing protein involved in virulence and host inflammatory response. Infect. Immun., 75, 4463, 2007. 178. Hébert, L. et al. Enterococcus faecalis constitutes an unusual bacterial model in lysozyme resistance. Infect. Immun., 75, 5390, 2007. 179. Shimada, T. et al. Effects of lysed Enterococcal faecalis FK-23 on allergen-induced serum antibody responses and active cutaneous anaphylaxis in mice. Clin. Exp. Allergy, 34, 1784, 2004. 180. Brown, M. and McClure, P. Microbiological risk assessment for emerging pathogens. In Emerging Foodborne Pathogens, Motarjemi, Y. and Adams, M. Eds. Woodhead Publishing Limited and CRC Press LLC, England, 2006. 181. Skovgaard, N. New trends in emerging pathogens. Int. J. Food Microbiol., 120, 217, 2007.
13 Helicobacter Norihisa Noguchi
Tokyo University of Pharmacy and Life Sciences
Contents 13.1 Introduction.....................................................................................................................................................................181 13.1.1 Morphology and Classification of Helicobacter . .............................................................................................181 13.1.2 Biology, Pathogenesis, and Medical Importance.............................................................................................. 182 13.1.3 Current Technologies for Detection of Helicobacter........................................................................................ 183 13.1.3.1 Immunological Techniques.............................................................................................................. 183 13.1.3.2 Urea Breath Test (UBT)................................................................................................................... 184 13.1.3.3 Molecular Techniques...................................................................................................................... 184 13.2 Methods.......................................................................................................................................................................... 186 13.2.1 Reagents, Supplies, and Equipment.................................................................................................................. 186 13.2.2 Sample Collection and Preparation.................................................................................................................. 187 13.2.3 Detection Procedures........................................................................................................................................ 188 13.3 Conclusions and Future Perspectives............................................................................................................................. 195 References.................................................................................................................................................................................. 196
13.1 Introduction 13.1.1 Morphology and Classification of Helicobacter Although it was once considered difficult for microbes to live in the stomachs of mammals, including humans, spiral-shaped bacteria have been detected in the gastric mucosa of some mammalian species. In 1982, Warren, and Marshall were the first to isolate a spiral-shaped Gram-negative bacterium, Helicobacter pylori, from patients with chronic gastritis.1 This organism was classified as Campylobacter pylori, which was transferred to a new genus, Helicobacter, and renamed Helicobacter pylori based on taxonomies developed using 16S rRNA sequences.2 Scanning electron microscopy revealed H. pylori to be a spiral-shaped bacterium with two to three turns and four to eight polar flagella (Figure 13.1a).3,4 Helicobacter isolated from gastric mucosa has strong urease activity. Urease, an enzyme that catalyzes the hydrolysis of urea to yield ammonia, is necessary for H. pylori to maintain a microenvironment of neutral pH around the bacterium.5 H. pylori is a pathogenic bacterium that causes peptic ulcers and chronic gastritis and is linked to mucosa-associated lymphoid tissue lymphoma.6–8 This has prompted the development of several methods for diagnosing H. pylori infection (Table 13.1).9 Spiral-shaped bacteria have also been found in the stomachs of some animals. The discovery of Helicobacter and the development of culture techniques made it possible to isolate spiral-shaped Helicobacter species other than H. pylori from animals such as cats, dogs, monkeys, and cheetahs.4 H. pylori is isolated from the upper gastrointestinal tract, including the
stomach, while other Helicobacter has been isolated from not only the stomach but also the intestinal tract and feces in animals. Morphological features, such as the form of flexispira, the presence or absence of periplasmic fibers, and the number and locations of flagella, differ among Helicobacter species. For instance, H. mustelae, which was isolated from the stomach of a ferret, is a slightly twisted, small rod form with multiple flagella at both poles; in contrast, H. felis, which was isolated from the stomach of a cat, has multiple flagella and periplasmic fibers at the bipoles.4 To identify these morphological features, micrographs of high resolution are needed. Helicobacter isolated from the stomach has urease activity, while some species of Helicobacter isolated from the intestinal tract and liver have no urease activity. In addition to their morphological differences, Helicobacter isolates from animals have 16S rRNA and 23S rRNA sequences that are specific to each species. Therefore, the ribosomal sequences can be used for the identification of each Helicobacter species. Analyzing the similarity of the 16S rRNA gene sequences, one of the molecular methods for classifying bacterial species, can be accomplished relatively easily through DNA sequencing. However, morphological and biochemical characterizations are usually necessary to identify Helicobacter species with certainty, because the DNA sequences of ribosomal RNA differs only slightly among Helicobacter species. Isolation by culturing is the gold standard in bacterial detection; however, DNA sequencing of the 16S rRNA and 23S rRNA genes is useful, because such isolation by culturing is difficult for most Helicobacter species. Currently, the genus Helicobacter comprises at least 31 species that inhabit defined sites within their hosts (Table 13.2).10 181
182
Molecular Detection of Foodborne Pathogens
(a) (b)
3.8 µm 2 µm
Figure 13.1 (a) Scanning electron micrograph of Helicobacter pylori (b) and the coccid cells.
Table 13.1 Methods for Detecting Helicobacter Method
Invasiveness
Culture
Invasive Noninvasive Invasive Noninvasive Invasive
Samples Biopsy, tissue Feces Biopsy Expiration Blood
Target
Bacteria Bacteria Urease test Urease UBT Urease ELISA Helicobacter antibodies, CagA antibodies Noninvasive Urine, saliva Helicobacter antibodies Feces Helicobacter ImmunoNoninvasive Urine Helicobacter antibodies chromatograpy Feces Helicobacter PCR Inversive Biopsy, gastric juice Genes for 16S rRNA, 23S rRNA, urease, CagA, etc. Noninvasive Feces, oral cavity Genes for 16S rRNA, 23S rRNA, urease Abbreviations: UBT, urea breath test; ELISA, enzyme-linked immunosorbent assay.
13.1.2 Biology, Pathogenesis, and Medical Importance Helicobacter is a microaerophilic bacterium, and is cultured on medium supplemented with blood and serum because of its high auxotroph. Cyclodextrin may be used as the supplement instead of blood, and brucella broth with cyclodextrin (0.1–1%) is reported to be useful for culturing H. pylori.11,12 However, whether these conditions apply to all Helicobacter species is controversial. Generally, the growth of H. pylori is better on agar than in liquid media. Helicobacter usually colonize in the digestive organs, such as the stomach, liver, and intestinal tract, and they are excreted in feces. H. pylori, which is found in gastric mucosa as a rod-shaped spiral, transforms into a coccoid form in feces (Figure 13.1b). Although isolation by culturing H. pylori from feces has been reported, the coccoid form of H. pylori is very difficult to culture. Consequently, isolating H. pylori by culturing from feces is impractical.13 Nevertheless, some Helicobacter species that colonize in the intestinal tract and liver can be cultured from feces (Table 13.2).
Detection Agent Bacteria Bacteria NH3 13CO , 14CO 2 2 IgG
Reference
IgG Helicobacter antigens IgG Helicobacter antigens DNA
4,9 42,63,85,99,100 27,101,102 28,29,103 104–106 107 108–110 24 111 23,112 40,82,113,114
DNA
42,60,71,80,87,88
As discussed above, however, it is difficult to isolate Helicobacter strains by culturing, and this process requires microbiological expertise. Rapid identification of a Helicobacter bacterium relies on detecting a protein that is specific to the bacterium in question. Gastric Helicobacter, which grow in an acidic environment, produce urease, while most enterohepatic Helicobacter do not (Table 13.2). Thus, urease is not used as a target in the detection of Helicobacter species. Because Helicobacter species other than H. bilis produce catalase, an antibody specific to H. pylori catalase may be useful for species detection and identification. Helicobacter isolated from the stomachs of animals, such as H. mustelae, H. felis, H. heilmannii, and H. acinonychis, are known to be associated with gastritis and gastric cancer, similar to H. pylori. Most of these bacteria have been isolated from lesions associated with gastritis (Table 13.2). However, pathogenetic factors, such as VacA and CagA in H. pylori, have not been found in H. felis.14 In gastric Helicobacter species, as well as H. pylori, the production of urease and flagella is associated with pathogenicity. H. heilmannii15 and H. felis16 have been isolated from humans, as a result of
183
Helicobacter
Table 13.2 Helicobacter Species and Hosts Helicobacter Species H. acinonychis H. anseris H. aurati H. baculiformis H. bilis H. bizzozeronii H. brantae H. canadiensis H. canis H. cetorum H. cholecystus H. cinaedi H. cynogastricus H. equorum H. felis H. fennelliae H. ganmani H. hepaticus H. marmotae H. mastomyrinus H. mesocricetorum H. muridarum H. mustelae H. nemestrinae H. pametensis H. pullorum H. pylori H. rodentium H. salomonis H. trogontum H. typhlonicus
Host Cheetah Goose Hamster Cat, human Mouse, rat, hamster, dog, cat, sheep, fox, human Dog, cat, human Goose Human, goose Dog, cat, human Dolphin, whale Hamster Human, hamster, dog, cat, fox, rat Dog Horse Cat, dog, cheetah, human Human Mouse Mouse Cat, marmot Mouse Hamster Mouse, rat Ferret Macaque Bird, pig, cat Bird Human, nonhuman primate, dog Mouse Dog, human Rat, pig, sheep Mouse
infections that may have been mediated by pets. H. hepaticus, H. canis, H. muridarum, and H. bilis have been isolated from the intestinal tracts and livers of animals. These Helicobacter species are linked with gastroenteritis, inflammatory bowel disease, and hepatitis. These enterohepatic species may be transferred from the intestinal tract to the liver by bacterial translocation. H. cinaedi,17,18 H. fennelliae,19 H. canis,20 and H. pullorum21 have been isolated from patients with diarrhea and gastroenteritis and from immune-compromised patients. In contrast to the wealth of information available for H. pylori, little is known about the infection and pathogenicity of Helicobacter species isolated from nonhuman animals. This argues for the need for further research. Another problem with identifying Helicobacter by culturing is that it usually requires sample collection by invasive procedures. Consequently, methods have been developed for detecting Helicobacter species by PCR using samples that can be collected by noninvasive processes. In this chapter, molecular methods for the detection of Helicobacter species are reviewed.
Urease
Reference
Stomach Feces Stomach Stomach Intestinal tract, liver
Site
+ + + + +
115 116 117 118 119
Stomach Feces Feces Feces Stomach Gallbladder Feces, blood Stomach Feces Stomach Feces Intestinal tract Intestinal tract, liver Intestinal tract, liver Intestinal tract, liver Feces Intestinal tract Stomach, feces Stomach Feces Intestinal tract, liver Stomach Intestinal tract Stomach Intestinal tract Feces
+ – – – + – – + – + – – + + + – + + + – – + – + + –
120 116 121 122 123 124 125 126 127 128 125 129 130 131 132 133 134 135 136 137 21 2 138 139 140 141
13.1.3 Current Technologies for Detection of Helicobacter 13.1.3.1 Immunological Techniques Two immunological methods are currently used to detect H. pylori: the detection of anti-H. pylori antibodies in blood and urine that result from H. pylori infection, and the detection of H. pylori in feces using an anti-H. pylori antibody.9,22 These methods do not require the multi-step sample preparation necessary for PCR detection. Anti-H. pylori antibodies are commercially available for use in the Latex agglutination test and enzyme-linked immunosorbent assay (ELISA). It is important to note, however, that detecting anti-H. pylori antibodies may fail to indicate H. pylori infection, because anti-H. pylori antibodies can persist in the body up to several months after the clearance of H. pylori. H. pylori in feces is detected by ELISA and immunochromatography using a monoclonal or polyclonal antibody against a surface antigen or catalase of H. pylori.23,24 Because these methods are noninvasive, highly sensitive, and specific,
184
commercial kits for detecting H. pylori using them are useful for diagnosing H. pylori infection.25 Even though feces contain a broad variety of bacterial species, commercially available anti-H. pylori antibodies are highly sensitive and specific for the detection of H. pylori. To detect Helicobacter species other than H. pylori, an antibody against the particular Helicobacter species is required. 13.1.3.2 Urea Breath Test (UBT) H. pylori produces urease, which hydrolyzes urea, that results in the production of ammonia. While some bacteria isolated from the oral cavity and stomach have urease activity, the activity of the urease from H. pylori is extremely strong.26 Consequently, urease activity, which can be detected as a pH increase due to ammonia production, has been used for the easy diagnosis of H. pylori infection.27 However, the detection of urease requires biopsies with viable H. pylori obtained by invasive procedures. Therefore, a urease breath test (UBT), which detects urease activity through a noninvasive procedure without endoscopy, was developed.28,29 In this method, 13C-labeled urea taken orally is hydrolyzed into ammonia and CO2 by the urease activity of H. pylori. As a result, 13Clabeled CO2 is absorbed into the body and released from the lungs during exhalation. Infection with H. pylori is diagnosed by measuring the amount of 13C-labeled CO2 in a breath. In the case of a positive result using this method, two possibilities should be considered: the presence of bacteria with urease activity in the oral cavity, and the presence of H. pylori with no urease activity. In fact, UBT is useful for detecting Helicobacter species other than H. pylori that also have urease acitvity.30,31 While an instrument for measuring 13C is required, UBT is generally used for the diagnosis of H. pylori infection, because this test requires no invasive procedures. 13.1.3.3 Molecular Techniques Isolation by culturing is the gold standard for the detection of Helicobacter; however, there are two major problems: the biopsies collected for culturing most Helicobacter require invasive procedures, and culturing Helicobacter is not easy. Skirrow-agar plates including polymyxin B, which are usually for the isolation of H. pylori, cannot be employed to isolate H. pullorum, because this species is susceptible to polymyxin B.32,33 Furthermore, it takes 3–10 days to detect and identify Helicobacter by culturing, although the exact time depends on the growth rate of each species. Some Helicobacter, such as H. heilmannii, has not yet been isolated by culture.34 Thus, 16S rRNA sequences data obtained by a molecular method, in addition to the bacteria’s morphological and biochemical properties, are helpful for identifying bacterial species. An immunological method for detecting H. pylori antigen in feces is commercially available, and it is a noninvasive, simple, and rapid procedure. However, the immunological reaction is specific to each Helicobacter species, so it is difficult to use in the simultaneous testing of multiple Helicobacter. In contrast, UBT can detect not only H. pylori
Molecular Detection of Foodborne Pathogens
but also other Helicobacter that have urease activity; moreover, UBT is applicable not only to humans but also to other animals, as long as it is possible to collect their breath. However, the limits of urease detection have to be defined because of the possible presence of non-Helicobacter bacteria with urease activity.35 On the other hand, molecular methods utilize the genetic information in DNA and can serve to screen simultaneously for different bacterial species. In fact, detection by PCR-based amplification of a target gene is the most general method available. PCR: Although PCR requires information about the nucleotide sequences of the target gene, PCR is able to detect the target rapidly using a small amount of DNA, i.e., a small sample of bacteria. Therefore, PCR is particularly useful for detecting bacteria that are difficult to culture, such as Helicobacter. Although the chromosomal DNA that is the temple for PCR is easily cleaved by physical forces, it is not necessary to take precautions against cleavage, because the size of the target gene is in most cases fewer than 2,000 bp. PCR can be performed on bacterial cells if the sample is confirmed to include a single bacterial strain; moreover, frozen samples as well as paraffin sections can be used. Since most samples are more stable than the biopsies containing viable H. pylori, the sensitivity of this Helicobacter detection method does not depend on how long the sample is stored or how it is transported. The following methods have been developed using PCR for the detection of Helicobacter. How specifically PCR amplifies Helicobacter target DNA depends on the primer sequences that bind to the target gene, as well as on the thermal cycling conditions. The sensitivity of PCR depends on the purity of the DNA sample and the amount of a target gene in the sample. Therefore, sequences of primers and extraction of DNA from a sample are important factors for optimal PCR. DNA extracted from bacterial cells, gastric tissue, gastric juice, dental plaques and feces can be used as a PCR template. Nevertheless, the methods for extracting DNA from gastric juice and dental plaque require further investigation because these samples frequently include PCR inhibitors, and they contain a relatively small amount of H. pylori. Target genes for detecting Helicobacter by PCR include the genes encoding urease [ureA, ureB, and glm (formally ureC)], which are detected in many Helicobacter species, and the genes encoding 16S rRNA and 23S rRNA, which are common to all bacterial species (Table 13.3). The 16S rRNA gene, which is highly conserved, is generally used for detecting bacteria including Helicobacter. Some pathogenetic genes can also serve as target genes, such as the cagA, vacA, and cdt genes. The cdt gene, which is associated with the vacuolation of the liver, differs from the vacA in H. pylori was reported to be specific to enterohepatic Helicobacter including H. hepaticus, H. bilis, H. canis, and H. pullorum.36–38 Consequently, the cdtB gene can be used effectively as the target gene to detect enterohepatic Helicobacter. The properties of PCR methods used to detect Helicobacter species are discussed as follows:
185
Helicobacter
Table 13.3 Target Genes for Detecting Helicobacter Species by PCR Helicobacter
Target Gene
H. pylori
23S rRNA 16S rRNA ureA ureB vacA
H. bilis H. bizzozeronii
H. cetorum H. equorum H. felis
H. heilmannii H. hepaticus
H. muridarum H. pullorum
cagA glmM 16S rRNA 16S rRNA ureB tRNA 16S rRNA 16S rRNA 23S rRNA 16S rRNA ureB tRNA ureB 16S rRNA 16S rRNA cdtB ureAB 16S rRNA 16S rRNA
cdtB H. rodentium H. salomonis
16S rRNA 16S rRNA ureB
H. typlonius Helicobacter spp.
tRNA 16S rRNA 16S rRNA
Accession Number
Reference
U00679 AE001439 (AE001553) AE000511(AE000644) AF507994 M60398 U05676 U29401 L11714 AAD07146 AF252626 U18766 Y09404 AF508003 –* AF292378 DQ307735 DQ307737 AY631948 AY686607 X69080 –* L25079 AF256625 L39122 AF123537 AF066862 AF066863 M80205 AF252624 L36143 L36144 AF123536 AF220065 U96297 AY368266 Y09405 AF508005 AJ130882 –* AF127912 –*
82 142 143 144,145 35 146 146 49 147 98 39 82,144 82,148 39 127 127 39 35 82,148 35 147 98 86 149 39 147 150 81 39 40,144 82,144 82,148 39 40,144
* Nucleotide sequences are available in the indicated references.
Standard PCR: Standard PCR relies on PCR for the amplification of the target gene. The amount of DNA extracted from the cells of Helicobacter bacteria and infected tissues is sufficient to allow easy amplification of the target gene. Therefore, in these cases, standard PCR can be conducted under optimal conditions. In the case of H. pylori, primers for detecting the 23S rRNA gene, which confers clarithromycin resistance, and primers for the pathogenetic genes cagA, vacA, and ureA/B have been designed. Similarly, in the case
of Helicobacter species other than H. pylori, the 16S rRNA and 23S rRNA genes and the gene encoding urease have been used as targets.39,40 When Helicobacter cells are available, colony-direct PCR can provide sufficient DNA to detect the target gene in a single amplification run. When the amplification is poor, conducting a second PCR reaction using the first PCR products as the template is also useful, as long as the possibility of a false positive is taken into consideration. The amplified DNA is analyzed by 1–3% agarose gel electrophoresis.41 Nested PCR: Nested PCR or semi-nested PCR consists of a first PCR reaction using primers with low specificity for a target gene, followed by a second PCR using primers with high specificity for the target gene. Nested PCR can be useful for analyzing DNA extracted from samples containing a small amount of Helicobacter, abundant bacteria other than Helicobacter, or substances that inhibit PCR, such as feces, gastric juice, and dental plaque. Nested PCR can detect the target gene with both high sensitivity and high specificity. Performing two rounds of low-specificity amplification (the first PCR in the nested PCR method) prior to the highspecificity amplification may also be helpful. Because of its high sensitivity, nested PCR can lead to false positives due to contamination during PCR procedures. Thus, the standard PCR is recommended; however, nested PCR is useful when samples containing a relatively small amount of Helicobacter, such as feces, are used. In these cases, a negative control should be performed in parallel to exclude the possibility of false positives. In this work, we use nested PCR in combination with UBT or a stool antigen test to diagnose infection with clarithromycin-resistant H. pylori.42 Multiplex-PCR: Multiplex-PCR is PCR using multiple sets of primers to amplify sequences of different lengths. Using multiplex-PCR, it is possible to amplify a variety of target genes in a single PCR, depending on the species and the presence of multiple genes. Multiplex-PCR is available for detecting and typing Helicobacter species, whereas the determination procedure is complicated. Real-time PCR: Real-time PCR can detect target genes readily and quantitatively. A mutation or SNP can be detected on the basis of differences in amplification rates for different amplicons. Agarose gel electrophoresis is not required to detect target genes, and it is possible to follow the amplification in real-time through the addition of fluorescent dyes that intercalate into double-stranded DNA, or through the use of TaqMan-PCR, which uses a labeling probe. Real-time PCR is useful for detecting mutations that confer clarithromycin resistance in H. pylori, as well as for detecting other Helicobacter species. Real-time PCR requires specific equipment. RT-PCR: PCR detects not only viable bacteria but also dead bacteria because it works at the level of DNA. In contract, it is difficult to detect mRNA from dead bacteria, since mRNA turnover is extremely rapid. Thus, RT-PCR using reverse transcriptase is useful for detecting viable Helicobacter species.43–46 PCR-RFLP: PCR-RFLP is a method for identifying bacteria based on the pattern of restriction fragments generated
186
by incubating PCR-amplified DNA with restriction enzymes. The usefulness of PCR-RFLP has been demonstrated for the detection of clarithromycin-resistant H. pylori based on mutations in the 23S rRNA gene.47 PCR-DGGE: PCR-DGGE uses denaturing gradient gel electrophoresis (DGGE) to analyze the PCR product.48 The gel, which contains a gradient of the DNA-denaturing reagent urea or formamide, can resolve amplicons identical in length but different in nucleotide sequence. The difference in the hydrogen-bounding strengths in A-T and G-C base pairs leads to the separation of fragments with different nucleotide sequences. In addition, amplification fragments containing GC-rich sequences (GC clamps) migrate very slowly because of the strong binding between GC clamps. PCR-DGGE is used to identify bacterial species based on sequence differences in 16S rRNA genes. LAMP: Loop-mediated isothermal amplification is a method for amplifying a target gene at 65oC using four types of primers.49,50 Unlike PCR, LAMP does not require a thermal cycler, and it is possible to amplify a target gene efficiently. The amplified DNA is then detected by agarose gel electrophoresis. A LAMP method targeting the glm gene in H. pylori has been used to detect this H. pylori species.49 Southern hybridization: Hybridization of radiolabeled DNA probes to target DNA has long been used to identify target sequences, and, more recently, a method using nonradio labeled probes has been developed.41 The same target gene as for PCR can be used as the DNA probe. Thus, the DNA probe is prepared using PCR. Southern and colony hybridizations can be applied as methods to detect Helicobacter species. Because the hybridizations require complicated procedures, PCR is usually preferred for its ease and high sensitivity. Nevertheless, fluorescence in situ hybridization (FISH) may be useful for detecting Helicobacter species in formalin-fixed samples.51–54
13.2 Methods 13.2.1 Reagents, Supplies, and Equipment The reagents, supplies, and equipment used to detect Helicobacter are listed in Table 13.4. When samples are collected and handled, the risk of infection with Helicobacter has to be considered. Thus, the samples should be handled in a safety cabinet until the extraction of DNA is complete. Certain molecular biology supplies, such as tips and tubes, should be autoclaved before use. To avoid contamination, the PCR tubes should be handled using forceps and not with bare hands. It is recommended that the preparation for PCR also be performed in the safety cabinet to avoid aerosol contamination. Sterilized, ultra-pure water should be used for PCR. Because many formulations of Taq polymerase are commercially available with different characteristics, the most suitable type should be selected for the particular detection method. For example, in cases of detection using cultured bacterial cells, such as colony-direct PCR, premixed PCR reagents are sufficient. In cases of detection using
Molecular Detection of Foodborne Pathogens
Table 13.4 Reagents, Supplies, and Equipment in the Present Works Materials
Reference
Reagent Highly purified H2O Taq polymerase PCR buffer dNTP mixture BSA LAMP kit Oligonucleotides for primers TAE buffer Agarose Molecular marker 100-bp ladder DNA extraction kit for tissues DNA extraction kit for feces DNA purification kit Supplies Pipette tips
Plastic microtube for PCR Plastic microtube Storage tube (for extraction of DNA) Pipetter
Equipment Microcentrifuge (at up to 15,000 rpm) Tabletop microcentrifuge (at up to 3,000 rpm) Agarose electrophoresis UV transilluminator Thermal cycler Grinder
42,57,74,75,79,82,85,87,151 82,87 75 49 82 41,74,79,82,88,114 82 79,82,152 87 49,74,113
2 µl 20 µl 1000 ml 250 µl 2 ml 2 ml
42
1000 µl 200 µl 100 µl 20 µl 2 µl
48,74,80 74,82 72,85,113 42,83
samples such as gastric tissue, gastric juice, and feces, the use of Taq polymerase with high amplification efficiency is recommended. To reduce the emergence of unwanted amplification fragments, Taq polymerase containing an antibody (“hot-start” formulation) may be useful. The activity of this type of Taq polymerase is inhibited by the binding of the antibody at room temperature, so that false-positive reactions due to the partial annealing of DNA with primers are prevented. Once a heat-shock treatment occurs in a DNA-denaturing procedure, the antibody is inactivated by heating, and the Taq polymerase begins to work. This helps to ensure that
Helicobacter
only DNA that specifically anneals with primers is used as the template. The hot-start type of Taq polymerase is relatively stable at high temperatures. When detecting differences in the 16S rRNA genes in order to identify bacterial species, high fidelity Taq polymerase is recommended. The reaction buffer provided with Taq polymerase is generally optimal. Oligonucleotide primers can be obtained commercially. Bovine serum albumin (BSA) at the levels recommended for restriction enzymes and PCR should be used. A low-speed microcentrifuge is useful for collecting drops in a tube. The pipetter used for PCR should be kept separate from other pipetters. Since the time necessary to maintain a constant temperature is different for each thermal cycler, the times for denaturing, annealing, and extension should be determined specifically. The equipment for electrophoresis of the PCR-DGGE samples is available commercially.
13.2.2 Sample Collection and Preparation Biopsies, feces, gastric juices, and dental plaque can be used as samples for the detection of Helicobacter species. The use of endoscopy to biopsy tissue and collect gastric juice samples is invasive for patients, but dental plaque and feces can easily be collected without endoscopy. Cultures. As with cultures of most bacteria, DNA can easily be extracted from Helicobacter cultures. Classical phenol-chloroform extraction, boiling, and commercial kits for DNA extraction are available for obtaining sufficient DNA for PCR.55 Mixed infection with clarithromycin-resistant and -susceptible H. pylori has been reported previously.42,56 Therefore, it is possible for a stomach to contain different strains. For the screening of different H. pylori strains without the extraction of DNA, colony-direct PCR can be used to amplify target DNA. While it is convenient to add bacterial cells directly by using a sterilized toothpick to a tube containing PCR mixture, care should be taken to not add too many cells in one tube, which may potentially lead to the inhibition of PCR amplification. Thus, it is recommended that 1 μl of cell suspension, which is prepared by transfering the bacterial cells from one colony to 100 μl of sterilized water, be added to the PCR mixture. Biopsy. Endoscopy is used to biopsy the gastric mucosa of Helicobacter-colonized stomachs. Stomach, intestinal tract, and liver tissues obtained surgically are also used. In the case of small animals in which endoscopy is difficult, surgical resection or slaughter is required to obtain samples. The biopsies and tissues so obtained are used for detection by culturing, urease test, or PCR. For culturing, biopsies are crushed using a mortar or some other tool, and the samples are spread on a plate for the selection of Helicobacter species. Because these samples contain few substances that inhibit PCR, extracting DNA from biopsies and tissues to use in PCR is simple; these sources can be subjected to classical phenolchloroform extraction, boiling, or commercial-kit-based extractions to obtain sufficient DNA of adequate quality for PCR. A crushing-by-beads method is also available for DNA
187
extraction from biopsies. Frozen biopsies and tissues are also suitable for extracting DNA for use in PCR. Gastric juice. DNA extracted from gastric juice obtained by endoscopy and a string device may be used as the template for PCR.57–60 Gastric juice can be frozen until use. Gastric juice is centrifuged, and DNA is extracted from the resuspended pellet by classical phenol-chloroform extraction and boiling, in a manner similar to DNA extraction from tissue biopsies.57 Commercial kits for DNA extraction from gastric juice are also available.57,58 Feces. Feces can be obtained noninvasively from infants and small animals, for which endoscopy is difficult. Thus, feces are useful as samples for the detection of Helicobacter species. In contrast to blood and tissues, however, feces include abundant bacteria, host-derived cells such as leukocytes, and substances that inhibit PCR. As a result, the extraction of DNA from feces must be done with care to ensure the purity of the isolated DNA and to minimize contamination with substances that inhibit PCR. DNA is extracted from feces mainly through chemical methods using commercial kits, or a physical method using a cell crusher.61 Though commercial kits are easy to use and require no special instruments,62–64 DNA extraction by commercial kits is readily affected by the chemical reagents and enzymes that are used for cell lysis and for the subsequent extraction and purification of DNA. This means that, when the amount of Helicobacter DNA in the feces is small, commercial extraction kits may not provide sufficient DNA for PCR.42 To reduce this problem, a method for removing substances that inhibit PCR using an antibody against H. pylori has been developed.65 As an alternative to chemical extraction, physical methods for crushing cells in feces using beads have been developed (Figure 13.2).42,66 These methods have been used to extract DNA from microbes, including spores and mycelium, from soil.67 In these studies, approximately 50 mg of feces were added to a tube containing three types of beads of different sizes [250 mg of silica powder (63–210 µm), 32.5 mg of ceramic beads (1–2 mm), and 75 mg of glass beads], 980 µl of sodium phosphate buffer, and 180 µl of 7.5 M guanidine solution containing 5% sarcosine. Then, the suspensions were homogenized for 20–30 sec in the homogenizer. Because of the amount of debris in feces, the binding of DNA to glass beads is negligible. Following the removal of residual cells by centrifugation, DNA is purified using a commercial kit designed to purify DNA for PCR. This method usually yields 1–25 µg of DNA from 50 mg of feces. The condition of the feces affects the amount of DNA obtained; diarrheal samples, for example, often do not yield sufficient DNA. Purified DNA can be stored at –20oC for at least 1 year. In fact, it has been reported that DNA suitable for PCR amplification can be obtained from 6-yearold feces stored at –80oC.42 In a study in which controlled amounts of H. pylori were artificially added to feces, the PCR-based method was found to be capable of detecting H. pylori in feces containing ≥10 cells/50 mg of feces. The “stool crushing-by-beads” method requires a specific type of homogenizer, which can be used in the extraction of not
188
Molecular Detection of Foodborne Pathogens
Step 1: Lysis of bacteria cells in stools Beads
Stools 50 mg
Crushing 20 sec
Tube 5% Sarcosine 7.5M Guanidine
Step 2 : Extraction and purification of DNA Purification
Centrifugation
DNA H2O
Supernatant Wash
(Salt precipitation)
Figure 13.2 Isolation of Helicobacter pylori DNA from feces using the crush-by-beads method.
only DNA but also RNA and proteins, and several manufacturers sell the required type of homogenizer.68 This method can also be used to extract of DNA from tissue. Plaque. Helicobacter species have been detected in human and dog oral cavities.69 In this method, dental plaque, tongue plaque, or saliva is collected with sterile cotton swabs. The collected plaque is suspended in sterilized water and washed by centrifugation and resuspension. A portion of the cell suspension is used for culturing and the remaining suspension is boiled and used as a template in PCR.70 A commercial kit for DNA extraction from tissue can also be used to extract DNA from plaque.71 In theory at least, DNA can be extracted from fixed gastric tissue sections and checked by PCR for the presence of H. pylori.72
13.2.3 Detection Procedures Primers, target genes, and conditions for the detection of H. pylori by PCR are shown in Table 13.5. The conditions for the detection of Helicobacter other than H. pylori are summarized in Table 13.6. The annealing temperature in PCR depends on the designed primers, so these data are also presented in Tables 13.5 and 13.6. Conditions such as temperature, number of cycles, and the composition of the reaction solution for PCR depend on the Taq polymerase used. For example, Taq polymerase with an antibody (“hot-start type”) requires at least 30 cycles, because this type of Taq polymerase is fully
activated by heat only after several cycles. Alternatively, hotstart PCR can be performed by adding Taq polymerase after the denaturation at 94–95˚C and annealing at 60˚C in order to prevent nonspecific reactions due to mismatched bindings of primers at low temperatures.73 In the case of samples such as feces and plaques, which include substances that inhibit PCR, the addition of BSA at a final concentration of 0.4– 0.5% increases the amplification efficiency.74,75 Helicobacter pylori. Since many studies have reported an association of H. pylori infection with peptic ulcers and gastric cancer, numerous methods for the diagnosis of H. pylori infection have been developed. Because they do not require invasive procedures or special equipment, UBT and the ELISA method for detecting H. pylori in feces are generally preferred over molecular methods for the diagnosis of infection with H. pylori. A molecular method using PCR is employed for detecting the mutation in 23S rRNA responsible for clarithromycin resistance and the presence of pathogenetic genes such as cagA and vacA.76,77 In particular, typing of the cagA gene is used in the analysis of H. pyloriassociated gastric cancer, because a specific type of CagA has been demonstrated to be associated with gastric cancer. Since H. pylori has only one copy of the glm gene, this gene can be used as a housekeeping gene to determine the quantity of the target gene.78 Methods for the detection of H. pylori have been presented in detail in the review by Megraud and Lehours.9
Semi-nested PCR
Semi-nested PCR
Semi-nested PCR
PCR
Method
ATTCCCATTAGCAGTGCT
CEF-4
TAGGAAGTGTGAGCCGATTTG
A-2R
GTCGGTTAAATACCGACCTG AGTGGAGGTGAAAATTCC TAAGAGCCAAAGCCCTTA
GGATAAGCTTTTAGGGGTGTTAGGGG GCTTACTTTCTAACACTAACGCGC ATAATGCTAAATTAGACAACTTGAG AGAAACAAAAGCAATACGATCATTC ATATTATGGAAGAAGCGAGAGC CATGAAGTGGGTATTGAAGC
GlmMF GlmMR CagAF CagAR A-2F2 A-2F3
HP4 CRF-4 RR-1
AACGATGAAGCTTCTAGCTTGTAG GTGCTTATTCSTNAGATACCGTCAT
HeliF HeliR
CCACAGCGATGTGGTCTCAG TGTGTAGCTACCCAGCGATGCTC
GTAGGTCCTGCTACTGAAGCCTTA ATGGAAATACAACAAACACAC CTGCTTGAATGCGCCAAAC GGCCCCAATGCAGTCATGGAT GCTGTTAGTGCCTAAAGAAGCAT GGAGCCCCAGGAAACATTG CATAACTAGCGCCTTGCAC GGCAATGGTGGTCCTGGAGCTAGGC GGAAATCTTTAATCTCAGTTCGG ACATTTTGGCTAAATAAACGCTG CCAACGTGCGTAAAAGGGAATTAG GTTAARAATRGTGTRAAYGG TTTAGCTTCTGATACCGC
ureB-R VA1-F VA1-R VAm-F3 VAm-R3 VA4-F VA4-R cagA5 cagA2 Lunil 1 R5280 cagA2530S cagA3000AS
HP1 HP2
TGGGATTAGCGAGTATG CCCATTTGACTCAATG AATGCAGAAATATCAC ACTTTATTGGCTGGTTT CGTCCGGCAATAGCTGCCATAGT
HPU54 HPU18 HPU55 HPU17 ureB-F
Primer Sequence (5’–3’)
GCCAATGGTAAATTAGTT CTCCTTAATTGTTTTTAC
HPU1 HPU2
Primer
Table 13.5 PCR Protocols to Detect Helicobacter Pylori Target
cagA (5’-end) cagPAI Empty site cagA
324 bp 550 bp
68 bp
783 bp 135 bp
993 bp
204 bp
23S rRNA
23S rRNA
ureA
cagA
128 bp 314 bp
glmM
294 bp
339 bp
16S rRNA
vacA m2
352 bp
370–670 bp
vacA m1b
290 bp
ureB
464 bp vacA s1/s2
ureB
115 bp
259 bp
ureB
ureA
132 bp
411 bp
Product
Reaction
94oC30s,50oC30s,72oC1m) × 20
94oC30s,50oC30s,72oC1m) × 30 2nd (CRF-4/CRR-1):
(95oC45s,65oC45s,72oC45s) × 30,72oC4m 2nd (HP4/HP2):described above 1st (CRF-4/CRR-1):
(94oC1m,55oC1m,72oC1m) × 20 1st (HP1/HP2): 95oC2m.
94oC1m,55oC1m,72oC1m) × 30 2nd (A-2F3/A-2R):
1st (A2F2/A-2R):
(94oC30s,55oC30s,72oC3m) × 40,72oC5m
(94oC30s,50oC45s,72oC45s) × 35,72oC5m 95oC5m,
94oC5m,
(94oC1m,55oC1m,72oC1m) × 35
(94oC1m,45oC1m,72oC1m) × 35, 72oC5m
95oC5m,
Year
2005 1998
2003
1998 1996
2007 1999
2007
2005
1992
(Continued)
62 152
63
60 156
154 155
113
57
153
Reference
Helicobacter 189
CCTGARACCGTTCCTACAGC CACAGCCACTTTCAATAACGA CGTCAAAATAATTCCAAGGG GTGGATGCYCATACRGCTWA RTGAGCTTGTTGATATTGAC TTGACCAACAACCACAAACCGAAG CTTCCCTTAATTGCGAGATTCC TAGATACGGCTAATGGCG ACTAGCCTGTCAGCATCG GTTACACCCGTTAGGCTCATCACCG GTCGTTTTTAGCGAG ATCAATGCGGGGCTTTACACGCAAA GCCTAAATCTGCG
VA1XR (-) HPMGF (+) HPMGR (–) MF1 (+) MR1 (+) cagAF (+) cagAR (–) lm-F3 glm-R3 lm-FIP
glm-BIP
ATGGAAATACAACAAACACA CTGCTTGAATGCGCCAAAC
VA1F (+) VA1R (–)
AGGATGCGTCAGTCGCAAGAT CCTGTGGATAACACAGGCCAGT
Hp23S 1942F Hp23S 2308R
Primer Sequence (5’–3’)
GGTCTCAGCAAAGAGTCCCT CCCACCAAGCATTGTCCT
Primer
Hp23S 1835F H23S 2327R
107/182 bp
176/203 bp
401/475 bp
259/286 bp
367 bp
493 bp
Product
Target
glmM (ureC)
cagA
vacA m region
vacA s region
23S rRNA
Reaction
63oC60m,80oC2m
(95oC1m,50oC1m,74oC1m) × 40,74oC5m
95oC2m,(94oC10s,63oC20) × 24 95oC2m,
(94oC15s,57oC15s,72oC20s) × 30 2nd (Hp23S 1942F/Hp23S 2308R):
95oC2m,(94oC30s,57oC30s,72Co30s) × 5,
1st (Hp23S1835F/Hp23S2327R):
Notes: C, temperature in °C; m, minutes; s, seconds; ( ) ×, (reaction condition) and cycle; N=A/T/C/G, B=C/G/T, D=A/G/T, R=A/G, S=G/C, W=A/T, Y=C/T. Abbreviations: LAMP, loop-mediated isothermal amplification; DGGE, denaturing gradient gel electrophoresis.
LAMP
PCR LiPA
Nested PCR
Method
Table 13.5 (Continued) Year
2006
1998
2006
49
146
42
Reference
190 Molecular Detection of Foodborne Pathogens
ATTCCACCTACCTCTCCCA TCTCCCATACTCTAGAAAAGT GCTTAACACATGCAAGTCGAA AGGCCCGGGAACCTATTCAC TATGACGGGTATCCGGC
ATTCCACCTACCTCTCCCA GCTATGACGGGTATCC
GATTTTACCCCTACACCA ACTTCACCCCAGTCGCTG GGGCGATAAAGTGCGCTTG
CTGGTCAATGAGAGCAGG GGAATTCCAGATCTATGAAA AAGATTAGCAGAAAAG GGAATTCGTCGACCTAGAA AATGCTAAAGAGTTG ATGAAACTAACGCCTAAAGAA CTAG GGAGAGATAAAGTGAATATGC GT GCTATGACGGGTATCC
ACTTCACCCCAGTCGCTG GTTATGTGCCTCTTAGTTTG AGAGTTCTCAGCATAACCT TGCGTAGGCGGGGTTGTAAG
CAGAGTTGTAGTTTCAAATGC
TTGGGAGGCTTTGTCTTTCCA
H676r Hbr g2 p13B F
R C97 forward
C98 reverse C05 reverse Hheilmannii F
Hheilmannii R Hpylori F
C97
C05 HceF HceR CAR577f
CAR636r
V832f
PCR
PCR
PCR
PCR
PCR
Hfelis R
Hfelis F
Hpylori R
CTGTTTTCAAGCTCCCC CTATGACGGGTATCCGGC
B39 H276f
PCR
Primer Sequence (5’–3’)
GCATTTGAAACTGTTACTCTG
Primer
B38
PCR
Method
Table 13.6 PCR to Detect Helicobacter Species
456 bp
78 bp
1,022 bp
1,200 bp
1,150 bp
1,707 bp
1,219 bp 580 bp
422 bp
375 bp
1.3 kb
374 bp
417 bp
Product
16S rRNA
16S rRNA
16S rRNA
ureB
ureB
ureB
16S rRNA
16S rRNA
16S rRNA
16S rRNA
Target Gene
H. bizzozeronii, H. salomonis H. suis
H. felis
H. cetorum
Helicobacter species
H. felis
H. pylori
H. heilmannii
Helicobacter species
Helicobacter species
H. bilis Bacteria
Helicobacter species
H. hepaticus
Target Bacteria
Samples
Reactions 94oC4m, (94oC60s,61oC135s,72oC150s) × 35, 72oC7m
94oC4m, (94oC1m,58oC2m,72oC3m) × 35, 72oC8m
94oC3m,57oC2m,72oC3m, (94oC30s,57oC30s,72oC1m) × 31, 72oC5m
94oC4m,55C, (94oC1m,55oC150s,72oC3m) × 30–40
94oC30s, (94oC2s,53oC2s,72oC30s) × 45
95oC3m, (94oC30s,60oC30s,72oC45s) × 40, 72oC5m
Culture, tissues 95oC3m, (94oC30s,60oC30s,72oC45s) × 35, 72oC5m
Feces
Gastric biospy
Tissue, bile
Feces
Culture, tissues 94oC5m, (94oC2s,53oC2s,72oC30s) × 35
Culture, feces
2004
2003
1998
1998
1997
1996
1995
Year
(Continued)
82
151
35
40
157
114
88
Reference
Helicobacter 191
GTTTGATGCGGAAGTTGTCG CAYGAYTGCACCACTTATGG TGRATTTTAAARCCAATSGC TGCGTAGGCGGGGTTGTAAG
CAGAGTTGTAGTTTCAAATGC
AGAGCGTGTAGGCGGAATGAT CGAGGAGACAAGCCCCCCGA GATTAGCTCTGCCTCGCGGCT
TTGGGAGGCTTTGTCTTTCCA GTGGAGTACAAGACCCGGGAA
CCAAGGGCTATGACGGGTGTAT CC TCTGGACTGAAGCCGGGGG
ACTTCCATCAGTTGGCTCACC CTATGACGGGTATCCGGC
ATTCCACCTACCTCTCCCA GTNGCNACBTGGAAYCTNCA
RGG DACNGGRAARTGRTC CTCCTAAGCCCACCAGAAATTG
CTTATCGCAGTCTAGTACG TTCCCCATAATAGGGTAGTTTA
UnR UvF UwR CAR577f
CAR636r
R574f R832r V1261r
V832f REVERS
HELIP2
EqF
EqR H276f
H676r VAT2
DHF1 Gan-F
16-23SR Gan-R
PCR
PCR
PCR
Semi-nested PCR
PCR
PCR
CGGATTTGATGCAAGAAGGC
UmF
Primer Sequence (5’–3’)
GATTAGCTCTGCCTCGCGGCT
Primer
V1261r
Method
Table 13.6 (Continued)
714 bp
400 bp
1,074 bp
1,107 bp
16S–23S rDNA internal spacer region
cdtB
16S rRNA
23S rRNA
H. ganmani
H. pullorum
Helicobacter species
H. equorum
Helicobacter species
Candidantus H. suis
433 bp
H. bizzozeronii, H. salomonis, H. felis
H. felis
H. felis
Target Bacteria
H. bovis
16S rRNA
16S rRNA
ure
ure
Target Gene
259 bp
78 bp
563 bp
1,770 bp
Product
Tissues
Culture
Tissues
Feces
Feces, culture
Paraffinembedded gastric biopsy specimen
Samples
94oC2m, (94oC30s,48oC30s,72oC30s) × 30, 72oC7m
94oC5m, (94oC1m,42oC2m,72oC3m) × 35, 72oC8m
95oC5m, (94oC1m,53oC1m,72oC1m) × 35, 72oC5m
94oC5m, (94oC10s,68oC40s,72oC90s) × 40, 72oC5m
94oC5m, (94oC2m,65oC1m,72oC1m) × 30, 72oC10m
95oC9m, (94oC45s,52oC45s,72oC45s) × 50, 72oC10m
95oC5m, (94oC1m,52oC1m,72oC1m) × 35, 72oC7m
Reactions
2004
2006
2007
2007
2006
2005
Year
80
89
79
87
158
72
Reference
192 Molecular Detection of Foodborne Pathogens
TaqMan PCR
Multiplex PCR
Multiplex PCR
RFLPPCR(AluI)
Nested PCR
CGTGGAGGATGAAGGTTTTA
AATTCCACCTACCTCTCCC GGGCGATAAAGTGCGCTTG
CTGGTCAATGAGAGCAGG AGGTCGCGGGTTCGAATCC
ACCAACTGGGCTAAGCGACC AACCAAYAGCCCCAGCAGCC TGGTTTTAAGGTTCCAGCGC TTTGGTGCTCACTAACGCCCTC TTCAATCTGATCGCGTAAAG TTGGGAGGCTTTGTCTTTCCA
GATTAGCTCTGCCTCGCGGCT TTGTGAAATGGAGCAAATCTT
2nd HelF
HelR2 F
R T3B(TET)
HT135R Bi1F(HEX) Bi2R Fe1F(NED) Fe3r V832f(NED)
V1261r 1201f
cdtBF
p30r
p30f
p25r
p25f
p17r
262r p17f
AAAAACT TAGCCAGTTTGGCATTCC AGGGACTCTTAAATATGCTCCT AGAGT ATTCATCGTGTTTGAATGCGTC AAATGGAACAGATAAAGATTT TAAAGCAACTTCAG CTATGCAAGTTGTGCGTTAAGC AT ATGGGTAAGAAAATAGCAAAA AGATTGCAA CTATTTCATATCCATAAGCTCTT GAGAATC ATGACAAAAAAATATTCTTTCA CAAAACTATTCATTGGT TTTATTTTAGATTCCATTTAACT GCTAAATCATCAATAGT CCGCAAATTGCAGCAATACTT
GATTTTACCCCTACACCA
C98
1375r 163f
GCTATGACGGGTATCC
1st C97
16S rRNA
447 bp
81 bp
807 bp
705 bp
435 bp
122 bp
cdtB
16S rRNA
ureB
434 bp
191 bp
ureB
tRNA
ureB
16S rRNA
373 bp
134–137 bp
580 bp
251 bp
398 bp
H. hepaticus
H. muridarum
H. hepaticus
H. bilis
H. typhlonius
H. rodentium
Candidantus H.suis
H.felis
H.bizzozeronii
H.salomonis, H.bizzozeronii, H.felis
H. heilmannii
Helicobacter species
Culture, tissues, feces
Culture, feces, tissues
Culture, tissues
Gastric biospy
Oral cavity, biopsy
50oC2m,95oC10m, (95oC15s,60oC60s) × 45
(94oC1m,55oC1m,72oC1m) × 30
95oC5m, (94oC1m,58oC1m,72oC1m) × 3, (94oC1m,60oC1m,72oC1m) × 35, 72oC7m
94oC3m,57oC2m,72oC3m, (94oC30s,57oC30s,72oC1m) × 30, 94oC20s,57oC20s,72oC5m
94oC5m, (94oC30s,57oC30s,72oC30s) × 35, 72oC7m
94oC5m, (94oC30s,57oC30s,72oC30s) × 40, 72oC7m
2001
2005
2004
1998
1998
2007
(Continued)
86
85
82
83
40
71
Helicobacter 193
Primer
Primer Sequence (5’–3’)
∼1,200 bp
GCGGCCGCCCGTCCCGCCG
CCCCCGCCCCGCCGCGGCC GCCTATGACGGGTATCCGGC TCGCCTTCGCAATGAGTTT GCTATGACGGGTATCC
ACTTCACCCCAGTCGCTG GAATAGACGGGGACCC
CGCCCGCCGCGCCCCGCGC CCGTCCCGCCGCCCCCGCC CGGGGTTGCGCTCGTTGC
1F-GC
2R(667–686) C97(1st)
C05(1st) BSF917
BSR1114GC
∼200 bp
∼470 bp
CTCACGACACGAGCTGAC
1R(1018–1035)
∼780 bp
200 bp
Product
1F(254–271)
AATATACGCGCACACCTCTCA TCTGACCAT CACCTGTGCATTTTGGACGA ACCAAGGCWATGACGGGTATC
CGGAGTTAGCCGGTGCTTATT FAM-AACCTTCATCCTCCACGC GGC-TAMRA CTATGACGGGTATCCGGC
R FAM
cdtBR F
cdtBP
16S rRNA (V3 region)
16S rRNA
16S rRNS
16S rRNA
Target Gene
Helicobacter species
Helicobacter species
Helicobacter species
Target Bacteria
Feces, tissues
Feces
Gastric biospy, feces
Samples
94oC10m, (94oC30s,50oC30s,72oC30s) × 35, 72oC5m
94oC4m, (94oC1m,50oC1m,72oC2m) × 30, 72oC5m
95oC10m, (94oC30s,55oC30s,72oC30s) × 35, 72oC5m
94oC2m, (94oC30s,55oC30s,72oC30s) × 30, 72oC5m
50oC2m,95oC10m, (95oC15s,60oC1m) × 40
Reactions
1993
2004 1998
2006
2003
2004
Year
48
80 40
81
74
75
Reference
Abbreviations: cdtB, cytolethal distending toxin B; ure, urease; FAM, 6-carboxyfluorescein; TAMRA, 6-carboxytetramethylrhodamine; LAMP, loop-mediated isothermal amplification; DGGE, denaturing gradient gel electrophoresis; °C, temperature in Celsius; m, minutes; s, seconds; ( ) ×, (reaction condition) and cycle; N=A/T/C/G, B=C/G/T, D=A/G/T, R=A/G, S=G/C, W=A/T, Y=C/T.
PCR-DGGE (nested PCR)
PCR-DGGE (Seminested PCR)
Quantitative PCR
Method
Table 13.6 (Continued)
194 Molecular Detection of Foodborne Pathogens
195
Helicobacter
Helicobacter genus. The set of primers (C97/C05) designed by Fox et al. and the primers adjacent to C97/ C05, which target the 16S rRNA gene, are frequently used.40 Gastric biopsies, feces, and tissues from the liver, gallbladder, intestinal tract, and oral cavity are used as samples. While standard PCR is enough to amplify the 16S rRNA gene when DNA is obtained from cultures and tissues, the amplification of DNA from feces and the oral cavity by standard PCR is usually difficult. In fact, because the amount of Helicobacter is not constant in samples from feces or the oral cavity, nested PCR had been demonstrated to be suitable for the detection of Helicobacter in these cases.71 Prachasilpchai et al. showed that there is no significant difference in the sensitivity of a histological test and of PCR for the detection of Helicobacter spp. in tissues from canine stomachs.79 Gastric Helicobacter. In animals, several Helicobacter species with host specificity have been isolated. For example, H. heilmannii—formerly “Gastrospirillum hominis,” H. felis, H. bizzozeronii, H.salomonis, H. bovis, and Candidatus H. suis have been isolated from stomachs. PCR methods targeting these Helicobacter species have been developed. The 16S rRNA gene can be analyzed for the identification of Helicobacter species by using primers designed for the region that is specific to each Helicobacter. However, the region suitable for primers is limited. Consequently, identification by sequencing of the 16S rRNA gene and by PCR-DGGE has been performed using a primer that is designed to recognize a sequence common to Helicobacter species.40,74,80,81 Culture of H. heilmannii (type II) is particularly difficult to analyze biochemically. Therefore, the detection and identification of H. heilmannii have been performed by genetic analysis using PCR.35,82 In this way, the presence of H. heilmannii in humans, cats, dogs, and pigs has been demonstrated.83,84 Furthermore, RFLP analysis of the ureB fragment obtained by PCR may be informative for identification if an appropriate restriction enzyme site for the discrimination of species is present.83 In addition to the 16S rRNA gene, the ureB gene is also available as a target gene for the identification of H. heilmannii, H. felis, H. pylori, and H. bizzozeronii.35 For the detection of H. salomonis, H. bizzozeronii, and H. felis, a tRNA gene is useful as a target gene.82 Multiplex-PCR with combinations of primers for the tRNA, 16S rRNA, and ureB genes makes it possible to identify each of these three Helicobacter species.82 Enterohepatic Helicobacter. Primers have been designed for the detection of Helicobacter species such as H. hepaticus, H. cetorum, H. equorum, H. ganmani, H. rodentium, H. typhlonicus, H. bilis, and H. muridarum in the intestinal tract and liver.80,85–88 Since these Helicobacter species lack urease activity, the major target gene is the 16S rRNA gene. Shames et al. demonstrated that including 3.0 mM MgCl2 in the PCR mixture is better than 1.5 mM MgCl2 for amplifying a clear, single band for the detection of H. hepaticus from mouse feces.88 In the case of H. hepaticus, H. cetorum, H. rodentium, H. typhlonicus, H. bilis, and H. muridarum, the set of primers targeting the 16S rRNA gene for the specific
detection of each Helicobacter species have been used successfully in multiplex-PCR.85 For the case of H. equorum, specific primers targeting the 23S rRNA gene have been developed,87 while primers targeting the internal spacer region between the 16S and 23S rRNA genes have been reported for the identification of H. ganmani.80 The cdt gene, which is a pathogenetic gene present in some enterohepatic Helicobacter such as H. hepaticus and H. pullorum, has been reported to be useful for the detection of these Helicobacter species;89 moreover, TaqMan PCR for the cdt gene has been shown to be suitable for the rapid detection of H. hepaticus.86
13.3 Conclusions and Future Perspectives Isolating bacteria is necessary for investigating the microbial characteristics and pathogenesis of Helicobacter species. Molecular methods allow the detection of Helicobacter, but they do not lead to the isolation of viable bacteria. Culturing, which is the gold standard in the detection of Helicobacter species, requires media, culture conditions, and sample types that must be optimized for each Helicobacter species. Several challenges remain in developing appropriate media and methods for culturing Helicobacter species. Previously, the presence of spiral bacteria other than H. pylori was detected histologically.15,90,91 For the detection of these bacteria, sequences of the 16S rRNA genes obtained from PCR are important for identifying bacteria that are difficult to culture, such as H. heilmannii.34,92 Furthermore, PCR-based methods will be useful for the detection and identification of novel Helicobacter discovered in the future. Immunoassay methods, including immunochromatography and ELISA, are easy and rapid procedures, and their use in the diagnosis of H. pylori infection is expected to increase. Nevertheless, these methods are less useful for detecting Helicobacter species other than H. pylori. Immunological detection of these other species requires commercially available antibodies specific for each Helicobacter species. With the amount of genomic information continuing to rise rapidly, however, genes specific to each Helicobacter species can be identified. This will allow the design of primers and probes for use in PCR for the simultaneous detection and subtyping of the bacteria. In H. pylori, differences in pathogenic genes such as the cagA and vacA genes have been reported to cause strain-specific differences in the pathogenicities of peptic ulcer and gastric cancer. Consequently, typing of the cagA gene may be useful for investigating the relationship between H. pylori infection and gastric cancer. Through the detection of mutations that confer antimicrobial resistance, it is possible to predict the resistance phenotype based on DNA sequencing.47 However, DNA sequencing requires complicated procedures. Although RFLP is simpler than DNA sequencing, a restriction enzyme that recognizes the mutation is required. DGGE is used for identifying Helicobacter species based on sequence differences among DNA amplicons, such as the amplicon for the 16S rRNA gene.80,81 If these methods prove applicable to
196
the analysis of pathogenetic genes, they may be useful for diagnosing pathogenesis, as well as for indentifying the species responsible. In addition, two new techniques have been developed for SNP analysis: the PCR Line Probe assay uses PCR and reverse hybridization, and real-time PCR uses probes labeled with fluorescent dyes.93,94 In addition to detecting SNPs, realtime PCR can rapidly detect both the presence and expression level of the target gene.95–97 In this way, real-time PCR can be used to perform phenotypic analyses, such as an analysis of the levels of pathogenesis in bacteria. Microarray analysis can also reveal information about changes in the expression levels of genes in Helicobacter species.98 These and other methods will continue to be developed as effective tools for examining target genes in Helicobacter infections.
References
1. Marshall, B.J., and Warren, J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311, 1984. 2. Goodwin, C.S., and Armstrong, J. A. Microbiological aspects of Helicobacter pylori (Campylobacter pylori). Eur. J. Clin. Microbiol. Infect. Dis. 9, 1, 1990. 3. Dunn, B.E., Cohen, H., and Blaser, M.J. Helicobacter pylori. Clin. Microbiol. Rev. 10, 720, 1997. 4. Solnick, J.V., and Schauer, D.B. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin. Microbiol. Rev. 14, 59, 2001. 5. Eaton, K.A. et al. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect. Immun. 59, 2470, 1991. 6. Huang, J.Q. et al. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114, 1169, 1998. 7. NIH ConsensusConference NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 272, 65, 1994. 8. Zucca, E. et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N. Engl. J. Med. 338, 804, 1998. 9. Megraud, F., and Lehours, P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin. Microbiol. Rev. 20, 280, 2007. 10. Euzeby, J.P. List of prokaryotic names with standing in nomenclature. Genus Helicobacter http://www.bacterio.cict. fr/h/helicobacter.html, accessed date 10 February 2009. 11. Fawcett, P.T., Gibney, K.M., and Vinette, K.M. Helicobacter pylori can be induced to assume the morphology of Helicobacter heilmannii. J. Clin. Microbiol. 37, 1045, 1999. 12. Taneera, J. et al. Influence of activated charcoal, porcine gastric mucin and beta-cyclodextrin on the morphology and growth of intestinal and gastric Helicobacter spp. Microbiology 148, 677, 2002. 13. Mizoguchi, H. et al. Diversity in protein synthesis and viability of Helicobacter pylori coccoid forms in response to various stimuli. Infect. Immun. 66, 5555, 1998. 14. Mohammadi, M. et al. Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect. Immun. 64, 238, 1996.
Molecular Detection of Foodborne Pathogens 15. Heilmann, K.L., and Borchard F. Gastritis due to spiral shaped bacteria other than Helicobacter pylori: clinical, histological, and ultrastructural findings. Gut 32, 137, 1991. 16. Germani, Y. et al. Strategy for the detection of Helicobacter species by amplification of 16S rRNA genes and identification of H. felis in a human gastric biopsy. Res. Microbiol. 148, 315, 1997. 17. Mammen, M.P., Jr. et al. Recurrent Helicobacter cinaedi bacteremia in a patient infected with human immunodeficiency virus: case report. Clin. Infect. Dis. 21, 1055, 1995. 18. Vandamme, P., et al. Identification of Campylobacter cinaedi isolated from blood and feces of children and adult females. J. Clin. Microbiol. 28, 1016, 1990. 19. Ng, V.L. et al. Successive bacteremias with “Campylobacter cinaedi” and “Campylobacter fennelliae” in a bisexual male. J. Clin. Microbiol. 25, 2008, 1987. 20. Burnens, A.P., et al. Novel Campylobacter-like organism resembling Helicobacter fennelliae isolated from a boy with gastroenteritis and from dogs. J. Clin. Microbiol. 31, 1916, 1993. 21. Stanley, J., et al. Helicobacter pullorum sp. nov.-genotype and phenotype of a new species isolated from poultry and from human patients with gastroenteritis. Microbiology 140, 3441, 1994. 22. Laheij, R.J. et al. Evaluation of commercially available Helicobacter pylori serology kits: a review. J. Clin. Microbiol. 36, 2803, 1998. 23. Gisbert, J.P., and Pajares, J.M. Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review. Helicobacter 9, 347, 2004. 24. Makristathis, A., et al. Two enzyme immunoassays and PCR for detection of Helicobacter pylori in stool specimens from pediatric patients before and after eradication therapy. J. Clin. Microbiol. 38, 3710, 2000. 25. Kolho, K.L. et al. Stool antigen tests for the detection of Helicobacter pylori in children. Diagn. Microbiol. Infect. Dis. 55, 269, 2006. 26. Mobley, H.L. et al. Characterization of urease from Campylobacter pylori. J. Clin. Microbiol. 26, 831, 1988. 27. McNulty, C.A., and Wise, R. Rapid diagnosis of Campylobacter-associated gastritis. Lancet 1, 1443, 1985. 28. Graham, D.Y. et al. Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet 1, 1174, 1987. 29. Kornberg, H.L., Davies, R.E., and Wood, D.R. The activity and function of gastric urease in the cat. Biochem. J., 56, 363, 1954. 30. Neiger, R., Seiler, G., and Schmassmann, A. Use of a urea breath test to evaluate short-term treatments for cats naturally infected with Helicobacter heilmannii. Am. J. Vet. Res. 60, 880, 1999. 31. Solnick, J.V. et al. Rhesus monkey (Macaca mulatta) model of Helicobacter pylori: noninvasive detection and derivation of specific-pathogen-free monkeys. Lab. Anim. Sci. 49, 197, 1999. 32. Atabay, H.I., Corry, J.E., and On, S.L. Identification of unusual Campylobacter-like isolates from poultry products as Helicobacter pullorum. J. Appl. Microbiol. 84, 1017, 1998. 33. Burnens, A.P., and Nicolet, J. Three supplementary diagnostic tests for Campylobacter species and related organisms. J. Clin. Microbiol. 31, 708, 1993. 34. Solnick, J.V. et al. An uncultured gastric spiral organism is a newly identified Helicobacter in humans. J. Infect. Dis. 168, 379, 1993. 35. Neiger, R. et al. Detection and prevalence of Helicobacter infection in pet cats. J. Clin. Microbiol. 36, 634, 1998.
Helicobacter 36. Chien, C.C. et al. Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J. Med. Microbiol. 49, 525, 2000. 37. Young, V.B. et al. Cytolethal distending toxin in avian and human isolates of Helicobacter pullorum. J. Infect. Dis. 182, 620, 2000. 38. Young, V.B., Knox, K.A., and Schauer, D.B. Cytolethal distending toxin sequence and activity in the enterohepatic pathogen Helicobacter hepaticus. Infect. Immun. 68, 184, 2000. 39. Dewhirst, F.E. et al. Discordant 16S and 23S rRNA gene phylogenies for the genus Helicobacter: implications for phylogenetic inference and systematics. J. Bacteriol. 187, 6106, 2005. 40. Fox, J.G. et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114, 755, 1998. 41. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989. 42. Noguchi, N., et al. Detection of mixed clarithromycinresistant and -susceptible Helicobacter pylori using nested PCR and direct sequencing of DNA extracted from faeces. J. Med. Microbiol. 56, 1174, 2007. 43. el-Zaatari, F.A. et al. Determination of Helicobacter pylori status by reverse transcription-polymerase chain reaction. Comparison with urea breath test. Dig. Dis. Sci. 40, 109, 1995. 44. Engstrand, L. et al. Reverse transcription and polymerase chain reaction amplification of rRNA for detection of Helicobacter species. J. Clin. Microbiol. 30, 2295, 1992. 45. Oksanen, K. et al. Reverse transcription-polymerase chain reaction in the diagnosis of Helicobacter pylori infection in Finnish children. J. Pediatr. Gastroenterol. Nutr. 28, 252, 1999. 46. Peek, R.M., Jr. et al. Detection of Helicobacter pylori gene expression in human gastric mucosa. J. Clin. Microbiol. 33, 28, 1995. 47. Alarcon, T. et al. Clarithromycin resistance among Helico bacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis. J. Clin. Microbiol. 41, 486, 2003. 48. Muyzer, G., de Waal, E.C., and Uitterlinden, A.G. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl. Environ. Microbiol. 59, 695, 1993. 49. Minami, M. et al. Use of a combination of brushing technique and the loop-mediated isothermal amplification method as a novel, rapid, and safe system for detection of Helicobacter pylori. J. Clin. Microbiol. 44, 4032, 2006. 50. Notomi, T. et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 28, E63, 2000. 51. Guimaraes, N. et al. Development and application of a novel peptide nucleic acid probe for the specific detection of Helicobacter pylori in gastric biopsy specimens. J. Clin. Microbiol. 45, 3089, 2007. 52. Juttner, S. et al. Reliable detection of macrolide-resistant Helicobacter pylori via fluorescence in situ hybridization in formalin-fixed tissue. Mod. Pathol. 17, 684, 2004. 53. Morris, J.M. et al. Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections. J. Clin. Microbiol. 43, 3494, 2005.
197 54. Russmann, H. et al. Rapid and accurate determination of genotypic clarithromycin resistance in cultured Helicobacter pylori by fluorescent in situ hybridization. J. Clin. Microbiol. 39, 4142, 2001. 55. Millar, B.C. et al. A simple and sensitive method to extract bacterial, yeast, and fungal DNA from blood culture material. J. Microbiol. Methods 42, 139, 2000. 56. Rimbara, E. et al. Susceptibilities to clarithromycin, amoxycillin, and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995–2001. Clin. Microbiol. Infect. 11, 307, 2005. 57. Datta, S. et al. Diagnosis and genotyping of Helicobacter pylori by polymerase chain reaction of bacterial DNA from gastric juice. J. Gastroenterol. Hepatol. 20, 1253, 2005. 58. Dominguez-Bello, M.G. et al. PCR detection of Helicobacter pylori in string-absorbed gastric juice. FEMS Microbiol. Lett. 198, 15, 2001. 59. Samuels, A.L. et al. Culture of Helicobacter pylori from a gastric string may be an alternative to endoscopic biopsy. J. Clin. Microbiol. 38, 2438, 2000. 60. Yoshida, H. et al. Use of a gastric juice-based PCR assay to detect Helicobacter pylori infection in culture-negative patients. J. Clin. Microbiol. 36, 317, 1998. 61. McOrist, A.L., Jackson, M., and Bird, A.R. A comparison of five methods for extraction of bacterial DNA from human faecal samples. J. Microbiol. Methods 50, 131, 2002. 62. Booka, M. et al. Polymerase chain reaction–restriction fragment length polymorphism analysis of clarithromycinresistant Helicobacter pylori infection in children using stool sample. Helicobacter 10, 205, 2005. 63. Fontana, C. et al. Detection of clarithromycin-resistant Helicobacter pylori in stool samples. J. Clin. Microbiol. 41, 3636, 2003. 64. Monteiro, L. et al. Detection of Helicobacter pylori DNA in human feces by PCR: DNA stability and removal of inhibitors. J. Microbiol. Methods 45, 89, 2001. 65. Monteiro, L., Gras, N., and Megraud, F. Magnetic immuno-PCR assay with inhibitor removal for direct detection of Helicobacter pylori in human feces. J. Clin. Microbiol. 39, 3778, 2001. 66. Rimbara, E. et al. Development of a highly sensitive method for detection of clarithromycin-resistant Helicobacter pylori from human feces. Curr. Microbiol. 51, 1, 2005. 67. Nishimura, H. et al. Mutations in KaiA, a clock protein, extend the period of circadian rhythm in the cyanobacterium Synechococcus elongatus PCC 7942. Microbiology 148, 2903, 2002. 68. Oda, K. et al. Proteomic analysis of extracellular proteins from Aspergillus oryzae grown under submerged and solidstate culture conditions. Appl. Environ. Microbiol. 72, 3448, 2006. 69. Fox, J.G. et al. Local immune response in Helicobacter pylori-infected cats and identification of H. pylori in saliva, gastric fluid and faeces. Immunology 88, 400, 1996. 70. Umeda, M. et al. High prevalence of Helicobacter pylori detected by PCR in the oral cavities of periodontitis patients. J. Periodontol. 74, 129, 2003. 71. Recordati, C. et al. Detection of Helicobacter spp. DNA in the oral cavity of dogs. Vet. Microbiol. 119, 346, 2007. 72. De Groote, D. et al. Detection of non-pylori Helicobacter species in Helicobacter heilmannii-infected humans. Helicobacter 10, 398, 2005. 73. D’Aquila, R.T. et al. Maximizing sensitivity and specificity of PCR by pre-amplification heating. Nucleic Acids Res. 19, 3749, 1991.
198 74. Al-Soud, W.A. et al. Assessment of PCR-DGGE for the identification of diverse Helicobacter species, and application to faecal samples from zoo animals to determine Helicobacter prevalence. J. Med. Microbiol. 52, 765, 2003. 75. Huijsdens, X.W. et al. Detection of Helicobacter species DNA by quantitative PCR in the gastrointestinal tract of healthy individuals and of patients with inflammatory bowel disease. FEMS Immunol. Med. Microbiol. 41, 79, 2004. 76. Higashi, H. et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl. Acad. Sci. USA 99, 14428, 2002. 77. Higashi, H. et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295, 683, 2002. 78. He, Q. et al. Real-time quantitative PCR for detection of Helicobacter pylori. J. Clin. Microbiol. 40, 3720, 2002. 79. Prachasilpchai, W. et al. Diagnosis of Helicobacter spp. infection in canine stomach. J. Vet. Sci. 8, 139, 2007. 80. Nilsson, H.O. et al. High prevalence of Helicobacter species detected in laboratory mouse strains by multiplex PCR-denaturing gradient gel electrophoresis and pyrosequencing. J. Clin. Microbiol. 42, 3781, 2004. 81. Zhang, L. et al. Nongastric Helicobacter species detected in the intestinal tract of children. J. Clin. Microbiol. 44, 2276, 2006. 82. Baele, M. et al. Multiplex PCR assay for differentiation of Helicobacter felis, H. bizzozeronii, and H. salomonis. J. Clin. Microbiol. 42, 1115, 2004. 83. Dieterich, C. et al. Presence of multiple Helicobacter heilmannii strains in an individual suffering from ulcers and in his two cats. J. Clin. Microbiol. 36, 1366, 1998. 84. Eaton, K.A. et al. Prevalence and varieties of Helicobacter species in dogs from random sources and pet dogs: animal and public health implications. J. Clin. Microbiol. 34, 3165, 1996. 85. Feng, S. et al. Differential detection of five mouse-infecting Helicobacter species by multiplex PCR. Clin. Diagn. Lab. Immunol. 12, 531, 2005. 86. Ge, Z. et al. Fluorogenic PCR-based quantitative detection of a murine pathogen, Helicobacter hepaticus. J. Clin. Microbiol. 39, 2598, 2001. 87. Moyaert, H. et al. Prevalence of Helicobacter equorum in faecal samples from horses and humans. Vet. Microbiol. 121, 378, 2007. 88. Shames, B. et al. Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay. J. Clin. Microbiol. 33, 2968, 1995. 89. Ceelen, L.M. et al. The cytolethal distending toxin among Helicobacter pullorum strains from human and poultry origin. Vet. Microbiol. 113, 45, 2006. 90. Andersen, L.P. New Helicobacter species in humans. Dig. Dis. 19, 112, 2001. 91. Kusters, J.G., and Kuipers, E.J. Non-pylori Helicobacter infections in humans. Eur. J. Gastroenterol. Hepatol. 10, 239, 1998. 92. Jalava, K. et al. A cultured strain of “Helicobacter heilmannii,” a human gastric pathogen, identified as H. bizzozeronii: evidence for zoonotic potential of Helicobacter. Emerg. Infect. Dis. 7, 1036, 2001. 93. Prokhorenko, I.A. et al. Phenylethynylpyrene-labeled oligonucleotide probes for excimer fluorescence SNP analysis of 23S rRNA gene in clarithromycin-resistant Helicobacter pylori strains. Mutat. Res. 599, 144, 2006.
Molecular Detection of Foodborne Pathogens 94. van Doorn, L.J. et al. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob. Agents Chemother. 45, 1500, 2001. 95. Lottspeich, C. et al. Evaluation of the novel Helicobacter pylori ClariRes real-time PCR assay for detection and clarithromycin susceptibility testing of H. pylori in stool specimens from symptomatic children. J. Clin. Microbiol. 45, 1718, 2007. 96. McDaniels, A.E. et al. Evaluation of quantitative real time PCR for the measurement of Helicobacter pylori at low concentrations in drinking water. Water Res. 39, 4808, 2005. 97. Schabereiter-Gurtner, C. et al. Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens. J. Clin. Microbiol. 42, 4512, 2004. 98. Goto, K. et al. Specific and quantitative detection of PCR products from Clostridium piliforme, Helicobacter bilis, H. hepaticus, and mouse hepatitis virus infected mouse samples using a newly developed electrochemical DNA chip. J. Microbiol. Methods 69, 93, 2007. 99. Liang, S., and Redlinger, T. A protocol for isolating putative Helicobacter pylori from fecal specimens and genotyping using vacA alleles. Helicobacter 8, 561, 2003. 100. Seymour, C. et al. Isolation of Helicobacter strains from wild bird and swine feces. Appl. Environ. Microbiol. 60, 1025, 1994. 101. Butcher, G.P. et al. Use of an ammonia electrode for rapid quantification of Helicobacter pylori urease: its use in the endoscopy room and in the assessment of urease inhibition by bismuth subsalicylate. Digestion 53, 142, 1992. 102. Prince, M.I. et al. The CLO test in the UK: inappropriate reading and missed results. Eur. J. Gastroenterol. Hepatol. 11, 1251, 1999. 103. Munster, D.J. et al. The fate of ingested 14C-urea in the urea breath test for Helicobacter pylori infection. Scand. J. Gastroenterol. 28, 661, 1993. 104. Kosunen, T.U. et al. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 339, 893, 1992. 105. Malfertheiner, P. et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56, 772, 2007. 106. Mitchell, H.M., et al. Antibody to Campylobacter pylori in families of index children with gastrointestinal illness due to C. pylori. Lancet 2, 681, 1987. 107. Ekstrom, A.M. et al. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 121, 784, 2001. 108. Kato, M. et al. Clinical usefulness of urine-based enzymelinked immunosorbent assay for detection of antibody to Helicobacter pylori: a collaborative study in nine medical institutions in Japan. Helicobacter 5, 109, 2000. 109. Kato, S. et al. Urine-based enzyme-linked immunosorbent assay for the detection of Helicobacter pylori infection in children. Pediatrics 107, E87, 2001. 110. Patel, P. et al. Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy. Lancet 344, 511, 1994. 111. Katsuragi, K. et al. Highly sensitive urine-based enzyme-linked immunosorbent assay for detection of antibody to Helicobacter pylori. Helicobacter 3, 289, 1998. 112. Gatta, L. et al. A rapid immunochromatographic assay for Helicobacter pylori in stool before and after treatment. Aliment Pharmacol. Ther. 20, 469, 2004.
Helicobacter 113. Panayotopoulou, E.G. et al. Strategy to characterize the number and type of repeating EPIYA phosphorylation motifs in the carboxyl terminus of CagA protein in Helicobacter pylori clinical isolates. J. Clin. Microbiol. 45, 488, 2007. 114. Riley, L.K. et al. Identification of murine helicobacters by PCR and restriction enzyme analyses. J. Clin. Microbiol. 34, 942, 1996. 115. Eaton, K.A. et al. Helicobacter acinonyx sp. nov., isolated from cheetahs with gastritis. Int. J. Syst. Bacteriol. 43, 99, 1993. 116. Fox, J.G. et al. Helicobacter anseris sp. nov. and Helicobacter brantae sp. nov., isolated from feces of resident Canada geese in the greater Boston area. Appl. Environ. Microbiol. 72, 4633, 2006. 117. Patterson, M.M. et al. Helicobacter aurati sp. nov., a ureasepositive Helicobacter species cultured from gastrointestinal tissues of Syrian hamsters. J. Clin. Microbiol. 38, 3722, 2000. 118. Baele, M. et al. Helicobacter baculiformis sp. nov., isolated from feline stomach mucosa. Int. J. Syst. Evol. Microbiol. 58, 357, 2008. 119. Fox, J.G. et al. Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J. Clin. Microbiol. 33, 445, 1995. 120. Hanninen, M.L. et al. Culture and characteristics of Helico bacter bizzozeronii, a new canine gastric Helicobacter sp. Int. J. Syst. Bacteriol. 46, 160, 1996. 121. Fox, J.G. et al. Helicobacter canadensis sp. nov. isolated from humans with diarrhea as an example of an emerging pathogen. J. Clin. Microbiol. 38, 2546, 2000. 122. Stanley, J. et al. Helicobacter canis sp. nov., a new species from dogs: an integrated study of phenotype and genotype. J. Gen. Microbiol. 139, 2495, 1993. 123. Harper, C.G. et al. Helicobacter cetorum sp. nov., a ureasepositive Helicobacter species isolated from dolphins and whales. J. Clin. Microbiol. 40, 4536, 2002. 124. Franklin, C.L. et al. Isolation of a novel Helicobacter species. Helicobacter cholecystus sp. nov., from the gallbladders of Syrian hamsters with cholangiofibrosis and centrilobular pancreatitis. J. Clin. Microbiol. 34, 2952, 1996. 125. Totten, P.A. et al. Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): two new Campylobacter species associated with enteric disease in homosexual men. J. Infect. Dis. 151, 131, 1985. 126. Van den Bulck, K. et al. Helicobacter cynogastricus sp. nov., isolated from the canine gastric mucosa. Int. J. Syst. Evol. Microbiol. 56, 1559, 2006. 127. Moyaert, H. et al. Helicobacter equorum sp. nov., a ureasenegative Helicobacter species isolated from horse faeces. Int. J. Syst. Evol. Microbiol. 57, 213, 2007. 128. Lee, A. et al. Isolation of a spiral-shaped bacterium from the cat stomach. Infect. Immun. 56, 2843, 1988. 129. Robertson, B.R. et al. Helicobacter ganmani sp. nov., a ureasenegative anaerobe isolated from the intestines of laboratory mice. Int. J. Syst. Evol. Microbiol. 51, 1881, 2001. 130. Fox, J. G. et al. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J. Clin. Microbiol. 32, 1238, 1994. 131. Fox, J.G. et al. Helicobacter marmotae sp. nov. isolated from livers of woodchucks and intestines of cats. J. Clin. Microbiol. 40, 2513, 2002. 132. Shen, Z. et al. A novel enterohepatic Helicobacter species ‘Helicobacter mastomyrinus’ isolated from the liver and intestine of rodents. Helicobacter 10, 59, 2005. 133. Simmons, J.H. et al. Helicobacter mesocricetorum sp. nov., A novel Helicobacter isolated from the feces of Syrian hamsters. J. Clin. Microbiol. 38, 1811, 2000.
199 134. Lee, A. et al. Helicobacter muridarum sp. nov., a microaerophilic helical bacterium with a novel ultrastructure isolated from the intestinal mucosa of rodents. Int. J. Syst. Bacteriol. 42, 27, 1992. 135. Fox, J.G. et al. Gastric colonization by Campylobacter pylori subsp. mustelae in ferrets. Infect. Immun. 56, 2994, 1988. 136. Bronsdon, M.A. et al. Helicobacter nemestrinae sp. nov., a spiral bacterium found in the stomach of a pigtailed macaque (Macaca nemestrina). Int. J. Syst. Bacteriol. 41, 148, 1991. 137. Dewhirst, F.E. et al. Phylogeny of Helicobacter isolates from bird and swine feces and description of Helicobacter pametensis sp. nov. Int. J. Syst. Bacteriol. 44, 553, 1994. 138. Shen, Z. et al. Helicobacter rodentium sp. nov., a ureasenegative Helicobacter species isolated from laboratory mice. Int. J. Syst. Bacteriol. 47, 627, 1997. 139. Jalava, K. et al. Helicobacter salomonis sp. nov., a canine gastric Helicobacter sp. related to Helicobacter felis and Helicobacter bizzozeronii. Int. J. Syst. Bacteriol. 47, 975, 1997. 140. Mendes, E.N. et al. Helicobacter trogontum sp. nov., isolated from the rat intestine. Int. J. Syst. Bacteriol. 46, 916, 1996. 141. Franklin, C.L. et al. Helicobacter typhlonius sp. nov., a novel murine urease-negative Helicobacter species. J. Clin. Microbiol. 39, 3920, 2001. 142. Alm, R.A. et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397, 176, 1999. 143. Tomb, J. F. et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388, 539, 1997. 144. O’Rourke, J.L. et al. Description of ‘Candidatus Helicobacter heilmannii’ based on DNA sequence analysis of 16S rRNA and urease genes. Int. J. Syst. Evol. Microbiol., 54, 2203, 2004. 145. Zambon, C.F. et al. Non-invasive diagnosis of Helicobacter pylori infection: simplified 13C-urea breath test, stool antigen testing, or DNA PCR in human feces in a clinical laboratory setting? Clin. Biochem. 37, 261, 2004. 146. van Doorn, L.J. et al. Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization. J. Clin. Microbiol. 36, 1271, 1998. 147. Roosendaal, R. et al. Slaughter pigs are commonly infected by closely related but distinct gastric ulcerative lesion-inducing gastrospirilla. J. Clin. Microbiol., 38, 2661, 2000. 148. Welsh, J., and McClelland, M. Genomic fingerprints produced by PCR with consensus tRNA gene primers. Nucleic Acids Res. 19, 861, 1991. 149. Shen, Z. et al. Development of a PCR-restriction fragment length polymorphism assay using the nucleotide sequence of the Helicobacter hepaticus urease structural genes ureAB. J. Clin. Microbiol. 36, 2447, 1998. 150. Ceelen, L. et al. Prevalence of Helicobacter pullorum among patients with gastrointestinal disease and clinically healthy persons. J. Clin. Microbiol. 43, 2984, 2005. 151. Harper, C.G. et al. Comparison of diagnostic techniques for Helicobacter cetorum infection in wild Atlantic bottlenose dolphins (Tursiops truncatus). J. Clin. Microbiol. 41, 2842, 2003. 152. Maeda, S. et al. Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. Gut 43, 317, 1998. 153. Clayton, C.L. et al. Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J. Clin. Microbiol. 30, 192, 1992. 154. Contreras, M. et al. Detection of Helicobacter-like DNA in the gastric mucosa of Thoroughbred horses. Lett. Appl. Microbiol. 45, 553, 2007.
200 155. Rugge, M. et al. Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer 85, 2506, 1999. 156. Kawamata, O. et al. Nested-polymerase chain reaction for the detection of Helicobacter pylori infection with novel primers designed by sequence analysis of urease A gene in clinically isolated bacterial strains. Biochem. Biophys. Res. Commun. 219, 266, 1996.
Molecular Detection of Foodborne Pathogens 157. Beckwith, C.S. et al., Fecal PCR assay for diagnosis of Helicobacter infection in laboratory rodents. J. Clin. Microbiol. 35, 1620, 1997. 158. Neubauer, C., and Hess, M. Detection and identification of food-borne pathogens of the genera Campylobacter, Arcobacter, and Helicobacter by multiplex PCR in poultry and poultry products. J. Vet. Med. B Infect. Dis. Vet. Public Health 53, 376, 2006.
14 Kocuria
Edoardo Carretto and Daniela Barbarini Fondazione IRCCS Policlinico San Matteo
Contents 14.1 Introduction.................................................................................................................................................................... 201 14.1.1 Classification of Kocuria species...................................................................................................................... 201 14.1.2 Biology, Pathogenesis, and Medical Importance.............................................................................................. 201 14.1.3 Kocuria and Food............................................................................................................................................. 202 14.1.4 Current Diagnostic Methods for Kocuria spp.................................................................................................. 202 14.2 Methods.......................................................................................................................................................................... 203 14.2.1 Automated Ribotyping...................................................................................................................................... 203 14.2.2 PCR Amplification of 16S rDNA Region......................................................................................................... 204 14.2.3 PCR Amplification of the 16S±23S rDNA Intergenic Region......................................................................... 204 14.3 Conclusions and Future Perspectives............................................................................................................................. 204 References.................................................................................................................................................................................. 205
14.1 Introduction The genus Kocuria belongs to the family Micrococcaceae, order Actinomycetales. It was created in 1995 on the basis of the phylogenetic and chemotaxonomic dissection of the genus Micrococcus.1 These microrganisms are Gram-positive cocci, catalase positive, coagulase negative, strictly aerobic, occurring often in tetrads or irregular clusters, and usually grow on simple media. In humans, they may colonize the skin, mucosae and oropharynx; they are also isolated from a great variety of animal sources and from other environments. Considering its relatively small genome size among actinomycetes, the existence of different Kocuria species suggests their capacity to adapt and prosper in their own ecological niche.2
14.1.1 Classification of Kocuria species At it stands, the genus Kocuria consists of 12 valid species: Kocuria rosea (the type species),1 K. varians,1 K. kristinae,1 K. palustris,3 K. rhizophila3 (whose complete genome was recently sequenced2), K. polaris,4 K. marina,5 K. carniphila,6 K. aegyptia,7 K. himachalensis,8 K. flava,9 and K. turfanensis.9 These species were recovered from different environments such as saline, alkaline desert (K. aegyptia), meat (K. carniphila), marine sediment (K. marina), the rhizoplane of narrowleaved cattail (K. palustris, K. rhizophila), an Antarctic cyanobacterial mat sample (K. polaris) and from plates used to detect cultivable bacteria from the air (K. flava and K. turfanensis).9 In general, the members of this genus are Gram-positive, aerobic, coccoid, nonencapsulated, nonhalophilic, and nonendospore-forming, with the presence of the fatty acid anteiso-C15:0 and MK-7(H2) and MK-8(H2) as the major
menaquinones. On Columbia blood agar, Kocuria kristinae (the species most frequently isolated in human infections) typically forms cream colonies. It is nonhemolytic, catalase positive, strictly aerobic, nonmotile, coagulase negative, and unable to reduce nitrate to nitrites and to hydrolyze gelatin, arginine and esculine. K. kristinae produces acid from threalose, glucose, fructose, mannose, glycerol, saccharose but not from mannitol, raffinose, arabinose, lactose, and ribose. The morphological characteristics of the other Kocuria species are variable and are fully illustrated in the first description of a species.1–9
14.1.2 Biology, Pathogenesis, and Medical Importance Up to 1995, members of the genus Kocuria have been regarded as part of the genus Micrococcus in the family Micrococcaceae. Micrococcus strains have been isolated from different clinical specimens, although their clinical relevance is often questionable. From a clinical point of view, Micrococcus luteus is the microrganism that was most frequently associated with diseases in humans. There are reports of bacteremia,10,11 pneumonia,12 intracranial abscesses,13 septic arthritis,14 and meningitis,15 either in immunosuppressed or immunocompetent hosts. Different reports suggest also that Micrococcus and related organisms can be involved in peritonitis in patients undergoing ambulatory peritoneal dialysis,16 endocarditis,17 or infection of cerebrospinal fluid shunts.18 Some authors found a significant association between Micrococcus catheter-related bacteremias and patients receiving epoprostenol by continuous intravenous infusion.19 After the rearrangement of the family Micrococcaceae in 1995, generating the new genus Kocuria, some reports 201
202
emphasized that two members of this genus (K. kristinae and K. rosea) were associated to human diseases. Since these microrganisms may colonize the skin, mucosae and oropharynx, it is not surprising that both species were involved in catheter-related bacteremias,20–22 and K. kristinae was also associated to a case of acute cholecystitis.23 It is possible that the true incidence of the bacteremia due to Kocuria spp. may be underestimated due to the following reasons: (i) the correct identification of micrococci isolated from clinical specimens is often cumbersome, since standard biochemical analysis does not work well on these microrganisms, which demonstrate phenotypic variability; (ii) the clinical interpretation of positive results may be misleading; (iii) these microorganisms are hastily discarded as contaminants. The repeated isolation from different blood cultures in the absence of other microorganisms, together with the isolation from a catheter, strongly suggests that Kocuria spp. may cause catheter-related bacteremia. Although this microorganism is intrinsically low-virulent and its presence in the bloodstream is often the expression of a transient bacteremia, the clinicians should not underestimate the repeated isolation of a Kocuria strain from blood cultures, considering the clinical signs of a sepsis syndrome resulting from catheterrelated infection.20 There are relatively few reports on literature about the drug susceptibilities of Kocuria spp. All the strains causing infections were susceptible to oxacillin, first generation cephalosporines, amoxicillin-clavulanate (these β-lactams can be considered as the drug of choice in case of infections due to Kocuria spp.), tetracyclines, glycopeptides, with a different degree of susceptibilities to penicillin and macrolides.20,21,23 To date, the link between Kocuria spp. and foodborne diseases has not been established; and these microorganisms have not been investigated at all in the routine panel of microbiological analysis relating to diarrheal illness. Given that Kocuria species isolated in humans (K. kristinae, K. rosea, K. varians) show the following biological characteristics: (i) colonizing microorganisms of the skin, mucosae and oropharynx, without any ability to cause systemic diseases (with the exception of foreign-body associated infections and a case of cholecystitis) or localized diseases (skin or soft tissues infections were never reported) and (ii) the lack of evidence of genes with particular virulence and with toxigenic activity, it is postulated that these microorganisms have no ability to cause intestinal diseases in humans.
14.1.3 Kocuria and Food Species belonging to the genera Pediococcus, Lactobacillus, Kocuria, and Staphylococcus are often used in the manufacture of fermented sausages as starter cultures. The most important roles of coagulase-negative staphylococci (CNS) and Kocuria spp. are: (i). the reduction of nitrate to nitrite, to promote the desired red color development and stability; (ii) peroxide decomposition and therefore, prevention of rancidity; and (iii) nitrite permanence with consequent maintenance of hygienic safety. Furthermore, the lipolytic and proteolytic activity of these bacteria may contribute to the
Molecular Detection of Foodborne Pathogens
flavor of fermented meat products by formation of esters and other aromatic compounds from amino acids. Mixed cultures of lactic acid bacteria and Staphylococcus xylosus, S. carnosus, S. saprophyticus, and K. varians are increasingly being used to standardize the quality of fermented sausages.24,25 Interestingly, certain strains are able to inhibit spoilage or pathogenic bacteria; in particular, the potential antilisterial activity of S. xylosus, S. carnosus, and Kocuria varians was investigated by a number of authors.26,27 A recent paper examined the in vitro and in vivo interactions occurring between S. xylosus and K. varians in the ripening of traditional fermented meat products of southern Italy. This study pointed out that S. xylosus strains produced unidentified compounds capable of positively or negatively affecting the growth of K. varians; and that a high stimulatory interaction assessed in vitro by using mixtures of K. varians K4 and certain S. xylosus strains, resulted in a strongly proteolytic activity on sarcoplasmic proteins, whereas a moderate stimulatory interaction, found between K. varians K4 and other S. xylosus strains, corresponded to a lower proteolytic activity.28
14.1.4 Current Diagnostic Methods for Kocuria spp. Usually, the strains of Kocuria spp. having medical interest grow well on simple nonselective media such as Columbia blood agar. Using a hierarchical approach to identify Kocuria spp., the first methods that can be used are phenotypic. Among the different phenotypic methods commercial systems, such as the API 20 Staph or the ID32 Staph ATB system (both from BioMérieux, Marcy l’Etoile, France) has been proven useful. The API 20 Staph system consists of a strip containing 20 dehydrated test substrates in single microtubes. These substrates are reconstituted by adding to each tube an aliquot of the medium, provided by the manufacturer, that has been inoculated with the strain to be studied. After a 24 h incubation at 35°C the reaction results were read and compared to a reference identification database provided by the manufacturer.29 The ID32 Staph ATB system is another standardized system consisting of 32 cupules, 26 of which are used as test cupules containing dehydrated test substrates. These substrates are reconstituted by adding to each tube an aliquot of the medium, provided by the manufacturer, that has been inoculated with the strain to be studied. After a 24 h incubation at 36°C the reaction results can be read either using the ATB™ Expression™ or miniAPI® instruments, or visually. The obtained results should be compared to a reference identification database provided by the manufacturer.30 Various automated identification and susceptibility test systems are currently on the market, among them Vitek 2 (BioMérieux, Marcy l’Etoile, France) and the BD Phoenix system (Becton Dickinson Diagnostic Systems, Sparks, MD). In a previous paper, Ben-Ami reported the possibility that Vitek 2 could misidentify S. epidermidis strains as Kocuria spp.31 However, quite recently, the Vitek 2 Grampositive identification card has been redesigned to increase
203
Kocuria
the accuracy in the identification of Gram-positive cocci; some Author pointed out that this new card seems to work on Kocuria strains better than the previous one.32 Finally, it has to be emphasized that there are evidences that, in general, manual systems work better on CNS compared with the automated systems.33 Unfortunately, use of phenotypic procedures to identify CNS can be problematic. Commercial identification kits or automated systems often provide unreliable results for most CNS species, in particular non S. epidermidis isolates. This is attributed mainly to the variable nature of diagnostic reactions applied to the species and to the subjectivity in interpretation.34 Misidentification of Kocuria species has also been described for the same reasons.31 Thus, the correct identification of an isolate phenotypically identified as Kocuria species should be confirmed using molecular techniques. The sequencing of the region encoding for the 16S rDNA was proven useful to correctly identify these bacteria.20,23 Ribotyping was proven very useful in the study of staphylococci34 both for molecular epidemiology purposes and for identification and taxonomic purposes. High quality databases of ribotyping profiles that include representative strains of nearly all described species and subspecies of CNS have been constructed and are useful for identification of unknown isolates.35 The RiboPrinter® Microbial Characterization System (DuPont-Qualicon, Wilmington, DE) is an automated instrument able to perform the ribotyping of bacterial isolates. After the generation of an electronic ribotype fingerprint, the instrument software compares it automatically to the reference DuPont identification databases. In the past, we demonstrated the usefulness of the RiboPrinter® in identifying CNS.34 In our experiments we did not include any Kocuria strains, since at that time the DuPont libraries that the instrument uses to identify the strains did not include Kocuria profiles. However, the most updated versions of the DuPont databases (version 6.8 for the EcoRI library and version 1.9 for the PvuII library) contain 26 different profiles of four different species of Kocuria: K. kristinae (five profiles), K. rosea (seven profiles), K. rhizophila (two profiles), and K. varians (11 profiles). In our experience this instrument demonstrated very useful to correctly identify Kocuria strains (unpublished data) and could be used as a first line molecular approach to confirm the putative phenotypical identification of these microrganisms, instead of the 16S rDNA sequencing. Since the food industry needs to check rapidly the presence and/or to monitor during fermentation the inoculated starter cultures, and the reliability of the identification of strains used as starter can have legal importance, efforts were made in developing molecular systems able to provide a correct identification for CNS. The gradient gel electrophoresis (DGGE) analysis of PCR amplified 16S ribosomal sequences has been applied for identification of Micrococcaceae involved in sausage fermentation. The results obtained showed that strains of S. xylosus, S. cohnii, S. intermedius, S. carnosus, K. varians e K. kristinae could be reliably identified on the basis of the analysis of the DGGE mobility of the 16S rDNA V3 region.36 More recently, a polyphasic approach combining the16S–23S
rDNA intergenic spacer region (ISR)-polymerase chain reaction (PCR) and the 16S rDNA V3 region PCR-DGGE techniques has been demonstrated very useful in determining the staphylococcal population of a fermented food product.37 Rossi et al. used a random amplified polymorphic DNA technique based on the rDNA 16S±23S spacer region amplification to identify strains belonging to S. xylosus, S. simulans, S. carnosus or closely related species and of Kocuria species in the sausage microflora, confirming the usefulness of this technique in differentiating among these bacterial species.25 To our knowledge, a number of PCR amplicon sequencingbased methods for identification of CNS have been reported, i.e., targeting the 16S rDNA gene,38 the manganese-dependent superoxide dismutase (sodA) gene,39 the glyceraldehyde3-phosphate dehydrogenase-encoding gene (gap gene).40 However none of the above molecular techniques have been evaluated (and therefore have been proven useful) to identify Kocuria spp.
14.2 Methods To confirm the appropriateness of the identification of Kocuria spp. it is often necessary to use molecular methods. Here we describe some quick protocol to identify these strains: (i) using the RiboPrinter® Microbial Characterization System; (ii) amplifying the 16S rDNA region; and (iii) amplifying the 16S±23S rDNA intergenic region.
14.2.1 Automated Ribotyping Isolated bacterial colonies of the putative Kocuria strains, grown in different culture media, should be subcultured in brain heart infusion agar. Two different experiments should be performed, since the isolates are better analyzed using either EcoRI or PvuII as restriction enzyme. After an overnight growth at 37°C on this medium, isolated colonies are collected using a plastic stick and suspended into the supplied sample buffer. The correct inoculum should be very heavy (four colonies in 40 µl of buffer). The bacterial suspension is then treated for 10 min at 80°C, to reduce viability and to inactivate nucleases. After addition of 5 µl of two lytic enzymes (supplied by the manufacturer) to 30 µl of the bacterial suspensions, samples can be loaded into the RiboPrinter® system together with the chosen restriction enzyme. From now on, all the process is fully automated and performed by the instrument. After the enzyme digestions, the protocol includes separation of restriction fragments by agarose gel electrophoresis, blotting onto a Nylon membrane, and hybridization with a chemiluminescently labeled rDNA probe corresponding to the Escherichia coli rrnB operon. The patterns obtained are then read by a Charge Coupled Device camera, and restriction patterns are automatically analyzed, producing normalized digital fingerprints that are stored in the computer internal database. After generation of the electronic ribotype fingerprint, the instrument software compares it automatically to the reference DuPont identification database. To date, the most updated versions of the DuPont databases
204
(version 6.8 for the EcoRI library and version 1.9 for the PvuII library) contain 26 different profiles of four different species of Kocuria: K. kristinae (three EcoRI profiles, two PvuII profiles), K. rosea (four EcoRI profiles, three PvuII profiles), K. rhizophila (two EcoRI profiles), and K. varians (two EcoRI profiles, ten PvuII profiles). For identification, a threshold value of 85% overall similarity (as determined by using an algorithm similar to the Pearson correlation coefficient in the range of molecular sizes from 1 to 48 kb) between the test fingerprint and the database reference fingerprint is used.
14.2.2 PCR Amplification of 16S rDNA Region Isolated bacterial colonies of the putative Kocuria strains, grown in different culture media, should be subcultured in nonselective media, such as brain heart infusion agar or Columbia blood agar. After the extraction of genomic DNA using conventional methods, the amplification of the 16S rDNA can be achieved using universal primers. Two of the most commonly used primers for bacterial 16S rDNA genes are 27F (5′-AGAGTTTGATCCTGGCTCAG-3′) spanning positions eight to 27 in Escherichia coli rDNA coordinates, and 1492R (5′-TACCTTGTTACGACTT-3′), commonly spanning positions 1492–1507, though longer versions are sometimes used, which amplify nearly the entire length of the gene.20,41–43 As an example, PCR mixtures can contain 50 mM KCl, 10 mM Tris (pH 8.3), 1.5 mM MgCl2, 2 mM each of the four deoxynucleoside triphosphates, 1 µM (each) oligonucleotide primer, 2.5 U of Taq DNA polymerase, and 1 pg to 100 ng of template DNA in a total reaction volume of 100 µl. Amplifications are carried out on a thermal cycler with a previous initial denaturation at 94°C for 5 min, followed by 25 cycles of 94°C for 60 sec, 50°C for 30 sec, and 72°C for 2 min, with a final 5 min extension step at 72°C. The amplicons can be kept at 4°C until purified. The PCR products can be sequenced using the ABI Big Dye Terminator technology with the same primers. The nucleotide sequences can be compared to GenBank contents using the BLAST program. Recently, we successfully used this approach to confirm the identification of a strain which caused repeated episodes of bacteremia; the nucleotide sequence, analyzed with BLAST program, revealed a higher homology (99.8%) with K. kristinae (AF323746). The sequence has been deposited in the GenBank/EMBL data library under accession number AJ316579.20 Commercial 16S rDNA sequencing kits are nowadays available to identify bacteria and some Authors point out that this molecular approach can be useful for strains expressing ambiguous biochemical profiles.44 However, to our knowledge these commercial systems have not been evaluated for the identification of Kocuria strains.
14.2.3 PCR Amplification of the 16S±23S rDNA Intergenic Region Isolated bacterial colonies of the putative Kocuria strains, grown in different culture media, should be subcultured in nonselective media, such as brain heart infusion agar
Molecular Detection of Foodborne Pathogens
or Columbia blood agar. After the extraction of genomic DNA using conventional methods, the amplification of the 16S±23S rDNA intergenic region can be achieved using universal primers.45 In a recent paper, Rossi et al. used primers OPL-01 (5′-GGCATGACCT-3′), OPL-02 (5′-TGGGCGTCAA-3′), OPL-05 (5′-ACGCAGGCAC-3′) and Hpy 1 (5′-CCGCAGCCAA-3′). PCR mixtures contained Taq buffer, 1.5 mM MgCl2, 2 mM each of the four deoxynucleoside triphosphates, 2.5 µM (each) of oligonucleotide primers, 2.5 U of Taq DNA polymerase, and 50 ng of template DNA in a total reaction volume of 50 µl. The amplification programme comprises initial denaturation at 94°C for 4 min, 45 cycles of denaturation at 94°C for 30 sec, annealing at 35°C for 30 sec, and extension at 72°C for 1 min, with a final extension at 72°C for 5 min. The electrophoresis on agarose gel of the PCR products allow to detect a single band at 500 bp for K. varians, at 550 bp for K. kristinae and a single band at 650 bp for K. rosea.25
14.3 Conclusions and Future Perspectives The genus Kocuria consists of a group of Gram-positive, catalase positive, coagulase negative, strictly aerobic cocci that have been long considered as part of the genus Micrococcus in the family Micrococcaceae. Although Micrococcus species such as M. luteus have been isolated from a variety of clinical specimens and implicated in several human diseases (e.g., catheter-related bacteremia, pneumonia, intracranial abscesses, septic arthritis, meningitis, peritonitis and endocarditis, etc.), there is a conspicuous lack of evidence concerning the ability of Kocuria species to induce intestinal (or foodborne) diseases in humans, despite the fact that Kocuria spp. are found in various animal, food and environmental specimens, and have the capacity to colonize the skin, mucosae, and oropharynx in human host; and that K. kristinae and K. rosea have been also associated with catheter-related bacteremia and/or acute cholecystitis. Given the close relationship between Kocuria and Micrococcus genera, and the relative short existence of Kocuria as an independent genus, it is possible that the role of Kocuria spp. in the causation of bacteremia and other human diseases may have been overlooked. Certainly, the current difficulty to correctly identify micrococcal isolates from clinical specimens by conventional procedures and the tendency to dispose the isolated micrococci as contaminants without detailed analysis may have contributed to the dearth of data on human diseases due to Kocuria spp. Considering that Kocuria species, along with Pediococcus, Lactobacillus, and Staphylococcus, are commonly applied in food industry as starter cultures, it is important to further verify the potential involvement of these bacteria in the initiation of disease process or exacerbation of the underlying diseases in mammalian hosts. The development and application of molecular tests for rapid, sensitive, and specific identification and detection of Kocuria species are not only vital to pinpoint the roles of these bacteria in disease initiation and/or exacerbation, but also provide a
Kocuria
differential diagnosis that will confirm or rule out the potential involvement of these bacteria in foodborne disease outbreaks. Future refinement of sample preparation procedures and adoption of real-time detection formats will further enhance the utility and performance of molecular tests for direct identification and differentiation of Kocuria spp. from clinical, food and environmental specimens.
References
1. Stackebrandt, E. et al. Taxonomic dissection of the genus Micrococcus: Kocuria gen. nov., Nesterenkonia gen. nov., Kytococcus gen. nov., Dermacoccus gen. nov., and Micrococcus Cohn 1872 gen. emend. Int. J. Syst. Bacteriol., 45, 682, 1995. 2. Takarada, H. et al. Complete genome sequence of the soil actinomycete Kocuria rhizophila. J. Bacteriol., 190, 4139, 2008. 3. Kovacs, G. et al. Kocuria palustris sp. nov. and Kocuria rhizophila sp. nov., isolated from the rhizoplane of the narrow-leaved cattail (Typha angustifolia). Int. J. Syst. Bacteriol., 49, 167, 1990. 4. Reddy, G.S. et al. Kocuria polaris sp. nov., an orange-pigmented psychrophilic bacterium isolated from an Antarctic cyanobacterial mat sample. Int. J. Syst. Evol. Microbiol., 53, 183, 2003. 5. Kim, S.B. et al. Kocuria marina sp. nov., a novel actinobacterium isolated from marine sediment. Int. J. Syst. Evol. Microbiol., 54, 1617, 2004. 6. Tvrzova, L. et al. Reclassification of strain CCM 132, previously classified as Kocuria varians, as Kocuria carniphila sp. Nov. Int. J. Syst. Evol. Microbiol., 55, 139, 2005. 7. Li, W.J. et al. Kocuria aegyptia sp. nov., a novel actinobacterium isolated from a saline, alkaline desert soil in Egypt. Int. J. Syst. Evol. Microbiol., 56, 733, 2006. 8. Mayilraj, S. et al. Kocuria himachalensis sp. nov., an actinobacterium isolated from the Indian Himalayas. Int. J. Syst. Evol. Microbiol., 56, 1971, 2006. 9. Zhou, G. et al. Kocuria flava sp. nov. and Kocuria turfanensis sp. nov., airborne actinobacteria isolated from Xinjiang, China. Int. J. Syst. Evol. Microbiol., 58, 1304, 2008. 10. Peces, R. et al. Relapsing bacteraemia due to Micrococcus luteus in a haemodialysis patient with a Perm-Cath catheter. Nephrol. Dial. Transplant., 12, 2428, 1997. 11. von Eiff, C. et al. Micrococcus luteus as a cause of recurrent bacteremia. Pediatr. Infect. Dis. J., 15, 711, 1996. 12. Souhami, L. et al. Micrococcus luteus pneumonia: a case report and review of the literature. Med. Pediatr. Oncol., 7, 309, 1979. 13. Selladurai, B.M. et al. Intracranial suppuration caused by Micrococcus luteus. Br. J. Neurosurg., 7, 205, 1993. 14. Wharton, M. et al. Septic arthritis due to Micrococcus luteus. J. Rheumatol., 13, 659, 1986. 15. Fosse, T. et al. Meningitis due to Micrococcus luteus. Infection, 13, 280, 1985. 16. Spencer, R.C. Infections in continuous ambulatory peritoneal dialysis. J. Med. Microbiol., 27, 1, 1988. 17. Richardson, J.F., Marples, R.R. and de Saxe, M.J. Characters of coagulase-negative staphylococci and micrococci from cases of endocarditis. J. Hosp. Infect., 5, 164, 1984. 18. Shapiro, S. et al. Origin of organisms infecting ventricular shunts. Neurosurg. 22, 868, 1988. 19. Yap, R.L. and Mermel, L.A. Micrococcus infection in patients receiving epoprostenol by continuous infusion. Eur. J. Clin. Microbiol. Infect. Dis., 22, 704, 2003.
205 20. Basaglia, G. et al. Catheter-related bacteremia due to Kocuria kristinae in a patient with ovarian cancer. J. Clin. Microbiol., 40, 311, 2002. 21. Altuntas, F. et al. Catheter-related bacteremia due to Kocuria rosea in a patient undergoing peripheral blood stem cell transplantation. BMC Infect. Dis., 4, 62, 2004. 22. Martinaud, C. et al. Bacteremia caused by Kocuria kristinae in a patient with acute leukaemia. Med. Mal. Infect., 38, 165, 2008. 23. Ma, E.S. et al. Kocuria kristinae infection associated with acute cholecystitis. BMC Infect. Dis., 5, 60, 2005. 24. Martin, B. et al. Molecular, technological and safety characterization of Gram-positive catalase-positive cocci from slightly fermented sausages. Int. J. Food Microbiol., 107, 148, 2006. 25. Rossi, F. et al. Identification by 16S-23S rDNA intergenic region amplification, genotypic and phenotypic clustering of Staphylococcus xylosus strains from dry sausages. J. Appl. Microbiol., 90, 365, 2001. 26. Ryser, E.T. et al. Isolation and identification of cheese-smear bacteria inhibitory to Listeria spp. Int. J. Food Microbiol., 21, 237, 1994. 27. Papamanoli, E. et al. Characterization of Micrococcaceae isolated from dry fermented sausage. Food Microbiol., 19, 441, 2002. 28. Tremonte, P. et al. Interactions between strains of Staphylococcus xylosus and Kocuria varians isolated from fermented meats. J. Appl. Microbiol., 103, 743, 2007. 29. Gemmell, C.G. and Dawson, J.E. Identification of coagulasenegative staphylococci with the API staph system. J. Clin. Microbiol., 16, 874, 1982. 30. Chesneau, O. et al. Usefulness of the ID32 staph system and a method based on rRNA gene restriction site polymorphism analysis for species and subspecies identification of staphylococcal clinical isolates. J. Clin. Microbiol., 30, 2346, 1992. 31. Ben-Ami, R. et al. Erroneous reporting of coagulase-negative Staphylococci as Kocuria spp. by the Vitek 2 system. J. Clin. Microbiol., 43, 1448, 2005. 32. Boudewijns, M. et al. Vitek 2 automated identification system and Kocuria kristinae. J. Clin. Microbiol., 43, 5832, 2005. 33. Layer, F. et al. Comparative study using various methods for identification of Staphylococcus species in clinical specimens. J. Clin. Microbiol., 44, 2824, 2006. 34. Carretto, E. et al. Identification of coagulase-negative staphylococci other than Staphylococcus epidermidis by automated ribotyping. Clin. Microbiol. Infect., 11, 177, 2005. 35. Chesneau, O. et al. The value of rRNA gene restriction site polymorphism analysis for delineating taxa in the genus Staphylococcus. Int. J. Syst. Evol. Microbiol., 50, 689, 2000. 36. Cocolin, L. et al. A novel polymerase chain reaction (PCR)denaturing gradient gel electrophoresis (DGGE) for the identification of Micrococcaceae strain involved in meat fermentations. Its application to naturally fermented Italian sausages. Meat Sci., 57, 59, 2001. 37. Blaiotta, G. et al. Combining denaturing gradient gel electrophoresis of 16S rDNA V3 region and 16S-23S rDNA spacer region polymorphism analyses for the identification of staphylococci from Italian fermented sausages. Syst. Appl. Microbiol., 26, 423, 2003. 38. Becker, K. et al. Development and evaluation of a quality-controlled ribosomal sequence database for 16S ribosomal DNA-based identification of Staphylococcus species. J. Clin. Microbiol., 42, 4988, 2004.
206 39. Blaiotta, G., Casaburi, A. and Villani, F. Identification and differentiation of Staphylococcus carnosus and Staphylococcus simulans by species-specific PCR assays of sodA genes. Syst. Appl. Microbiol., 28, 519, 2005. 40. Yugueros, J. et al. Glyceraldehyde-3-phosphate dehydrogenase-encoding gene as a useful taxonomic tool for Staphylococcus spp. J. Clin. Microbiol., 38, 4351, 2000. 41. Lane, D.J. et al. Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses. Proc. Natl. Acad. Sci. USA, 82, 6955, 1985. 42. Weisburg, W.G. et al. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol., 173, 697, 1991.
Molecular Detection of Foodborne Pathogens 43. Wilson, K.H., Blitchington, R.B. and Greene, R.C. Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction. J. Clin. Microbiol., 28, 1942, 1990. 44. Woo, P.C. et al. Usefulness of the MicroSeq 500 16S ribosomal DNA-based bacterial identification system for identification of clinically significant bacterial isolates with ambiguous biochemical profiles. J. Clin. Microbiol., 41, 1996, 2003. 45. Jensen, M.A., Webster, J.A. and Straus, N. Rapid identification of bacteria on the basis of polymerase chain reactionamplified ribosomal DNA spacer polymorphisms. Appl. Environ. Microbiol., 59, 945, 1993.
15 Listeria
Dongyou Liu
Mississippi State University
Hans-Jürgen Busse
University of Veterinary Medicine Vienna
Contents 15.1 Introduction.................................................................................................................................................................... 207 15.1.1 Classification, Morphology, and Biology.......................................................................................................... 207 15.1.2 Epidemiology ................................................................................................................................................... 208 15.1.3 Clinical Features . ............................................................................................................................................ 209 15.1.4 Pathogenesis.......................................................................................................................................................210 15.1.5 Genomics...........................................................................................................................................................210 15.1.6 Diagnosis........................................................................................................................................................... 212 15.1.6.1 Conventian Techniques.................................................................................................................... 212 15.1.6.2 Molecular Techniques...................................................................................................................... 213 15.2 Methods.......................................................................................................................................................................... 213 15.2.1 Sample Preparation .......................................................................................................................................... 213 15.2.2 Detection Procedures.........................................................................................................................................214 15.2.2.1 Multipex PCR Identification of Listeria Species..............................................................................214 15.2.2.2 Multiplex PCR Differentiation of L. monocytogenes Serogroups . ................................................ 215 15.2.2.3 Multipex PCR Determination of L. monocytogenes Virulence ..................................................... 215 15.3 Conclusions and Future Perspectives..............................................................................................................................217 References...................................................................................................................................................................................217
15.1 Introduction 15.1.1 Classification, Morphology, and Biology The genus Listeria encompasses a group of closely related, Gram-positive, nonspore-forming, rod-shaped bacteria of 0.4–0.5 µm×1–1.5 µm in size and a relatively low G+C content ranging from 36 to 39%.1–3 This latter feature in combination with Gram staining behavior implies the relatedness of Listeria to the Firmicutes (Gram-positives with low G+C content) like Bacillus, Brochothrix, Clostridium, Enterococcus, Streptococcus, and Staphylococcus. Taxonomically, the genus Listeria comprises so far six species: L. monocytogenes, L. ivanovii, L. seeligeri, L. innocua, L. welshimeri, and L. grayi, with L. ivanovii being further divided into two subspecies (L. ivanovii subsp. londoniensis and L. ivanovii subsp. ivanovii). Given their ability to endure arduous external conditions including extreme pH, temperature, and salt ranges,4,5 Listeria species are abundantly present in a diversity of environments (e.g., soil, water, effluents, and foods). Whereas L. monocytogenes is a facultative intracellular pathogen of both humans and animals, L. ivanovii (previously known as L. monocytogenes serotype 5) mainly infects ungulated
animals (e.g., sheep and cattle),6 and the other four species are essentially saprophytes that have adapted for free-living in soil and decaying vegetation.7 Using serological techniques that detect interactions between Listeria somatic (O)/flagellar (H) antigens and their corresponding antisera, Listeria can be subdivided into at least 15 serovars, with L. monocytogenes consisting of serovars 1/2a, 1/2b, 1/2c, 3a, 3b, 3c, 4a, 4ab, 4b, 4c, 4d, 4e, and 7; L. ivanovii of serovar 5; L. innocua of serovars 4ab, 6a, and 6b; nd L. welshimeri of serovars 6a and 6b; L. seeligeri of 1/2b, 4c, 4d, and 6b; and L. grayi of serovar Grayi (Table 15.1).8 Upon various genetic typing analyses, L. monocytogenes is grouped into three genetic lineages, with lineage I comprising serovars 1/2b, 3b, 4b, 4d, and 4e; lineage II covering serovars 1/2a, 1/2c, 3a, and 3c; and lineage III containing serovars 4a and 4c.9,10 More recently, it has been shown that L. monocytogenes lineage III can be further classified into three distinct genetic subgroups IIIA, IIIB, and IIIC, with subgroup IIIA being composed of typical rhamnose-utilizing avirulent serovar 4a (which react with inlA and lmo0733, but not with inlJ and inlC, lmo1134, and lmo2672 primers) and virulent serovar 4c strains (which react with inlA, lmo0733, inlJ, and/or inlC, but not with
207
208
Molecular Detection of Foodborne Pathogens
Table 15.1 Compositions of Somatic (O)/Flagellar (H) Antigens in Listeria Serovars
Table 15.2 L. monocytogenes Serovars Causing Human Listeriosis
Serovar
Serotype
1/2a 1/2b 1/2c 3a 3b 3c 4a 4ab 4b 4c 4d 4e 7 5 6a 6b
O-antigen I, II I, II I, II II, IV II, IV II, IV (V), VII, IX V, VI, VII, IX V, VI V, VII (V), VI, VIII V, VI (VIII), (IX) XII, XIII (V), VI, (VIII), X V, (VI), (VII), (IX), XV (V), (VI) (VII), IX, X, XI
H-antigen A, B A, B, C B, D A, B A, B, C B, D A, B, C A, B, C A, B, C A, B, C A, B, C A, B, C A, B, C A, B, C A, B, C A, B, C
Source: Adapted from Seeliger, H.P.R. and Jones, D., Listeria. In Bergey’s Manual of Systematic Bacteriology, vol. 2. pp. 1235–1245. Sneath, P.H.A. et al. (eds.). Williams and Wilkins, Baltimore, MD, 1986.
lmo1134 and lmo2672 primers); subgroup IIIC of atypical nonrhamnose-utilizing virulent serovar 4c strains (which react with inlA, lmo0733, inlJ, inlC, and lmo2672, but not with lmo1134 primers); and subgroup IIIB of atypical rhamnose-negative virulent nonserovar 4a and nonserovar 4c strains (which react with inlA and lmo2672 and inlC, but not with lmo0733, inlJ, and lmo1134 primers), some of which may be related to serovar 7 (which also react with ORF2819 primers).11,12 It is possible that subgroup IIIB (including serovar 7) may represent a novel subspecies within L. monocytogenes.11,12 In accordance with its virulence potential in mammalian hosts, L. monocytogenes is also differentiated into pathogenic and nonpathogenic strains. It is most notable that L. monocytogenes serovars 4b, 1/2a, 1/2b, and 1/2c are responsible for over 98% isolations from clinical cases of human listeriosis, with serova 4b alone accounting for 49% of Listeria-related foodborne diseases (Table 15.2).13 In experimental mouse models, L. monocytogenes serovars 4b, 1/2a, 1/2b, and 1/2c tend to display higher infectivity than other serovars through intragastric inoculation.14 However, all L. monocytogenes serovars except 4a have the capability to cause mouse mortality via intraperitoneal route (Table 15.3).15–17 In general, Listeria spp. are nutritionally undemanding and grow well on a number of nonselective microbiological media such as tryptone soy broth and brain heart infusion (BHI) broth, although the availability of biotin, riboflavin, thiamine, thioctic acid, cysteine, glutamine, isoleucine, leucine, and valine as well as carbohydrates (e.g., glucose) aids to their optimal growth. The colonies (measuring 0.5–1.5 mm in diameter) of Listeria spp. usually emerge after 24–48 h incubation on laboratory agar media (e.g., blood agar or BHI
4b 1/2a 1/2b 1/2c 3a/3b
No. of Isolates (%) 294/603 (49%) 163/603 (27%) 120/603 (20%) 22/603 (4%) 4/603 (<1%)
Tendency to Cause CNS infections > M/N diseases > Bacteraemia Bacteraemia > M/N diseases > CNS infections M/N diseases > Bacteraemia > CNS infections Bacteraemia > CNS infections > M/N diseases Bacteraemia
M/N diseases, maternal-neonatal diseases; CNS infections, central nerve system infections. Source: Adapted from Goulet V., Euro Surveill., 11, 79, 2006, which was based on the analysis of 603 L. monocytogenes isolates from 603 French patients during 2001–2003. Notes:
agar), and appear as round, translucent, low convex with a smooth surface and a crystalline center. After 3–7 days, older colonies become larger (3–5 mm in diameter) and often show a more opaque appearance. Upon extended incubation, some rough colonies with a sunken center may develop occasionally; and some Listeria cells from older cultures may lose their ability to retain the Gram stain, and fail to display characteristic violet color. The optimal growth temperatures for Listeria are between 30 and 37ºC; at 20–28ºC, Listeria are motile with peritrichous flagella, but become nonmotile at 37°C. Nonetheless, due to their psychrotrophic nature, Listeria are able to survive and grow below 0ºC and up to 45°C. In terms of their pH resistance, Listeria grow well between pH 6 and pH 9, and show remarkable ability to recover after treatment with 100 mM Tris buffer at pH 3 and pH 12.5,18 In addition, Listeria can tolerate a range of osmolarity and have been shown to grow in the presence of 10% NaCl and recover from a 20-h treatment with 7 M NaCl.18
15.1.2 Epidemiology Due to their renowned ability to withstand extreme pH, temperature, and salt ranges, Listeria spp. are widely distributed in all environments. Although Listeria spp. are rarely isolated from unpolluted seawater, ground-water and spring (with an average presence of about 1%) where the availaibilty of nutrients is limited, they are commonly found in river and bay waters, sewage, and industrial and farming effluents (with an average detection rate of ≥ 20%). Indeed, the incidence of Listeria spp. in water appears to increase with animal and human activity, as polluted water and sewage/sludge contain various nutrients essential for Listeria growth in compassion with unpolluted water. Listeria spp. are also routinely isolated in soil and plants (with an average presence of 20%) where they exist as saprophytes and sanvengers. L. monocytogenes (especially serovars 1/2a, 1/2b, and 1/2c, which happen to be commonly associated with human foodborne listeriosis) has the ability to adhere to the surfaces of food processing
209
Listeria
Table 15.3 L. monocytogenes Serovars and Relative Virulence PCR Strain
Source
Serovar
inlJ
inlC
LD50a
Relative Virulence (%)b
1
+
+
<7.0 × 10
70
1/2a
+
+
<1.1 × 107
100
2
+
+
1.6 × 109
30
Ruminant brain
4a
–
–
1.9 × 1010
0
HCC25
Catfish kidney
4a
–
–
3.5 × 1010
0
ATCC 19115
Human
4b
+
+
6.0 × 108
70
ATCC 19116
Chicken
4c
+
–
2.6 × 108
100
874
Cow brain
4c
+
+
<8.0 × 107
100
ATCC 19117
Sheep
4d
+
+
8.8 × 108
40
ATCC 19118
Chicken
4e
+
+
7.8 × 109
50
R2-142
Food
7
–
+
<5 × 107
100
HCC8
Catfish brain
EGD
Guinea pig
ATCC 19112
Human
ATCC 19114
8
Sources: Adapted from Liu, D., FEMS Microbiol. Lett., 233, 159, 2004 and Liu, D. et al., J. Clin. Microbiol., 44, 2229, 2006. LD50 (medium lethal dose) values were determined in A/J mouse strain via intraperitoneal route.15,16 b Relative virulence (%) is calculated by dividing the number of dead mice with the total number of mice tested using EGD as reference.16
a
benches, machineries, and floors, in which it develops into biofilm matrix with increased resistance to adverse conditions. On the whole, L. monocytogenes and especially L. innocua are more frequently isolated from the environments than L. seeligeri, L. ivanovii, and L. seeligeri; and L. grayi is seldom reported from environmental samples. Similarly, Listeria spp. are isolated more frequently from fish and seafoods caught in waters with farms and human settlements nearby than those harvested from unpolluted waters. In addition, a varity of meat products (e.g., chicken, pork, and beef) provide nutritional media for Listeria growth and maintenance, and it is no surprise that a relatviley high prevalence (often in the range of 20–65%) of L. monocytogenes and Listeria spp is frequently observed in these products. On the other hand, the presence of Listeria spp. and L. monocytogenes in raw bulk tank milk, dairy milk and vegetables is generally low (often <5%). Considering the tendency toward increased comsuption of processed and ready-to-eat (RTE) food products in recent decades, contaminated foods (e.g., “gravad” or smoked rainbow trout, smoked mussels, RTE meat, and dairy products) have been responsible for many of the human listeriosis outbreaks documented worldwide. This can be attributable to the fact that vacuum packaging, cooling, acid, and alkaline treatments may eliminate other bacteria in the manufactured food products but not Listeria spp., since Listeria are capable of producing fatty acids of the anteiso-type instead of the iso-type to enhance their resistance to cold temperature and other external stresses. While between 15 and 20% of wildlife and domestic animals are found to be infected with Listeria spp. (including pathogenic L. monocytogenes and L. ivanovii) via ingestion of Listeria-contaminated feed (e.g., silage and grasses) and water, the prevalence of Listeria spp. in human population is relatively low at about 3.4–7.7 cases of listeriosis per million as reported in the USA and France. However, the incidence of L. monocytogenes infections is notably higher among
pregnant women (accounting for about 17–24% of clinical cases of listeriosis) and elderly (50% of the cases involving people aged >70 years) as well as individuals with underlying diseases (e.g., cancer, organ transplantation, AIDS, chronic hepatic disorder and diabetes), who are taking medications (e.g., systemic steroids or cyclosporine), or receiving radiation treatment or chemotherapy. The prevalence of Listeria spp. in asymptomatic healthy adults ranges from 1 to 5%. Interestingly, of the 603 human listeriosis cases recorded in France during 2001–2003 in France (see Table 15.2), serovars 4b, 1/2a, and 1/2b accounted for 96% of the cases.13
15.1.3 Clinical Features L. monocytogenes (originally named Bacterium monocytogenes) was first identified in the UK by E.G.D. Murray in 1926 as a cause of infection with monocytosis in laboratory rodents. For a considerable period, this bacterium has been regarded largely as a bacterial pathogen of animals (e.g., ruminants, pigs, dogs, and cats), with the affected animals showing encephalitis signs (with uncoordinated posture and circular movement, the so-called “circling disease”), abortion or septicaemia. Along with a trend toward increasing consumption of RTE and heat-and-eat convenient food products, L. monocytogenes has emerged as a significant foodborne pathogen in the late 1970s and early 1980s, when several large outbreaks of foodrelated human listeriosis cases with significant morbidity and mortality occurred. In fact, with mortality rates on average approaching 30%, L. monocytogenes far exceeds other common foodborne pathogens, such as Salmonella enteritidis (with a mortality of 0.38%), Campylobacter species (0.02–0.1%) and Vibrio species (0.005–0.01%) in terms of disease severity.19,20 During the early stages of infection, human listeriosis often displays nonspecific flu-like symptoms (e.g., fever and chills,
210
fatigue, headache, and muscular and joint pain) and gastroenteritis (which may be observed before the onset of bacteraemia or in healthy individuals infected with a high dose of L. monocytogenes not accompanied by other symptoms). The severity and prognosis of the disease are clearly dependent on the immune status of individuals. In the immunocompetent individuals, the invading L. monocytogenes bacteria are valantly fought off and eliminated by host’s cell-mediated immune network and the disease symptoms often disappear with a short period (in a matter of days). However, in the immunocomprimised individuals such as pregnant women, neonates, the elderly, and individuals under chemotherapy that suppresses immune functions, L. monocytogenes has a propensity to cause especially severe problems with abortion and occasional death as frequent outcomes, given L. monocytogenes’ ability to cross host’s intestinal, blood-brain, and fetoplacental barriers, affecting the uterus at pregnancy, the central nervous system or the bloodstream. In early-onset fetomaternal/neonatal listeriosis, L. monocytogenes enter the blood stream of pregnant women (who may be asymptomatic), colonize the placenta, and invade the fetus, leading to abortion within the last third of the gestation period, with a stillborn fetus or the birth of a baby showing a severe, most often fatal septicemic syndrome known as “granulomatosis infantiseptica.” In the late-onset perinatal listeriosis resulting either from low-level transplacental infection or horizontal transmission at neonatology wards, newborns between weeks one and eight postpartum often show a febrile syndrome associated with meningitis, although gastroenteritis and pneumonia can also be observed. The mortality of later-onset listeriosis is generally lower than that in early-onset listeriosis.
15.1.4 Pathogenesis In a typical mode of infection, L. monocytogenes enters the host via contaminated foods. After sustaining exposure to host proteolytic enzymes, the acidic stomach environment (pH 2.0), bile salts and nonspecific inflammatory attacks, largely through the actions of several stress-response genes (opuCA, lmo1421, and bsh) and related proteins.4 L. monocytogenes adheres to and is internalized by host cells with the assistance of a family of surface proteins called internalins. The most notable internalins are InlA and InlB. Whereas InlA (an 88-kDa protein encoded by inlA) interacts with E-cadherin to mediate L. monocytogenes entry into epithelial cells, InlB (a 65-kDa protein encoded by inlB) recognizes C1q-R (or Met) to facilitate L. monocytogenes entry into a much broader range of host-cell types, including hepatocytes, fibroblasts, and epithelioid cells. Besides InlA and InlB, other internalins (e.g., InlC and InlJ) also appear to be involved in the later (i.e., post intestinal) stages of L. monocytogenes infection.21–23 This internalization process enhances L. monocytogenes evasion of host immune surveillance functions.7 Following its uptake by host cells, L. monocytogenes is primarily located in single-membraned vacuoles. Two virulence-associated molecules are responsible for lysis of the
Molecular Detection of Foodborne Pathogens
primary single-membraned vacuoles and subsequent escape by L. monocytogenes: listeriolysin O (LLO) and phosphatidylinositol-phospholipase C (PI-PLC). LLO (a 529-amino acid, 58-kDa protein encoded by hly) is a pore-forming, thiol-activated toxin that is essential for L. monocytogenes virulence. PI-PLC (a 33-kDa protein encoded by plcA), acting in synergy with phosphatidylcholine-phospholipase C (PC-PLC, a 29-kDa protein encoded by plcB), aids LLO in lysing the primary vacuoles.7 After lysis of the primary single-membraned vacuoles, L. monocytogenes is released to the cytosol, where it starts multiplying intracellularly shortly afterward (with generation time of 40–60 min, which is comparable to those observed in rich broth culture). The host cell cytoplasm hence allows listerial growth with high efficiency. The intracellular mobility and cell-to-cell spread of L. monocytogenes require another surface protein, ActA (a 67-kDa protein encoded by actA), which is cotranscribed with PC-PLC and mediates the formation of polarized actin tails that propel the bacteria toward the cytoplasmic membrane. At the membrane, bacteria become enveloped in filopodium-like structures that are recognized and engulfed by adjacent cells, resulting in the formation of secondary double-membraned vacuoles. A successful lysis of the secondary double-membraned vacuoles signals the beginning of a new infection cycle, which is dependent on PC-PLC upon activation by Mpl (a 60-kDa metalloprotease encoded by mpl).7 The genes encoding the virulence-associated proteins PI-PLC, LLO, Mpl, ActA, and PC-PLC are located in a 9.6-kb virulence gene cluster,23 which is primarily regulated by a pleiotropic virulence regulator, PrfA, (a 27-kDa protein encoded by prfA). The prfA gene is situated immediately downstream of, and sometimes cotranscribed with, the plcA gene. PrfA activates the transcription of many L. monocytogenes virulence-associated genes. The genes encoding InlA and InlB are positioned elsewhere in the genome. As the inlA and inlB genes possess a transcription binding site similar to that recognized by PrfA, they may also be partially regulated by PrfA. In addition to these virulence-associated genes and proteins, many other genes such as iap (encoding invasion-associated protein, or Iap, now known as p60) also play essential roles in L. monocytogenes virulence and pathogenicity.7 Belonging to a protein family with two other members in L. monocytogenes (p45, a peptidoglycan (PG) lytic protein encoded by the spl gene, and the hypothetical protein encoded by lmo394), p60 is a highly basic protein of 484 amino acids with an indirect role in modifying bacterial behavior via its impact on cell division.
15.1.5 Genomics The recent completion of the whole genome sequences of several Listeria strains has uncovered valuable new details on the differential genetic compositions among Listeria species (Table 15.4). Currently, the complete genome sequences of two L. monocytogenes serovar 1/2a (EGD-e and F6854) and two serovar 4b (F2365 and H7858) strains, one L.
211
Listeria
Table 15.4 Comparison of Listeria Genomes L. monocytogenes Feature Serovar Genome size (bp) G+C content (%) Protein-coding genes (ORFs) Strain-specific genes
EGD-e
F6854
F2365
H7858
L. innocua CLIP 11262
L. welshimeri SLCC 5334
1/2a 2,944,528 39 2853 61
1/2a 2,950,285 37.8 2973 97
4b 2,905,187 38 2821 51
4b 2,972,254 38 3024 69
6a 3,011,208 37.4 2973 149
6b 2,814,130 36.4 2780 311
Sources: Adapted from Glaser, P. et al., Science, 294, 849, 2001; Nelson, K.E. et al., Nucleic Acids Res., 32, 2386, 2004 and Hain, T. et al., J. Bacteriol., 188, 7405, 2007.
innocua strain (CLIP 11262) and one L. welshimeri strain (SLCC 5334) are available (Table 15.4).1–3 The sequencing analyses of 15 other L. monocytogenes strains covering serovars 1/2a (7), 1/2b (4), 1/2c (1), 4b (1), and unknown (2) are in progress. Comparison of the six Listeria genomes at the nucleotide and predicted protein levels shows that in addition to many shared genetic components, a total of 51, 97, 69, and 61 strain-specific genes are identifiable from L. monocytogenes serovar 1/2a strains EGD-e and F6854, and serovar 4b strains F2365 and H7858, respectively (Table 15.4). Further analysis reveals that 83 of these genes are limited to the serovar 1/2a strains (of lineage II), and 51 genes are limited to the serovar 4b strains (of lineage I). In addition, 149 and 311 speciesspecific genes are recognized in L. innocua CLIP 11262 and L. welshimeri SLCC 5334, respectively (Table 15.4).1–3 Since L. monocytogenes strain-specific genes tend to have atypical base composition, some of them may have been acquired by horizontal gene transfer. Moreover, some L. monocytogenes strain-specific genes encode putative surfaceassociated proteins such as internalins, which may contribute to the increased pathogenicity of the strains concerned.2 Surprisingly, 37 (44%) of the 83 serovar 1/2a-specific and 33 (65%) of the 51 serovar 4b-specific genes encode hypothetical proteins for which no biochemical information is available. The serovar 1/2a-specific genes include three clusters that encode pathways for the transport and metabolism of carbohydrates, an operon that encodes the biosynthetic pathway for the antigenic rhamnose substituents that decorate the cell wall-associated teichoic acid polymer in serovar 1/2a strains, five glycosyl transferases and an adenine-specific DNA methyltransferase.2 While the genomes of serovar 4b strains (F2365 and H7858) do not contain intact insertion sequence (IS) elements, they harbor four copies of transposase ORFA of the IS3 family. Similarly, the genomes of serovar 1/2a strains (F6854 and EGD-e) possess three copies of the same transposase ORFA in a corresponding location. The extra copy of the transposase ORFA in the serotype 4b strains F2365 and H7858 may have resulted from a duplication event (along with the associated regions). Further, an intact IS element (ISLmo1) is present in the serotype 1/2a strains F6854 (two
copies) and EGD-e (three copies), respectively. Because all L. monocytogenes genomes sequenced to date harbor copies of transposase ORFA, it is probable that transposase ORFA gene may have originated from the genome of an ancestral Listeria before the strains diverged, in comparison to ISLmo1, which may represent a recent acquisition in serovar 1/2a strains.2 Apart from possessing many unique genes, Listeria species/serovars also demonstrate differences among their shared genes. For example, Southern blot analysis with a virulencespecific internalin inlJ probe revealed that genomic DNA from the more pathogenic L. monocytogenes serovars (e.g., 1/2a, 1/2b, 1/2c, and 4b) tends to show a 5.0-kb HindIII band, and that from the less pathogenic serovars (e.g., 3a and 4c) forms a 1.5- or 2.0-kb HindIII fragment. On the other hand, genomic DNA from the nonpathogenic L. monocytogenes serovars (i.e., 4a) shows no band.12,24 Similarly, although being present in all L. monocytogenes serovars, transcriptional regulator gene lmo0733 is recognized as a HindIII band of 5.0 or 6.0 kb in the more pathogenic serovars (e.g., 1/2a, 1/2c, and 4b) and as a HindIII band of 1.0 or 1.5 kb in the less pathogenic or nonpathogenic serovars (e.g., 4a and 4c).12,24 In addition, examination of PG N-deacetylase gene pgdA (lmo0415) in Listeria by Southern blot indicates that L. monocytogenes serotypes 4a and 4c show a smaller band of 1.5 kb while other serotypes have a larger band of 4.0 or 5.0 kb. Further, whereas L. innocua and L. welshimeri display a band of 4.0 kb, L. seeligeri a band of 3.0 kb, L. ivanovii a band of 1.5 kb, L. grayi forms no band at all.12 Given that N-deacetylation of PG provides strength and rigidity to bacterial cell wall, it is no surpise that the absence of pgdA (lmo0415) in L. grayi renders it susceptible to lysozyme treament.12 Indeed, a L. monocytogenes mutant lacking PG N-deacetylase gene (i.e., pgdA or lmo0415) is also highly sensitive to killing by lysozyme, and has impaired ability to survive and/or replicate within macrophages.25 In addition, recent studies indicate that there are some unusual Listeria strains possessing genetic elements that normally belong to other Listeria species. For example, examination of several hemolytic L. innocua strains (e.g., PRL/NW 15B95 and J1-023) revealed the presence of Listeria pathogenicity island 1 (LIPI-1, or PrfA-regulated virulence gene
212
cluster), in these atypical L. innocua strains, contributing to their positive hemolytic reactions.26,27 The PrfA-regulated virulence gene cluster was previously found in L. monocytogenes, L. ivanovii, and L. seeligeri only.23 Futhermore, these atypical L. innocua strains also harbor L. monocytogenes internalin gene inlA and partial internalin gene inlB sequences.26,27 The L. innocua species status of these strains was only resolved after DNA–DNA hybridization, microarray, and PCR experiments targeting a host of L. innocua-specific genes.26,27 Similarly, L. monocyotogenes serovars 4a and 4c strains harboring L. innocua-specific genes lin0464, lin0372, and lin1073 have also been described.28–30 These findings suggest that L. innocua may have descended from L. monocytogenes through successive gene deletion, and that atypical hemolytic strains PRL/NW 15B95 and J1-023 may represent some intermediates that have yet to completely eliminate or lose the remaining L. monocytogenes genes.27 Doumith et al.31 also presented evidence that an ancestral L. monocytogenes strain (probably of serovar 1/2a) might have evolved to become serovar 4b through gene deletion, which latter gave rise to serovar 4a possibly via serovar 4c, and finally to L. innocua via additional gene deletion events. The fact that L. monocytogenes serovar 4c and 4a strains harboring L. innocua-specific genes lin0464, lin0372, and lin1073 indicates the possibility that during their transition to L. innocua, some L. monocytogenes strains may pick up certain L. innocua genes while shedding their own. Obviously, additional microarray and sequencing studies are required to determine what other L. innocua genes that have been gained by these unusual L. monocytogenes 4a and 4c strains, and what L. monocytogenes genes have been lost by these strains. The availability of these data will lead to a better understanding of Listeria evolution and yield new details on the phylogenetic relationship among individual Listeria species.
15.1.6 Diagnosis 15.1.6.1 Conventian Techniques (i) In vitro culture isolation: As Listeria are not distinguishable from other Gram-positive bacteria, and are often present in insufficient numbers for direct detection by serological and molecular procedures, in vitro culture enrichment and isolation are undertaken. For isolation of Listeria spp. from nonsterile samples such as food, environmental samples and feces, a range of selective broths and agars are available. PALCAM and OXFORD selective agars are recommended by ISO 11290-1, 2, for primary and secondary plating media, respectivley, for isolation of all Listeria spp.32 Furthermore, chromogenic medium ALOA is also useful for Listeria isolation. This agar medium incorporates 5-bromo-4-chloro3-indolyl-β-D-glucopyranosid as an enzyme substrate for β-D-glucosidase that is secreted by all Listeria spp, leading to the formation of typical blue-turquoise colonies. The inclusion in ALOA of L-α-phosphatidylinositol as a second substrate for phospholipase C, which is a virulence factor produced by pathogenic L. monocytogenes and L. ivanovii, results in the formation of typical blue-turquoise colonies with
Molecular Detection of Foodborne Pathogens
an outer white zone of precipitation. Application of selective chromogenic L. monocytogenes plating media facilitates the presumptive detection of L. monocytogenes within 24 or 48 h. Subsequent confirmation of Listeria identity can be then achieved with biochemical, immunological, and molecular tests. (ii) Biochemical tests: Besides being catalase positive, and indole and oxidase negative, Listeria species can hydrolyse aesculin, but not urea. Additionally, Listeria species show significant variations in their ability to hemolyse horse or sheep red blood cells, and in their ability to produce acid from L-rhamnose, D-xylose and α-methyl-D-mannoside. Of the six Listeria species, L. monocytogenes (producing listeriolysin or LLO), L. ivanovii (producing ivanolysin or ILO), and L. seeligeri (producing seeligeriolysin or SLO) are known to be hemolytic, while L. innocua, L. welshimeri, and L. grayi are generally not. This difference in hemolytic activity is utilized as one of the criteria for discrimination among Listeria species. Furthermore, L. ivanovii is differentiated biochemically from L. monocytogenes and other Listeria species by its production of a wide, clear or double zone of haemolysis on sheep or horse blood agar, a positive Christie–Atkins–Munch-Petersen (CAMP) reaction with Rhodococcus equi but not with hemolytic Staphylococcus aureus, and fermentation of D-xylose but not L-rhamnose.33 Additionally, L. ivanovii is distinguished from L. monocytogenes by its strong lecithinase reaction with or without charcoal in the medium, in comparison to L. monocytogenes, which requires charcoal for its lecithinase reaction.34 Similarly, L. innocua is distinguished from L. monocytogenes on the basis of its negative CAMP reaction and its failure to cause β-haemolysis or to show PI-PLC activity on chromogenic media. L. welshimeri is distinguished from other Listeria species by its negative β-haemolysis and CAMP reactions, and by its acid production from D-xylose and α-methyl-Dmannoside.35 The development and application of several commercial kits (e.g., API-Listeria, Listeria ID, Microbact 12L, and MICRO-ID Listeria) further facilitate the concurrent and convenient biochemical identification of L. monocytogenes and differentiation from other Listeria spp. (iii) Serological tests: Agglutination and enzyme-based immunoassay (EIA) employing polyclonal and monoclonal antibodies to Listeria antigens are examples of serological methods that provide an ease-of-use approach for speciesspecific identification of L. monocytogenes and other Listeria species. A large number of commercial kits on the basis of serological reactivity have been marketed by various companies. These include Assurance Listeria EIA, Dynabeads antiListeria, EIA Foss Listeria, ListerTest Listeria Rapid Test, Listeria-Tek, TECRA Listeria Visual Immuno Assay, Transia Plate Listeria, Vidas LIS, Vidas LMO, and VIP for Listeria, etc. In additon to species-specific identification, serological techniques are also useful for serotyping Listeria strains.36 Specifically, the presence of unique combinations of somatic (O) antigens of I–XV and flagellar (H) antigens of A–D in Listeria strains enables their classification into 15 serovars (Table 15.1).8 This information is critical for epidemiological
213
Listeria
tracking of L. monocytogenes involved in epidemic outbreaks of listeriosis. However, with both L. monocytogenes and L. seeligeri containing serovars 1/2a, 1/2b, 3b, 4a, 4b, 4c, and 6b, the inability of serotyping methods to correlate serovars directly with species identities limits their potential for clinical application. This is further exacerbated by the fact that due to antigen sharing among various L. monocytogenes serovars, with 1/2a and 3c both possessing H antigens A and B; 4a–d, 1/2b and 3b all having H antigens A, B, and C; 1/2c and 3a both harboring H antigens B and D; and multiple, common O antigens being present in different serotypes (Table 15.1), it can be a challenge to conclusively determine the serovar of some L. monocytogenes strains, especially among serovars 4a, 4b, and 4c, which demonstrate contrasting pathogenicity.24 The high cost of acquiring subtype-specific antisera also makes the use of serotyping methods unattractive. Like biochemical methods, serotyping methods are also liable to give occasional discrepant results because of their dependence on the phenotypic characteristics of Listeria bacteria. For these reasons, serotyping methods have largely been superseded by molecular procedures that are intrinsically more specific and sensitive for the identification and differentiation of Listeria species. (iv) In vivo assays: Because L. monocytogenes serovars demonstrate varied infectivity, pathogenicity, and virulence in mammalian hosts, in vivo assays based on animal models such as rodents offer a valuable means to confirm their virulence potential as well as their identity in light of the fact that L. innocua, L. seeligeri, L. welshimeri, and L. grayi are nonpathogenic. Interestingly, through intragastric injection, L. monocytogenes epidemic strains appeared to show higher invasiveness than environmental strains,37 although via intraperitoneal inoculation, all L. monocytogenes serovars but 4a were capable of causing mouse mortality (see Table 15.3).15– 17,38,39 Moreover, in vivo mouse models provide an indispensable tool for the studies of L. monocytogenes pathogenesis and virlence mechanisms that are not easily obtained with in vitro techniques. 15.1.6.2 Molecular Techniques While conventional techniques have proven useful for identification of Listeria bacteria, they often suffer from the shortcomings such as time-consuming and variability due to their dependence on the phenotypic characteristics of the bacteria. On the other hand, molecular procedures are intrinsically more specific and sensitive, and have been increasingly regarded as the methods of choice for improved identification and differentiation of Listeria species. A number of molecular characteristics of Listeria bacteria have been exploited for their identification. For example, the proportion of guanine and cytosine (or G+C content, usually expressed as a mol%) among Listeria species differs from each other (ranging from 36 to 38 mol%), and also from other bacteria (e.g., Esherichia coli at about 50 mol%). Random primer sites and repetitive elements (e.g., repetitive extragenic palindromes or REP; enterobacterial repetitive intergenic consensus sequences or ERIC; variable-number tandem repeats or
VNTR) offer useful targets for PCR-based amplification and differentiation, which are not depedent on the availability of detailed gene sequences of interest. Additionally, restriction enzyme sites provide a way to differentiate and type Listeria strains using pulse-field gel electrophoreis (PFGE), restriction fragment length polymorphism (RFLP) and ribotyping procedures, etc.40 More specific gene targets for Listeria identification comprise rRNA coding genes (i.e., small-subunit 16S and large subunit 23S rRNA genes as well as region 16S–23S intergenic spacer), house keeping genes (groESL, rpoB, recA, gyrB, and prs), genes encoding for invasion associated protein (iap), flagellin A (flaA) and fibronectin-binding protein (fbp), a large number of species-specific (e.g., hly, plcA, plcB, actA, mpl, inlA, inlB, delayed-type hypersensitivity gene, aminopeptide gene and putative transcriptional regulator gene lmo0733), and group-specific genes (e.g, lmo2821, lmo1134, and lmo2672).15,40,41 In addition, a number of genes unique to individual Listeria species have been also described and applied for improved differentiation of nonmoncytogenes Listeria species from L. monocytogenes.29,42–84 Incorporation of specific primers from some of these genes facilitated the development of multiplex PCR assays for improved differentiation among Listeria species.28 Further, specific primers have also been applied in multiplex PCR formats for separation of L. monocytogenes serovar groups.85,86 In addition, by using primers from inlA for species-specific recognition, and those from inlJ (or lmo2821) and inlC for virulence determination in a multiplex PCR, it is possible to differentiate L. monocytogenes naturally avirulent serovar 4a strains from other serovars with potential to cause mouse mortility via intraperitoneal route.17,87,88 The advent of microarray technology in recent years provides new opportunities for L. monocytogenes gene activation analysis in host-pathogen relationships, without the limitations that are encountered with the existing genomic and transcriptional procedures. In other words, the microarray technology combines the feature of genomic technique for confirming the presence of genes with that of transcription analysis for evaluating gene expression. This permits the investigation of the in/activation (down/up-regulation) of L. monocytogenes virulence-associated genes during distinct phases of infection in mammalian hosts and under other strenuous external conditions.89,90
15.2 Methods 15.2.1 Sample Preparation Bacterial isolation. As most food samples contain very few L. monocytogenes bacteria, an enrichment, and/or isolation process is required prior to identification by biochemical and molecular techniques. Typically, 25 g of food is homogenized using a blender in 225 ml of culture medium (e.g., half Fraser broth, which contains half a volume of acriflavine and nalidixic acid), and incubated at 30°C for 24 h. Afterward, a 0.1 ml of the primary enriched culture is added
214
Molecular Detection of Foodborne Pathogens
to 10 ml of full strength Fraser broth (which contains one volume of acriflavine and nalidixic acid), and incubated at 37°C for 24 h. A loopful of the secondary enrichment culture is then streaked onto BCM® Listeria monocytogenes plating medium at 37°C for 24 h for production of turguoise colonies.32
Alternatively, if Listeria DNA is intended for PCR only, it can be prepared by boiling. Namely, suspend one to two colonies in 100 μl of 50 mM NaOH, vortex, heat at 100°C for 10 min, add 10 µl of 1 M Tris pH 8.0, centrifuge at 13,000×g for 1 min, and use 2–5 μl in 25 µl PCR mixture.
DNA extraction:
15.2.2 Detection Procedures
(1) Transfer Listeria colonies (or retrieve isolates from frozen glycerol stocks) onto 5% sheep blood agar plate (e.g., Tryptic soy agar II, Becton Dickinson Microbiology Systems, Cockeysville, MD) and incubate at 37°C overnight. Then transfer several colonies of each strain into 5 ml of BHI broth (Difco Laboratories, Detroit, MI) and keep at 37°C for 16–18 h, shaking at 250 rpm (with OD at 620 nm of >1.0). (2) Pellet the bacteria at 3000 rpm for 10 min, and decant the supernatant. (3) Resuspend the cell pellet in 500 μl of DNA lysis buffer (30 mM Tris-HCl pH 8.0, 30 mM EDTA pH 8.0, 150 mM NaCl, 0.5% SDS, 0.5% Triton X-100 and 0.5% Tween 20) by vortexing; add 10 μl of freshly made lysozyme (10 mg/ml), and 5 μl of RNase A (10 mg/ml), and incubate at 37°C for 30 min. Note: a COmbination of detergents is included in this DNA lysis buffer to allow efficient lysis of all bacterial categories. While most Gram-negative and Gram-positive bacteria are readily lysed in the presence of 1% SDS, some Gram-positive bacteria such as Listeria tend to lyse more easily in the presence of 0.5–1% Triton X-100. (4) Add 10 μl of proteinase K (10 mg/ml), and incubate at 56°C for 1–2 h (when the lysate becomes clear). (5) Transfer the lysate to a 1.5 ml tube, add one volume (500 μl) of phenol/chloroform/isoamyl-alcohol (25:24:1), and mix by inversion. (6) Centrifuge at 13,000 rpm for 10 min (repeat Steps 6 and 7 once for increased DNA purity if desired). (7) Transfer supernatant to a new 1.5-ml tube, add one volume (about 500 μl) of isopropyl alcohol and 20 μl of 5 M NaCl (to a final concentration of 0.10–0.15 M), mix by inversion, and centrifuge at 13,000 rpm for 10 min at 4°C. (8) Discard supernatant, add 300 μl of 70% ethanol (stored at –20°C), and centrifuge at 13,000 rpm for 2 min at 4°C. (9) Discard supernatant, invert the tube on a paper towel, air dry for 10 min. (10) Dissolve the DNA pellet in 200 μl of 1×TE (10 mM Tris-HCl pH 8.0 and 1 mM EDTA pH 8.0), determine the DNA concentration at UV 260/280 nm in a spectrophotometer, and store at –20°C. A small amount of DNA from each strain is diluted in distilled water to 10 ng/µl for PCR analysis.
15.2.2.1 Multipex PCR Identification of Listeria Species Principle: Based on the six Listeria species-specific genes described previously,42–47 Huang et al.28 designed two multiplex PCR, with one focusing on L. welshimeri, L. monocytogenes, and L. seeligeri; and another on L. ivanovii, L. grayi, and L. innocua (Table 15.5) Procedure: (1) Prepare the PCR mixture (25 μl) containing 0.5 U Taq Gold DNA polymerase (Applied Biosystems, Foster City, CA), 1 × PCR buffer (10 mM Tris pH 8.3, 50 mM KCl, 2.5 mM MgCl2), 200 μM dNTPs, 25 pmol each primer (L. welshimeri, L. monocytogenes, and L. seeligeri in pool 1; L. ivanovii, L. grayi, and L. innocua in pool 2), 2 μl DNA (prepared by boiling method), and distilled water (to 25 μl). Include a tube containing PCR mixture without DNA template as a negative control in each run. (2) Run the following cycling program in a GeneAmp PCR System 9700 (Perkin Elmer, Boston, MA): one cycle of 95ºC for 9 min; 30 cycles of: 94ºC for 30 sec, 60ºC for 30 sec, and 72ºC for 1 min; and one cycle of 72ºC for 7 min. (3) After completion of PCR cycles, add 3 μl of 6 × DNA loading buffer into each tube; load 15 μl of PCR product on 2.0% agarose gel containing 0.5 μg/ml ethidium bromide. Include a DNA molecular marker in a spare lane. Run at 5 V per cm gel for about 30 min. Visualize under UV light box and and photograph. Note: in pool 1, L. welshimeri forms a band of 608 bp, L. monocytogenes a band of 453 bp, and L. seeligeri a band of 375 bp; in pool 2, L. ivanovii shows a band of 493 bp, L. grayi a band of 420 bp and L. innocua a band of 250 bp. Upon examination of a collection of 456 Listeria isolates collected from routine food quality monitoring schemes and 62 L. monocytogenes isolates from patients, the multiplex PCR had 100% agreement with biochemical methods.44 Nevertheless, it has been demonstrated recently that the lmo0733 gene encoding transcriptional regulator appears to be absent in L. monocytogenes lineage subgroup IIIB strains, which belong to atypical rhamnose-negative virulent non-4a and non-4c strains, some of which may be related to serovar 7,12 and which have been designated as novel evolutionary lineage IV in a more recent study (Ward et al., unpblished data). Therefore, if it is desirable to detect
215
Listeria
Table 15.5 Identities and Sequences of Listeria Primers for Species-Specific Identification Target Gene
Specificity
lwe7-571 (encoding phosphotransferase system enzyme IIBC) Lmo0733 (encoding transcriptional regulator) lse24-315 (encoding internalin)
L. welshimeri
liv22-228 (encoding N-acetylmuramidase)
L. ivanovii
lgr20-246 (encoding oxidoreductase)
L. grayi
iap (encoding invasion-associated protein)
L. innocua
All L. monocytogenes linages but lineage subgroup IIIB L. seeligeri
Primer Sequences (5′→3′)* Pool 1 TCCCACCATTGGTGCTACTCA TTGGCGTACCAAAGAAATACG CGCAAGAAGAAATTGCCATC TCCGCGTTAGAAAAATTCCA CGCGACGGCTAAAGTACTAA ATTGCTCGCTTTGAAGTCGT Pool 2 (N)15CGAATTCCTTATTCACTTGAGC (N)15GGTGCTGCGAACTTAACTCA CTGCACGATCAAGGTCAATC CGTATTGCGCACCAGTGATA TTGCTACTGAAGAAAAAGCA TCTGTTTTTGCTTCTGTAGC
PCR Product (bp) 608 453 375
493 420 250
*N, random nucleotide.
all L. monocytogenes serovars and strains, primers targeting inlA gene may be employed (see Section 15.2.2.3). 15.2.2.2 Multiplex PCR Differentiation of L. monocytogenes Serogroups Principle: Doumith et al.86 developed a multiplex PCR that incorporates L. monocytogenes lmo0737 gene primers for recongition of serovars 1/2a, 1/2c, 3a, and 3c; lmo1118 gene primers for detection of serovars 1/2c and 3c; ORF2819 primers for serovars 1/2b, 3b, 4b, 4d, and 4e; ORF2110 primers for serovars 4b, 4d, and 4e; and prs primers as an internal amplification control covering all L. monocytogenes serovars (Table 15.6). Procedure: (1) Prepare PCR mixture (100 μl) containing 2 U of Taq DNA polymerase (Roche, Boehringer), 0.2 mM dNTPs, 1 × PCR buffer (50 mM Tris-HCl, 10 mM KCl, 50 mM (NH4)2SO4, 2 mM MgCl2, pH 8.3), and the five primer sets (1 μM each for lmo0737, ORF2819, and ORF2110; 1.5 μM each for lmo1118; and 0.2 μM each for prs (Table 15.5). (2) Perform PCR amplification in a thermocycler for one cycle of 94°C for 3 min; 35 cycles of 94°C for 25 sec, 53°C for 1 min 10 sec, and 72°C for 1 min and 10 sec; and one cycle of 72°C for 7 min. (3) After completion, mix 5 μl of PCR mixture with 3 μl of loading buffer and separate on a 2% agarose gel in a TBE buffer (90 mM Trizma base, 90 mM boric acid, 2 mM EDTA, pH 8.3). (4) Stain the gel with ethidium bromide, and visualize with UV transilluminator. Note: all Listeria species (including serovars 4a and 4c) form a 370-bp fragment with the prs gene primers; serovars 1/2a and 3a show a 691 bp fragment with the lmo0737
primers only; serovars 1/2c and 3c display a 691 bp fragment with the lmo0737 primers and a 906 bp fragment with the lmo1118 primers; serovars 1/2b, 3b, and 7 show a 471 bp fragment with the ORF2819 primers; serovars 4b, 4d, and 4e form a 471 bp fragment with the ORF2819 primers and a 597 bp fragment with the ORF2110 primers.86 15.2.2.3 Multipex PCR Determination of L. monocytogenes Virulence Principle: A multiplex PCR was reported recently that incorporates inlA gene primers for species-specific confirmation (with an 800-bp product), and inlC and inlJ gene primers for virulence determination of L. monocytogenes (with 517 bp and 238 bp bands, respectively) (Table 15.7).17 The inclusion of both the inlC and inlJ gene primers in the multiplex PCR has added advantage in that it provides a double verification of L. monocytogenes virulence for in most cases. The usefulness of this multiplex PCR for virulence determination is supported by the observations that L. monocytogenes virulent strains with the potential to cause mouse mortalities via intraperitoneal inoculation of mice are positive with the inlC and/or inlJ gene primers, while naturally avirulent strains unable to produce mouse mortality are negative with these primers.17 Procedure: (1) Prepare the PCR mixture (25 μl) containing 0.8 U Taq DNA polymerase (Fisher Scientific, Houston, TX), 1 × PCR buffer, 200 μM dNTPs, 40 pmol each of inlA primers, 30 pmol each of inlC primers, 20 pmol each of inlJ primers, 10 ng (1 μl) of DNA, and distilled water (to 25μl). Include a tube containing PCR mixture without DNA template as a negative control in each run. (2) Run the following cycling program in a GeneAmp PCR System 9700 (Perkin Elmer, Boston, MA) or
216
Molecular Detection of Foodborne Pathogens
Table 15.6 Identities and Sequences of L. monocytogenes Primers for Serogrouping Target Gene
Specificity
lmo0737 (encoding protein ofunknown function) lmo1118 ( encoding protein ofunknown function) ORF2819 (encoding transcriptional regulator) ORF2110 (encoding secreted protein) prs (encoding phosphoribosyl pyrophos- phate synthetase)
L. monocytogenes serovars 1/2a, 1/2c, 3a, and 3c L. monocytogenes serovars 1/2c and 3c L. monocytogenes serovars 1/2b, 3b, 4b, 4d, and 4e L. monocytogenes serovars 4b, 4d, and 4e All Listeria species
Primer Sequences (5′→3′) AGGGCTTCAAGGACTTACCC ACGATTTCTGCTTGCCATTC AGGGGTCTTAAATCCTGGAA CGGCTTGTTCGGCATACTTA AGCAAAATGCCAAAACTCGT CATCACTAAAGCCTCCCATTG AGTGGACAATTGATTGGTGAA CATCCATCCCTTACTTTGGAC GCTGAAGAGATTGCGAAAGAAG CAAAGAAACCTTGGATTTGCGG
PCR Product (bp) 691 906 471 597 370
Table 15.7 Identities and Sequences of L. monocytogenes Internalin Gene Primers for Species- and Virulence Determination Target Gene
Specificity
inlA
All L. moocytogenes serovars
inlC
All L. moocytogenes serovars but 4a and some 4c All L. moocytogenes serovars but 4a and some IIIB
inlJ
Primer Sequences (5′→3′) ACGAGTAACGGGACAAATGC CCCGACAGTGGTGCTAGATT AATTCCCACAGGACACAACC CGGGAATGCAATTTTTCACTA TGTAACCCCGCTTACACAGTT AGCGGCTTGGCAGTCTAATA
other cycler: one cycle of 94ºC for 2 min; 30 cycles of: 94ºC for 20 sec, 55ºC for 20 sec, and 72ºC for 50 sec; and eon cycle of 72ºC for 2 min. (3) After completion of PCR cycles, add 3 μl of 6 × DNA loading buffer into each tube; separate the PCR products on 1.5% agarose gel containing 0.5 μg/ml ethidium bromide. Include a DNA molecular marker in a spare lane. (4) Visualize under UV light box and and photograph using a ChemiImager 5500 documentation system (BSI, Stafford, TX). Note: the species identity of the 29 L. monocytogenes strains was validated through the formation of an 800-bp band with the inlA gene primers, and the virulence potential of these strains was confirmed by the production of 517 bp and/or 238 bp bands with the inlC and inlJ gene primers in the multiplex PCR. Even though L. ivanovii strains also harbor a gene with homology to L. monoctyogenes inlC, and cross-react with L. monoctyogenes inlC gene primers, they can readily excluded by their negative reaction with L. monoctyogenes inlA gene primers included in the multiplex PCR.17 Although the presence of inlC and/or inlJ genes in a given L. monocytogenes strain implies its potential virulence and its ability to cause mouse mortality via the intraperitoneal route, it does not indicate the certainty of the strains harboring these genes to produce disease in humans via the
Nucleotide Positions 94612–94631 95411–95392 107306–107325 107822–107802 188989–189009 189226–189207
PCR Product (bp) 800 517 238
conventional oral ingestion. Considering that only three serotypes (1/2a, 1/2b, and 4b) are isolated from human listeriosis cases, many serotypes (e.g., 1/2c, 3a, 3b, 3c, 4c, 4d, and 4e) that are recognized as having virulence potential by the multiplex PCR may encounter difficulty crossing the host’s intestinal or other barriers during infection. Obviously, for a L. monocytogenes strain to be fully infective to humans via oral ingestion, it requires involvement of many other known and uncharacterized virulence genes and proteins. These undefined virulence genes and proteins require further characterization and examination. Nonetheless, an implication from the multiplex PCR results is that while L. monocytogenes serotypes other than 1/2a, 1/2b, and 4b are not commonly associated with human listeriosis, due presumably to their inability to efficiently cross human intestinal and other barriers, they (with the possible exclusion of serotype 4a) may have the potential to produce disease in humans whose immune functions are compromised, or who are exposed to these serotypes via intravenous transfusions or open wounds. The inlA primers described above can be utilized independently for species-specific confirmation of L. monocytogenes if it is unnecessary to determine the virulence potential with the inJ and inC primers. While the inlA primers recognize all L. monocytogenes serovars and lineages, the lmo0733 primers described in Section 15.2.2.1 do not cover the unusual lineage IIIB strains, which may include serovar 7. It appears that the inlA gene is also more conserved across L. monocytogenes
217
Listeria
serovars than inlB gene, as serovars 4a–4e were not detected with a pair of inlB primers designed from serovar 1/2a strain EGD-e.17 Although some L. monocytogenes strains isolated from nonsympomatic human carriers have been shown to produce truncated InlA protein occasionally,91 the incidence of inlA gene mutation in food-derived isolates is remarkably low.92
15.3 Conclusions and Future Perspectives Given its widespread occurrence and its capacity to withstand extreme external stresses such as extreme temperature, pH, and salt ranges, which often underscore many food processing routines, L. monocytogenes has become an increasingly important foodborne pathogen in recent decades. Considering the fact that the early clinical manifestations of human listeriosis are generally nonspecific, and that it can evolve quickly into life-threatening illness in vulnerable population groups (e.g., infants, pregnant women, elderly, and immunocompromised persons) without prompt antibiotic therapy, it is critical to develop a capability to rapidly, sensitively, and reliably detect, identify, and differentiate the pathogen concerned, and to promptly initiate appropriate control and prevention measures against the disease. Although conventional, phenotype-based tests are relatively slow and variable at times, they have played essential roles in the laboratory idenfication and diagnosis of L. monocytogenes and in the tracking of endemic and sporadic listeriosis outbreaks. Following the advent of new generation molecular methods, especially in vitro template amplification techniques such as PCR, speedy, and precise identification of L. monocytogenes has become a reality. While a large number of PCR-based assays targeting various genes have beem reported and proven valuable for discrimination of L. monocytogenes from other closely-related bacteria,42–84 the development and application of multiplex PCR has made species-, serogroupand virulence-specific determination of this bacterium possible and in a much more efficient manner.17,28,85,86 Furthermore, the increasing adoption of real-time PCR platform in the Listeria diagnosis provides unprecedented level of testing convenience and result availability. This also offers the opportunity to quantitate the organisms in the clinical, food, and environmental specimens, and contribute to the improved monitoring of the efficiency of chemotherapy and quality control measures in the food manufacturing facilities and environmental surveillance. In contrast to an increasing sophistication in the nucleic acid amplification and detection technologies, the progress in the development of sample preparation procedures prior to enzymatic amplification has been relatively slow.93 The fact that food samples come in different variety and complexicity, and many components in these samples (e.g., phenolics, glycogen, calcium ions, fat, and other organic substances) are inhibitory to DNA polymerase may have contributed to the inability of developing and optimizing rapid, efficient, and multi-purpose sample processing procedures applicable to all types of food samples. In addition, because many food
samples contain relatively few organisms of interest, which may be below the detection limit of most current molecular techniques, there is need to enrich and concentrate the target organisms before testing. While many concentration procedures based on filtration and centrifugation protocols have been designed and described for individual specimen types, there has been a lack of standardized and optimized procedures for dealing with the myriad type of food specimens. Similarly, although several selective enrichment media (i.e., ISO 11290, FDA BAM and USDA) incorporating acriflavine, nalidixic acid and cycloheximide are in common use, their application seems to be limited to the types of food samples examined, with the USDA method being suited for meat products and the FDA method for other food products (e.g., dairy products, seafood, and vegetables). Clearly, further research in the prior sample handling and processing is to maximize the performance of molecular assays for detection and identification of L. monocytogenes bacteria from various types of samples. This may include the determination of the optimal types and strengths of enrichment media or length of enrichment for individual specimen types containing low number of organisms of interest, and investigation of the most appropriate combination of physical separation and concentration procedures for various types of specimens prior to the enrichment step. The availability of rapid, efficient, and reliable sample preparation procedures is crucial for further strengthening the performance of the molecular tests for direct detection and identification of L. monocytogenes from clinical, food, and environmental specimens. This will not only help shorten the time from specimen submission to result finalization, but also benefit the control and prevention program against listeriosis.
References
1. Glaser, P. et al. Comparative genomics of Listeria species. Science, 294, 849, 2001. 2. Nelson, K.E. et al. Whole genome comparisons of serotype 4b and 1/2a strains of the food-borne pathogen Listeria monocytogenes reveal new insights into the core genome components of this species. Nucleic Acids Res., 32, 2386, 2004. 3. Hain, T. et al. Whole-genome sequence of Listeria welshimeri reveals common steps in genome reduction with Listeria innocua as compared to Listeria monocytogenes. J. Bacteriol., 188, 7405, 2007. 4. Sleator, R.D., Gahan, C.G.M., and Hill, C. A postgenomic appraisal of osmotolerance in Listeria monocytogenes. Appl. Environ. Microbiol., 69, 1, 2003. 5. Liu, D. et al. Comparative assessment of acid, alkali and salt tolerance in Listeria monocytogenes virulent and avirulent strains. FEMS Microbiol. Lett., 243, 373, 2005. 6. Low, J.C. and Donachie, W. A review of Listeria monocytogenes and listeriosis. Vet. J., 153, 9, 1997. 7. Vazquez-Boland, J.A. et al. Listeria pathogenesis and molecular virulence determinants. Clin. Microbiol. Rev., 14, 584, 2001. 8. Seeliger, H.P.R. and Jones, D. Listeria. In Bergey’s Manual of Systematic Bacteriology, vol. 2, pp. 1235–1245. Sneath, P.H.A. et al. (eds.). Williams and Wilkins, Baltimore, MD, 1986.
218
9. Rasmussen, O.F. et al. Listeria monocytogenes exists in at least three evolutionary lines: Evidence from flagellin, invasive associated protein and listeriolysin O genes. Microbiology, 141, 2053, 1995. 10. Wiedmann, M. et al. Ribotypes and virulence gene polymorphisms suggest three distinct Listeria monocytogenes lineages with differences in pathogenic potential. Infect. Immun., 65, 2707, 1997. 11. Roberts, et al. Genetic and phenotypic characterization of Listeria monocytogenes lineage III. Microbiology, 152, 685, 2006. 12. Liu, D. et al. Listeria monocytogenes subgroups IIIA, IIIB and IIIC delineate geneticall distinct populations with varied pathogenic potential. J. Clin. Microbiol., 44, 2229, 2006. 13. Goulet, V. Surveillance of human listeriosis in France, 20012003. Euro Surveill., 11, 79, 2006. 14. Barbour, A.H., Rampling, A. and Hormaeche, C.E. Variation in the infectivity of Listeria monocytogenes isolates following intragastric inoculation of mice. Infect. Immun., 69, 4657, 2001. 15. Liu, D. et al. Characterization of virulent and avirulent Listeria monocytogenes strains by PCR amplification of putative transcriptional regulator and internalin genes. J. Med. Microbiol., 52, 1066, 2003. 16. Liu, D. Listeria monocytogenes: Comparative interpretation of mouse virulence assay. FEMS Microbiol. Lett., 233, 159, 2004. 17. Liu, D. et al. A multiplex PCR for species- and virulencespecific determination of Listeria monocytogenes. J. Microbiol. Methods, 71, 133, 2007. 18. Liu, D., Epidemiology. In Handbook of Listeria monocytogenes. pp. 27–59. Liu, D. (ed.). Taylor and Francis CRC Press, Boca Raton, FL, 2008. 19. Altekruse, S.F., Cohen, M.L. and Swerdlow, D.L. Emerging foodborne diseases. Emerg. Infect. Dis., 3, 285, 1997. 20. Mead, P.S. et al. Food-related illness and death in the United States. Emerg. Infect. Dis., 5, 607, 1999. 21. Engelbrecht, F. et al. A new prfa-regulated gene of Listeria monocytogenes encoding a small, secreted protein which belongs to the family of internalins. Mol. Microbiol., 21, 823, 1996. 22. Sabet, C. et al. LPXTG protein InlJ, a newly identified internalin involved in Listeria monocytogenes virulence. Infect. Immun., 73, 6912, 2005. 23. Gouin, E., Mengaud, J. and Cossart, P. The virulence gene cluster of Listeria monocytogenes is also present in Listeria ivanovii, an animal pathogen, and Listeria seeligeri, a nonpathogenic species. Infect. Immun., 62, 3550, 1994. 24. Liu, D. et al. Listeria monocytogenes serotype 4b strains belonging to lineages I and III possess distinct molecular features. J. Clin. Microbiol., 44, 214, 2006. 25. Boneca, I.G. et al. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc. Natl. Acad. Sci. USA, 104, 997, 2007. 26. Johnson, J. et al. Natural atypical Listeria innocua strains with Listeria monocytogenes pathogenicity island 1 genes. Appl. Environ. Microbiol., 70, 4256, 2004. 27. Volokhov, D.V. et al. The presence of the internalin gene in natural atypically hemolytic Listeria innocua strains suggests descent from L. monocytogenes. Appl. Environ. Microbiol., 73, 1928, 2007. 28. Huang, B. et al. Comparison of multiplex PCR with conventional biochemical methods for the identification of Listeria species isolates from food and clinical samples in Queensland, Australia. J. Food Prot., 70, 1874, 2007.
Molecular Detection of Foodborne Pathogens 29. Liu, D., Lawrence, M.L. and Hitchins, A.D. Molecular characterization of Listeria monocytogenes strains harboring Listeria innocua transcriptional regulator gene lin0464. J. Rapid Methods Aut. Microbiol., 16, 412, 2008. 30. Chen, J. et al. Listeria monocytogenes serovar 4a is a possible evolutionary intermediate between L. monocytogenes serovars 1/2a and 4b and L. innocua, J. Microbiol. Biotechnol., 19, 51, 2008. 31. Doumith, M. et al. New aspects regarding evolution and virulence of Listeria monocytogenes revealed by comparative genomics and DNA arrays. Infect. Immun. 72, 1072, 2004. 32. Gorski, L. Phenotypic identification. In Handbook of Listeria monocytogenes. pp. 139–168. Liu, D. (ed.). Taylor and Francis CRC Press, Boca Raton, FL, 2008. 33. Rocourt, J. and Catimel, B. Biochemical characterization of species in the genus Listeria. Zbl. Bakteriol. Mikrobiol. Hyg. [A], 260, 221, 1985. 34. Ermolaeva, S. et al. A simple method for the differentiation of Listeria monocytogenes on induction of lecithinase activity by charcoal. Int. J. Food Microbiol., 82, 87, 2003. 35. Robinson, R.K., Batt, C.A. and Patel, P.D. (eds) Encyclopedia of Food Microbiology. Academic Press, San Diego, CA, 2000. 36. Palumbo, J.D. et al. Serotyping of Listeria monocytogenes by enzyme-linked immunosorbent assay and identification of mixed-serotype cultures by colony immunoblotting. J. Clin. Microbiol., 41, 564, 2003. 37. Kim, S.H. et al. Oral inoculation of A/J mice for detection of invasiveness differences between Listeria monocytogenes epidemic and environmental strains. Infect. Immun., 72, 4318, 2004. 38. Liu, D. et al. Characteristics of cell-mediated, anti-listerial immunity induced by a naturally avirulent Listeria monocytogenes serotype 4a strain HCC23. Arch. Microbiol., 188, 251, 2007. 39. Roche, S.M, Velge, P. and Liu, D. Virulence determination. In Handbook of Listeria monocytogenes. pp. 241–270. Liu, D. (ed.) Taylor and Francis CRC Press, Boca Raton, FL, 2008. 40. Liu, D. Identification, subtyping and virulence determination of Listeria monocytogenes, in important foodborne pathogen. J. Med. Microbiol., 55, 645, 2006. 41. Liu, D. et al. Genotypic identification. In Handbook of Listeria monocytogenes. pp. 169–201. Liu, D. (ed.). Taylor and Francis CRC Press, Boca Raton, FL, 2008. 42. Liu, D. et al. Identification of Listeria innocua by PCR targeting a putative transcriptional regulator gene. FEMS Microbiol. Lett., 203, 205, 2003. 43. Liu, D. et al. Identification of a gene encoding a putative phosphotransferase system enzyme IIBC in Listeria welshimeri and its application for diagnostic PCR. Lett. Appl. Microbiol., 38, 151, 2004. 44. Liu, D. et al. PCR detection of a putative N-acetylmuramidase gene from Listeria ivanovii facilitates its rapid identification. Vet. Microbiol., 101, 83, 2004. 45. Liu, D. et al. Species-specific PCR determination of Listeria seeligeri. Res. Microbiol., 155, 741, 2004. 46. Liu, D. et al. Isolation and PCR amplification of a speciesspecific, oxidoreductase-coding gene region in Listeria grayi. Can. J. Microbiol., 51, 95, 2005. 47. Liu, D. et al. Use of PCR primers derived from a putative transcriptional regulator gene for species-specific identification of Listeria monocytogenes. Int. J. Food Microbiol., 91, 297, 2004.
Listeria 48. Liu, D., Lawrence, M.L. and Ainsworth, A.J. A novel PCR assay for Listeria welshimeri targeting species-specific transcriptional regulator gene lwe1801. J. Rapid Methods Aut. Microbiol., 16, 154, 2008. 49. Vaneechoutte, M. et al. Comparison of PCR-based DNA fingerprinting techniques for the identification of Listeria species and their use for atypical Listeria isolates. Int. J. Syst. Bacteriol., 48, 127, 1998. 50. Jaradat, Z.W., Schutze, G.E. and Bhunia, A.K. Genetic homogeneity among Listeria monocytogenes strains from infected patients and meat products from two geographic locations determined by phenotyping, ribotyping and PCR analysis of virulence genes. Int. J. Food Microbiol., 76, 1, 2002. 51. Paillard, D. et al. Rapid identification of Listeria species by using restriction fragment length polymorphism of PCR-amplified 23S rRNA gene fragments. Appl. Environ. Microbiol., 69, 6386, 2003. 52. Wang, R.F, Cao, W.W. and Johnson, M.G. 16S rRNA-based probes and polymerase chain reaction method to detect Listeria monocytogenes cells added to foods. Appl. Environ. Microbiol., 58, 2827, 1992. 53. Czajka, J. et al. Differentiation of Listeria monocytogenes and Listeria innocua by 16S rRNA genes and intraspecies discrimination of Listeria monocytogenes strains by random amplified polymorphic DNA polymorphisms. Appl. Environ. Microbiol., 59, 304, 1993. 54. Manzano, M. et al. Temperature gradient gel electrophoresis of the amplified product of a small 16S rRNA gene fragment for the identification of Listeria species isolated from food. J. Food Prot., 63, 659, 2000. 55. Garrec, N. et al. Heteroduplex mobility assay for the identification of Listeria spp and Listeria monocytogenes strains: application to characterization of strains from sludge and food samples. FEMS Immunol. Med. Microbiol., 38, 57, 2003. 56. Somer, L. and Kashi, Y. A PCR method based on 16S rRNA sequence for simultaneous detection of the genus Listeria and the species Listeria monocytogenes in food products. J. Food Prot., 66, 1658, 2003. 57. Brehm-Stecher, B.F., Hyldig-Nielsen, J.J. and Johnson, E.A. Design and evaluation of 16S rRNA-targeted peptide nucleic acid probes for whole-cell detection of members of the genus Listeria. Appl. Environ. Microbiol., 71, 5451, 2005. 58. Rodríguez-Lázaro, D., Hernández, M. and Pla, M. Simultaneous quantitative detection of Listeria spp. and Listeria monocytogenes using a duplex real-time PCR-based assay. FEMS Microbiol. Lett., 233, 257, 2004. 59. Graham, T. et al. Genus- and species-specific detection of Listeria monocytogenes using polymerase chain reaction assays targeting the 16S/23S intergenic spacer region of the rRNA operon. Can. J. Microbiol., 42, 1155, 1996. 60. Graham, T.A. et al. Inter- and intraspecies comparison of the 16S-23S rRNA operon intergenic spacer regions of six Listeria spp. Int. J. Syst. Bacteriol., 47, 863, 1997. 61. Cai, S. et al. Rational design of DNA sequence-based strategies for subtyping Listeria monocytogenes. J. Clin. Microbiol., 40, 3319, 2002. 62. Bubert, A., Kohler, S. and Goebel, W. The homologous and heterologous regions within the iap gene allow genus- and species-specific identification of Listeria spp. by polymerase chain reaction. Appl. Environ. Microbiol., 58, 2625, 1992. 63. Bubert, A. et al. Detection and differentiation of Listeria spp. by a single reaction based multiplex PCR. Appl. Environ. Microbiol., 65, 4688, 1999.
219 64. Gray, D.I. and Kroll, R.G. Polymerase chain reaction amplification of the flaA gene for the rapid identification of Listeria spp. Lett. Appl. Microbiol., 20, 65, 1995. 65. Cocolin, L. et al. Direct identification in food samples of Listeria spp. and Listeria monocytogenes by molecular methods. Appl. Environ. Microbiol., 68, 6273, 2002. 66. Gilot, P. and Content, J. Specific identification of Listeria welshimeri and Listeria monocytogenes by PCR assays targeting a gene encoding a fibronectin-binding protein. J. Clin. Microbiol., 40, 698, 2002. 67. O’Connor, L. et al. Rapid polymerase chain reaction/DNA probe membrane-based assay for the detection of Listeria and Listeria monocytogenes in food. J. Food Prot., 63, 337, 2000. 68. Kohler, S. et al. The gene coding for protein p60 of Listeria monocytogenes and its use as a specific probe for Listeria monocytogenes. Infect. Immun., 58, 1943, 1990. 69. Koo, K. and Jaykus, L.A. Detection of Listeria monocytogenes from a model food by fluorescence resonance energy transfer-based PCR with an asymmetric fluorogenic probe set. Appl. Environ. Microbiol., 69, 1082, 2003. 70. Navas, J., Ortiz, S. and Martinez-Suarez, J.V. Simultaneous detection of Listeria monocytogenes in chicken meat enrichments by PCR and reverse-transcription PCR without DNA/ RNA isolation. J. Food Prot., 68, 407, 2005. 71. Jothikumar, N., Wang, X. and Griffiths, N.W. Real-time multiplex SYBR green I-based PCR assay for simultaneous detection of Salmonella serovars and Listeria monocytogenes. J. Food Prot., 66, 2141, 2003. 72. Rodríguez-Lázaro, D. et al. Rapid quantitative detection of Listeria monocytogenes in meat products by real-time PCR. Appl. Environ. Microbiol., 70, 6299, 2004. 73. Rodríguez-Lázaro, D. et al. Rapid quantitative detection of Listeria monocytogenes in salmon products: Evaluation of pre-real-time PCR strategies. J. Food Prot., 68, 1467, 2005. 74. Rodríguez-Lázaro, D. et al. A novel real-time PCR for Listeria monocytogenes that monitors analytical performance via internal amplification control. Appl. Environ. Microbiol., 71, 9008, 2005. 75. Wang, X., Jothikumar, N. and Griffiths, M.W. Enrichment and DNA extraction protocols for the simultaneous detection of Salmonella and Listeria monocytogenes in raw sausage meat with multiplex real-time PCR. J. Food Prot., 67, 189, 2004. 76. Rudi, K. et al. Detection of viable and dead Listeria monocytogenes on gouda-like cheeses by real-time PCR. Lett. Appl. Microbiol., 40, 301, 2005. 77. Berrada, H. et al. Quantification of Listeria monocytogenes in salads by real-time quantitative PCR. Int. J. Food Microbiol., 107, 202, 2006. 78. Rossmanith, P. et al. Detection of Listeria monocytogenes in food using a combined enrichment/real-time PCR method targeting the prfA gene. Res. Microbiol., 157, 763, 2006. 79. Choi, W.S. and Hong, C.-H. Rapid enumeration of Listeria monocytogenes in milk using competitive PCR. Int. J. Food Microbiol., 84, 79, 2003. 80. Blais, B.W. et al. A nucleic acid sequence-based amplification system for detection of Listeria monocytogenes hlyA sequences. Appl. Environ. Microbiol., 63, 310, 1997. 81. Norton, D.M. and Batt, C.A. Detection of viable Listeria monocytogenes with a 5′ nuclease PCR assay. Appl. Environ. Microbiol., 65, 2122, 1999. 82. Guilbaud, M. et al. Quantitative detection of Listeria monocytogenes in biofilms by real-time PCR. Appl. Environ. Microbiol., 71, 2190, 2005.
220 83. Oravcova, K. et al. Detection and quantification of Listeria monocytogenes by 5'-nuclease polymerase chain reaction targeting the actA gene. Lett. Appl. Microbiol., 42, 15, 2006. 84. Manzano, M. et al. Single-strand conformation polymorphism (SSCP) analysis of Listeria monocytogenes iap gene as tool to detect different serogroups. Mol. Cell. Probes, 11, 459, 1997. 85. Borucki, M.K., and Call, D.R. Listeria monocytogenes serotype identification by PCR. J. Clin. Microbiol., 41, 5537, 2003. 86. Doumith, M. et al. Differentiation of the major Listeria monocytogenes serovars by multiplex PCR. J. Clin. Microbiol., 42, 3819, 2004. 87. Liu, D. et al. Toward an improved laboratory definition of Listeria monocytogenes virulence. Int. J. Food Microbiol., 118, 101, 2007. 88. Sabet, C. et al. The Listeria monocytogenes virulence factor InlJ is specifically expressed in vivo and behaves as an adhesion. Infect. Immun., 76, 1368, 2008.
Molecular Detection of Foodborne Pathogens 89. Call, D.R., Borucki, M.K. and Loge, F.J. Detection of bacterial pathogens in environmental samples using DNA microarrays. J. Microbiol. Methods, 53, 235, 2003. 90. Borucki, M.K. et al. Selective discrimination of Listeria monocytogenes epidemic strains by a mixed-genome DNA microarray compared to discrimination by pulse-filed gel electrophoresis. J. Clin. Microbiol., 42, 5270, 2004. 91. Olier, M. et al. Assessment of the pathogenic potential of two Listeria monocytogenes human faecal carriage isolates. Microbiology, 148, 1855, 2002. 92. Handa-Miya, S. et al. Nonsense-mutated inlA and prfA not widely distributed in Listeria monocytogenes isolates from ready-to-eat seafood products in Japan. Int. J. Food Microbiol., 117, 312, 2007. 93. Liu, D. Preparation of Listeria monocytogenes specimens for direct molecular applications. Int. J. Food Microbiol., 122, 229, 2008.
16 Micrococcus
Friederike Hilbert and Hans-Jürgen Busse University of Veterinary Medicine Vienna
Contents 16.1 Introduction.................................................................................................................................................................... 221 16.1.1 Classification of the Genus Micrococcus.......................................................................................................... 221 16.1.2 Biology, Pathogenesis, and Medical Importance.............................................................................................. 222 16.1.3 Identification and Diagnosis of the Genus Micrococcus.................................................................................. 223 16.2 Methods.......................................................................................................................................................................... 223 16.2.1 Sample Collection and Preparation.................................................................................................................. 223 16.2.1.1 Sample Collection............................................................................................................................ 223 16.2.1.2 Preparation of the Food Matrix....................................................................................................... 223 16.2.2 Detection Procedures........................................................................................................................................ 224 16.3 Conclusions and Future Perspectives............................................................................................................................. 226 References.................................................................................................................................................................................. 226
16.1 Introduction 16.1.1 Classification of the Genus Micrococcus The genus Micrococcus was originally described by Cohn1 almost 140 years ago. After numerous reorganizations of the genus and reclassifications of certain species into new genera2,3 the genus now is encompassing a clade of four species including Micrococcus luteus4 the type species of the genus, Micrococcus lylae,4 Micrococcus antarcticus,5 and Micrococcus flavus.6 The species are separated from each other at 16S rRNA gene similarities between 96.9 and 98.3% but representatives of related species of the genus exhibit peptidoglycan type A2 (lysine based peptidoglycan and an interpeptide bridge consisting of the stem peptide) or A4α (lysine based peptidoglycan and aspartic acid as the interpeptide bridge) according to Schleifer and Kandler.7 Quinone systems consist predominantly of menaquinone with seven and/or eight isoprenoic units in the side chain and one of these units may be dihydrogenated such as MK-7 (H 2) and MK-8 (H2), MK-8 and MK-8 (H2) or MK-8 (H2). Chemotaxonomic characteristics such as peptidoglycan type and quinone system are considered to be highly conserved among species of a single genus with only few known exceptions. Already based on the characteristics so far collected for four species both quinone system and peptidoglycan type are unusually variable among species of the genus. The quinone system may be useful for identification of strains of M. flavus which has been reported to contain a quinone system consisting of the major compounds MK-7 (H 2) and MK-8 (H2). On the other hand M. lylae and M. antarcticus are characterized by quinone systems also found in certain M. luteus strains (Table 16.1) and hence they cannot
be identified based on this trait alone. On the other hand, peptidoglycan type A2 may be indicative for strains of M. luteus biovar I. Fatty acid profiles predominantly show iso-C15:0 and anteiso-C15:0 acids.4–6 Other fatty acids were reported only in minor amounts. Differences useful for differentiation between Micrococcus species are not reported. Hence, also fatty acid analysis, broadly applied in clinical diagnostics for rapid identification of pathogens apparently is not useful for reliable identification of Micrococcus species and especially for identification of M. luteus and M. lylae. Variability in physiological traits among strains of M. luteus4 makes it almost impossible to reliably distinguish this species from the other species of the genus. However, optimal growth temperatures suggest that M. luteus and M. lylae may possess the potential to cause human infections (Table 16.1). Among established bacterial species M. luteus is quite unique. Strains of this species exhibit significant variability in physiological traits as mentioned above but also in both peptidoglycan type and quinone system. Strains of this species either contain a peptidoglycan type A2 or A4α and the quinone system either consists of two major compounds MK-8 and MK-8 (H2) or only MK-8 (H2).4 Mainly based on this variability the species was recently subdivided into three biovars. Interestingly, strains of one of these biovars, biovar II exhibit a unique band after REP-PCR which is lacking in representatives of biovar I and biovar III.4 M. luteus is an inhabitant of the human skin whereas M. lylae is only rarely isolated from this habitat.8 Interestingly, at EMBL gene bank more than 50 sequence entries can be found which are sharing 99.5% or even higher 16S rRNA gene similarity with the type strain of this species. In contrast, only one entry can be found in the gene bank which shares 99.5% 221
222
Molecular Detection of Foodborne Pathogens
Table 16.1 Phenotypic Differentiation Between Micrococcus Species Characteristic Optimal growth temperature (°C)
M. luteus
M. lylae
M. flavus
M. antarcticus
37
37
31
16.8
Nitrate reduction
–
–
–
+
Voges–Proskauer reaction
–
–
–
+
MK-8, MK-8 (H2) or MK-8 (H2)
MK-8(H2)
MK-8 (H2), MK-7 (H2)
A2 or A4α
A4α
A4α
MK-8, MK-8 (H2) Not analyzed
–
–
+
– + – +
– – – +
– – + –
Major quinone(s) Peptidoglycan type
Hydrolysis of: Tween 80
v
D-Mannose D-Maltose L-Malate D-Trehalose
+ v v v
Assimilation of:
Sources: Wieser, M. et al., Int. J. Syst. Evol. Microbiol., 52, 629, 2002; Liu, H. et al., Int. J. Syst. Evol. Microbiol., 50, 715, 2000, and Liu, X.-Y. et al., Int. J. Syst. Evol. Microbiol., 57, 66, 2007.
16S rRNA gene sequence similarity with the type strain of M. lylae whereas several entries can found designated M. lylae but sharing less than 99.5% similarity. In bacterial systematics 16S rRNA gene sequences are not accepted as a tool for species identification because cases are known where genomically and phenotypically clearly separated species share 99.9% 16S rRNA gene similarity.9 However, values of 99.5% or higher may be suitable for preliminary identification of these strains as members of M. luteus or at least a very closely but so far undescribed species.
16.1.2 Biology, Pathogenesis, and Medical Importance The family Micrococcaceae includes Gram-positive bacteria found in a variety of different habitats e.g., water, various soils, insects, skin of humans and most other mammals and as a consequence are found on a diversity of different food. Nonspecific isolation of Micrococcus strains from grain, fruits, seeds, plants, milk, cheese, fresh meat and fermented meat, and fish products is common in food microbiology.10–13 On food some members of this genus are commensals in other cases different strains function as fermenters and ripers but also as spoilers as well as foodborne pathogens mainly caused by their production of biogenic amines (BA).14,15 M. luteus as well as M. lylae are known to be involved in ripening of certain naturally ripened products e.g., cheese, fermented fish products (e.g., shiokara, cassava), and salami type sausages. M. luteus is used as a starter culture strain for fermented fish products and fermented dry sausages. Nevertheless, Micrococcus spp. will never represent the main flora in neither of these products, which are lactobacilli, pediococci, staphylococci, and for
certain products yeasts and molds. However, in some fermented products Micrococcus spp. are considered to be essential for the development of aroma and flavor.10–13,16–19 Microbial enzymes produced by Micrococcus spp. which are involved in the development of flavor and aroma are a salt resistant glutaminase, an amylase, enzymes to degrade L-methionine to volatile sulfur compounds. Enzymes for protein hydrolysis and especially enzymes for lipolytic activity to modify generated carbonyl compounds are essential for the development of flavor. These activities have been shown to be essential for the specific odor of long air dried cured sausages.20 The action of enzymes required for ripening of fermented foods can cause spoilage of food as well. Hence, Micrococcus spp. as halotolerant microorganisms (5–10% NaCl),4 have been found in different spoiled food stuff. Fresh meat, sea food and insufficient thermal processing of products rich in fat are at risk to contain high numbers of Micrococcus spp. especially in the absence of other microbial spoilers as are pseudomonads and lactobacilli. Nevertheless, spoilage by Micrococcus spp. is rare. Typical changes include protein hydrolysis and lipolysis.21,22 Probably the greatest health threat for humans is related to the capability of micrococci to produce BA. As Micrococcus spp. are found on different raw, fermented, and sometimes even in heat treated foods many studies include Micrococcus as reference strains to test the effect of antimicrobial activity of different products or treatments or to study the effect of transfer from one environment to another which might be important for extraintestinal infections.23,24 BA are formed by decarboxylation of free amino acids. Many different bacterial species found in food are able to produce sufficient amounts of decarboxylase to be released
223
Micrococcus
in the food matrix and produce BA such as histamine, putrescine, cadaverine, tyramine, phenylethylamine, and further.25–27 Certain strains of M. luteus have also been shown to produce cadaverine in foods but there is no evidence from literature of capability for production of other BA.27 Cadaverine itself has only little toxic effects but it potentiates the toxicity of histamine in food by inhibiting histamine-metabolizing enzymes such as diamine oxidase and histamine N-methyl-transferase.28 The toxicity of histamine and other BA in humans are based on the interaction of histamine with cellular membrane receptors, effecting the cardiovascular system, smooth muscles, and eventually motor neuron stimulation. Symptoms in humans of biogenic amine poisoning are urticaria, flushing, headache, abdominal cramps, diarrhea, and vomiting. The effect varies individually (histamine intolerance) and it is dose and matrix dependent. Thus, the same amount of BA may cause no to severe symptoms if administered with different food matrices.25,29 The whole family of Micrococcus strains may also play an important role as normal gut microflora and may also be involved in symptoms of digestive disorders in humans.30 Thus, the role of Micrococcus spp. in food is highly diverse as the genus itself. Additionally, strains of the genus are known as opportunistic pathogens for extraintestinal disease mainly in immunocompromised persons,31,32 meningitis,33 septic arthritis,34 endocarditis,35–37 infections of leukemia patients with indwelling lines and patients undergoing continuous amulatory peritoneal dialysis or with ventriculo-peritoneal shunt,38 intracranial suppuration,39 bacteraemia,40,41 chronic cutaneous infections in HIV positive patients,42 and catheter infection.43
16.1.3 Identification and Diagnosis of the Genus Micrococcus For the sampling of food and food stuff—if no specific advice is given—the specific International Standard has to be followed dealing with the product concerned e.g., DIN 10162. A portion of the product is homogenized with 1:10 of adequate dilution medium e.g., peptone solution (ISO 6887) using a stomacher 400 or by Ultra turrax. A dilution series (depending of expected colony counts) are plated. For meat and meat products, cheese as well as for fish and fish products in which Micrococcus spp. may be found the detection and isolation of Micrococcus spp. is difficult as most strains are not able to compete with Staphylococcus spp.16,20 In most cases Micrococcus spp. are not able to grow on Baird–Parker agar, incubated aerobically at 30 or 37°C for 48 h and thus, cannot be isolated in parallel with Staphylococcus spp. even though, some articles and books refer to it.44 In some cases M. luteus and M. lylae can be detected on colony count agar especially if the product harbors a low number of bacteria. Suggestions for the isolation of M. luteus with the addition of 20 µg/ml furazolidone to colony count agar are confirmed in our studies.45,46 However, since the existence of furazolidone sensitive micrococci was reported47 not all members of the
micrococci community will be detected using this selective medium. In products containing a rather high number of other bacterial species a combination of 5% sodium chloride and 20 µg/ml furazolidone has been found useful.46 Furthermore, verification of colonies by aerobic/anaerobic growth to distinguish between facultative anaerobes and Gram staining has to be done. Discrimination from e.g., Kocuria varians and differentiation between the Micrococcus species by biochemical reactions such as tests for katalase reaction, lysostaphin resistance testing, assimilation of lactose, glucose, gelatin, glycerol, and nitrate reduction (see Table 16.1) is complicated by highly similar reaction profiles. Thus, there is an essential need for molecular tools allowing identification of members of the genus Micrococcus as well as to discriminate between species. To the best of our knowledge no molecular detection method for Micrococcus from food has been developed.
16.2 Methods 16.2.1 Sample Collection and Preparation 16.2.1.1 Sample Collection As M. luteus and M. lylae are found in a variety of different food with unpredictable amounts ranging from one to 105 cfu per gram/ml, respectively, the sampling procedure and preparation are dependent on the product as well on the purpose of detection. Hence, not only general procedures have to be followed, such as cooling and fast transport to the laboratory as well as rapid sample analysis but also to control these specific food products at different processing steps, at different times of fermentation, or during shelf life. Further chemical analysis on the food matrix might be necessary e.g., analysis of BA to define safety, accurate shelf life, or consistent sensorial quality. In some cases it might be necessary to analyze Micrococcus isolates for their ability to cause biogenic amine production in food, to define their spectrum of lipolytic activity, protein hydrolysis and/or their carbohydrate degradation ability to categorize the isolate as spoiler, fermenter or pathogen. However, it appears to be feasible to replace some of these growth dependent examinations by development of PCRs directed to genes coding for certain enzymes such as ornithine- and lysine-decarboxylase or arginine-dihydrolase. 16.2.1.2 Preparation of the Food Matrix The complexity of food matrices, their preparation and the choice of the best possible way to detect different bacteria or elute bacterial DNA are still considered as one of the upper most important problems in food microbiology and thus, have been described, experimentally processed and extensively discussed for most foodborne pathogens,48,49 but so far not for Micrococcus spp. Nevertheless, one can assume that protocols for preparation of food matrices used for the isolation and identification of other foodborne pathogens might be useful also for micrococci.
224
Meat and meat products. Micrococcus spp. occurs in fermented meat products as well as products conserved by high salt concentrations and low temperature thermal processing. Examples of these products are dry-fermented sausages, traditional made and temperature sensitive products like pâté containing liver or lard.11,12,18,19 These products are difficult to process further for microbial DNA analysis as they contain substances e.g., proteinases that are able to disturb microbial DNA extraction as well as DNA polymerase activity for amplification.49,50 Additionally the removal of fat, proteins as well as DNA from meat species is challenging. Nonetheless, there are methods that are considered to allow direct DNA isolation from meat and meat products and further amplification e.g., real-time PCR and thus, quantification of microorganisms.50–53 In the case of dry fermented sausage as well as products containing lard, the separation of fat is most important. Various filtration and centrifugation steps prior to DNA preparation are essential.51,53 Dairy products. Micrococcus spp. are reported to be found on smear ripened cheese e.g., Gubeen cheese on traditionally made goat and sheep cheese, and on Camembert-like and blue-veined cheeses also.16,17 In some cases it is not essential to homogenize cheese if only the surface flora needs to be analyzed.54 But to analyze total cheese one has to homogenize a specific volume of the dairy product in adequate suspension e.g., 0.1% peptone solution or physiological sodium chloride solution. Like certain meat products dairy food matrices may harbor substances to reduce the amount of extracted DNA and/or inhibit further DNA amplification. Fish and seafood. Micrococcus spp. are reported to be mainly found in traditionally fermented fish (e.g., cassava fish for further production of lanhouin) or fish sausage.17,18 As fish and especially fish products are at risk to contain significant high values of BA, the detection of Micrococcus spp. which are able to produce BA in fish and sea food is relevant to human health.25 Thus, next to the isolation and/ or detection of Micrococcus spp. it is important to identify their ability to produce BA by molecular or traditional based methods. A suitable and easy isolation method for Micrococcus DNA extraction from all above mentioned food matrices is given by Stevens and Jaykus55 and by Rossmanith et al.56 Both methods are described below and are slightly adapted to fit the purpose: (1) Eleven grams of the sample is diluted in 25 ml sterile 0.9% saline solution and 8 ml of 25% w/v sodium citrate solution supplemented with polyethylene glycol to a final concentration of 4% and treated by a stomacher for at least 2 min at room temperature. For meat and fish products containing larger particle the homogenized product is filtered through cheesecloth. Samples are centrifuged at 9700×g for 15 min at 4°C. The pellet is transferred to DNA extraction using either DNAzol or a commercial kit for total microbial DNA extraction.
Molecular Detection of Foodborne Pathogens
(2) The sample is diluted 1:2 in lysis buffer containing 1× PBS, 8 M urea and 1% SDS. The sample is treated by a stomacher for 3 min. Lysis buffer is added to a volume of 40 ml and lysis is carried out at 45°C for 30 min at constant shaking at 200 rpm following a centrifugation step for 30 min at room temperature and 3220×g. The supernatant is discharged and the pellet dissolved in 500–1500 µl of 1× PBS. Hard cheese and sausage samples are sedimentated for 5 min and the supernatant is further centrifuged at 8000×g for 5 min. DNA isolation from the remaining pellet is performed using a commercial kit for total microbial DNA isolation.
16.2.2 Detection Procedures (i) PCR detection of M. luteus: So far there are no standard protocols used for detection and identification of Micrococcus spp. on a molecular level but the following procedure can be used for obtaining template DNA for proposed PCR amplification (see Table 16.2). Suspective colonies on e.g., LB agar containing 5% sodium chloride and 20 µg/ml furazolidone can be directly used for template DNA extraction as described by three cycles of freeze-thawing.57 (1) One loop of biomass is suspended in 50–100 µl sterile ddH20. (2) rapidly frozen in liquid nitrogen. (3) followed by melting at 60°C for 5min. (4) Repeat steps 2 and 3 twice. (5) Cell debris is pelleted in a microcentrifuge at approximately 10000×g. The supernatant is ready for use in PCR (and can be stored at –20°C for several weeks). If colony counts are expected at 104 per g/ml of food a direct molecular detection might be possible and total microbial DNA isolation can be performed as described in Section 16.2.2. PCR and sequencing of the 16S rRNA gene might be performed as follows:
(1) Quantification of template DNA. (2) Use 5 ng (extracted from culture). (3) 10× dNTPs (2 mM each). (4) 100 mM forward primer and 100 mM reverse primer (stock) (see Table 16.3). (5) PCR reaction buffer including MgCl2 (10×). (6) Taq polymerase (e.g., 5 U/µl). (7) A typical reaction of 25 µl includes: 1–5 µl template DNA, 2.5 µl 10× dNTPs, 0.1 µl forward primer, 0.1 µl reverse primer, 2.5 µl 10× PCR buffer, 0.5 U Taq polymerase (0.1µl of 5 U/µl) adjust with ddH2O to 25 µl. (8) PCR conditions are given in Table 16.3.
225
Micrococcus
Table 16.2 Primers and PCR Conditions Primer Com1 Com2 ML-recA-for ML-recA-rev
Sequence (5′–3′) cagcagccgcggtaatac ccgtcaattcctttgagttt gccctggacccggtctacgcccg cgccgatcttctcgcgcagctgg
Target Gene 16S RNA gene variable region V4-5 recA
Table 16.3 Characteristics Differentiating Micrococcus luteus and Kocuria varians (formerly Micrococcus varians) Characteristics Aerobic acid from glucose Nitrate reduced to nitrite Simmons citrate agar Inorganic nitrogen agar
Micrococcus luteus
Kocuria varians
– – – +
+ + + –
Sources: Kocur, M., In Bergey’s Manual of Systematic Bacteriology, Sneath, P.H.A. et al. (eds.), Williams & Wilkins, Baltimore, 1986.
(9) Amplicons can be purified directly or after detection in gel electrophoreses and excised from the matrix using different commercial kits. (10) Subject to automated sequencing using the above mentioned forward and/or reverse primers, match, and analyze sequence to existing database. Construction of specific primers for the detection of micrococci is hampered by the limited genomic sequences deposited at gene banks. The 16S rRNA gene is most likely not suitable to reach this goal because of the highly conserved character of this gene. More promising might be primers directed to so-called house-keeping genes which are less conserved then 16S rRNA genes but sufficiently conserved to construct Micrococcus-specific primers. However, among commonly studied house-keeping genes we could only find nine recA gene sequences of micrococci in gene banks of which only two were of well characterized strains, M. luteus ATCC 381 (AF214783) and Micrococcus lylae ATCC 27566 (AF214778). After alignment with corresponding gene of two Arthrobacter spp. (closely related to Micrococcus) we were able to construct a primer pair (see Table 16.3) which should allow specific amplification of partial recA with M. luteus and M. lylae resulting in an amplicon of 310 bp. However the suitability, selectivity, and specificity of this approach have not been tested so far because of unavailability of sufficient number of well characterized strains of both species. (ii) Molecular detection of biogenic amine producing bacteria: Some Gram-positive species (e.g., Clostridium, Micrococcus, Lactobacillus, Leuconostoc, and Tetragen ococcus) generate BA including histamine, tyramine,
Amplicon Size (bp) variable 310
Annealing Temperature
Reference
54°C
Schwieger et al.58 This study
–
phenylalanine, putrescine, and cadaverine from free amino acids in fermented foods and beverages as a result of their amino acid decarboxylase activities. Although BA such as histamine and tyramine do not affect the sensory quality of the food products, these compounds have been implicated in a number of food poisoning cases. These bacteria harbor genes hdc and tyrdc encoding for histidine and tyrosine decarboxylases, respectively, which are involved in the production of BA from free amino acids. By employing primers targeting hdc and tyrdc genes as well as 16S rRNA gene of bacteria as an internal PCR control, Coton, and Coton60 developed a multiplex PCR for the early detection of potential tyramine and histamine producing bacteria directly on bacterial colonies. Specifically, the following three primer sets are utilized: HDC3 (5′-GATGGTATTGTTTCKTATGA-3′) and HDC4 (5′-CAAACACCAGCATCTTC-3′) for a 440-bp hdc gene fragment; TD2 (5′-ACATAGTCAACCATRTTGAA-3′) and TD5 (5′-CAAATGGAAGAAGAAGTAGG-3′) for a 1100-bp tyrdc gene fragments; and 16S rRNA universal primers BSF8 (5′-AGAGTTTGATCCTGGCTCAG-3′) a nd BSR15 41 (5′-AAGGAGGTGATCCAGCCGCA-3′) for a 1530-bp fragment as the PCR internal control. Primer concentrations are 20 pmol for HDC3, HDC4, TD2, and TD5 and 5 pmol for BSF8 and BSR1541; and the PCR amplification program consists of one cycle of 95°C for 5 min; 32 cycles of 95°C for 45 sec, 52°C for 45 sec, and 72°C 1 min 15 sec; and one cycle of 72°C for 5 min. After completion, 18 μl of each PCR sample are separated on 0.8% (wt/vol) agarose gels in 1× TBE buffer at 100 V for 50 min and then visualized with ethidium bromide staining using a GelDoc 2000. The authors successfully detected HDC+/TyrDC+ strains of Clostridium, Enterococcus, Lactobacillus, Oenococcus, and Tetragenococcus. Unfortunately, while pyruvoyl-dependent HDC activity has been observed in the genus Micrococcus, the hdc, and tyrdc-equivalent gene sequences are not found in micrococci, which prevent the PCR application of the HDC3, HDC4, TD2, and TD5 primers for the detection of tyramine and histamine producing micrococci. Perhaps, the gene responsible for pyruvoyl-dependent HDC activity in micrococci may have evolved over time so that it differs significantly from that in Clostridium, Enterococcus, Lactobacillus, Oenococcus, and Tetragenococcus. Further examination of micrococcal genome is clearly needed to identify distinct gene sequence accounting for its pyruvoyldependent HDC activity for subsequent PCR application.
226
16.3 Conclusions and FUture Perspectives In food microbiology species of the genus Micrococcaceae have been described as fermenters, spoilers, and pathogens. But because they do not attach major importance in one of these multifarious functions not much research has been undertaken to clarify their role in food. In most cases isolation of micrococci is mainly coincidently as no standard protocols exist in food microbiology for isolation or even further characterization. The recent reclassifications of certain species especially the classification of e.g., M. varians into K. varians sets new requirements in differentiation of micrococci. The differentiation between M. luteus and K. varians is essential to studying fermentation and spoilage in food microbiology, as they have different functions in food fermentation, production of BA and/or spoilage. For instance K. varians is known to be a beneficial microorganisms of main importance in food fermentation and interaction with other fermenters e.g., staphylococci.61 Nevertheless, the differentiation to micrococci will cause problems because both species have similar growth requirements and hence, are difficult to discriminate (see Table 16.3). Therefore, new methods have to be described, adopted, and evaluated for detecting this genus in food. In order to develop a PCR system for rapid identification two strategies appear to be most promising: (i) Development of a PCR which generates genomic fingerprints characteristic for Micrococcus species. Recently, it has been demonstrated that M. luteus biovar II strains exhibit a characteristic band after REP-PCR which was not detected in representatives of biovar I and III strains. This observation indicates a rather high genomic variability among strains of this species which is also demonstrated by the high degree of variability in phenotypic characteristics and it may be difficult to construct primers which in PCR produce M. luteus-specific fingerprints. (ii) Development of a species specific-PCR. In order to develop such an approach sequence information from house-keeping genes are urgently needed. These genes should be present in all Micrococcus species and strains and sufficiently variable to construct primers for specific identification at the species level. Unfortunately, quite a few sequences other than 16S rRNA gene sequences are available from gene banks which hamper the design of such a PCR-approach. Since the biggest threat for humans is the capability of M. luteus to decarborxylate lysine and to produce the biogenic amine cadaverine the most useful tool would be a PCR specifically detecting the gene coding for lysine-decarboxylase but also for this gene no sequence information is available concerning M. luteus. So far, it is unknown whether lysine decarboxylation activity is a common trait of M. luteus or only certain strains of this species and hence, such a PCR would have the advantage to discriminate between hazardous and nonhazardous strains of the species. However, also for this gene no sequence information from M. luteus is accessible. Hopefully, in the near future the complete genome of a representative of a Micrococcus
Molecular Detection of Foodborne Pathogens
species will be sequenced. This information would be a huge step forward to identify house-keeping genes or other gene target and their sequences and to construct species- or genusspecific primers. However, for any of these developments a large number of reliable identified strains of the species in question will have to be subjected to the system to test its suitability. The two species M. luteus and K. varians share in the the 16S rRNA genes less than 95% similarity and hence a PCR may be developed to distinguish the two species. Since the 16S rRNA similarities are quite low it appears to be achievable to develop a duplex PCR with three or four primers which amplifies two 16S rRNA gene fragments of different sizes specific for M. luteus and K. varians, respectively.
References
1. Cohn, F. Untersuchungen über Bakterien. Beitr. Biol. Pfanz., 1, 127, 1872. 2. Stackebrandt, E. et al. Taxonomic dissection of the genus Micrococcus: Kocuria gen. nov., Nesterenkonia gen. nov., Kytococcus gen. nov., Dermacoccus gen. nov., and Micrococcus Cohn 1872 gen. emend. Int. J. Syst. Bacteriol., 45, 682, 1995. 3. Koch, C., Schumann, P. and Stackebrandt, E. Reclassification of Micrococcus agilis (Ali-Cohen 1889) to the genus Arthrobacter as Arthrobacter agilis comb. nov. and remendation of the genus Arthrobacter. Int. J. Syst. Bacteriol., 45, 837, 1995. 4. Wieser, M. et al. Emended descriptions of the genus Micrococcus, Micrococcus luteus (Cohn 1872) and Micrococcus lylae (Kloos et al. 1974). Int. J. Syst. Evol. Microbiol., 52, 629, 2002. 5. Liu, H. et al. Characterization of Micrococcus antarcticus sp. nov., a psychrophilic bacterium from Antarctica. Int. J. Syst. Evol. Microbiol., 50, 715, 2000. 6. Liu, X.-Y. et al. Micrococcus flavus sp. nov., isolated from activated sludge in a bioreactor. Int. J. Syst. Evol. Microbiol., 57, 66, 2007. 7. Schleifer, K.H. and Kandler, O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev., 36, 407, 1972. 8. Kloos, W.E. and Musselwhite, M.S. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol., 30, 381, 1975. 9. Stackebrandt, E. and Goebel, B.M. 1 Taxonomic note: a place for DNA-DNA reassociation and 16S rRNA sequence analysis in the present species definition in bacteriology. Int. J. Syst. Bacteriol., 44, 846, 1994. 10. Anihouvi, V.B. Microbiological changes in naturally fermented cassava fish (Pseudotolithus sp.) for lanhouin production. Int. J. Food Microbiol., 116, 287, 2007. 11. Coppola, R. et al. Characterization of micrococci and staphylococci isolated from soppressata molisana, a Southern Italy fermented sausage. Food Microbiol., 14, 47, 1997. 12. Garcia Fontán, M.C. et al. Microbiological characteristics of “androlla”, a Spanish traditional pork sausage. Food Microbiol., 24, 52, 2007. 13. Gardini, F., Tofalo, R. and Suzzi, G. A survey of antibiotic resistance in Micrococcaceae isolated from Italian dry fermented sausages. J. Food Prot., 6, 937, 2003.
Micrococcus 14. Prado, B. et al. Numerical taxonomy of microorganisms isolated from goat cheese made in Chile. Curr. Microbiol., 43, 396, 2001. 15. Straub, B.W. et al. The formation of biogenic amines by fermentation organisms. Z. Lebensm. Unters. Forsch., 201, 79, 1995. 16. Fernandez-García, E., Tomillo, J. and Nuñez, M. Formation of biogenic amines in raw milk Hispánico cheese manufactured with proteinases and different levels of starter culture. J. Food Prot., 63, 1551, 2000. 17. Addis E. et al. The growth, properties and interactions of yeasts and bacteria associated with the maturation of Camembert and blue-veined cheeses. Int. J. Food Microbiol., 69, 25, 2001. 18. Aryanta, R.W., Fleet, G.H. and Buckle, K.A. The occurrence and growth of microorganisms during the fermentation of fish sausage. Int. J. Food Microbiol., 13, 143, 1991. 19. Cordero, M.R. and Zumalacárregui, J.M. Characterization of micrococcaceae isolated from salt used for Spanish dry-cured ham. Lett. Appl. Microbiol., 31, 303, 2000. 20. Vilar, I. et al. A survey on the microbiological changes during the manufacture of dry-cured lacón, a Spanish traditional meat product. J. Appl. Microbiol., 89, 1018, 2000. 21. Lücke, F.-K. Fermented sausages. In: Microbiology of Fermented Foods. 2nd Edn. Vol 2. pp. 441–483. B.J.B. Wood (ed.). Blackie Academic & Professional, London, United Kingdom, 1998. 22. Jay, J.M. A review of recent taxonomic changes in seven genera of bacteria commonly found in foods. J. Food Prot., 66, 1304, 2003. 23. Sierra, M. et al. Numerical taxonomy of an ‘atypical’ population of gram-positive cocci isolated from freshly dressed lamb carcasses. Int. J. Food Microbiol., 24, 363, 1995. 24. Mauriello, G. et al. Antimicrobial activity of a nisin-activated plastic film for food packaging. Lett. Appl. Microbiol. 41, 464, 2005. 25. Lehane, L. and Olley, J. Histamine fish poisoning revisited. Int. J. Food Microbiol., 58, 1, 2000. 26. Leuschner, R.G., Heidel, M. and Hammes, W.P. Histamine and tyramine degradation by food fermenting microorganisms. Int. J. Food Microbiol., 39, 1, 1998. 27. Lakshmanan, R., Shakila, R.J. and Jeyasekaran, G. Changes in the halophilic amine forming bacterial flora during saltdrying of sardines (Sardinella gibbosa). Food Res. Int., 35, 541, 2002. 28. Taylor, S.L. and Sumer, S.S., Determination of histamine, cadaverine and putrescine. In: Seafood Quality Determination. Proceedings of an International Symposium. pp. 245–253. Kramer, D.E. and Liston, J. (eds.). Elsevier Science, Amsterdam, 1986. 29. Bardocz, S. Polyamines in food and their consequences for food quality and human health. Trends Food. Sci. Technol., 6, 341, 1995. 30. Bouhnik, Y. et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J. Gastroenterol., 94, 1327, 1999. 31. Ronald, J. et al. Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension. Chest, 126, 90, 2004. 32. Albertson, D., Natsios, G.A., and Gleckman, R. Septic shock with Micrococcus luteus. Arch. Intern. Med., 138, 487, 1978. 33. Fosse, T. et al. Meningitis due to Micrococcus luteus infection. Infection, 13, 280, 1985.
227 34. Wharton, M. et al. Septic arthritis due to Micrococcus luteus. J. Rheumatol., 13, 659, 1986. 35. Glupezynski, Y. et al. Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria. Antimicrob. Agents Chemother., 29, 52, 1986. 36. Dürst, U.N. et al. Micrococcus luteus: a rare pathogen of valve prosthesis endocarditis. Z. Kardiol., 80, 294, 1991. 37. Seifert, H., Kaltheuner, M. and Perdreau-Remington, F. Micrococcus luteus endocarditis: case report and review of the literature. Int. J. Med. Microbiol., 282, 431, 1995. 38. Magee, J.T. et al. Micrococcus and Stomatococcus spp. from human infections. J. Hosp. Infect., 16, 67, 1990. 39. Selladurai, B. et al. Intracranial suppuration caused by Micrococcus luteus. Br. J. Neurosurg., 7, 205, 1993. 40. von Eiff, C. et al. Micrococcus luteus as a cause of recurrent bacteremia. Pediatr. Infect. Dis. J., 15, 711, 1996. 41. Peces, R. et al. Relapsing bacteraemia due to Micrococcus luteus in a haemodialysis patient with a Perm-Cath catheter. Nephrol. Dial. Transplant., 12, 2428, 1997. 42. Smith, K.J. et al. Micrococcus folliculitis in HIV-1 disease. Br. J. Dermatol., 141, 558, 1999. 43. Oudiz, R.J. et al. Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension. Chest, 126, 90, 2004. 44. Gleman, A., Drabkin, V. and Glatman, L. Evaluation of lactic acid bacteria, isolated from lightly preserved fish products, as starter cultures for new fish-based food products. Innov. Food Sci. Emerg., 1, 219, 2000. 45. von Rheinbaben, K.E. and Hadlok, R.M. Rapid distinction between micrococci and staphylococci with furazolidone agars. Antonie Van Leeuwenhoek, 47, 41, 1981. 46. Muhri, S., Busse, J. and Hilbert, F., unpublished results. 47. Baker, J.S. Comparison of various methods for differentiation of staphylococci and micrococci. J. Clin. Microbiol., 19, 875, 1984. 48. Powell, H.A. et al. Proteinase inhibition of the detection of Listeria monocytogenes in milk using polymerase chain reaction. Lett. Appl. Microbiol., 18, 59, 1994. 49. Wilson, I.G. Inhibition and facilitation of nucleic acid amplification. Appl. Environ. Microbiol., 63, 3741, 1997. 50. Taylor, T.M. et al. Effect of food matrix and cell growth on PCR-based detection of Escherichia coli O157:H7 in ground beef. J. Food Prot., 68, 225, 2005. 51. Fukushima H. et al. Rapid separation and concentration of food-borne pathogens in food samples prior to quantification by viable-cell counting and real-time PCR. Appl. Environ. Microbiol., 73, 92, 2007. 52. Rodríguez-Lázaro, D. et al. Rapid quantitative detection of Listeria monocytogenes in salmon products: evaluation of pre-real-time PCR strategies. J. Food Prot., 68, 1467, 2005. 53. Stevens, K.A. and Jaykus, L.A., Bacterial separation and concentration from complex sample matrices: a review, Crit. Rev. Microbiol., 30, 7, 2004a. 54. Brennan, N.M. et al. Biodiversity of the bacterial flora on the surface of a smear cheese. Appl. Environ. Microbiol., 68, 820, 2002. 55. Stevens, K.A. and Jaykus, L.A. Bacterial separation and concentration from complex sample matrices: a review. Crit. Rev. Microbiol., 30, 7, 2004. 56. Rossmanith, P. et al. Development of matrix lysis for concentration of gram positive bacteria from food and blood. J. Microbiol. Methods, 69, 504, 2007. 57. Wieser, M. and Busse, H.-J. Rapid identification of Staphylococcus epidermidis. Int. J. Syst. Evol. Microbiol., 50, 1087, 2000.
228 58. Schwieger, F. and Tebbe, C.C. A new approach to utilize PCR-single-strand-conformation polymorphism for 16S rRNA gene-based microbial community analysis. Appl. Environ. Microbiol., 64, 4870, 1989. 59. Kocur, M., Genus I. Micrococcaceae Cohn 1872, 151AL. In Bergey’s Manual of Systematic Bacteriology. Vol. 2, pp. 1004–1008. Sneath, P.H.A. et al. (eds.). Williams & Wilkins, Baltimore, 1986.
Molecular Detection of Foodborne Pathogens 60. Coton, E. and Coton, M. Multiplex PCR for colony direct detection of Gram-positive histamine- and tyramine-producing bacteria. J. Microbiol. Methods, 63, 296, 2005. 61. Tremente, P. et.al. Interaction of Staphylococcus cylosus and Kocunia Varians isolated from fermented meats. J. Apple. Microbiol., 103, 743, 2007.
17 Mycobacterium Irene R. Grant
Queen’s University Belfast
Catherine E.D. Rees
University of Nottingham
Contents 17.1 Introduction ................................................................................................................................................................... 229 17.1.1 Classification of Mycobacterium avium subsp. paratuberculosis ................................................................... 229 17.1.2 Biology, Pathogenesis, and Medical Importance.............................................................................................. 230 17.1.3 Current Methods for the Detection of Foodborne Map.................................................................................... 231 17.1.3.1 Phenotypic Techniques.................................................................................................................... 231 17.1.3.2 Bacteriophage-Based Techniques.................................................................................................... 232 17.1.3.3 Molecular Techniques...................................................................................................................... 232 17.2 Methods.......................................................................................................................................................................... 237 17.2.1 Reagents and Equipment................................................................................................................................... 237 17.2.2 Sample Preparation .......................................................................................................................................... 237 17.2.3 Detection Procedures . ..................................................................................................................................... 238 17.3 Conclusions and Future Perspectives ............................................................................................................................ 239 References.................................................................................................................................................................................. 240
17.1 Introduction 17.1.1 Classification of Mycobacterium avium subsp. paratuberculosis The genus Mycobacterium in the family Mycobacteriaceae contains both fast-growing and slowgrowing species.1 The slow-growing species include the important animal or human pathogenic species Mycobacterium tuberculosis (M.tb), Mycobacterium bovis, Mycobacterium leprae and Mycobacterium avium subsp. avium. Being most closely related to M. avium subsp. avium and M. avium subsp. silvaticum,2 M. avium subsp. paratuberculosis (Map) is an acid-fast, rod-shaped bacterium possessing a thick, lipidrich (waxy) cell wall, which confers on it the properties of acid-fastness (the ability to resist decolorisation by acidified alcohol in the Ziehl-Neelsen stain) and hydrophobicity. The lipid-rich cell wall gives mycobacteria, generally, a survival advantage and increased resistance to chemicals (e.g., chlorine3) and physical processes (e.g., pasteurization,4,5 UV light6), but the consequence of this defense is slow growth due to restricted uptake of nutrients through the cell wall. Characteristics that distinguish Map from other Mycobacterium spp. include its extremely slow growth (up to 18 weeks to form colonies on solid media) and its inability to produce mycobactin (an iron-chelating compound). This
requirement for culture media to be supplemented with synthetic mycobactin J for growth to occur in vitro is used as a differential diagnostic for the species. A conundrum exists however as under appropriate conditions in vivo the organism must be capable of much more rapid growth; this is demonstrated by the fact that high numbers are found in the feces of cattle showing clinical symptoms of disease despite digesta flow rates in the range of 3–5 liters per hour (see Croom et al.7). Molecular identification relies on the detection of specific signature sequences which may be either insertion elements which tend to be present in multicopies (IS900, ISMav2, ISMap02; see Section 17.1.3.3 (i)) or single copy genes within the genome of Map (F57, hspX, locus 251 and locus 255; see Table 17.1 and later discussion of specificity of these different Map-specific targets). Sequencing of the complete genome of Map strain K-10 was carried out by researchers at the University of Minnesota, in collaboration with the National Animal Disease Center, Ames, Iowa. The Map genome sequence was released in January 2004 and deposited in the GenBank database (accession no. AE016958). Analysis showed that Map K-10 has a single circular sequence of 4,829,781 base pairs, with a G + C content of 69.3%. A comparison of the genome sequences of Map and three other Mycobacterium spp. (M.
229
230
Molecular Detection of Foodborne Pathogens
Table 17.1 Map-Specific PCR Targets (in Chronological Order of Publication) Target
GenBank Accession No.
Type of Target
No. of Copies per Map Cell
Reference
14–20 1 1
51 59 60
≥3 1
61
6
63
IS900 F57 hspX
X16293 X70277
Insertion element Gene locus Gene
ISMav2
AF286339
Insertion sequence
Loci 251 and 255 ISMap02
Genes EF514846
Insertion element
tuberculosis, M. leprae and M. bovis) was recently published and this has shed some new light on the genetic basis of mycobactin J dependence and slow growth in Map,8 as well as assisting in the continuing search for novel Mapspecific sequences for use in PCR-based detection methods and the development of microarray analysis methods (see Section 17.1.3.3 (v)).
17.1.2 Biology, Pathogenesis, and Medical Importance Map is well known as an animal pathogen, being the causative agent of Johne’s disease in ruminants,9 but other animals, such as alpacas, rabbits, foxes, stoats, and weasels can also be infected. Johne’s disease is prevalent in domestic animals worldwide (cattle, sheep, and goats principally) and has significant economic impacts for producers. It is generally believed that calves become infected by Map early in life by ingestion of the bacterium in infected milk or colostrum, or via an infected farm environment (fecal-oral route), and it takes a few years (typically 2–5 years) for clinical symptoms of Johne’s disease (weight loss, emaciation, chronic persistent diarrhea, failure to thrive) to become evident. Map is known to be shed in the milk and feces of infected animals. Infections with Map can be latent for years and diagnosis of paratuberculosis can be a challenge in the latent stages of the infection. ELISA tests are used to identify Map-infected animals and an interferon-γ assay (IFN-γ) to identify those where the infection has progressed to the disseminated state. For a recent review of the efficacies of these immunological tests see Nielsen and Toft.10 Once animals progress to the clinical stage of infection, feces may contain up to 1010 Map/g whereas milk aseptically obtained from the udder of an infected animal is thought to contain low levels of Map (2–8 CFU per 50 ml11). However, fecal contamination can, and does, occur during the milking process so low natural levels of Map in a cow’s milk may be augmented by Map from feces. Unfortunately, current cultural methods for Map do not permit accurate enumeration to verify the numbers of viable Map cells present in raw milk. A possible link between Map and Crohn’s disease in humans—though not necessarily causative—has long been suspected but this remains a contentious issue. Crohn’s
62
disease is a chronic inflammatory bowel disease of unknown etiology that typically affects young people in the 15–25 year age group. The clinical and pathological resemblance of Crohn’s disease and Johne’s disease was first recognized as long ago as 1913. The two diseases share common symptoms (chronic weight loss and diarrhea) and common pathology (ileum most frequently involved and granulomatous inflammation),12,13 but there are also distinct differences, for example acid-fast bacteria are not visible in gut sections from Crohn’s patients whereas abundant acid-fast bacteria are visible in sections of gut from cattle affected by Johne’s disease. Opinion in the gastroenterology community remains divided about the role, if any, of Map in Crohn’s disease. The current thinking regarding the aetiology of Crohn’s disease is that it is multifactoral with genetic predisposition (NOD2/CARD15 mutations on chromosome 16, along with the recently identified autophagy genes ATG16L1 and IRGM14), exogenous factors (possibly an infectious agent such as Map) and host specific-factors (e.g., “leaky gut,” vascular supply, hormones, neuronal activity) acting together to induce a chronic state of dysregulated mucosal immune function.15 A number of systematic reviews and meta-analyses of the evidence linking Map to Crohn’s disease have been published recently.16–18 Feller et al.16 considered both PCR and ELISA studies, Abubakar et al.17 considered only results of studies involving nucleic-acid based methods, whilst Waddell et al.18 considered all methods used to detect Map in Crohn’s patients (culture, PCR, FISH, DNA hybridization, and ELISA). The consensus opinion of these three studies, a recent review by Behr and Kapur,19 and indeed previous reviews of the evidence linking Map and Crohn’s disease by the UK Food Standards Agency, European Commission, Food Safety Authority of Ireland and UK National Association for Crohn’s and Colitis (previously summarized by Grant20), is that there is evidence of an association between Map and Crohn’s disease. Feller et al.16 concluded that the association seems to be specific. Waddell et al.18 concluded that evidence for the zoonotic potential of Map is not strong, but should not be ignored. The outstanding unanswered question highlighted by all reviews is: what is Map’s role in the etiology of Crohn’s disease? Further research is necessary on the medical front to answer this question. Assuming Map does have a role in Crohn’s disease and is, therefore, zoonotic, the most likely candidates as vehicles
231
Mycobacterium
of transmission of Map from animals to humans are milk and other dairy products, ground beef and water. Readers are directed to comprehensive reviews of the evidence of Map in food by Gould et al.,21, Grant22, and Griffiths.23 Cows’ milk has received most attention to date because, as described above, ingestion of Map-infected colostrum or milk is recognized as a primary means of transmission of Johne’s disease from cow to calf,24 and to control the spread of Johne’s disease within a herd it is recommended that calves are not fed such milk.25 Cows’ milk forms a significant element of the diet of most people, particularly that of young children, and therefore transmission of Map infection to vulnerable groups via milk is plausible. As most milk is consumed after pasteurization the focus of much of the research on Map in milk has been to assess the efficacy of milk pasteurization to inactivate Map. It is becoming more widely accepted that, despite the fact that HTST pasteurization at minimum 72oC for at least 15 sec should, according to numerous pasteurization experiments (reviewed by Grant22), theoretically achieve a 3–7 log10 reduction in numbers of this bacterium, that low numbers of viable Map may be present in commercially HTST pasteurized milk on occasion. The findings of several large scale surveys of retail pasteurized milk in the UK, Republic of Ireland, Czech Republic, USA, and Argentina illustrate this fact (reviewed by Grant20). The mechanism of this low-level Map survival has yet to be elucidated but estimates of the number of Map surviving HTST pasteurization are: 4–20 CFU/50 ml,26 10–20 CFU/150 ml,27 and 0.002–0.004 CFU/ ml.28 The public health consequences of low levels of Map in pasteurized cows’ milk being periodically consumed by susceptible individuals remains uncertain. Foods other than cow’s milk have not been extensively studied to date. Johne’s disease also affects sheep and goats and Map has been detected and/or isolated from the milk of these domesticated animals,29–31 and cheese made from these types of milk.32 Theoretically beef could also be a potential food vehicle of transmission of Map to humans, although to date there is no evidence of Map being detected in retail ground/minced beef (see Jaravata et al.33 as the only published study), which suggests that beef may not be as important a vehicle as cows’ milk. However this study used detection methods developed for analysis of milk rather than beef and a properly validated survey of beef samples is still required to determine if beef is a significant potential vehicle of transmission of Map to humans. Water represents another potential vehicle of transmission of Map to humans. Specifically surface waters have been shown to be contaminated with Map by run-off from pastures grazed by animals with Johne’s disease. Map has been detected by PCR and/or culture in untreated surface water entering water treatment plants in two separate studies in Northern Ireland34 and South Wales, UK.35 Laboratory studies indicate that chlorination has a limited effect on inactivation of Map.3 Chlorination on its own is generally only applied to pristine upland waters and ground waters but is more commonly applied in combination with other water treatment processes for waters likely to have high microbial
loads, hence there is a need to investigate the ability of other water treatment processes to remove or inactivate Map to determine whether contaminated ground waters are potential sources of human transmission. The fact that Map is known to be responsible for an animal disease that results in significant economic losses to agriculture, and there is a question mark remaining over its potential role in human disease, means that there is a need to be able to diagnose infected animals shedding Map in either milk or feces so that the cycle of infection and contamination of both the environment and food can be broken. There is increasing interest amongst milk processors, particularly baby milk manufacturers, in being able to identify Map-infected milk supplies or to monitor the Map status of milk from their suppliers. Ideally a rapid, sensitive detection method for Map would permit producers to quickly assess presence/absence of viable Map in milk. However in the absence of such a commercially available test, PCR currently offers the best alternative for rapid indication of presence/absence of Map but this of course does not indicate the viability of the cells detected. In addition some debate currently surrounds the importance of positive Map PCR results in fecal samples as it is argued that cells may be only transiently present in the gut rather than being established as a pathogen. Given the limits of current testing methods, the fact that results of studies using PCR and/or culture to detect Map in Crohn’s disease patients have varied is perhaps not surprising. A review of the current evidence for and against the relationship between Map and Crohn’s disease can be found in Behr and Kapur.19
17.1.3 Current Methods for the Detection of Foodborne Map 17.1.3.1 Phenotypic Techniques Culture is the “gold standard” method of detecting viable Map in clinical or food specimens. However, Map is the slowest growing of the cultivable mycobacteria, with a generation time under optimal growth conditions of over 20 h,36 so primary culture from veterinary, clinical or food specimens can take 6 months or longer from testing to confirmation of the identity of an isolate as Map. However, once established, a Map isolate will produce colonies within 4–6 weeks upon subculture at the optimum growth temperature of 37oC under aerobic conditions. Colonies are small (1–2 mm), usually white and domed with an entire margin on Herrold’s Egg Yolk medium plus mycobactin J (HEYM); rough and pigmented colonies are rarely seen. Map’s extremely slow growth is generally attributed to its inability to produce mycobactin, a siderophore that is responsible for the binding or transport of iron into cells. Consequently mycobactin J (commercially available from Synbiotics Europe SAS, Lyon, France or Allied Monitor, Inc., MO) must be included in any media used to culture this bacterium in the laboratory. Automated or semi-automated broth culture systems— BACTEC 12B and MGIT (Becton Dickinson) and Trek ESP (Trek Diagnostic Systems) —have now been widely
232
adopted for culture of Map from diagnostic specimens (principally feces) and for milk testing. These offer a more rapid indication of growth of Map (cultures are incubated for up to 40 days) than culture on solid HEYM, but the main deficiency of all these broth culture systems is that frequently mixed cultures of acid-fast and non-acid-fast bacteria and/ or fungal contaminants are obtained. Hence the detection of the growth of Map must be confirmed from culture-positive samples either by sub-culture on to solid agar medium followed by PCR confirmation of any suspect acid-fast colonies that grow, or by PCR testing of a portion of the broth culture following DNA extraction.37,38 Whilst culture remains the only means available to demonstrate the presence of viable Map in a sample the method is problematic for a number of reasons. Firstly, chemical decontamination of the sample is required, the purpose of which is to inactivate the non-acid-fast bacteria present in the sample that would overgrow the mycobacteria during the long incubation period. Commonly used decontaminants include 0.75% cetylpyridinium chloride (CPC, also referred to as HPC) for milk,39,40 and CPC in conjunction with double incubation in Brain Heart Infusion broth and an antibiotic cocktail for feces (Cornell method37). These treatments were developed to not affect the viability of acid-fast cells present in samples, which have more chemically resistant cell walls than other common eubacterial forms. In reality the decontamination step is known to adversely affect Map viability to some degree, resulting in the recovery of only a fraction of the Map cells originally present in a sample leading to an underestimate of either the number of Map present or the number of Map-positive samples. A second problem with this methodology is that if decontamination has not been effective cultures can be overgrown by non-acid-fast bacteria since there is no selective growth medium for Map that would suppress the growth of these organisms. Certain antibiotics can be added to HEYM (vancomycin, amphotericin B, and nalidixic acid) or to broth cultures used in the automated detection systems BACTEC and MGIT (PANTA; polymyxin B, amphotericin B, nalidixic acid, trimethoprim, and azlocillin) to suppress the growth of competitive microorganisms, however this may in turn prevent recovery of Map cells (see Grant et al.41), especially if they are of sub-lethally injured or stressed. Thirdly, the long incubation periods required due to the slow growth of Map necessitates the use of sealed glass bottles instead of Petri dishes, making accurate enumeration of colonies difficult. In summary, culture of Map is deficient in terms of specificity, sensitivity, and speed, the very properties provided by PCR methods for the detection of Map. 17.1.3.2 Bacteriophage-based Techniques Bacteriophage-based rapid methods of identification for M. tuberculosis have been developed42–44 and produced as a commercial assay for the detection of M.tb in human sputum samples (FASTPlaqueTBTM, Biotec Laboratories, Ipswich, UK). This assay detects the replication of a Mycobacteriumspecific phage (D29) rather than the growth of the M.tb cell
Molecular Detection of Foodborne Pathogens
and results are available within 48 h (see Rees and Loessner45). It has recently been demonstrated that the FASTPlaqueTBTM reagents can also be used to detect the presence of viable Map cells in milk.6,46,47 The advantage of using phage to detect the Map cells over conventional culture methods is that the specificity of the phage-host interaction removes the need for chemical decontamination of the milk sample prior to the assay, thus increasing the sensitivity of the test. Some growth of normal milk flora does occur in the agar but this can be reduced by addition of the antibiotic supplement supplied with the FASTplaqueTBTM kit (NOA; nystatin, oxacillin, and aztreonam). To carry out the milk assay 50 ml milk samples are centrifuged to concentrate the mycobacterial cells. These are resuspended in a modified Middlebrook 7H9 medium and phage is added to the sample. After a period of incubation to allow phage infection (1 h) a virucide is added to inactivate any phage that have not infected a mycobacterial cell; the only phage that survive are those that have infected a target cell. The infected cells are then mixed with a lawn of the fast-growing M. smegmatis in a soft agar, and these cells act as hosts to further replicate phage released from the primary infection. After 18 h incubation, plaques are formed in the M. smegmatis lawn indicating the fact that the phage was protected from the virucide and that the sample contained a target mycobacterial cell. As this cell must be viable to allow phage replication the phage test provides live/dead differentiation but does not give specific identification of the Mycobacterium sp. detected. Hence the phage test alone is useful when examining spiked milk samples and can be used to enumerate the number of viable cells present in a sample.6 To allow identification of Map cells in naturally infected milk samples, PCR is used to confirm the identity of the cell detected; DNA is extracted from the plaque and then multicopy signature sequences are amplified by PCR from the single cell detected (in this case IS900; see Section 17.1.3.3 (i)). The combined phage PCR assay sensitively detects viable Map cells in milk samples within 48 h.47 17.1.3.3 Molecular Techniques (i) Single PCR: Once DNA has been successfully isolated from either cultured cells or a processed sample (see Section 17.2.2) the presence of Map can be confirmed by PCR amplification of the Map-specific sequences. PCR methods are currently used to directly detect Map in food samples in food surveillance studies,41 to confirm the presence of Map in broth cultures (Trek ESP II, MGIT, BACTEC) that contain acid-fast bacteria (e.g., Kim et al.,48 Shin et al.49), to confirm that a suspect acid-fast isolate from solid culture media is Map (e.g., Secott et al.50); and to confirm whether Map or another Mycobacterium sp. has produced a plaque in the FASTPlaqueTBTM phage amplification assay.47 The most commonly used genetic sequence to differentiate Map from other mycobacteria species is the insertion sequence IS900 first reported by Green et al.51. Map has 14–20 copies of IS900, which encodes a 43-kDa DNA binding protein (termed p43). For many years it was thought that IS900 was
Mycobacterium
specific for Map and hence this DNA sequence has been used to design primers for PCR tests and is still routinely used to detect this organism in veterinary, clinical, and food samples or to confirm an acid-fast isolate as Map. However, reports of IS900-like sequences in other mycobacteria began to emerge in the late 1990s and more have been identified as other mycobacterial species have been included in the studies (M. scrofulaceum-type strains,52 M. avium isolates from HIV patients,53 strain 2333 related to M. cookie,54 M. porcinum55) and this has cast doubt on the specificity of IS900 as a signature sequence for Map. IS900 belongs to a family of related insertion elements found in the order Actinomycetales.56 Included in this group are IS901 (specific for M. avium subsp. avium), IS902 (specific for M. avium subsp. silvaticum), IS1110 (found in some M. avium complex isolates) and IS1613 (derived from M. avium subsp. avium) and the greatest degree of homology between these elements is found in the 3′ region of IS900.52 Recently Mobius et al.57 carried out a systematic comparison of different primer sets that have been designed for amplification of IS900 sequences and found that some performed better than others; the most specific single-round PCR assay was found to be the primer sequences published by Bauerfeind et al.58 This was somewhat surprising since the primers were designed to amplify a region in the more conserved 3′ region of IS900 but this group also recommend the use of a high annealing temperature (65°C) to increase stringency and overcome this problem. To avoid issues of primer cross-reactivity, it is common now to use restriction analysis, originally advocated by Cousins et al.52 or DNA sequencing of IS900 PCR products to confirm that the amplicon obtained results from amplification of Map genomic DNA and not from that of another mycobacterial species. It is now widely accepted that IS900 PCR alone cannot be used to test for the presence of Map in food.9 The questionable specificity of IS900 has prompted researchers to seek more specific targets. Genes are highly conserved across the mycobacteria with only a limited number of sequences being identified that can differentiate between Map and other Mycobacterium spp. However several alternatives to IS900 for PCR detection of Map have been reported—F5759, gene encoding the HspX protein60 and ISMav261—see Table 17.1. Recent publication and analysis of the genome sequence of Map has uncovered further new sequences with no homologues amongst other mycobacteria—Locus 251 and Locus 255 (one copy of each, Bannantine et al.62) and ISMap02 (six copies, Stabel, and Bannantine63). The same scale of PCR testing of isolates recovered from food has not been undertaken with these new targets as has been performed using IS900 and therefore their efficacy has not been fully evaluated. However there has been a recent report of non-Map specific sequences being amplified with primers specific for F57 (in M. obuense) and ISMav2 (in M. smegmatis and M. fortuitum).57 (ii) Nested/semi-nested PCR: When using PCR to confirm the identity of cultured Map cells from a suspect acid-fast colony or broth culture, high numbers of Map are likely to be
233
present and therefore sensitivity of PCR assays is not an issue. However when trying to detect low numbers of Map cells from complex samples such as milk, the minimum detection limits of standard PCR methods were considered by some to be leading to false negative results. This is especially a problem when single copy gene sequences are targeted, as the presence of only one copy of the target gene sequence inherently reduces the sensitivity of PCR detection compared to amplification of multicopy insertion sequences such as IS900. To increase detection sensitivity nested or semi-nested IS900 PCR methods were developed.56,64 Nested PCR methods consist of two separate PCR amplifications (30–40 cycles each) involving two different primer sets. The sequence amplified by the second set of primers occurs within the PCR product formed by the first set of primers. In semi-nested PCR one of the primers in the second set is the same as for the first amplification (e.g., primers for F57 PCR described by Vansnick et al.65). Primers for nested PCR methods targeting IS900 are detailed in Table 17.2. These nested IS900 PCR methods have generally achieved a 10–100 fold increase in Map detection sensitivity compared to standard IS900 PCR. However, it must be recognized that the extreme sensitivity of detection when nested PCR is used means that low levels of Map DNA that may be carried over by hands, pipettes, tubes in the laboratory can lead to false-positive results, unless stringent separation and segregation of the different steps in the PCR process and equipment used at each step. A nested/semi-nested PCR approach has also been used when low copy number Map-specific sequences are being targeted (F5765 and ISMap0263), due to the fact that the low concentration of the target sequence inherently reduces the sensitivity of PCR detection compared to the IS900 target which is present in multiple (14–20) copies per Map cell. Published primers for F57 and ISMap02 semi-nested and nested PCR, respectively, are detailed in Table 17.2. Again the specificity and sensitivity of the nested Map-specific PCR detection assays has been recently evaluated by Mobius et al.57 who found that the most sensitive assays had a detection limit of 1 CFU for nested PCR. Interestingly they also reported that the most crucial factor in determining the sensitivity of an assay (single or nested PCR) was the different abilities of the primer pairs to bind to the target DNA under the PCR conditions specified rather than the number of copies of the specific sequence being targeted in the Map genome. This suggests that further optimization of PCR conditions could be carried out for existing primer pairs to increase assay sensitivity. (iii) Real-time PCR: In recent years there has been growing interest in developing real-time PCR methods for detection of Map as it brings the prospect of more rapid and automated detection systems that can be used for routine analysis of samples. Real-time systems use either DNA binding dyes (e.g., SYBR Green) or fluorogenic probes as detailed in Table 17.3. The advantage of fluorogenic probes over DNA binding dyes is that specific hybridization between probe and target is required to generate fluorescent signal, and nonspecific amplification due to mis-priming or primer-dimer
234
Molecular Detection of Foodborne Pathogens
Table 17.2 Published Primer Sets Targeting the Different Map-Specific Sequences used for Conventional and Nested/ Semi-Nested PCR Detection Methods Target IS900 single
IS900 nested
Primer Details (5’ – 3’)
Product Size (bp)
Comments on use, Specificity
Reference
IS900/15OC: CGC TAA TTG AGA GAT GCG ATT GG IS900/921: ATC AAC TCC AGC AGC GCG GCC TCG
229
Amplify IS900-like sequences—strain 2333 related to M. cookii54 M. fortuitum and M. intracellulare, Mobius et al.57
106
P11: CGT CGT TAA TAA CCA TGC AG P36: GGC CGT CGC TTA GGC TTC GA
278
Amplify IS900-like sequences—strain 2333, Englund et al.54; M. scrofulaceum-type, Cousins et al.52
107
P90: TCG GGG CCG TCG CTT AGG P91: GAG GTC GAT CGC CCA CGT GA
400
Amplify IS900-like sequences—M. avium subsp. avium HIV isolates, Naser et al.53; strain 2333, Englund et al.54
108
MK5: TTC TTG AAG GGT GTT CGG GGC C MK6: GCG ATG ATC GCA GCG TCT TTG G
558
Specific for Map but by-products observed (Mobius et al.57)
109
P90+: GAA GGG TGT TCG GGG CCG TCG CTT AGG P91+: GGC GTT GAG GTC GAT CGC CCA CGT GAC
413
Amplify IS900-like sequences—M. scrofulaceum type, Cousins et al.52; M. porcinum, Taddei et al.55
93
MP3c: CTG GCT ACC AAA CTC CCG A MP4c: GAA CTC AGC GCC CAG GAT
314
Amplify IS900-like sequences from strain 2333
58
S204: TGA TCT GGA CAA TGA CGG TTA CGG A S749: CGC GGC ACG GCT CTT GTT
563
Amplify IS900-like sequences from strain 2333
64
1st round: S204/S749 (as above) 2nd round: S347: GCC GCG CTG CTG GAG TTG A S535: AGC GTC TTT GGC GTC GGT CTT G 1st round: TJ1: GCT GAT CGC CTT GCT CAT TJ2: CGG GAG TTT GGT AGC CAG TA 2nd round: TJ3: CAG CGG CTG CTT TAT ATT CC TJ4: GGC ACG GCT CTT GTT GTA GT
64
210
356
Described as “uniquely specific for IS900” and designed to avoid amplification of IS900-like sequences from 2333, WA isolates, etc.
56
294
hspX
Left: GAC CGG CTA TCT GTG GAA C Right: CTC GTC GGC TTG CAC CTG
211
110
F57
f57p1: TTG GAC GAT CCG AAT ATG T f57p2: AGT GGG AGG CGT ACC A
254
77
F57: CCT GTC TAA TTC GAT CAC GGA CTA GA R57: TCA GCT ATT GGT GTA CCG AAT GT F57Rn: TGG TGT ACC GAA TGT TGT TGT CAC R57: as 1st round
432
III20: GAT CAT TCC CGG ATG TGT G III21: AGA CTG CGG TGA AAC TGC T
269
ISMav1: GTA TCA GGC CGT GAT GGC GG ISMav2: CGC GAC CAG CGC TCG ATA CA
318
ISMav2-F: GTG AGT TGT CCG CAT CAG AT ISMavB2: GCA TCA AAG AGC ACC TCG AC
494
49
Locus 251
251F: CAC GTG CTG TCC CCA TCG GC 251R: CTA CGT CTT CGT GAC CAA AG
417
62
Locus 255
255F: CAG TCA CCC CGC GGC CGG TA 255R: TCT ACT GAC CCG CAG ATC GAA
402
ISMav2
False-positive due to M. obuense, Mobius et al.57
65
424 61 Nonspecific products due to M. fortuitum and M. smegmatis reported by Mobius et al.57
By-products reported by Mobius et al.57 with “other mycobacteria”
102
62
(Continued)
235
Mycobacterium
Table 17.2 (Continued) Target ISMap02
Primer Details (5’ – 3’)
Product Size (bp)
Forward: GCA CGG TTT TTC GGA TAA CGA G Reverse: TCA ACT GCG TCA CGG TGT CCT G
278
Forward 2nd: GAT AAC GAG ACC GTG GAT GC Reverse 2nd: AAC CGA CGC CGC CAA TAC G
117
artifacts do not generate signal. Quite a number of different primer sets have been published targeting the range of Map-specific elements and genes (Table 17.3). The ability to monitor the real-time progress of a PCR is a significant advantage. Reactions are characterized by the point in time during cycling (threshold cycle, CT) when amplification of a PCR product is first detected rather than the amount of PCR product at the end of a fixed number of cycles. Real-time PCR can become quantitative if appropriate standard curves are constructed relating CT value to copy number of the target element/gene. Real-time PCR assays are reported to: have equivalent or greater detection sensitivity compared to conventional PCR depending on Map target employed;63,66,69 achieve equivalent detection sensitivity for Map as culture;68,69 be faster than conventional PCR—30–40 mins for 40 cycles compared to a 1–2 h;70,71 and be able to detect multiple targets simultaneously (e.g., IS900 + Locus 251, IS900 + F5772), an approach advocated by Herthnek and Bolske73 to circumvent IS900 specificity issues. (iv) Inclusion of internal Controls in PCR reactions: Increasingly, an internal amplification control (IAC) molecule is being included in PCR reactions so that PCR inhibition can be distinguished from lack of amplification of a PCR product and to allow test results to be validated.74 Contaminants which lead to nonamplification of the organism-specific target result in a false-negative result being recorded. This is very important when processing with samples that contain organic matter, be it milk or feces.75 If the IAC molecule does not amplify and produce the expected PCR product then this is indicative of the presence of inhibitory substances in the sample. Inhibition may be total, resulting in complete reaction failure, or partial, resulting in reduced sensitivity of detection. IAC molecules added to Map PCR reactions have included the human β-actin gene,54,64 the Listeria monocytogenes hly gene,76 the pUC19 plasmid DNA,77,78 and by genetically modifying a plasmid containing an insert of M. bovis-hspX.79 As expected commercially-available PCR detection kits for Map, such as ADIAVET ParaTub PCR (ADIAGENE, St Brieuc, France), BACTOTYPE Detection kit M. paratuberculosis Milk Test (Labor Diagnostik, Leipzig, Germany), and M. paratuberculosis 209/700IC kit (Sacace Technologies Srl, Caserta, Italy), all incorporate IAC as part of their QC procedures. (v) NASBA: Nucleic acid sequence-based amplification (NASBA) normally involves amplification of an RNA template using temperatures within a narrow range (isothermal;
Comments on Use, Specificity
Reference 63
generally 37–42°C). The reaction uses the enzyme reverse transcriptase to synthesize cDNA from a RNA target sequence, RNase H to digest the RNA strand and then synthesis of up to 100 RNA copies from the cDNA by the enzyme T7 RNA polymerase from the cDNA template. This RNA then acts as a template in the next round of amplification, leading to a rapid increase in the concentration of the amplified product. NASBA requires two primers, one that is homologous to the 3′ end of the target sequence and includes a bacteriophage T7 promoters sequence at the 3′ end to allow second round synthesis of RNA, and a second primer homologous to the 5′ end of the sequence. A NASBA detection assay has been developed that targets the dnaA gene of Map.80 This assay incorporated a molecular beacon probe so that amplification of the target gene could be detected by real-time PCR; this probe is homologous to a sequence located between the two amplification primers and includes a stem-and-loop-structure which is double-labeled with a fluorescent dye at the 5′ end and a universal quencher at the 3′ end. When this probe hybridizes to the target RNA, the fluorescent reporter dye and the quencher are linearly separated and results in an increase in fluorescence intensity proportional to the concentration of the target RNA molecular to which it hybridizes. The fluorescent signal is then quantified using standard real-time PCR methodologies. As molecular beacon probes can be labeled with different fluorescent dyes, a multiplex PCR was developed to allow the simultaneous amplification and detection of the target gene and an IAC molecule.76 The NASBA assay had a sensitivity of approximately 200 cells per reaction, and was able to detect 103 Map cells in artificially contaminated drinking water or 104 Map cells added to pasteurized semi-skimmed milk indicating, again, that contamination by organic matter from the sample matrix is a consistent problem for molecular methods of detection. (vi) Microarrays: The advent of whole genome sequence analysis has led to the development of microarray technology where every gene or every sequence of a bacterial genome is displayed on a solid support in an ordered grid which can then be hybridized with DNA from other species or isolates to allow comparison of whole genome content. This technology is not used for routine identification of organisms but has led to rapid advances in our understanding of the stability of genomes and identification of variable regions that may otherwise have been missed. For instance, genome comparison using microarrays has identified large sequence polymorphisms (LSPs) that are variably present in different strains of Map, and that these
236
Molecular Detection of Foodborne Pathogens
Table 17.3 Published Primer and Probe Sets Targeting Map-Specific Sequences used for Quantitative Real-Time PCR MAP Target IS900
Real-Time PCR Equipment
Primers and Probes (5′–3′)
Reference
Primers of Collins et al. (1993) Probe: TET-CGG ACC GTA ACT ACC CGC GGC GTG ATG GGT CCG-dabcyl
ABI PRISM 7700 Sequence Detection System
70
F2: AAT GAC GGT TAC GGA GGT GGT R2: GCA GTA ATG GTC GGC CTT ACC Probe P2: FAM-TCC ACG CCC GCC CAG ACA GG-TAMRA
ABI PRISM 7700 Sequence Detection System
105
P90: GTT CGG GGC CGT CGC TTA GG P91: GAG GTC GAT CGC CCA CGT GA SYBR green
LightCycler
71
F1: CGG GTA TGG CTT TCA TGT GGT R1: GTC GAT CGC CCA CGT GAC FL-labeled probe: CCA CCT CCG TAA CCG TCA TTG TCC AGA LC Red 640-labeled probe: CAA CCC AGC AGA CGA CCA CGC
LightCycler
111
Forward: CGG GCG GCC AAT CTC Reverse: CAG GGA CGT CGG GTA TG Probe: FAM – TTC GGC CAT CCA ACA CAG CAA CC- TAMRA
GeneAmp 5700 Sequence Detection System
66
IS900QF: CCG GTA AGG CCG ACC ATT A IS900QR: ACC CGC TGC GAG AGC A Probe: FAM-CAT GGT TAT TAA CGA CGA CGC GCA GC-TAMRA
ABI PRISM 7700 Sequence Detection System
112
SF187: TGG TCG TCT GCT GGG TTG A SR239: GCC ACA ACC ACC TCC GTA AC SYBR green
ABI 5700 Sequence Detection System
113
SF214: ATG ACG GTT ACG GAG GTG GTT SR289: TGC AGT AAT GGT CGG CCT TAC Probe PR265: FAM-CGA CCA CGC CCG CCC AGA-TAMRA F57
MAPf57p1: TTG GAC GAT CCG AAT ATG T MAPf57p2: AGT GGG AGG CGT ACC A Probes: MAPf57-3iFluo: CAC GCA GGC ATT CCA AGT MAPf57-5iRed705: TGA CCA CCC TTC CCG TCG (IC probe)
LightCycler
78
Locus 251
251F: GCA AGA CGT TCA TGG GAA CT 251R: GCG TAA CTC AGC GAA CAA CA Probe: FAM-CTGACTTCACGATGCGGTTCTTC-BHQ
SmartCycler II
72
ISMap02
Forward: GCA CGG TTT TTC GGA TAA CGA G Reverse: TCA ACT GCG TCA CGG TGT CCT G
Unclear—MJ Research?
63
Forward 2nd: GAT AAC GAG ACC GTG GAT GC Reverse 2nd: AAC CGA CGC CGC CAA TAC G SYBR green ISMav2
ISMav2 F: GAT GAG TGG GTC GAG GAC TAC AA ISMav2 R: CCG TTG AGC CGG TGT GAT Probe: FAM – CCA AGC CCT AAA GAT - MGB
ABI 7000 Sequence Detection System
114
hspX
Forward hspX Primer: GAC CGG CTA TCT GTG GAA C Reverse hspX Primer: CTC GTC GGC TTG CAC CTG hspX Upstream Probe: GCA CCC GTC GTG GTA TCT-FLU hspX Downstream Probe: LC RED 640-AAT CTG CAA GCC AAT CCG G-PHOSPHORYLATION
LightCycler
79
Key for probe labels: FAM=5-carboxyfluorescein, MGB=minor groove binder,TAMRA=6-carboxy-tetramethyl-rhodamine, FL=fluorescein,TET=tetrachloro6-carboxyfluorescein, dabcyl=4-dimethylaminophenylazobenzoic acid, FLU=fluorescein, BHQ=Black Hole Quencher 1.
LSPs can be the result of either horizontal gene transfer or insertion or deletion events.81 When the Map genome content was compared with other members of the M. avium complex, it was noted that genes predicted to be involved in metabolic
pathways were overrepresented in the LSPs, and that a polymorphism within the mycobactin biosynthesis operon potentially explains the mycobactin J dependency of Map when grown in vitro.82 Similarly Marsh et al.83 used microarrays to compare
237
Mycobacterium
the genomic content of sheep (S) and cattle (C) strains that are known to have different host tropisms. They identified three large genomic deletions in the sheep strain, totaling 29,208 bp and involving 24 open reading frames providing a genetic basis for the different behavior of these host-adapted strains that had been previously reported. These studies have been reviewed, along with other methods of whole genome analysis that are outside the scope of this chapter, by Turenne et al.84
17.2 Methods 17.2.1 Reagents and Equipment Reagents
Consumables
Equipment
Map-specific primers—see Tables 17.2 and 17.3 Lysis buffer
Pipette tips
Centrifuges—50 ml and 1.5 ml capacity
Centrifuge tubes: 50 ml, 1.5 ml
Tris-EDTA buffer
dNTPs
Lysing matrix blue (QBiogene) or Zirconium beads 0.1 mm Sterile pastettes
Bead-beater— FastPrep (QBiogene), BioSpec mini beadbeater, or similar Conventional thermal cycler or real-time PCR system
Taq polymerase
PCR tubes
Phenol:chloroform:isoamylalcohol (25:24:1) Isopropanol 70% alcohol Phosphate-buffered saline containing 0.05% Tween 20 (wash buffer if using IMS) Antibody or peptide coated magnetic beads for IMS
Gel electrophoresis equipment Magnetic rack if using IMS Pipettes
17.2.2 Sample Preparation Sample preparation steps employed for foods are key to providing high purity DNA free from inhibitors and in maximal quantities for PCR purposes. This means concentrating low numbers of Map in milk by centrifugation, removing milk inhibitors by immunomagnetic separation (IMS), peptidemediated capture or magnetic capture and washing, lysing the tough Map cell wall by bead-beating, and purifying and precipitating the DNA released. Due to the low levels of Map expected to be present in milk samples it is usual to test samples of up to 50 ml milk and use centrifugation to concentrate this into a more appropriate sample volume (1 ml) before further processing. The vast majority of published milk surveillance studies have tested pellet only by both culture and PCR.26,41,66,85–92
However, there is some debate about how Map segregates into the three milk fractions (cream, whey, and pellet) upon centrifugation and, therefore, whether testing the pellet ensures adequate detection sensitivity or whether cream and pellet should be combined before further processing. Millar et al.93 were the first to comment on segregation of Map in milk fractions following centrifugation. These researchers found that disaggregated intact Map spiked into whole pasteurized cows’ milk gave an IS900 PCR signal which segregated into both the cream and pellet fractions after centrifugation, although a much stronger PCR signal was obtained from the pellet fraction, whereas when milk was spiked with Map DNA in the same study a PCR signal was observed equally in all three milk fractions. When Millar et al.93 applied IS900 PCR to naturally infected raw milk samples IS900 PCR signals were observed in all three milk fractions, but most consistently the pellet and cream fractions tested positive for Map. Gao et al.40 also reported that more live Map could be recovered from the pellet of heat treated milk than from raw milk, although they also state that spiked Map cells preferentially partitioned into cream in raw milk. In a subsequent study Gao et al.94 advised heat treatment of 50 ml raw milk samples in a 95oC waterbath for 10 min until the internal temperature reaches over 85oC followed by cooling in ice water for 10 min prior to DNA extraction to maximize sedimentation of Map in the pellet fraction, resulting in stronger PCR signal and less background signal (smearing). They also reported that if the cream and pellet fractions obtained from raw milk were treated with 0.75% hexadecylpyridinium chloride (the usual decontaminant prior to culture) for 30 min at room temperature before further centrifugation and discard of the supernatant and cream layer then the PCR signal in the resultant pellet increased. Pooling of pellet and cream fractions prior to further extraction definitely improved PCR detection sensitivity according to Gao et al.94 as did inclusion of 0.0037% bovine serum albumen in the PCR reaction.95 C-18-carboxypropylbetaine (CB-18) has been tried as an aid to sedimentation of Map from milk96 but no improvement over a dilution and centrifugation method was observed for Map, whereas CB-18 had been shown to aid sedimentation of M. bovis from milk previously.97 Once Map cells have been concentrated by centrifugation, the pellet, or pellet and cream, can either be lysed directly or subjected to IMS, peptide-mediated capture or magnetic bead capture to selectively separate Map from milk components that may prove inhibitory to subsequent PCR before lysis. The first IMS for Map was developed by Grant et al.98 using rabbit anti-Map polyclonal IgG antibody secondary coated on to Sheep anti-rabbit IgG Dynabeads (Dynal). IMS achieves two things; the simultaneous selection of Map from a mixed background microflora and removal of milk components (such as Ca2+ ions, proteins, thermonucleases75) that may inhibit PCR. The use of the original IMS method in conjunction with IS900 PCR (IMS-PCR) was subsequently described by Grant et al.99 for Map in milk and further improvements to this method (inclusion of bead beating and DNA purification steps) to improve PCR detection sensitivity were described by Khare et al.66 An IMS method employing monoclonal antibody capture has also been described100 and is now part
238
of a commercial IMS-real-time PCR kit for Map in milk (AnDiaTec ParaTub-SL IMS-Taqman Real-time PCR kit, AnDiaTec GmbH & Co KG, Korwesheim, Germany). Stratmann et al.101,102 used Map-specific peptides aMP3 and aMptD rather than antibody to achieve magnetic capture, with similar or greater detection sensitivity by PCR than antibody capture, and peptide capture is now part of another commercial detection kit for Map in milk (BACTOTYPE M. paratuberulosis milk test, Labor Diagnostik, Leipzig, Germany). In contrast, the commercially available Adiapure DNA extraction kit (Adiagene) incorporates magnetic capture with uncoated beads (identity unknown), which have been found to work just as well for concentrating Map from milk samples as the original polyclonal antibody-based IMS method in a recent study.67 Probably the hydrophobic nature of Map (and other mycobacterial) cells make them physically attracted to beads of a certain composition. We have certainly observed significant levels of nonspecific binding of several Mycobacterium spp. to different types of uncoated magnetic beads, including Pierce MagnaBind carboxyl derivatized beads (Grant et al., unpublished data,). Once concentrated from milk (by centrifugation alone or by magnetic separation) Map cells must be lysed to release DNA for PCR purposes. The cell wall of Map has been described by one researcher (Prof. John Hermon-Taylor) as “teflon coated” and boiling alone (95–100oC for 15 min), a method that proves adequate for the lysis of many other bacteria, is generally not sufficient for Map lysis unless large numbers of Map are present in a sample (e.g., when confirming acid-fast cells present in a broth culture or from a colony to be Map by PCR). However, in situations where low numbers of Map are suspected/expected boiling is not sufficient for lysis. A variety of approaches have been studied, including the use of commercial DNA extraction kits (e.g., InstaGene Matrix, QIAamp Tissue kit, Adiapure) but the consensus opinion is that bead-beating in some shape or form is necessary for maximal release of Map DNA. The two main disruptor systems used for Map are the Bio101 FastPrep Cell Disrupter instrument (Qbiogene), also known as the Hybaid Ribolyser, and the Mini Bead-beater (BioSpec). Bluecapped Lysing matrix B tubes (QBiogene) are used with the FastPrep machine and 0.1 mm zirconia/silica beads (BioSpec) are used with the mini beadbeater. Bead-beating is generally preceded by resuspension of the pellet or magnetic beads with cells attached in a lysis buffer, typically containing Tris, EDTA sodium chloride and sodium dodecyl sulphate at pH 8, and treatment with proteinase K to weaken the cell wall, followed by isopropanol precipitation of DNA. Odumeru et al.94 compared a number of extraction protocols and reported a PCR detection limit of 105 CFU/ml with boiling alone which increased to 102 CFU/ml if cells were subjected to bead-beating (BioSpec mini bead-beater), boiling and isopropanol precipitation instead. Sequence capture following lysis to pull out Map-specific sequences using biotin-labeled specific probes and streptavidin-labeled Dynabeads has also been investigated.103,104 Whilst results demonstrate that sequence capture works for Map—Vansnick et al.104 report that sequence capture PCR has the same sensitivity as fecal culture for detection of Map in feces (100 Map/g feces)—this approach has not
Molecular Detection of Foodborne Pathogens
been adopted for milk in the same way as magnetic separation prior to lysis to date. In summary, a combination of, at least, centrifugation, harsh lysis, physical grinding (bead-beating), and nucleic acid purification are needed to facilitate maximal extraction of Map DNA from milk and other food matrices. Additional steps might include magnetic separation or sequence capture to more specifically extract Map DNA only.
17.2.3 Detection Procedures (i) Typical DNA extraction protocol: (1) Centrifuge 50 ml of milk at 2,500 × g for 15 min. Discard whey fraction and resuspend cream and pellet in 1 ml PBS containing 0.05% Tween 20 (PBS-T; Sigma P3563). Transfer samples to 1.5 ml microcentrifuge tubes using a pastette. (2) If applying immunomagnetic dispense an appropriate volume of beads (10 µl) into each sample. Vortex each tube briefly then mix gently for 30 min at room temperature on a Dynal mixer or flat-bed mixer. (3) Transfer tubes to magnetic rack for 10 min in order to capture beads then carefully pipette off the fluid leaving the beads adhering to the back of the tube. (4) Wash beads twice with 1 ml PBS-T with capture for 2 min on magnetic rack between washes. (5) Resuspend immunomagnetic beads (IMB) after immunomagnetic separation in 700 µl TEN lysis buffer (2 mM EDTA, 400 mM NaCl, 10 mM TrisHCl, pH 8.0, 0.6 % SDS) containing 20 µg proteinase K (Sigma) and incubate overnight at 37°C. (6) After overnight proteinase K treatment, transfer samples to FastPrep Lysing Matrix B (blue-capped) tubes (QBiogene). (7) Place tubes in the Bio101 FastPrep cell disruptor and mechanically disrupt cells by vibration for 45 sec at 6.5 m/sec, then remove tubes and place on ice for 15 min to allow foam to settle. (8) Add 700 µl phenol:chloroform:isoamylalcohol (25:24:1) pH 8.0 (Sigma) to each blue-capped tube and vortex for 1 min. (9) Centrifuge samples at 10,000 rpm in a benchtop microfuge for 10 min and then transfer top aqueous layer to a fresh 1.5 ml microcentrifuge tube containing 400 µl (0.6 vol) isopropanol (Sigma) using a Pasteur pipette to precipitate DNA (NB. IMB will sediment at bottom of phenol layer in the process). Place tubes in –20°C freezer for at least 30 min. (10) Recover DNA by centrifuging at 10,000 rpm in a benchtop microfuge for 10 min. Wash DNA pellet once with 500 µl 70% ethanol centrifuging in a benchtop microfuge at 10,000 rpm for 10 min. (11) Decant ethanol carefully and allow DNA pellet to air dry briefly before resuspending DNA in 50 µl Tris-EDTA (TE) buffer pH 8.0. (12) Perform IS900 PCR using 5 µl of template DNA per reaction.
239
Mycobacterium
1
2
3
- 1000 bp
- 500 bp
- 100 bp
Figure 17.1 PCR amplification of IS900 element. Agarose gel (1.5% v/w) electrophoresis of IS900 PCR amplicon (400 bp) amplified from purified Map ATCC 19851 DNA using P90/P91 primers and protocol described in Section 17.2.3 (ii) (lane 1). Template DNA was prepared by resuspending one colony of Map in 1 ml distilled water in a sterile 1.5 ml Eppendorf tube and boiling for 20 min. Samples were then centrifuged at 13,000 × g for 3 min, and the supernatant extracted and frozen to –20ºC as a positive control DNA sample). As a negative control, template DNA was prepared in the same way from M. smegmatis cells (lane 2). The band at the bottom of this sample running at ~100 bp represents amplification of nontemplate specific primer dimer; this will also appear in positive samples but is most intense in absence of specific template for primers used in PCR reaction. Molecular weight markers (lane 3) are Promega 100 bp ladder (PR-G2101).
(ii) IS900 Single PCR procedure: In Section 17.2.1 (i) the different PCR targets and primer pairs that have been characterized to date are reviewed, including a critique of their relative specificity. Despite some criticisms, IS900 PCR is still the most commonly performed diagnostic PCR assay performed and a suggested protocol is included below. Readers should be aware that buffer composition, thermal cycle programmes, and expected product sizes all differ depending on the primer set chosen; see Table 17.2 and the individual publications cited for PCR protocols for alternative targets/primer pairs. Suggested PCR protocol: (1) Prepare sufficient PCR supermix for the number of PCR reactions required (i.e., no. of samples+positive, control+negative control) using the following components per 45 µl reaction:
Molecular grade water 0.037 % (w/v) Bovine serum albumin
26 µl 5 µl
10x Taq buffer without MgCl2 MgCl2 (50 mM) Primer P90* (30 pmol/µl)
5 µl 1.75 µl 2 µl
Primer P91* (30 pmol/µl)
2 µl
dNTP mix (25 mM of each NTP) Platinum Taq DNA polymerase** (5 U/µl)
3 µl 0.25 µl
* Primers of Vary et al.106. Sequences detailed in Table 17.2. ** Hot Start Taq DNA polymerase available from Invitrogen.
(2) Dispense the supermix in 45 µl aliquots in 0.5 ml PCR thermotubes and add 5 µl sample DNA template, 5 µl molecular biology grade water (negative control) or 5 µl of DNA from a confirmed culture of Map lysed by boiling (positive control). (3) Place tubes on thermal cycler and run the following program: one cycle of 94oC for 2 min, 62oC for 15 sec, and 72oC for 1 min; 35 cycles of 94oC for 30 sec, 62oC for 15 sec, and 72oC for 1 min; and one cycle of 94oC for 30 sec, 62oC for 15 sec, and 72oC for 5 min. (4) Visualize PCR product by 1–2 % (w/v) agaraose gel electrophoresis using 15 µl PCR product mixed with 5 µl loading dye per lane. Run gel at 100 V for 1–1.5h. (5) Confirm the presence of expected Map-specific 400 bp IS900 product by staining gel with ethidium bromide and viewing on UV transilluminator (see Figure 17.1).
17.3 Conclusions and Future Perspectives Molecular detection methods for Map have come a long way in recent years as there has been intense research effort to improve and optimize PCR detection methods for Map in milk. This research has been driven by the potential link between Map and Crohn’s disease and the potential need to control Johne’s disease in the food producing animal population and/or monitor Map contamination of animalderived foods by food producers and processors. Current PCR methods permit the rapid, sensitive, and specific detection of Map DNA in food although the origin of this DNA—whether from live or dead Map—is still not differentiable by PCR methods. Accurate quantitation of viable Map levels existing in naturally infected raw milk would assist risk assessment and enable prediction of process efficiency (pasteurization) in the food industry. Whilst real-time PCR methods now afford the possibility to quantify Map in a milk sample, Map viability is not confirmed by real-time PCR unless the concentration of PCR product is shown to increase over time, i.e., minimum two PCR reactions at different time points, during incubation.105 Efforts to detect and quantify RNA as opposed to DNA of Map have to date not been very successful. Our recent work describing a phagebased test to detect viable Map cells in milk demonstrates that rapid, sensitive, and specific detection of Map cells is
240
possible and that further development of these assays may produce practical tests that can be used both for veterinary diagnosis of disease and screening of suspected food vehicles of transmission.
References
1. Wayne, L.G. and Kubica, G.P. Family Mycobacteriaceae. In Bergey’s Manual of Determinative Bacteriology, Vol. 2, pp. 1435–1457. Sneath, P.H.A. et al. (eds). Baltimore, MD: Williams and Wilkins, 1986. 2. Thorel, M.F., et al. Numerical taxonomy of mycobactindependent mycobacteria, emended description of Mycobact erium avium, and description of Mycobacterium avium subsp. avium subsp. nov., Mycobacterium avium subsp. paratuberculosis subsp. nov., and Mycobacterium avium subsp. silvaticum subsp. nov. Int. J. Syst. Bacteriol., 40, 254, 1990. 3. Whan, L. et al. Bactericidal effect of chlorine on Mycobacterium paratuberculosis in drinking water. Lett. Appl. Microbiol., 33, 227, 2001. 4. Grant, I.R. et al. Inactivation of Mycobacterium paratuberculosis in cow’s milk at pasteurization temperatures. Appl. Environ. Microbiol., 62, 631, 1996. 5. Grant, I.R., Ball, H.J. and Rowe, M.T. Effect of high-temperature, short-time (HTST) pasteurization on milk containing low numbers of Mycobacterium paratuberculosis. Lett. Appl. Microbiol., 26, 166, 1998. 6. Altic, L.C. et al. UV light inactivation of Mycobacterium avium subsp. paratuberculosis in milk assessed by FASTPlaqueTBTM phage assay and culture. Appl. Environ. Microbiol., 73, 3728, 2007. 7. Croom, W.J. et al. Cholinergic manipulation of digestive function in ruminants and other domestic livestock: a review. J. Anim. Sci., 68, 3023, 1990. 8. Li, L. et al. The complete genome sequence of Mycobacterium avium subspecies paratuberculosis. Proc. Natl. Acad. Sci. USA, 102, 12344, 2005. 9. Harris, N.B. and Barletta, R.G. Mycobacterium avium subsp. paratuberculosis in veterinary medicine. Clin. Microbiol. Rev., 14, 489, 2001. 10. Nielsen, S.S. and Toft, N. Ante-mortem diagnosis of paratuberculosis: a review of accuracies of ELISA, interferon-γ assay and faecal culture techniques. Vet. Microbiol., 129, 217, 2008. 11. Sweeney, R.W., Whitlock, R.H., and Rosenberger, A.E. Mycobacterium paratuberculosis cultured from milk and supramammary lymph nodes of infected asymptomatic cows. J. Clin. Microbiol., 30, 166, 1992. 12. Chiodini, R.J. Crohn’s disease and the mycobacterioses: a review and comparison of two disease entities. Clin. Microbiol. Rev., 2, 90, 1989. 13. Greenstein, R.J. Is Crohn’s disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne’s disease. Lancet Infect. Dis., 3, 507, 2003. 14. Fisher S.A., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn’s disease. Nat. Genet., 40, 710, 2008. 15. Chacon, O., Bermudez, L.E. and Barletta, R.G. Johne’s disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Ann. Rev. Microbiol., 58, 329, 2004. 16. Feller, M. et al. Mycobacterium avium subspecies paratuberculosis and Crohn’s disease: a systematic review and metaanalysis. Lancet Infect. Dis., 7, 607, 2007.
Molecular Detection of Foodborne Pathogens 17. Abubakar, I. et al. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn’s disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm. Bowel Dis., 14, 401, 2008. 18. Waddell, L.A. et al. The zoonotic potential of Mycobacterium avium spp. paratuberculosis—a systematic review. Can. J. Pub. Health, 99, 145, 2008. 19. Behr, M.A., and Kapur, V. The evidence for Mycobacterium paratuberculosis in Crohn’s disease. Curr. Opin. Gastroent., 24, 17, 2008. 20. Grant, I.R. Zoonotic potential of Mycobacterium avium ssp. paratuberculosis: the current position. J. Appl. Microbiol., 98, 1282, 2005. 21. Gould, G. et al. Mycobacterium avium subsp. paratuberculosis (Map) and the food chain. ILSI Report Series, International Life Sciences Institute (Europe), Brussels, Belgium, 2004. 22. Grant, I.R. Mycobacterium avium subsp. paratuberculosis in foods: current evidence and potential consequences. Int. J. Dairy Technol., 59, 112, 2006. 23. Griffiths, M.W. Mycobacterium paratuberculosis. In Emerging Foodborne Pathogens, pp. 522–556. Motarjemi, Y. and Adams, M. (eds). Cambridge, England: Woodhead Publishing, 2006. 24. Manning, E.J.B. and Collins, M.T. Mycobacterium avium subsp. paratuberculosis: pathogen, pathogenesis and diagnosis. Rev. Sci. Tech. – Off. Intern. Epizoot., 20, 133, 2001. 25. Collins, M.T. Update on paratuberculosis: 3. Control and zoonotic potential. Irish Vet. J., 57, 49, 2004. 26. Grant, I.R. et al. Effect of commercial scale HTST pasteurisation on the viability of Mycobacterium paratuberculosis in naturally infected cows’ milk. Appl. Environ. Microbiol., 68, 602, 2002. 27. Grant, I.R. et al. Efficacy of various pasteurisation time/ temperature conditions in combination with homogenisation on the inactivation of Mycobacterium avium subsp. paratuberculosis in milk. Appl. Environ. Microbiol., 71, 2853, 2005. 28. McDonald, W.L. et al. Heat inactivation of Mycobacterium avium subsp. paratuberculosis in milk. Appl. Environ. Microbiol., 71, 1785, 2005. 29. Grant, I.R. et al. Incidence of Mycobacterium paratuberculosis in raw sheep and goats’ milk in England, Wales and Northern Ireland. Vet. Microbiol., 79, 123, 2001. 30. Djonne, B. et al. Detection by immunomagnetic PCR of Mycobacterium avium subsp. paratuberculosis in milk from dairy goats in Norway. Vet. Microbiol., 92, 135, 2003. 31. Muehlherr, J.E. et al. Microbiological quality of raw goat’s and ewe’s bulk-tank milk in Switzerland. J. Dairy Sci., 86, 3849, 2003. 32. Ikonomopoulos, J. et al. Detection of Mycobacterium avium subsp. paratuberculosis in retail cheeses from Greece and the Czech Republic. Appl. Environ. Microbiol., 71, 8934, 2005. 33. Jaravata, et al. Survey of ground beef for the detection of Mycobacterium avium paratuberculosis. Foodborne Pathog. Dis., 4, 102, 2007. 34. Whan, L. et al. Occurrence of Mycobacterium avium subsp. paratuberculosis in untreated water in Northern Ireland. Appl. Environ. Microbiol., 71, 7107, 2005. 35. Pickup, R.W. et al. Mycobacterium avium subsp. paratuberculosis in lake catchments, in river water abstracted for domestic use, and in effluent from domestic sewage treatment works: diverse opportunities for environmental cycling and human exposure. Appl. Environ. Microbiol., 72, 4067, 2006.
Mycobacterium 36. Lambrecht, R.S., Carriere, J.F. and Collins, M.T. A model for analyzing growth kinetics of a slowly growing Mycobacterium sp. Appl. Environ. Microbiol., 54, 910, 1998. 37. Shin, S.J. Report on the committee on Johne’s disease. Proc. Ann. Meet. US Anim. Health Assoc., 93, 380, 1989. 38. Sweeney, R.W., Whitlock, R.H. and McAdams, S.C. Comparison of three DNA preparation methods for real-time polymerase chain reaction confirmation of Mycobacterium avium subsp. paratuberculosis growth in an automated broth culture system. J. Vet. Diag. Invest., 18, 587, 2006. 39. Dundee, L. et al. Comparative evaluation of four decontamination protocols for the isolation of Mycobacterium avium subsp. paratuberculosis from milk. Lett. Appl. Microbiol., 33, 173, 2001. 40. Gao, A. et al. Development of improved method for isolation of Mycobacterium avium subsp. paratuberculosis from bulk tank milk: Effect of age of milk, centrifugation, and decontamination. Can. J. Vet. Res., 69, 81, 2005. 41. Grant, I.R., Ball, H.J. and Rowe, M.T. Incidence of Mycobacterium paratuberculosis in bulk raw and commercially pasteurised cows’ milk from approved dairy processing establishments in the United Kingdom. Appl. Environ. Microbiol., 68, 2428, 2002. 42. Stewart, G.S.A.B. et al. Methods for rapid microbial detection, PCT Patent WO 92/02633, 1992. 43. Wilson S.M. et al. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat. Med., 3, 465, 1997. 44. McNerney, R. et al. Inactivation of mycobacteriophage D29 using ferrous ammonium sulphate as a tool for the detection of viable Mycobacterium smegmatis and M. tuberculosis. Res. Microbiol., 149, 487, 1998. 45. Rees, C.E.D and Loessner, M.J. Phage identification of bacteria. In Practical Handbook of Microbiology, 2nd Ed., pp. 85–99. Goldman., E., and L.H. Green (eds). Boca Raton, Florida: CRC Press, 2008. 46. Rees, C.E.D. and Dodd, C.E.R. Phage for rapid detection and control of bacterial pathogens in food. Adv. Appl. Microbiol., 59, 159, 2006. 47. Stanley, E.C. et al. Development of a new, combined rapid method using phage and PCR for detection and identification of viable Mycobacterium paratuberculosis bacteria within 48 hours. Appl. Environ. Microbiol., 73, 1851, 2007. 48. Kim, S.G. et al. Use of conventional and real-time polymerase chain reaction for confirmation of Mycobacterium avium subsp. paratuberculosis in a broth-based culture system ESP II. J. Vet. Diag. Invest., 16, 448, 2004. 49. Shin, S.J. et al. Development of a polymerase chain reaction test to confirm Mycobacterium avium subsp. paratuberculosis in culture. J. Vet. Diag. Invest., 16, 116, 2004. 50. Secott, T.E. et al. Mycobacterium paratuberculosis detection in bovine feces is improved by coupling agar culture enrichment to an IS900-specific polymerase chain reaction assay. J. Vet. Diag. Invest., 11, 441, 1999. 51. Green, E.P. et al. Sequence and characteristics of IS900, an insertion element identified in a human Crohn’s disease isolate of Mycobacterium paratuberculosis. Nucleic Acid Res., 17, 9063, 1989. 52. Cousins, D.V. et al. Mycobacteria distinct from Mycobacterium avium subsp. paratuberculosis isolated from the faeces of ruminants possess IS900-like sequences detectable by IS900 polymerase chain reaction: implications for diagnosis. Mol. Cell. Probes, 13, 431, 1999.
241 53. Naser, S.A. et al. Occurrence of the IS900 gene in Mycobacterium avium complex derived from HIV patients. Mol. Cell. Probes, 13, 367, 1999. 54. Englund, S., Bölske, G. and Johansson, K.-E. An IS900like sequence found in a Mycobacterium sp. other than Mycobacterium avium subsp. paratuberculosis. FEMS Microbiol. Lett., 209, 267, 2002. 55. Taddei, R. et al. Mycobacterium porcinum strains isolated from bovine bulk milk: implications for Mycobacterium avium subsp. paratuberculosis detection by PCR and culture. Vet. Microbiol., 130, 338, 2008. 56. Bull, T.J. et al. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn’s disease. J. Clin. Microbiol., 41, 2915, 2003. 57. Mobius, P. et al. Comparison of 13 single-round and nested PCR assays targeting IS900, ISMav2, f57 and locus 255 for detection of Mycobacterium avium subsp. Paratuberculosis. Vet. Microbiol., 126, 324, 2008. 58. Bauerfeind, R. et al. Molecular characterization of Mycobacterium paratuberculosis isolates from sheep, goats and cattle by hybridization with a DNA probe to insertion element IS900. J. Clin. Microbiol., 34, 1617, 1996. 59. Poupart, P. et al. Preparation of a specific RNA probe for detection of Mycobacterium paratuberculosis and diagnosis of Johne’s disease. J. Clin. Microbiol., 31, 1601, 1993. 60. Ellingson, J.L.E., Bolin, C.A. and Stabel, J.R. Identification of a gene unique to Mycobacterium avium subsp. paratuberculosis and application to diagnosis of paratuberculosis. Mol. Cell. Probes, 12, 133, 1998. 61. Strommenger, B., Stevenson, K., and Gerlach, G.-F. Isolation and diagnostic potential of ISMav2, a novel insertion sequence-like element from Mycobacterium avium subspecies paratuberculosis. FEMS Microbiol. Lett., 196, 31, 2001. 62. Bannantine, J.P. et al. Genome scale comparison of Mycobacterium avium subsp. paratuberculosis with Mycobacterium avium subsp. avium reveals potential diagnostic sequences. J. Clin. Microbiol., 40, 1303, 2002. 63. Stabel, J.R. and Bannantine, J.P. Development of a nested PCR method targeting a unique multicopy element, ISMap02, for detection of Mycobacterium avium subsp. paratuberculosis in fecal samples. J. Clin. Microbiol., 43, 4744, 2005. 64. Englund, S. et al. Single PCR and nested PCR with a mimic molecule for detection of Mycobacterium avium subsp. paratuberculosis. Diag. Microbiol. Infect. Dis., 33, 163, 1999. 65. Vansnick, E. et al. Newly developed primers for the detection of Mycobacterium avium subspecies paratuberculosis. Vet. Microbiol., 100, 197, 2004. 66. Khare, S. et al. Rapid and sensitive detection of Mycobacterium avium subsp. paratuberculosis in bovine milk and feces by a combination of immunomagnetic bead separation-conventional PCR and real-time PCR. J. Clin. Microbiol., 42, 1075, 2004. 67. Donaghy, J.A. et al. An inter-laboratory ring trial for the detection and isolation of Mycobacterium avium subsp. paratuberculosis from raw milk artificially contaminated with naturally infected faeces. Food Microbiol., 25, 128, 2008. 68. Christopher-Hennings, J. et al. Comparison of two DNA extractions and nested PCR, real-time PCR, a new commercial PCR assay, and bacterial culture for detection of Mycobacterium avium subsp. paratuberculosis in bovine feces. J. Vet. Diag. Invest., 15, 87, 2003.
242 69. Bögli-Stuber, K. et al. Detection of Mycobacterium avium subspecies paratuberculosis in Swiss dairy cattle by realtime PCR and culture: a comparison of two assays. J. Appl. Microbiol., 99, 587, 2005. 70. Fang, Y. et al. Comparison of real-time, quantitative PCR with molecular beacons to nested PCR and culture methods for detection of Mycobacterium avium subsp. paratuberculosis in bovine faecal samples. J. Clin Microbiol., 40, 287, 2002. 71. O’Mahony, J. and Hill, C. A real time PCR assay for the detection and quantitation of Mycobacterium avium subsp. paratuberculosis using SYBR Green and the LightCycler. J. Microbiol. Methods, 51, 283, 2002. 72. Rajeev, S. et al. Evaluation of multiple genomic targets for identification and confirmation of Mycobacterium avium subsp. paratuberculosis isolates using real-time PCR. Vet. Microbiol., 105, 215, 2005. 73. Herthnek, D. and Bolske, G. New PCR systems to confirm real-time PCR detection of Mycobacterium avium subsp. paratuberculosis. BMC Microbiol., 6, 87, 2006. 74. Ballagi-Pordány, A. and Belák, S. The use of mimics as internal standards to avoid false negatives in diagnostic PCR. Mol. Cell. Probes, 10, 159, 1996. 75. Wilson, I.G. Problems with the polymerase chain reaction: inhibition, facilitation, and potential errors in molecular methods. In Methods in Biotechnology, Vol. 14, Food Microbiology Protocols. pp. 427–480. Spencer, J.F.T. and Ragout de Spencer, A.L (eds). Totowa, NJ: Humana Press Inc., 2001. 76. Rodríguez-Lázaro, D. et al. Construction strategy for an internal amplification control for real-time diagnostic assays using nucleic acid sequence-based amplification: development and clinical application. J. Clin. Microbiol., 42, 5832, 2004. 77. Tasara, T., Hoelzle, L.E. and Stephan, R. Development and evaluation of a Mycobacterium avium subspecies paratuberculosis (MAP) specific multiplex PCR assay. Int. J. Food Microbiol., 104, 279, 2005. 78. Tasara, T., and Stephan, R. Development of an F57 sequencebased real-time PCR assay for detection of Mycobacterium avium subsp. paratuberculosis in milk. Appl. Environ. Microbiol., 71, 5957, 2005. 79. Brey, B.J. et al. Design and development of an internal control plasmid for the detection of Mycobacterium avium subsp. paratuberculosis using real-time PCR. Mol. Cell. Probes, 20, 51, 2006. 80. Rodríguez-Lázaro, D. et al. A molecular beacon-based realtime NASBA assay for detection of Mycobacterium avium subsp. paratuberculosis in water and milk. FEMS Microbiol. Letts., 237, 119, 2004. 81. Wu, C. et al. Whole-genome plasticity among Mycobacterium avium subspecies: insights from comparative genomic hybridizations. J. Bacteriol., 188, 711, 2006. 82. Semret, M. et al. Extensive genomic polymorphism within Mycobacterium avium. J. Bacteriol., 186, 6332, 2004. 83. Marsh, I.B. et al. Genomic comparison of Mycobacterium avium subsp. paratuberculosis sheep and cattle strains by microarray hybridization. J. Bacteriol., 188, 2290, 2006. 84. Turenne, C.Y. et al. Mycobacterium avium in the postgenomic era. Clin. Microbiol. Rev., 20, 205, 2007. 85. Giese, S.B. and Ahrens, P. Detection of Mycobacterium avium subsp. paratuberculosis in milk from clinically affected cows by PCR and culture. Vet. Microbiol., 77, 291, 2000. 86. O’Reilly, C.E. et al. Surveillance of bulk raw and commercially pasteurised cows’ milk from approved Irish liquid-milk pasteurisation plants to determine the incidence of Mycobacterium paratuberculosis. Appl. Environ. Microbiol., 70, 5138, 2004.
Molecular Detection of Foodborne Pathogens 87. Pillai, S.R. and Jayarao, B.M. Application of IS900 PCR for detection of Mycobacterium avium subsp. paratuberculosis directly from raw milk. J. Dairy Sci., 85, 1052, 2002. 88. Corti, S. and Stephan, R. Detection of Mycobacterium avium subsp. paratuberculosis specific IS900 insertion sequences in bulk-tank milk samples obtained from different regions throughout Switzerland. BMC Microbiol., 2, 15, 2005. 89. Jayarao, B.M. et al. Evaluation of IS900-PCR assay for detection of Mycobacterium avium subsp. paratuberculosis infection in cattle using quarter milk and bulk tank milk samples. Foodborne Pathog. Dis., 1, 17, 2004. 90. Ayele, W.Y. et al. Mycobacterium avium subsp. paratuberculosis cultured from locally and commercially pasteurised cow’s milk in the Czech Republic. Appl. Environ. Microbiol., 71, 1210, 2005. 91. Bosshard, C., Stephan, R. and Tasara, T. Application of an F57 sequence-based real-time PCR assay for Mycobacterium paratuberculosis detection in bulk tank raw milk and slaughtered healthy dairy cows. J. Food Prot., 69, 1662, 2006. 92. Ellingson, J.L.E. et al. Detection of viable Mycobacterium avium subsp. paratuberculosis in retail pasteurized whole milk by two culture methods and PCR. J. Food Prot., 68, 966, 2005. 93. Millar, D. et al. IS900 PCR to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurized cows’ milk in England and Wales. Appl. Environ. Microbiol., 62, 3446, 1996. 94. Gao, A. et al. Improved template DNA preparation procedure for detection of Mycobacterium avium subsp. paratuberculosis in milk by PCR. J. Microbiol. Methods, 69, 417, 2007. 95. Odumeru, J. et al. Use of the bead beater for preparation of Mycobacterium paratuberculosis template DNA in milk. Can. J. Vet. Res., 65, 201, 2001. 96. Özbek, A. et al. Evaluation of two recovery methods for detection of Mycobacterium avium subsp. paratuberculosis by PCR: Direct-dilution-centrifugation and C18-carboxypropylbetaine processing. FEMS Microbiol. Lett., 229, 145, 2003. 97. Antognoli, M.C. et al. A one-tube nested polymerase chain reaction for the detection of Mycobacterium bovis in spiked milk samples: an evaluation of concentration and lytic techniques. J. Vet. Diagn. Invest., 13, 111, 2001. 98. Grant, I.R., Ball, H.J. and Rowe, M.T. Isolation of Mycobacterium paratuberculosis from milk by immunomagnetic separation. Appl. Environ. Microbiol., 64, 3153, 1998. 99. Grant, I.R. et al. Improved detection of Mycobacterium avium subsp. paratuberculosis in milk by immunomagnetic PCR. Vet. Microbiol., 77, 369, 2000. 100. Metzger-Boddien, C. et al. Automated high-throughput immunomagnetic separation-PCR for detection of Mycobacterium avium subsp. paratuberculosis in bovine milk. Int. J. Food Microbiol., 110, 201, 2006. 101. Stratmann, J. et al. Peptide aMptD-mediated capture PCR for detection of Mycobacterium avium subsp. paratuberculosis in bulk milk samples. Appl. Environ. Microbiol., 72, 5150, 2006. 102. Stratmann, J. et al. Development of a peptide-mediated capture PCR for detection of Mycobacterium avium subsp. paratuberculosis in milk. J. Clin. Microbiol., 40, 4244, 2002. 103. Halldórsdóttir, S. et al. Detection of Mycobacterium avium subsp. paratuberculosis by buoyant density centrifugation, sequence capture PCR and dot blot hybridisation. Vet. Microbiol., 87, 327, 2002. 104. Vansnick, E. et al. A DNA sequence capture extraction method for detection of Mycobacterium avium subsp. paratuberculosis in feces and tissue samples. Vet. Microbiol., 122, 166, 2007.
Mycobacterium 105. Kim, S.G. et al. Development and application of quantitative polymerase chain reaction assay based on the ABI 7700 system (TaqMan) for detection and quantification of Mycobacterium avium subsp. paratuberculosis. J. Vet. Diag. Invest., 14, 126, 2002. 106. Vary, P.H. et al. Use of highly specific DNA probes and the polymerase chain reaction to detect Mycobacterium paratuberculosis in Johne’s disease. J. Clin. Microbiol., 28, 933, 1990. 107. Moss, M.T. et al. Specific detection of Mycobacterium paratuberculosis by DNA hybridisation with a fragment of the insertion element IS900. Gut, 32, 395, 1991. 108. Moss, M.T. et al. Polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp silvaticum in long term cultures from Crohn’s disease and control tissues. Gut, 33, 1209, 1992. 109. Doran, T.J. et al. Putative functional domain within ORF2 on the Mycobacterium insertion sequences IS900 and IS902. Immun. Cell. Biol., 72, 427, 1994.
243 110. Ellingson, J.L.E. et al. Evaluation of the accuracy and reproducibility of a practical PCR panel assay for rapid detection and differentiation of Mycobacterium avium subspecies. Mol. Cell. Probes, 14, 153, 2000. 111. O’Mahony, J. and Hill, C. Rapid real-time PCR assay for detection and quantitation of Mycobacterium avium subsp. paratuberculosis DNA in artificially contaminated milk. Appl. Environ. Microbiol., 70, 4561, 2004. 112. Rodríguez-Lázaro, D. et al. Real-time PCR-based methods for detection of Mycobacterium avium subsp. paratuberculosis in water and milk. Int. J. Food Microbiol., 101, 93, 2005. 113. Ravva, S.V. and Stanker, L.H. Real-time quantitative PCR detection of Mycobacterium avium subsp. paratuberculosis and differentiation from other mycobacteria using SYBR Green and TaqMan assays. J. Microbiol. Methods, 63, 305, 2005. 114. Wells, S.J. et al. Evaluation of a rapid fecal PCR test for detection of Mycobacterium avium subsp. paratuberculosis in dairy cattle. Clin. Vacc. Immunol., 13, 1125, 2006.
18 Staphylococcus
Paolo Moroni, Giuliano Pisoni University of Milan
Paola Cremonesi, Bianca Castiglioni
Institute of Agricultural Biology and Biotechnology
Contents 18.1 Introduction.................................................................................................................................................................... 245 18.1.1 Morphology and Biology.................................................................................................................................. 245 18.1.2 Pathogenesis and Clinical Features.................................................................................................................. 246 18.1.3 Conventional Testing........................................................................................................................................ 247 18.1.4 Molecular Testing............................................................................................................................................. 247 18.1.4.1 Standard PCR.................................................................................................................................. 247 18.1.4.2 Multiplex PCR ................................................................................................................................ 249 18.1.4.3 Real-Time PCR ............................................................................................................................... 250 18.2 Methods.......................................................................................................................................................................... 252 18.2.1 Reagents and Equipment................................................................................................................................... 252 18.2.2 Sample Collection and Preparation.................................................................................................................. 252 18.2.2.1 Sample Collection............................................................................................................................ 252 18.2.2.2 Sample Pretreatment........................................................................................................................ 253 18.2.2.3 DNA Extraction............................................................................................................................... 253 18.2.3 Detection Procedure......................................................................................................................................... 253 18.3 Conclusions and Further Perspectives............................................................................................................................ 254 References.................................................................................................................................................................................. 255
18.1 Introduction 18.1.1 Morphology and Biology Being a Gram-positive coccus in the genus Staphylococcus, Staphylococcus aureus tends to be arranged in irregular clusters or grape-like clusters when viewed through a microscope and has large, round, golden-yellow colonies, often with hemolysis, when grown on blood agar plates. The golden appearance is the etymological root of the bacteria’s name: the name derived from Greek staphylo (bunch of grapes) and aureus means “golden” in Latin. S. aureus is a facultative anaerobe (fermentative) with the following main features: (i) it can grow at an aw of 0.86 and pH above 4.81 and within the temperature range 7–48°C with an optimum of 35–40°C; (ii) it is catalase positive (meaning that it can produce the enzyme “catalase”) and able to convert hydrogen peroxide (H2O2) to water and oxygen, which makes the catalase test useful to distinguish staphylococci from enterococci and streptococci; (iii) it is oxidase negative; and (iv) it is nonmotile. S. aureus can be differentiated easily from most other staphylococci by its ability to produce coagulase and a heat-stable endonuclease. S. aureus is primarily coagulase-positive (CPS) (meaning that it can produce the enzyme “coagulase” that causes clot formation) while most other Staphylococcus
species are coagulase-negative (CNS). However, while the majority of S. aureus strains are CPS, some may be atypical and do not produce coagulase enzyme. Members of the S. aureus species produce a number of extracellular compounds including membrane-damaging toxins, epidermolytic toxin, toxic shock syndrome toxin, pyrogenic exotoxin, exoenzymes (coagulase and thermostable nuclease) and staphylococcal enterotoxins (SE). The natural reservoirs for S. aureus are the skin and the mucous membrane of humans and animal. Many staphylococcal species have become adapted to life on particular animal species but, in contrast, S. aureus is present on most marine and terrestrial mammals, and may be present as a nonaggressive member of the normal skin microflora or may be associated with infectivity and disease. Up to 30–50% of the human population are carriers of S. aureus; the body sites most often colonized are the nostrils, throat, hair, and hands. This organism may also be isolated from healthy domestic and food animals as well as being associated with disease, particularly mastitis. S. aureus strains have been classified into biotypes according to their human or animal origin: six different biotypes (human, non-β-hemolytic human, avian, bovine, ovine, and nonspecific) have been identified based on biochemical characteristics.2 245
246
Molecular Detection of Foodborne Pathogens
18.1.2 Pathogenesis and Clinical Features Staphylococcal food poisoning (SFP) relies on one single type of virulence factor: the SEs. The SEs are a group of extracellular protein with molecular weights in the range of 27000–30000 Daltons, and similar composition and biological activity. To date, 19 types of staphylococcal SEs have been described.3 On the basis of their antigenicity and mode of action in the host, SEs have been divided into two groups. The members of group 1, classical emetic toxins designated SEA, SEB, SEC1, SECbov, SED, and SEE, are the cause of about 95% of SFP in humans.4 These toxins are resistant to gastrointestinal proteases and after their intestinal absorption, the patient can develop symptoms of food poisoning, depending on the SE amount ingested.4,5 Group 2, includes toxins possibly involved in the remaining 5% of SFP outbreaks, i.e., the recently identified SEs, designated SEG, SEH, SEI, SEJ, SEK, SEL, SEM, SEN, SEO, SEP, SEQ, SER, and SEU,6–12 the emetic activities of which are not currently fully understood (Table 18.1). The symptoms of SFP are abdominal cramps, nausea, vomiting, sometimes followed by diarrhea.6 The onset of symptoms is rapid (from 30 min to 8 h) and spontaneous remission is usually observed after 24 h. Hospitalization is required in approximately 10% of the cases.13 In all cases of SFP, the foodstuff or one of the ingredients was contaminated with a SE-producing S. aureus strain and was exposed, at least for a while, to temperatures that allow S. aureus growth. Most of the time the foodstuff reaches this temperature because of a failure in the refrigeration process, or because a growth-permissive temperature is required during processing (e.g., cheese making). Many different foods can be a good growth medium for S. aureus, and have been implicated in SFP, including milk and cream, cream-filled pastries, butter, ham, cheeses, sausages, canned meat, salads, cooked meals and sandwich fillings. The foods that are most often involved in SFP differ widely from one country to another. In the United Kingdom,
Table 18.1 Major Characteristics of 18 Staphylococcal Enterotoxins (SE) SE Type A B C1 C2 C3 C (bovine) C (sheep) C (goat) D E G
Reference [119] [120] [121] [122] [123] [124] [124] [124] [125] [126] [127]
SE Type H I J K L M N O P Q R
Reference [128] [127] [129] [130] [131] [7] [7] [7] [132] [133] [134]
U
[135]
for example, 53% of the SFP reported between 1969 and 1990 were due to meat products, meat-based dishes, and especially ham; 22% of the cases were due to poultry, and poultry-based meals, 8% were due to milk products, 7% to fish and shellfish and 3.5% to eggs.14 In France, in a 2-year period (1999–2000), among the cases of SFP in which the food involved had been identified, milk products and especially cheeses were responsible for 32% of the cases, meats for 22%, sausages and pies for 15%, fish and seafood for 11%, eggs and egg products for 11% and poultry for 9.5%.15 In the United States, among the SFP cases reported between 1975 and 1982, 36% were due to red meat, 12.3% to salads, 11.3% to poultry, 5.1% to pastries and only 1.4% to milk products and seafoods. In 17.1% of the cases, the food involved was unknown.16 During a 5-year period (1988–1992), S. aureus caused 5.1% of the food poisoning outbreaks reported in Europe17 and in Italy it caused four of the 233 outbreaks reported. S. aureus has been isolated from several foods: meat and meat products, chicken, milk, and dairy products, fermented food items, vegetables, fish products, etc.14,18 Salted food products, such as ham, have been reported to be responsible for about 24% of all the cases of staphylococcal intoxication.19 Thus, the origins of SFP differ widely among countries; this may be due to differences in the consumption and food habits in each of the countries. In France, for example, the consumption of raw milk cheeses is much higher than in Anglo-Saxon countries. This may explain the relative importance of milk products involved in SFP in France. In any case, the main sources of contamination are humans (handlers contaminate food via manual contact or via the respiratory tract by coughing and sneezing), and contamination occurs after heat treatment of the food. Nevertheless, in foods such as raw meat, sausages, raw milk, and raw milk cheese, contaminations from animal origins are more frequent and due to animal carriage or to infections (e.g., mastitis). Some S. aureus strains, so-called ‘‘endemic strains’’, are present in some processing plants, such as poultry processing lines,20–22 consequently food products may originally become contaminated during or after processing. However, the presence of large numbers of staphylococci is not sufficient cause to incriminate a specific food as the vehicle of food poisoning because not all staphylococci are enterotoxigenic. In addition, demonstration of enteroxigenicity of food isolates is only circumstantial evidence of enterotoxigenic staphylococcal contamination and the potential for causing food poisoning cannot be ascertained without demonstrating the actual presence of the SE in a suspect food. Conversely, neither the absence of S. aureus nor the presence of small numbers of bacteria is complete assurance that the food is safe (because the SE is extremely resistant and may survive processes which kill the bacterial cells). Concerning S. aureus in food, it should be noted that only the enterotoxinogenic strains possess a risk to public health and the criteria applied should prevent the production of SE during processing and the occurrence of SE in the final product. It is generally considered that enterotoxinogenic staphylococci must reach levels of at least 105–106 cfu/g or ml to
Staphylococcus
produce detectable amounts of SE and, in Europe, low degree contaminations by S. aureus are tolerated in most foodstuffs (up to 104 cfu/g in raw milk cheeses, in France), as they are not considered a risk for public health.
18.1.3 Conventional Testing Risk assessment in foodstuffs relies on classical microbial detection and quantification of CPS staphylococci on a selective Baird-Parker medium, whose composition is standardized (EN ISO 6888/1 and 2).23,24 The sensitivity of these routine tests is around 102 cfu/g for solid foodstuffs and 10 cfu/g for liquid samples. The different media used for the detection and quantification of S. aureus have been reviewed by Baird and Lee.25 Food testing using microbiological criteria may have limited usefulness for food safety for a number of reasons, including low prevalence of the pathogen, or low diagnostic sensitivity of the testing procedure applied. While the finding of a pathogen in a foodstuff may indicate a problem for public health, necessitating appropriate risk management action; the failure on the other hand to detect a pathogen in a food product does not necessarily mean that the pathogen is absent from that food product, process or food lot.
18.1.4 Molecular Testing Use of DNA-based assays may circumvent some of the problems associated with conventional microbiological procedures. Perhaps the greatest single advantage of DNAbased diagnostic assays is that these methods focus on the unique nucleic acid composition of the bacterial genome rather than on phenotypic expression of products that nucleic acids encode. Therefore, DNA-based identification assays are subject to less variability compared with diagnostic methods based on phenotypic characterization, allowing reliable detection and quantification down to one single nucleic acid target per PCR sample. Moreover, not only the presence of the pathogen but also of the genes encoding for SEs production is important to evaluate as enterotoxins nonproducing strains may also occur. 18.1.4.1 Standard PCR Many polymerase chain reaction (PCR) protocols have been developed for the direct detection or for identification of S. aureus in milk and dairy products.26–33 These PCR methods allow identification of bacteria within hours. However, the sensitivities of PCR assay often vary with different DNA extraction methods, suggesting that the DNA extraction protocols are important for optimization of the assay if it is to be applied to food.34 Consequently, the development of a sample preparation strategy that can effectively sequester high-quality DNA of the pathogenic bacteria from food samples before PCR amplification is needed. Indeed, molecular procedures require highly purified template DNA.35,36 In addition, the PCR-based detection of pathogens is made more difficult when raw material with high
247
level of background microflora or complex food matrices are involved.18,37 First, these difficulties could be due to small concentrations of the pathogenic DNA present in a typical sample. Second, various factors affect DNA recovery, including the degree of cellular lysis, binding of DNA to particulate material, and degradation or shearing of DNA. Furthermore, in the case of Gram-positive bacteria such as S. aureus and streptococci, an optimal sample processing method should efficiently lyse resistant bacterial cell walls without damaging target DNA. In addition, direct detection of pathogenic bacteria in food samples38 is hampered by the presence of PCR-inhibitory substances frequently associated with the food matrix itself.39 Particularly in milk, components such as Ca2 + , proteinase, fats, and milk proteins may block DNA and shield it from access by polymerase.40 Breaking down casein and the casein micelle with the enzyme pronase would allow better access to the bacteria for lysis by lysozyme and proteinase K.35 Moreover, cheeses are often regarded as difficult matrices to be assayed by PCR because of the high fat content18,40 which is reported to be one of the major factors reducing the sensitivity of the PCR assay.39 Finally, it is possible that the poor sensitivity of detection of S. aureus is caused by the abundance of DNA extracted from the background microflora of the raw milk acting as inhibiting competitor in PCR reactions. In this case false positive results may occur because of parallel amplification of target genes, such as the regions coding for ribosomal RNA (rRNA), from closely related species.41 To overcome PCR inhibition problems and to increase the sensitivity of the assay, overnight selective-enrichment was frequently used to increase the level of pathogen detection.31,32,34,38 After the enrichment step, sufficient bacteria were present to allow pathogens to be detected when the original sample had as little as 1 cfu/ml. The higher sensitivity of the assay may be due to the dilution of inhibitory substances in the enrichment broth and the increased number of organisms.32 In milk samples, another effect of enrichment before PCR may be the reduced detection of DNA from nonviable bacteria. However, although the prior enrichment step increases the target concentration, it precludes quantification.36,42,43 The vast number of procedures used for this purpose and articles published focusing on this topic indicate that these problems are still far from being solved.44–49 Therefore, the separation and concentration of foodborne pathogens directly from food samples without culture enrichment represent two of the most important aspects of sample preparation. Methods for separating bacteria directly from a food matrix and then concentrating them depend on several chemical, physical, and biological principles. Numerous methods for isolating bacterial DNA directly from milk have been reported in the literature and involve a wide variety of substances including Chelex-100,28 spin columns,29,32,33 lysozyme and proteinase K,31 diatomaceous earth,50 alkaline extraction,30 and pronase.48,51 Methods that use proprietary reagents such as Insta-Gene Matrix (BioRad) and PrepMan Ultra reagent (Applied Biosystems) were also evaluated. Although these
248
reagents were faster and more convenient than other methods evaluated, results were not consistent and reproducible when trying to isolate bacterial DNA from milk.52 The method first described by Allmann and coworkers48 and modified by Hein coworkers51 was one of the most consistent and reproducible system evaluated for isolation of bacteria directly from whole milk samples. Even a buoyant density gradient centrifugation were recently used to separate bacteria from complex food matrices, as well as to remove compounds that inhibit rapid detection methods, such as PCR, and to prevent false-positive results due to DNA originating from dead cells.53 A specific, sensitive, and rapid method to extract DNA directly from the main Gram-positive bacteria (including S. aureus) found in milk and raw cheese samples was also described by Cremonesi and coworkers.54,55 The DNA extraction method is based on the lysing and nuclease-inactivating propertie